Citrus Sinensis ID: 015731
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | 2.2.26 [Sep-21-2011] | |||||||
| Q06548 | 410 | Protein kinase APK1A, chl | yes | no | 0.895 | 0.875 | 0.690 | 1e-146 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.955 | 0.929 | 0.649 | 1e-144 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.890 | 0.917 | 0.675 | 1e-144 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.882 | 0.896 | 0.662 | 1e-139 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.857 | 0.884 | 0.626 | 1e-132 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.830 | 0.675 | 0.630 | 1e-128 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.830 | 0.781 | 0.632 | 1e-127 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.822 | 0.673 | 0.636 | 1e-125 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.802 | 0.755 | 0.624 | 1e-123 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.820 | 0.802 | 0.595 | 1e-114 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 516 bits (1330), Expect = e-146, Method: Compositional matrix adjust.
Identities = 250/362 (69%), Positives = 291/362 (80%), Gaps = 3/362 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + +GA++K KD G+ GS + SV PRTEGEIL N+KSFSF
Sbjct: 1 MGICLSAQVKAE-SSGASTKYDAKD-IGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSF 58
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK+ATRNFRPDSVLGEGGFGCVFKGWIDE + +RPGTG+VIAVK+LNQ+ QGH E
Sbjct: 59 AELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQE 118
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
WL E+ +LGQ H +LVKLIGYCLED+HRLLVYEFMP+GSLENHLFR G Y QPLSW +
Sbjct: 119 WLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGL-YFQPLSWKL 177
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
R+KVALGAAKGLA+LHS + +VIYRDFKTSNILLD YNAKLSDFGLAKDGP G +SHVS
Sbjct: 178 RLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVS 237
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
TRVMGT+GYAAPEY+ATGHLT KSDVYSFGVVLLE+LSGRR +DKNRPS E NL+EWAKP
Sbjct: 238 TRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKP 297
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
YL +KR+IF+V+D R++ QYS+ A K A L+++CL+ E K RP M EVV LE IQ N
Sbjct: 298 YLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLN 357
Query: 361 DA 362
A
Sbjct: 358 AA 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1317), Expect = e-144, Method: Compositional matrix adjust.
Identities = 250/385 (64%), Positives = 297/385 (77%), Gaps = 2/385 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + P GA+ K + N + GS S S+ PRTEGEIL N+KSF+F
Sbjct: 1 MGICLSAQIKAVSP-GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTF 59
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK ATRNFRPDSVLGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH E
Sbjct: 60 AELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQE 119
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
WL E+ +LGQ HPNLVKLIGYCLED+HRLLVYEFMP+GSLENHLFR G SY QPLSWT+
Sbjct: 120 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG-SYFQPLSWTL 178
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
R+KVALGAAKGLA+LH+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVS
Sbjct: 179 RLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVS 238
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
TR+MGTYGYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRR +DKNRP E L+EWA+P
Sbjct: 239 TRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARP 298
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
L +KR++F+V+D R++ QYS+ A K A LA++CL+ E K RP M+EVV LE IQ N
Sbjct: 299 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLN 358
Query: 361 DAGVSRDESLQNSDRSTYKRKGLNE 385
+AG + +Q R +N+
Sbjct: 359 EAGGRNIDMVQRRMRRRSDSVAINQ 383
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 246/364 (67%), Positives = 297/364 (81%), Gaps = 7/364 (1%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG + GSS+ +S S +PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDG--SKGSST--ASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFR G Y QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFY-QPLSW 175
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SH
Sbjct: 176 NTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSH 235
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGT GYAAPEY+ATGHL+ KSDVYSFGVVLLE+LSGRR IDKN+P EHNL++WA
Sbjct: 236 VSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWA 295
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+PYL +KRR+ +VMD R++GQYSL ALK AVLA+ C+S + K RPTM+E+VK +E++
Sbjct: 296 RPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHI 355
Query: 359 TNDA 362
+A
Sbjct: 356 QKEA 359
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1270), Expect = e-139, Method: Compositional matrix adjust.
Identities = 237/358 (66%), Positives = 288/358 (80%), Gaps = 4/358 (1%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G S S S+V+ +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGLSLS-SRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFR GA Y +PL W +
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGA-YFKPLPWFL 176
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
R+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VS
Sbjct: 177 RVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVS 236
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
TRVMGTYGYAAPEYM++GHL A+SDVYSFGV+LLE+LSG+R +D NRP++E NL++WA+P
Sbjct: 237 TRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARP 296
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
YL SKR++ ++D R++ QY A++ A +A++CLS EPK RPTMD+VV+AL+Q+QD
Sbjct: 297 YLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 223/356 (62%), Positives = 275/356 (77%), Gaps = 12/356 (3%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
+TEGEIL + +KSFSFN LK ATRNFR DSV+GEGGFGCVF+GW+DE T P + +G+
Sbjct: 35 KTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGL 94
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
VIAVKRLN + QGH EWLTEI +LGQL HPNLVKLIGYCLED+ RLLVYEFM KGSLEN
Sbjct: 95 VIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLEN 154
Query: 164 HLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223
HLF G +PLSW +R+KVAL AAKGLA+LHSD KVIYRD K SNILLD ++NAKLS
Sbjct: 155 HLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLS 214
Query: 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 283
DFGLA+DGP G QS+VSTRVMGT+GYAAPEY++TGHL A+SDVYSFGVVLLE+L GR+ +
Sbjct: 215 DFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQAL 274
Query: 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343
D NRP++E NL++WA+PYL S+R++ ++D R+ QY A++ A +A++CLS EPK R
Sbjct: 275 DHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSR 334
Query: 344 PTMDEVVKALEQIQDTNDAGVSRDE----------SLQNSDRSTYKRKGLNENGQG 389
PTMD+VV+AL Q+QD+ + D L+ D+ Y+R GLN+ G
Sbjct: 335 PTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVGLKTEDK--YQRNGLNKKTVG 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1176), Expect = e-128, Method: Compositional matrix adjust.
Identities = 213/338 (63%), Positives = 264/338 (78%), Gaps = 5/338 (1%)
Query: 29 TSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGW 88
++ ++S S S P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGW
Sbjct: 101 STTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGW 160
Query: 89 IDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148
I+E+ AP +PGTG+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD
Sbjct: 161 IEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQ 220
Query: 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDF 207
RLLVYEFMP+GSLENHLFR PL W+IRMK+ALGAAKGL++LH + K VIYRDF
Sbjct: 221 RLLVYEFMPRGSLENHLFRRSL----PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDF 276
Query: 208 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVY 267
KTSNILLD +YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVY
Sbjct: 277 KTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 336
Query: 268 SFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALK 327
SFGVVLLEML+GRR +DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K
Sbjct: 337 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQK 396
Query: 328 TAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365
LA +CLS +PK RP M +VV+AL+ + D S
Sbjct: 397 VTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASS 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 213/337 (63%), Positives = 266/337 (78%), Gaps = 4/337 (1%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRTEGEIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+
Sbjct: 55 TPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGS 114
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+V+AVK+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSL
Sbjct: 115 GIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSL 174
Query: 162 ENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221
ENHLFR GA QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+K
Sbjct: 175 ENHLFRRGA---QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSK 231
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAK GPTG ++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRR
Sbjct: 232 LSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRR 291
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
+DK++ E +L++WA PYL KR++F++MD R+ GQY A A LA++CL+ + K
Sbjct: 292 AVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAK 351
Query: 342 FRPTMDEVVKALEQIQDTNDA-GVSRDESLQNSDRST 377
RP M EV+ L+Q++ T GV ++ +S R +
Sbjct: 352 LRPKMSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGS 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 214/336 (63%), Positives = 263/336 (78%), Gaps = 6/336 (1%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
+ T+ +S+ SS+S P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFK
Sbjct: 94 SSTTTTSNAESSLST-PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFK 152
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
GW++E+ AP +PGTG+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+ED
Sbjct: 153 GWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIED 212
Query: 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYR 205
D RLLVYEFMP+GSLENHLFR PL W+IRMK+ALGAAKGL++LH + K VIYR
Sbjct: 213 DQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRMKIALGAAKGLSFLHEEALKPVIYR 268
Query: 206 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSD 265
DFKTSNILLD YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSD
Sbjct: 269 DFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSD 328
Query: 266 VYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAA 325
VYSFGVVLLEML+GRR +DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A
Sbjct: 329 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGA 388
Query: 326 LKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361
K LA +CLS + K RP M EVV+ L+ + D
Sbjct: 389 QKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 203/325 (62%), Positives = 256/325 (78%), Gaps = 3/325 (0%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
RTEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+
Sbjct: 60 RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
V+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 164 HLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223
HLFR GA QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLS
Sbjct: 180 HLFRRGA---QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLS 236
Query: 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 283
DFGLAK GPTG +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRR +
Sbjct: 237 DFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAM 296
Query: 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343
D + E++L++WA PYL KR++F++MD ++ GQY A A LA++CL+ + K R
Sbjct: 297 DNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLR 356
Query: 344 PTMDEVVKALEQIQDTNDAGVSRDE 368
P M EV+ LEQ++ G +
Sbjct: 357 PKMSEVLVTLEQLESVAKPGTKHTQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/341 (59%), Positives = 252/341 (73%), Gaps = 12/341 (3%)
Query: 22 SRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGF 81
SR + + S+ R S P + +++ F+ L+T T++FRPD +LGEGGF
Sbjct: 27 SRSVSDLSDPSTPRFRDDSRTPISYAQVI------PFTLFELETITKSFRPDYILGEGGF 80
Query: 82 GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIG 141
G V+KG+ID++ + + +AVK LN+E LQGH EWLTE+ LGQL HPNLVKLIG
Sbjct: 81 GTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIG 137
Query: 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 201
YC EDDHRLLVYEFM +GSLENHLFR + PLSW+ RM +ALGAAKGLA+LH+ +
Sbjct: 138 YCCEDDHRLLVYEFMLRGSLENHLFRKTTA---PLSWSRRMMIALGAAKGLAFLHNAERP 194
Query: 202 VIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT 261
VIYRDFKTSNILLD +Y AKLSDFGLAK GP G ++HVSTRVMGTYGYAAPEY+ TGHLT
Sbjct: 195 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 254
Query: 262 AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS 321
A+SDVYSFGVVLLEML+GR+ +DK RPS+E NL++WA+P L KR++ Q++D R+E QYS
Sbjct: 255 ARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYS 314
Query: 322 LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362
+ AA K LA CLS PK RP M +VV+ LE +Q T DA
Sbjct: 315 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | ||||||
| 255584865 | 410 | Protein kinase APK1B, chloroplast precur | 0.982 | 0.960 | 0.730 | 1e-169 | |
| 224112765 | 415 | predicted protein [Populus trichocarpa] | 0.987 | 0.954 | 0.743 | 1e-166 | |
| 356501055 | 392 | PREDICTED: protein kinase APK1A, chlorop | 0.925 | 0.946 | 0.759 | 1e-165 | |
| 255637885 | 392 | unknown [Glycine max] | 0.925 | 0.946 | 0.757 | 1e-164 | |
| 356501057 | 390 | PREDICTED: protein kinase APK1A, chlorop | 0.920 | 0.946 | 0.754 | 1e-164 | |
| 356551743 | 399 | PREDICTED: protein kinase APK1A, chlorop | 0.910 | 0.914 | 0.753 | 1e-161 | |
| 449450018 | 401 | PREDICTED: protein kinase APK1A, chlorop | 0.957 | 0.957 | 0.703 | 1e-160 | |
| 357492229 | 418 | Serine/threonine protein kinase [Medicag | 0.987 | 0.947 | 0.692 | 1e-159 | |
| 224106475 | 391 | predicted protein [Populus trichocarpa] | 0.955 | 0.979 | 0.695 | 1e-158 | |
| 224098423 | 368 | predicted protein [Populus trichocarpa] | 0.807 | 0.880 | 0.821 | 1e-158 |
| >gi|255584865|ref|XP_002533148.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223527043|gb|EEF29229.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1547), Expect = e-169, Method: Compositional matrix adjust.
Identities = 298/408 (73%), Positives = 337/408 (82%), Gaps = 14/408 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MGSCFS + +SPL +GA+ + K G+ SGSSS V S PRTEGEIL SN+KSF
Sbjct: 1 MGSCFSVRIKAESPLHHGADPRNRSKGGHDVSGSSSAVPST---PRTEGEILQSSNLKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
SFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG+VIAVKRLNQE QGH
Sbjct: 58 SFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGIVIAVKRLNQEGFQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWL EI +LGQL HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR ASY+QPLSW
Sbjct: 118 QEWLAEINYLGQLDHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-ASYVQPLSW 176
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+R+++AL AAKGLA+LHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+SH
Sbjct: 177 NLRIQIALDAAKGLAFLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSKSH 236
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLEM+SGRR IDKNRPSRE NL+EWA
Sbjct: 237 VSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEMISGRRAIDKNRPSREQNLVEWA 296
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+PYL +KR+IFQVMDAR+EGQYSL ALK A LA++C+S EP+FRP M+EVVKALEQ+ +
Sbjct: 297 RPYLGNKRKIFQVMDARVEGQYSLKDALKVANLAVQCISPEPRFRPKMEEVVKALEQLLE 356
Query: 359 TND---AGVSRDESLQNSDRST-----YKRKGLNENGQGKASVHHRPS 398
+ND + SR ESL+ +R++ Y RK E GKA+ + RPS
Sbjct: 357 SNDNEGSRGSRHESLRKVNRNSNNGPRYHRKSTAETCDGKAASYPRPS 404
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112765|ref|XP_002316286.1| predicted protein [Populus trichocarpa] gi|222865326|gb|EEF02457.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1524), Expect = e-166, Method: Compositional matrix adjust.
Identities = 304/409 (74%), Positives = 338/409 (82%), Gaps = 13/409 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MGSCFSA + +SP NG N+K + K GN SGSSS+VSS +V PRT+GEIL SN+K
Sbjct: 1 MGSCFSARIKAESPSRNGGNTKYAGKGGNDKSGSSSKVSSSTVPSTPRTQGEILQSSNLK 60
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SFSF+ LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG VIAVKRLNQES Q
Sbjct: 61 SFSFSELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGTVIAVKRLNQESSQ 120
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPL 176
GH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR ASY QPL
Sbjct: 121 GHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-ASYFQPL 179
Query: 177 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
SW +RMKVAL AAKGL YLHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+
Sbjct: 180 SWNLRMKVALDAAKGLEYLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSK 239
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
SHVSTR+MGTYGYAAPEYMATGHLTA+SDVYSFGVVLLEMLSGRR IDKNRPS+EHNL+E
Sbjct: 240 SHVSTRIMGTYGYAAPEYMATGHLTARSDVYSFGVVLLEMLSGRRAIDKNRPSKEHNLVE 299
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
WA+PYL SKRRIFQVMDARI+GQYS ALK A LAI+CLS EPK+RP M+ VVKALEQ+
Sbjct: 300 WARPYLSSKRRIFQVMDARIQGQYSSSDALKAANLAIQCLSTEPKYRPNMEAVVKALEQL 359
Query: 357 QDTND---AGVSRDESLQNSDRST-----YKRKGLNENGQGKASVHHRP 397
++ND + SR E+ + +RS+ Y RK + E GK + + P
Sbjct: 360 HNSNDNDGSKGSRGENPRRVNRSSSNGPKYHRKNVKEVSNGKPASYAGP 408
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501055|ref|XP_003519344.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/379 (75%), Positives = 318/379 (83%), Gaps = 8/379 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFR ASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRR-ASYFQPLSW 178
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SH
Sbjct: 179 NIRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSH 238
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIEWA
Sbjct: 239 VSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIEWA 298
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
KPYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD
Sbjct: 299 KPYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQD 358
Query: 359 TND----AGVSRDESLQNS 373
++D G SRD++ + S
Sbjct: 359 SDDRVGGVGSSRDQTTRRS 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255637885|gb|ACU19261.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1503), Expect = e-164, Method: Compositional matrix adjust.
Identities = 287/379 (75%), Positives = 317/379 (83%), Gaps = 8/379 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFR ASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRR-ASYFQPLSW 178
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SH
Sbjct: 179 NIRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSH 238
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++ G+R +D NRPS EHNLIEWA
Sbjct: 239 VSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMFGKRALDSNRPSGEHNLIEWA 298
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
KPYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD
Sbjct: 299 KPYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQD 358
Query: 359 TND----AGVSRDESLQNS 373
++D G SRD++ + S
Sbjct: 359 SDDRVGGVGSSRDQTTRRS 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501057|ref|XP_003519345.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/379 (75%), Positives = 315/379 (83%), Gaps = 10/379 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG C +DG + S+ SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGNYHSCKEEDGLSSKASTP---SVPPTPRTEGEILKSSNMKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 58 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFR ASY QPLSW
Sbjct: 118 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRR-ASYFQPLSW 176
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SH
Sbjct: 177 NIRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSH 236
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIEWA
Sbjct: 237 VSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIEWA 296
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
KPYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD
Sbjct: 297 KPYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQD 356
Query: 359 TND----AGVSRDESLQNS 373
++D G SRD++ + S
Sbjct: 357 SDDRVGGVGSSRDQTTRRS 375
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551743|ref|XP_003544233.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-161, Method: Compositional matrix adjust.
Identities = 284/377 (75%), Positives = 316/377 (83%), Gaps = 12/377 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVS--VVPRTEGEILLGSNIK 56
MG C SA + +SP NG +SK K+ +G S S+VS+ S PRTEGEIL SN+K
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLS---SKVSTPSDPPTPRTEGEILKSSNMK 57
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SF+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQ
Sbjct: 58 SFNFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQ 117
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPL 176
GH EWLTEI +LGQL HPNLVKLIGYCLEDD RLLVYEF+ KGSL+NHLFR ASY QPL
Sbjct: 118 GHSEWLTEINYLGQLRHPNLVKLIGYCLEDDQRLLVYEFLTKGSLDNHLFRR-ASYFQPL 176
Query: 177 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
SW RMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +
Sbjct: 177 SWNFRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDK 236
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
SHVSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIE
Sbjct: 237 SHVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIE 296
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
WAKPYL +KRRIFQVMDARIEGQY+L ++K A LAI+CLS EP+FRP MDEVV+ALE++
Sbjct: 297 WAKPYLSNKRRIFQVMDARIEGQYTLRESMKVANLAIQCLSVEPRFRPKMDEVVRALEEL 356
Query: 357 QDTND----AGVSRDES 369
QD+ D G SRD++
Sbjct: 357 QDSEDRAGGVGSSRDQT 373
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450018|ref|XP_004142761.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] gi|449527906|ref|XP_004170949.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1474), Expect = e-160, Method: Compositional matrix adjust.
Identities = 282/401 (70%), Positives = 331/401 (82%), Gaps = 17/401 (4%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MGSC SA + +SPL NG +S+ +R DGN S+S+ SSVS PRTEGEIL SN+K
Sbjct: 1 MGSCLSARIKAESPLHNGLSSRYAR-DGNDKGNSTSK-SSVSTPRTPRTEGEILQSSNLK 58
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
+FS+N LK ATRNFRPDSVLGEGGFG VFKGWIDE ++A +PGTG+VIAVKRLNQE Q
Sbjct: 59 NFSYNELKAATRNFRPDSVLGEGGFGSVFKGWIDEQSFAVTKPGTGLVIAVKRLNQEGFQ 118
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPL 176
GH EWLTEI +LGQL+HPNLV+LIG+CLED+HRLLVYEFMP+GSLENHLFR +S+ QPL
Sbjct: 119 GHREWLTEIDYLGQLHHPNLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRR-SSHFQPL 177
Query: 177 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
SW++R+KVALGAAKGLA+LHSD+AKVIYRDFK+SNILLD +YNAKLSDFGLAKDGPTG +
Sbjct: 178 SWSLRLKVALGAAKGLAFLHSDEAKVIYRDFKSSNILLDSDYNAKLSDFGLAKDGPTGDR 237
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
S+VSTRVMGT+GYAAPEYM TGHLTAKSDVYSFGVVLLE+LSGRR IDKNRPS EHNL+E
Sbjct: 238 SYVSTRVMGTFGYAAPEYMITGHLTAKSDVYSFGVVLLEILSGRRAIDKNRPSGEHNLVE 297
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
WAKPYL SKRR+ Q++DARIEGQYS G ALK A LAI+C+S EPK RP M+ VVKALEQ+
Sbjct: 298 WAKPYLTSKRRVLQMLDARIEGQYSTGGALKAAKLAIQCISTEPKLRPNMNAVVKALEQL 357
Query: 357 QDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 397
QD+++ SR + LN + QG S +++P
Sbjct: 358 QDSSETSGSRGT----------LSEPLNTSSQGSGSTNNKP 388
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492229|ref|XP_003616403.1| Serine/threonine protein kinase [Medicago truncatula] gi|355517738|gb|AES99361.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 284/410 (69%), Positives = 329/410 (80%), Gaps = 14/410 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSG-SSSRVSSVSV---VPRTEGEILLGSN 54
MG C SA + +SP NG++SK R G SG SS +VS+ PRTEGEIL SN
Sbjct: 1 MGCCLSARIKAESPPRNGSSSK-DRSRETGLSGRSSGKVSTAPTAPPTPRTEGEILKSSN 59
Query: 55 IKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES 114
+KSF+F+ LKTATRNFRPDSV+GEGGFG VFKGWIDE+T P RPGTG+VIAVKRLNQE
Sbjct: 60 MKSFTFSELKTATRNFRPDSVVGEGGFGAVFKGWIDENTLVPVRPGTGVVIAVKRLNQEG 119
Query: 115 LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQ 174
LQGH EWLTEI +LGQL+HPNLVKLIGYC ED+HRLLVYEF+ KGSL+NHLFR ASY Q
Sbjct: 120 LQGHSEWLTEINYLGQLHHPNLVKLIGYCFEDEHRLLVYEFLTKGSLDNHLFRR-ASYFQ 178
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
PLSW+IRMKVAL AAKGLAYLHSD+AKVIYRDFKTSNILLD NYNAKLSDFGLAKDGP G
Sbjct: 179 PLSWSIRMKVALDAAKGLAYLHSDEAKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPAG 238
Query: 235 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294
SHVSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNL
Sbjct: 239 DNSHVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDNNRPSGEHNL 298
Query: 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
IEWAKPYL SKRR+FQVMDARIEGQY++ A+K A LA++CLS EP+FRP MDE+V+ LE
Sbjct: 299 IEWAKPYLNSKRRVFQVMDARIEGQYTVRQAMKVADLAVRCLSVEPRFRPKMDEIVRVLE 358
Query: 355 QIQDTN-----DAGVSRDESLQNSDRSTYKRKGLNENGQG-KASVHHRPS 398
++Q ++ G SRD++++ S + ++ N G + +RPS
Sbjct: 359 ELQSSSVDTAGGVGSSRDQNIKRSVHDIKRSVHVSRNSNGPRQHRSNRPS 408
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106475|ref|XP_002314178.1| predicted protein [Populus trichocarpa] gi|222850586|gb|EEE88133.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1457), Expect = e-158, Method: Compositional matrix adjust.
Identities = 278/400 (69%), Positives = 323/400 (80%), Gaps = 17/400 (4%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIKSF 58
MG C SA+ A S CS T G+SS+VSS+SV PR+EGEIL SN+KSF
Sbjct: 1 MGICLSAQIK------AESSCS------TVGTSSKVSSLSVPPTPRSEGEILQSSNLKSF 48
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
SF+ LK ATRNFRPDSVLGEGGFG VFKGWIDE T++ A+PGTGMVIAVKRLNQ+ QGH
Sbjct: 49 SFSDLKMATRNFRPDSVLGEGGFGSVFKGWIDEQTFSAAKPGTGMVIAVKRLNQDGFQGH 108
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWL E+ +LGQLY+P+LVKLIGYCLED+HRLLVYEFMP+GSLENHLFR G SY QPLSW
Sbjct: 109 KEWLAEVNYLGQLYNPHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG-SYFQPLSW 167
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+RMKV+LGAAKGLA+LHS + KVIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SH
Sbjct: 168 NLRMKVSLGAAKGLAFLHSAETKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKSH 227
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGTYGYAAPEY+ATGHLTAKSDVYSFGVVLLEMLSGRR +DKNRPS EHNL+EWA
Sbjct: 228 VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 287
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
KPYL +KR+IF+++D+R+EGQYS+ A K + LA++CLS E KFRPTMDEVV ALEQ+QD
Sbjct: 288 KPYLANKRKIFRILDSRLEGQYSMDVAYKVSTLALRCLSIETKFRPTMDEVVTALEQLQD 347
Query: 359 TNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRPS 398
+ + G + + N R +R + G G + + RPS
Sbjct: 348 SKETGTANGH-VGNKPR-IRRRSANDATGGGSIAAYPRPS 385
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098423|ref|XP_002311169.1| predicted protein [Populus trichocarpa] gi|222850989|gb|EEE88536.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1452), Expect = e-158, Method: Compositional matrix adjust.
Identities = 267/325 (82%), Positives = 291/325 (89%), Gaps = 1/325 (0%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRT+GEIL SN+KSFSFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGT
Sbjct: 29 TPRTQGEILQSSNLKSFSFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGT 88
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+VIAVKRL+QES QGH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL
Sbjct: 89 GIVIAVKRLSQESFQGHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 148
Query: 162 ENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221
ENHLFR ASY QPLSW +RMKVALGAA+GLAYLHSDKAKVIYRDFK SNILLD +Y AK
Sbjct: 149 ENHLFRR-ASYFQPLSWNLRMKVALGAAEGLAYLHSDKAKVIYRDFKASNILLDSSYGAK 207
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAKDGPTGS+SHVSTRVMGT+GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR
Sbjct: 208 LSDFGLAKDGPTGSKSHVSTRVMGTHGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 267
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
IDKNRPS+E L+EWA+PYL SKRRIFQVMDARI+GQYS ALK A LAI+CLS EP+
Sbjct: 268 AIDKNRPSKEQYLVEWARPYLSSKRRIFQVMDARIQGQYSSSDALKAANLAIQCLSAEPR 327
Query: 342 FRPTMDEVVKALEQIQDTNDAGVSR 366
+RP M+EVVKALEQ+ ++N+ SR
Sbjct: 328 YRPNMEEVVKALEQLHNSNNNDGSR 352
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | ||||||
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.920 | 0.872 | 0.648 | 1.1e-128 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.890 | 0.917 | 0.662 | 1.4e-128 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.932 | 0.946 | 0.622 | 2.1e-125 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.932 | 0.877 | 0.580 | 2.7e-116 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.872 | 0.709 | 0.606 | 9.1e-116 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.872 | 0.714 | 0.606 | 1.2e-113 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.910 | 0.856 | 0.570 | 3.2e-113 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.867 | 0.768 | 0.595 | 1.6e-111 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.832 | 0.810 | 0.609 | 5.3e-111 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.780 | 0.808 | 0.616 | 2.6e-109 |
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1263 (449.7 bits), Expect = 1.1e-128, P = 1.1e-128
Identities = 240/370 (64%), Positives = 284/370 (76%)
Query: 16 GANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
GA+ K + N + PRTEGEIL N+KSF+F LK ATRNFRPDSV
Sbjct: 26 GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSV 85
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH EWL E+ +LGQ HPN
Sbjct: 86 LGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPN 145
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
LVKLIGYCLED+HRLLVYEFMP+GSLENHLFR G SY QPLSWT+R+KVALGAAKGLA+L
Sbjct: 146 LVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG-SYFQPLSWTLRLKVALGAAKGLAFL 204
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
H+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVSTR+MGTYGYAAPEY+
Sbjct: 205 HNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYL 264
Query: 256 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR 315
ATGHLT KSDVYS+GVVLLE+LSGRR +DKNRP E L+EWA+P L +KR++F+V+D R
Sbjct: 265 ATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNR 324
Query: 316 IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDR 375
++ QYS+ A K A LA++CL+ E K RP M+EVV LE IQ N+AG + +Q R
Sbjct: 325 LQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMR 384
Query: 376 STYKRKGLNE 385
+N+
Sbjct: 385 RRSDSVAINQ 394
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
Identities = 241/364 (66%), Positives = 289/364 (79%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG+ PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDGS----KGSSTASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFR G Y QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFY-QPLSW 175
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SH
Sbjct: 176 NTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSH 235
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
VSTRVMGT GYAAPEY+ATGHL+ KSDVYSFGVVLLE+LSGRR IDKN+P EHNL++WA
Sbjct: 236 VSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWA 295
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+PYL +KRR+ +VMD R++GQYSL ALK AVLA+ C+S + K RPTM+E+VK +E++
Sbjct: 296 RPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHI 355
Query: 359 TNDA 362
+A
Sbjct: 356 QKEA 359
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1232 (438.7 bits), Expect = 2.1e-125, P = 2.1e-125
Identities = 236/379 (62%), Positives = 293/379 (77%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G + +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGL-SLSSRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFR GA Y +PL W +
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGA-YFKPLPWFL 176
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
R+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VS
Sbjct: 177 RVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVS 236
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
TRVMGTYGYAAPEYM++GHL A+SDVYSFGV+LLE+LSG+R +D NRP++E NL++WA+P
Sbjct: 237 TRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARP 296
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
YL SKR++ ++D R++ QY A++ A +A++CLS EPK RPTMD+VV+AL+Q+QD N
Sbjct: 297 YLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD-N 355
Query: 361 DAGVSRDESLQNSDRSTYK 379
S+ ++++ + +K
Sbjct: 356 LGKPSQTNPVKDTKKLGFK 374
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
Identities = 227/391 (58%), Positives = 284/391 (72%)
Query: 1 MGSCF--SAETDS----PLPNGAN--SKCSRKDGNGTXXXXXXXXXXXX-----XPRTEG 47
MG+C SA+ DS P N A+ S+ S K T PRTEG
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 48 EILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
EIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+G+V+AV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 108 KRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR 167
K+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 168 TGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227
GA QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+KLSDFGL
Sbjct: 181 RGA---QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGL 237
Query: 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287
AK GPTG ++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRR +DK++
Sbjct: 238 AKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSK 297
Query: 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 347
E +L++WA PYL KR++F++MD R+ GQY A A LA++CL+ + K RP M
Sbjct: 298 VGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMS 357
Query: 348 EVVKALEQIQDTNDA-GVSRDESLQNSDRST 377
EV+ L+Q++ T GV ++ +S R +
Sbjct: 358 EVLAKLDQLESTKPGTGVGNRQAQIDSPRGS 388
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 216/356 (60%), Positives = 265/356 (74%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 115 PVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 174
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 175 LTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 234
Query: 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAK 221
NHLFR PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD +YNAK
Sbjct: 235 NHLFRRSL----PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAK 290
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR
Sbjct: 291 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 350
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
+DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K LA +CLS +PK
Sbjct: 351 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPK 410
Query: 342 FRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 397
RP M +VV+AL+ + D S Q K G G + H+P
Sbjct: 411 IRPKMSDVVEALKPLPHLKDMA-SSSYYFQTMQAERLKNGSGRSQGFGSRNGQHQP 465
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
Identities = 216/356 (60%), Positives = 265/356 (74%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFKGW++E+ AP +PGTG
Sbjct: 109 PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 168
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 169 LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 228
Query: 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAK 221
NHLFR PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD YNAK
Sbjct: 229 NHLFRRSL----PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAK 284
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR
Sbjct: 285 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
+DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K LA +CLS + K
Sbjct: 345 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSK 404
Query: 342 FRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 397
RP M EVV+ L+ + D S Q K + +G+G S + +P
Sbjct: 405 IRPKMSEVVEVLKPLPHLKDMA-SASYYFQTMQAERLKAGSGSGSGRGFGSRNGQP 459
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 219/384 (57%), Positives = 275/384 (71%)
Query: 1 MGSCF--SAETD----SPLPNGANS------KCSRKDGNGTXXXXXXXXXXXXXP----R 44
MG+C SA+ D SP N A+S K SR G P R
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 45 TEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV 104
TEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+V
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 165 LFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224
LFR GA QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLSD
Sbjct: 181 LFRRGA---QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSD 237
Query: 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284
FGLAK GPTG +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRR +D
Sbjct: 238 FGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMD 297
Query: 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 344
+ E++L++WA PYL KR++F++MD ++ GQY A A LA++CL+ + K RP
Sbjct: 298 NSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRP 357
Query: 345 TMDEVVKALEQIQDTNDAGVSRDE 368
M EV+ LEQ++ G +
Sbjct: 358 KMSEVLVTLEQLESVAKPGTKHTQ 381
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
Identities = 212/356 (59%), Positives = 261/356 (73%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P GE+ S ++ F FN LK ATRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 76 PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 135
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HP+LVKL+GYC+E+D RLLVYEFMP+GSLE
Sbjct: 136 LTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLE 195
Query: 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAK 221
NHLFR PL W++RMK+ALGAAKGLA+LH + K VIYRDFKTSNILLD YNAK
Sbjct: 196 NHLFRRTL----PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 251
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAKD P +SHVSTRVMGTYGYAAPEY+ TGHLT KSDVYSFGVVLLE+L+GRR
Sbjct: 252 LSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRR 311
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
+DK+RP+ E NL+EW +P+L K+R ++++D R+EG YS+ A K +A +CL+ + K
Sbjct: 312 SVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSK 371
Query: 342 FRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 397
RP M EVV+AL+ + + D S S Q + G+ G G S + P
Sbjct: 372 ARPKMSEVVEALKPLPNLKDFA-SSSSSFQTMQ--PVAKNGVRTQGGGFVSRNGPP 424
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 208/341 (60%), Positives = 265/341 (77%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNFRPDSV+GEGGFG V+KGWIDE T +P++PG+G
Sbjct: 56 PRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSG 115
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH-RLLVYEFMPKGSL 161
MV+AVK+L +E QGH +WL E+ LG+L+H NLVKLIGYC + DH RLLVYE+MPKGSL
Sbjct: 116 MVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSL 175
Query: 162 ENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221
ENHLFR GA +P+ W R+KVA+GAA+GLA+LH +A+VIYRDFK SNILLD +NAK
Sbjct: 176 ENHLFRRGA---EPIPWRTRIKVAIGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAK 230
Query: 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
LSDFGLAK GPTG ++HVST+VMGT GYAAPEY+ATG +TAKSDVYSFGVVLLE+LSGR
Sbjct: 231 LSDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRL 290
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
+DK + E NL++WA PYL KR++F++MD ++ GQY A TA A++CL+ EPK
Sbjct: 291 TVDKTKVGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPK 350
Query: 342 FRPTMDEVVKALEQIQDTNDAG-VSRDESLQNSDRSTYKRK 381
RP M +V+ LE+++ T +G +S S S++ K
Sbjct: 351 LRPKMSDVLSTLEELEMTLKSGSISNSVMKLTSSSSSFTAK 391
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
Identities = 196/318 (61%), Positives = 259/318 (81%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNF+P+S++GEGGFGCV+KGWI E + +P++PG+G
Sbjct: 57 PRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSG 116
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
MV+AVK+L E QGH EWLTE+ +LG+L+H NLVKLIGYCLE + RLLVYE+MPKGSLE
Sbjct: 117 MVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLE 176
Query: 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222
NHLFR GA +P+ W RMKVA AA+GL++LH +AKVIYRDFK SNILLD+++NAKL
Sbjct: 177 NHLFRRGA---EPIPWKTRMKVAFSAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKL 231
Query: 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
SDFGLAK GPTG ++HV+T+V+GT GYAAPEY+ATG LT+KSDVYSFGVVLLE+LSGR
Sbjct: 232 SDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPT 291
Query: 283 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 342
+DK++ E NL++WA PYL +R++F++MD ++ GQY A A +A++CL+ EPK
Sbjct: 292 LDKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKL 351
Query: 343 RPTMDEVVKALEQIQDTN 360
RP M +V+ L+Q++ ++
Sbjct: 352 RPDMADVLSTLQQLETSS 369
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q06548 | APK1A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6906 | 0.8952 | 0.8756 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 401 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-36 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-55
Identities = 82/224 (36%), Positives = 117/224 (52%), Gaps = 27/224 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQLYHP 134
LGEGGFG V+ + TG +A+K + +E LE L EI+ L +L HP
Sbjct: 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+VKL G +++H LV E+ GSL++ L LS +++ L +GL Y
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE----NEGKLSEDEILRILLQILEGLEY 107
Query: 195 LHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
LHS +I+RD K NILLD N KL+DFGL+K S + ++GT Y APE
Sbjct: 108 LHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPE 163
Query: 254 -YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK-------NRPS 289
+ G+ + KSD++S GV+L E+ + +I K RPS
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPS 207
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 97/287 (33%), Positives = 139/287 (48%), Gaps = 36/287 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+ LG G FG V+K GTG ++AVK L + S + EI+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L +L HPN+V+LI + DH LV E+ G L ++L R G PLS K+AL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQ 106
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+GL YLHS +I+RD K NILLD N K++DFGLAK S S ++T V GT
Sbjct: 107 ILRGLEYLHS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTP 162
Query: 248 GYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
Y APE + G K DV+S GV+L E+L+G+ + L +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQ 209
Query: 307 RIFQVMDARIEGQYSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVK 351
I +++ +E ++ L KCL+ +P RPT +E+++
Sbjct: 210 LIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-52
Identities = 90/286 (31%), Positives = 136/286 (47%), Gaps = 37/286 (12%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+VKL+G C E++ +V E+M G L ++L LS + + AL A+G
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARG 114
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YG 248
+ YL S I+RD N L+ N K+SDFGL++D R G
Sbjct: 115 MEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIR 168
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
+ APE + G T+KSDV+SFGV+L E+ + G +P + E YL++ R
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE------QPYPGMSNEE-VLEYLKNGYR 221
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+ Q + E L ++C + +P+ RPT E+V+ L
Sbjct: 222 LPQPPNCPPE----------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-52
Identities = 90/283 (31%), Positives = 139/283 (49%), Gaps = 30/283 (10%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG T G + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+VKL+G C E++ ++V E+MP G L ++L + + LS + + AL A+G
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARG 115
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+ YL S I+RD N L+ N K+SDFGL++D + + A
Sbjct: 116 MEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMA 172
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310
PE + G T+KSDV+SFGV+L E+ + G P + E YL+ R+ +
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGE------EPYPGMSNAE-VLEYLKKGYRLPK 225
Query: 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+ E L ++C + +P+ RPT E+V+ L
Sbjct: 226 PPNCPPE----------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 86/300 (28%), Positives = 133/300 (44%), Gaps = 68/300 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V+KG T GT +AVK L + S + E+L E + +L H
Sbjct: 6 KLGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+V+L+G C + + +V E+MP G L + L + G + L+ +++AL AKG+
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGME 116
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST------RVMGTY 247
YL S ++RD N L+ N K+SDFGL++D + M
Sbjct: 117 YLES--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM--- 171
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG--------------RRVIDKNRPSREHN 293
APE + G T+KSDV+SFGV+L E+ + + D R R N
Sbjct: 172 ---APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPEN 228
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
++++M ++C + +P+ RPT E+V+ L
Sbjct: 229 ----------CPDELYELM--------------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-48
Identities = 83/306 (27%), Positives = 131/306 (42%), Gaps = 71/306 (23%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQLY 132
LGEG FG V+KG + G +AVK L S + ++L E + + +L
Sbjct: 2 KLGEGAFGEVYKGKLKGK-------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL----FRTGASYIQPLSWTIRMKVALGA 188
HPN+V+L+G C E++ LV E+M G L ++L + LS + A+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP------TGSQSHVSTR 242
AKG+ YL S K ++RD N L+ + K+SDFGL++D + + R
Sbjct: 115 AKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG--------------RRVIDKNRP 288
M APE + G T+KSDV+SFGV+L E+ + + R
Sbjct: 173 WM------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ E+ ++++M + C +P+ RPT E
Sbjct: 227 PKP----EYCPD------ELYELM--------------------LSCWQLDPEDRPTFSE 256
Query: 349 VVKALE 354
+V+ LE
Sbjct: 257 LVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ LGEG FG V+ TG ++A+K + ++ ++ E L EIK L
Sbjct: 1 YEILEKLGEGSFGKVYLAR---------DKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGA---SYIQPLSWTIRMKVA 185
+L HPN+V+L ++D LV E+ G L + L + G + I
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI----- 106
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
L YLHS +++RD K NILLD + + KL+DFGLA+ ++T V G
Sbjct: 107 ---LSALEYLHS--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-G 158
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI-DKNRPSREHNLIEWAKPYLQS 304
T Y APE + D++S GV+L E+L+G+ ++ I KP
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 218
Query: 305 KRRIF--QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ D L K L +P+ R T +E ++
Sbjct: 219 PEWDISPEAKD-----------------LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
F +G+GGFG V+K TG +A+K + ES + + + EI+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
+ HPN+VK G L+ D +V EF GSL++ L S Q L+ + V
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELL 108
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
KGL YLH +I+RD K +NILL + KL DFGL+ + ++GT +
Sbjct: 109 KGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYW 163
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + K+D++S G+ +E+ G+
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWL-TEIKHLGQLY 132
+LG G FG V+ +D+ T G ++AVK + + LE L EI+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 133 HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRTGA---SYIQPLSWTIRMKVALG 187
HPN+V+ G E + + E++ GSL + L + G I+ +T ++
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR--KYTRQI----- 110
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+GLAYLHS +++RD K +NIL+D + KL+DFG AK + V GT
Sbjct: 111 -LEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
+ APE + +D++S G ++EM +G+
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 29/291 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LGEG FG V Y P TG +AVK LN + H ++ EI+ L L H
Sbjct: 12 LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 135 NLVKLIGYCLEDDHR---LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
N+VK G C E L+ E++P GSL ++L R + + KG
Sbjct: 67 NIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----LLLFSSQICKG 121
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST--RVMGTYGY 249
+ YL S + I+RD NIL++ K+SDFGLAK P + + Y
Sbjct: 122 MDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLIEWAKPYLQSKRRI 308
APE + T ++ SDV+SFGV L E+ + D ++ P E + Q + +
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIA---QGQMIV 232
Query: 309 FQVMDARIEGQ-YSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVKALEQI 356
++++ EG+ + V L C EP+ RP+ +++ ++++
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 92/293 (31%), Positives = 138/293 (47%), Gaps = 19/293 (6%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R + VLGEG FG V + Y PA GTG ++AVK L +E Q + W EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL-----YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
L LYH N+VK G C E L+ E++P GSL ++L + + Q L +
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------ 112
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH-VSTRV 243
A +G+AYLHS I+RD N+LLD + K+ DFGLAK P G + + V
Sbjct: 113 AQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
+ A E + + SDV+SFGV L E+L+ K P ++ + K
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQM 228
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+ R+ ++++ + + +L C E KFRPT ++ L+++
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 36/216 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
++G G FG V+KG ++ T G +A+K+++ E + + + EI L L
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG-------ASYI-QPLSWTIRMKV 184
HPN+VK IG D ++ E+ GSL + + G A Y+ Q L
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------- 109
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
+GLAYLH + VI+RD K +NIL + KL+DFG+A S V+
Sbjct: 110 -----QGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVV 160
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT + APE + + SD++S G ++E+L+G
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 26/211 (12%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQL 131
+ +G+G FG V G Y G +AVK L + + Q +L E + L
Sbjct: 12 ATIGKGEFGDVMLG-----DYR------GQKVAVKCLKDDSTAAQ---AFLAEASVMTTL 57
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPNLV+L+G L+ + +V E+M KGSL ++L G + I ++ AL +G
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ---QLGFALDVCEG 114
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+ YL ++RD N+L+ + AK+SDFGLAK+ SQ S ++ + A
Sbjct: 115 MEYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWTA 167
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
PE + + KSDV+SFG++L E+ S RV
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 82/293 (27%), Positives = 124/293 (42%), Gaps = 29/293 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++R LGEG FG V+ D A V+A K ++ L EI+ L
Sbjct: 1 SYRILRKLGEGSFGEVYLA-RDRKLVA------LKVLAKKLESKSKEVERF--LREIQIL 51
Query: 129 GQLYHP-NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L HP N+VKL + ++ LV E++ GSLE+ L + G S + + +
Sbjct: 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI- 110
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFGLAK----DGPTGSQSHVSTR 242
L YLHS +I+RD K NILLD + KL DFGLAK G T S + +
Sbjct: 111 -LSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 243 VMGTYGYAAPEY---MATGHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIEWA 298
+GT GY APE ++ + ++ SD++S G+ L E+L+G + S ++
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ LK K L+ +PK R + +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 55/294 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIK 126
+ +G+G FG V+ G + +K L+ S + + L E+K
Sbjct: 1 KYEIIKQIGKGSFGKVYLV---RRKS------DGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI-----QPLSWTIR 181
L +L HPN++K E +V E+ G L + + Q L W ++
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ L YLHS K +++RD K NI L N KL DFG++K + + T
Sbjct: 112 L------CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 242 RVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
V GT Y +PE Y KSD++S G VL E+ + + + NL+
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE------NLL 209
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349
E A L+ + I QYS + L+ V L +P+ RP++ ++
Sbjct: 210 ELALKILKGQYP-------PIPSQYS--SELRNLVS--SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
F + LG G FG V++G W + + +A+K L + L ++ E++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+L H +L+ L C + ++ E M KGSL R+ + P++ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A+G+AYL I+RD NIL+ + K++DFGLA+ ++ Y
Sbjct: 114 AEGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYK 169
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + G + KSDV+SFG++L EM +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 26/230 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLY 132
VLG G FG V+KG WI P + +A+K L +E+ + + E L E + +
Sbjct: 14 VLGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSL----ENHLFRTGASYIQPLSWTIRMKVALGA 188
HP++V+L+G CL L+ + MP G L NH G+ Y+ L+W +++
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYL--LNWCVQI------ 118
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
AKG++YL ++ ++++RD N+L+ + K++DFGLAK + + +
Sbjct: 119 AKGMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE-HNLIE 296
+ A E + T KSDV+S+GV + E+++ G + + P+ E +L+E
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 47/287 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
+G+G FG V+KG + +AVK ++L E + L Q HP
Sbjct: 3 IGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+VKLIG C++ +V E +P GSL L + L+ ++++L AA G+ Y
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEY 108
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
L S I+RD N L+ N K+SDFG++++ G + + APE
Sbjct: 109 LESKNC--IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDK---NRPSREHNLIEWAKPYLQSKRRIFQV 311
+ G T++SDV+S+G++L E S N+ +RE
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------------------- 206
Query: 312 MDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALE 354
RIE Y + A L ++C + +P+ RP+ E+ L+
Sbjct: 207 ---RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 78/214 (36%), Positives = 106/214 (49%), Gaps = 33/214 (15%)
Query: 76 LGEGGFGCVF----KGWIDEHTYAPARPGTGM-VIAVKRLNQESLQGHLEWLTEIKHLGQ 130
LG+G FG V K YA M V+ K++ + H LTE L +
Sbjct: 1 LGKGSFGKVLLVRKKD--TGKLYA-------MKVLKKKKIIKRKEVEHT--LTERNILSR 49
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLS-WTIRMKVA-LG 187
+ HP +VKL Y + + +L LV E+ P G L +HL + G S R A +
Sbjct: 50 INHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGR-----FSEERARFYAAEIV 103
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
A L YLHS +IYRD K NILLD + + KL+DFGLAK+ + +T GT
Sbjct: 104 LA--LEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC-GTP 157
Query: 248 GYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + G+ A D +S GV+L EML+G+
Sbjct: 158 EYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 57/298 (19%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G + P + + +A+K L S + L++LTE +GQ
Sbjct: 9 EKVIGGGEFGEVCRGRLKL----PGKKE--IDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+++L G + +++ E+M GSL+ L + + + G A G
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASG 118
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG--- 248
+ YL S+ V +RD NIL++ N K+SDFGL S TY
Sbjct: 119 MKYL-SEMNYV-HRDLAARNILVNSNLVCKVSDFGL---------SRRLEDSEATYTTKG 167
Query: 249 ------YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 301
+ APE +A T+ SDV+SFG+V+ E++S G R PY
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER------------------PY 209
Query: 302 LQSKRRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALEQ 355
+ V+ A +E Y L + L + C + RPT ++V L++
Sbjct: 210 WDMSNQ--DVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYH 133
LGEG FG VF G Y ++AVK L + + ++ E + L H
Sbjct: 12 ELGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG---------ASYIQPLSWTIRMKV 184
N+VK G C E D ++V+E+M G L L G S + L+ + +++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A+ A G+ YL S ++RD T N L+ + K+ DFG+++D T V M
Sbjct: 128 AVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ PE + T +SDV+SFGVVL E+ +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 47/284 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN---QESLQGHLEWLTEIKHLGQ 130
VLG+G G V+K + P TG + A+K+++ E + L L E+K L
Sbjct: 7 KVLGQGSSGVVYKV-----RHKP----TGKIYALKKIHVDGDEEFRKQL--LRELKTLRS 55
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
P +VK G + + +V E+M GSL + L + G + + +A
Sbjct: 56 CESPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQIL 109
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
KGL YLH+ + +I+RD K SN+L++ K++DFG++K +T V GT Y
Sbjct: 110 KGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTY 166
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR-RI 308
+PE + + +D++S G+ LLE G+ P+L +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKF------------------PFLPPGQPSF 208
Query: 309 FQVMDARIEG-QYSLGAALKTAVLA---IKCLSNEPKFRPTMDE 348
F++M A +G SL A + CL +PK RP+ E
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR----LNQESLQGHLEWLT-EIKHLGQ 130
LG G FG V++G + G AVK + ++ Q ++ L EI L +
Sbjct: 8 LGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM--KVALGA 188
L HPN+V+ +G E+D+ + E +P GSL L + G S+ +P+ IR+ + L
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPV---IRLYTRQIL-- 112
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM---- 244
GL YLH ++RD K +NIL+D N KL+DFG+AK V
Sbjct: 113 -LGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSF 161
Query: 245 -GTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
G+ + APE G +D++S G +LEM +G+
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V+KG P + +A+K L + + E+ E + + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-----------TGASYIQPLSWTIRMK 183
N+V L+G C ++ +++E++ G L L R + L + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
+A+ A G+ YL S ++RD N L+ K+SDFGL++D + V ++
Sbjct: 129 IAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ + PE + G T +SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 90/293 (30%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG G FG V KG Y + G + +AVK L QE G E+L E + QL HP
Sbjct: 3 LGHGNFGSVVKGV-----YLM-KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV-ALGAAKGLA 193
+V+LIG C + +LV E P G L + I +K A A G+A
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPL--LKYLKKRREIP----VSDLKELAHQVAMGMA 109
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG----- 248
YL S ++RD N+LL + AK+SDFG+++ GS + +T T G
Sbjct: 110 YLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLK 163
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
+ APE + G ++KSDV+S+GV L E S G AKPY + K
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPYGEMKGA 205
Query: 308 IFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+V+ A +E L + + + C P+ RPT E+ +
Sbjct: 206 --EVI-AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG G V+K TG +A+K RL +++ + + EI +
Sbjct: 25 EKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDC 72
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+V L D +V E+M GSL + + + +P + + L +G
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVL---QG 128
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
L YLHS VI+RD K+ NILL + + KL+DFG A S V+GT + A
Sbjct: 129 LEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMA 184
Query: 252 PEYMATGHL-TAKSDVYSFGVVLLEMLSG 279
PE + K D++S G++ +EM G
Sbjct: 185 PE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 89/304 (29%), Positives = 136/304 (44%), Gaps = 37/304 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R+ + LG+G FG V + Y P + TG V+AVK+L Q S HL + EI+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKL-QHSTAEHLRDFEREIE 57
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGS----LENHLFRTGASYIQPLSWTI 180
L L H N+VK G C R LV E++P GS L+ H R + + I
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
KG+ YL S + ++RD T NIL++ K+ DFGL K P + +
Sbjct: 118 --------CKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK- 166
Query: 241 TRVMG---TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLIE 296
R G + Y APE + + SDV+SFGVVL E+ + DK+ P E +
Sbjct: 167 VREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAE--FMR 220
Query: 297 WAKPYLQSKRRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
Q + ++ +++ G + + +C +N+P RP+ E+ +
Sbjct: 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
Query: 354 EQIQ 357
E I+
Sbjct: 281 EAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIK 126
LG G G V K RP TG ++AVK + E +Q + L E+
Sbjct: 3 LEYLGELGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQI--LRELD 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L + P +V G + + E+M GSL+ L + I K+A+
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAV 107
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-- 244
KGL YLH K K+I+RD K SNIL++ KL DFG VS +++
Sbjct: 108 AVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNS 154
Query: 245 ------GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y APE + + KSD++S G+ L+E+ +GR
Sbjct: 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + +AVK L + S Q ++L E + + H
Sbjct: 13 ALGHGAFGEVYEG---LYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR--MKVALGAAKG 191
N+V+LIG E R ++ E M G L++ L +P S T++ + A AKG
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
YL I+RD N LL AK++DFG+A+D S R M
Sbjct: 129 CKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291
+ PE G T+K+DV+SFGV+L E+ S + R ++E
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 87/314 (27%), Positives = 147/314 (46%), Gaps = 38/314 (12%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ES 114
KS + N + ++ + ++V+ G G +KG GM VK +N S
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQFVVKEINDVNS 728
Query: 115 LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQ 174
+ +EI +G+L HPN+VKLIG C + L++E++ +L L +
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--------R 775
Query: 175 PLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233
LSW R K+A+G AK L +LH V+ + I++D L L T
Sbjct: 776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834
Query: 234 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293
++ +S+ Y APE T +T KSD+Y FG++L+E+L+G+ D +
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-S 887
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGA--ALKTAVLAIKCLSNEPKFRPTMDEVVK 351
++EWA+ Y S + +D I G S+ ++ LA+ C + +P RP ++V+K
Sbjct: 888 IVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 352 ALEQIQDTNDAGVS 365
LE ++ + V+
Sbjct: 947 TLESASRSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 88/287 (30%), Positives = 140/287 (48%), Gaps = 50/287 (17%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
++GEG FG V +G E+T G +AVK + + + Q LE E + +L+
Sbjct: 12 EIIGEGEFGAVLQG---EYT--------GQKVAVKNIKCDVTAQAFLE---ETAVMTKLH 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
H NLV+L+G L + +V E M KG+L N L RT + + ++ +L A+G+
Sbjct: 58 HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQF--SLDVAEGM 113
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
YL S K +++RD NIL+ + AK+SDFGLA+ G G ++++ + AP
Sbjct: 114 EYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAP 166
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312
E + ++KSDV+S+GV+L E+ S R PY K + +V
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGR-----------------APY--PKMSLKEVK 207
Query: 313 DARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
+ +E Y + G VL C EPK RP+ ++ + LE+
Sbjct: 208 EC-VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
LG+G FG V +G W G + +AVK L + L + ++L E + L H
Sbjct: 3 LGDGSFGVVRRGEWS-----TSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
NL++L G L ++V E P GSL + L + + + A+ A G+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGH---FLISTLCDYAVQIANGMR 111
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST---RVMGTYGYA 250
YL S + I+RD NILL + K+ DFGL + P +V +V + +
Sbjct: 112 YLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWC 167
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS 278
APE + T + SDV+ FGV L EM +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 84/297 (28%), Positives = 145/297 (48%), Gaps = 35/297 (11%)
Query: 76 LGEGGFG----CVFKGWID-EHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLG 129
LGEG FG C +G + AP G +++AVK L + + ++L EIK +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-------TGASYIQPLSWTIRM 182
+L +PN+++L+G C+ DD ++ E+M G L L + T A+ I +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+A+ A G+ YL S ++RD T N L+ +Y K++DFG++++ +G + R
Sbjct: 133 YMAVQIASGMKYLAS--LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR---EHNLIEWAK 299
+ + A E + G T SDV++FGV L EM + + K +P + +IE
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENTG 246
Query: 300 PYLQSK-RRIFQVMDARIEGQYSL--GAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+ +++ R+I+ Q L K L ++C S + K RPT +++ L
Sbjct: 247 EFFRNQGRQIYL-------SQTPLCPSPVFK---LMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
+G+G FG VF+ P P T ++AVK L +E S ++ E + + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQ------------------PL 176
N+VKL+G C L++E+M G L L R + Q PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 177 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-----DG 231
S T ++ +A A G+AYL S++ K ++RD T N L+ N K++DFGL++ D
Sbjct: 128 SCTEQLCIAKQVAAGMAYL-SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 232 PTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290
S++ + R M PE + T +SDV+++GVVL E+ S
Sbjct: 186 YKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS------------ 227
Query: 291 EHNLIEWAKPY--LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+PY + + I+ V D + L+ L C S P RP+
Sbjct: 228 -----YGMQPYYGMAHEEVIYYVRDGNVLSCPD-NCPLELYNLMRLCWSKLPSDRPSFAS 281
Query: 349 VVKALEQ 355
+ + L++
Sbjct: 282 INRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 88/315 (27%), Positives = 138/315 (43%), Gaps = 56/315 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N LGEG FG V K R G V AVK L + + L + L+E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATA---FRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNL 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL---FRTGASYI----------- 173
L Q+ HP+++KL G C +D LL+ E+ GSL + L + G SY+
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 174 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
+ L+ + A ++G+ YL + K+++RD N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 229 KD------GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRR 281
+D S+ + + M A E + T +SDV+SFGV+L E+++ G
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
P R NL L++ R+ + + E Y+ L + C EP
Sbjct: 229 PYPGIAPERLFNL-------LKTGYRMERPENCS-EEMYN---------LMLTCWKQEPD 271
Query: 342 FRPTMDEVVKALEQI 356
RPT ++ K LE++
Sbjct: 272 KRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 24/217 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE----SLQGHLEWL-T 123
N+R +LG+G FG V Y TG +AVK++ + + + L
Sbjct: 3 NWRRGKLLGQGAFGRV---------YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVY-EFMPKGSLENHLFRTGASYIQPLSWTIRM 182
EI+ L L H +V+ G CL DD L ++ E+MP GS+++ L GA L+ T+
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTR 107
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
K +G+ YLHS+ +++RD K +NIL D N KL DFG +K T S +
Sbjct: 108 KYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 243 -VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
V GT + +PE ++ K+DV+S G ++EML+
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-24
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 43/275 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+G+G FG VFK R V A+K+++ + E + E + L +L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS----WTIRMKVALGAA 189
+++ L+ +V E+ G L L +PL W +++ LG
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLG-- 113
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
LA+LHS K +++RD K+ N+ LD N K+ D G+AK ++ + ++GT Y
Sbjct: 114 --LAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYY 167
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
+PE KSDV++ GVVL E +G+ D N + LI +I
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKII 214
Query: 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 344
+ + + YS L A L +CL+ + + RP
Sbjct: 215 RGVFPPVSQMYS--QQL--AQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 27/216 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWL-TEIKHL 128
VLG+G +G V+ G + G +IAVK++ N + + E L E+ L
Sbjct: 7 VLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L H N+V+ +G CL+D+ + EF+P GS+ + L R G PL + K
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQI 111
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRVM 244
G+AYLH++ V++RD K +N++L N KL DFG A+ G G+ S++ +
Sbjct: 112 LDGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT + APE + KSD++S G + EM +G+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 32/261 (12%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+A+KR++ E Q ++ L E++ + Q HPN+VK + D LV ++ G
Sbjct: 25 NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84
Query: 160 SLEN---HLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216
SL + + G + + T+ +K L KGL YLHS+ I+RD K NILL
Sbjct: 85 SLLDIMKSSYPRGG-LDEAIIATV-LKEVL---KGLEYLHSNGQ--IHRDIKAGNILLGE 137
Query: 217 NYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGV 271
+ + K++DFG LA G V +GT + APE M H K+D++SFG+
Sbjct: 138 DGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI 195
Query: 272 VLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV 330
+E+ +G K P + ++ P L++ +YS + + +
Sbjct: 196 TAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY---------KKYS--KSFRKMI 244
Query: 331 LAIKCLSNEPKFRPTMDEVVK 351
CL +P RPT +E++K
Sbjct: 245 --SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGLA--KGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRT-----GASYIQPLSWTIRMKVALGAA 189
++V+L+G L+V E M KG L+++L + P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-------GPTGSQSHVSTR 242
G+AYL + K ++RD N ++ + K+ DFG+ +D G + + R
Sbjct: 130 DGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 186
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
M APE + G T KSDV+SFGVVL EM +
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 72/221 (32%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 76 LGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+G G FG V+ +D TG ++AVK R+ + E E+K L L
Sbjct: 8 IGGGTFGKVYTAVNLD----------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
HPNLVK G + + + E+ G+LE L G I + L +GL
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGR--ILDEHVIRVYTLQL--LEGL 112
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY--- 249
AYLHS +++RD K +NI LD N KL DFG A + +T MG
Sbjct: 113 AYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLA 164
Query: 250 AAPEYMA---------TGHLTAKSDVYSFGVVLLEMLSGRR 281
P YMA GH A +D++S G V+LEM +G+R
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 75/302 (24%), Positives = 126/302 (41%), Gaps = 52/302 (17%)
Query: 76 LGEGGFGCV-------FKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTE 124
LGEG FG V + + ++ +++AVK L + + + ++L E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLKE 69
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR------TGASYIQPLSW 178
+K L +L PN+ +L+G C D ++ E+M G L L + A + LS+
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+ + +A A G+ YL S ++RD T N L+ NY K++DFG++++ +
Sbjct: 130 STLLYMATQIASGMRYLES--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297
V R + A E + G T KSDV++FGV L E+L+ R
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE---------------- 231
Query: 298 AKPYLQSKRRIFQVMDARIEGQYSLGA----ALKTAV------LAIKCLSNEPKFRPTMD 347
+PY QV++ G L ++C + + RPT
Sbjct: 232 -QPY--EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288
Query: 348 EV 349
E+
Sbjct: 289 EI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLEWLT--EIKHLGQ 130
V+GEG +G V K R TG ++A+K+ + ++ E+K L Q
Sbjct: 7 GVVGEGAYGVVLK----------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ 56
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRTGASY--IQPLSWTIRMKVALG 187
L H N+V L LV+E++ + LE G ++ W +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL------- 109
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+ +AY HS +I+RD K NIL+ + KL DFG A+ S ++ V T
Sbjct: 110 -LQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATR 165
Query: 248 GYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 280
Y APE + K DV++ G ++ E+L G
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLT 123
+F+ ++GEG F V E T A+K +L +E ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYV--KI 50
Query: 124 EIKHLGQL-YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
E + L +L HP ++KL Y +D+ L V E+ P G L ++ + G+ L
Sbjct: 51 EKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCT 104
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP--------- 232
A L YLHS +I+RD K NILLD + + K++DFG AK
Sbjct: 105 RFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 233 -----TGSQSHVSTR----VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
SQ + R +GT Y +PE + SD+++ G ++ +ML+G+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + T +AVK L ++ +L E + + +L H
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
LV+L C E++ +V E+M KGSL + L ++G L + M A A+G+AYL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMGT---YGY 249
S I+RD NIL+ N K++DFGLA +D + R G +
Sbjct: 120 ES--RNYIHRDLAARNILVGENLVCKIADFGLARLIED------DEYTAR-EGAKFPIKW 170
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
APE G T KSDV+SFG++L E+++ RV
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-23
Identities = 87/293 (29%), Positives = 139/293 (47%), Gaps = 46/293 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLY 132
V+G+G FGCV+ G ID G + AVK LN+ L+ ++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 133 HPNLVKLIGYCLEDDHR-LLVYEFMPKGSLENHLFRTGASYIQPLSW--TIRMKVALG-- 187
HPN++ L+G CL + L+V +M G L N +I+ + T++ + G
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--------FIRSETHNPTVKDLIGFGLQ 106
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV 243
AKG+ YL S K ++RD N +LD ++ K++DFGLA+D +H ++
Sbjct: 107 VAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
+ A E + T T KSDV+SFGV+L E+++ R P + + + YL
Sbjct: 165 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA----PPYPDVDSFDITV-YLL 216
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
RR+ Q +Y + + + C +P+ RPT E+V +EQI
Sbjct: 217 QGRRLLQ-------PEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 46/254 (18%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V+ G W+++ +A+K + +E +++ E + + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
LV+L G C E LV+EFM G L ++L S + + L +G+AY
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAY 115
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-------DGPTGSQSHVSTRVMGTY 247
L S + VI+RD N L+ N K+SDFG+ + TG++ V
Sbjct: 116 LES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------- 166
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--------HNLIEWAK 299
+++PE + ++KSDV+SFGV++ E+ S + +NR + E L K
Sbjct: 167 -WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY---K 222
Query: 300 PYLQSKRRIFQVMD 313
P L S+ ++++M
Sbjct: 223 PRLASQ-SVYELMQ 235
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWL--------TE 124
++G+G +G V+ TG ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
I+ L L H N+V+ +G+ +++ + E++P GS+ + RT + + L +V
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
+GLAYLHS +++RD K N+L+D + K+SDFG++K + + +
Sbjct: 118 L----EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 245 GTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRR 281
G+ + APE + + +AK D++S G V+LEM +GRR
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 9e-23
Identities = 88/277 (31%), Positives = 128/277 (46%), Gaps = 37/277 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+ K G L+D ++ E++ GS + L G PL T + KGL Y
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG-----PLDETQIATILREILKGLDY 116
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
LHS+K I+RD K +N+LL + KL+DFG+A G +GT + APE
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 314
+ +K+D++S G+ +E+ G + P + LI P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------P 219
Query: 315 RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+EG YS LK V A CL+ EP FRPT E++K
Sbjct: 220 TLEGNYS--KPLKEFVEA--CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 38/218 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHLG 129
+GEG +G V+K TG ++A+K++ E + + + EIK L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 130 QLYHPNLVKLIGYCLEDDHR--LLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKV 184
+L HPN+V+L +V+E+M G L++ + S I+ MK
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY-----MKQ 108
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
L +GL YLHS +++RD K SNIL++ + KL+DFGLA+ T S T +
Sbjct: 109 LL---EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRV 162
Query: 245 GTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
T Y PE + AT + D++S G +L E+ G+
Sbjct: 163 ITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LTEIKHLGQ 130
+GEG +G V+K TG ++A+K++ L+ E L EIK L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKI---KLRFESEGIPKTALREIKLLKE 54
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
L HPN++KL+ LV+EFM L L + + L ++ +
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKD---RQRGLPESLIKSYLYQLLQ 109
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVMGTY 247
GLA+ HS +++RD K N+L++ KL+DFGLA+ P +H V TR
Sbjct: 110 GLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR----- 162
Query: 248 GYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + D++S G + E+LS R
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-22
Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G +G V++G ++ + +AVK L +++++ E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
LV+L+G C + ++ EFM G+L ++L + + + + +A + + YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYL 120
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-------DGPTGSQSHVSTRVMGTYG 248
+K I+RD N L+ N+ K++DFGL++ G++ +
Sbjct: 121 --EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------- 170
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEM 276
+ APE +A + KSDV++FGV+L E+
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-----EWLTEIKHLG 129
+LGEG FG V +G + G+ + +AVK + L H E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLS------QDDGSQLKVAVKTMK---LDIHTYSEIEEFLSEAACMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLF--RTGASYIQPLSWTIR 181
HPN++KLIG C E +++ FM G L + L R G P ++
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQ 113
Query: 182 M--KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS---Q 236
K + A G+ YL + I+RD N +L + ++DFGL+K +G Q
Sbjct: 114 TLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
++ + + A E +A T+KSDV++FGV + E+ + R H + +
Sbjct: 172 GRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD 226
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
YL+ R+ Q D ++ Y L C +PK RPT ++ + LE I
Sbjct: 227 ----YLRHGNRLKQPEDC-LDELYD---------LMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-22
Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 94 YAPARPGTGMVIAVKRL----NQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147
Y TG ++AVK++ N S Q + EI+ + +L HP++++++G ED
Sbjct: 17 YQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76
Query: 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
H L E+M GS+ + L + G + + +GL+YLH + ++I+RD
Sbjct: 77 HFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN--QIIHRDV 129
Query: 208 KTSNILLD-LNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA 262
K +N+L+D +++DFG LA G TG+ +++GT + APE +
Sbjct: 130 KGANLLIDSTGQRLRIADFGAAARLAAKG-TGA-GEFQGQLLGTIAFMAPEVLRGEQYGR 187
Query: 263 KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL 322
DV+S G V++EM + + + + S L IF++ A S+
Sbjct: 188 SCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------------IFKIASA--TTAPSI 232
Query: 323 GAALKTAV--LAIKCLSNEPKFRPTMDEVVK 351
L + + ++CL +P+ RP E++K
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQ 130
S LGEG G V K + TGM+ A+K + + LQ + L E++
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQI--LRELEINKS 55
Query: 131 LYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRTGASYIQPLSWTIRM------ 182
P +VK G L++ + E+ GSL+ + Y + R+
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-------SIYKKVKKRGGRIGEKVLG 108
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
K+A KGL+YLHS K+I+RD K SNILL KL DFG++ G + S T
Sbjct: 109 KIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVN-SLAGTF 163
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y APE + + SDV+S G+ LLE+ R
Sbjct: 164 T-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYH 133
+LG+G FG VFKG + + T +AVK ++ Q +++L+E + L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+VKLIG C + +V E +P G + L + L +K AL AA G+A
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMA 107
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YL S I+RD N L+ N K+SDFG+++ G S + + + APE
Sbjct: 108 YLESKNC--IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPE 164
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLS 278
+ G +++SDV+S+G++L E S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 3e-22
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 43/225 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLE 120
+ LGEG +G V+K D+ T G ++A+K RL+ E +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIPSTALR---- 47
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLS 177
EI L +L HPN+VKL+ + LV+E+ K L+ + I+ +
Sbjct: 48 ---EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM 104
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + L +GLAY HS ++++RD K NIL++ + KL+DFGLA+ G
Sbjct: 105 YQL-----L---RGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR--AFGIPL 152
Query: 238 HVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
T + T Y APE + + + TA D++S G + EM++G+
Sbjct: 153 RTYTHEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-22
Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 42/301 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPA-------RPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LGEG FG V + P R G +++AVK L + + ++L E+K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR--------TGASYIQP---- 175
L +L PN+++L+G C+++D ++ E+M G L L G + P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 176 --LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233
+S++ + VAL A G+ YL S ++RD T N L+ N K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 234 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-- 291
G + R + + A E + G T SDV++FGV L E+L + K +P E
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGELT 246
Query: 292 -HNLIEWAKPYLQ-SKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+IE A + + R+++ +G Y L ++C S + + RP+ +
Sbjct: 247 DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE---------LMLQCWSRDCRERPSFSD 297
Query: 349 V 349
+
Sbjct: 298 I 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYH 133
+GEG G VFK E TG +A+K++ L+G + L EIK L H
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P +VKL+ +LV E+MP L +PL KG+A
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ-SH-VSTRVMGTYGY 249
Y+H +++RD K +N+L+ + K++DFGLA+ SH V+TR Y
Sbjct: 114 YMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WY 166
Query: 250 AAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + D+++ G + E+L+G
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYHP 134
LGEG FG V + Y P TG +AVK L ES H+ L EI+ L LYH
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 135 NLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
N+VK G C ED L+ EF+P GSL+ +L R ++ ++K A+ KG+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGM 122
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAA 251
YL S + ++RD N+L++ + K+ DFGL K T + + V + + A
Sbjct: 123 DYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS 278
PE + SDV+SFGV L E+L+
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 9e-22
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMV-IAVKRLNQESL-QGHLEWLTEIKHLGQLY 132
LG G FG V++G D PG+G + +AVK L + + Q E+L E +
Sbjct: 3 LGSGAFGEVYEGTATDI-----LGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP--LSWTIRMKVALGAAK 190
HPN+VKL+G CL ++ + ++ E M G L ++L P L+ + + L AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 191 GLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
G YL ++ I+RD N L+ D + K+ DFGLA+D +
Sbjct: 118 GCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + G T +SDV+SFGV++ E+L+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 87/277 (31%), Positives = 131/277 (47%), Gaps = 37/277 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG V+KG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+ + G L+ ++ E++ GS + L + G PL T + KGL Y
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG-----PLEETYIATILREILKGLDY 116
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
LHS++ I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE
Sbjct: 117 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPEV 172
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 314
+ K+D++S G+ +E+ G P R LI P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------P 219
Query: 315 RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+EGQYS K V A CL+ +P+FRPT E++K
Sbjct: 220 TLEGQYS--KPFKEFVEA--CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 76 LGEGGFG----CVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKH 127
LGEG FG C +G ++D+ +++AVK L +++ + ++L EIK
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR------TGASYIQPLSWTIR 181
+ +L PN+++L+ C+ D ++ E+M G L L R + + +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ +A A G+ YL S ++RD T N L+ NY K++DFG++++ +G +
Sbjct: 133 IFMATQIASGMKYLSS--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
R + + + E + G T SDV++FGV L E+L+
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI-----QP------LSWTIRMKV 184
+VK G C + D ++V+E+M G L L G + QP L + + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A A G+ YL S ++RD T N L+ N K+ DFG+++D + V M
Sbjct: 129 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ PE + T +SDV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L +G L E K L ++
Sbjct: 1 LGKGGFGEV---------CACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 133 HPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV-ALGAAK 190
+V L Y E D LV M G L+ H++ G +P R A
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVG----EPGFPEARAIFYAAQIIC 106
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
GL +LH + +++YRD K N+LLD + N ++SD GLA + G + GT GY
Sbjct: 107 GLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYM 161
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + D ++ G L EM++GR
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------L 122
+F V+G+G FG V I + T + A+K +N+ Q +E L
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKRD------TKKMFAMKYMNK---QKCVEKGSVRNVL 48
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
E + L +L HP LV L Y +D+ + LV + + G L HL + + ++
Sbjct: 49 NERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----QVK 103
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ L YLHS +I+RD K NILLD + ++DF +A + + T
Sbjct: 104 FWIC-EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---T 157
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
GT GY APE + + D +S GV E L G+R
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 50/228 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F LG G FG V + H G+G A+K L++ + +E L E
Sbjct: 1 DDFEFIKTLGTGSFGRVM---LVRHK------GSGKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
+ L + HP LV L G +DD L LV E++P G L +HL ++G +
Sbjct: 52 KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSG-------------R 97
Query: 184 VALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
A+ L YLHS ++YRD K N+LLD + K++DFG AK
Sbjct: 98 FPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK------ 149
Query: 236 QSHVSTRVM---GTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSG 279
V R GT Y APE + + G+ A D ++ G+++ EML+G
Sbjct: 150 --RVKGRTYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 39/287 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ P VLG+G FG E T Y + +V L + S + + L EI
Sbjct: 1 HYIPIRVLGKGAFG--------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVI 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIRMKV 184
L L HPN++ + ++D+ L+ E+ G+L + + R + L + ++
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A+ +Y+H KA +++RD KT NI L KL DFG++K GS+ ++ V+
Sbjct: 113 AV------SYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV 162
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
GT Y +PE KSD+++ G VL E+L+ +R D P NL+
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV-------- 211
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+I Q + YS + L + V + L +P+ RPT DEV+
Sbjct: 212 --KIVQGNYTPVVSVYS--SELISLVHS--LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKH 127
F LGEG +G V+K + TG V+A+K + +E LQ E + EI
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE----------TGQVVAIKVVPVEEDLQ---EIIKEISI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L Q P +VK G ++ +V E+ GS+ + + T + + I
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI----LYQ 107
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
KGL YLHS+K I+RD K NILL+ AKL+DFG++ T + + +T V+GT
Sbjct: 108 TLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQ-LTDTMAKRNT-VIGTP 163
Query: 248 GYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
+ APE G+ K+D++S G+ +EM G+
Sbjct: 164 FWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 75/295 (25%), Positives = 123/295 (41%), Gaps = 33/295 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ESLQGHLEWLTEI 125
N + + LG G FG VF G ++ VK L + E+LQ E+ E+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKG----IEEEGGETLVLVKALQKTKDENLQ--SEFRREL 59
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI-----QPLSWTI 180
+L H N+V+L+G C E + ++ E+ G L+ L R S PLS
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL-RATKSKDEKLKPPPLSTKQ 118
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
++ + A G+ +L A+ ++RD N L+ K+S L+KD S+ +
Sbjct: 119 KVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKL 175
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
+ + APE + + KSDV+SFGV++ E+ + + E
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLN 229
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
LQ+ + V + Y L +C + PK RP+ E+V AL +
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMT---------RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 84/295 (28%), Positives = 132/295 (44%), Gaps = 44/295 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV-KRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V +G +++ M IA+ R E ++L+E + + HP
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFDHP 60
Query: 135 NLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLF--RTGASYIQPLSWTIRMKVAL 186
N+++LIG CL+ +++ FM G L + L R G P +M V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKF 117
Query: 187 GA--AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVST 241
A G+ YL S I+RD N +L+ N N ++DFGL+K +G Q ++
Sbjct: 118 MTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301
+ + A E +A T KSDV+SFGV + E+ + + P E++ I Y
Sbjct: 176 MPV---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEI---YDY 226
Query: 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
L+ R+ Q D ++G YSL + C PK RP+ + + LE+
Sbjct: 227 LRQGNRLKQPPDC-LDGLYSLMS---------SCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG+ A K + ES + +++ EI L + HPN
Sbjct: 13 LGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGA----SYIQPLSWTIRMKVALGAAKG 191
+V L ++ ++ EF G+L++ + I+ + + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
L +LHS K VI+RD K NILL L+ + KL+DFG++ + Q + +GT + A
Sbjct: 116 LNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 252 PEYMATGHLT-----AKSDVYSFGVVLLEMLSGR 280
PE +A K+D++S G+ L+E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF + H P + M++AVK L + S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG----------ASYIQPLSWTIRMKVA 185
+V+ G C E L+V+E+M G L L G L+ + +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
A G+ YL S ++RD T N L+ K+ DFG+++D + V R M
Sbjct: 129 SQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ PE + T +SD++SFGVVL E+ +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 50/295 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIK 126
+ + +G+G FG V G ++ G +AVK + N + Q +L E
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATAQA---FLAEAS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L G S L +K +
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFS 108
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
L + + YL ++ ++RD N+L+ + AK+SDFGL K+ + +Q V
Sbjct: 109 LDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKW 165
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
T APE + + KSDV+SFG++L E+ S RV PY
Sbjct: 166 T----APEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PY---P 201
Query: 306 RRIFQVMDARIEGQYSLGA--ALKTAVLAI--KCLSNEPKFRPTMDEVVKALEQI 356
R + + R+E Y + A V + +C + RP+ ++ + LE I
Sbjct: 202 RIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-20
Identities = 73/300 (24%), Positives = 120/300 (40%), Gaps = 78/300 (26%)
Query: 76 LGEGGFGCV----FKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL 131
LG G FG V ++G ID +A+K + + ++ +++ E K + +L
Sbjct: 12 LGSGQFGVVHLGKWRGKID--------------VAIKMIREGAMSED-DFIEEAKVMMKL 56
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRTGASYIQPLSWTIRMKVA 185
HPNLV+L G C + +V E+M G L N+L T + +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE----------WLLDMC 106
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVST 241
+ + YL S I+RD N L+ + K+SDFGLA+ D T SQ
Sbjct: 107 SDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----- 159
Query: 242 RVMGT---YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-----HN 293
GT +A PE ++KSDV+SFGV++ E+ S ++ + + E
Sbjct: 160 ---GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+P L ++ +M C +P+ RP +++ L
Sbjct: 217 GYRLYRPKLAPT-EVYTIMY--------------------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y +++AVK L S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI--------QPLSWTIRMKVALG 187
+VK G C+E D ++V+E+M G L L G + L+ + + +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
A G+ YL S ++RD T N L+ N K+ DFG+++D + V M
Sbjct: 129 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ PE + T +SDV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-------LQGHLEWL 122
++ ++G G +G V++G TG V+A+K +N ++ +Q + L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
++++ Q PN+ K G RL ++ E+ GS+ L + G I ++
Sbjct: 54 SQLRQ-SQP--PNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGP--IAEKYISVI 106
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
++ L A L Y+H K VI+RD K +NIL+ N KL DFG+A S S ST
Sbjct: 107 IREVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRST 160
Query: 242 RVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
V GT + APE + G K+D++S G+ + EM +G R LI +KP
Sbjct: 161 FV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
R+E L+ V A CL EPK R + +E++K
Sbjct: 220 -------------PRLEDN-GYSKLLREFVAA--CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 77/298 (25%), Positives = 124/298 (41%), Gaps = 66/298 (22%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG V+K ID+ T V+A+K ++ E + +E + EI+ L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
Q P + K G L+ ++ E+ GS L + G L T +
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG-----KLDETYIAFILREV 107
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR---VMG 245
GL YLH + I+RD K +NILL + KL+DFG++ G + ++ +G
Sbjct: 108 LLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVG 160
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR------------RVIDKNRPSREHN 293
T + APE + K+D++S G+ +E+ G +I KN P
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP----- 215
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
P L+ ++S K V CL+ +PK RP+ E++K
Sbjct: 216 ------PSLE-------------GNKFS--KPFKDFVSL--CLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ V+G G FG V + R ++ +K++ E + L E +
Sbjct: 1 KYEKIRVVGRGAFGIV---------HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQ 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIRMK 183
L L HPN+++ LED ++V E+ P G+L ++ + S + L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFGLAKDGPTGSQSHVSTR 242
+AL H +++RD KT NILLD + K+ DFG++K S+S T
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302
V+GT Y +PE KSD+++ G VL E+ S +R + NL P L
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANL-----PAL 209
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 350
K I A I +YS L+ +L++ L+ +P RP + +++
Sbjct: 210 VLK--IMSGTFAPISDRYS--PDLRQLILSM--LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 77/237 (32%), Positives = 114/237 (48%), Gaps = 31/237 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+AVK+++ Q + +W + E+K L QL
Sbjct: 29 IGHGSFGAV---------YFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
HPN ++ G L++ LV E+ GS + L + +PL + GA +GL
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAITHGALQGL 134
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
AYLHS +I+RD K NILL KL+DFG A S+S + +GT + AP
Sbjct: 135 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAP 186
Query: 253 EY---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQS 304
E M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNDSPTLQS 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 86/277 (31%), Positives = 129/277 (46%), Gaps = 37/277 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+ K G L+ ++ E++ GS + L R G +K L KGL Y
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGP--FDEFQIATMLKEIL---KGLDY 116
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
LHS+K I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPEV 172
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 314
+ +K+D++S G+ +E+ G P R LI P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------P 219
Query: 315 RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ G++S K + A CL+ +P FRPT E++K
Sbjct: 220 TLTGEFS--KPFKEFIDA--CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEI---KHLGQL 131
LGEG FG V K E T +AVK L ++ + L + ++E+ K +G+
Sbjct: 20 LGEGAFGQVVKA---EAVGLDNPNET-STVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-----TGASYI------QPLSWTI 180
H N++ L+G C ++ +V E+ G+L + L AS + L+
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
+ A A+G+ +L S K I+RD N+L+ ++ K++DFGLA+D +
Sbjct: 134 LVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
T + APE + T +SDV+SFGV+L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V GT + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVL---------LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HP L +L D V E++ G L H+ R+G + +P + ++ LG
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLG--- 108
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGY 249
L +LH +IYRD K N+LLD + K++DFG+ K+G G V+T GT Y
Sbjct: 109 -LQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDY 162
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE ++ D ++ GV+L EML+G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL---NQESLQGHLEWLTEIKHLGQLY 132
LG G G V K +H P TG V+A K + + S++ + L E++ + +
Sbjct: 13 LGAGNGGSVSKV---KH-----IP-TGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECR 61
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
P +V G L +++ + EFM GSL+ + G P+ I K+A+ +GL
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGL 116
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
YL+ + ++++RD K SNIL++ KL DFG++ + + ++ +GT Y +P
Sbjct: 117 TYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE----LINSIADTFVGTSTYMSP 171
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLSGR 280
E + G T KSDV+S G+ ++E+ G+
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + + + H ++ E++ L +L +
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTIR 181
HPN++ L+G C + L E+ P G+L + L F S LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 242 RVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ MG + A E + T SDV+S+GV+L E++S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG VF+G + P R + I + Q ++L+E +GQ H
Sbjct: 12 VIGAGEFGEVFRGILK----MPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHH 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+++L G + +++ E+M G+L+ +L R ++ G A G+ Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLR---GIAAGMKY 122
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAA 251
L ++RD NIL++ N K+SDFGL++ D P G+ + ++ + A
Sbjct: 123 L--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310
PE +A T+ SDV+SFG+V+ E++S G R PY +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER------------------PYWDMSNH--E 218
Query: 311 VMDARIEGQYSLGAALK--TAV--LAIKCLSNEPKFRPTMDEVVKALEQI 356
VM A +G + L A + +AV L ++C + RP ++V L+++
Sbjct: 219 VMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 45/222 (20%)
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQ 130
LG+G FG V+ + TG ++A+K++ + S + + L E+K L +
Sbjct: 5 KQLGDGTFGSVYLARNKE----------TGELVAIKKMKKKFYSWEECMN-LREVKSLRK 53
Query: 131 L-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF-----RTGASYIQPLSW-TIRMK 183
L HPN+VKL E+D V+E+M E +L+ R G +P S IR
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKG----KPFSESVIR-S 103
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ----SHV 239
+ +GLA++H K +RD K N+L+ K++DFGLA++ S+ +V
Sbjct: 104 IIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRSRPPYTDYV 159
Query: 240 STRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
STR Y APE + + ++ D+++ G ++ E+ + R
Sbjct: 160 STR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 50/290 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------------QESLQGHLEWL 122
LG G FGCV+K + ++A+K +N +S+ + +
Sbjct: 8 LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFM---PKGSLENHLFRTGASYIQPLSWT 179
T IK QL HPN+V+ LE+D +V + + P G N L + + W
Sbjct: 60 TIIKE--QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
I +++ L L YLH +K ++++RD +NI+L + ++DFGLAK +S +
Sbjct: 118 IFVQMVLA----LRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL 170
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
T V+GT Y+ PE + K+DV++FG +L +M + P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLAT 223
Query: 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349
+++ V + EG YS + CL+ + + RP + +V
Sbjct: 224 KIVEA------VYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V++G + T +AVK L ++ ++L E + + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
L++L C ++ +V E M GSL +L ++ L I M A A G+AYL
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK-LPQLIDM--AAQVASGMAYL 119
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTYGYAAPEY 254
+ I+RD N+L+ N K++DFGLA+ ++ + + APE
Sbjct: 120 EAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEA 175
Query: 255 MATGHLTAKSDVYSFGVVLLEMLS-GR 280
+ KSDV+SFG++L E+++ GR
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWL 122
+ R++ LGEG FG V+K + TG V+A+K++ + + + L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITAL 55
Query: 123 TEIKHLGQLYHPNLVKLIGYCLE--DDH---RLLVYEFMP------KGSLENHLFRTGAS 171
EIK L +L HPN+V LI +E D R VY P G LEN + S
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-- 229
I+ M L +G+ YLH + +++RD K +NIL+D K++DFGLA+
Sbjct: 116 QIKCY-----MLQLL---EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 230 -------DGPTGSQSHVSTRVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
G G + T ++ T Y PE + T D++ G V EM + R
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 67 TRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE- 124
R +LG G FG V KG WI P + +A+K + S + + +T+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIR 181
+ +G L H +V+L+G C +L V + P GSL +H+ R + P L+W ++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQ 117
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ AKG+ YL ++ ++++R+ NILL + +++DFG+A + + +
Sbjct: 118 I------AKGMYYL--EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ A E + G T +SDV+S+GV + EM+S
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+GEG FG V + I + G M A+K L + S H ++ E++ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 132 -YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP-----------LSWT 179
+HPN++ L+G C + + E+ P G+L + L ++ P L+
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
++ A A G+ YL S+K + I+RD N+L+ N +K++DFGL++ G + +V
Sbjct: 120 QLLQFASDVATGMQYL-SEK-QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173
Query: 240 STRVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ MG + A E + T KSDV+SFGV+L E++S
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 45/264 (17%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--------NQESLQGHLEWLT-E 124
+++G G FG V+ G +G ++AVK++ +++ + L+ L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
I L +L H N+V+ +G L+ DH + E++P GS+ L GA + + L +R V
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETL---VRNFV 112
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR-- 242
KGL YLH+ +I+RD K +NIL+D K+SDFG++K S S +
Sbjct: 113 R-QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 243 --VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------------RVIDKNR 287
+ G+ + APE + T K+D++S G +++EML+G+ ++ +
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229
Query: 288 PSREHNLIEWAKPYLQSKRRIFQV 311
P N+ A +L + F++
Sbjct: 230 PEIPSNISSEAIDFL---EKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ LG+G +G V+K R A+K ++ S+ + + + EI+
Sbjct: 1 DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L + HPN++ L+ + +V E+ P G L + + + ++ +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFI 110
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+GL LH K +++RD K++NILL N K+ D G++K + +++ +GT
Sbjct: 111 QLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGT 164
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
Y APE + KSD++S G +L EM + P E A+ +
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF-------APPFE------ARSMQDLRY 211
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349
++ + I YS L+ + + L +PK RP D++
Sbjct: 212 KVQRGKYPPIPPIYS--QDLQNFIRS--MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 46/295 (15%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G P + +A+K L + + ++L+E +GQ
Sbjct: 9 EEVIGAGEFGEVCRG----RLKLPGKREI--FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASY--IQPLSWTIRMKVALGAA 189
HPN++ L G + +++ EFM G+L++ L + + IQ L +R G A
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ-LVGMLR-----GIA 116
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG---T 246
G+ YL + ++RD NIL++ N K+SDFGL++ + T +G
Sbjct: 117 AGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305
+ APE +A T+ SDV+S+G+V+ E++S G R PY
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWDMS 216
Query: 306 RRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALEQI 356
+ V++A IE Y L + L + C + RP ++V L+++
Sbjct: 217 NQ--DVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLY 132
S +GEG +G V + T G+ +A+K+++ Q L EIK L +
Sbjct: 11 SYIGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 133 HPNLVK----LIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLS---------W 178
H N++ + E + + +V E M E L++ + Q LS
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKT--QHLSNDHIQYFLYQ 114
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-DGPTGSQS 237
+R GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+ P +
Sbjct: 115 ILR---------GLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 280
T + T Y APE M K+ D++S G +L EMLS R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQG---HLEWLT 123
+ LGEG + V+K D+ T G ++A+K +L + + L
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPL---SWTI 180
EIK L +L HPN++ L+ + LV+EFM LE + + + + P S+ +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYML 109
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
+GL YLHS+ +++RD K +N+L+ + KL+DFGLA+ GS +
Sbjct: 110 MT------LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKM 159
Query: 241 TRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
T + T Y APE H D++S G + E+L
Sbjct: 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 84/304 (27%), Positives = 138/304 (45%), Gaps = 58/304 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQGHLE-----WL 122
+ + V+G G FG V G + PG + +A+K L G+ E +L
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLK-------LPGKREIPVAIKTLKA----GYTEKQRRDFL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+E +GQ HPN++ L G + ++V E+M GSL+ L + + T+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF------TVIQ 107
Query: 183 KVAL--GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQS 237
V + G A G+ YL SD V +RD NIL++ N K+SDFGL++ D P + +
Sbjct: 108 LVGMLRGIASGMKYL-SDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296
++ + APE +A T+ SDV+S+G+V+ E++S G R
Sbjct: 166 TRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER--------------- 208
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKA 352
PY + + V+ A EG Y L A + L + C + RP +++V
Sbjct: 209 ---PYWEMSNQ--DVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262
Query: 353 LEQI 356
L+++
Sbjct: 263 LDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L+ G L E + L ++
Sbjct: 1 LGKGGFGEVC---------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 133 HPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
P +V L Y E H LV M G L+ H++ G ++ + I + G
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE-MERVIHYSAQI--TCG 107
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+ +LHS ++YRD K N+LLD N +LSD GLA + G T+ GT GY A
Sbjct: 108 ILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMA 162
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
PE + + D ++ G + EM++GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G+ + HT +A+K L Q S+ +L E + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGHTK----------VAIKSLKQGSMSPE-AFLAEANLMKQLQHPR 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
LV+L ++ ++ E+M GSL + L +T ++ I M A A+G+A++
Sbjct: 63 LVRLYAVVTQEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDM--AAQIAEGMAFI 118
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMGTYGYAAP 252
++ I+RD + +NIL+ K++DFGLA +D ++ + T AP
Sbjct: 119 --ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----AP 172
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
E + G T KSDV+SFG++L E+++ R+
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 46/218 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH-------L 128
+G+GG+G VF A + TG ++A+KR+ + L L E++H L
Sbjct: 9 VGQGGYGQVF--------LAKKK-DTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVAL 186
LVKL+ Y +DD L L E++P G L G S + M A+
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
A L Y+H RD K N L+D + + KL+DFGL+K T + S V
Sbjct: 115 DALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------- 159
Query: 247 YGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSG 279
+P+YMA L K D +S G +L E L G
Sbjct: 160 ---GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 68 RNFRPDSV------LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
R+ P+ V LG+G FG V+K E TG + A K + +S + ++
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDY 56
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
+ EI+ L HP +VKL+G D ++ EF P G+++ + +P I
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
++ + L YLHS K+I+RD K N+LL L+ + KL+DFG++ Q S
Sbjct: 117 RQML----EALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS- 169
Query: 242 RVMGTYGYAAPEY-----MATGHLTAKSDVYSFGVVLLEM 276
+GT + APE M K+D++S G+ L+EM
Sbjct: 170 -FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 23/223 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K LN+ + + ++E++ E + + H
Sbjct: 14 VLGSGAFGTVYKG-----IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSL----ENHLFRTGASYIQPLSWTIRMKVALGAA 189
P+LV+L+G CL +L V + MP G L H G+ + L+W +++ A
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQI------A 119
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
KG+ YL ++ ++++RD N+L+ + K++DFGLA+ + + + +
Sbjct: 120 KGMMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 291
A E + T +SDV+S+GV + E+++ G + D P+RE
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ Y ++ M +AVK L +E+L L+ ++ H
Sbjct: 42 TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS---H 94
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
LG H N+V L+G C L++ E+ G L N L R S+ L+ + +
Sbjct: 95 LGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQ 149
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
AKG+A+L S I+RD N+LL K+ DFGLA+D S V
Sbjct: 150 VAKGMAFLASKNC--IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + T +SDV+S+G++L E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 46/286 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLT-EIKHLGQLY 132
+G+G FG V K R G ++ K ++ ++ + L E+ L +L
Sbjct: 7 TIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 133 HPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHL--FRTGASYI-QPLSWTIRMKVALG 187
HPN+V+ ++ ++ L V E+ G L + + YI + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 188 AAKGLAYLH---SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
L H V++RD K +NI LD N N KL DFGLAK S T V
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYV- 171
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
GT Y +PE + KSD++S G ++ E+ + P A+ LQ
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------PPFT-------ARNQLQL 218
Query: 305 KRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPTMDE 348
+I + RI +YS L +K L+ +P RP+ +E
Sbjct: 219 ASKIKEGKFRRIPYRYSSELNEVIK------SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 6e-18
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 44/229 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
+ +G G +G V +D+ T G +A+K+++ + L L EIK
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 128 LGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
L L H N++ L+ + + +V E M + + + ++ QPL+ +
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSP----QPLT-DDHI 105
Query: 183 KV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTG 234
+ L +GL YLHS A VI+RD K SNIL++ N + K+ DFGLA+ D
Sbjct: 106 QYFLYQIL---RGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 235 SQ--SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 280
+V TR Y APE + + T D++S G + E+L+ +
Sbjct: 161 GFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-18
Identities = 75/266 (28%), Positives = 113/266 (42%), Gaps = 50/266 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIA---VKRLNQES-LQGHLEWLTEIKHLGQL 131
+G G FG V G GM A VK L + L +L E++ +L
Sbjct: 3 IGNGWFGKVLLGEAH----------RGMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+++ +G C+E LLV EF P G L+N+L Q + ++A A G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQSHVSTRVMG 245
L +LH +A I+ D N L + + K+ D+GLA + T V R
Sbjct: 113 LLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167
Query: 246 TYGYAAPEYMATGH-------LTAKSDVYSFGVVLLEM----------LSGRRVIDKNRP 288
+ APE + T KS+++S GV + E+ LS +V+ +
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQV 222
Query: 289 SREHNLIEWAKPYLQSK--RRIFQVM 312
RE + I+ KP L K R ++VM
Sbjct: 223 VREQD-IKLPKPQLDLKYSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LGE FG ++KG H Y P +V A+K L + Q E+ E + +L+HP
Sbjct: 13 LGECAFGKIYKG----HLYLPGMDHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRTGASYIQPLS---WTIR--------M 182
N+V L+G ++ +++E++ +G L L R+ S + S T++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+A+ A G+ YL S +++D NIL+ + K+SD GL+++ + V +
Sbjct: 128 HIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ + PE + G ++ SD++SFGVVL E+ S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 77/292 (26%), Positives = 135/292 (46%), Gaps = 60/292 (20%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V G W ++ +A+K + + S+ E++ E K + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMKLSHE 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
LV+L G C + +V E+M G L N+L R QP +++ +G+AY
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL---LEMCKDVCEGMAY 115
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVMGT---Y 247
L S + I+RD N L+D K+SDFGL++ D T S +G+
Sbjct: 116 LESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS--------VGSKFPV 165
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK--NRPSREH--NLIEWAKPYL 302
++ PE + ++KSDV++FGV++ E+ S G+ ++ N + E + +P+L
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL 225
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
S+ +++ +M YS C + + RPT +++ ++E
Sbjct: 226 ASE-KVYAIM-------YS-------------CWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 65/255 (25%), Positives = 120/255 (47%), Gaps = 33/255 (12%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + HPN+V++ L D +V EF+ G+
Sbjct: 43 TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 161 LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220
L + + T + Q + V L K L++LH+ VI+RD K+ +ILL +
Sbjct: 103 LTDIVTHTRMNEEQIAT------VCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRV 154
Query: 221 KLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
KLSDFG ++K+ P ++GT + APE ++ + D++S G++++EM
Sbjct: 155 KLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 336
+ G P + +P LQ+ +RI + +++ + + L++ + L
Sbjct: 209 VDG-------EPPY------FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS--FLDRML 253
Query: 337 SNEPKFRPTMDEVVK 351
+P R T E++
Sbjct: 254 VRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLYH 133
+G G FG VF G + +AVK +E+L L+ +L E + L Q H
Sbjct: 3 IGRGNFGEVFSGRLR---------ADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSH 52
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+V+LIG C + +V E + G L G L +++ AA G+
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGME 108
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YL S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 109 YLESKHC--IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLS 278
+ G +++SDV+SFG++L E S
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 42/226 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K RL+ E+ + EI
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFM-----------PKGSLENHLFRTGASYIQP 175
L +L HPN+VKL+ ++ LV+EF+ P + L + SY+
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK---SYLFQ 108
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
L +GLA+ HS + V++RD K N+L++ KL+DFGLA+ G
Sbjct: 109 L------------LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGV 152
Query: 236 QSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
T + T Y APE + + + D++S G + EM++ R
Sbjct: 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP-----------LSWTIR 181
HPN++ L+G C + L E+ P G+L + L ++ P LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167
Query: 242 RVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ MG + A E + T SDV+S+GV+L E++S
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
F+ VLG G FG V+KG WI P + +A+K L + S + + E L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL----ENHLFRTGASYIQPLSWTIRMK 183
+ + +P++ +L+G CL +L + + MP G L H G+ Y+ L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 118
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
AKG+ YL ++ ++++RD N+L+ + K++DFGLAK + + +
Sbjct: 119 -----AKGMNYL--EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ A E + T +SDV+S+GV + E+++
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 21/196 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLE---WLTEIKHLGQLYHPNLVKLI--GYCLEDDHRLLVYEF 155
TG +A+K L ++ + + + E +LYHPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 156 MPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL- 214
+P +L L GA P T R+ L LA H +++RD K NI++
Sbjct: 61 VPGRTLREVLAADGA---LPAGETGRL--MLQVLDALACAH--NQGIVHRDLKPQNIMVS 113
Query: 215 --DLNYNAKLSDFGLAKDGP-----TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVY 267
+ +AK+ DFG+ P + +T V+GT Y APE + +T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 268 SFGVVLLEMLSGRRVI 283
++G++ LE L+G+RV+
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + S + + E L E + +
Sbjct: 14 VLGSGAFGTVYKG-----IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF----RTGASYIQPLSWTIRMKVALGAA 189
P + +L+G CL +L V + MP G L +++ R G+ + L+W +++ A
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL--LNWCVQI------A 119
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
KG++YL ++ ++++RD N+L+ + K++DFGLA+ + + +
Sbjct: 120 KGMSYL--EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
A E + T +SDV+S+GV + E+++ G + D P+RE L+ R+
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE------IPDLLEKGERL 230
Query: 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
Q I+ ++ +KC + + RP E+V ++
Sbjct: 231 PQPPICTID----------VYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 58/290 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V G + +A+K +N+ ++ +++ E K + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQ----------IKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPK 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLF-RTGASYIQPLSWTIRMKVALGAAKGLAY 194
LV+L G C + +V EFM G L N+L R G LS + + + +G+ Y
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEGMEY 115
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAA 251
L ++ I+RD N L+ K+SDFG+ + D S S V ++
Sbjct: 116 L--ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSP 169
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRP-------SREHNLIEWAKPYLQ 303
PE ++KSDV+SFGV++ E+ + G+ +K SR L +P L
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---RPKLA 226
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
S +++VM C +P+ RPT E+++A+
Sbjct: 227 SM-TVYEVM--------------------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E++ L QL
Sbjct: 23 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGS----LENHLFRTGASYIQPLSWTIRMKVALGA 188
HPN ++ G L + LV E+ GS LE H +PL + GA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK--------KPLQEVEIAAICHGA 124
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
+GLAYLHS + I+RD K NILL KL+DFG A S + +GT
Sbjct: 125 LQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPY 176
Query: 249 YAAPEY---MATGHLTAKSDVYSFGVVLLEM 276
+ APE M G K DV+S G+ +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 75/303 (24%), Positives = 112/303 (36%), Gaps = 59/303 (19%)
Query: 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQ 130
+GEG FG V++G Y + + +AVK + E +L E + Q
Sbjct: 10 LGRCIGEGQFGDVYQG-----VYM-SPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HP++VKLIG ++ +V E P G L ++L L + + +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLST 118
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
LAYL S + ++RD N+L+ KL DFGL++ S S + +
Sbjct: 119 ALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWM 175
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS----------GRRVIDK----NRPSREHNLIE 296
APE + T+ SDV+ FGV + E+L VI + R N
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN--- 232
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
P L YS L KC + +P RP E+ L I
Sbjct: 233 -CPPTL-----------------YS---------LMTKCWAYDPSKRPRFTELKAQLSDI 265
Query: 357 QDT 359
Sbjct: 266 LQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
+F LG G G V K H +G+++A K + HLE
Sbjct: 2 DFEKLGELGAGNGGVVTKV---LHRP------SGLIMARKLI-------HLEIKPAIRNQ 45
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
+ E+K L + P +V G D + E M GSL+ L + G + I
Sbjct: 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPENI 100
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
K+++ +GL YL +K K+++RD K SNIL++ KL DFG++ Q S
Sbjct: 101 LGKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDS 153
Query: 241 --TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
+GT Y +PE + H T +SD++S G+ L+EM GR
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 70/216 (32%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKH 127
FR +VLG G FG V + E+ TG + A+K L + + +E L K
Sbjct: 1 FRCLAVLGRGHFGKVL---LAEYK------KTGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 128 L----GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
+ HP LV L +DH V E+ G L H+ + +P +
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAAC 109
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
V LG L YLH +K ++YRD K N+LLD K++DFGL K+G G ST
Sbjct: 110 VVLG----LQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-F 161
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
GT + APE + T D + GV++ EML G
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 89/312 (28%), Positives = 136/312 (43%), Gaps = 70/312 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E+K L ++
Sbjct: 33 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
HPN ++ G L + LV E+ GS + L + +PL + GA +GL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAITHGALQGL 138
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
AYLHS +I+RD K NILL KL+DFG A S + + +GT + AP
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAP 190
Query: 253 EY---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQSKR- 306
E M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249
Query: 307 ----RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL--------- 353
R F +D+ CL P+ RPT +E++K +
Sbjct: 250 SDYFRNF--VDS--------------------CLQKIPQDRPTSEELLKHMFVLRERPET 287
Query: 354 ---EQIQDTNDA 362
+ IQ T DA
Sbjct: 288 VLIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G P T +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRT---GASYIQPLSWTIRMKVALGAA 189
++V+L+G + L++ E M +G L+++L R P S +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
G+AYL+++K ++RD N ++ ++ K+ DFG+ +D + + +
Sbjct: 130 DGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEM 276
+PE + G T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG++ A K ++ +S + +++ EI L HPN
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+VKL+ +++ ++ EF G+++ + +P IR+ V + L YL
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEP---QIRV-VCKQTLEALNYL 119
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
H +K +I+RD K NIL L+ + KL+DFG++ Q S +GT + APE +
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVV 175
Query: 256 ATGH-----LTAKSDVYSFGVVLLEM 276
K+DV+S G+ L+EM
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 20/234 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + HPN
Sbjct: 27 IGQGASGTV---------YTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V + L D +V E++ GSL + + T Q + V + L +L
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFL 131
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
HS++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 132 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 256 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 308
K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT 123
N+R +LG G FG V Y TG +AVK++ +QE+ +
Sbjct: 3 NWRLGKLLGRGAFGEV---------YLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRTGASYIQPLSWTI 180
EI+ L L H +V+ G CL D + +L ++ E+MP GS+++ L GA L+ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-----LTENV 107
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
+ +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 108 TRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 241 TR-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ V GT + +PE ++ K+DV+S ++EML+
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 28/222 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLT-- 123
N+R +LG+G FG V+ + +D TG +A K++ + ES + E
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 124 -EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRTGASYIQPLSWT 179
EI+ L L H +V+ G CL D + L ++ E+MP GS+++ L GA L+ +
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTES 106
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 107 VTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164
Query: 240 STR-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
R V GT + +PE ++ K+DV+S G ++EML+ +
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 70/247 (28%), Positives = 95/247 (38%), Gaps = 58/247 (23%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGH-LEWLTEI 125
+F V+G G FG V+ TG V A+K L + + + E
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWT----I 180
L P +VKL Y +D+ L LV E+MP G L N L R + P
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIA 108
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS--- 237
+ +AL + L ++H RD K NIL+D + + KL+DFGL K
Sbjct: 109 ELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 238 -------------------HVSTRVM-----GTYGYAAPE-YMATGHLTAKSDVYSFGVV 272
H RV GT Y APE T + + D +S GV+
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVI 219
Query: 273 LLEMLSG 279
L EML G
Sbjct: 220 LYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G VFK +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ L + P +V G D + E M GSL+ L + G Q L KV+
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVS 109
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+ KGL YL +K K+++RD K SNIL++ KL DFG++ ++ +G
Sbjct: 110 IAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVG 164
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
T Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLE---WLT 123
N+R +LG+G FG V Y TG +AVK++ + ES + E
Sbjct: 3 NWRLGKLLGQGAFGRV---------YLCYDADTGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRTGASYIQPLSWTI 180
EI+ L L H +V+ G CL D + L ++ E MP GS+++ L GA L+ +
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENV 107
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 108 TRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165
Query: 241 TR-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
+ V GT + +PE ++ K+D++S G ++EML+ +
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 39/294 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY 132
+LG+G FG V + + G+ +AVK L + E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLF--RTGASYIQPLSWTIRMKV 184
HPN++KLIG L + +++ FM G L L R G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRF 118
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
+ A G+ YL S I+RD N +L+ N ++DFGL+K +G
Sbjct: 119 MIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK--PYL 302
+ A E +A T SDV++FGV + E+++ R + +E ++ YL
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEIYNYL 228
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
R+ Q D +E Y L +C S EPK RP+ + LE I
Sbjct: 229 IKGNRLKQPPDC-LEDVYE---------LMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 20/234 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G VF TG +A+K++N + + EI + +L +PN
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V + L D +V E++ GSL + + T Q + V + L +L
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFL 131
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
H+++ VI+RD K+ N+LL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 132 HANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 256 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 308
K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+LN++ L +G+ + E + L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRT-----GASYIQPLSWTIRMKVAL 186
H + + Y + L LV M G L H++ G + +T ++
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI---- 106
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRV 243
GL +LH + ++IYRD K N+LLD + N ++SD GLA KDG + ++ +
Sbjct: 107 --ISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---- 158
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT G+ APE + D ++ GV L EM++ R
Sbjct: 159 -GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 74/247 (29%), Positives = 111/247 (44%), Gaps = 48/247 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRTG-ASYIQPLSWTIRMKV 184
+ + + V + Y E D LV M G L+ H++ G A + + +
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-------RA 104
Query: 185 ALGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
AA+ GL LH ++ ++YRD K NILLD + + ++SD GLA P G +
Sbjct: 105 VFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKG 160
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301
RV GT GY APE + T D ++ G +L EM++G+ P+
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ------------------SPF 201
Query: 302 LQSKRRI 308
Q K++I
Sbjct: 202 QQRKKKI 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 40/282 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + +T +AVK L ++ +L E + + +L H
Sbjct: 14 LGNGQFGEVWMGTWNGNTK----------VAVKTLKPGTMSPE-SFLEEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
LV+L + ++ +V E+M KGSL + L + G L + M A A G+AY+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAAPE 253
++ I+RD +++NIL+ K++DFGLA+ + + R + + APE
Sbjct: 119 --ERMNYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QSKRRIFQVM 312
G T KSDV+SFG++L E+++ RV PY + R + + +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMNNREVLEQV 216
Query: 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
+ + L ++C +P+ RPT + + LE
Sbjct: 217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R D LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTW----------NGTTKV-AIKTLKPGTMMPE-AFLQEAQI 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ +L H LV L + ++ +V EFM KGSL + L Y++ L + M +
Sbjct: 55 MKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLK-LPQLVDMAAQI- 111
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
A G+AY+ ++ I+RD + +NIL+ N K++DFGLA+ + + R +
Sbjct: 112 -ADGMAYI--ERMNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKF 165
Query: 248 --GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QS 304
+ APE G T KSDV+SFG++L E+++ RV PY
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMV 208
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
R + + ++ G L C +P RPT + + LE
Sbjct: 209 NREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 8e-16
Identities = 70/238 (29%), Positives = 109/238 (45%), Gaps = 20/238 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + +PN
Sbjct: 27 IGQGASGTV---------YTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V + L D +V E++ GSL + + T Q + V + L +L
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFL 131
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
HS++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 132 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 256 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRIFQVM 312
K D++S G++ +EM+ G P R LI P LQ+ R+ V
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 32/288 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G + T +AVK +N+ SL+ +E+L E +
Sbjct: 14 LGQGSFGMVYEGNARD--IIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRTGASYIQ---PLSWTIRMKVALGAA 189
++V+L+G + L+V E M G L+++L R A P + +++A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
G+AYL++ K ++RD N ++ ++ K+ DFG+ +D + + +
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKRR 307
APE + G T SD++SFGVVL E+ S L E +PY L +++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAE--QPYQGLSNEQV 230
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
+ VMD Q T ++ + C PK RPT E+V L+
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 18/175 (10%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
Q P + KL D+ LV E++ G + + G P W +
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWA--KQYIAEVV 107
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
G+ LH +I+RD K N+L+D + KL+DFGL+++G + + +GT Y
Sbjct: 108 LGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDY 159
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-----EHNLIEWAK 299
APE + SD +S G V+ E L G P I W +
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 32/201 (15%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT--EIKHLGQLYHPNLVKLIGYC---LEDDHRLLVYEF 155
TG +A+K++ + L T E+K L L H N++ L LED + V E
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY--FVTEL 91
Query: 156 MPKGSLENHLFRTG---ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212
+ G+ + L + +IQ + I +GL Y+HS A V++RD K SNI
Sbjct: 92 L--GTDLHRLLTSRPLEKQFIQYFLYQI--------LRGLKYVHS--AGVVHRDLKPSNI 139
Query: 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGV 271
L++ N + K+ DFGLA+ +VSTR Y APE M T + D++S G
Sbjct: 140 LINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGC 194
Query: 272 VLLEMLSGRRVIDKNRPSREH 292
+ EML G+ + P ++H
Sbjct: 195 IFAEMLEGKPLF----PGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FGCV KG Y + + I V + E E + E + + QL +P
Sbjct: 3 LGSGNFGCVKKG-----VYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPY 56
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM--KVALGAAKGLA 193
+V++IG C E + +LV E G L + F +G +S + + +V++G +
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMG----MK 109
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAA 251
YL + ++RD N+LL + AK+SDFGL+K S+ R G + + A
Sbjct: 110 YL--EGKNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYA 166
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS 278
PE + +++SDV+S+G+ + E S
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V G AVK L ++++ E KH
Sbjct: 2 VIGKGSFGKVLLA---------KHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV- 184
L + HP LV L Y + +L V +++ G L HL R S+ +P R +
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEP-----RARFY 101
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A A L YLHS +IYRD K NILLD + L+DFGL K+G S++ ++
Sbjct: 102 AAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFC 157
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
GT Y APE + D + G VL EML G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG +G V+K D+ T G ++A+K RL+ E + + EIK L QL
Sbjct: 13 GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 132 YHPNLVKLIGYCLEDDHRL----------LVYEFMPK---GSLENHLFRTGASYIQPLSW 178
H N+V L + L LV+E+M G LE+ L +I+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-- 121
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
MK L +GL Y H K ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 122 ---MKQLL---EGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 239 VSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287
+ +V+ T Y PE + DV+S G +L E+ + + + N+
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 38/199 (19%)
Query: 101 TGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
TG + A+K + + + + LTE L Q P +VKL Y + L LV E
Sbjct: 17 TGDIYAIKVIKKADMIRKNQVDQV--LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVME 73
Query: 155 FMPKGSLENHLFRTGA-------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
++P G L + L G+ YI + L YLHS+ +I+RD
Sbjct: 74 YLPGGDLASLLENVGSLDEDVARIYIAEI------------VLALEYLHSNG--IIHRDL 119
Query: 208 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS------TRVMGTYGYAAPEYM-ATGHL 260
K NIL+D N + KL+DFGL+K G Q +++ R++GT Y APE + GH
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH- 178
Query: 261 TAKSDVYSFGVVLLEMLSG 279
+ D +S G +L E L G
Sbjct: 179 SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 48/293 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R + LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW----------NGTTRV-AIKTLKPGTMSPE-AFLQEAQV 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ +L H LV+L + ++ +V E+M KGSL + L Y++ L + M +
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR-LPQLVDMAAQI- 111
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
A G+AY+ ++ ++RD + +NIL+ N K++DFGLA+ + + R +
Sbjct: 112 -ASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKF 165
Query: 248 --GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
+ APE G T KSDV+SFG++L E+ + RV PY
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMV 208
Query: 306 RRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALE 354
R +V+D ++E Y + + L +C EP+ RPT + + LE
Sbjct: 209 NR--EVLD-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 46/288 (15%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPAR---PGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G FG V+ ++HT + PG+ V A +L E +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--------------FLAEANVMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
L H LVKL + + ++ EFM KGSL + L ++ QPL I + A
Sbjct: 57 TLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQI--A 112
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY-- 247
+G+A++ ++ I+RD + +NIL+ + K++DFGLA+ + + R +
Sbjct: 113 EGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPI 167
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QSKR 306
+ APE + G T KSDV+SFG++L+E+++ R+ PY S
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-----------------PYPGMSNP 210
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
+ + ++ + + ++C N P+ RPT + + L+
Sbjct: 211 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 41/283 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G+ + T +AVK L S+Q LE E + L H
Sbjct: 14 LGAGQFGEVWMGYYNNSTK----------VAVKTLKPGTMSVQAFLE---EANLMKTLQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LV+L +++ ++ E+M KGSL + L + L I + A+G+A
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQI--AEGMA 117
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAA 251
Y+ ++ I+RD + +N+L+ + K++DFGLA+ + + R + + A
Sbjct: 118 YI--ERKNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTA 172
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311
PE + G T KSDV+SFG++L E+++ ++ P ++ + A LQ R+ ++
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKI---PYPGMSNSDVMSA---LQRGYRMPRM 226
Query: 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
+ E L +KT C + + RPT D + L+
Sbjct: 227 ENCPDE----LYDIMKT------CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G V+KG TG ++A+K++ ES + + + EI L +L H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGAS-YIQPL---SWTIRMKVALGAA 189
PN+V L +++ L++EF+ L+ +L Y+ S+ ++
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------L 111
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+G+ + HS +V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 112 QGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 250 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + + + D++S G + EM + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR------LNQESLQGHLE 120
NF+ + +G+G F V+K G V+A+K+ ++ ++ Q +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQ---D 48
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE---NHLFRTGASYIQPLS 177
L EI L QL HPN++K + +E++ +V E G L H + +
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
W +++ L ++HS ++++RD K +N+ + KL D GL + S++
Sbjct: 109 WKYFVQL----CSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKT 160
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
+ ++GT Y +PE + KSD++S G +L EM
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 64/312 (20%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQG 117
L T F V+GEG +G V+K + T G ++A+K ++ +E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEEEEIKE 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL------LVYEFMPKGS---LENHLFRT 168
L + HPN+ G ++ + LV E GS L L +
Sbjct: 52 EYNIL---RKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 169 GASYIQP-LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227
G + +++ +R +GLAYLH +K VI+RD K NILL N KL DFG+
Sbjct: 107 GKRLKEEWIAYILR-----ETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 228 AKDGPTGSQSHVSTR--VMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGR 280
+ S + R +GT + APE +A A+SDV+S G+ +E+ G+
Sbjct: 160 SAQ----LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
Query: 281 RVIDKNRPSREHNLIEWAK-PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNE 339
+ P R I P L+S + + I +CL
Sbjct: 216 PPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFIS----------------ECLIKN 259
Query: 340 PKFRPTMDEVVK 351
+ RP M+E+++
Sbjct: 260 YEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 69 NFRPDSVLGEGGFG--CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ +G G FG + + I EH YA VI RL QE H+ E +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI---RLKQEQ---HVH--NEKR 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
L ++ HP +++L + E D R L + E++P G L ++L R + S + +
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRF----SNSTGLFY 106
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR-- 242
A L YLHS +++YRD K NILLD + KL+DFG AK + R
Sbjct: 107 ASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTW 156
Query: 243 -VMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSG 279
+ GT Y APE + GH A D ++ G+++ EML G
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V YA T + IA+K + + + EI L H
Sbjct: 15 VLGKGTYGIV---------YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM--KVALGAAKGL 192
N+V+ +G E+ + E +P GSL L R+ ++ TI K L +GL
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQIL---EGL 121
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
YLH + ++++RD K N+L++ Y+ K+SDFG +K + + GT Y
Sbjct: 122 KYLHDN--QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYM 176
Query: 251 APEYMATGH--LTAKSDVYSFGVVLLEMLSGR 280
APE + G A +D++S G ++EM +G+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 76 LGEGGFGCVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHL 128
LGEG FG V ID+ +P + +AVK L ++ + L L +K +
Sbjct: 23 LGEGCFGQVVMAEALGIDKD-----KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLS 177
G+ H N++ L+G C +D ++ E+ KG+L +L + + ++
Sbjct: 78 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + A+G+ YL S K I+RD N+L+ N K++DFGLA+D
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKC--IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+T + APE + T +SDV+SFGV++ E+ +
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 6 MVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
P + + C + RL V E++ G L H+ + G + +P + ++A+G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIG-- 113
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYG 248
L +LHS +IYRD K N++LD + K++DFG+ K+ G +TR GT
Sbjct: 114 --LFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPD 166
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE +A D ++FGV+L EML+G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+LG G G V+K + T ++AVK + + +++ + ++E++ L +
Sbjct: 8 ILGHGNGGTVYKAY---------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P ++ G ++ + EFM GSL+ + + + + ++A+ KGL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLT 109
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YL S K+++RD K SN+L++ KL DFG++ T + ++ +GT Y APE
Sbjct: 110 YLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPE 163
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGR 280
++ SDV+S G+ +E+ GR
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--H 133
LGEG FG V + + + +RP + +AVK L + L L L +L H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTIRM 182
N++ L+G C ++ ++ E+ KG+L L F + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
A A+G+ YL S + I+RD N+L+ + K++DFGLA+ ++
Sbjct: 138 SCAYQVARGMEYLESRRC--IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + T +SDV+SFG+++ E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y V+A+K+++ Q + +W + E++ L +L
Sbjct: 23 IGHGSFGAV---------YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
HPN ++ G L + LV E+ GS + L + +PL V GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGL 128
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
AYLHS +I+RD K NILL KL DFG A S + +GT + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAP 180
Query: 253 EY---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQSKRR 307
E M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPALQSG-- 237
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK------------ALEQ 355
+S + V + CL P+ RPT + ++K ++
Sbjct: 238 -----------HWS--EYFRNFVDS--CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 356 IQDTNDA 362
IQ T DA
Sbjct: 283 IQRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LG G FG V KG + +AVK L ++ L E L E + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKK-------SEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P +V++IG C E + +LV E G L L + + ++ + + G+
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ-----VSMGMK 109
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAA 251
YL ++ ++RD N+LL + AK+SDFGL+K +++ + G + + A
Sbjct: 110 YL--EETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYA 166
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLS 278
PE M ++KSDV+SFGV++ E S
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 57/225 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G VFK E TG ++A+K+ +++ L EI+ L QL H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 134 PNLVKLI-------------GYCLEDDHRLL-VYEFMPKGSLENHLFRTGASYIQPLSWT 179
PNLV LI YC DH +L E P+G E+ I+ + W
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGVPEHL--------IKKIIWQ 108
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQS 237
+ + + H K I+RD K NIL+ KL DFG A+ GP +
Sbjct: 109 T--------LQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
Query: 238 -HVSTRVMGTYGYAAPEYMATGHLTAKS--DVYSFGVVLLEMLSG 279
+V+TR Y APE + G DV++ G V E+L+G
Sbjct: 159 DYVATR-----WYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G V+K D T IA+K RL QE + EI L ++ H
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRTGASYIQPLSWTIRMKVALGA 188
N+V+L + LV+E++ L+ H+ F I+ + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI-------- 111
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+G+AY HS + V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 112 LRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 248 GYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + H + D++S G + EM++ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
+F VLG+G FG V R GT + A+K L ++ + +E + E
Sbjct: 1 DFNFLMVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ L P + + C + RL V E++ G L H+ + G + +P + ++
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEI 110
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
++G L +LH + +IYRD K N++LD + K++DFG+ K+ V+TR
Sbjct: 111 SVG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTF 161
Query: 245 -GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284
GT Y APE +A D +++GV+L EML+G+ D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 71/210 (33%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY 132
VLG+G FG VF P G + A+K L + +L+ + E L ++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA-AK 190
HP +VKL Y + + +L L+ +F+ G L L + + + +K L A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSK------EVMFTEEDVKFYLAELAL 109
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
L +LHS +IYRD K NILLD + KL+DFGL+K+ + S GT Y
Sbjct: 110 ALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 251 APEYM-ATGHLTAKSDVYSFGVVLLEMLSG 279
APE + GH T +D +SFGV++ EML+G
Sbjct: 166 APEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 53/225 (23%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPG-TGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V++ AR +G ++A+K R++ E + L EI L L
Sbjct: 15 IGEGTYGIVYR----------ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR 64
Query: 133 HPNLVKL---------------IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177
HPN+V+L + YC +D LL + MP P S
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP----------------TPFS 106
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + L +GL YLH + +I+RD K SN+LL K++DFGLA+ G +
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162
Query: 238 HVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
T + T Y APE + T + TA D+++ G +L E+L+ +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 61/222 (27%), Positives = 89/222 (40%), Gaps = 50/222 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLGQ 130
LG GGFG V A+K + + Q H+ +E + L +
Sbjct: 1 LGVGGFGRVELV-----KVKS----KNRTFALKCVKKRHIVETGQQEHI--FSEKEILEE 49
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI-RMKVALGAA 189
HP +VKL + + ++ E+ G L WTI R +
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL----------------WTILRDRGLFDEY 93
Query: 190 KG----------LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
YLH+ +IYRD K N+LLD N KL DFG AK +G ++
Sbjct: 94 TARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151
Query: 240 STRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y APE + G+ + D +S G++L E+L+GR
Sbjct: 152 ---FCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 76/230 (33%), Positives = 107/230 (46%), Gaps = 59/230 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT--EIKHL 128
LG+G +G V+K ID T V+A+K++ N Q T EI L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKIFDAFRNATDAQ-----RTFREIMFL 60
Query: 129 GQLY-HPNLVKLIG-YCLEDDHRL-LVYEFMP--------KGSLEN-HLFRTGASYI--Q 174
+L HPN+VKL+ E+D + LV+E+M LE+ H YI Q
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH-----KRYIMYQ 115
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DG 231
L K L Y+HS VI+RD K SNILL+ + KL+DFGLA+ +
Sbjct: 116 LL-------------KALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
++ V T + T Y APE + + T D++S G +L EML G+
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E +
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
L ++ +V L Y E D LV M G L+ H++ G +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD------EERAV 105
Query: 186 LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
AA+ GL LH ++ ++YRD K NILLD + ++SD GLA + P G + R
Sbjct: 106 FYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
V GT GY APE + T D + G ++ EM+ G+
Sbjct: 162 V-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVS 240
K+A+ K L YLHS K VI+RD K SN+L++ N KL DFG+ +G S
Sbjct: 107 KIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAK 160
Query: 241 TRVMGTYGYAAPEY----MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
T G Y APE + KSDV+S G+ ++E+ +GR D
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS----------- 209
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
W P+ Q K+ + + ++S KCL K RP E+++
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN----KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LGE FG V+KG H + A +A+K L ++ +G L E+ E +L H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF--------------RTGASYIQPLSWT 179
PN+V L+G ++ +++ + L L +T S ++P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ + A G+ +L S V+++D T N+L+ N K+SD GL ++ +
Sbjct: 127 --VHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ + +PE + G + SD++S+GVVL E+ S
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 63/191 (32%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 101 TGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHRLLVYE 154
TG V+AVK++ N+E + L L + H P +VK GY + D + E
Sbjct: 39 TGHVMAVKQMRRTGNKEENKRILMDLDVV----LKSHDCPYIVKCYGYFITDSDVFICME 94
Query: 155 FMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214
M L+ L R P+ I K+ + K L YL +K VI+RD K SNILL
Sbjct: 95 LM-STCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYL-KEKHGVIHRDVKPSNILL 148
Query: 215 DLNYNAKLSDFGLAKDGP-TGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSF 269
D + N KL DFG++ G S++ TR G Y APE + ++DV+S
Sbjct: 149 DASGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
Query: 270 GVVLLEMLSGR 280
G+ L+E+ +G+
Sbjct: 205 GISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLY 132
++GEG +G V K E TG ++A+K+ + ++ + EI+ L QL
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPK---GSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
H NLV LI LV+EF+ LE + S ++ + I
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--------L 110
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+G+ + HS +I+RD K NIL+ + KL DFG A+ + V T + T Y
Sbjct: 111 RGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWY 166
Query: 250 AAPEYMATGHLTAKS-DVYSFGVVLLEMLSG 279
APE + ++ D+++ G ++ EML+G
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P +AVK L ++ + L L +K +G+
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 82
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTI 180
H N++ L+G C +D ++ E+ KG+L +L + + LS+
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D H+
Sbjct: 142 LVSCAYQVARGMEYLASKKC--IHRDLAARNVLVTEDNVMKIADFGLARD-----IHHID 194
Query: 241 TRVMGTYG-----YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
T G + APE + T +SDV+SFGV+L E+ +
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 68/255 (26%), Positives = 121/255 (47%), Gaps = 33/255 (12%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + +H N+V + L D +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 161 LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220
L + + T + Q + V L + L+YLH+ VI+RD K+ +ILL +
Sbjct: 106 LTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRI 157
Query: 221 KLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
KLSDFG ++K+ P ++GT + APE ++ + D++S G++++EM
Sbjct: 158 KLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 336
+ G P + +P LQ+ RRI + R++ + + + L+ L + L
Sbjct: 212 IDG-------EPPY------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-GFLDLM-L 256
Query: 337 SNEPKFRPTMDEVVK 351
EP R T E+++
Sbjct: 257 VREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 22/235 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A++++N + + EI + + +PN
Sbjct: 28 IGQGASGTV---------YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V + L D +V E++ GSL + + T Q + V + L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFL 132
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-AKDGPTGSQSHVSTRVMGTYGYAAPEY 254
HS++ VI+RD K+ NILL ++ + KL+DFG A+ P S+ + ++GT + APE
Sbjct: 133 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 187
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 308
+ K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P + +AVK L ++ L L +K +G+
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK- 76
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTI 180
H N++ L+G C +D ++ E+ KG+L +L F T + L++
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D +
Sbjct: 136 LVSCAYQVARGMEYLASQKC--IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
T + APE + T +SDV+SFGV+L E+ +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 73/230 (31%), Positives = 112/230 (48%), Gaps = 38/230 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKH 127
VLG+GG+G VF+ TG + A+K L + ++ H + E
Sbjct: 2 KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L + HP +V LI Y + +L L+ E++ G L HL R G +++ + +++L
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISL 111
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG-PTGSQSHVSTRVMG 245
L +LH + +IYRD K NILLD + KL+DFGL K+ G+ +H G
Sbjct: 112 A----LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCG 162
Query: 246 TYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG---------RRVIDK 285
T Y APE M +GH A D +S G ++ +ML+G ++ IDK
Sbjct: 163 TIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 69/212 (32%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA-- 188
HP L L Y + RL V E+ G L HL R + + R + GA
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSED-----RARF-YGAEI 104
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
L YLHS V+YRD K N++LD + + K++DFGL K+G + + GT
Sbjct: 105 VSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 160
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + D + GVV+ EM+ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A KRL ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ + + V + Y E D LV M G L+ H++ G + +
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERAL 105
Query: 186 LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
AA+ GL LH + +YRD K NILLD + ++SD GLA P G + R
Sbjct: 106 FYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGR 161
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
V GT GY APE + T D + G ++ EM+ G+
Sbjct: 162 V-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 30/213 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K RL E + EI L +L
Sbjct: 7 IGEGTYGVVYK----------ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPL---SWTIRMKVALGA 188
HPN+V+L+ + +++L LV+EF+ L+ ++ + + + P S+ ++
Sbjct: 57 HPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL------ 108
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
+G+AY HS +V++RD K N+L+D KL+DFGLA+ G T + T
Sbjct: 109 LQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLW 164
Query: 249 YAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + + D++S G + EM++ R
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG VFK H T ++A+K+ + E + L EIK L L H
Sbjct: 20 IGQGTFGEVFKA---RHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 134 PNLVKLIGYC-----LEDDHR---LLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRM 182
N+V LI C + ++ LV+EF G L N + S I+ + M
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-----M 125
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVS 240
K+ L GL Y+H +K +++RD K +NIL+ + KL+DFGLA+ S+ +
Sbjct: 126 KMLL---NGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 241 TRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEM 276
T + T Y PE + D++ G ++ EM
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
+LG+G FG VF + GT A+K L ++ + +E K + L
Sbjct: 2 MLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 133 --HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
HP L L YC ++ V E++ G L H+ ++ + P + ++ G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICG- 108
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
L +LHS ++YRD K NILLD + + K++DFG+ K+ G + GT
Sbjct: 109 ---LQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPD 161
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + D +SFGV+L EML G+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQL 131
+L EG FG +F G IDE +PG + VK + + +Q L L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGL 65
Query: 132 YHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYI-----QPLSWTIRMKVA 185
H N++ ++ C+ED + ++Y +M G+L+ LF Q LS + +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPT-----GSQSHV 239
+ A G++YLH K VI++D N ++D K++D L++D P G +
Sbjct: 124 IQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ M A E + ++ SDV+SFGV+L E+++
Sbjct: 182 PVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 69/225 (30%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ + + V + Y E D LV M G L+ H++ G +
Sbjct: 52 RILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD------EQRAI 105
Query: 186 LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
AA+ GL L + +++YRD K NILLD + ++SD GLA P G V R
Sbjct: 106 FYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR 161
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287
V GT GY APE + T D + G ++ EM+ G+ K +
Sbjct: 162 V-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ S +G G +G V A TG +A+K+L++ +S E++
Sbjct: 17 YQNLSPVGSGAYGQVCS--------AFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 128 LGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRT---GASYIQPLSW 178
L + H N++ L+ LV M G+ N++ + +IQ L +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
I +GL Y+HS A +I+RD K SNI ++ + K+ DFGLA+ +
Sbjct: 126 QI--------LRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175
Query: 239 VSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR 280
V+TR Y APE M H D++S G ++ E+L+G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 73/214 (34%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V R G AVK L ++ + E KH
Sbjct: 2 VIGKGSFGKVL---------LAKRKLDGKCYAVKVLQKKIVLNR----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
L + HP LV L Y + +L V +F+ G L HL R S+ +P + R A
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRA---RFYAA 103
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
A L YLHS ++YRD K NILLD + L+DFGL K+G +QS +T G
Sbjct: 104 -EIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCG 158
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
T Y APE + D + G VL EML G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
VLG+G FG V + G G AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
+P L L +H V EF+ G L H+ G + + AA+
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--------YRATFYAAE 104
Query: 191 ---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
GL +LHS +IYRD K N++LD + + K++DFG+ K+ G ++ GT
Sbjct: 105 IVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTP 160
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + T D +SFGV+L EML G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G +G V+K D T G ++A+K + E EI L + H
Sbjct: 9 QRIGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+V G L D +V E+ GSL++ T PLS V KGLA
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLA 115
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YLH I+RD K +NILL + + KL+DFG++ T + + + + GT + APE
Sbjct: 116 YLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-LTATIAKRKSFI-GTPYWMAPE 171
Query: 254 YMA---TGHLTAKSDVYSFGVVLLEM 276
A G K D+++ G+ +E+
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G V K +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ L + P +V G D + E M GSL+ L + + I KV+
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-----KRIPEEILGKVS 109
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+ +GLAYL +K ++++RD K SNIL++ KL DFG++ ++ +G
Sbjct: 110 IAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVG 164
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 283
T Y +PE + H + +SD++S G+ L+E+ GR I
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 40/296 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGH-LEWLTEI 125
+ + + +GEG +G VFK A G +A+KR+ Q +G L + E+
Sbjct: 1 QQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 52
Query: 126 ---KHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177
+HL HPN+V+L C + LV+E + + L +L + +
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT-- 109
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
TI+ + +GL +LHS + V++RD K NIL+ + KL+DFGLA+ S
Sbjct: 110 ETIK-DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 163
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
T V+ T Y APE + D++S G + EM + + +
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------- 214
Query: 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+ +I V+ E + AL K KF +DE+ K L
Sbjct: 215 ----VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F ++KG + PG + + +K L + L + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+LVKL G C+ D++ ++V E++ G L+ L R + L W ++ VA A L Y
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNV--SLHW--KLDVAKQLASALHY 116
Query: 195 LHSDKAKVIYRDFKTSNILL---DLNYN----AKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
L K+++ + NIL+ LN KLSD G+ S+ R+
Sbjct: 117 LEDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 248 GYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
+ APE + G LT +D +SFG LLE+ S + L +
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS------------------NGEEPLSTL 210
Query: 306 RRIFQVMDARIEGQYSLGAALKT------AVLAIKCLSNEPKFRPTMDEVVKAL 353
+ E Y L A L +C + +P RP+ +++ L
Sbjct: 211 SS------SEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQL 131
+G G FG V K +G ++AVKR+ +++ + L L +
Sbjct: 12 IGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
P +VK G + + E M SL+ + I K+A+ K
Sbjct: 63 --PYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGY 249
L YL + K+I+RD K SNILLD N N KL DFG++ G S TR G Y
Sbjct: 120 LNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPY 173
Query: 250 AAPEYMATGHLTA---KSDVYSFGVVLLEMLSGR 280
APE + +SDV+S G+ L E+ +G+
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLTEIKHL 128
VLG+G FG V A + GT A+K L ++ + LE + E + L
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV---LEDDDVECTMVERRVL 49
Query: 129 GQLY-HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ HP L L +C +H V E++ G L H IQ +
Sbjct: 50 ALAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH--------IQSSGRFDEARAR 99
Query: 186 LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
AA+ GL +LH +IYRD K N+LLD + + K++DFG+ K+ G ++
Sbjct: 100 FYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--AST 155
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y APE + D +SFGV+L EML G+
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V + E +G + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 133 --HPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
HP L +L C + RL V EF+ G L H IQ + AA
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFH--------IQKSRRFDEARARFYAA 103
Query: 190 K---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ L +LH +IYRD K N+LLD + KL+DFG+ K+G ++ ++ GT
Sbjct: 104 EITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
Y APE + D ++ GV+L EML G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E +TE + L
Sbjct: 2 LLGKGTFGKVI--LVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA-- 188
HP L L Y + RL V E+ G L HL R +T GA
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEI 104
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
L YLHS V+YRD K N++LD + + K++DFGL K+G + + + GT
Sbjct: 105 VSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPE 160
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + D + GVV+ EM+ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL----QGHLEWLTEIKHLGQ 130
LG G FG V I +H GTG A+K L +E L H+ E L +
Sbjct: 26 LGTGSFGRV---RIAKHK------GTGEYYAIKCLKKREILKMKQVQHV--AQEKSILME 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
L HP +V ++ +++ + EF+ G L HL R + ++ ++ L
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLA--- 130
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
YLHS +IYRD K N+LLD + K++DFG AK P + + + GT Y
Sbjct: 131 -FEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYL 182
Query: 251 APEYMAT-GHLTAKSDVYSFGVVLLEMLSG 279
APE + + GH A D ++ GV+L E ++G
Sbjct: 183 APEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 35/214 (16%)
Query: 78 EGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQES-LQGH-LEWLTEIKHLGQLYHP 134
EG +G V++ AR TG ++A+K+L E +G + L EI L +L HP
Sbjct: 15 EGTYGVVYR----------ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 135 NLVKL----IGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKVALG 187
N+V + +G L D +V E++ K +E S ++ L M L
Sbjct: 65 NIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-----MLQLL- 116
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
G+A+LH + +++RD KTSN+LL+ K+ DFGLA+ GS T+++ T
Sbjct: 117 --SGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTL 170
Query: 248 GYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + D++S G + E+L+ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 38/107 (35%), Positives = 60/107 (56%), Gaps = 4/107 (3%)
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+GL YLHS A +++RD K N+L++ N K+ DFGLA+ H++ V+ Y Y
Sbjct: 114 RGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 250 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
APE M + H T+ D++S G + E+L R + P ++ +LI
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLG-Q 130
VLG+G FG V GT V A+K L ++ + + +TE + L
Sbjct: 2 VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 131 LYHPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
HP L L C + RL V E++ G L + R+ + +P S +V L
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLA-- 108
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
L +LH + VIYRD K NILLD + KL+DFG+ K+G +T GT Y
Sbjct: 109 --LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDY 162
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + D ++ GV++ EM++G+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIK 126
++P +G G +G V +G +A+K++ + L E+K
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 127 HLGQLYHPNLVKLIGYCLED---------DHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177
L H N++ + D +V + M S +H+ + QPL+
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLM--ESDLHHIIHSD----QPLT 105
Query: 178 WTIRMKVALGAA-KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
++ L +GL Y+HS A VI+RD K SN+L++ + ++ DFG+A+ +
Sbjct: 106 -EEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 237 SH--VSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRR 281
H T + T Y APE + + T D++S G + EML GRR
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 66/210 (31%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V +G A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HP L L Y + RL V E++ G L HL R + S
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVS 106
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
L YLHS K++YRD K N++LD + + K++DFGL K+G T + + + GT Y
Sbjct: 107 ALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYL 162
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + D + GVV+ EM+ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 7 VLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
P + + C + RL V E++ G L + + G + +P + ++A+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIG--- 113
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVM-G 245
L +LHS +IYRD K N++LD + K++DFG+ K DG V+T+ G
Sbjct: 114 -LFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCG 163
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
T Y APE +A D ++FGV+L EML+G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 33/225 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YHPN--LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+ + + Y +L + + M G L HL + G + + A
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEI 106
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
GL ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+G
Sbjct: 107 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHG 160
Query: 249 YAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292
Y APE + G + +D +S G +L ++L G + P R+H
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG------HSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 61/334 (18%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ V+G+G +G V ID HT G +A+K++N E + L EIK
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
L L HP++V++ L R +V+E M + H + P +
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFL 109
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGS--Q 236
L + L Y+H+ A V +RD K NIL + + K+ DFGLA+ D PT
Sbjct: 110 YQLL---RALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 237 SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294
+V+TR Y APE + T D++S G + E+L+G+ + + +L
Sbjct: 165 DYVATR-----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219
Query: 295 I-----------------EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 337
I E A+ YL S R+ Q A L + L+
Sbjct: 220 ITDLLGTPSPETISRVRNEKARRYLSSMRK----KQPVPFSQKFPNADPLALRLLERLLA 275
Query: 338 NEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQ 371
+PK RPT +E AL A V R+ S Q
Sbjct: 276 FDPKDRPTAEE---ALADPYFKGLAKVEREPSAQ 306
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 46/220 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLN-QESLQG-HLEWLTEI---KHLG 129
+GEG +G V+K AR TG +A+K++ S +G L L EI K L
Sbjct: 7 IGEGAYGTVYK----------ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE 56
Query: 130 QLYHPNLVKLIGYCL--EDDHRL---LVYEFMPKGSLENHLFRTGASYIQPLSWTIR--M 182
HPN+V+L+ C D L LV+E + + L +L + + P TI+ M
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP--ETIKDLM 113
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+ L +G+ +LHS ++++RD K NIL+ + K++DFGLA+ S T
Sbjct: 114 RQLL---RGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTS 165
Query: 243 VMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEM 276
V+ T Y APE Y D++S G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G ++AVK+++ Q E+ + H N+V++ L D +V EF+ G+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 161 LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220
L + + T + Q + V L K L+ LH+ VI+RD K+ +ILL +
Sbjct: 104 LTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRV 155
Query: 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
KLSDFG S ++GT + APE ++ + D++S G++++EM+ G
Sbjct: 156 KLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
Query: 281 ------------RVIDKNRPSREHNL 294
++I N P + NL
Sbjct: 214 PPYFNEPPLKAMKMIRDNLPPKLKNL 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 37/221 (16%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYH 133
G G +G V+K G A+K+ + Q EI L +L H
Sbjct: 9 GRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 134 PNLVKLIGYCLEDDHRL--LVYEFMPKGSLE--NHLFRTGASYIQP-----LSWTIRMKV 184
N+V L+ LE + L++++ + + I P L W I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---- 117
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSH 238
G+ YLHS+ V++RD K +NIL+ K+ D GLA+ + P +
Sbjct: 118 ----LNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 239 VSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLS 278
+ V+ T Y APE + H T D+++ G + E+L+
Sbjct: 172 LD-PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
+ +LG G FG + +G + P++ + +A+ L S + +L E LGQ
Sbjct: 10 ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
H N+V+L G + ++V E+M G+L++ L + L M + G A G
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASG 119
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG-LAKDGPTGSQSHVSTRVMGTYGYA 250
+ YL + +++ +L++ + K+S F L +D + +S + + A
Sbjct: 120 MKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW--A 175
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRR 281
APE + H ++ SDV+SFG+V+ E++S G R
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRL----NQESLQ-GHLEWLT 123
+ P + +G G +G V+K AR P +G +A+K + N++ L + +
Sbjct: 2 YEPVAEIGVGAYGTVYK----------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA 51
Query: 124 EIKHLGQLYHPNLVKLIGYC--LEDDHRL---LVYEFMPKGSLENHLFRTGASYIQPLSW 178
+K L HPN+V+L+ C D LV+E + + L +L + + P
Sbjct: 52 LLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAE- 108
Query: 179 TIR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
TI+ M+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+ S
Sbjct: 109 TIKDLMRQFL---RGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR---IYSC 160
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 277
T V+ T Y APE + D++S G + EM
Sbjct: 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLG 129
V+G+G FG V R G AVK L ++++ Q H+ + L
Sbjct: 2 VIGKGSFGKVL---------LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LK 51
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L HP LV L Y + +L V +++ G L HL R +++P + +VA
Sbjct: 52 NLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVA--- 106
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGT 246
+ YLHS +IYRD K NILLD + L+DFGL K+G P + S GT
Sbjct: 107 -SAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS----TFCGT 159
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
Y APE + D + G VL EML G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 68/210 (32%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HP L L Y + RL V E+ G L HL R + S
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVS 106
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
L YLHS+K V+YRD K N++LD + + K++DFGL K+G + + GT Y
Sbjct: 107 ALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYL 163
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + D + GVV+ EM+ GR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKH 127
NF+ LGEG + V+KG TG ++A+K ++ ++ +G + EI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKV 184
+ +L H N+V+L ++ +LV+E+M K ++ H R S+T ++
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTR 242
KG+A+ H ++ V++RD K N+L++ KL+DFGLA+ P + S
Sbjct: 110 ----LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNE 160
Query: 243 VMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 280
V+ T Y AP+ + + S D++S G ++ EM++GR
Sbjct: 161 VV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 68/241 (28%), Positives = 106/241 (43%), Gaps = 51/241 (21%)
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
L+ +F V+G G FG V + H + V A+K L++ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHK------SSKQVYAMKLLSKFEMIKR 84
Query: 119 LE----WLTEIKHLGQLYHPN---LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGA 170
+ W E + + + H N +V+L Y +DD L +V E+MP G L N + +
Sbjct: 85 SDSAFFW--EERDI--MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM----S 135
Query: 171 SYIQPLSW----TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226
+Y P W T + +AL A + ++H RD K N+LLD + + KL+DFG
Sbjct: 136 NYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFG 187
Query: 227 ----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLS 278
+ +G T V GT Y +PE + + G+ + D +S GV L EML
Sbjct: 188 TCMKMDANG----MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 279 G 279
G
Sbjct: 243 G 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G +AVK ++ Q E+ + H N+V++ L + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 161 LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220
L + + +T + Q + V + L YLHS VI+RD K+ +ILL L+
Sbjct: 105 LTDIVSQTRLNEEQIAT------VCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRV 156
Query: 221 KLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
KLSDFG ++KD P ++GT + APE ++ + D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 277 LSG 279
+ G
Sbjct: 211 VDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YH---PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
P +V + D + + M G L HL + G + + + A
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEI 106
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
GL ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+G
Sbjct: 107 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHG 160
Query: 249 YAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294
Y APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
NFR + +G G F V++ + + +A+K++ L + + + E
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV----------PVALKKVQIFDLMDAKARADCIKE 52
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRTGASYIQPLSWTIRM 182
I L QL HPN++K +ED+ +V E G L + F+ I P +
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI-PEKTVWKY 111
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
V L +A L ++HS +V++RD K +N+ + KL D GL + S++ +
Sbjct: 112 FVQLCSA--LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHS 165
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
++GT Y +PE + KSD++S G +L EM
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 69 NFRPDSVLGEGGFGCVF--KGWID-EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ +GEG FG ++ K D EH T M + K +++ E+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EV 50
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGA---SYIQPLSWTIRM 182
L ++ HPN+V E+ +V E+ G L + R S Q LSW +++
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 241
+ GL ++H D+ K+++RD K+ NI L N AKL DFG+A+ ++
Sbjct: 111 SL------GLKHIH-DR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 286
+GT Y +PE K+D++S G VL E+ + + + N
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G VFK E T ++A+KR+ + + L EI L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA----LGA 188
N+V+L L D +L LV+E+ + L + Y + I ++
Sbjct: 59 KNIVRLYD-VLHSDKKLTLVFEY-----CDQDLKK----YFDSCNGDIDPEIVKSFMFQL 108
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGT 246
KGLA+ HS V++RD K N+L++ N KL+DFGLA+ P S V+ T
Sbjct: 109 LKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA---EVV-T 162
Query: 247 YGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRR 281
Y P+ + A + T+ D++S G + E+ + R
Sbjct: 163 LWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 71/251 (28%), Positives = 113/251 (45%), Gaps = 42/251 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
V+G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 23 VVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH-- 71
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
H N+ G ++ DD LV EF GS+ + + T + ++ W
Sbjct: 72 ---HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWI--AY 125
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVST 241
+ +GLA+LH+ K VI+RD K N+LL N KL DFG++ D G ++
Sbjct: 126 ICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---- 179
Query: 242 RVMGTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
+GT + APE +A +SD++S G+ +EM G + P R LI
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239
Query: 297 W-AKPYLQSKR 306
P L+SK+
Sbjct: 240 RNPPPKLKSKK 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 44/263 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V G ++ Y PA+ + VK L S+Q +++L E + L H
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
NL++ +G C E LLV EF P G L+ +L + + T ++A A GL +
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQSHVSTRVMGTYG 248
LH K I+ D N LL + K+ D+GL+ + T Q V R
Sbjct: 116 LH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------ 167
Query: 249 YAAPEYMATGH-------LTAKSDVYSFGVVLLEM----------LSGRRVIDKNRPSRE 291
+ APE + H T +S+V+S GV + E+ LS +V+ RE
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVRE 225
Query: 292 HNLIEWAKPYLQ--SKRRIFQVM 312
L + KP L+ R ++VM
Sbjct: 226 QQL-KLPKPRLKLPLSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 28/250 (11%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLL-VYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V E+
Sbjct: 19 TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEY 77
Query: 156 MPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215
+ G L H+ R + + +++L L YLH + +IYRD K N+LLD
Sbjct: 78 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLA----LNYLH--ERGIIYRDLKLDNVLLD 130
Query: 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLE 275
+ KL+D+G+ K+G + ++ GT Y APE + D ++ GV++ E
Sbjct: 131 SEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188
Query: 276 MLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL--GAALKTAVLAI 333
M++GR D S P ++ +FQV+ +E Q + ++K A +
Sbjct: 189 MMAGRSPFDIVGSSD--------NPDQNTEDYLFQVI---LEKQIRIPRSLSVKAASVLK 237
Query: 334 KCLSNEPKFR 343
L+ +PK R
Sbjct: 238 SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V+ D+ A R I V LN E++Q + E + L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLE---NHLFRTGASYIQP--LSWTIRMKVALGAA 189
+VK LE D ++ E+ L+ L TG + + W I++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
G+ Y+H + ++++RD K NI L N K+ DFG+++ GS ++T GT Y
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGS-CDLATTFTGTPYY 171
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEM 276
+PE + +KSD++S G +L EM
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 80/320 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----HLEWLTEIKHLGQL 131
+G+GG G V+ Y P +A+K++ +E L +L E K L
Sbjct: 10 IGKGGMGEVYLA------YDPV---CSRRVALKKI-REDLSENPLLKKRFLREAKIAADL 59
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRTGASYIQPLSWTIRMKVALGA- 188
HP +V + C + D VY MP +G L ++ + LS + K ++GA
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKS-VWQKESLSKELAEKTSVGAF 115
Query: 189 -------AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----------- 230
+ Y+HS V++RD K NILL L + D+G A
Sbjct: 116 LSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 231 --GPTGSQSHVST---RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS------- 278
T +++GT Y APE + + +D+Y+ GV+L +ML+
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
Query: 279 --GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 336
GR++ ++ IE A PY + + Q+ A+K L
Sbjct: 234 KKGRKISYRDVILSP---IEVA-PYREIPPFLSQI--------------------AMKAL 269
Query: 337 SNEPKFR-PTMDEVVKALEQ 355
+ +P R ++ E+ + LE
Sbjct: 270 AVDPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 70/251 (27%), Positives = 113/251 (45%), Gaps = 42/251 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
++G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 13 LVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-- 61
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
H N+ G ++ DD LV EF GS+ + + T + ++ W
Sbjct: 62 ---HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWI--AY 115
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVST 241
+ +GL++LH + KVI+RD K N+LL N KL DFG++ D G ++
Sbjct: 116 ICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---- 169
Query: 242 RVMGTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
+GT + APE +A KSD++S G+ +EM G + P R LI
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229
Query: 297 W-AKPYLQSKR 306
P L+SK+
Sbjct: 230 RNPAPRLKSKK 240
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 32/169 (18%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
EI+ L + HPN+VK + ++ EFM GSLE Q L+
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIADE--QFLA-----D 172
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
VA G+AYLH + +++RD K SN+L++ N K++DFG+ S + +
Sbjct: 173 VARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV---------SRILAQT 221
Query: 244 M-------GTYGYAAPEYMATGHLTAK-----SDVYSFGVVLLEMLSGR 280
M GT Y +PE + T D++S GV +LE GR
Sbjct: 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRL-LVYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V EF
Sbjct: 19 TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEF 77
Query: 156 MPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215
+ G L H+ R + L + + L +LH +IYRD K N+LLD
Sbjct: 78 VSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLD 130
Query: 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLE 275
+ KL+D+G+ K+G ST GT Y APE + D ++ GV++ E
Sbjct: 131 AEGHIKLTDYGMCKEG-IRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188
Query: 276 MLSGRRVID 284
M++GR D
Sbjct: 189 MMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 31/233 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLTEIKHLGQ 130
LG+G +G V A +A+K++ + + L L ++H
Sbjct: 8 LGQGAYGIVCSA-----RNAETSEEET--VAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 131 LYHPNLVKLIGYCLEDD---HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
H N+ L + + L +YE + + L + + R+G QPL+
Sbjct: 61 --HKNITCLYDMDIVFPGNFNELYLYEELMEADL-HQIIRSG----QPLTDAHFQSFIYQ 113
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVM 244
GL Y+HS A V++RD K N+L++ + K+ DFGLA+ + P + + T +
Sbjct: 114 ILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYV 170
Query: 245 GTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGRRVIDKNRPSREH-NLI 295
T Y APE M + K+ DV+S G +L E+L GR+ + K + + N I
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL-GAAKGLA 193
N+V L D LV+E++ K L+ ++ G I + +K+ L +GLA
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMH---NVKIFLYQILRGLA 118
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
Y H + KV++RD K N+L++ KL+DFGLA+ ++++ + V T Y P+
Sbjct: 119 YCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD 174
Query: 254 -YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
+ + + + D++ G + EM SGR + + E +LI
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ P +G G +G V E T +A+K++ ++ L E
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRTGASYIQPLSW 178
IK L L H N++ + + HR +VYE M + L + S Q LS
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSS-QTLSD 107
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ-- 236
+GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+
Sbjct: 108 DHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
Query: 237 -SHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRR 281
+V TR Y APE + T DV+S G + E+L GR+
Sbjct: 166 TEYVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 119 LEWLTEIKHLGQL--YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQP 175
++W+ KH+ + +P LV L C + RL LV E++ G L H+ R +
Sbjct: 39 IDWVQTEKHVFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQ-----RK 92
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
L A L +LH + +IYRD K N+LLD + + KL+D+G+ K+G G
Sbjct: 93 LPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG-LGP 149
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
ST GT Y APE + D ++ GV++ EM++GR D I
Sbjct: 150 GDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------I 198
Query: 296 EWAKPYLQSKRRIFQVM 312
P + ++ +FQV+
Sbjct: 199 ITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
NF+ + +G G F V++ +D A + V+ + + + EI
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--------VQIFEMMDAKARQDCVKEID 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRTGASYIQPLSWTIRMKV 184
L QL HPN++K + +ED+ +V E G L + F+ I P + V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI-PERTVWKYFV 113
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
L +A + ++HS +V++RD K +N+ + KL D GL + S++ + ++
Sbjct: 114 QLCSA--VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 167
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
GT Y +PE + KSD++S G +L EM
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF G + A+K L + ++ H
Sbjct: 1 NFELLRVLGTGAYGKVFL------VRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT--R 52
Query: 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
TE + L + P LV L Y + D +L L+ +++ G L HL++ + I
Sbjct: 53 TERQVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
V LA H + +IYRD K NILLD + L+DFGL+K+ +
Sbjct: 112 AEIV-------LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 241 TRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSG 279
+ GT Y APE + GH A D +S GV+ E+L+G
Sbjct: 165 S-FCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
LA H +I+RD K++NILL N KL DFG +K V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311
PE + K+D++S GV+L E+L+ +R D + +V
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEEV 253
Query: 312 MDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPT 345
M + G+Y S+ ++ V A+ LS++PK RP+
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTAL--LSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 34/279 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + A+K + E + EI + H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V G L D + EF GSL++ TG PLS + V+ +GL YL
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYL 122
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
HS K K ++RD K +NILL N + KL+DFG++ S +GT + APE
Sbjct: 123 HS-KGK-MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVA 178
Query: 256 AT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312
A G D+++ G+ +E+ + + P R L K Q + +
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNFQPPK-----L 231
Query: 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+++ S +K A L+ PK RPT +++++
Sbjct: 232 KDKMKWSNSFHHFVKMA------LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 91/360 (25%), Positives = 133/360 (36%), Gaps = 106/360 (29%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIK---HLG 129
LG G FG V I+ + + T +AVK L + + H E ++E+K H+G
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIG 68
Query: 130 QLYHPNLVKLIGYCLEDDHRLLV-YEFMPKGSLENHL----------------FRTGASY 172
+H N+V L+G C + L+V EF G+L N+L FR G S
Sbjct: 69 --HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSG 126
Query: 173 IQPLSWTIRMKV----------------------------------------------AL 186
+S ++ ++ +
Sbjct: 127 YGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSF 186
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
AKG+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 187 QVAKGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK- 305
+ APE + T +SDV+SFGV+L E+ S A PY K
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASPYPGVKI 287
Query: 306 -----RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
RR+ + R Y+ +T + C EP RPT E+V+ L + N
Sbjct: 288 DEEFCRRLKEGTRMRAP-DYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 53/285 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LG+G +G V+K RP TG+ +A+K + E + + + E+ L + P
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+V G + + E+M GSL+ G + + + ++ KGL +
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK--LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
L ++ +I+RD K +N+L++ N KL DFG++ + + ++ +G Y APE
Sbjct: 118 L-KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPER 172
Query: 255 MATGHLTA------KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-LQSKRR 307
+ +G +SDV+S G+ +LEM GR PY ++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY------------------PYPPETYAN 214
Query: 308 IFQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPT 345
IF + A ++G YS A A KCL+ P RPT
Sbjct: 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVA----KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 41/242 (16%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRTGASYIQPLSWT 179
EIK+L ++ N++K+ G+ ++ L L+ E+ +G L L + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLSFK 122
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
++ +A+ KGL L+ Y++ + + L+ NY K+ GL K + +V
Sbjct: 123 TKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181
Query: 240 STRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
+ V Y + + + T K D+YS GVVL E+ +G ++ +N ++E
Sbjct: 182 NFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-KIPFENLTTKE------ 229
Query: 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL----AIKCLSNEPKFRPTMDEVVKAL 353
+ D I SL L + C S++ RP + E++ L
Sbjct: 230 -------------IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
Query: 354 EQ 355
Sbjct: 277 SL 278
|
Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW----TIRMKVALGAA 189
P +V+L +D + +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFYTAEVVLALDAI 158
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+ +H RD K N+LLD + + KL+DFG T V GT Y
Sbjct: 159 HSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209
Query: 250 AAPEYMAT----GHLTAKSDVYSFGVVLLEMLSG 279
+PE + + G+ + D +S GV L EML G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 75 VLGEGGFGCVF--KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
V+G+G FG V + +E YA V+ K + ++ + H+ + L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK------VLQKKAILKKKEEKHIMSERNVL-LKNVK 54
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HP LV L + + +L V +++ G L HL R +++P + ++A
Sbjct: 55 HPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIA----SA 108
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTYGY 249
L YLHS ++YRD K NILLD + L+DFGL K+ G+ S GT Y
Sbjct: 109 LGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS----TFCGTPEY 162
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
APE + D + G VL EML G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW 121
K +F LG G FG V + P +A+KR + + Q ++
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPP--------VAIKRFEKSKIIKQKQVDH 77
Query: 122 L-TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
+ +E K L + HP V L G ++ + LV EF+ G L R + +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFY 136
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
++ L YL S ++YRD K N+LLD + K++DFG AK T + +
Sbjct: 137 AAQIVLI----FEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT--- 187
Query: 241 TRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288
+ GT Y APE + GH A +D ++ G+ + E+L G N P
Sbjct: 188 --LCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+GEG FG K + + G VI +++ S + E E+ L + HPN
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRTGASYI--QPLSWTIRMKVALGAAKGL 192
+V+ E+ + +V ++ G L + + G + Q L W +++ +AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
H K+++RD K+ NI L + KL DFG+A+ S ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLS 278
E KSD+++ G VL EM +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+V L + LV+E++ L+ +L G + + + I M L +GL+Y
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCG-NLMSMHNVKIFMFQLL---RGLSY 118
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE- 253
H K K+++RD K N+L++ KL+DFGLA+ ++++ + V T Y P+
Sbjct: 119 CH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
+ + + D++ G +L EM +GR + + E +LI
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 37/206 (17%)
Query: 101 TGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158
TG+ +AVK+L++ +S+ E++ L + H N++ L+ F P
Sbjct: 41 TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 88
Query: 159 GSLE--------NHLFRTGASYI---QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
SLE HL + I Q L+ + +GL Y+HS A +I+RD
Sbjct: 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDL 146
Query: 208 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDV 266
K SN+ ++ + K+ DFGLA+ +V+TR Y APE M H D+
Sbjct: 147 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDI 201
Query: 267 YSFGVVLLEMLSGRRVIDKNRPSREH 292
+S G ++ E+L+GR + P +H
Sbjct: 202 WSVGCIMAELLTGRTLF----PGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 101 TGMVIAVKRLNQESLQGHL---EWLTEIKHLGQLYHPNLVKLIGY-----CLEDDHRL-L 151
TG +A+K+L + Q L E++ L + H N++ L+ L+ H L
Sbjct: 39 TGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97
Query: 152 VYEFMPK--GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 209
V FM G L H + IQ L + + KGL Y+H+ A +I+RD K
Sbjct: 98 VMPFMGTDLGKLMKHE-KLSEDRIQFLVYQM--------LKGLKYIHA--AGIIHRDLKP 146
Query: 210 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYS 268
N+ ++ + K+ DFGLA+ + +V TR Y APE + H T D++S
Sbjct: 147 GNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWS 201
Query: 269 FGVVLLEMLSGR 280
G ++ EML+G+
Sbjct: 202 VGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 55/199 (27%)
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+GL YLH+ ++I+RD KT NI ++ + D G A+ P + + + + GT
Sbjct: 168 EGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVET 222
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS---------REH-------- 292
APE +A +K+D++S G+VL EML+ I ++ PS H
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 293 -----------------NLIEWA----KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 331
IE+A +PY + FQ ++ I+G++ L
Sbjct: 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPC--FQRVNLPIDGEF----------L 330
Query: 332 AIKCLSNEPKFRPTMDEVV 350
K L+ + RP+ +E++
Sbjct: 331 VHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 55/160 (34%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGA-SYIQPLSWT 179
L E L Q+ P +V L + + +L LV F+ G L +HL R G + +T
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ AL LH K VIYRD K NILLD + L DFGL K
Sbjct: 100 AELLCAL------ENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDK 149
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ GT Y APE + T D ++ GV+L EML+G
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 54/248 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTE 124
++F+ +LG+G G VF + GTG + A+K L+++ + + LTE
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ L L HP L L + + LV ++ P G L L + QP + +V
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR-----QPGK-CLSEEV 104
Query: 185 A-LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----------- 229
A AA+ L YLH ++YRD K NILL + + LSDF L+K
Sbjct: 105 ARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 230 ---DGPTGSQSH----------VSTRVM---GTYGYAAPEYMA-TGHLTAKSDVYSFGVV 272
G S + S R GT Y APE ++ GH + D ++ G++
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGIL 221
Query: 273 LLEMLSGR 280
L EML G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 69 NFRPDSVLGEGGFGCVF-KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL----T 123
NF VLG G +G VF + H +G + A+K L + ++ + T
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD-------SGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 124 E---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWT 179
E ++H+ Q P LV L Y + D +L L+ +++ G L HL + Q +
Sbjct: 54 ERQVLEHIRQ--SPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
V LA H K +IYRD K NILLD N + L+DFGL+K+ +
Sbjct: 111 SGEIV-------LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVER 162
Query: 240 STRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSG 279
+ GT Y AP+ + GH A D +S GV++ E+L+G
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 31/184 (16%)
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRTGASYIQ---PLS 177
EI L + H ++ LI +R V MPK + LF +Y+ PL
Sbjct: 135 REIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCD--LF----TYVDRSGPLP 183
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + + LAYLH +I+RD KT NI LD NA L DFG A +
Sbjct: 184 LEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA------CKL 235
Query: 238 HVSTRVMGTYGYA------APEYMATGHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSR 290
YG++ +PE +A AK+D++S G+VL EM + K S
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 291 EHNL 294
L
Sbjct: 296 SSQL 299
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 31/159 (19%)
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSW----TIRMKVALGA 188
P +V+L Y +DD L +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLALDA 157
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVM 244
+ ++H RD K N+LLD + + KL+DFG + K+G + V
Sbjct: 158 IHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV----- 204
Query: 245 GTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSG 279
GT Y +PE + + G+ + D +S GV L EML G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQL-Y 132
+GEG F V K + TG A+K + + +SL+ L EI+ L +L
Sbjct: 7 IGEGTFSEVLKA---QSRK------TGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSP 56
Query: 133 HPNLVKLIGYCLEDDH-RL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HPN+++LI + RL LV+E M + +L+ +PL K
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLK 111
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
L ++H + + +RD K NIL+ + KL+DFG + T + T Y
Sbjct: 112 SLDHMHRNG--IFHRDIKPENILIK-DDILKLADFGSCR---GIYSKPPYTEYISTRWYR 165
Query: 251 APEYMAT-GHLTAKSDVYSFGVVLLEMLS 278
APE + T G+ K D+++ G V E+LS
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 44/131 (33%), Positives = 60/131 (45%), Gaps = 12/131 (9%)
Query: 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210
LV ++M G L HL + G + I V LA H K ++YRD K
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV-------LALEHLHKYDIVYRDLKPE 125
Query: 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYS 268
NILLD + L DFGL+K + + + GT Y APE + G+ T D +S
Sbjct: 126 NILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVDFWS 182
Query: 269 FGVVLLEMLSG 279
GV++ EM G
Sbjct: 183 LGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF TG + A+K L + +L H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 123 TE---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSW 178
TE ++H+ Q P LV L Y + + +L L+ +++ G + HL+ Q ++
Sbjct: 53 TERNVLEHVRQ--SPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLY-------QRDNF 102
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+ LA H K ++YRD K NILLD + L+DFGL+K+ + +
Sbjct: 103 SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
Query: 239 VSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSG 279
+ GT Y APE + GH A D +S G+++ E+L+G
Sbjct: 163 TYS-FCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + AVK + E EI + + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
+V G L + + E+ GSL++ TG PLS V +GLAYL
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYL 122
Query: 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 255
HS K K ++RD K +NILL N + KL+DFG+A S +GT + APE
Sbjct: 123 HS-KGK-MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVA 178
Query: 256 A---TGHLTAKSDVYSFGVVLLEM 276
A G D+++ G+ +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRTGASYIQP--LSWTIRMKV 184
L ++ HPN+V D H +V E+ G L + + G + + L W ++M
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-- 109
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
L H + +V++RD K+ NI L N KL DFG A+ T ++ T V
Sbjct: 110 ------CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV- 161
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
GT Y PE KSD++S G +L E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 52/160 (32%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 133 HPNLVKLIGYCLEDDHRL-----LVYEFMPKGS---LENHLFRTGASYIQPLSWTIRMKV 184
HPN+VK G + D + LV E GS L L G Q L + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG----QRLDEAMISYI 133
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
GA GL +LH+++ +I+RD K +NILL KL DFG++ T ++ +T V
Sbjct: 134 LYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSV- 189
Query: 245 GTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSG 279
GT + APE +A A+ DV+S G+ +E+ G
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGH-LEWLTEIKHLGQL 131
LGEG + V+KG + T G ++A+K RL E +G + E L L
Sbjct: 12 KLGEGSYATVYKG-RSKLT--------GQLVALKEIRLEHE--EGAPFTAIREASLLKDL 60
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
H N+V L LV+E++ L+ ++ G + + + + L +G
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLL---RG 115
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSHVSTRVMGTYGY 249
LAY H + +V++RD K N+L+ KL+DFGL AK P+ + S+ V+ T Y
Sbjct: 116 LAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLWY 169
Query: 250 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
P+ + + + D++ G + EM +GR
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 51/251 (20%)
Query: 61 NGLKTATRNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-- 117
N + + + + LGEG +G V K D T G ++A+K++ +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDV 51
Query: 118 ------------HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLE 162
H L E+K + ++ H N++ L+ +E D LV + M K ++
Sbjct: 52 TKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD 111
Query: 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222
+ T S ++ + I GL LH K ++RD +NI ++ K+
Sbjct: 112 RKIRLT-ESQVKCILLQI--------LNGLNVLH--KWYFMHRDLSPANIFINSKGICKI 160
Query: 223 SDFGLAK-------DGPTGSQSHVSTRVMGTYG-----YAAPE-YMATGHLTAKSDVYSF 269
+DFGLA+ + R T Y APE M D++S
Sbjct: 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 270 GVVLLEMLSGR 280
G + E+L+G+
Sbjct: 221 GCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 15/187 (8%)
Query: 124 EIKHLGQLYHPNLVKLI-GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI---QPLSWT 179
E + L QL HPN+V + ED +V F G L + L + Q + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+++ +AL YLH + +++RD KT N+ L K+ D G+A+ +Q +
Sbjct: 109 VQIAMAL------QYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDM 158
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID-KNRPSREHNLIEWA 298
++ ++GT Y +PE + KSDV++ G + EM + + + K+ S + +IE
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218
Query: 299 KPYLQSK 305
P +
Sbjct: 219 LPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ RP LG G G VF +D +AVK++ Q L EIK
Sbjct: 8 MDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFM-PKGSLENH----LFRTGASYI--------- 173
+ +L H N+VK VYE + P GS L + YI
Sbjct: 56 IRRLDHDNIVK-------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL 102
Query: 174 ------QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFG 226
PLS +GL Y+HS A V++RD K +N+ ++ + K+ DFG
Sbjct: 103 ANVLEQGPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFG 160
Query: 227 LAK--DGPTGSQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
LA+ D + ++S ++ + Y +P ++ + T D+++ G + EML+G+
Sbjct: 161 LARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM---KVAL-GAAK 190
N+V L + LV+E++ K L+ +L G S I M K+ L +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS--------INMHNVKLFLFQLLR 115
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
GL Y H + KV++RD K N+L++ KL+DFGLA+ ++++ + V T Y
Sbjct: 116 GLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYR 171
Query: 251 APE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
P+ + + + + D++ G + EM +GR
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K ++ ++ +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+V L + V+E+M + + G + P + + M L +GLAY
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQLL---RGLAY 118
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE- 253
+H +++RD K N+L+ KL+DFGLA+ SQ++ S V T Y P+
Sbjct: 119 IH--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDV 174
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGR 280
+ ++ D++ G + +EML G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 49/185 (26%), Positives = 73/185 (39%), Gaps = 23/185 (12%)
Query: 99 PGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158
T +K L + S E LT I H PN+V L Y + +D LV +
Sbjct: 15 TRTQQTFILKGLRKSSEYSR-ERLTIIPHC----VPNMVCLHKYIVSEDSVFLVLQHAEG 69
Query: 159 GSLENHL---FRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215
G L +H+ ++ W M VAL A LH + ++ RD +NILLD
Sbjct: 70 GKLWSHISKFLNIPEECVK--RWAAEMVVALDA------LH--REGIVCRDLNPNNILLD 119
Query: 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLE 275
+ +L+ F + + Y APE T D +S G +L E
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFE 174
Query: 276 MLSGR 280
+L+G+
Sbjct: 175 LLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD- 230
Y +PL+ + + A+G+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 231 --GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-------GRR 281
P + R+ + APE + T +SDV+SFGV+L E+ S G +
Sbjct: 224 YKDPDYVRKG-DARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
ID+ R P + I+ +M + C N P+
Sbjct: 281 -IDEEFCRRLKEGTRMRAPE-YATPEIYSIM--------------------LDCWHNNPE 318
Query: 342 FRPTMDEVVKALEQIQDTN 360
RPT E+V+ L + N
Sbjct: 319 DRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 45/279 (16%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
G + K D S ++ + E ++ ++I ++ ++++
Sbjct: 21 NKGGSGKFEMNDKKLDEEERSHNNNAG--EDEDEEKMIDNDIN-------RSPNKSYKLG 71
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
+++G G FG V++ ID T +A+K++ Q+ + E L + L
Sbjct: 72 NIIGNGSFGVVYEAICID----------TSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 133 HPNLVKLIGY----CLEDDHRLL----VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
H N++ L Y C + + + + V EF+P+ + ++ PL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKD--GPTGSQSHVST 241
L + LAY+HS + +RD K N+L+D N + KL DFG AK+ S S++ +
Sbjct: 178 QL--CRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 242 RVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSG 279
R Y APE M + T D++S G ++ EM+ G
Sbjct: 234 RF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLY 132
V+GEG +G V K E T ++A+K+ ++E+ + L E+K L L
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRTGASYIQPLSWTIRMKVALGAAKG 191
N+V+L LV+E++ K LE G + S+ ++ K
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKA 112
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+ + H K +++RD K N+L+ N KL DFG A++ GS ++ T + T Y +
Sbjct: 113 IHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRS 169
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
PE + D++S G +L E+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
GL Y+HS A +I+RD K N+ ++ + K+ DFGLA+ +V TR Y
Sbjct: 128 CGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180
Query: 250 AAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 280
APE + H D++S G ++ EML+G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 79/317 (24%), Positives = 129/317 (40%), Gaps = 48/317 (15%)
Query: 101 TGMVIAVKRLNQESL--QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLEDDHRL-LVYEFM 156
TG + A+K + + L Q + + E + L P + +L Y +D L LV E+
Sbjct: 25 TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQ 83
Query: 157 PKGSLENHLFRTGASYIQPLS--WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214
P G L + L R + + ++ + + +A+ + + Y+H RD K N+L+
Sbjct: 84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH--------RDIKPENVLI 135
Query: 215 DLNYNAKLSDFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKS------DVY 267
D + KL+DFG A + V S +GT Y APE + T + K D +
Sbjct: 136 DRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 268 SFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY-SLGAAL 326
S GV+ EM+ GR P E + + +R + D ++ + L +L
Sbjct: 194 SLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL 247
Query: 327 KTAV---LAIKCLSNEPKF--------RPTMDEVVKALEQIQDTNDAGVSRDESLQNSDR 375
L + L P F R ++ V L+ DT++ DE +NS R
Sbjct: 248 LCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNF----DEPEKNSTR 303
Query: 376 STYK-RKGLNENG-QGK 390
+ L NG GK
Sbjct: 304 RSQSSTTQLKPNGFSGK 320
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+GL Y+HS A +I+RD K SN+ ++ + ++ DFGLA+ +V+TR Y
Sbjct: 129 RGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 250 AAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 280
APE M H D++S G ++ E+L G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 50/169 (29%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A+G+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 184 ARGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKR 306
+ APE + T +SDV+SFGV+L E+ S A PY +Q
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS-----------------LGASPYPGVQINE 284
Query: 307 RIFQVMD--ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
Q + R+ + + +LA C +PK RPT +V+ L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLA--CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K+ E + + L EI L L
Sbjct: 9 IGEGTYGKVYK----------ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS 58
Query: 133 H-PNLVKLIG--YCLEDDHRL---LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+V+L+ + E + + LV+E++ L+ + G +PL
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDG--PTGSQSHVSTRV 243
KG+A+ H K V++RD K N+L+D K++D GL + P S +H
Sbjct: 118 QLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----E 171
Query: 244 MGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG 279
+ T Y APE + + H + D++S G + EM
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 70/261 (26%), Positives = 108/261 (41%), Gaps = 77/261 (29%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ----ESLQ-GHLEWLT 123
+F V+G G FG V + + TG + A+K+L + E Q H+
Sbjct: 2 DFESIKVIGRGAFGEV--RLVQKKD-------TGHIYAMKKLRKSEMLEKEQVAHVR--A 50
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFR-------TGASYIQP 175
E L + +P +VKL Y +D++ L L+ E++P G + L + YI
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI-- 107
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-------- 227
+ TI +A+ + L Y+H RD K N+LLD + KLSDFGL
Sbjct: 108 -AETI---LAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155
Query: 228 --------AKDGPTGSQSHVST---------------RVM-----GTYGYAAPE-YMATG 258
+ P+ +S R + GT Y APE ++ TG
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 259 HLTAKSDVYSFGVVLLEMLSG 279
+ + D +S GV++ EML G
Sbjct: 216 Y-NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 8 ETDSPLPNGANSKCSRKDGNGTSGS-SSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTA 66
E P N + +G S +S + P G + L L
Sbjct: 91 ELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLA-- 148
Query: 67 TRNFRPDSVLGEGGFG----CVFKGWIDE-------HTYAPARPGTGMVIAVKRLNQESL 115
+FR L G FG C + +E ++ +P +IA +
Sbjct: 149 --HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 116 QGHLEWLTEIKHLGQLYHPNLVKL--------IGYCLEDDHRLLVYEFMPKGSLENHLFR 167
LE EI LG+L H N++K+ Y + + +Y FM + +
Sbjct: 207 AIQLE--NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK--- 261
Query: 168 TGASYIQPLSWTIR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225
+PL R MK L A + Y+H K +I+RD K NI L+ + L DF
Sbjct: 262 -----DRPLLKQTRAIMKQLLCA---VEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDF 311
Query: 226 GLAKDGPTGSQSHVSTRVMGTYGYA------APEYMATGHLTAKSDVYSFGVVLLEMLS 278
G A R YG+ +PE +A +D++S G++LL+MLS
Sbjct: 312 GTA-------MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
AKG+++L S I+RD NILL K+ DFGLA+D S V
Sbjct: 224 AKGMSFLASKNC--IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 130 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
APE + D++S G ++ EM+ G + P +H + +W K Q
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF----PGTDH-IDQWNKIIEQ 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 2/105 (1%)
Query: 174 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233
PL ++ + A+G+ +L S I+RD N+LL AK+ DFGLA+D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC--IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 234 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
S V + APE + T +SDV+S+G++L E+ S
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 43/200 (21%)
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR-------MK 183
L HPN+++ +G C+E LLV+E+ G L+ SY+ W R +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLK--------SYLSQEQWHRRNSQLLLLQR 103
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG-SQSHVST- 241
+A A G+ ++H K ++ D N L + K+ D+G+ GP+ + ++ T
Sbjct: 104 MACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETE 158
Query: 242 -RVMGTYGYAAPEYMATGH---LTAK----SDVYSFGVVLLEM----------LSGRRVI 283
+ APE + H +TA+ S+V++ GV L E+ LS R V+
Sbjct: 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218
Query: 284 DKNRPSREHNLIEWAKPYLQ 303
+ ++ L KP L+
Sbjct: 219 NHVIKDQQVKLF---KPQLE 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 32/186 (17%)
Query: 137 VKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLS--WTIRMKVALGAAKGLA 193
+ + Y +D++ L LV ++ G L L + + ++ + M +A+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGY 249
Y+H RD K NIL+D+N + +L+DFG L +DG QS V+ +GT Y
Sbjct: 123 YVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVA---VGTPDY 169
Query: 250 AAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
+PE + G + D +S GV + EML G P +L+E +
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNH 223
Query: 305 KRRIFQ 310
K R FQ
Sbjct: 224 KER-FQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 53/171 (30%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 133 HPNLVKLIG-YCLED----DHRLLVYEFMPKGS---LENHLFRTGASYIQPLSWTIRMKV 184
HPN+VK G Y +D D LV E GS L + G +P+ I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE- 132
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A GL +LH +K I+RD K +NILL KL DFG++ S +
Sbjct: 133 ---ALMGLQHLHVNKT--IHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSV 185
Query: 245 GTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290
GT + APE +A A+ DV+S G+ +E+ G + P R
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 26/193 (13%)
Query: 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL 260
K+++RD K++NI L KL DFG +K V++ GT Y APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 261 TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY 320
+ K+D++S GV+L E+L+ R P+ +R ++M + G+Y
Sbjct: 249 SKKADMWSLGVILYELLTLHR------------------PFKGPSQR--EIMQQVLYGKY 288
Query: 321 S---LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAGVSRDESLQNSDR 375
+ L LS P RPT +++ L+ + + V E++ DR
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDR 348
Query: 376 STYKRKGLNENGQ 388
R+ L E+G+
Sbjct: 349 EEILRQ-LQESGE 360
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
APE + D++S G ++ EM+ G + P +H + +W K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLF----PGTDH-IDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 66/241 (27%), Positives = 96/241 (39%), Gaps = 80/241 (33%)
Query: 75 VLGEGGFG--CVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQ--------------- 116
V+G G FG V K TG V A+K LN+ E L+
Sbjct: 8 VIGRGAFGEVAVVK-----------MKNTGQVYAMKILNKWEMLKRAETACFREERDVLV 56
Query: 117 -GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL-------ENHLFR 167
G W+T + Y +D++ L LV ++ G L E+ L
Sbjct: 57 NGDRRWITNLH---------------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE 101
Query: 168 TGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG- 226
A + + M +A+ + L Y+H RD K N+LLD N + +L+DFG
Sbjct: 102 DMARF-----YLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGS 148
Query: 227 ---LAKDGPTGSQSHVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLS 278
L DG QS+V+ +GT Y +PE + G + D +S GV + EML
Sbjct: 149 CLRLLADGTV--QSNVA---VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203
Query: 279 G 279
G
Sbjct: 204 G 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 53/207 (25%), Positives = 77/207 (37%), Gaps = 52/207 (25%)
Query: 101 TGMVIAVKRLNQES--------LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-L 151
T ++AVK++N +S LQ EI QL HPN++ D L +
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQ------EIITSRQLQHPNILP-YVTSFIVDSELYV 76
Query: 152 VYEFMPKGS----LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
V M GS L+ H F G L + L Y+HS I+R
Sbjct: 77 VSPLMAYGSCEDLLKTH-FPEG------LPELAIAFILKDVLNALDYIHSKG--FIHRSV 127
Query: 208 KTSNILLDLNYNAKLSDF----GLAKDG---------PTGSQSHVSTRVMGTYGYAAPEY 254
K S+ILL + LS + K G P S ++ + +PE
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--------WLSPEV 179
Query: 255 MATGHL--TAKSDVYSFGVVLLEMLSG 279
+ KSD+YS G+ E+ +G
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T + + T + T Y
Sbjct: 135 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSG 279
APE + D++S G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 25/150 (16%)
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLS--WTIRMKVALGAAKGLAYLHSD 198
Y +D++ L LV ++ G L L + + ++ + M +A+ + L Y+H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 199 KAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEY 254
RD K N+LLD+N + +L+DFG + +DG QS V+ +GT Y +PE
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVA---VGTPDYISPEI 174
Query: 255 M-----ATGHLTAKSDVYSFGVVLLEMLSG 279
+ G + D +S GV + EML G
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS------GRRVIDK 285
APE + D++S G ++ EM+ GR ID+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 63/255 (24%), Positives = 99/255 (38%), Gaps = 74/255 (29%)
Query: 101 TGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
T + A+K L + + H++ +I L + + +VKL Y +D L V +
Sbjct: 25 TNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKLY-YSFQDKDNLYFVMD 81
Query: 155 FMPKGSLENHLFRTGAS-------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
++P G + + L R G YI L+ I +H K I+RD
Sbjct: 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIE------------SVH--KMGFIHRDI 127
Query: 208 KTSNILLDLNYNAKLSDFGLA-------------------KDG--PTGSQSHVSTRVM-- 244
K NIL+D + + KL+DFGL +D P+ S + +
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 245 ------------------GTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285
GT Y APE + TG+ T D +S GV+L EML G+
Sbjct: 188 LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLA 246
Query: 286 NRPSR-EHNLIEWAK 299
+ P+ + +I W
Sbjct: 247 DTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 41/213 (19%)
Query: 153 YEFMPKGSLENHL---FRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 209
Y+ ++N L G + + LS+T ++ A+G+ +L S ++RD
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQV------ARGMEFLASKNC--VHRDLAA 265
Query: 210 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSF 269
N+LL K+ DFGLA+D S + APE + T SDV+S+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 270 GVVLLEMLS------GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLG 323
G++L E+ S ++D ++ + AKP + + ++ +M
Sbjct: 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD-HATQEVYDIM----------- 373
Query: 324 AALKTAVLAIKCLSNEPKFRPT---MDEVVKAL 353
+KC ++EP+ RP+ + ++V++L
Sbjct: 374 ---------VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K + + +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+V L + LV+E++ + G + P + + + L +GL+Y
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFLFQLL---RGLSY 118
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE- 253
+H + +++RD K N+L+ KL+DFGLA+ SH + + T Y P+
Sbjct: 119 IH--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSG 279
+ + + D++ G + +EM+ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 76 LGEGGFGCVFKGWIDE-HTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F +FKG E Y + +K L++ + + QL H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHK---TEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+LV G C+ D ++V E++ GSL+ +L + +SW +++VA A L +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI--NISW--KLEVAKQLAWALHF 115
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT--YGYAAP 252
L DK + + + N+LL + K + K G V + + + P
Sbjct: 116 LE-DK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173
Query: 253 EYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311
E + +L+ +D +SFG L E+ SG ++P L S++++ Q
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA----------LDSQKKL-QF 217
Query: 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
+ R Q + A L +C+ EP FRP+ +++ L
Sbjct: 218 YEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 46/180 (25%)
Query: 136 LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV-ALGAAKGLA 193
+VK+ Y +D L L+ EF+P G + L + + + I V A+ A L
Sbjct: 63 VVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----------------LAKDGPTG--- 234
++H RD K N+LLD + KLSDFG L + P+
Sbjct: 122 FIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 235 --------------SQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG 279
++ ++ +GT Y APE +M TG+ D +S GV++ EML G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 46/234 (19%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
Q+ H ++V L G C+ D ++V EF+ G L+ + R L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLA 115
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILL-----DLNYNA--KLSDFGLAKDGPTG--SQSHVS 240
L+YL DK +++ + T NILL D KLSD G+ P S+
Sbjct: 116 SALSYLE-DK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECV 169
Query: 241 TRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
R+ + APE + + +L+ +D +SFG L E+ + P ++ L E
Sbjct: 170 ERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDKTLAE--- 217
Query: 300 PYLQSKRRIFQVMDARIEGQYSLGA--ALKTAVLAIKCLSNEPKFRPTMDEVVK 351
K R + EGQ L + A L C++ +P RP +++
Sbjct: 218 -----KERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 40/255 (15%)
Query: 76 LGEGGFGCVFKG----WIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ 130
+G G +G V+K D+ YA + GTG+ ++ R EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 131 LYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLF-RTGASYIQPLSWTIRMKVAL- 186
L HPN++ L L R L++++ F R + +P+ M +L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 187 -GAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAK--DGPTGSQSHV 239
G+ YLH++ V++RD K +NIL+ K++D G A+ + P + +
Sbjct: 115 YQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 240 STRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
V+ T+ Y APE + H T D+++ G + E+L+ + R+ + I+ +
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH----CRQED-IKTS 226
Query: 299 KPYLQSK-RRIFQVM 312
PY + RIF VM
Sbjct: 227 NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 20/145 (13%)
Query: 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207
H +V E++ G L GA + RM A L YLH+ +++RD
Sbjct: 75 HLCMVMEYVEGGDCATLLKNIGALPVD----MARMYFA-ETVLALEYLHN--YGIVHRDL 127
Query: 208 KTSNILLDLNYNAKLSDFGLAKDG-------------PTGSQSHVSTRVMGTYGYAAPEY 254
K N+L+ + KL+DFGL+K G ++ + +V GT Y APE
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187
Query: 255 MATGHLTAKSDVYSFGVVLLEMLSG 279
+ D ++ G++L E L G
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 64/252 (25%), Positives = 98/252 (38%), Gaps = 62/252 (24%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLT 123
+F V+G G FG V + TG V A+K L + + GH+
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER 52
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+I L + +VK+ Y +D L L+ EF+P G + L + + + I
Sbjct: 53 DI--LVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 183 KV-ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS---- 237
V A+ + L ++H RD K N+LLD + KLSDFGL ++
Sbjct: 110 TVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 238 -----------------------------HVSTRVMGTYGYAAPE-YMATGHLTAKSDVY 267
++ +GT Y APE +M TG+ D +
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWW 220
Query: 268 SFGVVLLEMLSG 279
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 101 TGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPK 158
TG ++ V+ + E+ + HL+ L L + HPN++ ++ FM
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 159 GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218
GS N L +T + + +S + + GA +GL YLH + I+R+ K S+IL+ +
Sbjct: 84 GS-ANSLLKT--YFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDG 138
Query: 219 NAKLSD----FGLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMA---TGHLTAKSDVY 267
LS + L ++G + ST V+ + +PE + G+ KSD+Y
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIY 194
Query: 268 SFGVVLLEMLSGR 280
S G+ E+ +GR
Sbjct: 195 SVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 58/193 (30%)
Query: 136 LVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLS--WTIRMKVALGAAKGL 192
+VKL Y +D D+ V +++P G + + L R + + L+ + + +A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKM 120
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL---------AKDGPTGS-------- 235
++H RD K NIL+DL+ + KL+DFGL +K GS
Sbjct: 121 GFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 236 ----------------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVY 267
Q ++ ++GT Y APE + T D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 268 SFGVVLLEMLSGR 280
S GV+L EML G+
Sbjct: 233 SVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 3/91 (3%)
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+ + YLH ++ +I+RD K NI ++ + L DFG A P ++ GT
Sbjct: 193 RAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIAT 249
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
APE +A D++S G+VL EM +
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 63/272 (23%), Positives = 96/272 (35%), Gaps = 90/272 (33%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F V+G+G FG V + TG + A+K L + +E+
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLK----------SEMFKK 42
Query: 129 GQLYH-------------PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQ 174
QL H P +V L Y +D L L+ EF+P G L L + ++ +
Sbjct: 43 DQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSE 100
Query: 175 PLS--WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL----- 227
++ + +A+ A L ++H RD K NIL+D + KLSDFGL
Sbjct: 101 DVTRFYMAECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFH 152
Query: 228 ----------------AKDGPTGSQSHV-------------------STRVM-----GTY 247
K+ S + R+M GT
Sbjct: 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
Y APE + D +S G ++ E L G
Sbjct: 213 DYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 95 APARPGTGMVIAVKRLNQES--------LQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145
A +P TG + V+R+N E+ LQG L H+ +L+ HPN+V +
Sbjct: 19 ARYKP-TGEYVTVRRINLEACTNEMVTFLQGEL-------HVSKLFNHPNIVPYRATFIA 70
Query: 146 DDHRLLVYEFMPKGSLENHL---FRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 202
D+ +V FM GS ++ + F G S + I + G K L Y+H
Sbjct: 71 DNELWVVTSFMAYGSAKDLICTHFMDGMSEL-----AIAY-ILQGVLKALDYIH--HMGY 122
Query: 203 IYRDFKTSNILLDLNYNAKLS----DFGLAKDGPTGSQSH----VSTRVMGTYGYAAPEY 254
++R K S+IL+ ++ LS + + G H S +V+ + +PE
Sbjct: 123 VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP---WLSPEV 179
Query: 255 MATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291
+ AKSD+YS G+ E+ +G V K+ P+ +
Sbjct: 180 LQQNLQGYDAKSDIYSVGITACELANG-HVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A G+ +L S ++RD N+L+ K+ DFGLA+D S
Sbjct: 249 ANGMEFLASKNC--VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ APE + T SDV+SFG++L E+ +
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
Y+H + +I+RD KT N+L++ + L DFG A + + GT APE
Sbjct: 275 YIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332
Query: 254 YMATGHLTAKSDVYSFGVVLLE 275
+A T D++S G+V+ E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
E+ + +L H N+V+ I L ++ L + EF G L ++ + + + I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI- 120
Query: 182 MKVALGAAKGLAYLHSDK-----AKVIYRDFKTSNILLDL-------------NYN---- 219
+ + LAY H+ K +V++RD K NI L N N
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEML 277
AK+ DFGL+K+ S +H +GT Y +PE + T KSD+++ G ++ E+
Sbjct: 181 AKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 278 SGR 280
SG+
Sbjct: 238 SGK 240
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 57/187 (30%)
Query: 142 YCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLS--WTIRMKVALGAAKGLAYLHSD 198
Y +D D+ V +++P G + + L R G + + L+ + + A+ + + ++H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIH-- 124
Query: 199 KAKVIYRDFKTSNILLDLNYNAKLSDFGL---------AKDGPTGS-------------- 235
RD K NIL+D + + KL+DFGL +K +G
Sbjct: 125 ------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 236 ----------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVL 273
Q ++ ++GT Y APE + T D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 274 LEMLSGR 280
EML G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 6/103 (5%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQL-Y 132
LG G FG V ++ Y + M +AVK L + E L +E+K L L
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP 175
H N+V L+G C L++ E+ G L N L R S+I P
Sbjct: 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICP 140
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 54/242 (22%)
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ Q+ H +L + G C+ ++V EF+ G L+ L + P++W ++ VA
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV--PVAW--KITVAQQ 125
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNA----KLSDFGLAKDGPTGSQSHVS 240
A L+YL DK +++ + NILL L KLSD G++ S+
Sbjct: 126 LASALSYLE-DK-NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL--SREERV 181
Query: 241 TRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEM-------LSGRRVIDKNR-PSRE 291
R+ + APE + G L+ +D +SFG LLE+ L R +K R ++
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK 237
Query: 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
H L E + L A L +CL+ EP RP+ +++
Sbjct: 238 HRLPEPSCKEL--------------------------ATLISQCLTYEPTQRPSFRTILR 271
Query: 352 AL 353
L
Sbjct: 272 DL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.001
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 44/163 (26%)
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK-- 190
+PN +KL +L+ +++ G L + ++ + L A+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD---------------LLKKEGKLSEAEVK 112
Query: 191 --------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAKDGPTGSQS 237
L LH K +I+ D K N+L Y+ L D+GL K G+ S
Sbjct: 113 KIIRQLVEALNDLH--KHNIIHNDIKLENVL----YDRAKDRIYLCDYGLCK--IIGTPS 164
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSG 279
GT Y +PE + GH S D ++ GV+ E+L+G
Sbjct: 165 CYD----GTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 16/108 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
+LG G FG V +G Y +R M +AVK L +++L L+ +T H
Sbjct: 44 ILGSGAFGKVVEG----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMT---H 96
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP 175
LG H N+V L+G C + ++ E+ G L N+L + +++
Sbjct: 97 LGP--HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 16/110 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ + + + +AVK L +E+L L+ L+ H
Sbjct: 45 TLGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS---H 97
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177
LGQ H N+V L+G C L++ E+ G L N L + +++ +
Sbjct: 98 LGQ--HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM 145
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.2 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.87 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.66 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.44 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.1 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.11 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.1 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.83 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.68 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-53 Score=395.07 Aligned_cols=252 Identities=29% Similarity=0.416 Sum_probs=217.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+|...++||+|||+.||.+. +..+|+.||+|++.+..+ ...+.+.+|+++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~---------~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEAR---------DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEE---------EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 679999999999999999994 445799999999988644 34566889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+++|||.|+|..++|..++++.+ ++++..+..++.||+.||.|||+++ |+|||||..|+|++++.+|||+|
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgD 161 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGD 161 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecc
Confidence 9999999999999999999998654 5999999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+|....... +...+.||||.|.|||++....++..+||||+||++|.||.|++||+...-..-...++
T Consensus 162 FGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------- 231 (592)
T KOG0575|consen 162 FGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------- 231 (592)
T ss_pred cceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--------
Confidence 99999865432 24567899999999999999999999999999999999999999997653211111111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. -+..+|...+.+..+||.+||+.||.+|||+.+||.|=..
T Consensus 232 --------~--~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 232 --------L--NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred --------h--cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1 1123344667889999999999999999999999998655
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=379.54 Aligned_cols=256 Identities=28% Similarity=0.368 Sum_probs=211.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-------HHHHHHHHHHHhccCCCcccc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~e~~~l~~l~hpni~~ 138 (401)
..+.|.+.+.||+|+||.|-+| ....||+.||||++++..... ...+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 4567899999999999999999 555689999999998764322 223568999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN- 217 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~- 217 (401)
++++|...+..||||||+.||+|.+.+-..+. +.+....-+++|++.||.|||++| |+||||||+|||+..+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDA 313 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCC
Confidence 99999999999999999999999999988764 788888999999999999999999 9999999999999665
Q ss_pred --CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCc-c
Q 015731 218 --YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-E 291 (401)
Q Consensus 218 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~ 291 (401)
..+||+|||+|+...... .+.+.|||+.|.|||++.+.. +..++|+|||||++|-+++|.+||....... .
T Consensus 314 e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 779999999999865333 567899999999999996654 3458899999999999999999997654322 1
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.. ++...+.. ...-...+++..+||.+||..||++|||+.|+|+|-|.-
T Consensus 391 ~e----------------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 391 KE----------------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred HH----------------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 11 11111111 111235678899999999999999999999999998763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=365.54 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=215.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+.+.++.||+|..|+||++ .|..|++.+|+|.+.... .....++.+|+++++..+||+||.+|+.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 45677889999999999999 677799999999995443 23456789999999999999999999999999
Q ss_pred C-eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 147 D-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 147 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
. .++|+||||.+|+|.+++...+. +++....+++.+|+.||.|||. ++ ||||||||+|||++..|+|||||
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~-----i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGR-----IPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEecc
Confidence 8 59999999999999999988753 9999999999999999999996 66 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||.+...... ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+..
T Consensus 223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-------------- 284 (364)
T KOG0581|consen 223 FGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-------------- 284 (364)
T ss_pred ccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--------------
Confidence 9999865433 4567899999999999999999999999999999999999999997642111
Q ss_pred cchhhhhhhhhhc---CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIE---GQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~---~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+..++..... ..++.. ++.++.+|+..||+.||.+|||+.++++|=+-.
T Consensus 285 -~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 285 -LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred -CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 111222222221 233443 788999999999999999999999999996544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=368.70 Aligned_cols=208 Identities=31% Similarity=0.499 Sum_probs=186.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..+|.+.+.||.|+||+||+| ++..++..||||.+.+... +..+.+..|+.+|+.++|||||++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg---------~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKG---------RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEe---------EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 367999999999999999999 5555789999999988753 33445789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC------C
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------Y 218 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~------~ 218 (401)
+++.+|||||||.||+|.+++...+. +++..+..++.||+.||++||+++ ||||||||+|||++.. .
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~ 152 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRGR-----LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSP 152 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCc
Confidence 99999999999999999999998864 999999999999999999999999 9999999999999764 5
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.+||+|||+|+....+. ...+.+|++.|||||++..+.|+.|+|+||+|+|+|++++|++||....+.+...
T Consensus 153 ~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 153 VLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred eEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 68999999999876443 5667899999999999999999999999999999999999999998776654433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=372.35 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=215.4
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH---HHHHHHHHHHhcc-CCCcccce
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQL-YHPNLVKL 139 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l-~hpni~~~ 139 (401)
.....+|.+++.||+|+|++|++| .+..++..||||++.+..+... ..+..|-.+|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 345578999999999999999999 4555899999999988754322 2355788888888 89999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
+..|+|+..+|+|+||+++|+|.++|++.+. +++.-...++.+|+.||+|||++| ||||||||+|||++.+++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmh 212 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGH 212 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCc
Confidence 9999999999999999999999999999875 999999999999999999999999 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCc---------ce--eeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 015731 220 AKLSDFGLAKDGPTGSQS---------HV--STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 288 (401)
++|+|||.|..+...... .. ...++||..|.+||+|.....++.+|||+||||+|+|+.|.+||.+.++
T Consensus 213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 999999999865443222 11 2558999999999999999999999999999999999999999987654
Q ss_pred CccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... +.++. +.-.++...++...+||+++|..||.+|+|+++|.+|
T Consensus 293 yliF----------------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 YLIF----------------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHH----------------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2211 11221 2223445556788899999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=359.92 Aligned_cols=251 Identities=29% Similarity=0.397 Sum_probs=211.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|+++++||+|+||+||.++ +..|++.+|+|++++..... .....+|..+|..++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vr---------k~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVR---------KKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEE---------EcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3679999999999999999984 44589999999999876643 34577899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
++...+|||+||+.||.|...|++.+. +++..+.-++..|+.||.|||++| ||||||||+|||++.+|+++|+
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEe
Confidence 999999999999999999999998765 999999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||+++...... ....+++||+.|||||++.+..|+.++|.||||+++|+|++|.+||...+.....+.+
T Consensus 168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I-------- 237 (357)
T KOG0598|consen 168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI-------- 237 (357)
T ss_pred ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--------
Confidence 999998643322 2345589999999999999999999999999999999999999999776532211111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP----TMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----s~~eil~~ 352 (401)
...+ ....+...+.+..+++.++|..||++|. ++.+|-+|
T Consensus 238 --------~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 238 --------LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred --------hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1111 1122333677888999999999999996 56666555
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.68 Aligned_cols=290 Identities=55% Similarity=0.963 Sum_probs=249.8
Q ss_pred CccccchhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC
Q 015731 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133 (401)
Q Consensus 54 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h 133 (401)
....|++.++..+++.|....+||+|+||.||+|.+.+ |..||||.+.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56779999999999999999999999999999998764 47899998877654314469999999999999
Q ss_pred CcccceeeEEeeCC-eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-CCeEEeccCCCc
Q 015731 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSN 211 (401)
Q Consensus 134 pni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~dlkp~N 211 (401)
||+++++|||.+.+ +.+||+||+++|+|.+++...... +++|..+++|+.+++.||+|||... ++|+|||||+.|
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 99999999999998 599999999999999999876532 6999999999999999999999853 379999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCcceeeec-ccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV-MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
||+|++...||+|||+++..+.. .. ..... .||.+|+|||.+..+..+.++||||||+++.||++|+.+.+...+..
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred eeECCCCCEEccCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999765431 11 11222 79999999999988899999999999999999999999988776666
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIE-GQYSL-GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+..|..+.+... .+.+++|..+. ..+.. .....+..+..+|++.+|.+||++.+|++.|+.+...
T Consensus 286 ~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 677889998777766 77888998876 55554 5667788999999999999999999999999666544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=349.74 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=216.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|+.+.++|+|+||.||+| .++.||+.||||++..... ...+-.++|++.|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 46888899999999999999 6667999999999866543 223346799999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++|+|||+ -++.+.+.... ..++...+.++++|++.|+.|+|+++ ++||||||+||||+.+|.+|||||
T Consensus 73 krklhLVFE~~d-hTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDF 145 (396)
T KOG0593|consen 73 KRKLHLVFEYCD-HTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDF 145 (396)
T ss_pred cceeEEEeeecc-hHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccc
Confidence 999999999994 47777777665 45899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh-hhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-YLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~ 303 (401)
|+|+.... .....+..+.|.+|+|||++.+ ..|+..+||||+||++.||++|.+.|.+..+.+....|..... ++.
T Consensus 146 GFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 146 GFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 99997653 3335777889999999999977 6899999999999999999999999999988887766643221 111
Q ss_pred hcchhhh---------hhhh----hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRIFQ---------VMDA----RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~---------~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....++. +... .++..+ +..+.-+.+|+++||+.||.+|++.++++.|
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111110 0000 011111 2345578899999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=349.84 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=208.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceee-EEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG-YCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~-~~~ 144 (401)
.+|+++++||.|+||.||++ .+..+|..+|.|.+.-..+ .....+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 46899999999999999999 5566899999999885544 33456889999999999999999998 455
Q ss_pred eCCe-eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--CCeEEeccCCCcEEEcCCCceE
Q 015731 145 EDDH-RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK--AKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 145 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~ivH~dlkp~Nil~~~~~~~k 221 (401)
+++. ++||||+|.+|+|...++..+. ..+.++++.+|+++.|++.||.++|+.- ..|+||||||.||+++.+|.+|
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 5555 8999999999999999976553 2366999999999999999999999932 2399999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|+|||+++.+.... ......+|||+||+||.+.+..|+.++||||+||++|||+.-++||.+.+-.
T Consensus 169 LGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------------ 234 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------------ 234 (375)
T ss_pred eccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------------
Confidence 99999999754332 2345689999999999999999999999999999999999999999775311
Q ss_pred hhhcchhhhhhhhhhcCC---CC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQ---YS-LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.+..+.-... .+ ..++.++..||..|+.+||..||+.-.++..+.
T Consensus 235 --------~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 235 --------SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111111112 22 567889999999999999999998655554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=363.13 Aligned_cols=266 Identities=33% Similarity=0.549 Sum_probs=218.8
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcE-EEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~-~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
...+.+.||.|+||+||+|.+. |.. +|+|++....... ...|.+|+.+|.+|+|||||+++|++.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3455567999999999999886 344 9999998765433 4579999999999999999999999998
Q ss_pred CC-eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceEEe
Q 015731 146 DD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLS 223 (401)
Q Consensus 146 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~kl~ 223 (401)
.. ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++++ |||||||++|||++.++ ++||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEEC
Confidence 87 7999999999999999998841 1559999999999999999999999865 89999999999999997 99999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||+++...... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||....+...
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------- 254 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------- 254 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----------
Confidence 999998644321 2233468999999999998 55899999999999999999999999987654111
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCcc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRD 367 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~ 367 (401)
...+.....+...+..++..+..|+.+||+.||..||++.+|+..|+.+........+..
T Consensus 255 ------~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~ 314 (362)
T KOG0192|consen 255 ------ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED 314 (362)
T ss_pred ------HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence 112222233334455577889999999999999999999999999999977665544443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=364.77 Aligned_cols=269 Identities=25% Similarity=0.333 Sum_probs=219.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccC-CCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~-hpni~~~~~~~ 143 (401)
.-++|.+++.||.|+||.||+| +...+|..||||.+++....- ...-++|+.-|++|+ |||||++++++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence 3468999999999999999999 556689999999998764321 222468999999998 99999999999
Q ss_pred eeCC-eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 144 LEDD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 144 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
.+.+ .+|+||||| ..+|+++++.+. .++++..+..|++||++||+|+|.+| +.||||||+|||+..+..+||
T Consensus 79 ~d~~~~L~fVfE~M-d~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 79 RDNDRILYFVFEFM-DCNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred hccCceEeeeHHhh-hhhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEe
Confidence 9988 999999999 779999999885 67999999999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
+|||+|+...... ..+..+.|.+|+|||++ +...|+.+.|||++|||++|+.+-++.|.+..+.++...+.-....
T Consensus 152 aDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 152 ADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred cccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 9999999754333 46778899999999987 5578999999999999999999999999999887776655321110
Q ss_pred -----hhhcchhhhhhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 302 -----LQSKRRIFQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 302 -----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
+.....+...+.-.+.. .+-...+.++.+||.+||..||.+|||+.++|+|-
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00111112222222111 11223788999999999999999999999999973
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=330.43 Aligned_cols=269 Identities=28% Similarity=0.352 Sum_probs=217.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.+|...+.||+|.||.||+|+ +..||+.||||++......+ .....+|++.|+.++|+||+.++++|.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~---------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKAR---------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEE---------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 478889999999999999995 44589999999998775442 3457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+.+.||+||+ .-+|+..++... ..++...+..++.+++.||+|||++. |+||||||.|+|++.+|.+||+||
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADF 145 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADF 145 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecc
Confidence 99999999999 559999998776 56899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH---------
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI--------- 295 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~--------- 295 (401)
|+++.+..... ..+..+-|.+|+|||++.| ..|+..+||||.|||+.||+-|.+.|.+.++.++...+
T Consensus 146 GLAr~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 146 GLARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP 223 (318)
T ss_pred cchhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence 99998654433 3344478999999998866 57999999999999999999999999998876665554
Q ss_pred -Hhhhhh-hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 296 -EWAKPY-LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 296 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+|..-. +.+-..+.......+ ..+-..++.++.+|+.+||..||.+|+|+.++++|=..
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred ccCccccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 121100 011111111111111 11334566777999999999999999999999998544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=356.86 Aligned_cols=256 Identities=28% Similarity=0.360 Sum_probs=213.0
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-----hhHHHHHHHHHHHhccC-CCcccce
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLY-HPNLVKL 139 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~-hpni~~~ 139 (401)
..+.|.+.+.||+|+||+|++| .+..+|..||+|++..... .....+.+|+.+++.+. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a---------~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLA---------KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEe---------eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 3468999999999999999999 5555789999998877522 12334668999999998 9999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-C
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-Y 218 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~ 218 (401)
++++.....+|+||||+.||+|.+++.+.+ ++.+..+..++.|++.||+|||++| |+||||||+|||++.+ +
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEG 158 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCC
Confidence 999999999999999999999999999854 3889999999999999999999998 9999999999999999 9
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.+||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||..........
T Consensus 159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--- 233 (370)
T KOG0583|consen 159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--- 233 (370)
T ss_pred CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH---
Confidence 99999999998763 2223456789999999999998877 75 78999999999999999999998733211111
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGA-ALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.+... .-.++... +.++.+|+.+||..||.+|+|+.+|++|=|.-.
T Consensus 234 -------------ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 234 -------------KIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------HHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 01111 11223333 789999999999999999999999998777665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=364.06 Aligned_cols=250 Identities=28% Similarity=0.387 Sum_probs=217.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-c--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-L--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.-|++++-||.|+-|.|.+| +|..||+..|||++.+.. . .....+.+|+-+|+.+.|||++++|+++.
T Consensus 12 GpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 45899999999999999998 788899999999998762 2 12335779999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+..++|+|.||++||.|++++...+. +++..+.+++.||+.|+.|+|..+ |+||||||+|+|++..+.|||+|
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIAD 155 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIAD 155 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeec
Confidence 99999999999999999999988864 999999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||+|..-..+. ...+.||++.|.+||++.|..| +.++||||+|||||.||+|+.||++.+.
T Consensus 156 FGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------------- 217 (786)
T KOG0588|consen 156 FGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------------- 217 (786)
T ss_pred cceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---------------
Confidence 99998654433 4566799999999999999888 5799999999999999999999975432
Q ss_pred hcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..++.+... -+++...+.++.+||.+||.+||.+|.|++||++|-+-.
T Consensus 218 -----r~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 218 -----RVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred -----HHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 222222222 234556788999999999999999999999999997655
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=331.40 Aligned_cols=237 Identities=29% Similarity=0.385 Sum_probs=207.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++++.||.|+||.|.++ +++.+|..+|+|++.+..... .+...+|-.+|+.+.||+++++++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LV---------r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLV---------REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEE---------EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 57999999999999999998 445579999999999876543 344678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+.+||||||.+||.|..++++.+. +++..+..++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEe
Confidence 99999999999999999999998764 999999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+|+.... ...+.|||+.|+|||++....|+.++|.|+||+++|||+.|.+||...++....
T Consensus 188 FGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY------------ 250 (355)
T KOG0616|consen 188 FGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY------------ 250 (355)
T ss_pred ccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH------------
Confidence 999987533 356789999999999999999999999999999999999999999876652211
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
..++..+ -.++...+..+.+|+.++|+.|-.+|
T Consensus 251 ----~KI~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 251 ----EKILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----HHHHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222222 24566778889999999999999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=357.67 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=218.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
...|.....||+|+.|.||.| ....+++.||+|.+....-...+-+++|+.+|+..+|+|||++++.|..+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 356888889999999999999 45567899999999887655566688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+.+|+||||++||+|.|.+.... +++.++..|+..++.||+|||.+| |+|||||.+|||++.+|.+||+|||
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFG 414 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR------MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFG 414 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeee
Confidence 99999999999999999998765 899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ...+.+||++|||||++....|+++.||||||++++||+-|++||-..++.....++...
T Consensus 415 Fcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-------- 484 (550)
T KOG0578|consen 415 FCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------- 484 (550)
T ss_pred eeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc--------
Confidence 9987654332 467789999999999999999999999999999999999999999876664444333211
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...+...+...+..+.+|+.+||+.|+.+|+++.|+|+|
T Consensus 485 -------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 -------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111122345667889999999999999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=353.10 Aligned_cols=272 Identities=26% Similarity=0.320 Sum_probs=214.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....|+.++.||+|+||.||+| ++..+|+.||+|++...... ...-..+|+.||++|+||||+++.+++
T Consensus 115 ~~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 3467888999999999999999 56668999999998876532 233456899999999999999999998
Q ss_pred eeC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 144 LED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 144 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
.+. ..+|||+||| .-+|.-++.... -.+++.++..++.||+.||+|||++| |+|||||..||||+.+|.+|
T Consensus 186 t~~~~~siYlVFeYM-dhDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LK 258 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYM-DHDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLK 258 (560)
T ss_pred EecCCceEEEEEecc-cchhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEE
Confidence 876 7899999999 558988887654 34999999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||+|+.+...... ..+..+-|.+|+|||++.|. .|+.++|+||+||||.||++|+++|.+..+..+...|--.-.
T Consensus 259 iaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG 337 (560)
T KOG0600|consen 259 IADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG 337 (560)
T ss_pred eccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence 9999999976554432 36667889999999998764 799999999999999999999999999887776655421100
Q ss_pred h-hhhcchhhhhhhhhh---cCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 301 Y-LQSKRRIFQVMDARI---EGQY-------SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 301 ~-~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
- ..+-+....+..... ...+ -...+....+|+..||..||.+|.|+.++|.+=.
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 0 000000001110000 0011 1123566778999999999999999999998743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=342.94 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=214.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH-HHHHHHHHHHhccCCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
....|++.++||.|..++||+|++. .++++||||+++.+..... ..+.+|+..++.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~---------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCI---------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeec---------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 4478999999999999999999554 4689999999998876554 67889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.+..+|+||.||.+|++.++++..-. ..+.+..+..|+.++++||.|||++| .||||||+.||||+.+|.|+|+|
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLad 169 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLAD 169 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcC
Confidence 99999999999999999999987754 45999999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCC-Cccee-eecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 225 FGLAKDGPTGS-QSHVS-TRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 225 fg~~~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||.+....... ..... ..+.||++|||||++.. ..|+.|+||||||++..||.+|..||....|.+.....--..+
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 99776433322 22222 56789999999999744 4799999999999999999999999988776543322111111
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.... ...+........+..+..++..||+.||.+|||+.++++|=
T Consensus 250 p~~~--------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 250 PTLL--------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CCcc--------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 0000 00001111122344777899999999999999999999873
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=352.50 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=212.2
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH---HHHHHHHHHHhccCCCccccee
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l~hpni~~~~ 140 (401)
+...++|+++++||+|+||.||+| +...||.++|+|++++..+... ..++.|-.+|...++|+||+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred cCCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 445589999999999999999999 5666899999999999876433 3477899999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
-.|++.+.+||||||++||++..+|.+.+. |++..+..++.+++.||+-||+.| +|||||||+|+|||..|++
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~~~~-----L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMRKDT-----LTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHhcCc-----CchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCE
Confidence 999999999999999999999999988764 999999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCC----------------------CCCc----ce-------------------eeecccccCccccccc
Q 015731 221 KLSDFGLAKDGPT----------------------GSQS----HV-------------------STRVMGTYGYAAPEYM 255 (401)
Q Consensus 221 kl~Dfg~~~~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~ 255 (401)
||+|||++.-... .... .. ....+|||.|+|||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999852111 0000 00 1124799999999999
Q ss_pred ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh-HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHH
Q 015731 256 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIK 334 (401)
Q Consensus 256 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 334 (401)
.+..|+..+|.||||||+||||.|.+||....+..-... ..|.. . +..+.....+.+..+||.+
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----------~----l~fP~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----------T----LKFPEEVDLSDEAKDLITR 425 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------h----ccCCCcCcccHHHHHHHHH
Confidence 999999999999999999999999999988776443221 12221 1 1112223345789999999
Q ss_pred ccccCCCCCC---CHHHHHHH
Q 015731 335 CLSNEPKFRP---TMDEVVKA 352 (401)
Q Consensus 335 ~L~~dp~~Rp---s~~eil~~ 352 (401)
||. ||.+|. .++||.+|
T Consensus 426 ll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred Hhc-CHHHhcCcccHHHHhcC
Confidence 999 999997 58888887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=344.25 Aligned_cols=263 Identities=30% Similarity=0.446 Sum_probs=211.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|...+.||+|+||.||++.. ..+|...|||.+..........+.+|+.+|.+|+|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~---------~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATN---------KKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEe---------cCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 4678889999999999999944 3458999999988775444556789999999999999999999754444
Q ss_pred --eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEEee
Q 015731 148 --HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSD 224 (401)
Q Consensus 148 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl~D 224 (401)
.++++|||+++|+|.+++.+.+. .+++..+..+..||++||+|||++| |||+||||+|||++. ++.+||+|
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEecc
Confidence 69999999999999999998763 3999999999999999999999998 999999999999999 79999999
Q ss_pred ccCCcCCCC-CCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 225 FGLAKDGPT-GSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 225 fg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
||++..... ...........||+.|||||++.++ ....++|||||||++.||+||.+||.... ...
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~---------- 229 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEA---------- 229 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chH----------
Confidence 999886543 1112223457899999999999853 33459999999999999999999997530 000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.....+........++...+.+..+|+.+|+..||++|||+.++|+|....+...
T Consensus 230 ---~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 230 ---EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 0011111111223556667889999999999999999999999999987665544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=353.21 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=214.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|.+.+.||+|+||.||+| .++.+.+.||+|.+.+... ++...+.+|+++++.|+||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47889999999999999999 6777899999999987643 345568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
..++++|+||+.| +|..++...+. ++++.+..++++++.||.|||+++ |+|||+||.|||++.++.+|++||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdF 144 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDF 144 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechh
Confidence 9999999999966 99999988765 999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+|+.... ...+.+...||+.|||||+..++.|+..+|+||||||+||+++|++||-...
T Consensus 145 g~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------ 204 (808)
T KOG0597|consen 145 GLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ 204 (808)
T ss_pred hhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------
Confidence 99997543 3446677899999999999999999999999999999999999999994321
Q ss_pred chhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 306 RRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 306 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.+++..... ..++...+..+..|++.+|..||..|.|..+++.|
T Consensus 205 --i~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 205 --ITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --HHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1222222221 23455788899999999999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=342.23 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=214.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH---HHHHHHHHHHhccCCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...+|++.+.||+|+||+|-+|+ ....|+.||||.|.+....+. ..+.+|++||..|+||||+.+|++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~---------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV 121 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAY---------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV 121 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehh---------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence 44789999999999999999984 445799999999988766443 457899999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
|+..+.+.|||||..+|.|++|+.+.+. +++..+..++.||+.|+.|+|.++ ++|||||.+|||+++++++||
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKI 194 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKI 194 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeee
Confidence 9999999999999999999999998864 999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
+|||++..+.... ...++||++.|.+||++.|..| ++.+|-||||++||.|+.|..||++.+...
T Consensus 195 ADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----------- 260 (668)
T KOG0611|consen 195 ADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----------- 260 (668)
T ss_pred eccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-----------
Confidence 9999998765443 4667899999999999998887 689999999999999999999998864211
Q ss_pred hhhcchhhhhhhhhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
++...-.+.| .+..+....-||.+||.+||++|.|+.+|..|.|-
T Consensus 261 ---------lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 261 ---------LVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---------HHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1111111111 12234456679999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=351.12 Aligned_cols=261 Identities=30% Similarity=0.444 Sum_probs=216.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+.+.+.+.||+|.||.||.|.++.. ..||+|.+....+ ....|.+|+.+|++|+|+|||++++++..
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 334566778999999999999999863 3589998877644 34578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..+||||||++.|+|.++|..... ..+.....+.++.||++|++||.+++ +|||||.+.||||+++..+||+||
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccc
Confidence 8899999999999999999998332 45889999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...+ +.........-...|+|||.+....++.+||||||||+||||+| |+.|+.+....
T Consensus 348 GLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------- 411 (468)
T KOG0197|consen 348 GLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------- 411 (468)
T ss_pred ccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------
Confidence 99994332 22222222233567999999999999999999999999999999 77887665421
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...+.++...+-.-|..++..+.+++..||+.+|++|||++.+...|+.+...+
T Consensus 412 --ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 412 --EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred --HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 122334444444556778999999999999999999999999999999886543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=353.98 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=210.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhcc-CCCccccee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
...++|.++++||+|.||+|+++ ..+++++.+|||++++...- +.+....|-+|+... +||.+++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~la---------e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~ 435 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLA---------ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF 435 (694)
T ss_pred ccccceEEEEEeccCcCceEEEE---------EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence 44578999999999999999999 45557899999999987653 234466777777766 599999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
..|++.+++|+||||+.||++..+.+.. .+++..+..++..|+.||+|||++| ||+||||.+|||+|.+|++
T Consensus 436 ~~fQT~~~l~fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 436 SCFQTKEHLFFVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred cccccCCeEEEEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcE
Confidence 9999999999999999999955444433 3899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||+++..... .....+++||+.|+|||++.+..|+.++|.|+|||+|||||.|..||.+.++.+..+.|.
T Consensus 508 kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---- 581 (694)
T KOG0694|consen 508 KIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---- 581 (694)
T ss_pred EecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----
Confidence 99999999864322 225678999999999999999999999999999999999999999998876433222111
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 352 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~ 352 (401)
. .+..++...+.+...+++++|..||++|.-+ .+|.+|
T Consensus 582 ------------~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 582 ------------N--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred ------------c--CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 1 1245677888999999999999999999854 566555
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=330.30 Aligned_cols=273 Identities=23% Similarity=0.283 Sum_probs=219.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..+.|+++..|++|+||.||+| +++.|++.||+|+++.+.... ....++|+.+|.+++|||||.+.+++
T Consensus 74 sv~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVV 144 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVV 144 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEE
Confidence 3467899999999999999999 677799999999998765322 23457999999999999999999988
Q ss_pred ee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 144 LE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 144 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
+. -+.+|||||||+. +|..++.... +++....+..++.|++.||+|||.+. |+|||||++|+|++..|.+|
T Consensus 145 vG~~~d~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred eccccceeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEE
Confidence 74 3679999999954 9999998776 67999999999999999999999999 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||+|+.+... ....+..+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+....++.+.|-....
T Consensus 218 iaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 218 IADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred ecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 9999999986543 334667788999999999876 4689999999999999999999999999988776655411110
Q ss_pred h--------hhh-----cchhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 301 Y--------LQS-----KRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 301 ~--------~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. +.. ...+.......++..+... .+..-++|+..+|..||.+|.|+.+.|+|=+.-
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR 365 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence 0 000 0111111222222223222 567788999999999999999999999996543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=339.34 Aligned_cols=271 Identities=26% Similarity=0.310 Sum_probs=215.9
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------------hhHHHHHHHHHHHh
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------------QGHLEWLTEIKHLG 129 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------------~~~~~~~~e~~~l~ 129 (401)
....++|++.+.||+|.||.|.+|+ +..+++.||+|++.+... ...+.+.+|+.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar---------~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLAR---------DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEe---------ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 4456889999999999999999995 445799999999976432 12246789999999
Q ss_pred ccCCCcccceeeEEeeC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEecc
Q 015731 130 QLYHPNLVKLIGYCLED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207 (401)
Q Consensus 130 ~l~hpni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 207 (401)
+|+|||||+++++..+. +.+|||+|||..|.+...=.. ...+++.++++++.+++.||+|||.+| ||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI 236 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI 236 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence 99999999999998764 789999999998877542211 122999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeeccCCcCCCCCCC---cceeeecccccCcccccccccCC----CCcccchhhHHHHHHHHHhCC
Q 015731 208 KTSNILLDLNYNAKLSDFGLAKDGPTGSQ---SHVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 208 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~ 280 (401)
||.|+|++++|++||+|||.+.....+.. ........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999999999999999999986533321 11223468999999999986632 357899999999999999999
Q ss_pred CCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 281 RVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.||-+....... ..+++..+.-+........+.+||++||..||+.|.++.+|..|.|-.+...
T Consensus 317 ~PF~~~~~~~l~----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 317 LPFFDDFELELF----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CCcccchHHHHH----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 999765432221 2333334433334456778999999999999999999999999999988866
Q ss_pred CCCCCc
Q 015731 361 DAGVSR 366 (401)
Q Consensus 361 ~~~~~~ 366 (401)
....+.
T Consensus 381 ~~~~s~ 386 (576)
T KOG0585|consen 381 SPQSSE 386 (576)
T ss_pred CCccCC
Confidence 664444
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.87 Aligned_cols=282 Identities=26% Similarity=0.336 Sum_probs=223.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc--cchhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....|...+.||.|+||.|+.| .+..+|+.||+|++... .....++..+|+++|+.++|+||+.+++++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA---------~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~ 90 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSA---------KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF 90 (359)
T ss_pred ccceecccccccCcceeeEEEE---------EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence 4466777899999999999999 45568999999999843 334456788999999999999999999998
Q ss_pred ee-----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 144 LE-----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 144 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.. -+.+|+|+|+| +.+|...++... .++...+..+++||+.||+|+|+.+ ++||||||.|++++.+.
T Consensus 91 ~p~~~~~f~DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADC 162 (359)
T ss_pred ccccccccceeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCC
Confidence 65 36789999999 779999998764 3899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.+||+|||+|+...........+..+.|.+|+|||++ ....|+.+.||||+|||+.||++|++.|.+.+...+..++..
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9999999999976543333345778889999999987 456899999999999999999999999999887666555532
Q ss_pred hhhhhhhcchhhh--------hhh-------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhcC
Q 015731 298 AKPYLQSKRRIFQ--------VMD-------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTN 360 (401)
Q Consensus 298 ~~~~~~~~~~~~~--------~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~~ 360 (401)
..+.. ....+.. .+. ..+...+ ...+....+|+.+||..||.+|+|++|+|+| |..+.+-+
T Consensus 243 ~lGtP-~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 243 LLGTP-SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred hcCCC-CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 21111 0000000 000 0011111 2456788899999999999999999999999 77776666
Q ss_pred CCCCCc
Q 015731 361 DAGVSR 366 (401)
Q Consensus 361 ~~~~~~ 366 (401)
+.+...
T Consensus 321 dEP~~~ 326 (359)
T KOG0660|consen 321 DEPVCQ 326 (359)
T ss_pred cCCCCC
Confidence 666443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.30 Aligned_cols=258 Identities=28% Similarity=0.339 Sum_probs=218.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH---HHHHHHHHHHhccCCCcccceee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l~hpni~~~~~ 141 (401)
...+.|++++.||+|.-|+||++... +++..+|+|++.+..+... .++..|-+||..++||.++.+|.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~---------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELR---------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEec---------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 34467888999999999999999554 4678999999999876543 34667999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
.|+.+...|++||||+||+|..+++++.. .-+++..+..++..|+.||+|||..| ||+|||||+||||.++|+|.
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEE
Confidence 99999999999999999999999998876 56999999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCC---------------------------------CCCc---------------------ceeeeccccc
Q 015731 222 LSDFGLAKDGPT---------------------------------GSQS---------------------HVSTRVMGTY 247 (401)
Q Consensus 222 l~Dfg~~~~~~~---------------------------------~~~~---------------------~~~~~~~gt~ 247 (401)
|+||.++..... .... .....++||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998753211 0000 0112367999
Q ss_pred CcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHH
Q 015731 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALK 327 (401)
Q Consensus 248 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (401)
.|+|||++.|...+.++|.|+|||++|||+.|..||.+.+. ...+..++.+.+.-......+..
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~ 363 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSA 363 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhH
Confidence 99999999999999999999999999999999999988653 33344555555554444577889
Q ss_pred HHHHHHHccccCCCCCCC----HHHHHHH
Q 015731 328 TAVLAIKCLSNEPKFRPT----MDEVVKA 352 (401)
Q Consensus 328 ~~~li~~~L~~dp~~Rps----~~eil~~ 352 (401)
+.+||+++|..||.+|.. +.||.+|
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999998 9999887
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=346.04 Aligned_cols=270 Identities=24% Similarity=0.395 Sum_probs=220.5
Q ss_pred cchhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCc
Q 015731 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPN 135 (401)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpn 135 (401)
.+..++....+...+.+.||+|.||+||+|.|+. .||||+++.... ...+.|+.|+..+++-+|-|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 4456677777888999999999999999998875 399999987654 34567999999999999999
Q ss_pred ccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 136 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
|+-++|++..... .||+.+|+|-+|+.++.... ..+.....+.|+.||++|+.|||.++ |||||||..|||+.
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH 522 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc
Confidence 9999999998877 99999999999999998776 45889999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
+++.|||+|||++................|...|||||+++.+ .|++.+||||||+++|||++|..||.........
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 9999999999999865444433344456788999999999543 6889999999999999999999999844332211
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+ ++.+.. .+. -.....++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 603 fmV--GrG~l~-----pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 FMV--GRGYLM-----PDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEe--cccccC-----ccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111 000000 000 011234567888999999999999999999999999988774
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=342.87 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=216.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..|+..++||+|.||.||+| .+..+++.||+|++..+...+ .+.+.+|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 45778899999999999999 455589999999999886654 34577899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..++++||||.||++.+.+..... +.+..+..++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~Dfg 156 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFG 156 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecc
Confidence 999999999999999999987653 577888889999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++-....... ...+++||+.|||||++.+..|+.++||||||++.+||.+|.+|+....|.....+|.-
T Consensus 157 Va~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------- 225 (467)
T KOG0201|consen 157 VAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------- 225 (467)
T ss_pred eeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---------
Confidence 9987554332 33678999999999999988999999999999999999999999998888655544421
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.....+....+..+++|+..||+.||+.||+|.++|+|
T Consensus 226 --------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 --------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --------CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11223334566778999999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=346.30 Aligned_cols=272 Identities=28% Similarity=0.395 Sum_probs=209.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.++..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 346899999999999999999965321 2234577899999875432 2345688999999999 899999999988
Q ss_pred eeC-CeeEEEEEecCCCChHHHHhhcCCC---------------------------------------------------
Q 015731 144 LED-DHRLLVYEFMPKGSLENHLFRTGAS--------------------------------------------------- 171 (401)
Q Consensus 144 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------- 171 (401)
... ..+++||||+++|+|.+++......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999999754210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeeccc
Q 015731 172 ------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245 (401)
Q Consensus 172 ------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 245 (401)
...++++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+++...............+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 0135788899999999999999999988 99999999999999999999999999976433222112223345
Q ss_pred ccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHH
Q 015731 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGA 324 (401)
Q Consensus 246 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (401)
+..|+|||++.+..++.++|||||||++|||++ |..||........ ... .... ......+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~----------~~~~~~~~~~ 302 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKD----------GTRMRAPENA 302 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhc----------CCCCCCCCCC
Confidence 678999999988889999999999999999997 9999976432110 000 0000 0011112334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 325 ALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 325 ~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 56788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=312.89 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=218.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++++.||+|.||.||.|+. ..++..||+|++.+.... ...++.+|+++...|+||||+++|++|.
T Consensus 22 ~dfeigr~LgkgkFG~vYlare---------kks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLARE---------KKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhccccccccCCccccEeEeee---------ccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 6799999999999999999954 457889999999887653 2456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+...+||++||..+|+|+..+..... ..+++...+.+..|++.||.|+|.++ ++||||||+|+|++..+.+||+|
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccC
Confidence 99999999999999999999986554 45889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||.+...+. ....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.
T Consensus 168 fGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------------- 230 (281)
T KOG0580|consen 168 FGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------------- 230 (281)
T ss_pred CCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------------
Confidence 999876442 246678999999999999999999999999999999999999999976542111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..++.. .+-.++...+..+.++|.+||..+|.+|.+..|++.|-|-.
T Consensus 231 ---YkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 231 ---YKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ---HHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 111111 12244567788999999999999999999999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=312.63 Aligned_cols=268 Identities=26% Similarity=0.343 Sum_probs=217.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+.++|++.+.||+|||+-||++ ++..++..+|+|++.....++.+..++|++..++++|||+++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 44589999999999999999998 677789999999998887777788899999999999999999998865
Q ss_pred eC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 ED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.+ ...|++++|+..|+|.+.+..... ....+++..++.|+.+|++||++||...+++.||||||.||++++.+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 44 348999999999999999987653 224599999999999999999999999888999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcce-------eeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 220 AKLSDFGLAKDGPTGSQSHV-------STRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
++|.|||.++..+-...... ......|..|+|||++. +...+.++|||||||++|+|+.|..||+..-.
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~- 246 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ- 246 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-
Confidence 99999999986432211111 12245688999999984 45678999999999999999999999964321
Q ss_pred ccchhHHhhhhhhhhcchh-hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 290 REHNLIEWAKPYLQSKRRI-FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
....+ .......+..+-....+..+.++|++||+.||.+||++.+++.++..+.
T Consensus 247 --------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 1122222222333347889999999999999999999999999998764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=335.56 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=220.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+..-|.+.+.||+|.|+.|.+| .|..||+.||||++.+..+.. ...+.+|++.|+.++|||||++|++.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi 86 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI 86 (864)
T ss_pred eeeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence 3456889999999999999988 677899999999999887654 34588999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE-cCCCceEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKL 222 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~-~~~~~~kl 222 (401)
.....+|||+|+-.+|+|++||.+.. ..+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEe
Confidence 99999999999999999999998876 45999999999999999999999977 9999999999877 55688999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
.|||++..+.++. ..++.+|+..|-|||++.|..|+ +++||||||+|||.|++|++||+..+.-.
T Consensus 161 TDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------- 226 (864)
T KOG4717|consen 161 TDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------- 226 (864)
T ss_pred eeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------
Confidence 9999998876655 45678999999999999998885 78999999999999999999998765322
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+-.+++.+ ...+...+.+|.+||..||..||++|.+++||..+-|-
T Consensus 227 -----TLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 227 -----TLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred -----hhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 222333332 35677889999999999999999999999999987553
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=317.37 Aligned_cols=262 Identities=26% Similarity=0.327 Sum_probs=215.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..+.|.+.++||+|.|+.||++ .+..||+.+|+|+++.... ...+++.+|++|.+.|+||||+++++.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 3467999999999999999998 7778999999999987644 3456788999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc---CCCce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~---~~~~~ 220 (401)
.+....|||+|++.|++|..-+-.... .++..+..++.||+++|.|+|.++ |||||+||+|+++. ..--+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R~~-----ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~v 152 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAV 152 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCce
Confidence 999999999999999999877765532 788888999999999999999999 99999999999994 33458
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++.....+ .......|||.|+|||++....|+..+|||+.|+|+|-|+.|.+||.+.+......-|...
T Consensus 153 KL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-- 227 (355)
T KOG0033|consen 153 KLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-- 227 (355)
T ss_pred eecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--
Confidence 99999999876633 2456678999999999999999999999999999999999999999775432221111100
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
+-....+.-...+++..+|+.+||..||.+|.|+.|.|+|-|-.+...
T Consensus 228 ------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 228 ------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred ------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 011111222345678889999999999999999999999988765443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=351.85 Aligned_cols=268 Identities=22% Similarity=0.255 Sum_probs=220.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeE-Ee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGY-CL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~-~~ 144 (401)
..++++.++|.+|||+.||+|.... .|..||+|++-..+......+.+|+.+|++|. |+|||.+++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 4678899999999999999996554 45889999988777677778899999999996 9999999993 22
Q ss_pred e------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 E------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
. .-.++|+||||.||.|.|+++.+.. ..|++.++++|++|+++||.+||...++|||||||-+||||+.+|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 1 1357899999999999999997765 349999999999999999999999999999999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcc-e------eeecccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 015731 219 NAKLSDFGLAKDGPTGSQSH-V------STRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 288 (401)
..||||||.++......... . .-...-|+.|+|||++ .+..++.|+|||+|||+||-|+....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999997532222110 0 1123468999999987 667889999999999999999999999976532
Q ss_pred CccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCc
Q 015731 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 366 (401)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~ 366 (401)
..+++....-+....++..+.+||..||+.||.+||++-++++++.++....-....-
T Consensus 264 --------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 264 --------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred --------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 2334444444445678999999999999999999999999999999987665544433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=338.15 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=217.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..|..++++|+|+||.++++ .++..+..+++|.+....... .....+|+.+++++.|||||.+.+.|++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57899999999999999987 666778899999998775533 3357799999999999999999999999
Q ss_pred CCe-eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDH-RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++. .+|||+||+||+|.+.+.+... ..++++.+..|+.|++.|+.|||+++ |+|||||+.|||++.++.|+|+|
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecc
Confidence 888 9999999999999999988874 45999999999999999999999888 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++...... ....+..||+.|++||++.+..|+.++|||||||++|||++-+++|...+-....
T Consensus 150 fGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li------------ 215 (426)
T KOG0589|consen 150 FGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI------------ 215 (426)
T ss_pred hhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH------------
Confidence 99999865443 2456688999999999999999999999999999999999999999765421111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..++. ..-...+..++.++..++..||..+|..||++.++|.+
T Consensus 216 ----~ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 216 ----LKINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----HHHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11111 11245667888999999999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=312.31 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=209.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hh----HHHHHHHHHHHhcc-CCCcc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QG----HLEWLTEIKHLGQL-YHPNL 136 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~----~~~~~~e~~~l~~l-~hpni 136 (401)
.-..|...++||.|..+.|.++ .++.+|..+|+|++..... .. .+.-.+|+.+|+++ .||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 3467888999999999999888 6777899999999865321 11 23356799999998 59999
Q ss_pred cceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 137 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
+++.++++.+..+|+|+|.|+.|.|.|++...- .++++....|+.|+.+|++|||.++ ||||||||+|||+++
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILldd 158 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDD 158 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecc
Confidence 999999999999999999999999999998775 3999999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
+.+++|+|||+++....+. .....||||+|+|||.+.. ..|+..+|+|++|+|+|.|+.|.+||
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF------- 228 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF------- 228 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch-------
Confidence 9999999999999877665 3556899999999998843 46889999999999999999999999
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
|-+..+..- ..++..+..-.- =...+....+||.+||+.||.+|.|++|+|.|-+.+
T Consensus 229 ------wHRkQmlML---R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 229 ------WHRKQMLML---RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ------hHHHHHHHH---HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 333221111 111111111001 124567788999999999999999999999996654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.16 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=205.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|+.+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRD---------RISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEE---------cCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 3689999999999999999954 44689999999875432 23345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..++||||+.+++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~D 144 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTD 144 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEe
Confidence 9999999999999999999997654 3889999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 145 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----------- 208 (291)
T cd05612 145 FGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE----------- 208 (291)
T ss_pred cCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 9998764322 223568999999999988889999999999999999999999997653211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~~ 355 (401)
.+.... ..++...+..+.+|+++||+.||.+||+ +.++++|-+.
T Consensus 209 -----~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 209 -----KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred -----HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 001110 1223334667889999999999999995 9999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=329.11 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=204.8
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
|+..+.||+|+||.||+|.. ..+|..||+|.+...... ....+.+|+.+++.++|+||+++++++.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQV---------RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEE---------ecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 77789999999999999954 346899999998765432 223467899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999988865432 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---------- 214 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---------- 214 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----------
Confidence 987643322 2234568999999999998899999999999999999999999997654321111000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
... ......++...+..+.+|+.+||+.||.+||+ +.++++|-+
T Consensus 215 ---~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 215 ---RRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred ---HHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 000 00111233345678889999999999999997 899998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=339.70 Aligned_cols=267 Identities=27% Similarity=0.355 Sum_probs=207.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 45799999999999999999965321 2345678899999875432 3345678999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------------------------------------------------
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS----------------------------------------------------- 171 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------------- 171 (401)
+.+..++||||+++|+|.+++......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999999999753210
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCC
Q 015731 172 -----------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234 (401)
Q Consensus 172 -----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 234 (401)
....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 0124788899999999999999999988 999999999999999999999999999765433
Q ss_pred CCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhh
Q 015731 235 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 313 (401)
Q Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (401)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...++ +.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~--------------~~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM--------------IK 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH--------------HH
Confidence 22111222345667999999988899999999999999999998 888886543211 11111 11
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 314 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 314 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.......+...+.++.+|+.+||+.||++|||+.+|++.|++
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 101111122235678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=336.43 Aligned_cols=244 Identities=29% Similarity=0.369 Sum_probs=199.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
++||+|+||.||+|.. ..+|..+|+|++..... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVRE---------KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 4699999999999944 44689999999876532 22345678999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+||||+.+++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 72 FVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 9999999999999997654 3899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .
T Consensus 145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----------------~ 206 (323)
T cd05571 145 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------L 206 (323)
T ss_pred cccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH----------------H
Confidence 32211 12334579999999999988899999999999999999999999996543211100 0
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 353 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L 353 (401)
+... ...++...+.++.+|+.+||+.||++|| ++.++++|=
T Consensus 207 ~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 207 ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 0000 1122334567888999999999999999 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.56 Aligned_cols=276 Identities=26% Similarity=0.416 Sum_probs=208.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCc-------cCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~ 138 (401)
.++|++.+.||+|+||.||+|.+..... ...+..++..||+|.+...... ....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3679999999999999999998654220 0113345678999998765322 3456889999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGAS--------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
+++++.+.+..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 999999999999999999999999998654311 1134778889999999999999999988 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRV 282 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p 282 (401)
|||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999876433322222233455788999999988889999999999999999987 5567
Q ss_pred CCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 283 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
|...... ..+........... .......+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7654321 11111111111000 00001112344567889999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=335.14 Aligned_cols=256 Identities=27% Similarity=0.305 Sum_probs=217.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccC-CCcccceee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLY-HPNLVKLIG 141 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~-hpni~~~~~ 141 (401)
....|.+.+.||.|.||.||+| +++.+|..+|+|++.+..... ...+.+|+.+|+++. ||||+.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3467999999999999999999 566689999999998876643 346889999999998 999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC----C
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----N 217 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~----~ 217 (401)
+|++...+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. +
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCC
Confidence 999999999999999999999999876 1899999999999999999999988 999999999999943 3
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+.++++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.........+..
T Consensus 176 ~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred CcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 5799999999998655 3356778999999999999989999999999999999999999999987664332221111
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. +..+....-...+..+.+++.+||..||.+|+|+.++|+|-|-
T Consensus 253 ~--------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 253 G--------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred C--------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 1 0112223334557889999999999999999999999999773
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.59 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=209.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||++.. ..+|..+|+|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQH---------KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEE---------CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 36899999999999999999944 44788999999876532 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEcc
Confidence 999999999999999999997654 389999999999999999999985 5 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+. .+....
T Consensus 148 fg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~ 221 (331)
T cd06649 148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDG 221 (331)
T ss_pred Cccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--cccccc
Confidence 9998754322 1234568999999999988889999999999999999999999996543211110000 000000
Q ss_pred ----------------------------cchhhhhhhh----hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 ----------------------------KRRIFQVMDA----RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ----------------------------~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
......+.+. ..........+.++.+|+.+||+.||++|||+.++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000011110 01111122356789999999999999999999999999
Q ss_pred HHhc
Q 015731 353 LEQI 356 (401)
Q Consensus 353 L~~i 356 (401)
-+.-
T Consensus 302 ~~~~ 305 (331)
T cd06649 302 TFIK 305 (331)
T ss_pred hHHh
Confidence 7653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.32 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=205.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+|++.+.||+|+||.||+|.. ..+++.+|+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKH---------KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5799999999999999999954 34688999999876532 23345788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999998754 3889999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....+.....
T Consensus 162 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----------- 225 (329)
T PTZ00263 162 FGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE----------- 225 (329)
T ss_pred ccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH-----------
Confidence 9998764322 223578999999999988889999999999999999999999997543211100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
.+.... ..++...+..+.+|+.+||+.||.+||+ +.+++.|-+
T Consensus 226 -----~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 226 -----KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred -----HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 011111 1122334567889999999999999996 799998854
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=336.73 Aligned_cols=256 Identities=25% Similarity=0.314 Sum_probs=206.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+..|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 36899999999999999999543 4688999999976533 23345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~D 144 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTD 144 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999997654 3889999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 145 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------- 211 (333)
T cd05600 145 FGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK-------- 211 (333)
T ss_pred CcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH--------
Confidence 999875433 2234578999999999988899999999999999999999999997654322111110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..................+.++.+|+.+||..+|.+||++.++++|-+
T Consensus 212 --~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 212 --YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred --hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 000000000000011234678889999999999999999999999843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=350.56 Aligned_cols=276 Identities=28% Similarity=0.422 Sum_probs=228.0
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...+.++.+.||+|+||+||+|..... ........||||.++..... ...+|.+|++++..|+|||||+++|+|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 345667789999999999999966542 23345788999999887665 5678999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCC---------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASY---------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+++.++||+|||..|+|.++|....... ..+++..+.+.|+.||+.|++||-++. +|||||-..|+||.
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG 637 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec
Confidence 9999999999999999999997654321 234899999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 294 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 294 (401)
++..|||+|||+++.....+.........-..+|||||.+..+.|+.+|||||+||+|||+++ |..||.+....+....
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999999997655444443334455789999999999999999999999999999998 8888877654332222
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
++ ...+ -.-+..++.+++.|+..||+.+|++||+++||-..|....+......
T Consensus 718 i~----------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 718 IR----------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred HH----------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence 21 1111 33456788899999999999999999999999999998866655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=336.31 Aligned_cols=242 Identities=30% Similarity=0.494 Sum_probs=207.2
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
++-||.|+.|.||+|++++ +.||||+++.-. ..+++.|++|+|||||.+.++|.....+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~n-----------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN-----------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeeccC-----------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 4669999999999998874 569999775322 2689999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
||||..|.|+.+|+... ++.......|..+|+.|+.|||.++ |||||||.-||||+.+..|||+|||.++...
T Consensus 191 MEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999998764 4888999999999999999999999 9999999999999999999999999988644
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
.. ...-.++||..|||||++.++..+.++|||||||+|||||||..||.+-+. ..|-| ..-
T Consensus 264 ~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw------------GVG 324 (904)
T KOG4721|consen 264 DK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW------------GVG 324 (904)
T ss_pred hh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEE------------ecc
Confidence 32 234457899999999999999999999999999999999999999965321 12223 223
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
...+.-..+..++..+.-|++.||+..|..||++.+|+.||+-...
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 3344456677888999999999999999999999999999987643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=327.60 Aligned_cols=268 Identities=23% Similarity=0.262 Sum_probs=202.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|+. ..++..+|+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRH---------KETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEE---------CCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 3689999999999999999954 34688999999875432 223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.++.|..+.. .. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~-~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Df 144 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEE-MP----NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDF 144 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHh-cC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeec
Confidence 999999999998766654433 22 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh--
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ-- 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 303 (401)
|++......... ......|++.|+|||++.+..++.++|||||||++|+|++|++||......+....+........
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07848 145 GFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223 (287)
T ss_pred cCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence 999865332211 22345689999999999888899999999999999999999999987543222111111000000
Q ss_pred ------hcchhhhhhhhh------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 ------SKRRIFQVMDAR------IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ------~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
............ ....+....+..+.+|+++||+.||++|||++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0001112245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=336.95 Aligned_cols=269 Identities=26% Similarity=0.359 Sum_probs=208.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++.+ +||||+++++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345799999999999999999965321 1233567899999976433 2344578999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCC-----------------------------------------------------
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGA----------------------------------------------------- 170 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 170 (401)
.+.+..++||||+.+|+|.+++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999865321
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcc
Q 015731 171 ------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 171 ------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 238 (401)
....++++..+++++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 01134788899999999999999999988 9999999999999999999999999987643322211
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhc
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE 317 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (401)
......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~ 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQ 333 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccC
Confidence 1222335667999999988889999999999999999997 9999975432111 0011111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 318 GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 318 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...+...+.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=322.02 Aligned_cols=266 Identities=26% Similarity=0.437 Sum_probs=211.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|...... ...+...+++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 46899999999999999999765321 123457899999875433 2344678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCC-----------CCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYI-----------QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
...+++|||+++++|.+++........ ..+++..++.++.|++.||.|||+++ ++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 999999999999999999976532111 45888999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 294 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 294 (401)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-- 236 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-- 236 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence 999999999999875433222222333456788999999988889999999999999999998 99998764431111
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+........+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 237 ---------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 ---------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111223445678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.45 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=202.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||+|.. ..++..||+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRS---------KLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEE---------CCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 5799999999999999999954 346889999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCc
Confidence 99999999996 59999887654 34788999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh------
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK------ 299 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------ 299 (401)
++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07871 149 LARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226 (288)
T ss_pred ceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence 9875432211 1233567899999998865 568899999999999999999999997654432221111000
Q ss_pred --hhhhhcchhhhhhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 --PYLQSKRRIFQVMDARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 --~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.................. ......+.++.+|+.+||+.||.+|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000000000 0011235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=332.27 Aligned_cols=254 Identities=25% Similarity=0.306 Sum_probs=198.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|+..+.||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.+++.++|+||+++++++.++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIH---------RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEE---------CCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 4678889999999999999954 34688999999865432 2245678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 145 ~~~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG 213 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFG 213 (353)
T ss_pred CeEEEEEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccc
Confidence 9999999999999986422 2567788899999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
++........ ......|+..|+|||++.. ...+.++|||||||++|+|++|+.||..............
T Consensus 214 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---- 287 (353)
T PLN00034 214 VSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---- 287 (353)
T ss_pred cceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----
Confidence 9876432211 1234578999999998743 2345689999999999999999999974322111111000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.............+.++.+||.+||+.||++|||+.|+++|-+..+
T Consensus 288 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 288 ----------ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ----------HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 0000111223345678899999999999999999999999865543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=338.93 Aligned_cols=268 Identities=23% Similarity=0.275 Sum_probs=211.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-C-----Ccccceee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H-----PNLVKLIG 141 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pni~~~~~ 141 (401)
-+|.+.++||+|+||.|.+|+. ..|++.||||+++..... ..+...|+.+|..|+ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d---------~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYD---------HKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEe---------cCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 4788899999999999999954 458999999999876543 334567899998886 3 48999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--CCc
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYN 219 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~--~~~ 219 (401)
+|...+++|||+|.+ ..+|+++++.+.. .+++...+..++.||+.||.+||..+ |||+||||+|||+.+ ...
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCc
Confidence 999999999999999 7799999998875 67999999999999999999999988 999999999999954 347
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh-
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA- 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~- 298 (401)
|||+|||.++..... ......+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.++.+....|.-.
T Consensus 330 vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred eeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 999999999874332 22677899999999999999999999999999999999999999998876655443110
Q ss_pred --------------hhhhhhcchhh------------------h-----hhhhhhc-------CCCCHHHHHHHHHHHHH
Q 015731 299 --------------KPYLQSKRRIF------------------Q-----VMDARIE-------GQYSLGAALKTAVLAIK 334 (401)
Q Consensus 299 --------------~~~~~~~~~~~------------------~-----~~~~~~~-------~~~~~~~~~~~~~li~~ 334 (401)
..++....... . ..+.... ..........+.+++++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 00111100000 0 0000000 01112445677899999
Q ss_pred ccccCCCCCCCHHHHHHHHHhc
Q 015731 335 CLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 335 ~L~~dp~~Rps~~eil~~L~~i 356 (401)
||..||.+|+|+.++|+|-+--
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred HhccCchhcCCHHHHhcCcccc
Confidence 9999999999999999995543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=317.05 Aligned_cols=269 Identities=24% Similarity=0.305 Sum_probs=207.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCc-ccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPN-LVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpn-i~~~~~~~~ 144 (401)
..|...+.||+|+||+||+|+ ...+|+.||+|++...... ......+|+.+|+.|+|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar---------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKAR---------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEE---------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 457777889999999999994 4457899999998776442 3345679999999999999 999999998
Q ss_pred eCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+.+ ..++||||+ ..+|..++....... ..++...+..++.||+.||+|||+++ |+||||||+||+|+.+|
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSG 157 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCC
Confidence 877 889999999 779999998876321 34777899999999999999999999 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH--
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-- 295 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-- 295 (401)
.+||+|||+|+..... ....+...+|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.++...|
T Consensus 158 ~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cEeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 9999999999864422 2235667899999999999776 7999999999999999999999999988764433322
Q ss_pred --------HhhhhhhhhcchhhhhhhhhhcCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 296 --------EWAKPYLQSKRRIFQVMDARIEGQYSL---GAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 296 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.|.....-..... ..........+.. .......+++.+||+.+|.+|.|++.++.|
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HcCCCCccCCCCccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111000000000 0000000000011 112467789999999999999999999998
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=320.90 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=199.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccceeeEEee----C
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE----D 146 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~~~~~~~~----~ 146 (401)
..||+|++|.||+|.++ |..||+|.+....... ...+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 57999999999999653 6789999987654322 3457799999999999999999999877 3
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
...++||||+.+|+|.+++.... .+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEccc
Confidence 57899999999999999997653 388999999999999999999984 6 889999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|++....... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 168 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---------- 232 (283)
T PHA02988 168 GLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---------- 232 (283)
T ss_pred chHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----------
Confidence 9987543221 23467899999999966 678999999999999999999999997643211100
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
...........+...+..+.+|+.+||+.||++|||+.++++.|++++.
T Consensus 233 ------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 ------LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111111122333467789999999999999999999999999998864
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=317.76 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=206.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|++.. ....+..+|+|.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 568999999999999999997642 223578899999886533 2334678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++++|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCc
Confidence 99999999999999999997643 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
.+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ++.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~-------- 220 (266)
T cd05064 153 RLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA-------- 220 (266)
T ss_pred ccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH--------
Confidence 87653221111 1112334678999999988899999999999999999875 9999976532111 110
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+........+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 221 ------~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 ------VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000011122334566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=345.22 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=205.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
..|.+.+.||+|+||.||+|.... ..+..+|+|.+..........+.+|+.+++.++||||+++++++..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~--------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGS--------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcC--------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 348999999999999999995432 126788999876554444456778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..||||||+++|+|.+++..... ...++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcC
Confidence 99999999999999998865321 1245889999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+...............+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---~------------ 280 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---M------------ 280 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------
Confidence 9865433322233456799999999999888899999999999999999999999965432110 0
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....... ....+...+..+.+++.+||+.||++||++.+++.+
T Consensus 281 -~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 281 -QQVLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -HHHHhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0000000 011233456688999999999999999999999865
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.55 Aligned_cols=271 Identities=27% Similarity=0.413 Sum_probs=213.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|.+.+.||+|+||.||++..... ....++..+|+|.+..........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35789999999999999999965331 22345678999998766544555688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC--------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA--------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+..++||||+++++|.+++..... .....+++..++.++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 999999999999999999975542 12234899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-- 235 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-- 235 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 999999999875433221111222345678999999988889999999999999999998 89998654421111000
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.... ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 236 --------------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 --------------TQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --------------HcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000 00111224457899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=328.82 Aligned_cols=269 Identities=28% Similarity=0.378 Sum_probs=206.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||++.. ..++..+|+|.+..... .....+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSH---------KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEE---------CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 46899999999999999999944 44688999998876432 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~D 147 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 147 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEee
Confidence 999999999999999999997654 388999999999999999999974 6 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH------hh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE------WA 298 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~------~~ 298 (401)
||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. +.
T Consensus 148 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (333)
T cd06650 148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA 223 (333)
T ss_pred CCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcc
Confidence 9998754322 1233468999999999988889999999999999999999999997543211110000 00
Q ss_pred hh---------------hhhh---cchhhhhhhhhhc---CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 KP---------------YLQS---KRRIFQVMDARIE---GQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~~---------------~~~~---~~~~~~~~~~~~~---~~~-~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.. +... ......+...... ... ....+.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred ccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 00 0000 0000000000000 000 11245678899999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=330.27 Aligned_cols=245 Identities=28% Similarity=0.372 Sum_probs=199.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
++||+|+||.||++.. ..+|..+|+|++..... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVRE---------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 4699999999999944 44689999999876532 22345778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 72 lv~Ey~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 72 FVMEYVNGGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred EEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 9999999999999887653 3899999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---------------- 206 (328)
T cd05593 145 GITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------- 206 (328)
T ss_pred CCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------------
Confidence 32211 122345799999999999888899999999999999999999999975432111000
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
... ....++...+.++.+|+.+||+.||.+|+ ++.++++|-+
T Consensus 207 ~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 207 ILM--EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred hcc--CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 000 01122334566788999999999999997 8999998843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=329.84 Aligned_cols=244 Identities=29% Similarity=0.369 Sum_probs=198.6
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
+.||+|+||.||++.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 4699999999999944 44689999999876532 22335678999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 lv~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 72 FVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 9999999999999887654 3899999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
..... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .
T Consensus 145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~ 206 (323)
T cd05595 145 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------L 206 (323)
T ss_pred ccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence 32211 12234578999999999988899999999999999999999999997543211110 0
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 353 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L 353 (401)
.... ...++...+..+.+++.+||+.||.+|| ++.++++|-
T Consensus 207 ~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 207 ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HhcC--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 0000 0112334566788999999999999998 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.97 Aligned_cols=258 Identities=25% Similarity=0.310 Sum_probs=204.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
+|++.+.||+|+||.||+++.. ....++..+|+|++..... .....+..|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 4888999999999999998643 2345789999999875432 2234567899999999 599999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~ 147 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLT 147 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999997654 3899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. .
T Consensus 148 DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~--- 221 (332)
T cd05614 148 DFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--R--- 221 (332)
T ss_pred eCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--H---
Confidence 99998764332211 22345799999999998765 47889999999999999999999997543222111110 0
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.+.. ....++...+..+.+++.+||+.||++|| +++++++|-+
T Consensus 222 -------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 222 -------RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred -------HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 0000 11122334566788999999999999999 8889998854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.64 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=200.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..++..+|+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKS---------KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEE---------CCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 36899999999999999999954 346889999998754322 23356789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+...++||||+ .++|.+++.... ..++...+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Df 147 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADF 147 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCC
Confidence 99999999999 568888887643 34888999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... .+.........
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 223 (303)
T cd07869 148 GLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGT 223 (303)
T ss_pred CcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCC
Confidence 9987532211 12234568999999999865 4578899999999999999999999976432111 01000000000
Q ss_pred c--c------hhhhhhhhhhc--CCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 K--R------RIFQVMDARIE--GQY-------SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~--~------~~~~~~~~~~~--~~~-------~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. . ........... ... ....+..+.+|+.+||+.||++|||+.++++|=+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 0 0 00000000000 000 00123567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=325.49 Aligned_cols=243 Identities=28% Similarity=0.340 Sum_probs=197.4
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||+|+||.||+|.. ..++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 1 lg~G~~g~Vy~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRK---------RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 79999999999954 34688999999876432 2334577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 72 LAFINGGELFHHLQREG-----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred EcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 99999999999997654 3899999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... ...
T Consensus 145 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~----------~~~ 206 (312)
T cd05585 145 KDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYR----------KIL 206 (312)
T ss_pred cCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHH----------HHH
Confidence 221 12334579999999999998899999999999999999999999997543211 000 111
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRP---TMDEVVKALE 354 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~eil~~L~ 354 (401)
.. ...++...+..+.+|+.+||+.||.+|| ++.+++.|-+
T Consensus 207 ~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 207 QE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred cC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 11 1122334567788999999999999997 5788888743
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.97 Aligned_cols=271 Identities=27% Similarity=0.386 Sum_probs=208.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.++||+|+||.||+|..... ....+++.||+|++..... .....+.+|+.++.++ +||||+++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 346899999999999999999964321 2334678999999875432 2234577899999999 899999999987
Q ss_pred ee-CCeeEEEEEecCCCChHHHHhhcCCC---------------------------------------------------
Q 015731 144 LE-DDHRLLVYEFMPKGSLENHLFRTGAS--------------------------------------------------- 171 (401)
Q Consensus 144 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------- 171 (401)
.. +..++++|||+++++|.+++......
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46788999999999999998653210
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccc
Q 015731 172 -----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246 (401)
Q Consensus 172 -----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 246 (401)
...++++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++................++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 0125889999999999999999999988 999999999999999999999999999865332222122234456
Q ss_pred cCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHH
Q 015731 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAA 325 (401)
Q Consensus 247 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (401)
..|+|||++.+..++.++|||||||++|+|++ |..||.+...... .. ..+........+...+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~ 302 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC--------------RRLKEGTRMRAPEYAT 302 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH--------------HHHhccCCCCCCccCC
Confidence 78999999988999999999999999999998 9999976432111 00 0000000111122345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 326 LKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 326 ~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.++.+++.+||+.+|++||++.+++++|+.+.+
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.98 Aligned_cols=265 Identities=27% Similarity=0.421 Sum_probs=209.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|.+.+.||+|+||.||+|..... ....++..+|+|.+...... ....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 5688999999999999999966431 12345788999998765443 345788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA---------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
...++||||+++++|.+++..... .....+++..+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 999999999999999999976532 12244788999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHH
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 296 (401)
+.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE 235 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH
Confidence 9999999999875432221112223345778999999998899999999999999999998 9999865432111 11
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.. ........+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus 236 ~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CI--------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH--------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 0011111223456788899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=332.23 Aligned_cols=254 Identities=24% Similarity=0.279 Sum_probs=198.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||+||+|. +..++..+|+|++..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQ---------KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 368999999999999999994 444789999999976532 22345678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~D 144 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSD 144 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999997654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc---------------------------------ceeeecccccCcccccccccCCCCcccchhhHHH
Q 015731 225 FGLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGV 271 (401)
Q Consensus 225 fg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 271 (401)
||++......... ......+||+.|+|||++.+..++.++|||||||
T Consensus 145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv 224 (363)
T cd05628 145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (363)
T ss_pred ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence 9998753221100 0012357999999999998889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCC---CCCCHHH
Q 015731 272 VLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK---FRPTMDE 348 (401)
Q Consensus 272 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rps~~e 348 (401)
++|+|++|..||....+......+. .. ...+........+..+.+++.+|+. +|. .||++.|
T Consensus 225 il~ell~G~~Pf~~~~~~~~~~~i~-------------~~-~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 225 IMYEMLIGYPPFCSETPQETYKKVM-------------NW-KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH-------------cC-cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 9999999999997654321111000 00 0000000111245677888888664 444 5689999
Q ss_pred HHHH
Q 015731 349 VVKA 352 (401)
Q Consensus 349 il~~ 352 (401)
|++|
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=334.31 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=202.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQK---------KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 3689999999999999999954 44688999999976532 22344678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D 144 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSD 144 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEee
Confidence 9999999999999999999997654 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcc------------------------------------eeeecccccCcccccccccCCCCcccchhh
Q 015731 225 FGLAKDGPTGSQSH------------------------------------VSTRVMGTYGYAAPEYMATGHLTAKSDVYS 268 (401)
Q Consensus 225 fg~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 268 (401)
||++.......... .....+||+.|+|||++.+..++.++||||
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 224 (364)
T cd05599 145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224 (364)
T ss_pred cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec
Confidence 99986432211000 011246999999999998889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC---
Q 015731 269 FGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT--- 345 (401)
Q Consensus 269 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps--- 345 (401)
|||++|+|++|..||....+......+ .... ..+........+..+.+||.+||. +|.+|++
T Consensus 225 lG~il~el~~G~~Pf~~~~~~~~~~~i------~~~~--------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 225 LGVIMYEMLVGYPPFCSDNPQETYRKI------INWK--------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred chhHHHHhhcCCCCCCCCCHHHHHHHH------HcCC--------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 999999999999999765432111000 0000 000001111345678899999996 9999997
Q ss_pred HHHHHHHHH
Q 015731 346 MDEVVKALE 354 (401)
Q Consensus 346 ~~eil~~L~ 354 (401)
+.++++|-+
T Consensus 290 ~~~ll~h~~ 298 (364)
T cd05599 290 VNEIKSHPF 298 (364)
T ss_pred HHHHhcCCC
Confidence 999999843
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=330.35 Aligned_cols=249 Identities=25% Similarity=0.291 Sum_probs=204.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|.+.+.||+|+||.||+|..... .+..+|+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 5799999999999999999965431 246899998865432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEec
Confidence 9999999999999999999997654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.....
T Consensus 175 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----------- 238 (340)
T PTZ00426 175 FGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----------- 238 (340)
T ss_pred CCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-----------
Confidence 9998764321 234579999999999988889999999999999999999999997654311100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.+.... ..++...+..+.+++++||+.||.+|+ +++++++|-+
T Consensus 239 -----~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 239 -----KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred -----HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 011111 112333456788999999999999995 8999999843
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=334.16 Aligned_cols=254 Identities=27% Similarity=0.325 Sum_probs=205.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|.+.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRD---------KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEE---------CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 3689999999999999999954 34689999999876532 23345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..++||||+.+++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~D 144 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLAD 144 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeec
Confidence 9999999999999999999998763 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCC---------------------------CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHH
Q 015731 225 FGLAKDGPTGS---------------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 277 (401)
Q Consensus 225 fg~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 277 (401)
||++....... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 224 (350)
T cd05573 145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224 (350)
T ss_pred CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence 99987643322 001123456899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhh--hhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHH
Q 015731 278 SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD--ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKALE 354 (401)
Q Consensus 278 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~eil~~L~ 354 (401)
+|..||.......... .+.. ..+........+..+.+||.+||. ||.+||+ +.++++|-+
T Consensus 225 ~g~~Pf~~~~~~~~~~----------------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 225 YGFPPFYSDTLQETYN----------------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred cCCCCCCCCCHHHHHH----------------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 9999997654211110 0111 001111111246788899999997 9999999 999999844
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=317.81 Aligned_cols=271 Identities=24% Similarity=0.304 Sum_probs=206.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~- 146 (401)
-.|.-.+++|.|+||.||.|.+.+ +++.||||++....... -+|+.+|+.++|||||++..+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 357778999999999999996654 58899999887665322 2799999999999999999887643
Q ss_pred -C---eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-CceE
Q 015731 147 -D---HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 221 (401)
Q Consensus 147 -~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~k 221 (401)
. ...+||||+ -.+|.++++.... ..+.++...+.-+.+||+.||.|||+.| |+||||||.|+|+|.+ |.+|
T Consensus 91 ~~d~~~lnlVleym-P~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYM-PETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred CCchhHHHHHHHhc-hHHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEE
Confidence 2 346899999 4599999985321 1245888888899999999999999988 9999999999999876 9999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|||||.|+....+.. ......|..|+|||++.| ..|+.+.||||.||++.||+-|++.|.+.+..+....+-....
T Consensus 167 icDFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eccCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 999999998655543 345678999999999866 5799999999999999999999999999776555444321111
Q ss_pred hhhhcchh------------hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhc
Q 015731 301 YLQSKRRI------------FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDT 359 (401)
Q Consensus 301 ~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~ 359 (401)
. .....+ .++.......-+....+.++.+|+.++|..+|.+|.++.|++.| +..+.+.
T Consensus 244 ~-Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 244 T-PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred C-CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 000111 11111111111334567889999999999999999999999987 4444433
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=334.76 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=200.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.|++++.||+|+||+||+|.. ..++..+|+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACK---------VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 588899999999999999944 447899999999765432 23457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DF 145 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDF 145 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeC
Confidence 999999999999999999997654 3889999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCC---------------------------------------------cceeeecccccCcccccccccCCC
Q 015731 226 GLAKDGPTGSQ---------------------------------------------SHVSTRVMGTYGYAAPEYMATGHL 260 (401)
Q Consensus 226 g~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 260 (401)
|++........ ........||+.|+|||++.+..+
T Consensus 146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 225 (381)
T cd05626 146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225 (381)
T ss_pred cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence 98753211000 000123579999999999988889
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCCCCccchh-HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHcc--c
Q 015731 261 TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL--S 337 (401)
Q Consensus 261 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L--~ 337 (401)
+.++|||||||++|||++|..||....+...... +.| ............+.++.+|+.+|+ .
T Consensus 226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW---------------ENTLHIPPQVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc---------------ccccCCCCCCCCCHHHHHHHHHHccCc
Confidence 9999999999999999999999976543211100 000 000111111234567888998844 5
Q ss_pred cCCCCCCCHHHHHHHHH
Q 015731 338 NEPKFRPTMDEVVKALE 354 (401)
Q Consensus 338 ~dp~~Rps~~eil~~L~ 354 (401)
.++..||++.+++.|-+
T Consensus 291 ~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 291 EERLGRNGADDIKAHPF 307 (381)
T ss_pred ccccCCCCHHHHhcCcc
Confidence 56666999999999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=318.00 Aligned_cols=269 Identities=27% Similarity=0.422 Sum_probs=213.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||.||+|..... ....++..+++|.+..........+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 5688899999999999999965431 223456779999987766555567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+++ ++||||||+||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 999999999999999999765321 1134789999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 295 (401)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~ 235 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI 235 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 99999999999875433222222233456788999999988889999999999999999998 999986543311 11
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.. + ........+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 236 ~~-------------~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 EC-------------I-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HH-------------H-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 0 00000111223456788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.05 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=197.1
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHH---HhccCCCcccceeeEE
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKH---LGQLYHPNLVKLIGYC 143 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~---l~~l~hpni~~~~~~~ 143 (401)
|++.+.||+|+||.||+|... .++..||+|++..... .....+..|.++ ++.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 677899999999999999543 4688999999876532 122345555554 4567899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..|+||||+.+++|..++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~ 143 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIA 143 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeC
Confidence 9999999999999999999888643 3899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus 144 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~---------- 211 (324)
T cd05589 144 DFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---------- 211 (324)
T ss_pred cccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence 999987532211 12334679999999999988889999999999999999999999997653211110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 353 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L 353 (401)
.+... ...++...+..+.+++.+||+.||.+|| ++.++++|-
T Consensus 212 ------~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 212 ------SIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ------HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 01110 1112334566788999999999999999 688888874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.52 Aligned_cols=265 Identities=19% Similarity=0.221 Sum_probs=200.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||+|+||.||+|. +..+++.||+|.... ..+.+|+.++++|+||||+++++++..+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~---------d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACI---------DNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEE---------ECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 3679999999999999999994 445789999997542 2456899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++|||++ +++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCC
Confidence 9999999999 578988887653 3889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc----hhHHhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH----NLIEWAKPYL 302 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~ 302 (401)
++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||-........ ..+.......
T Consensus 228 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~ 306 (391)
T PHA03212 228 AACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306 (391)
T ss_pred ccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence 987532211 11233457999999999998888999999999999999999999876543221100 0000000000
Q ss_pred ---------hhcchhhhhh----hhhhc--CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 303 ---------QSKRRIFQVM----DARIE--GQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 303 ---------~~~~~~~~~~----~~~~~--~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.......... ..... ... ....+.++.+||.+||+.||.+|||+.|+++|=+.
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0000000000 00000 000 11345678899999999999999999999998664
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=328.81 Aligned_cols=270 Identities=26% Similarity=0.379 Sum_probs=200.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||+|. +..+|..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAI---------DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEE---------ECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58889999999999999994 44478999999987532 23344678999999999999999999987643
Q ss_pred -----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 147 -----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~k 143 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLK 143 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEE
Confidence 3579999999 579999887653 3899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCC-cceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 222 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
|+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+...
T Consensus 144 L~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~ 223 (338)
T cd07859 144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223 (338)
T ss_pred EccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 999999975432221 112234578999999999865 57889999999999999999999999765432211111000
Q ss_pred h--h------hhhhc--chhhhhhhhhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 K--P------YLQSK--RRIFQVMDARIEGQY---SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~--~------~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. + ..... ......+........ ....+..+.+++.+||+.||++|||+.|+++|-+.
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 0 0 00000 000000000000000 01234567899999999999999999999998554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.98 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=210.5
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni~~~~~~ 142 (401)
...++|++.++||+|+||.||+|..... .+..++..||+|++..... .....+.+|+.+++++. ||||++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 3457899999999999999999965321 2334466899999975433 23456889999999996 9999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCC---------------------------------------------------
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGAS--------------------------------------------------- 171 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------- 171 (401)
+.+.+..|+||||+++|+|.+++......
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999998653210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 172 ----------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 172 ----------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
....+++..+..++.||+.||.|||+++ |+|+||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 0124788888999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSR 290 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 290 (401)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999876433222212223456788999999988889999999999999999997 888986532211
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
. .. ..+........+...+..+.+++.+||+.||++||++.+|.+.|+++.
T Consensus 348 ~--~~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 T--FY--------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--HH--------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0 00 000001111122345678889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.51 Aligned_cols=267 Identities=23% Similarity=0.392 Sum_probs=207.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|..... ....++..+|+|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456799999999999999999976432 2234567899998865432 33456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
++...++||||+++++|.+++...... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 999999999999999999999764321 1234678889999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 298 (401)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .+..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRFV 234 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH
Confidence 99999999875433222111122345678999999988889999999999999999999 6888865432111 1100
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... .....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 235 -------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -------------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -------------HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 0011122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.84 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=200.4
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
++.||+|+||.||+++... ...++..||+|++..... .....+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 3689999999999996532 234688999999876432 223346789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.|+||||+.+++|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999997654 3788889999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 148 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~---------------- 209 (323)
T cd05584 148 KESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI---------------- 209 (323)
T ss_pred eecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----------------
Confidence 7432221 1223457899999999998888899999999999999999999999764421110
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
..+... ....+...+..+.+|+.+||+.||++|| ++.++++|-+
T Consensus 210 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 210 DKILKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHHcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 011111 1122334456788999999999999999 8999998743
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=328.95 Aligned_cols=245 Identities=29% Similarity=0.369 Sum_probs=198.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
+.||+|+||.||++. +..+|..+|+|++...... ....+..|+.+++.++||||+++++++.+.+..|
T Consensus 1 ~~lG~G~~g~V~~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVK---------EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999994 3447899999999765322 2345678999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.++|+|||++.
T Consensus 72 lv~E~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 72 FVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 9999999999999887654 38999999999999999999997 67 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------------- 208 (325)
T cd05594 145 EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------- 208 (325)
T ss_pred ecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------------
Confidence 532211 1223457999999999998889999999999999999999999999754321111100
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
... ...++...+.++.+|+.+||+.||++|+ ++.++++|-+
T Consensus 209 --~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 209 --LME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred --hcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 000 1112233456788999999999999996 9999998843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=333.72 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=200.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++.. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQK---------KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3689999999999999999944 44789999999866432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~D 144 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSD 144 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999997653 3889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc---------------------------------------------ceeeecccccCcccccccccCC
Q 015731 225 FGLAKDGPTGSQS---------------------------------------------HVSTRVMGTYGYAAPEYMATGH 259 (401)
Q Consensus 225 fg~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 259 (401)
||+++........ ......+||+.|+|||++.+..
T Consensus 145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 224 (377)
T cd05629 145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence 9998632110000 0001246999999999998889
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHcccc
Q 015731 260 LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSN 338 (401)
Q Consensus 260 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 338 (401)
++.++|||||||++|+|++|..||...........+ .|. ..+........+.++.+||.+||.
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCCCCCCCHHHHHHHHHHhc-
Confidence 999999999999999999999999765431111000 000 000000111245678899999997
Q ss_pred CCCCC---CCHHHHHHHHH
Q 015731 339 EPKFR---PTMDEVVKALE 354 (401)
Q Consensus 339 dp~~R---ps~~eil~~L~ 354 (401)
+|.+| +++.+++.|-+
T Consensus 289 ~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 289 NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred CHhhcCCCCCHHHHhcCCC
Confidence 77665 59999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=321.71 Aligned_cols=263 Identities=23% Similarity=0.376 Sum_probs=206.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|.+... ....+..+|+|.+..... ....++.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 5799999999999999999976431 122345699999875432 3345688899999999999999999998865
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..++|++|+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccc
Confidence 5779999999999999998654 34888999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------------- 220 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------------- 220 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence 9986543332212222334678999999988899999999999999999997 9999875432110
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
............+..++..+..++.+||..||.+||++.+++.+|..+...
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 221 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 011111111112223456788999999999999999999999999888543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=312.03 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=207.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|.+... ..+...+|+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 5789999999999999999976531 224568999988765432 345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccc
Confidence 99999999999999999997654 24899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~------- 221 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV------- 221 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH-------
Confidence 9987642222111222334678999999988889999999999999999998 999986543211 11100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
........+...+..+.+++.+||+.+|++||++.+++++|.++
T Consensus 222 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 -------EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00001111233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=333.37 Aligned_cols=254 Identities=23% Similarity=0.287 Sum_probs=200.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
+|++.+.||+|+||.||+|. +..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVR---------KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEE---------ECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 68999999999999999994 444689999999876432 123456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999997654 3888999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCC-----------------------------------------cceeeecccccCcccccccccCCCCccc
Q 015731 226 GLAKDGPTGSQ-----------------------------------------SHVSTRVMGTYGYAAPEYMATGHLTAKS 264 (401)
Q Consensus 226 g~~~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 264 (401)
|++........ ........||+.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 99753210000 0001234799999999999988999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCCccchhH-HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 265 DVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 265 DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
|||||||++|+|++|..||....+......+ .|. ...........+..+.++|.+|+ .+|.+|
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 9999999999999999999765432211100 000 00001111234567778888876 599999
Q ss_pred C---CHHHHHHHHH
Q 015731 344 P---TMDEVVKALE 354 (401)
Q Consensus 344 p---s~~eil~~L~ 354 (401)
+ ++.++++|-+
T Consensus 290 ~~~~t~~ell~h~~ 303 (376)
T cd05598 290 LGKNGADEIKAHPF 303 (376)
T ss_pred CCCCCHHHHhCCCC
Confidence 9 9999999944
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=332.29 Aligned_cols=255 Identities=23% Similarity=0.254 Sum_probs=203.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...+|++.+.||+|+||.||+|. +..++..+|+|++..... .....+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVR---------HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34679999999999999999994 444789999999875432 223346789999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+++..|+||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~~------l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL 183 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNYD------IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL 183 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999986543 788889999999999999999988 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 184 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------ 256 (370)
T cd05596 184 ADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------ 256 (370)
T ss_pred EeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------
Confidence 99999876432211 122345799999999998543 4788999999999999999999999765431110
Q ss_pred hhhhhhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 015731 299 KPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 354 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~ 354 (401)
..+.... +........+..+.+|+.+||+.+|.+ |+++.++++|-+
T Consensus 257 ----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 257 ----------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ----------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 1111111 111111235678889999999999988 999999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.63 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=206.3
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||+||+|.. ..+|..||+|++..... .....+.+|+.++..++|+||+++++.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKR---------VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEE---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 3447899999999999999999944 44689999999876533 234457789999999999999999887
Q ss_pred EeeCC--------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 143 CLEDD--------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 143 ~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
+...+ .+++||||+.+|+|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl 176 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL 176 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE
Confidence 65432 36899999999999999976432 2246899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--- 253 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--- 253 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 99999999999998765433222233456799999999999988899999999999999999999999975432110
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.. ..... .....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 254 ---~~----------~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 ---MH----------KTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HH----------HHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 00000 0112334456788999999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=319.52 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=196.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhcc---CCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l---~hpni~~~~~~ 142 (401)
++|++.+.||+|+||.||+|.... .++..+|+|.+...... ....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 479999999999999999995432 24678999988654321 123445666666555 69999999998
Q ss_pred Ee-----eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 143 CL-----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 143 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
+. .....++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~ 146 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS 146 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC
Confidence 85 3456899999994 699999876542 34899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+.++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+..
T Consensus 147 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 147 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred CCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 999999999987643321 23345689999999999888899999999999999999999999987654322211110
Q ss_pred hhhhhhhcchhhh-------hhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 298 AKPYLQSKRRIFQ-------VMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 298 ~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... ........ ....... .......+..+.+|+.+||+.||++|||+.++++|
T Consensus 224 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 224 VIGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HhCC-CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 00000000 0000000 00111245677899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.61 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=199.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.|++++.||+|+||.||+|. +..++..+|+|++..... .....+.+|+.++++++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~---------~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLAR---------KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEE---------ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999994 444689999999876532 223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DF 145 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDF 145 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeEC
Confidence 999999999999999999997654 3889999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCC---------------------------------------------cceeeecccccCcccccccccCCC
Q 015731 226 GLAKDGPTGSQ---------------------------------------------SHVSTRVMGTYGYAAPEYMATGHL 260 (401)
Q Consensus 226 g~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 260 (401)
|++........ ........||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 225 (382)
T cd05625 146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225 (382)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence 99753210000 000123468999999999988899
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCC
Q 015731 261 TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEP 340 (401)
Q Consensus 261 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 340 (401)
+.++|||||||++|+|++|+.||....+......+ . .. ............+..+.++|.+|+ .+|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV------I-------NW-QTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH------H-------cc-CCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 99999999999999999999999765432111000 0 00 000111111234567788888876 599
Q ss_pred CCCCC---HHHHHHHH
Q 015731 341 KFRPT---MDEVVKAL 353 (401)
Q Consensus 341 ~~Rps---~~eil~~L 353 (401)
.+|++ +.+++.|-
T Consensus 291 ~~R~~~~~~~ei~~hp 306 (382)
T cd05625 291 EDRLGKNGADEIKAHP 306 (382)
T ss_pred hHcCCCCCHHHHhcCC
Confidence 99997 99999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=314.58 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=206.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|.+.. .+..++..+++|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 468889999999999999997532 2334578899999875433 2335677899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
...++||||+.+++|.+++..... .....+++..+..++.|++.||.|||+++ ++|+||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 999999999999999999864321 01134788899999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccch
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 293 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 293 (401)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..+...
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-- 235 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-- 235 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999976533322222233445678999999988889999999999999999998 8889865432111
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+ ..........+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus 236 -~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IE--------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 011111111223345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.19 Aligned_cols=269 Identities=20% Similarity=0.285 Sum_probs=195.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC------CCcccc
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY------HPNLVK 138 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~------hpni~~ 138 (401)
...++|++.++||+|+||+||+|.. ..++..||||++..... ....+..|+.+++.+. |++|++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~---------~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWD---------RKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEE---------cCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 3457899999999999999999954 34688999999864321 1223344555555554 556888
Q ss_pred eeeEEeeC-CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcC
Q 015731 139 LIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 139 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~ 216 (401)
+++++..+ .++++||+++ +++|.+++.+.. .+++..+..++.||+.||.|||+ .| ||||||||+|||++.
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMET 267 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEec
Confidence 98888764 5789999998 889999887653 38999999999999999999998 47 999999999999976
Q ss_pred CC----------------ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 015731 217 NY----------------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 217 ~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 280 (401)
++ .+||+|||.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998764221 233467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhHHhhhhhhh----------hcchhhhh-------hhhh-----hc--CCCCHHHHHHHHHHHHHcc
Q 015731 281 RVIDKNRPSREHNLIEWAKPYLQ----------SKRRIFQV-------MDAR-----IE--GQYSLGAALKTAVLAIKCL 336 (401)
Q Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-------~~~~-----~~--~~~~~~~~~~~~~li~~~L 336 (401)
.||...........+......+. ....+... .+.. .. ..........+.+||.+||
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 422 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence 99987654332222211100000 00000000 0000 00 0000112456789999999
Q ss_pred ccCCCCCCCHHHHHHHHHhc
Q 015731 337 SNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 337 ~~dp~~Rps~~eil~~L~~i 356 (401)
+.||++|||+.|+|+|=+..
T Consensus 423 ~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 423 HYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CcChhhCCCHHHHhcCcccc
Confidence 99999999999999986654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.72 Aligned_cols=267 Identities=28% Similarity=0.383 Sum_probs=208.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478899999999999999975421 1222446789998875543 23456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGA-------------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 208 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 208 (401)
..+++|||+.+++|.+++..... ....++++..++.++.|++.||+|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 99999999999999999865321 11245889999999999999999999988 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 287 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 287 (401)
|+||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875433222111222345678999999988889999999999999999998 999997654
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
+..... ..........+...+..+.+++.+||+.+|.+||++.++++.|+++-.
T Consensus 235 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFN-----------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHH-----------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 321111 111111112233445678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=328.40 Aligned_cols=255 Identities=23% Similarity=0.250 Sum_probs=203.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|.+.+.||+|+||.||+|.. ..+|..+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVRE---------KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 3689999999999999999944 44688999999986543 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~D 145 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLAD 145 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEecc
Confidence 9999999999999999999998763 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
||++......... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 146 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~----- 219 (330)
T cd05601 146 FGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN----- 219 (330)
T ss_pred CCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-----
Confidence 9999765432211 223457899999999986 4567889999999999999999999997643211100
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..... ...+........+..+.+|+.+||. +|.+|||+.++++|-
T Consensus 220 -~i~~~--------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 220 -NIMNF--------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred -HHHcC--------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 00000 0000111112346678899999998 999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.15 Aligned_cols=257 Identities=23% Similarity=0.253 Sum_probs=202.7
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~ 141 (401)
...++|++.+.||+|+||.||++.. ..++..+|+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRH---------KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3457899999999999999999944 44688999999875432 22334678999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
++.+++..|+||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~~------~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEE
Confidence 9999999999999999999999996543 788999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 183 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~----- 256 (370)
T cd05621 183 LADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----- 256 (370)
T ss_pred EEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 99999997643222 1122346799999999998653 3788999999999999999999999765321110
Q ss_pred hhhhhhhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 015731 298 AKPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 355 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~~ 355 (401)
..+.... +........+..+.+++.+||..++.+ |+++.++++|-+.
T Consensus 257 -----------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 257 -----------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred -----------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 1111111 111111234667889999999865544 8999999999553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.32 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=209.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||.|+||.||+|.... +..+++|.+..........+..|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 4579999999999999999995542 678999998877655566788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEcccc
Confidence 999999999999999999976542 44899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~-------- 216 (261)
T cd05148 150 LARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQ-------- 216 (261)
T ss_pred chhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH--------
Confidence 9876533221 1123345678999999988889999999999999999998 8999965432111 110
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 ------ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111111222345567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=324.44 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=199.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCC-cccceeeEEe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHP-NLVKLIGYCL 144 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hp-ni~~~~~~~~ 144 (401)
+|++.+.||+|+||.||+|.. ..++..||+|++..... .....+..|..++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAER---------KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 488899999999999999954 34688999999876532 2334567889999988764 6888999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~D 144 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIAD 144 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEee
Confidence 9999999999999999999997654 3889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 145 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~----------- 211 (324)
T cd05587 145 FGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----------- 211 (324)
T ss_pred cCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99986432211 12334679999999999998889999999999999999999999997643211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~ 352 (401)
.+.. ....++...+..+.+++.+||+.||.+|++. .++++|
T Consensus 212 -----~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 212 -----SIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -----HHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0000 0112233456678899999999999999976 677776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=320.55 Aligned_cols=243 Identities=27% Similarity=0.413 Sum_probs=193.0
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhc-cCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~-l~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|... .++..||+|++..... .....+..|..++.. ++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 47999999999999543 4688999999876532 122334556666654 4899999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~ 144 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCK 144 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence 99999999999999987654 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~---------------- 206 (316)
T cd05592 145 ENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD---------------- 206 (316)
T ss_pred ECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence 533222 12344579999999999988889999999999999999999999997653211100
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 352 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-eil~~ 352 (401)
.+.. ....++...+.++.+++.+||+.||.+||++. ++++|
T Consensus 207 ~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 207 SILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0000 01122334566788999999999999999875 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=311.32 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=206.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+|+.+++.++||||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 468888999999999999996543 57889999987543 33456789999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999999999976542 34889999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------------- 215 (263)
T cd05052 151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------------- 215 (263)
T ss_pred ccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--------------
Confidence 8765432211 1111234567999999988889999999999999999998 89998654321110
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...........+...+..+.+++.+||..||++||++.++++.|+.+
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ---ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00111111222334567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=316.98 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=205.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.|++.++||+|+||.||++... .++..||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4788899999999999999543 36889999998764332 22346789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Df 146 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999999988865432 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 147 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---------- 213 (285)
T cd05605 147 GLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---------- 213 (285)
T ss_pred CCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----------
Confidence 9987643222 122346899999999998888999999999999999999999999764322111000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
...+. .....++...+..+.+|+.+||+.||.+|| ++.++++|-+.
T Consensus 214 ---~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 214 ---ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred ---HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 00000 011122334567788999999999999999 89999888443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=323.54 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=198.5
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..++..||+|++...... ....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVEL---------KKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 4799999999999954 346889999999865332 233467899999888 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCcccc
Confidence 99999999999999887653 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc--cchhHHhhhhhhhhcch
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR--EHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 307 (401)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+...
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------- 215 (329)
T cd05588 145 EGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ------- 215 (329)
T ss_pred ccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH-------
Confidence 422111 12334679999999999998899999999999999999999999996432211 1111111110
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT------MDEVVKALE 354 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~eil~~L~ 354 (401)
.+.... ...+...+..+.+++.+||+.||.+|++ +.++++|-+
T Consensus 216 --~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 216 --VILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred --HHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 111111 1123345667889999999999999987 788988733
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.34 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=197.2
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..++..||+|++..... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAEL---------KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 4699999999999954 34688999999876532 2233466788888765 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~ 144 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCK 144 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccce
Confidence 99999999999999987654 3889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~---------------- 206 (321)
T cd05591 145 EGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE---------------- 206 (321)
T ss_pred ecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH----------------
Confidence 532221 12334578999999999988889999999999999999999999997654211110
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-------TMDEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-------s~~eil~~L 353 (401)
.+... ...++...+.++.+++.+||+.||++|| ++.++++|-
T Consensus 207 ~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 207 SILHD--DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 01100 0112233466888999999999999999 899999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=323.27 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=196.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..++..||+|++..... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARL---------KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEE---------cCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 4699999999999954 34688999999876432 2234466788888776 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~ 144 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCK 144 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence 99999999999999887654 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---------------- 206 (320)
T cd05590 145 EGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---------------- 206 (320)
T ss_pred ecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH----------------
Confidence 532211 12334579999999999988889999999999999999999999997654211100
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~eil~~L 353 (401)
.+... ...++...+..+.+++.+||+.||.+||++ ++++.|-
T Consensus 207 ~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 207 AILND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred HHhcC--CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 00000 011223356678899999999999999998 7888773
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=311.42 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=203.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|.+... .......+++|.+...... ...++..|+..++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 5789999999999999999976431 1112235888887644322 23457788889999999999999998764
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++++||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCc
Confidence 56788999999999999997654 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---------- 224 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---------- 224 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------
Confidence 9976543332222233456778999999988889999999999999999998 99999765432111111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........+..++..+..++.+||..||.+|||+.|+++.|..+.+.
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 225 -------EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -------HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00000011112345678899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=320.90 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=195.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
...+|++.+.||+|+||.||+|... .++..||+|+..... ...|+.++++++||||+++++++.+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP---------GQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC---------CCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEe
Confidence 3467999999999999999999543 467889999754432 2468999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++|||++ .++|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecC
Confidence 99999999999 568998887644 45899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh---
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL--- 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--- 302 (401)
|++....... ......||..|+|||++.+..++.++|||||||++|+|+++..++....+.............+
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 202 GAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred ccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 9987532211 2234568999999999988899999999999999999998655543322221111100000000
Q ss_pred -h----hcch---------hhhhhhhhhc--CCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 303 -Q----SKRR---------IFQVMDARIE--GQY-------SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 303 -~----~~~~---------~~~~~~~~~~--~~~-------~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
. .... .......... ... ....+..+.+||.+||+.||.+|||+.|+++|=
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp 352 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence 0 0000 0000000000 000 012244566799999999999999999999984
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.90 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=193.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..+|..||+|++..... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAEL---------KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 4799999999999954 44789999999876532 2233456677777654 899999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 99999999999999987653 3889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~------------- 206 (316)
T cd05620 145 ENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE------------- 206 (316)
T ss_pred ecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH-------------
Confidence 432211 123456799999999999988999999999999999999999999975432111 00
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 352 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-eil~~ 352 (401)
.+.. ....++...+.++.+++.+||+.||.+||++. ++++|
T Consensus 207 ~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 207 SIRV--DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHh--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0000 01122333566788999999999999999984 66655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.77 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=196.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+++++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEe---------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46999999999999543 3588999998765432 2345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 72 MELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred EeeccCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccc
Confidence 99999999999987543 34889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
.............+..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-----------------~~~ 208 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-----------------REA 208 (252)
T ss_pred cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-----------------HHH
Confidence 2211111111123456999999988889999999999999999998 8888865332110 011
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111111223344668889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.48 Aligned_cols=273 Identities=32% Similarity=0.472 Sum_probs=206.6
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC--
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED-- 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~-- 146 (401)
|++.+.||+|+||+||++.... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4889999999999999875432 3445688999999876533 2345678899999999999999999987653
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++.... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~------l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecc
Confidence 46899999999999999997643 899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ....+..... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-ch
Confidence 988654322111 11223456679999999888899999999999999999999999865432110 1110000000 00
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
...............+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111111112223345678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.98 Aligned_cols=255 Identities=35% Similarity=0.547 Sum_probs=197.6
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
+.+.||.|.||.||+|.+.. .....+..|+||.+..... .....+.+|++.+++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45689999999999998873 3445688999999966433 33667899999999999999999999999888899
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++..
T Consensus 78 lv~e~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccc---cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 99999999999999988722 45899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
..................|+|||.+.+..++.++||||||+++|||++ |..||....... .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~---~---------- 216 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II---E---------- 216 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH---H----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---c----------
Confidence 532222222333456778999999988889999999999999999999 678876542211 00 0
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.+ ........+..++..+..++.+||..||.+|||+.++++.|
T Consensus 217 ~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 KL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 11111122334566788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.53 Aligned_cols=265 Identities=27% Similarity=0.393 Sum_probs=208.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|.+.+.||+|+||.||++..... ....++..+++|.+..........+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788899999999999999965421 23446778999988766555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
+..+++|||+.+++|.+++..... .....+++..++.++.||+.||+|||+++ ++|+||||+||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 999999999999999999976532 11134889999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 295 (401)
++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999875432221111222345678999999988889999999999999999998 89998654321111000
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 238 -----------------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 -----------------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----------------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000011122234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=321.60 Aligned_cols=246 Identities=28% Similarity=0.357 Sum_probs=198.6
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~l 151 (401)
+.||+|+||.||+++.. ....+|..+|+|++...... ....+..|+.++++++||||+++++++.+++..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 67999999999998543 23347899999999765432 23456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 76 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 999999999999997653 3899999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
.... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .+
T Consensus 149 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----------------~i 210 (318)
T cd05582 149 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----------------MI 210 (318)
T ss_pred CCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----------------HH
Confidence 3321 12334678999999999988888999999999999999999999997643211100 01
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 352 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~ 352 (401)
... ....+...+..+.+|+.+||+.||.+||+ +.+++.|
T Consensus 211 ~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 211 LKA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 110 11223334667889999999999999999 5667765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=320.32 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=203.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccC-CCcccceee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIG 141 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~-hpni~~~~~ 141 (401)
...+.|++++.||+||.+.||++...+ ...+|+|.+.... .....-+..|+..|.+|+ |.+||++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 445789999999999999999984432 3456776554432 233456889999999994 999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
|-..++.+|||||+- ..+|..+|++.... .+...+..+..||+.++.++|.+| |||.||||.|+|+- .|.+|
T Consensus 428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~----~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 428 YEVTDGYLYMVMECG-DIDLNKILKKKKSI----DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eeccCceEEEEeecc-cccHHHHHHhccCC----CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEE
Confidence 999999999999986 77999999887642 343478899999999999999999 99999999999997 67999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----------HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
|+|||+|...............+||+.||+||.+... ..++++||||||||||+|+.|++||.....
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-- 577 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-- 577 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--
Confidence 9999999988887777788889999999999998432 256789999999999999999999964211
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....+..+.++..+-+++.. ...++.++++.||..||++|||+.|+|+|
T Consensus 578 -------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 -------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11122333333332233221 12238899999999999999999999997
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=321.26 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=196.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..++..+|+|++..... .....+..|+.++.++ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRL---------KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 4799999999999954 34688999999976532 2233466788888776 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~ 144 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence 99999999999999887653 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc--chhHHhhhhhhhhcch
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--HNLIEWAKPYLQSKRR 307 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 307 (401)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||........ .....+...
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------- 215 (329)
T cd05618 145 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------- 215 (329)
T ss_pred cccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH-------
Confidence 532211 122345789999999999988999999999999999999999999964221111 111111110
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT------MDEVVKA 352 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~eil~~ 352 (401)
.+... ...++...+..+.+++.+||+.||.+||+ +.++++|
T Consensus 216 --~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 216 --VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --HHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 01111 11233445677889999999999999998 5788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.17 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=204.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----hHHHHHHHHHHHhccCCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
+.|.+.+.||+|++|.||.|.. ..++..+|+|.+...... ....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYD---------VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEE---------cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 4689999999999999999943 346889999987654321 23457789999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l 145 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKL 145 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999997654 3889999999999999999999988 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcce-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~------ 216 (263)
T cd06625 146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I------ 216 (263)
T ss_pred eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H------
Confidence 99999875432211111 1234578899999999888899999999999999999999999865432110 0
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
............+...+..+.+++.+||..+|.+|||+.+++++.+
T Consensus 217 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 217 -------FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -------HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 0111111112233445678889999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.75 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=204.2
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|.+.+.||+|+||.||+|.... +..++..+|+|.+..... .....+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5788999999999999997643 233568899999875432 23356789999999999999999999886655
Q ss_pred e------eEEEEEecCCCChHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 148 H------RLLVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 148 ~------~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
. .+++|||+++++|..++..... .....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeE
Confidence 4 7999999999999999865432 12245899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..++.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~- 228 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL- 228 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence 9999999886543322111222334678999999988889999999999999999999 888886543211 11110
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
........+...+..+.+++.+||+.||.+|||+.+++++|+++
T Consensus 229 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 -------------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111122334566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=323.80 Aligned_cols=270 Identities=24% Similarity=0.256 Sum_probs=205.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
...+|.+.+.||+|+||.||+|.... ..++..+++|.+.... ...+|+.+++.++||||+++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEee
Confidence 34679999999999999999986432 2357889999886542 34579999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++|||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred CCEEEEEehhc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccC
Confidence 99999999999 57899988543 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh-
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS- 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 304 (401)
|++................||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.-....+..
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 9997654433322333467999999999998888999999999999999999999999765443211111100000000
Q ss_pred --------cchhh---hhhhhhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 --------KRRIF---QVMDARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 --------~~~~~---~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...+. ..........+. ...+.++.++|.+||..||.+|||+.|++.|=+.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 00000 000000000011 1234577889999999999999999999998554
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.88 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=210.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||++..... ........+|+|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3446799999999999999999966431 1123457899998876432 2334578899999999 79999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
+..++..++||||+.+++|.+++..... .....+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 9999999999999999999999975321 12345899999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSR 290 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 290 (401)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986543322111222334667999999988889999999999999999997 888886543211
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
... ..........+...+..+.+|+.+||..||++|||+.++++.|+.+
T Consensus 243 ~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LFK-----------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHH-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111 1111111122334466788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=328.17 Aligned_cols=260 Identities=23% Similarity=0.257 Sum_probs=203.8
Q ss_pred HHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccc
Q 015731 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~ 138 (401)
.+....++|++.+.||+|+||.||+|. +..++..+|+|++..... .....+.+|+.+++.++||||++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~---------~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVR---------HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEE---------ECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344556899999999999999999994 444789999999865432 22334678999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+++++.+++..|+||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSG 179 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCC
Confidence 9999999999999999999999999986543 788899999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
.++|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 180 ~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-- 256 (371)
T cd05622 180 HLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-- 256 (371)
T ss_pred CEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH--
Confidence 99999999997643322 1122346799999999998653 3788999999999999999999999764321110
Q ss_pred HHhhhhhhhhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 015731 295 IEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 355 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~~ 355 (401)
..+.... +........+..+.+++.+||..++.+ |+++.++++|.+.
T Consensus 257 --------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 257 --------------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred --------------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 1111100 111111235667889999999844433 7899999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=325.25 Aligned_cols=270 Identities=29% Similarity=0.426 Sum_probs=216.8
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc---chhHHHHHHHHHHHhccCCCcccce
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
+.....+-.+.+.||+|+||.||+|.+... .......||+|...... .....++.+|.+++++++||||+++
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 334445666779999999999999987642 11112238999888532 3556779999999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
||+......+++|||+|.||+|.++|.+... .++......++.+.+.||+|||+++ ++||||-.+|+|++.++.
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCe
Confidence 9999999999999999999999999998763 4899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceee-ecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVST-RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 297 (401)
+||+|||+++..... .... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.......
T Consensus 301 vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~----- 372 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK----- 372 (474)
T ss_pred EEeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-----
Confidence 999999998864311 1111 1124578999999999999999999999999999999 78898776432111
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
..+.........+...+..+..++.+||..||++||++.++.+.|+.+......
T Consensus 373 -----------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 -----------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111122233344556677888899999999999999999999999998666553
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.61 Aligned_cols=266 Identities=26% Similarity=0.360 Sum_probs=209.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|.+.+.||+|+||.||+|..... .+..++..+|+|.+..... .....+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 346799999999999999999975321 2344677899998876532 2344678999999999 799999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
...+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEEC
Confidence 999999999999999999999976442 23899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~------- 254 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y------- 254 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H-------
Confidence 9999876543322112223345778999999988889999999999999999998 99998654321110 0
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 255 -------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 -------KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00010011111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=319.83 Aligned_cols=243 Identities=27% Similarity=0.397 Sum_probs=193.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhc-cCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~-l~hpni~~~~~~~~~~~~~ 149 (401)
+.||+|+||.||+|... .++..||+|++..... ........|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 46999999999999543 4688999999876532 122345567777765 4899999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCK 144 (316)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcce
Confidence 99999999999999997653 3888999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-------------- 208 (316)
T cd05619 145 ENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------------- 208 (316)
T ss_pred ECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Confidence 532211 1233457899999999998888999999999999999999999999764321110000
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 352 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-eil~~ 352 (401)
.. ....++...+.++.+++.+||+.||.+||++. +++.|
T Consensus 209 ---~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 209 ---RM-DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ---Hh-CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 00 00112233556788999999999999999997 67664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.80 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=197.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.++||+|+||.||+|.. ..++..||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~---------~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAIC---------IDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEee
Confidence 346799999999999999999954 34688999998854321 23479999999999999999987643
Q ss_pred C--------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 146 D--------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 146 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
. ..+++||||++ ++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPN 206 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCC
Confidence 2 24679999995 588777754321 1245899999999999999999999988 9999999999999866
Q ss_pred C-ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 218 Y-NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 218 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+
T Consensus 207 ~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4 69999999998654322 1234568999999998865 46899999999999999999999999876543222111
Q ss_pred Hhhh--hhhhhc----c-----hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 296 EWAK--PYLQSK----R-----RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 296 ~~~~--~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.... +..... . .+.......+...++...+.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 1000 000000 0 000000011111122234568899999999999999999999999855
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=324.99 Aligned_cols=272 Identities=23% Similarity=0.348 Sum_probs=210.4
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccC-CCcccceee
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLY-HPNLVKLIG 141 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~-hpni~~~~~ 141 (401)
....++|.+.+.||+|+||.||+|.+... .+..++..||+|++...... ....+.+|+.+|.++. ||||+++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 34446788999999999999999976532 23345678999999765332 2345788999999997 999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCC--------------------------------------------------
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGAS-------------------------------------------------- 171 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------- 171 (401)
++...+..++||||+.+|+|.+++......
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 999999999999999999999999754310
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccC
Q 015731 172 -------------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 208 (401)
Q Consensus 172 -------------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 208 (401)
....+++..+..++.||+.||.|||+.+ ++|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 1124677788999999999999999988 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 287 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 287 (401)
|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999875432221111223456788999999988889999999999999999998 888886543
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..... ............+...+.++.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 347 ~~~~~----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQF----------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHH----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 21100 0000111111122335678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.39 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=204.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3579999999999999999996442 45799998765432 345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCc
Confidence 999999999999999999976532 34788899999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~------- 217 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL------- 217 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH-------
Confidence 99865432211 1222345678999999988888999999999999999998 9999965432111 1100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
............+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 218 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 -------QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -------HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00001111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.94 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=199.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
+|.+.+.||+|+||.||+|.. ..++..+|+|++...... ....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAER---------KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 478899999999999999954 446889999998765321 223456677777776 5899999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~D 144 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIAD 144 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEcc
Confidence 9999999999999999999987654 3889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 145 fG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~----------- 211 (323)
T cd05616 145 FGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----------- 211 (323)
T ss_pred CCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99987532211 12334578999999999998899999999999999999999999997643211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~ 352 (401)
.+.... ..++...+.++.+++.+||+.||.+|++. .++++|
T Consensus 212 -----~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 -----SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111111 12233456788899999999999999984 677765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.02 Aligned_cols=277 Identities=27% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee--
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-- 145 (401)
.+|++.+.||+|+||.||+|.... .+..++..+|+|.+..........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 578999999999999999996542 3445788999999877655555678899999999999999999997653
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCC
Confidence 456899999999999999997643 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcce-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........... .....++..|+|||.+.+..++.++||||||+++|||++|..++............. .......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN-DKQGQMI 231 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc-ccccccc
Confidence 99986543322111 111223456999999988889999999999999999999887654322110000000 0000000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...+...+............+..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001111111111122234556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.22 Aligned_cols=273 Identities=25% Similarity=0.355 Sum_probs=210.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|.+.+.||+|+||.||++...... .....++..+|+|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467999999999999999999654211 01123456799999876432 3345677899999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+.+..|+||||+.+++|.+++...... ....+++..++.++.|++.||+|||+++ ++|+||||+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheE
Confidence 999999999999999999999765321 1134889999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999999875433221111122234568999999988889999999999999999998 88888653321100
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
..+........+...+..+.+|+.+||..+|.+|||+.++++.|+++....
T Consensus 253 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 -----------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -----------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 011111111223345668889999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=318.96 Aligned_cols=244 Identities=28% Similarity=0.426 Sum_probs=196.8
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||+||+|.. ..++..||+|++..... .....+..|..+++.+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAEL---------KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 4799999999999954 34688999999876532 2234466788888877 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCe
Confidence 99999999999999887664 3899999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 145 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~------------- 206 (318)
T cd05570 145 EGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ------------- 206 (318)
T ss_pred ecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH-------------
Confidence 422211 122345689999999999988999999999999999999999999975432110 00
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~L 353 (401)
.+... ...++...+..+.+|+.+||+.||.+||++ .++++|-
T Consensus 207 ~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 207 SILED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHHcC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 00000 111223456678899999999999999999 9998873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=319.79 Aligned_cols=244 Identities=28% Similarity=0.354 Sum_probs=192.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHH-HHhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~-~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||+||+|.. ..+|+.||+|++...... ....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKH---------KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 4699999999999954 446899999998765322 2233445544 56778999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCK 144 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence 99999999999999987654 3889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||........ . .
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~----------~ 206 (323)
T cd05575 145 EGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------Y----------D 206 (323)
T ss_pred ccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------H----------H
Confidence 532211 123345789999999999888999999999999999999999999975432110 0 0
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM----DEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~eil~~L 353 (401)
.+..... ......+..+.+++.+||+.||.+||++ .++++|-
T Consensus 207 ~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 207 NILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 1111111 1222346778899999999999999987 4776653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=310.86 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=205.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.+.|.+.+.||+|+||.||+|.+... ....++..+++|.+...... ....+..|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 35689999999999999999976431 11225778999988654322 33458889999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC---ce
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~---~~ 220 (401)
.+..++||||+.+++|.+++...... ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 99999999999999999999765421 1235899999999999999999999988 99999999999997654 59
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~------ 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME------ 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence 9999999886532221111112233567999999988889999999999999999997 999997654321111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..........+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus 233 -----------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 -----------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111223344567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=326.41 Aligned_cols=269 Identities=25% Similarity=0.324 Sum_probs=202.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||+|.. ..+|..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTD---------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEE---------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 478899999999999999943 3468899999886532 23345678999999999999999999999877
Q ss_pred C-----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 147 D-----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 147 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
+ ..|+||||+ .++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++
T Consensus 72 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~k 143 (372)
T cd07853 72 HIDPFEEIYVVTELM-QSDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLK 143 (372)
T ss_pred CccccceEEEEeecc-ccCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEE
Confidence 6 789999999 468888876543 4899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||....+......+.....
T Consensus 144 L~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g 222 (372)
T cd07853 144 ICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222 (372)
T ss_pred eccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999976433221 122334678999999998764 478999999999999999999999987654333222211000
Q ss_pred --hhh----hcchhhhhh-hhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 301 --YLQ----SKRRIFQVM-DARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 301 --~~~----~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ........+ ...... ......+.++.+|+.+||+.||.+|||+.++++|-+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 000 000000000 000000 1112235678899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.76 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=206.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|..... .....+..+|+|.+...... ....+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3578889999999999999976432 12234678999999765432 234577899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
...++++||+.+++|.+++..... .....+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 999999999999999999853321 11234788889999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 294 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 294 (401)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--- 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 999999999999876543322222233456778999999988889999999999999999998 8888865432111
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. ...........+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I--------------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H--------------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1111111112234456778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=311.52 Aligned_cols=276 Identities=27% Similarity=0.390 Sum_probs=210.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCcc-------CCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYA-------PARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-------~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~ 138 (401)
..+|++.+.||+|+||.||+|........ ..+...+..+|+|.+..... .....+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 36799999999999999999976532111 13344567899999876543 23456788999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
+++++..+...+++||++.+++|.+++....... ...+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence 9999999999999999999999999997654211 135899999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSR 290 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~ 290 (401)
+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999876433322222334456778999999988889999999999999999998 66777543321
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..+......... .........+...+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 --~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 --QVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111100000 0011111122234568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.31 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=194.6
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||+|+||.||++.. ..+|..+|+|.+...... ....+..|++++++++||||+++++++.++...++|
T Consensus 1 lg~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQV---------KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEE---------ccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 79999999999954 346899999998754332 223455799999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++..... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 72 ~e~~~g~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146 (277)
T ss_pred EecCCCCCHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence 999999999988865542 34888999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .... ...
T Consensus 147 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~----------~~~ 211 (277)
T cd05607 147 DGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKR----------RTL 211 (277)
T ss_pred CCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHH----------Hhh
Confidence 322 2234568999999999988889999999999999999999999997543211110 0000 001
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..... ......+.++.+|+.+||+.||.+||+++|+++.+.
T Consensus 212 ~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 212 EDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 00000 001134667899999999999999999966554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.27 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=198.5
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||+|+||+||++. +..+++.+|+|.+...... ....+..|+.+++.++||||+++.+++..+...++|
T Consensus 1 lg~G~~g~Vy~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQ---------MRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEE---------EccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999994 4447889999998765432 224567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999988754321 1245899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
.... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||............ .....
T Consensus 149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~ 214 (280)
T cd05608 149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------KQRIL 214 (280)
T ss_pred CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHhhc
Confidence 3221 123457899999999999889999999999999999999999999754321111000 00011
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.. ...++...+..+.+++.+||+.||++|| ++.++++|-+
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 11 1122334567888999999999999999 7888998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.71 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=204.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 467999999999999999998643 246799999876542 345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcc
Confidence 999999999999999999976542 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||..........
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------------ 215 (261)
T cd05068 149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ------------ 215 (261)
T ss_pred eEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------------
Confidence 98765422111 1111223457999999988889999999999999999999 999997543211100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 216 -----QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0001111112234557788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.23 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=208.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|..... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 46789999999999999999976532 1234568899999875532 334567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
....++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 99999999999999999999764321 1134788899999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ++.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~- 234 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFV- 234 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHH-
Confidence 9999999875433322222233456788999999988889999999999999999998 89898654332111 100
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 -------------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000111122334678889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=326.83 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=200.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..++..+|+|++..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQK---------KDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3688899999999999999944 44689999999875432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++.+|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++| |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~D 144 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSD 144 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999997654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc---------------------------------ceeeecccccCcccccccccCCCCcccchhhHHH
Q 015731 225 FGLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGV 271 (401)
Q Consensus 225 fg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 271 (401)
||++......... ......+||+.|+|||++.+..++.++|||||||
T Consensus 145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 224 (360)
T cd05627 145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (360)
T ss_pred ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence 9998743221100 0012347999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC---CHHH
Q 015731 272 VLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP---TMDE 348 (401)
Q Consensus 272 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e 348 (401)
++|+|++|..||....+......+. . . ...+........+.++.+||.+|+. ||.+|+ ++.+
T Consensus 225 ilyel~tG~~Pf~~~~~~~~~~~i~------~-------~-~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~e 289 (360)
T cd05627 225 IMYEMLIGYPPFCSETPQETYRKVM------N-------W-KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEE 289 (360)
T ss_pred eeeecccCCCCCCCCCHHHHHHHHH------c-------C-CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence 9999999999997654322111000 0 0 0000001111245678889998774 999998 4789
Q ss_pred HHHHH
Q 015731 349 VVKAL 353 (401)
Q Consensus 349 il~~L 353 (401)
+++|=
T Consensus 290 i~~hp 294 (360)
T cd05627 290 IKSHP 294 (360)
T ss_pred HhcCC
Confidence 99883
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=315.90 Aligned_cols=258 Identities=21% Similarity=0.230 Sum_probs=198.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++.. ..++..||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKM---------KNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 4689999999999999999954 44688999999875332 22334778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~D 145 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLAD 145 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEE
Confidence 9999999999999999999997643 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... .
T Consensus 146 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~ 218 (331)
T cd05597 146 FGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------G 218 (331)
T ss_pred CCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------H
Confidence 999875433221 11223468999999999853 45788999999999999999999999754321110 0
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 354 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~ 354 (401)
.... ...... +. ......+..+.+++.+||..++++ |+++.++++|-+
T Consensus 219 ~i~~-~~~~~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 219 KIMN-HKEHFQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHc-CCCccc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0000 000000 00 011124667888999988654443 789999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.10 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=199.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 458889999999999999996543 45799998765433 3456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCC
Confidence 9999999999999999987543 23889999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+ . ..
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~----~~- 217 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---S----RG- 217 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----CC-
Confidence 8754322111 1112234567999999988889999999999999999999 89999655421111111 0 00
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.....+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 218 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 ---------FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00011122345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=318.30 Aligned_cols=271 Identities=28% Similarity=0.372 Sum_probs=205.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.... .....+++.||+|++..... .....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeecc----CCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4689999999999999999996432 12345688999999875432 2334577899999999 6899999999876
Q ss_pred e-CCeeEEEEEecCCCChHHHHhhcCCC----------------------------------------------------
Q 015731 145 E-DDHRLLVYEFMPKGSLENHLFRTGAS---------------------------------------------------- 171 (401)
Q Consensus 145 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 171 (401)
. +...++||||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45678999999999999998753210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceee
Q 015731 172 ----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241 (401)
Q Consensus 172 ----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 241 (401)
....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0123678888999999999999999988 9999999999999999999999999987643222111122
Q ss_pred ecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCC
Q 015731 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY 320 (401)
Q Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (401)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ...........
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~--------------~~~~~~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC--------------RRLKEGTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH--------------HHHhccCCCCC
Confidence 2345677999999988889999999999999999997 8989865432110 00 00000001111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 321 SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 321 ~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+...+..+.+++.+||+.||.+|||+.+|+++|+.+.+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 222345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=311.07 Aligned_cols=269 Identities=25% Similarity=0.391 Sum_probs=207.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....+|++.+.||+|+||.||+|..... .....+..+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 3457899999999999999999975432 1223466899998865432 2334577899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.+.+..++||||+.+|+|.+++...... .....+...+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~ 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDF 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCC
Confidence 9999999999999999999999764321 1234567788999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ ..+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~ 233 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF 233 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 999999999875433222111222345677999999988889999999999999999998 788886543211 1100
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.... .....+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus 234 -------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 -------------VMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------------HHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0000 00111223356889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=317.88 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=198.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhcc-CCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|... .++..+|+|++...... ....+..|..++.++ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 47999999999999543 46889999999865432 233467888988888 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~ 144 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCK 144 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccce
Confidence 99999999999999887653 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............+...
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~--------- 213 (327)
T cd05617 145 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ--------- 213 (327)
T ss_pred eccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH---------
Confidence 432211 123446799999999999988999999999999999999999999975433222211111110
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT------MDEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps------~~eil~~L 353 (401)
.+.... ...+...+..+.+++.+||+.||.+|++ +.++++|-
T Consensus 214 ~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 214 VILEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred HHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 111111 1223345567889999999999999998 46887773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=312.12 Aligned_cols=274 Identities=24% Similarity=0.364 Sum_probs=211.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
...+|.+.+.||+|+||.||+|...... ......+..+|+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3467999999999999999999653210 01223466899999875432 3345678999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
......++||||+.+++|.+++...... ....+++..+..++.||+.||.|||++| ++||||||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 168 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNV 168 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceE
Confidence 9999999999999999999999764321 1235788899999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCcc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 291 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 291 (401)
+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999986543322222223345678999999988889999999999999999998 7888865432111
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.. .+........+..++..+.+|+.+||+.+|.+|||+.++++.|.++....
T Consensus 249 ~~-----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 249 FK-----------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HH-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 00 00000111122345667889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.49 Aligned_cols=256 Identities=27% Similarity=0.345 Sum_probs=202.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||+|+||.||+|.. ..++..+|+|++..........+.+|+.++++++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARN---------LHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEE---------CCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 35799999999999999999954 346889999998765444445677899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCc
Confidence 99999999999999999987543 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
++........ ......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+......+ .
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~----- 222 (267)
T cd06646 152 VAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S----- 222 (267)
T ss_pred cceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e-----
Confidence 9876432211 122346888999999874 345778999999999999999999998654322111000 0
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.. ....... ......+..+.+++.+||..+|++|||+++++++|
T Consensus 223 -~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 -KS---NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cC---CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0000000 01123456788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.55 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=200.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||++. +..+|..+|+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAF---------DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEE---------EcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 45789999999999999999994 44468999999986542 22345677899999999999999999998
Q ss_pred eeCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LEDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
.... ..|+||||+. ++|.+.+.. .++...+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~ 159 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 159 (359)
T ss_pred ccCCCccccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC
Confidence 6543 5799999995 567776632 2788889999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE- 296 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~- 296 (401)
+.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 160 ~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 160 CTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999987532211 2234568999999999998899999999999999999999999998654321110000
Q ss_pred h-hhh---hhhh-cchhhhhhhhhh------------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 297 W-AKP---YLQS-KRRIFQVMDARI------------------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 297 ~-~~~---~~~~-~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
- ..+ +... ............ ........+..+.+|+.+||+.||++|||+.|+++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 000 0000 000000000000 0001112346788999999999999999999999997
Q ss_pred Hhc
Q 015731 354 EQI 356 (401)
Q Consensus 354 ~~i 356 (401)
+.-
T Consensus 317 ~~~ 319 (359)
T cd07876 317 YIT 319 (359)
T ss_pred hhh
Confidence 643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=306.39 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=207.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 57999999999999999999543 3688999998764322 23345788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECc
Confidence 999999999999999999988643211 134789999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~------- 219 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQK------- 219 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHH-------
Confidence 999876433221 1223468889999999988888999999999999999999999985432210 011100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
+.............+..+.+++.+||+.+|.+||++.++++.+++++
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 ------IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000111112345577899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=313.66 Aligned_cols=269 Identities=28% Similarity=0.379 Sum_probs=206.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||++. +..++..+|+|.+..... .....+.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~---------~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVL---------HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEE---------EcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368999999999999999994 444688999998875432 2234578999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~df 144 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 144 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccC
Confidence 99999999999999999997653 38999999999999999999997 46 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......................
T Consensus 145 g~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
T cd06615 145 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220 (308)
T ss_pred CCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc
Confidence 988654322 1234568899999999988888999999999999999999999986543222111110000000000
Q ss_pred ----------------chhhhhhhhhhc---CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 ----------------RRIFQVMDARIE---GQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ----------------~~~~~~~~~~~~---~~~-~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.......+.... ... ....+.++.+|+.+||..||++|||+.+++++.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000000 000 112466789999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=307.69 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=203.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|++.+.||+|+||+||+|.+.... ......||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDG-----ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCC-----CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 367899999999999999999754321 112345899988754332 34567889999999999999999999875
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
...+++|+|+++|+|.+++.... ..+++..++.++.||+.||.|||+++ ++||||||+||++++++.++|+||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCC
Confidence 45789999999999999997643 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~--------- 221 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---P--------- 221 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---------
Confidence 99986543222111122234678999999988889999999999999999998 8899865432111 1
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 222 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 222 -----DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -----HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111111223345678899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=315.54 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=198.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++... .++..+|+|++..... .....+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 36899999999999999999544 4678999999875432 12234678899999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~D 145 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLAD 145 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999997643 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||++....... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||..........
T Consensus 146 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------ 218 (332)
T cd05623 146 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------ 218 (332)
T ss_pred cchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------
Confidence 99987543221 11223357999999999985 3467889999999999999999999997543211110
Q ss_pred hhhhhcchhhhhhhhhhcCCC---CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQY---SLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKA 352 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~ 352 (401)
.+........+ ....+..+.+|+.+||..++.+ |+++.++++|
T Consensus 219 ----------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 ----------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01110000011 1234677889999998765544 6899999999
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=316.11 Aligned_cols=257 Identities=21% Similarity=0.237 Sum_probs=198.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++.. ..++..+|+|++..... .....+.+|..++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKM---------KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4789999999999999999954 34688999999876432 22334678899999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+.||+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~D 145 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLAD 145 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEe
Confidence 9999999999999999999998643 34889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||++........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i---- 220 (331)
T cd05624 146 FGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---- 220 (331)
T ss_pred ccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH----
Confidence 999875433221 11233569999999999865 46788999999999999999999999754321110000
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKAL 353 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L 353 (401)
...... ..+. ......+..+.+++.+||..++.+ |++++++++|-
T Consensus 221 --~~~~~~------~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 221 --MNHEER------FQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred --HcCCCc------ccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000000 0000 001124567889999999876554 46899999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.06 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=206.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||+|+||.||+|.. ..++..+++|.+..........+.+|+.+++.+.||||+++++.+.++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMD---------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEE---------CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 36899999999999999999953 346889999998776555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccc
Confidence 9999999999999999998653 2788999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .+.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~~-------- 229 (296)
T cd06654 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIA-------- 229 (296)
T ss_pred cchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HHh--------
Confidence 9875432221 1223468899999999988888999999999999999999999997654311100 000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.........+...+..+.+++.+||..||.+||++.+++++-+.
T Consensus 230 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred -----cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 00000011123345678899999999999999999999997443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=309.45 Aligned_cols=276 Identities=28% Similarity=0.428 Sum_probs=205.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCC-----ccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHT-----YAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~ 141 (401)
++|++.+.||+|+||.||+|+..... ...........||+|.+..... .....+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 68999999999999999998654311 0011223345689999876432 23345889999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGAS-------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
++...+..++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence 999999999999999999999998654211 1123688899999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCccc
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSREH 292 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~ 292 (401)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 9999999999999876433322212223345678999999988889999999999999999998 566776543211
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+......... .........+...+..+.+|+.+||+.||++|||+.+|++.|.+
T Consensus 241 -~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 -VIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111100000 00000011122345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.79 Aligned_cols=276 Identities=25% Similarity=0.401 Sum_probs=206.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCc------c-CCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccce
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY------A-PARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~-~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
++|++.+.||+|+||.||++....... . .....++..+|+|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999985432110 0 01223456799999876532 234568899999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
++++.+++..++||||+.+++|.+++....... ...+++..+..++.|++.||+|||+++ ++|+||||+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence 999999999999999999999999997654211 134778899999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCcc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSRE 291 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~ 291 (401)
++.++.++|+|||++................++..|++||...++.++.++|||||||++|||++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999876433222112222344678999998888889999999999999999998 6778865433211
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+.......... ........+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 243 ---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 ---IENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100000000 0000111122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=312.02 Aligned_cols=273 Identities=24% Similarity=0.368 Sum_probs=209.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
..+|.+.+.||+|+||.||+|...... .........+|+|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 367899999999999999999653210 01223466799998875432 3345678899999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+.+..++||||+.+++|.+++..... .....+++..+..++.||+.||.|||++| ++|+||||+||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 99999999999999999999976431 11235889999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976533221111122234467999999988889999999999999999999 88888654321111
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.. .........+..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 247 ~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 247 KL-----------------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HH-----------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 10 0000111223344567889999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.01 Aligned_cols=270 Identities=25% Similarity=0.323 Sum_probs=203.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|.+.+.||+|+||.||+|+. ..++..+|+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRS---------KLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEe---------cCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 5799999999999999999954 346889999998754332 233567899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg 149 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFG 149 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccc
Confidence 99999999995 58888886654 34788999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh------
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK------ 299 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------ 299 (401)
++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+....+....
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07872 150 LARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227 (309)
T ss_pred cceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9875332211 1233467899999998854 467899999999999999999999997765433222211100
Q ss_pred --hhhhhcchhhhhhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 --PYLQSKRRIFQVMDARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 --~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+.................. ......+.++.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 0000000000000000000 0011345678899999999999999999999998655
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=315.75 Aligned_cols=243 Identities=29% Similarity=0.356 Sum_probs=191.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHH-HHhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~-~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..+|..+|+|++..... .....+..|.. +++.++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKR---------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 4699999999999943 44689999999876532 22234455554 46778999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+.+++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~ 144 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCK 144 (325)
T ss_pred EEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcc
Confidence 99999999999999887653 4899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----------------~ 206 (325)
T cd05604 145 EGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----------------D 206 (325)
T ss_pred cCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----------------H
Confidence 532211 1233457999999999999889999999999999999999999999764321110 0
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD----EVVKA 352 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~----eil~~ 352 (401)
....... ......+..+.+++.+||+.||.+||++. ++++|
T Consensus 207 ~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 207 NILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 1111111 11223456788999999999999999875 56555
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.45 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=197.5
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
.||+|+||.||+|.+.. ..++..+|+|++..... .....+.+|+.+++.++||||+++++++. ++..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 68999999999996532 23578899999865432 23456788999999999999999999875 4567899
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++||||||.||+++.++.++|+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 74 MELAELGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccC
Confidence 99999999999997643 3889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 233 TGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----------------- 209 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ----------------- 209 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------
Confidence 322111 1112234578999999988888999999999999999998 999997543211111
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+........+...+.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus 210 ~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 210 MIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111111123334567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.81 Aligned_cols=266 Identities=23% Similarity=0.273 Sum_probs=198.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
...|.+.+.||+|+||.||+|.. ..++..||+|.... ..+.+|+.+|++|+||||+++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~---------~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSH---------PDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEE---------CCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 45799999999999999999944 44688999996432 2345899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++|||++ .++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccC
Confidence 9999999999 579998886543 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc--------chhHHhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--------HNLIEWA 298 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--------~~~~~~~ 298 (401)
+++...............||..|+|||++.+..++.++|||||||++|||++|..++-....... ...+.+.
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 99764332222223345799999999999988999999999999999999998765433221110 0111111
Q ss_pred hhhhhh-c----chhh-hhhh---hhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 299 KPYLQS-K----RRIF-QVMD---ARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 299 ~~~~~~-~----~~~~-~~~~---~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...... . ..+. .... ........ ...+..+.+||.+||+.||.+|||+.|+|+|=+
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 100000 0 0000 0000 00000000 123457889999999999999999999999844
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=310.27 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=203.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.|+..++||+|+||.||++.. ..+++.+|+|.+...... ....+.+|+.+++.++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQV---------RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEE---------cCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 367788999999999999944 447899999988654322 22346789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Df 146 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDL 146 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999998865442 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 147 g~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------- 214 (285)
T cd05630 147 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 214 (285)
T ss_pred cceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------
Confidence 9987543222 1223468999999999988889999999999999999999999997643211110000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~~ 355 (401)
.... .....++...+..+.+|+.+||+.||.+||| +.|+++|-+.
T Consensus 215 ----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 215 ----RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred ----hhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 0000 0011122334567889999999999999999 8999998553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=302.86 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=204.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|.+.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK---------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc---------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 4778899999999999999554 3688999998865432 3345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~ 146 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLG 146 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccc
Confidence 999999999999999999987532 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---------- 211 (256)
T cd08529 147 VAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL---------- 211 (256)
T ss_pred cceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 9876543221 1234568889999999988889999999999999999999999997554211 000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... .....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 212 ---~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 ---KIIRG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---HHHcC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00000 0111222456788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.13 Aligned_cols=268 Identities=26% Similarity=0.381 Sum_probs=206.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
++|++.++||+|+||.||+|..... +....+++|.+.... ......+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 4789999999999999999966431 122347888776432 23345678899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
.+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence 99999999999999999999764311 1134889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccch
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 293 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 293 (401)
+.++.++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986422111 0111123456999999988889999999999999999997 999996543211100
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
..........+..++..+.+|+.+||+.+|.+||++.++++.|..+.+......
T Consensus 230 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 230 -----------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred -----------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 001111111223355678899999999999999999999999998877664433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.81 Aligned_cols=239 Identities=27% Similarity=0.325 Sum_probs=189.0
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHH-HHHhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI-KHLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~-~~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
+.||+|+||.||+|.. ..++..+|+|++...... ....+..|. .+++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~fg~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARH---------KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 4699999999999954 346889999998764321 122334444 356778999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+.+++|.+++.... .+.+..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~ 144 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCK 144 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCc
Confidence 99999999999999997654 3788888999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~------------- 206 (325)
T cd05602 145 ENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD------------- 206 (325)
T ss_pred ccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------
Confidence 532211 123345799999999999988999999999999999999999999975432111 00
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e 348 (401)
.+.... .......+..+.+++.+||+.||.+||++.+
T Consensus 207 ~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 207 NILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHhCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 011111 1122345667889999999999999998773
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.19 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=197.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccC-CCcccceeeEEe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~-hpni~~~~~~~~ 144 (401)
+|++.+.||+|+||.||+|. +..+|..||+|++..... .....+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAE---------RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47788999999999999994 444789999999876532 22334667888888875 577888999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~D 144 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIAD 144 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEec
Confidence 9999999999999999999987654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 145 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~--------- 210 (323)
T cd05615 145 FGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F--------- 210 (323)
T ss_pred cccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---------
Confidence 99987532211 122345689999999999888899999999999999999999999976532111 0
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~ 352 (401)
..+... ...++...+..+.+++.+||+.||.+|++. .++++|
T Consensus 211 ----~~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 211 ----QSIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----HHHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 011111 112233455678899999999999999974 566666
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.67 Aligned_cols=255 Identities=33% Similarity=0.498 Sum_probs=202.0
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHH--HHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|++.+.||+|+||+||++. +..+++.+|+|++......... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~---------~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAK---------NKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEE---------ETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEE---------ECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 6778899999999999994 4457889999999887654332 2356999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++|||++.+++|.+++.... .+++..++.++.||+.||.+||+++ ++|+||||+||+++.++.++|+|||.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~ 144 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGS 144 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTT
T ss_pred cccccccccccccccccccccc-----ccccccccccccccccccccccccc--cccccccccccccccccccccccccc
Confidence 9999999999989999998443 3899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+.... ..........++..|+|||++. +..++.++||||||+++|+|++|..||...........+....
T Consensus 145 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~------- 215 (260)
T PF00069_consen 145 SVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL------- 215 (260)
T ss_dssp TEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-------
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-------
Confidence 87531 1122344567899999999997 7888999999999999999999999997652111111111000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
........ .........+.+++.+||+.||++||++.++++|=
T Consensus 216 --~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 216 --KRPLPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp --HTHHHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred --cccccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 00000000 00001126888999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.64 Aligned_cols=274 Identities=29% Similarity=0.394 Sum_probs=219.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
....++.+.||+|.||.||.|...... .......||+|.+..... ....+|++|..+|+.++||||++++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345667789999999999999776432 111145689998877643 456679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASY--IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
....+|++|||.||+|..+|++..... ...++....+.++.||+.|+.||++++ +|||||..+|+|++....+||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 999999999999999999998873322 245899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||+|+...............-...|||||.+..+.++.++|||||||++||+++ |..||...+..+...
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--------- 915 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--------- 915 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---------
Confidence 9999995433322222222233467999999999999999999999999999999 888997765422211
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCC
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 363 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~ 363 (401)
.+...-+-+.+..++..+.+++..||+.+|++||++..|++.+..+.+.....
T Consensus 916 --------~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 916 --------DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred --------HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 01111133456678899999999999999999999999999999886665443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.72 Aligned_cols=244 Identities=25% Similarity=0.294 Sum_probs=189.9
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhcc---CCCcccceeeEEeeCCee
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l---~hpni~~~~~~~~~~~~~ 149 (401)
||+|+||+||+|. +..++..||+|++....... ...+..|..++..+ .||||+++++++.+.+..
T Consensus 1 lG~G~~g~Vy~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVR---------KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEE---------ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999994 44468999999987643322 22344566666554 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~ 144 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSK 144 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCc
Confidence 99999999999999987654 3899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
...... .......||..|+|||++.+. .++.++|||||||++|+|++|..||...........+
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------------- 209 (330)
T cd05586 145 ANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------------- 209 (330)
T ss_pred CCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------------
Confidence 532221 123345799999999998654 5789999999999999999999999764321110000
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHHHH
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP----TMDEVVKALE 354 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----s~~eil~~L~ 354 (401)
...... ......+..+.+++.+||+.||.+|| ++.++++|-+
T Consensus 210 ---~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 210 ---AFGKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred ---HcCCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 000000 00112456788999999999999998 6888888744
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=302.77 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=208.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|... .+|..+|+|.+..... .....+.+|+.++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 57999999999999999999543 4688999998864322 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999999865321 1245899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ......
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----- 218 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK----- 218 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-----
Confidence 999875433221 123346888999999998888999999999999999999999998543211 000000
Q ss_pred cchhhhhhhhhhcCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSL-GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
. .........+. ..+..+.+++.+||..+|.+|||+.+|++.|..+.
T Consensus 219 -----~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 -----K-IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----h-hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 00000111122 45668889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=304.26 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||.|.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468899999999999999996542 34599998875443 3456889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCcc
Confidence 9999999999999999997643 24899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----------- 214 (256)
T cd05113 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----------- 214 (256)
T ss_pred ceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-----------
Confidence 875433221 11112335567999999988889999999999999999998 99998654321110000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. ......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 215 -----~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 -----SQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 0001111223568889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.75 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=198.3
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeC-
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~- 146 (401)
|.+.+.||+|+||.||+|.+... .....+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 45678999999999999976432 122468999886542 23345678899999999999999999987532
Q ss_pred -----CeeEEEEEecCCCChHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 147 -----DHRLLVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
...++||||+.+++|.+++..... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCE
Confidence 256899999999999998753321 12244899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||++................+++.|++||.+.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~--- 225 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD--- 225 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence 9999999986543321111122345678999999988889999999999999999999 7888865432110 00
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 226 -~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 -YLRQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 0011223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=303.85 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=202.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+|++.+.||+|+||.||++. +..++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQ---------HVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEE---------EcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 47888999999999999994 44568899999886433 233456778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~ 146 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGS 146 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCc
Confidence 99999999999999998875432 34789999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... .
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~-------- 210 (255)
T cd08219 147 ARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------L-------- 210 (255)
T ss_pred ceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------H--------
Confidence 87543321 1223456889999999998888999999999999999999999999754321100 0
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... .......+...+..+.+|+.+||+.||.+||++.+++..
T Consensus 211 --~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 --KVC-QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --HHh-cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 000111233455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.08 Aligned_cols=276 Identities=29% Similarity=0.388 Sum_probs=206.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+.|++.+.||+|+||.||+|.+.. ....++..+|+|.+..... .....+.+|+.+++.+.||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 457899999999999999996543 3455788999999875532 3345688999999999999999999998775
Q ss_pred --CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 147 --DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++|+|
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECC
Confidence 57899999999999999987653 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++......... .......++..|+|||.+.+..++.++|||||||++|+|+++..|+...........-.... ..
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~-~~- 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-QM- 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc-cc-
Confidence 9998865432221 11223456778999999988889999999999999999999876643221100000000000 00
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.................+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000111111112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.00 Aligned_cols=275 Identities=24% Similarity=0.364 Sum_probs=211.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
...+|++.+.||+|+||.||+|...... ......+..+|+|.+..... .....+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3457999999999999999999653211 01122345789998875432 2345688999999999 799999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
.+++..+++|||+++++|.+++..... .....+++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 165 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNV 165 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence 999999999999999999999976431 11245888999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCcc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 291 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 291 (401)
+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999875433221111222234567999999988889999999999999999998 8888865432111
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
. ..+........+...+..+.+++.+||+.+|.+||++.+++++|+.+.....
T Consensus 246 ~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 246 F-----------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred H-----------------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 0 0011111112233445678899999999999999999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=317.12 Aligned_cols=244 Identities=28% Similarity=0.357 Sum_probs=191.8
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHH-HHhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~-~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
++||+|+||.||+|.. ..++..+|+|++...... ....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKR---------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 4799999999999954 346889999998765332 2233445544 57888999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+++++|...+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCK 144 (321)
T ss_pred EEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCc
Confidence 99999999999998887643 3888999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....... .. .
T Consensus 145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~----------~ 206 (321)
T cd05603 145 EGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MY----------D 206 (321)
T ss_pred cCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HH----------H
Confidence 532211 12334578999999999988889999999999999999999999997643211 00 0
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH----HHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD----EVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~----eil~~L 353 (401)
.+.... ...+...+..+.+++.+||+.||.+||++. ++++|.
T Consensus 207 ~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 207 NILHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred HHhcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 111111 122334556788999999999999999764 665553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.81 Aligned_cols=269 Identities=22% Similarity=0.264 Sum_probs=200.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|+ +..++..+|+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 84 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEE---------ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence 345789999999999999999994 344688999999875432 233457789999999999999999998
Q ss_pred EeeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 143 CLED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 143 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
+... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~ 154 (355)
T cd07874 85 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS 154 (355)
T ss_pred eeccccccccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECC
Confidence 8643 35799999995 577776643 2788899999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
++.++|+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (355)
T cd07874 155 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_pred CCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999997643221 2234578999999999988899999999999999999999999997654322111000
Q ss_pred h----------------hhhhhhhcchhhhh-----h-hhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 W----------------AKPYLQSKRRIFQV-----M-DARI--EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 ~----------------~~~~~~~~~~~~~~-----~-~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. ...+.......... . +... ........+..+.+||.+||+.||.+|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00000000000000 0 0000 000111234677899999999999999999999998
Q ss_pred HHh
Q 015731 353 LEQ 355 (401)
Q Consensus 353 L~~ 355 (401)
-+.
T Consensus 312 p~~ 314 (355)
T cd07874 312 PYI 314 (355)
T ss_pred cch
Confidence 543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=303.71 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=201.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 4579999999999999999996542 45699998876543 3446889999999999999999999875 4
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...+++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCce
Confidence 568999999999999999976432 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~-------- 215 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ-------- 215 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--------
Confidence 98764332211 1122235567999999988889999999999999999999 889986543211 1110
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.........+...+..+.+|+.+||..+|.+|||+.++++.|++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ------VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111112233456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=321.71 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=200.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|+. ..++..+|+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEE---------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 347899999999999999999954 3468889999987542 22344677899999999999999999987
Q ss_pred eeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 162 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 162 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC
Confidence 643 35799999994 578777743 2788889999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+.++|+|||+++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus 163 ~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 163 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred CcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999997643221 22345689999999999998999999999999999999999999976553222111100
Q ss_pred h---------h-------hhhhhcchh-----hhhhhh---hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 298 A---------K-------PYLQSKRRI-----FQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 298 ~---------~-------~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
. . .+....... ...... ..........+..+.+||.+||+.||.+|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0 0 000000000 000000 000001112345788999999999999999999999985
Q ss_pred Hh
Q 015731 354 EQ 355 (401)
Q Consensus 354 ~~ 355 (401)
+.
T Consensus 320 ~~ 321 (364)
T cd07875 320 YI 321 (364)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.64 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=194.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhcc---CCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l---~hpni~~~~~~~ 143 (401)
+|++.+.||+|+||.||+|.. ..++..+|+|.+...... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARD---------PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEE---------CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 588899999999999999944 447899999988754221 122344566666554 799999999987
Q ss_pred ee-----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 144 LE-----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 144 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.. ....++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~ 145 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGG 145 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence 64 345799999995 589888876542 34899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-Hh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~ 297 (401)
.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|.+||...........+ ..
T Consensus 146 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 146 QVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred CEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 99999999987643221 123346789999999998888999999999999999999999999765432211111 00
Q ss_pred hhhhhhhcchhhhhh---hhhh-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 298 AKPYLQSKRRIFQVM---DARI-------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... .....+.... .... ........+..+.+++.+||+.||.+|||+.+++.|
T Consensus 223 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 223 IGL--PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCC--CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000000 0000 001112345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=307.58 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=201.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.++||+|+||.||+|. +..++..+|+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAY---------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEE---------EcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368889999999999999994 344688999999865422 2344678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg 140 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFG 140 (279)
T ss_pred CEEEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999986542 2688889999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch-hHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-LIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 305 (401)
++...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ...+.
T Consensus 141 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------- 209 (279)
T cd06619 141 VSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL------- 209 (279)
T ss_pred cceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-------
Confidence 98754322 1234578999999999988889999999999999999999999996533211110 00000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
....+...........+.++.+++.+||+.||.+||++.+++++-+..
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 210 ---QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred ---HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 000000001111123456788999999999999999999999986653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=302.73 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=200.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 45889999999999999998543 245799998865432 3346778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCccc
Confidence 9999999999999999997654 24899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+......
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------ 213 (256)
T cd05059 147 ARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES------------ 213 (256)
T ss_pred ceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH------------
Confidence 8754322111 1111223457999999988889999999999999999999 7889875432111000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 214 -----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 -----VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000111122233567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.07 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=203.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|..... ...+..||+|.+.... ......+..|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4588899999999999999966531 1234579999987653 23345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCc
Confidence 99999999999999999987653 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecc---cccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVM---GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
++................ .+..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~--- 225 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE--- 225 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---
Confidence 987543322111111111 2357999999988889999999999999999886 999986543211 111110
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.......+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 226 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 -----------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----------cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011111233456788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.89 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=203.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+.|++.+.||.|+||.||+|.. ..++..+++|.+..........+.+|+.+++.++||||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKN---------KETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEE---------CCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 36799999999999999999944 346889999998876655566788899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCc
Confidence 99999999999999988876543 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
++....... .......++..|+|||.+. ...++.++|||||||++|+|++|..||....+... .....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~--- 228 (292)
T cd06644 156 VSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA--- 228 (292)
T ss_pred cceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh---
Confidence 886532221 1123456888999999884 34567899999999999999999999865432110 00000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
... ......+...+.++.+++.+||..||++||++.++++|-+
T Consensus 229 --------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 229 --------KSE--PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred --------cCC--CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 0000112234567889999999999999999999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.84 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=205.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||.|+||.||+|... |..+|+|.+..... ...++.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 357899999999999999998543 67799999977654 456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccc
Confidence 999999999999999999976542 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
.+....... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 148 ~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---------- 209 (256)
T cd05039 148 LAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V---------- 209 (256)
T ss_pred ccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----------
Confidence 998653221 12234567999999988888999999999999999997 9999865432111 0
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...........+...+..+.+++.+||..+|.+|||+.++++.|..+
T Consensus 210 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 ----PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00001111112233467888999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.68 Aligned_cols=256 Identities=32% Similarity=0.467 Sum_probs=205.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|..... ..++..+++|.+....... ...+.+|+..++.++|+||+++++++.++...++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4799999999999976531 1347889999988765433 56788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 153 YEFMPKGSLENHLFRTGAS----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
|||+++++|.+++...... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875211 0245899999999999999999999988 999999999999999999999999999
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----------- 218 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LE----------- 218 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HH-----------
Confidence 87654332222334567889999999988889999999999999999999 6999876532111 10
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..........+...+..+.+++.+||..||.+|||+.+++++|+
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 ---YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00001112223445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.02 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=203.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.++||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT- 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence 3467999999999999999999543 367899998876543 3456889999999999999999999874
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccC
Confidence 4678999999999999999876442 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ..
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~-------- 214 (260)
T cd05067 147 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ-------- 214 (260)
T ss_pred cceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH--------
Confidence 99876442211 11122345678999999988889999999999999999999 9999975432111 10
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+........+...+..+.+++.+||+.+|++||++++++..|+.+
T Consensus 215 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 215 ------NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0011111112233456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.75 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=205.8
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e 154 (401)
+||+|+||+||.|+ +..|...+|||-+.........-+..|+.+-++|+|.|||+++|.+-+++++-|.||
T Consensus 582 VLGKGTYG~VYA~R---------D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAAR---------DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeec---------cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999994 445778899999887766555567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-CCCceEEeeccCCcCC
Q 015731 155 FMPKGSLENHLFRTGASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDG 231 (401)
Q Consensus 155 ~~~~~~L~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 231 (401)
.++||+|.+++...- .|+ .+..+-.+..||++||.|||.+. |||||||-+||||+ -.|.+||+|||.+++.
T Consensus 653 qVPGGSLSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred cCCCCcHHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhh
Confidence 999999999998765 345 78888999999999999999998 99999999999994 5789999999998875
Q ss_pred CCCCCcceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 232 PTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
.. ......++.||..|||||++.. ..|+.++|||||||++.||.||++||-....... -.+
T Consensus 727 Ag--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMF 789 (1226)
T KOG4279|consen 727 AG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMF 789 (1226)
T ss_pred cc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhh
Confidence 33 2335667889999999999954 4689999999999999999999999954321110 112
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.---+....++...+.++..+|.+|+.+||.+||+++++|..
T Consensus 790 kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 790 KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2222233456778889999999999999999999999999874
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.88 Aligned_cols=253 Identities=31% Similarity=0.461 Sum_probs=199.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
++||+|+||.||+|.+.. ...++..+|+|.+...... ...++.+|+.+++.++||||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 479999999999996542 2224578999998866542 3456889999999999999999999876 4568999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++.... .+++..+..++.|++.+|.|||..+ ++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred EEeCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceee
Confidence 99999999999997654 3899999999999999999999988 9999999999999999999999999988653
Q ss_pred CCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 233 TGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...+..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----------- 212 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----------- 212 (257)
T ss_pred cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH-----------
Confidence 322111 0111223467999999988889999999999999999998 999996543211 111110
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.......+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 213 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 ---SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00011122334567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.53 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=203.3
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCee
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+.+++.++||||+++++++..++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK---------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC---------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 678899999999999999543 46788999998766555556678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+++++|..++.... .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccc
Confidence 99999999999998876533 35899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
...... .......++..|+|||++. +..++.++|||||||++|+|++|.+||....+... .....
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~------ 221 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA------ 221 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh------
Confidence 543221 1223356889999999873 34577899999999999999999999865432111 00000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. ........+...+..+.+++.+||+.||.+||++.++++|-+..
T Consensus 222 -----~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 222 -----K--SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred -----h--cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 0 00000111223456889999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.57 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=212.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+-|.|+..||.|+||+||+| +...++...|.|+|........+.++-|+.||..++||+|+++++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA---------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKA---------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhh---------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 45788899999999999999 455578888999998877777778889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.++|+.|||.||-+..++-..+ .++++..+.-+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccc
Confidence 9999999999999998887766 56999999999999999999999999 99999999999999999999999998
Q ss_pred CcCCCCCCCcceeeecccccCccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+.... ........+.|||+|||||+. ....|+.++||||||++|.||..+.+|-...++....-.+....+
T Consensus 177 SAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-- 252 (1187)
T KOG0579|consen 177 SAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-- 252 (1187)
T ss_pred cccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC--
Confidence 86532 222345678999999999986 346899999999999999999999999876655433222211110
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. ---+...+..+.+|+++||..||..||++.++++|-+
T Consensus 253 ------PT-------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 253 ------PT-------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred ------Cc-------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 00 0113345667889999999999999999999999843
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.51 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=207.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+|++.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 46888999999999999999543 3588999998765332 23346788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..+++|||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998875322 1245899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ...
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~---~~~----- 218 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS---LCK----- 218 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HH---Hhh-----
Confidence 999876433221 1223468899999999988888999999999999999999999986532210 00 000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
...............+..+.+++.+||+.||.+|||+.+|++.++++.
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 -----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000011112245678899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.08 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=208.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.++||+|+||.||+|..... ...++..+++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 46899999999999999999976541 123468899998865422 334557889999999999999999998766
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
+...+++++|+.+++|.+++...... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEE
Confidence 57789999999999999998765321 1145899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|++++ |+.||....+.. ...+..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~- 233 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK- 233 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH-
Confidence 999999976433322111223345678999999988889999999999999999998 999997643311 111110
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
. .........++..+.+++.+||..||++|||+.++++.|..+..
T Consensus 234 ---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 ---D----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---c----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00111122345678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.60 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=206.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|.+... .......+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 5789999999999999999976431 122244689998876643 234567889999999999999999999887
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCc
Confidence 78899999999999999997654 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
.+................++..|+|||.+....++.++|+||||+++|+|++ |..||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------------- 221 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------------- 221 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------------
Confidence 9986543322211122233567999999988888999999999999999998 99999765431111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+...+..+.+++.+||..||.+||++.++++.|..+..
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 222 ----DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111112222345678899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=311.02 Aligned_cols=267 Identities=26% Similarity=0.421 Sum_probs=218.8
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.......+.+.||+|.||.|.+|..+. +..||+|+++...... ...|.+|+++|.+|+||||++++++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 345678889999999999999996653 6889999998876554 46799999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
..++.+++|+||++.|+|.+++..+... .+.......|+.||+.|++||.+.+ +|||||.+.|||+++++++||+
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEec
Confidence 9999999999999999999999988642 1355566779999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||+++....+.........+-..+|||+|.+..+.++.++|+|+||+++||+++ ...||...... +.++
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vve----- 751 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVE----- 751 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHH-----
Confidence 9999997666665555556677889999999999999999999999999999754 67788654321 1111
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+...+..-.........+..++.++.+++.+||..|-++||+++++..+|.+.
T Consensus 752 --n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 --NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111111112222334567889999999999999999999999999998763
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=316.98 Aligned_cols=268 Identities=23% Similarity=0.290 Sum_probs=199.7
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYD---------TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEE---------CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 4457899999999999999999943 44688999999875432 233456789999999999999999998
Q ss_pred EeeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 143 CLED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 143 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
+... ...|++|+++ +++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~ 153 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNE 153 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECC
Confidence 7543 4578999998 88998887543 3899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
++.+||+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+
T Consensus 154 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 154 DCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999998864322 234568999999999866 56889999999999999999999999764432111100
Q ss_pred H-hhh-h---hhhh--cchhhhhhhhhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 296 E-WAK-P---YLQS--KRRIFQVMDARIEGQ-------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 296 ~-~~~-~---~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. ... + .... ......... .+... .....+..+.+|+.+||+.||.+|||+.++++|-+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 0 000 0 0000 000000000 00000 0001234577999999999999999999999996554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=305.89 Aligned_cols=266 Identities=28% Similarity=0.391 Sum_probs=205.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|..... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 46799999999999999999975421 1234578899999876533 234568889999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccC
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGA-----------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 208 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 208 (401)
+...++||||+++++|.+++..... .....+++..++.++.|++.||.|||+++ ++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 9999999999999999999975421 11134788899999999999999999988 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 287 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 287 (401)
|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875432221111222334667999999988889999999999999999997 877885443
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ... .+.+... ...+...+..+.+|+.+||+.||.+|||+.|+++.|++
T Consensus 238 ~~~---~~~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEE---VIY-------------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH---HHH-------------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 211 000 0000000 01122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=310.29 Aligned_cols=265 Identities=28% Similarity=0.420 Sum_probs=203.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|.+... +....+++|.+..... .....+.+|+.++.++ +||||+++++++.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccC-------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 5689999999999999999965421 1223567777654322 2344677899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
++..|+||||+++++|.+++...... ....+++..++.++.||+.||+|||+++ ++||||||+||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence 99999999999999999999765321 1135789999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccch
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 293 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 293 (401)
+.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 232 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-- 232 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--
Confidence 999999999999986421111 1111234567999999988888999999999999999998 9999865432111
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.. ..........+...+..+.+|+.+||+.+|.+||++.+++..|+.+.+...
T Consensus 233 -~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 -YE--------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -HH--------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 000000111122345678899999999999999999999999998755553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=299.20 Aligned_cols=250 Identities=29% Similarity=0.380 Sum_probs=211.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHH---HHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
-++|..+++||+|.||+|.++ ..+.+|+.+|+|+++++-.....+ -+.|-++|+..+||.+..+.-.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 367889999999999999998 566789999999999886644433 45789999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
+..+.+|+||||..||.|.-.+.+.. .+++.....+-..|+.||.|||+++ ||.||||.+|++++.+|++||+
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEee
Confidence 99999999999999999999998764 3888899999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||+++.... ......+++|||.|+|||++....|+.++|.|.+|+++|||++|+.||-..+......+|-..
T Consensus 311 DFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----- 383 (516)
T KOG0690|consen 311 DFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----- 383 (516)
T ss_pred ecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----
Confidence 9999985322 223467799999999999999999999999999999999999999999776544433332111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~ 352 (401)
+-.++...+++...|+..+|..||.+|. .+.||.+|
T Consensus 384 -------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1234556677888999999999999995 56777665
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=309.61 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=206.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||+|+||.||+|.. ..++..||+|.+..........+.+|+.+++.++||||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAID---------IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEE---------CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 37899999999999999999953 346889999998765555556678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.+. .+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg 160 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG 160 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCc
Confidence 9999999999999999998653 3788999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+......+.
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---------- 228 (297)
T cd06656 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------- 228 (297)
T ss_pred cceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec----------
Confidence 9875433221 1233468889999999988888999999999999999999999997654322111000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.........+...+..+.+|+.+||..||.+||++.++++|=+
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 229 -----TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred -----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0000000112234566788999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=319.84 Aligned_cols=248 Identities=29% Similarity=0.381 Sum_probs=204.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..|.=++.||.|+||.||.|++ ..+.++||||++.-... .....++.|+..|++|.|||+|.+.++|.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd---------~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHHHHHHhcCCccceeEEeec---------cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 3455567899999999999954 44789999999876533 34556889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.+...||||||| -|+-.|++.-.. +++.+..+..|+.+.+.||.|||+++ .||||||..|||+++.|.|||+|
T Consensus 97 re~TaWLVMEYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 97 REHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred ccchHHHHHHHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeecc
Confidence 999999999999 678899887766 67999999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||.+....+ ...++|||+|||||++. .+.|+-++||||||++..||.-.++|+-..+......
T Consensus 170 FGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-------- 235 (948)
T KOG0577|consen 170 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------- 235 (948)
T ss_pred ccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--------
Confidence 999976543 34578999999999983 4679999999999999999999999975443221111
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.+.+ ....---....+..+..|+..||+.-|.+|||.+++++|-
T Consensus 236 -----HIAQ---NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 236 -----HIAQ---NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -----HHHh---cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1111 0001111345677888999999999999999999999873
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.60 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=204.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|+..+.||+|+||.||+|.... .......+++|.+..... .....+..|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKM------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 467888999999999999996542 112345799999876532 3345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCc
Confidence 99999999999999999997643 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCccee-eecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHVS-TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
++............ .....+..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~---~~-------- 221 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---MK-------- 221 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH--------
Confidence 98765332211111 11223457999999988889999999999999999997 9999865432111 00
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..............+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 222 ------~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 ------AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000111112223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=305.95 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||.||+|.. ..++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARN---------VNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEE---------cCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 5788899999999999999944 4468899999987665444556778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccee
Confidence 9999999999999999987654 3899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
+....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+........
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-------- 222 (267)
T cd06645 153 SAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-------- 222 (267)
T ss_pred eeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--------
Confidence 87543221 1223457899999999874 4557889999999999999999999986543321111000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... ....... .....+..+.+++.+||+.+|++||++.++++|
T Consensus 223 ~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 KSN---FQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccC---CCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 0000000 011234567899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.65 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=201.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|++.+.||+|+||.||+|.+.. ...+|+|++..... ....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 3579999999999999999996542 23599999876443 33467899999999999999999998754
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCC
Confidence 568999999999999999976432 34789999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
.+......... ......++..|+|||...+..++.++|||||||++|+|++ |..||...........+
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~---------- 216 (262)
T cd05071 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------- 216 (262)
T ss_pred ceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH----------
Confidence 98754332211 1122345678999999988889999999999999999999 88888654321110000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
........+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 217 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 217 -------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00011112334566788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=301.37 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=204.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||+|+||.||+|.+.. ....+..+|+|.+..... .....+..|+.++++++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKL------PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEec------CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578899999999999999996542 112345799998875432 2345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCC
Confidence 99999999999999999997654 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcce-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
++........... .....++..|++||.+.+..++.++|+|||||++|++++ |..||........ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----- 223 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----- 223 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh-----
Confidence 9886543221111 111223567999999988889999999999999999886 9999865432111 11000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.......+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 224 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ---------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0001112233456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.72 Aligned_cols=255 Identities=29% Similarity=0.364 Sum_probs=205.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||.|+||.||+|.. ..++..+++|.+..........+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARD---------IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEe---------cCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 5789999999999999999954 3467889999988765555667889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECcccc
Confidence 9999999999999999987653 34899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-------- 217 (262)
T cd06613 148 SAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-------- 217 (262)
T ss_pred chhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence 87643221 112335678899999998766 78899999999999999999999997644321110000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.. .. ...........+..+.+++.+||..+|.+|||+.+++.|
T Consensus 218 ~~---~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 218 KS---NF--PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hc---cC--CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 000011223456778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.02 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=194.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|.+.. ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 468999999999996542 23467899998876543 2334678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++...........++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999997654322234677788899999999999999988 9999999999999999999999999987543
Q ss_pred CCCCcceeeecccccCcccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATG-------HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
............++..|+|||++.+. .++.++||||||+++|+|++ |..||....+.... .+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~----- 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV----- 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh-----
Confidence 32221122234577889999988532 35789999999999999996 99999654332111 0000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........ ........+..+.+++.+|+ .+|.+|||+.+|+..|+
T Consensus 224 ~~~~~~~~----~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLP----KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCC----CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000 11112234456778999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.02 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=201.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---------hHHHHHHHHHHHhccCCCcccce
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------GHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
+|.+.+.||+|+||.||+|.. ..++..+|+|.+...... ....+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMN---------ASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEe---------cCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 478889999999999999953 345788999988654321 12357789999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~ 144 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGG 144 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCC
Confidence 999999999999999999999999997654 3888999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCC----cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 220 AKLSDFGLAKDGPTGSQ----SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
++|+|||.+........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ +
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~ 221 (267)
T cd06628 145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I 221 (267)
T ss_pred EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H
Confidence 99999999876542111 1112234578899999999888889999999999999999999999975432110 0
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus 222 -------------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 222 -------------FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -------------HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00000 11112333456788899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.79 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=206.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||.|+||.||+|. +..+++.+++|.+..........+.+|+.+++.++||||+++++++.+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAI---------DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEE---------EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 469999999999999999994 34468899999887665555567789999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~ 161 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGF 161 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999988653 3889999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......+ ..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~---- 229 (296)
T cd06655 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT---- 229 (296)
T ss_pred chhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh----
Confidence 875433221 122346888999999998888899999999999999999999999765432111000 00
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
........+...+..+.+++.+||..||.+||++.++++|=+.
T Consensus 230 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 230 -----NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred -----cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 0000001122345678899999999999999999999988544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=306.67 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=206.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||.|+||.||++... .++..+|+|.+..........+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK---------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc---------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 356999999999999999999543 36889999998766555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+++++|.+++.... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g 148 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFG 148 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCc
Confidence 99999999999999999987654 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
++........ ......++..|+|||.+. ...++.++||||||+++|+|++|..||......... ..+.
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~~--- 221 (280)
T cd06611 149 VSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKIL--- 221 (280)
T ss_pred cchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHHh---
Confidence 8875432221 223456889999999874 344677999999999999999999999764321110 0000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..... ....+...+..+.+++.+||+.+|.+||++.++++|-+-
T Consensus 222 --------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 222 --------KSEPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred --------cCCCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 00000 001122345678899999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=299.30 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=199.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe-eC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-ED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~-~~ 146 (401)
.+|++.+.||+|+||.||++... |..+++|.+.... ....+.+|+.++++++|+|++++++++. ++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 57899999999999999998543 5678999886543 2346789999999999999999999754 55
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCc
Confidence 678999999999999999976543 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 148 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~-------- 211 (256)
T cd05082 148 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR-------- 211 (256)
T ss_pred cceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------
Confidence 987533221 12234567999999988889999999999999999997 99988643211 11100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ------VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011111122234466788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.23 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=201.2
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
|+..+.||+|+||+||+|... .+++.+|+|.+...... ....+.+|+.+++.++|+||+.+++.+.++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 677789999999999999544 46889999998765332 223467899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg 147 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCC
Confidence 999999999999999988865432 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++....... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. .
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~------- 215 (285)
T cd05632 148 LAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--R------- 215 (285)
T ss_pred cceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--H-------
Confidence 987543222 1233468999999999988889999999999999999999999997543211110000 0
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L 353 (401)
.... ....+....+..+.+|+.+||+.||++||+ +.+++.|-
T Consensus 216 ---~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 216 ---RVLE--TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred ---hhhc--cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence 0000 011122334567789999999999999999 77888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=297.92 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=197.0
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~ 153 (401)
.||+|+||.||+|.+.. ...+..+|+|++...... ....+.+|+.++++++||||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 38999999999996542 124667999998765432 2345889999999999999999999876 45789999
Q ss_pred EecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCC
Q 015731 154 EFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233 (401)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 233 (401)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 74 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 74 EMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred EeCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9999999999987543 34899999999999999999999988 99999999999999999999999999875433
Q ss_pred CCCcce-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 234 GSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 234 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~ 210 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----------------SF 210 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----------------HH
Confidence 221111 111223568999999988889999999999999999996 99999765321110 11
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+........+...+.++.+++.+||..||++||++.+|++.|+.+
T Consensus 211 ~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 211 IEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111111223344567888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=301.55 Aligned_cols=252 Identities=28% Similarity=0.352 Sum_probs=216.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+-|.+++.||+|+||.||+| .|..+|.++|+|.+..+. +..++..|+.++++++.|++|++|+.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 44778889999999999998 777899999999987664 4567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.+++|||||..|++.+.+.-+. +++++..+..++..-+.||+|||... -+|||||..|||++.+|..||+|||.
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccc
Confidence 9999999999999999998776 67999999999999999999999977 89999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+-...+. -....+..||+.|||||++..-.|+.++||||||++..||.-|++||....|.....++.-
T Consensus 176 AGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---------- 243 (502)
T KOG0574|consen 176 AGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---------- 243 (502)
T ss_pred cchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----------
Confidence 9765432 2234567899999999999888999999999999999999999999988777555443321
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.+...-..+...+.++-+++++||-.+|++|-|+-++++|-
T Consensus 244 -----~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 -----KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred -----CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 01111122445677888999999999999999999999883
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.89 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=202.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||+|.. ..++..||+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRS---------KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEE---------cCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 5799999999999999999954 346889999988654322 233567899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 149 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFG 149 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCc
Confidence 99999999995 69999887654 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh------
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK------ 299 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------ 299 (401)
++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+....
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 150 LARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227 (301)
T ss_pred chhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 9875332211 1223457889999998865 457889999999999999999999997654322111110000
Q ss_pred --hhhhhcchhhhhhhhhhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 --PYLQSKRRIFQVMDARIE----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 --~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+................. .......+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 000000000000000000 00112245678899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.32 Aligned_cols=257 Identities=29% Similarity=0.418 Sum_probs=204.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 34689999999999999999996542 46699998876543 34568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECcc
Confidence 8999999999999999999976542 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+...... ...
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~------- 216 (261)
T cd05034 148 GLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ------- 216 (261)
T ss_pred ccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------
Confidence 99876533111 11112234567999999988889999999999999999998 9999965432111 100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.........+...+..+.+++.+||..+|.+||+++++++.|+.+
T Consensus 217 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 217 -------VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred -------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 000011111223356788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.55 Aligned_cols=254 Identities=28% Similarity=0.364 Sum_probs=199.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
+...|++.+.||+|+||.||+|... .+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 4567899999999999999999543 468899999986543 2344677899999988 6999999999987
Q ss_pred eC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 ED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.. ...|+||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~ 148 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENA 148 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCC
Confidence 53 468999999999999999976432 45889999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.++|+|||++....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||....+.....
T Consensus 149 ~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~ 226 (272)
T cd06637 149 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226 (272)
T ss_pred CEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 99999999987543221 1233456889999999985 3457889999999999999999999996443211110
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. ..............+..+.+|+.+||..||.+|||+.++++|
T Consensus 227 ~----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 L----------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred H----------------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 000000111122345678899999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.13 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=190.5
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee--CCeeE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRL 150 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~--~~~~~ 150 (401)
.+.||+|+||.||+|.... ..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 4689999999999996532 23578899998875432 2346789999999999999999998854 46789
Q ss_pred EEEEecCCCChHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE----cCCCceEE
Q 015731 151 LVYEFMPKGSLENHLFRTGA----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKL 222 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~----~~~~~~kl 222 (401)
+||||+ +++|.+++..... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999999 5689888764321 11235899999999999999999999998 9999999999999 45678999
Q ss_pred eeccCCcCCCCCCC-cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc------hh
Q 015731 223 SDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH------NL 294 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~------~~ 294 (401)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ..
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999976433211 112234578999999999876 45889999999999999999999999754432110 00
Q ss_pred HHhhhhhhh-----hcchhh------hhh---hhh-hc--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015731 295 IEWAKPYLQ-----SKRRIF------QVM---DAR-IE--------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351 (401)
Q Consensus 295 ~~~~~~~~~-----~~~~~~------~~~---~~~-~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~ 351 (401)
......... ...... ... ... .. .......+..+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000000 000 000 00 0000112345789999999999999999999998
Q ss_pred H
Q 015731 352 A 352 (401)
Q Consensus 352 ~ 352 (401)
|
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=299.20 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=201.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
+|++.+.||+|++|.||++.. ..+++.+|+|.+..... .....+.+|+.++++++|||++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRH---------RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEE---------cCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 488999999999999999954 34678899999865432 233457789999999999999999988764
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+...|+||||+++++|.+++..... ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecc
Confidence 4568999999999999999976432 45899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... .......+++.|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~------ 212 (257)
T cd08223 147 GIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVY------ 212 (257)
T ss_pred cceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH------
Confidence 9987543221 12334568899999999988889999999999999999999999986533110 000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...... ....+...+..+.+++.+||+.||.+||++.++++|
T Consensus 213 ----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 ----RIIEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----HHHhcC-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 112234466788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=303.65 Aligned_cols=276 Identities=27% Similarity=0.351 Sum_probs=209.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
++|++.+.||+|+||.||+|.+.. .+..++..+|+|.+...... ....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 568888999999999999997653 22446889999998866543 45578899999999999999999999887
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcc
Confidence 568899999999999999997654 24899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||.+.......... ......++..|++||.+.+..++.++||||||+++|+|++|..|+...........-.. ....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~ 230 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQM 230 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccc
Confidence 99998754322111 11123445679999999888899999999999999999999998855322111000000 0000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
........+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00001111111111122334457788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=290.48 Aligned_cols=267 Identities=24% Similarity=0.236 Sum_probs=207.8
Q ss_pred HHhCCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 65 TATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
..+++|.+. ++||-|-.|+|..+ .++.||+.+|+|++.... ...+|+++--.. .|||||.++++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidV 123 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDV 123 (400)
T ss_pred cchhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehh
Confidence 456777774 68999999999888 566789999999886543 345677664444 69999999998
Q ss_pred Eee----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--
Q 015731 143 CLE----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-- 216 (401)
Q Consensus 143 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-- 216 (401)
|.. ...+.+|||.++||.|+..++.++. .+++++.+..|+.||..|+.|||+.+ |.||||||+|+|.+.
T Consensus 124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTS 198 (400)
T ss_pred hhhhccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCC
Confidence 764 3567889999999999999999876 77999999999999999999999988 999999999999954
Q ss_pred -CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 217 -NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
|-.+||+|||+|+..... ....+.+-|++|.|||++..+.|+...|+||+||++|-|++|.+||-...-...
T Consensus 199 ~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---- 271 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---- 271 (400)
T ss_pred CCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC----
Confidence 556999999999864321 234567889999999999989999999999999999999999999965432110
Q ss_pred Hhhhhhhhhcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 296 EWAKPYLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
.+....++...... .+-=..++....++|+++|..+|.+|.|+.+++.|-|--+..--+..+
T Consensus 272 --------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp 335 (400)
T KOG0604|consen 272 --------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP 335 (400)
T ss_pred --------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence 00000111111111 000124678889999999999999999999999998876554444443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=296.85 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=197.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
++||+|+||.||+|... . +..+++|.+...... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe---------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 47999999999999543 2 678999988765443 455688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++.... ..+++..+..++.+++.+|.|||+++ ++||||+|+||+++.++.++|+|||++....
T Consensus 71 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 71 MELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred EEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 99999999999997643 34789999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+......+
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---------------- 208 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---------------- 208 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH----------------
Confidence 2221111111233567999999988889999999999999999999 88888665432111111
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........+...+..+.+++.+||..+|.+|||+.|+++.|.
T Consensus 209 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 -ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111111122344568889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.59 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=205.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.++||+|+||.||+|+. ..+|..||+|++..... ....++.+|+.+++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d---------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYD---------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEE---------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 5799999999999999999954 44688999999875422 22446889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCC------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGA------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+++..++||||++|++|.+++..... .....+++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCC
Confidence 99999999999999999999865321 11133567788999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCC----------------cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 015731 219 NAKLSDFGLAKDGPTGSQ----------------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 282 (401)
.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999975421100 0011234699999999999988999999999999999999999999
Q ss_pred CCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhchhc
Q 015731 283 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDT 359 (401)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~eil~~L~~i~~~ 359 (401)
|......... +.. . .............+..+.+++.+||+.||++|| +++++++.|+.+.+.
T Consensus 231 F~~~~~~ki~----~~~----------~-i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKIS----YRD----------V-ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhh----hhh----------h-ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9763321110 000 0 000000000113445678899999999999996 677788888877554
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=296.88 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=201.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
++||+|++|.||+|.+.. ...+...+|+|.+..... .....+.+|+.++++++||||+++++++.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999997653 122345799999988766 455678899999999999999999999988 889999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred EEecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccc
Confidence 999999999999987542 35899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 233 TGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 233 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
..... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~------------ 213 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI------------ 213 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH------------
Confidence 32211 11122456778999999988889999999999999999998 9999865432111 1000
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 214 -DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -HhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000011112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=299.80 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=205.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|.+.+.||+|+||.||+|..... ......+++|...... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 5688999999999999999975431 1234568999887654 3345568899999999999999999998875
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCc
Confidence 55789999999999999997643 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--------- 222 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE--------- 222 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------
Confidence 98754332211 1122234567999999988889999999999999999986 999996554221111000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.......+...+..+.+++.+||..+|.+|||+.++++.|..+.+.+
T Consensus 223 --------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 223 --------NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00011122344567889999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.14 Aligned_cols=252 Identities=27% Similarity=0.344 Sum_probs=205.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 36889999999999999999543 468899999987654 23345677899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++|+||+++++|.+++... ++++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g 143 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFG 143 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999998754 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+
T Consensus 144 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~----------- 210 (274)
T cd06609 144 VSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI----------- 210 (274)
T ss_pred cceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-----------
Confidence 987654322 1233456888999999998888999999999999999999999999754421110000
Q ss_pred hhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 307 RIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
........... .+..+.+++.+||..+|++|||++++++|-+-
T Consensus 211 ------~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 211 ------PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred ------hhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 00001111111 55678899999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=298.02 Aligned_cols=251 Identities=29% Similarity=0.388 Sum_probs=204.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||.|+||.||+|... .++..+++|.+..... ...+.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK---------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc---------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 57999999999999999999554 3578899999876532 557889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEccccc
Confidence 9999999999999999987544 45899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+ .
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---------~-- 212 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---------P-- 212 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---------c--
Confidence 886543221 123345788999999998888999999999999999999999999764432211000 0
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. ........+...+..+.+++.+||+.||++|||+.+++++
T Consensus 213 --~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 --N--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --c--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 0000011122345678899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=300.80 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=207.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.+.||.|+||.||+|+.... ....+...+++|.+...... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 5788999999999999999976542 22345678999988765443 345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCC----CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASY----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999997654211 125899999999999999999999988 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 159 ~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----- 229 (275)
T cd05046 159 SLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----- 229 (275)
T ss_pred cccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH-----
Confidence 9999986432211 111223356778999999988888999999999999999998 788886433211 110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 --------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111111122344567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=298.19 Aligned_cols=255 Identities=29% Similarity=0.393 Sum_probs=200.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|.+.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.+++.++|||++++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3568999999999999999996542 34589998765432 3346788999999999999999998875 4
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCc
Confidence 568999999999999999976432 34789999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+... ..+
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~-------- 215 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ-------- 215 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--------
Confidence 98754332211 1122345678999999988889999999999999999999 8999875432111 100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.........+...+..+.+++.+||+.||.+||+++++++.|+.+
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 216 ------VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ------HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000011112234566788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=305.15 Aligned_cols=264 Identities=23% Similarity=0.396 Sum_probs=203.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|+..+.||+|+||.||+|.+... .......+|+|.+...... ...++.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 5788999999999999999976431 1111246899988765332 234578899999999999999999998754
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccc
Confidence 4678999999999999987654 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...... .++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~-------- 223 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDL-------- 223 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--------
Confidence 9986543322111222345678999999988889999999999999999997 8899865432111 111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.........+...+..+.+++.+||..+|++||++.++++.|+.+....
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 224 ------LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ------HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0000001112224457889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=298.87 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=203.8
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc------hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
+|+..+.||+|+||.||++.. ..++..+|+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 478889999999999999843 34688999999875431 123467899999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAK 221 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~k 221 (401)
+.+.+..++||||+.+++|.+++.+.. ++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .++
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999997653 4889999999999999999999998 99999999999998776 599
Q ss_pred EeeccCCcCCCCCCC--cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 222 LSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|+|||.+........ ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........+
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 220 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---- 220 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----
Confidence 999999876543211 11122346788999999998888999999999999999999999999654321111111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
............+...+.++.+++.+||..+|.+||++.++++|
T Consensus 221 ---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 ---------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01111111223444567788899999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=297.34 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.++||.|+||.||.+.. ..++..+++|.+..... .....+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRR---------TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEE---------cCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 588899999999999998843 34688999998765532 3345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..+++|||+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~ 146 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFG 146 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCc
Confidence 999999999999999999976532 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------------- 211 (256)
T cd08221 147 ISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------------- 211 (256)
T ss_pred ceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-------------
Confidence 9876433221 2234568999999999988888999999999999999999999996543211100
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
....... .......+.++.+++.+||+.+|.+||++.++++++
T Consensus 212 ---~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 ---KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0000111 111234566788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=298.08 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=197.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-----hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.+|+..+.||+|+||.||+|. +..++..+++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCY---------DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEE---------EcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368999999999999999994 444688999998764321 223457789999999999999999998
Q ss_pred Eee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 143 CLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 143 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+.+ ....+++|||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNV 145 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCE
Confidence 875 367899999999999999997654 3788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC-cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-------- 217 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-------- 217 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--------
Confidence 9999999875432111 1112234578899999999888899999999999999999999999965422110
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
............++...+..+.+++ +||..+|++||+++|+++|
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 218 --------IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0011111111223344556677787 6888899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=303.05 Aligned_cols=267 Identities=27% Similarity=0.346 Sum_probs=207.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||+||++... .+|..+|+|++..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 57889999999999999999543 3688999998765432 2345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+++++|.+++...+ ++++..+..++.+++.+|.|||+ ++ ++|+||+|+||+++.++.++|+||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccC
Confidence 99999999999999999887653 48999999999999999999997 46 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~--- 219 (284)
T cd06620 149 GVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG--IL--- 219 (284)
T ss_pred Ccccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH--HH---
Confidence 9886532211 12346899999999998888999999999999999999999999765432111000000 00
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.....+.............+.++.+|+.+||+.||.+|||+.|++++.+.++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000011100000011112556788999999999999999999999997776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=299.07 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=191.2
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3699999999999965321 2456789998765433 2234578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++...........++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999998765332334567888999999999999999988 9999999999999999999999999986533
Q ss_pred CCCCcceeeecccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
............++..|+|||++.. ..++.++|||||||++|+|++ |..||....+... .... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~~~ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQV---VRE 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHHH---hhc
Confidence 2221111222345677999998742 356789999999999999999 7888865432111 0000 000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...... ........+..+..++..|| .||++|||+++|++.|
T Consensus 226 --~~~~~~----~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 --QDIKLP----KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --cCccCC----CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 000000 11122334566677888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.21 Aligned_cols=268 Identities=24% Similarity=0.303 Sum_probs=198.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 4788899999999999999543 46889999988654322 234577899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 146 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFG 146 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECccc
Confidence 99999999996 689888865432 135899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-H-hhh---h
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-E-WAK---P 300 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~---~ 300 (401)
++....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+ . +.. .
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 147 LARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred ceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 987543221 12233457889999998865 35688999999999999999999999765432111000 0 000 0
Q ss_pred hhhhcchhhh---hhhh---hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 301 YLQSKRRIFQ---VMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 301 ~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.......... .... ..........+.++.+++.+||+.||.+|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0000 00000111246678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=298.86 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=199.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|...... .....+..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999765421 1123456899998765432 3345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-----ceEEeec
Q 015731 153 YEFMPKGSLENHLFRTGAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-----NAKLSDF 225 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-----~~kl~Df 225 (401)
|||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999754321 1133788999999999999999999988 99999999999998877 8999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~------- 225 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH------- 225 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH-------
Confidence 99875433222112223345678999999988889999999999999999998 999986443211 1100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
+........+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 -------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0001111223345677889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=306.81 Aligned_cols=255 Identities=28% Similarity=0.355 Sum_probs=203.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|... .++..+|+|.+...... ....+..|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc---------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 36888999999999999999543 46889999998765433 3345788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++...|+||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~d 146 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSD 146 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEee
Confidence 99999999999999999999875432 45899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc---------------------------ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHH
Q 015731 225 FGLAKDGPTGSQS---------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 277 (401)
Q Consensus 225 fg~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 277 (401)
||++......... .......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~ 226 (316)
T cd05574 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226 (316)
T ss_pred cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence 9988753221100 0111346788999999998888899999999999999999
Q ss_pred hCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 015731 278 SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT----MDEVVKA 352 (401)
Q Consensus 278 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps----~~eil~~ 352 (401)
+|..||......... ................+..+.+++.+||+.||++||+ +.+++.|
T Consensus 227 ~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 227 YGTTPFKGSNRDETF----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hCCCCCCCCchHHHH----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999999765431110 1111111111111225678999999999999999999 8888886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.96 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=199.6
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
....+|++.+.||+|+||.||+|.. ..++..+|+|.+..... .....+..|+.+++.|+||||++++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkd---------k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKH---------KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEE---------CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 3446899999999999999999954 44688999999875433 234568899999999999999999998
Q ss_pred Eee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-----CCeEEeccCCCcEEEc
Q 015731 143 CLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK-----AKVIYRDFKTSNILLD 215 (401)
Q Consensus 143 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~ivH~dlkp~Nil~~ 215 (401)
|.+ ...+||||||+.+++|.++|..... ....+++..++.|+.||+.||.|||+.+ .+||||||||+||||+
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 864 4578999999999999999976421 1135899999999999999999999843 2399999999999995
Q ss_pred C-----------------CCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc--CCCCcccchhhHHHHHHHH
Q 015731 216 L-----------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEM 276 (401)
Q Consensus 216 ~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l 276 (401)
. .+.++|+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|+|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 3458999999997643322 2234578999999999854 4578999999999999999
Q ss_pred HhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 277 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
++|..||....... .++ ..+.... .......+..+.+||.+||..+|.+||++.++|.+-
T Consensus 237 LTGk~PF~~~~~~~--qli--------------~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 237 CSGKTPFHKANNFS--QLI--------------SELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred HHCCCCCCcCCcHH--HHH--------------HHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 99999996543211 000 0000000 000112356788999999999999999999999763
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=323.43 Aligned_cols=286 Identities=21% Similarity=0.269 Sum_probs=194.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccC------CCCCCCcEE----EEEEcccccchhHHHHHHHHHHHhccCCC
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAP------ARPGTGMVI----AVKRLNQESLQGHLEWLTEIKHLGQLYHP 134 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~------~~~~~~~~~----avK~~~~~~~~~~~~~~~e~~~l~~l~hp 134 (401)
....+|++++.||+|+||+||+|.+....... .....+... +.|.+... ......+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCC
Confidence 34578999999999999999998654321000 000011111 11211111 12234577899999999999
Q ss_pred cccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 135 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
||+++++++.+.+..|+|++++ +++|.+++...............+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 9999999999999999999999 668888876543222222446677889999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCccch
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHN 293 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~ 293 (401)
+.++.+||+|||++........ .......|+..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986543221 122345799999999999988999999999999999999998754 43322211111
Q ss_pred hHHhhhh-------hhhhcchhhhhhhhhhc----CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 294 LIEWAKP-------YLQSKRRIFQVMDARIE----GQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 294 ~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+.+.... +......+...+..... ... ....+..+.+++.+||+.||.+|||+.|++.|-+.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 1111000 00000001111100000 000 01123456778999999999999999999998554
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=286.56 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=199.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~ 145 (401)
++.+.+..||.|+.|.|++++. ..+|..+|||.+..... ++.+++++.+.++...+ +|.||+++++|..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~---------rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRF---------RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEE---------cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 4456678899999999999954 45799999999987643 44566788888877664 8999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..+++.||.| ..-+..++.... .++++..+-++...++.||.||..+ -+|+|||+||+|||+++.|.+|||||
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecc
Confidence 99999999998 445566665554 5699999999999999999999876 35999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|++-+..+.. ..+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+.....+. +.
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-lt------- 305 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LT------- 305 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HH-------
Confidence 9987654433 345567999999999984 357889999999999999999999999875431110 00
Q ss_pred hhcchhhhhhh-hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 303 QSKRRIFQVMD-ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 303 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.+++ ....-......+..+.+|+..||..|+.+||...++|+|
T Consensus 306 -------kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 -------KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -------HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 0111 000011112267889999999999999999999999987
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.42 Aligned_cols=256 Identities=25% Similarity=0.310 Sum_probs=220.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...|.+.+.||+|.|+.|.+| .+..|+..||+|++.+..... ...+.+|+++++.|+|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La---------~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLA---------RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEee---------EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 467999999999999999999 555689999999998876533 345789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
....+|+||||+.+|.+++++.+.+. +.+..+..++.|++.|++|||+++ |||||||++|||++.+..+||+|
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeec
Confidence 99999999999999999999998875 666888999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++..+..+. ...+.+|++.|.|||++.+..| ++++|+|++|+++|.|+.|..||++.......
T Consensus 199 fgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------- 264 (596)
T KOG0586|consen 199 FGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------- 264 (596)
T ss_pred cccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------
Confidence 99998765433 5667899999999999988776 68999999999999999999999876532211
Q ss_pred hcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 304 SKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 304 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.+.+. -..+..++.++.++|+++|..+|.+|++++++.++-|.-.....
T Consensus 265 ---------~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 265 ---------PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ---------chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 11111 23455667789999999999999999999999999887655544
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.19 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=206.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..|+..+.||.|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.+.||||+++++++.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 45788899999999999999543 3678999998875542 3345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg 146 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccc
Confidence 9999999999999999998653 3788899999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------------ 212 (277)
T cd06640 147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------------ 212 (277)
T ss_pred cceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh------------
Confidence 9876433221 12334678899999999888889999999999999999999999975443211110
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.............+..+.+++.+||+.+|.+||++.+++.|-+..
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 213 -----IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred -----hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 011111223345677888999999999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.65 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=194.1
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEe-eCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-EDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~-~~~~~~l 151 (401)
+.||+|+||.||+|.+.. ....+..+|+|.+.... ......+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999997542 22345789999886432 233456788999999999999999999765 4566899
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 75 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccc
Confidence 999999999999997653 23677788899999999999999988 999999999999999999999999998754
Q ss_pred CCCCCcc--eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 232 PTGSQSH--VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 232 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
....... ......++..|+|||.+.+..++.++|||||||++|+|++| .+||....... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~----------- 214 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY----------- 214 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-----------
Confidence 3211100 11123456789999999888899999999999999999995 55665432111 1100
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
+........+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 ---LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00000011112234578899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=308.82 Aligned_cols=268 Identities=20% Similarity=0.231 Sum_probs=196.6
Q ss_pred CCCcccCC--CCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 72 PDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 72 ~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++++||+| +|++||++ .+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLA---------RYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEE---------eecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 56789999 78899998 4445799999999876532 22334667999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++++||+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~ 147 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRS 147 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccch
Confidence 99999999999999999976432 34889999999999999999999988 99999999999999999999999986
Q ss_pred CcCCCCCCCc-----ceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 228 AKDGPTGSQS-----HVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 228 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~ 225 (327)
T cd08227 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNG 225 (327)
T ss_pred hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcC
Confidence 5432211100 00112346778999999865 45889999999999999999999999753321100 000000
Q ss_pred hhh---hc-----ch-------------hhh--h-------hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 015731 301 YLQ---SK-----RR-------------IFQ--V-------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 350 (401)
Q Consensus 301 ~~~---~~-----~~-------------~~~--~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil 350 (401)
... +. .. ... . .............+..+.+|+.+||+.||++|||+.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 000 00 00 000 0 000000011223466788999999999999999999999
Q ss_pred HHHHh
Q 015731 351 KALEQ 355 (401)
Q Consensus 351 ~~L~~ 355 (401)
+|-+.
T Consensus 306 ~~p~f 310 (327)
T cd08227 306 NHSFF 310 (327)
T ss_pred cChhh
Confidence 98553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.98 Aligned_cols=247 Identities=31% Similarity=0.466 Sum_probs=195.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
++||+|+||.||+|... .+..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 47999999999999533 3678999988765432 234578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 71 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 71 MELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred EECCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecc
Confidence 99999999999987543 34789999999999999999999988 9999999999999999999999999987533
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
..... ......++..|+|||++.+..++.++||||||+++|++++ |..||...........+
T Consensus 145 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---------------- 207 (250)
T cd05085 145 DGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---------------- 207 (250)
T ss_pred ccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----------------
Confidence 22111 1112234567999999988889999999999999999998 99998654321110000
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 208 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 -EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001111222334678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.95 Aligned_cols=253 Identities=28% Similarity=0.388 Sum_probs=199.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-----chhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.+|++.+.||+|+||.||.|.. ..+|..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYD---------ADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEE---------cCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 4689999999999999999954 3468899999875432 1223457789999999999999999998
Q ss_pred EeeC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 143 CLED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 143 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+.+. ..++++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNV 145 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCE
Confidence 8763 56889999999999999987653 3788889999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------- 217 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-------- 217 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--------
Confidence 99999998754321111 112234588899999999888889999999999999999999999965321110
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.............+...+..+.+++.+||. +|++||+++++++|-
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 218 --------IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred --------HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 011111111122344566778899999995 999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.42 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=202.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
...+|++.+.||+|+||.||++.... +..+++|.+..... ....+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 34689999999999999999996442 45699998875432 34567889999999999999999999887
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCC
Confidence 778999999999999999976432 34788899999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|.+......... ......++..|+|||.+.+..++.++|+|||||++|++++ |..||........ ..+.
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~------ 216 (260)
T cd05073 147 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL------ 216 (260)
T ss_pred cceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH------
Confidence 998764332211 1222345677999999988889999999999999999998 8999975432111 1100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
............+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 --------ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --------hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00001111223456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=297.77 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=200.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc------hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
+|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 5888999999999999998542 478899998764321 123457789999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..++||||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEe
Confidence 999999999999999999999997653 3789999999999999999999988 999999999999999999999
Q ss_pred eeccCCcCCCCCC----CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 223 SDFGLAKDGPTGS----QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 223 ~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+|||++....... .........++..|+|||.+.+..++.++||||||+++|+|++|..||...........+
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--- 220 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--- 220 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---
Confidence 9999887542111 111123356889999999998888899999999999999999999999654321110000
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... .......+...+..+.+++.+||+.+|.+||++.+++.|
T Consensus 221 ----~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 221 ----GAH--------RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----hhc--------cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 001112233456678899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=299.34 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=191.6
Q ss_pred cccCCCCeeEEEEEecCCC---------------ccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccce
Q 015731 75 VLGEGGFGCVFKGWIDEHT---------------YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~---------------~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
.||+|+||.||+|.+.... ....+......+++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999753211 1112233456789999876654445567889999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY- 218 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~- 218 (401)
++++.++...++||||+++++|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886543 34889999999999999999999988 99999999999997543
Q ss_pred ------ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCc
Q 015731 219 ------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSR 290 (401)
Q Consensus 219 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~ 290 (401)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999987643221 12356788999998865 56889999999999999985 6899887654321
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..... ... ...+......+.+++.+||+.+|++|||+.+++++|.
T Consensus 230 ~~~~~-----------------~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFY-----------------EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH-----------------Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11100 000 0111122346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.43 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=200.3
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch----------hHHHHHHHHHHHhccCCCcccc
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------GHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~e~~~l~~l~hpni~~ 138 (401)
+|.+.+.||.|+||.||+|. ...+|..+|+|.+...... ..+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLAL---------NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEe---------ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57888999999999999994 3346889999987542110 1234678999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+++++...+..++||||+.+++|.+++.... ++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~ 145 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADG 145 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCC
Confidence 9999999999999999999999999997663 3888999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.++|+|||++................++..|+|||.+.... ++.++|+||||+++|+|++|..||....... .
T Consensus 146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~ 220 (272)
T cd06629 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----A 220 (272)
T ss_pred eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----H
Confidence 99999999987643322221223456888999999986654 7899999999999999999999986432210 0
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
... .. . ...............+..+.+++.+||+.+|.+||++.++++|-
T Consensus 221 ~~~-~~--~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 221 MFK-LG--N----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred HHH-hh--c----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 000 00 0 00001111112223567889999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.81 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=202.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.|+..+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 4667788999999999999543 3678999998875432 23446789999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred ceEEEEEccCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccc
Confidence 999999999999999988643 3889999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+..... +
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~---------- 212 (277)
T cd06642 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L---------- 212 (277)
T ss_pred cccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----------
Confidence 876433211 1223467889999999988889999999999999999999999986543221110 0
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.............+..+.+++.+||+.+|.+||++.++++|-+
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 213 ----IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ----hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 0000111222345567889999999999999999999999855
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.12 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=191.6
Q ss_pred CcccCCCCeeEEEEEecCCCcc---CCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYA---PARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~---~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
+.||+|+||.||+|.+...... .........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999976432100 0112345578999887665444556788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-------eEEe
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-------AKLS 223 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~-------~kl~ 223 (401)
+||||+.+++|..++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886543 34899999999999999999999988 999999999999976654 8999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||.........
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--------- 219 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--------- 219 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---------
Confidence 99988654221 2235788899999886 467889999999999999998 578877643221100
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
....... .........+.+|+.+||+.||.+||++.+|+++|
T Consensus 220 --------~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 --------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000 01112245788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=301.30 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=204.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.++++++||||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR---------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 36889999999999999999543 468899999886542 22345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+++++|..++..... ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999998876421 1358999999999999999999996 46 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|++....... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...........
T Consensus 148 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----- 218 (286)
T cd06622 148 GVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ----- 218 (286)
T ss_pred CCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-----
Confidence 9987543221 2234578899999998543 357899999999999999999999965432111000
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
+...... .....+...+..+.+++.+||+.+|.+||++.+++.+-+....
T Consensus 219 --------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 219 --------LSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred --------HHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 0011111 1122334467788999999999999999999999998665433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.24 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=195.6
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~~l 151 (401)
++||+|+||.||+|.+... +....+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 4699999999999966431 112357888877432 23344678899999999 79999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 152 VYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
||||+++++|.+++...... ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeE
Confidence 99999999999999764311 1134789999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------ 222 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------ 222 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------
Confidence 999999986322111 1111223567999999988889999999999999999997 999986543211100
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..........+...+..+.+++.+||..||.+|||+.+++..|..+.
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 -----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----------HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00000111122234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=296.77 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=201.0
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|.+.+.||+|+||.||+|.+.. ...++..+|+|++..... ....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6778899999999999996542 345688999998875432 33456788999999999999999999886532
Q ss_pred ------eeEEEEEecCCCChHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 148 ------HRLLVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
..+++++|+.+++|.+++..... .....+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCE
Confidence 24788999999999988754321 11234788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |.+||........ ..+..
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~ 229 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI 229 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH
Confidence 9999999886543222111222345678999999988888999999999999999999 8888865432111 11000
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.. .....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ----~~----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ----KG----------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----cC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00011223456888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=302.16 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=203.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++... .+++.+|+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK---------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 36889999999999999999554 3688999999876432 23445788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d 144 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITD 144 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999997764 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 145 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------- 208 (290)
T cd05580 145 FGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----------- 208 (290)
T ss_pred CCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 9998765432 233468899999999988888899999999999999999999997544211000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
..... ...++...+..+.+++.+||..||.+|+ +++|+++|-+
T Consensus 209 -----~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 209 -----KILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred -----HHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 00000 1122233467888999999999999999 8888888743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=301.19 Aligned_cols=258 Identities=29% Similarity=0.358 Sum_probs=201.1
Q ss_pred HHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCccccee
Q 015731 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
+.....+.|++.+.||+|+||.||+|... .++..+|+|++..... ....+..|+.+++++ +||||++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 33445678999999999999999999543 4678999998865432 334577899999888 799999999
Q ss_pred eEEee------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 141 GYCLE------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 141 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
+++.. ....+++|||+.+++|.+++..... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili 154 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL 154 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence 98853 4678999999999999999976543 34788889999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
+.++.++|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|+|++|..||....+.
T Consensus 155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 9999999999999875432111 123356889999999875 346788999999999999999999999654332
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.....+ .............+..+.+|+.+||+.||.+||++.|+++|
T Consensus 233 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 233 RALFLI----------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhhhH----------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111100 00000001112345678999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=296.39 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=198.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+.+.....||+|+||.||+|.. ..++..+++|.+..........+.+|+.+++.++|+||+++++++..++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARD---------LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEe---------cCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 3444456899999999999954 3367889999887765555667889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEEee
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSD 224 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl~D 224 (401)
..++||||+++++|.+++.... .++ ++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.++|+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEec
Confidence 9999999999999999997653 224 78888899999999999999988 999999999999976 67999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
||.+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ..+..
T Consensus 153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~--- 224 (268)
T cd06624 153 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV--- 224 (268)
T ss_pred chhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh---
Confidence 999875432211 12234578899999998553 378899999999999999999999864321110 00000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.........+...+.++.+++.+||+.+|.+|||+.+++.|
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 ---------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00001122334456778899999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=298.42 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=192.1
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~ 153 (401)
+.||.|+||.||+|....... ........+++|.+..........+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999996543110 001234568888886655444556788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc--------eEEeec
Q 015731 154 EFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--------AKLSDF 225 (401)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~--------~kl~Df 225 (401)
||+.+|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999997654 24889999999999999999999988 999999999999977665 699999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|++..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||....+....
T Consensus 153 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----------- 215 (258)
T cd05078 153 GISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----------- 215 (258)
T ss_pred ccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-----------
Confidence 98865432 123457888999999876 45789999999999999999985 555433221100
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..... ...++...+.++.+|+.+||+.||++|||++++++.|+
T Consensus 216 ------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 ------QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 11223334467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=302.46 Aligned_cols=267 Identities=25% Similarity=0.316 Sum_probs=200.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... .+|..+|+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 36889999999999999999543 4688999998865432 123456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||||++++.|..++.... .+++..+..++.||+.+|.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~df 144 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDF 144 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECcc
Confidence 999999999998888877765432 3899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-hhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~ 303 (401)
|++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+. .......
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07847 145 GFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222 (286)
T ss_pred ccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99986543221 1223457888999999865 457889999999999999999999997655432211111 0000000
Q ss_pred hcchh-------hhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRI-------FQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... ............ ....+..+.+|+.+||+.+|++||++.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 000000000000 01235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.20 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=202.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||.+... .+|..+|+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 5888999999999999998543 3688999998875432 2344678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~ 146 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFG 146 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999999876432 34789999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ .
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~-------- 210 (256)
T cd08218 147 IARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------V-------- 210 (256)
T ss_pred ceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------H--------
Confidence 9876433221 12234578889999999888889999999999999999999999864321100 0
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...... .....+...+..+.+++.+||+.+|.+||++.++++|
T Consensus 211 --~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 --LKIIRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHHhcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000000 0111233456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.44 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=202.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.+++.++||||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 5888999999999999999543 3688999999876532 2345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-CceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Df 225 (401)
+..++||||+++++|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.+ +.++|+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~ 146 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDF 146 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccC
Confidence 999999999999999999976542 44899999999999999999999988 9999999999999755 45799999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~------------ 211 (256)
T cd08220 147 GISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL------------ 211 (256)
T ss_pred CCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH------------
Confidence 9988654322 1223467889999999988888999999999999999999999996543211100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... .....+...+..+.+++.+||+.+|.+|||+.+++.|
T Consensus 212 ----~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 212 ----KIMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----HHHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00000 0111222356678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=303.18 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=201.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
.|.....||+|+||.||++.. ..++..+|+|.+..........+.+|+.+++.++||||+++++.+..++.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATE---------KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEE---------CCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 345557799999999999844 34688999999876554555668899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++||||+++++|.+++... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcch
Confidence 99999999999999988543 3788999999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+...... .
T Consensus 166 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~ 230 (292)
T cd06658 166 AQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------I 230 (292)
T ss_pred hhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------H
Confidence 75432221 12335688999999999888899999999999999999999999975432111000 0
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
........ ......+..+.+++.+||..||.+|||+++++++-+
T Consensus 231 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 231 RDNLPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred HhcCCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 00011111 111234557889999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=301.56 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=202.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||.|+||.||+|... .+|..+++|++..... .....+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR---------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC---------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5888999999999999999543 3588999999876542 2245678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+ +++|.+++.... .++++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeee
Confidence 9999999999 999999987654 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh--------
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-------- 297 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-------- 297 (401)
++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...........+..
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07832 145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223 (286)
T ss_pred ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence 9886543321 122345688999999998654 468999999999999999999888865443211110000
Q ss_pred hhhhhhhcchhhhhhhhhh----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 298 AKPYLQSKRRIFQVMDARI----EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..+................ ........+..+.+++.+||+.||.+||++++++.|-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000000000000 0000112357888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.14 Aligned_cols=256 Identities=31% Similarity=0.494 Sum_probs=202.8
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
+++.+.||.|+||.||++..... ...++..+|+|.+...... ....+..|+..++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 45778999999999999976541 1134588999999766543 45578899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCc
Confidence 9999999999999999976542 12899999999999999999999988 999999999999999999999999999
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~---------- 216 (258)
T smart00219 151 RDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY---------- 216 (258)
T ss_pred eecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----------
Confidence 8654432211 112236788999999988889999999999999999998 788886532111 1100
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.........+...+..+.+++.+||..||.+|||+.++++.|
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 ----LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000011112233567888999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.70 Aligned_cols=281 Identities=22% Similarity=0.259 Sum_probs=205.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..|+....||+|+||.||+|.-.+. +..-...+|+|.++.+... ......+|+.+++.++||||+.+..+|..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~-----n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNT-----NDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccC-----CcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 5699999999999999999943321 1111347899998876332 12346799999999999999999999887
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC----Cce
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNA 220 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~----~~~ 220 (401)
+..+++++||.+. +|...++-........++...+..|+.||+.|+.|||++- |+||||||.||+|..+ |.+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 8899999999954 9999998766655567999999999999999999999999 9999999999999877 999
Q ss_pred EEeeccCCcCCCCCCCcc-eeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch-----
Q 015731 221 KLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN----- 293 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~----- 293 (401)
||+|||+++.+...-... .....+.|..|+|||++.|. .|+.+.|||++|||+.||++-.+.|.+....-...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999999764432211 23446779999999998774 68999999999999999999999997653321111
Q ss_pred --hHH----------hhhhhhhhcchhhhhhh-hhhcCCCCH----------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 015731 294 --LIE----------WAKPYLQSKRRIFQVMD-ARIEGQYSL----------GAALKTAVLAIKCLSNEPKFRPTMDEVV 350 (401)
Q Consensus 294 --~~~----------~~~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~li~~~L~~dp~~Rps~~eil 350 (401)
+.. ..++.+..--.....+. .+.....+. ..+....+|+.+||+.||.+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 100 00000000000000000 000001110 0123367899999999999999999999
Q ss_pred HHHHhc
Q 015731 351 KALEQI 356 (401)
Q Consensus 351 ~~L~~i 356 (401)
+|.-..
T Consensus 336 eh~yF~ 341 (438)
T KOG0666|consen 336 EHPYFT 341 (438)
T ss_pred cccccc
Confidence 986543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=294.19 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=201.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-----hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+|+..+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL---------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEc---------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 4788899999999999999543 3578899998865432 2345678999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.++...+++|||+++++|.+++.... ++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~ 144 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLA 144 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999997653 3889999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||++....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||....+.... ..
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~------ 213 (258)
T cd06632 145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FK------ 213 (258)
T ss_pred cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HH------
Confidence 999987643322 223456889999999987666 889999999999999999999999654321110 00
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..........+...+..+.+++.+||+.+|.+||++.+++.|
T Consensus 214 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 --------IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 000000112223346678899999999999999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.70 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=189.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee--CCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~--~~~~~l 151 (401)
..||+|+||.||+|.... ..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~-------~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecC-------CCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 579999999999996532 23568899998875432 2356789999999999999999998853 567899
Q ss_pred EEEecCCCChHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE----cCCCceEEe
Q 015731 152 VYEFMPKGSLENHLFRTGA----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLS 223 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~----~~~~~~kl~ 223 (401)
||||+ +++|.+++..... .....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+
T Consensus 78 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 78 LFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999 5688888753321 11235889999999999999999999988 9999999999999 456789999
Q ss_pred eccCCcCCCCCCCc-ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc-------hh
Q 015731 224 DFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-------NL 294 (401)
Q Consensus 224 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-------~~ 294 (401)
|||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||......... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99999865332211 12234568999999999866 45789999999999999999999999754321110 00
Q ss_pred HHhhhhh-------hhh---cchhhhhhhh---h---------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 295 IEWAKPY-------LQS---KRRIFQVMDA---R---------IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 295 ~~~~~~~-------~~~---~~~~~~~~~~---~---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....... ... .......... . .........+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 000 0000000000 0 0000111224567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=302.39 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=196.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|+||.||+|.. ..+|..+|+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~---------~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEE---------CCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 488889999999999999954 346889999988654321 123567899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg 144 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFG 144 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccc
Confidence 99999999995 68888876543 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCC-ccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS-REHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 304 (401)
++........ ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...... .....+ ......
T Consensus 145 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~ 219 (284)
T cd07839 145 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI---FRLLGT 219 (284)
T ss_pred hhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH---HHHhCC
Confidence 9875432211 12234578899999998664 4689999999999999999998886432221 110000 000000
Q ss_pred --cc---hhhhhhhhhhc---------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 305 --KR---RIFQVMDARIE---------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 305 --~~---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.. ......+.... .......+..+.+++.+||+.||.+|||+.++++|-
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 220 PTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred CChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 00 00000000000 011123457888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=301.23 Aligned_cols=263 Identities=26% Similarity=0.293 Sum_probs=201.2
Q ss_pred HHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCccccee
Q 015731 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
.+....++|++.+.||+|+||.||+|.. ..++..+|+|++..... ....+.+|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~ 81 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLN---------KKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFY 81 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEE---------CCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeee
Confidence 3345568899999999999999999954 34688999998765332 234567899999999 699999999
Q ss_pred eEEe-----eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 141 GYCL-----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 141 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+++. .++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~ 158 (286)
T cd06638 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT 158 (286)
T ss_pred eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC
Confidence 9874 456789999999999999988643211 245888999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
.++.++|+|||++........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|..||....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred CCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 999999999999876433211 1233468999999998743 457889999999999999999999986543311
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. ... . .... .....+...+..+.+++.+||+.||++|||+.|++++++
T Consensus 237 ~~--~~~-------~----~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 237 AL--FKI-------P----RNPP--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred HH--hhc-------c----ccCC--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 11 000 0 0000 000011123457889999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.84 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=199.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 46888899999999999999654 256799998875433 2346788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcc
Confidence 9999999999999999987644 34789999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..+.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~--------- 213 (256)
T cd05112 147 TRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET--------- 213 (256)
T ss_pred eeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---------
Confidence 8754322111 1112234568999999988889999999999999999998 899986543211 0100
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
+........+...+..+.+|+.+||+.+|++|||+.+++++|
T Consensus 214 -----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 214 -----INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000000011112356788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.61 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
+|++.+.||.|+||.||++. +..++..+|+|.+..... .....+..|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVR---------RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEee---------ecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 48889999999999999994 444688999998875433 234567889999999999999999997754
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh-----hCCCCeEEeccCCCcEEEcCCCc
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH-----SDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
+...+++|||+++++|.+++..... ...++++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCC
Confidence 4568999999999999999976421 2245899999999999999999999 777 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...+
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~--- 220 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS--- 220 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH---
Confidence 99999999886543321 123356899999999998888899999999999999999999999764311 1111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..........+...+..+.+++.+||+.+|.+||++.+|++|
T Consensus 221 -----------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 -----------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011111122344556788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=299.95 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=205.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||.||++.. ..++..+++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAID---------VATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEE---------cCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 6899999999999999999943 3357889999987655455566889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..|+|+||+++++|.+++.+.. +++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~ 161 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 161 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999999999987543 788899999999999999999988 99999999999999999999999998
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+........ ......+++.|++||.+.+..++.++|+||||+++|+|++|..||....+......+.
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----------- 228 (293)
T cd06647 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------- 228 (293)
T ss_pred eeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-----------
Confidence 875433221 1233468889999999988888999999999999999999999997654322111000
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.........+...+..+.+++.+||..+|.+||++.+++.|-+.
T Consensus 229 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 229 ----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 00000001122345578899999999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.59 Aligned_cols=259 Identities=27% Similarity=0.321 Sum_probs=197.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHH-HhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~-l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||++. +..+|..||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMR---------HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEE---------EcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 368899999999999999994 445789999999876532 223445566665 566789999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++..|++|||++ ++|.+++...... ...+++..++.++.||+.||.|||++ + ++||||||+||+++.++.++|+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEee
Confidence 999999999994 6898888654321 24589999999999999999999987 7 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... ..+
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----- 217 (283)
T cd06617 148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQL----- 217 (283)
T ss_pred ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHH-----
Confidence 99987643221 1223467889999998854 456889999999999999999999986432110 000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
................+.++.+++.+||..+|.+||++.++++|-+...
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 218 --------KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred --------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 0001100000011234567889999999999999999999999865544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=301.36 Aligned_cols=268 Identities=26% Similarity=0.331 Sum_probs=201.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+++++.++|+||+++++++.+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK---------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC---------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 36889999999999999999543 4688999998875432 223567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.++.|..+.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~ 144 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDF 144 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEee
Confidence 99999999999876665554433 23899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh-hhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-YLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~ 303 (401)
|++........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+..... ...
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07833 145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223 (288)
T ss_pred ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99886544322 122345678899999999777 788999999999999999999999976543221111110000 000
Q ss_pred h-------cc-----hhhhhhh-hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 S-------KR-----RIFQVMD-ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~-------~~-----~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. .. ....... ......++...+.++.+|+++||..+|++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00 0000000 000111222347789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=299.99 Aligned_cols=268 Identities=25% Similarity=0.330 Sum_probs=197.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||+|... .++..||+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 57999999999999999999543 36789999998654322 223466899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccc
Confidence 99999999996 59999887654 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............+........
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07844 149 LARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226 (291)
T ss_pred cccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence 9875322111 1122346788999998865 457899999999999999999999996544211100000000000000
Q ss_pred chhhhh--------------hhhhhcCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 306 RRIFQV--------------MDARIEGQ-YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 306 ~~~~~~--------------~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...... ....+... ........+.+++.+||+.+|.+|||+.+++.+-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000000 00000000 0011126778999999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.85 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=205.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||++... .++..+++|.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 36788899999999999999543 4688999998876543 3345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++++||+.+++|.+++.... .++++..+..++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~ 145 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDF 145 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999998753 358999999999999999999999 88 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|.+....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ......
T Consensus 146 g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~------ 214 (265)
T cd06605 146 GVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQ------ 214 (265)
T ss_pred ccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHH------
Confidence 9886542211 11256888999999998888999999999999999999999999654321111 111000
Q ss_pred chhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...... ....+.. .+..+.++|.+||..||.+|||+.+++.+=+.
T Consensus 215 ----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 215 ----YIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ----HHhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 011110 1111222 56778999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=292.88 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=206.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+|++.+.||+|++|.||+|.. ..++..+++|++..... .....+.+|+..+..++||||+++++++...+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~---------~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRH---------KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEE---------cCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 588899999999999999944 44689999999877654 33556889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..++||||+++++|.+++.... ++++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999997653 48999999999999999999999 98 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....+........+
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------- 214 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------- 214 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------
Confidence 98865432221 2244678899999999888889999999999999999999999976543111111111
Q ss_pred hhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.. ......+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 215 ----~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ----ICD-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----Hhc-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 111112223 56789999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=291.89 Aligned_cols=247 Identities=33% Similarity=0.508 Sum_probs=197.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5689999999999999998732 46779999886543 234678899999999999999999998765
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCcc
Confidence 47999999999999999976542 34789999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~------------ 209 (254)
T cd05083 147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC------------ 209 (254)
T ss_pred ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------------
Confidence 87533221 12234567999999988889999999999999999997 9999875542111100
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.............+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 210 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 -----VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01111111223345678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=292.27 Aligned_cols=252 Identities=29% Similarity=0.409 Sum_probs=201.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|.+.+.||+|+||.||+|... .++..+++|.+...... ....+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL---------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC---------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5888999999999999999543 35789999998766543 456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g 144 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFG 144 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccc
Confidence 99999999999999999997653 3788899999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcce--eeecccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGSQSHV--STRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
++........... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... +....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~ 217 (264)
T cd06626 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMF 217 (264)
T ss_pred cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHH
Confidence 9886543322111 12346788999999987655 789999999999999999999999654311 11000
Q ss_pred hhhcchhhhhhhhhhcCCCCH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSL--GAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... ......+. ..+..+.+++.+||+.+|.+||++.+++.+
T Consensus 218 ~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 218 HVGA---------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHhc---------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 00111111 236677899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=293.23 Aligned_cols=268 Identities=23% Similarity=0.280 Sum_probs=205.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC--CCc----ccc
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--HPN----LVK 138 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~--hpn----i~~ 138 (401)
....+|.+...+|+|+||.|..+++.. ++..+|+|+++.... ..+..+-|+++|.++. .|+ +++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 347899999999999999999996554 488999999976542 2344567999999983 333 677
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-- 216 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-- 216 (401)
+.+||.-.++.|||+|.+ |-++.+++.++.. .+++...+..+++|++.++++||+.+ ++|.||||+|||+..
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE 229 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence 888899999999999998 8899999988664 67999999999999999999999988 999999999999832
Q ss_pred ------------------CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 015731 217 ------------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278 (401)
Q Consensus 217 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 278 (401)
+..|+|+|||.|+..... ....+.|..|+|||++.+-.++..+||||+||||+||++
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 235899999999864332 255678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccchhHHhhh--------------hhhhhc----------chhhhhhhh--hh--cCCCCHHHHHHHHH
Q 015731 279 GRRVIDKNRPSREHNLIEWAK--------------PYLQSK----------RRIFQVMDA--RI--EGQYSLGAALKTAV 330 (401)
Q Consensus 279 g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~----------~~~~~~~~~--~~--~~~~~~~~~~~~~~ 330 (401)
|...|.+........+.+... .++... +......+. .+ -..-...+...+++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999998876333211111100 000000 000000000 00 00112356778999
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 015731 331 LAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 331 li~~~L~~dp~~Rps~~eil~~L 353 (401)
|+.+||..||.+|+|+.|+|.|-
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHccCccccccHHHHhcCH
Confidence 99999999999999999999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.98 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=201.1
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCee
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
|.....||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 444567999999999999543 36789999998765444455678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+++++|.+++... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEecCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999999987553 3789999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......+ . ..
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~----~~---- 232 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---R----DS---- 232 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---h----cc----
Confidence 5432211 123356889999999998888999999999999999999999999754321111000 0 00
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
... ........+..+.+++.+||+.+|.+||++.+++++-...
T Consensus 233 --~~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 233 --PPP--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred --CCC--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 000 0011112345678999999999999999999999985544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=296.00 Aligned_cols=256 Identities=28% Similarity=0.366 Sum_probs=200.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|... .++..+++|++..... ....+.+|+.+++++ .||||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 3578999999999999999999543 4678999998876543 335678999999998 7999999999997
Q ss_pred eCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+.. ..++||||+.+++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCC
Confidence 644 58999999999999999875431 1145899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.++|+|||++....... .......|+..|+|||.+.. ..++.++||||||+++|+|++|..||....+....
T Consensus 151 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 227 (275)
T cd06608 151 EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL- 227 (275)
T ss_pred eEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-
Confidence 99999999987543221 12234568899999998743 34678899999999999999999999654321110
Q ss_pred hHHhhhhhhhhcchhhhhhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. .+..... ....+...+..+.+|+.+||..||++|||+.++++|
T Consensus 228 -~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 -F--------------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -H--------------HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0000000 011122345678899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.54 Aligned_cols=250 Identities=26% Similarity=0.323 Sum_probs=203.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
+|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|+.++++++||||+++++.+.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 4788899999999999999543 4688999999876532 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+...++||||+.+++|.+++.... ++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~ 144 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDF 144 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeec
Confidence 999999999999999999997652 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------- 211 (258)
T cd05578 145 NIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---------- 211 (258)
T ss_pred ccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----------
Confidence 9988654332 223356888999999998888899999999999999999999999765432111100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM--DEVVKA 352 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~--~eil~~ 352 (401)
..... .....+...+..+.+++.+||..||.+||++ +|+++|
T Consensus 212 ----~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 212 ----AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ----HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 00000 1122333456788999999999999999999 776654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=292.56 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=205.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||.|+||.||+|... .++..+++|++..... .....+.+|+.+++.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL---------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc---------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 46899999999999999999543 3578899999875432 2445678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++|||++++++|.+++..... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccc
Confidence 999999999999999999976432 134899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCc--ceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 227 LAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 227 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
++......... .......|+..|+|||.+... .++.++|+||||+++|+|++|..||............ ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~---- 221 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQ---- 221 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH--hc----
Confidence 98765433222 122344688999999998766 7889999999999999999999999765432211100 00
Q ss_pred hcchhhhhhhhhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. ......... ....+..+.+++.+||+.||.+||++.++++|
T Consensus 222 ~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 222 N-------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C-------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000000000 12445678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.31 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=201.3
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+|.+.+.||+|+||.||+|... .+|..||+|.+...... ....+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK---------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC---------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 4788899999999999999543 35889999998765432 233466899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~ 144 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLA 144 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEc
Confidence 9999999999999 999999997654 24899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-hhh-h
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAK-P 300 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~-~ 300 (401)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....+......+. ... +
T Consensus 145 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~ 222 (298)
T cd07841 145 DFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222 (298)
T ss_pred cceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence 9999976543221 1223456788999998854 457889999999999999999988887654322111110 000 0
Q ss_pred hh---hhcchhhhhhhhhhc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 301 YL---QSKRRIFQVMDARIE-----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 301 ~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. ............... .......+..+.+++.+||+.||++|||+.|++++=+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 00 000000000000000 0011234677889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.82 Aligned_cols=267 Identities=25% Similarity=0.354 Sum_probs=199.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK---------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC---------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 36888999999999999999543 35789999988654322 23457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+...++||||+++++|.++..... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~df 144 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDF 144 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEee
Confidence 999999999999888887665432 3899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-hhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~ 303 (401)
|++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+. +......
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07846 145 GFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222 (286)
T ss_pred eeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence 9987643322 12233567889999998865 446789999999999999999999997544321111110 0000000
Q ss_pred hcchhh---hhh----hhhhcC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRIF---QVM----DARIEG-----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~---~~~----~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...... .+. ...... ......+..+.+|+.+||+.+|.+||++.++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 000 000000 0012346778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=291.39 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=189.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++||||+++++.+.+....|+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 3699999999999864321 2345677787665432 3345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++.+.... ...++...+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred EecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccC
Confidence 9999999999999765321 234677788899999999999999988 9999999999999999999999999876422
Q ss_pred CCCCcceeeecccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
............++..|+|||++.. ..++.++||||||+++|+|++ |..||....+... +. .....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~~ 224 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LN---HVIKD 224 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHhh
Confidence 2111112234567889999998743 245778999999999999997 4667754332110 00 00000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
......+ .......+..+.+++..|| .+|.+||++++|++.|.
T Consensus 225 --~~~~~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 --QQVKLFK----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred --cccccCC----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0011111 1122234567788999999 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.48 Aligned_cols=274 Identities=22% Similarity=0.262 Sum_probs=200.2
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc---chhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
+|.+.+.||+|+||.||+|..... .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999965321 268899999988743 2223456789999999999999999999998
Q ss_pred C--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC----CCc
Q 015731 146 D--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----NYN 219 (401)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~----~~~ 219 (401)
. ...++||||+. ++|.+++..........+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccce
Confidence 8 88999999995 57888776544332246899999999999999999999988 999999999999998 899
Q ss_pred eEEeeccCCcCCCCCCC-cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch----
Q 015731 220 AKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN---- 293 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---- 293 (401)
++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|.+||..........
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999886433222 111223467889999998765 457899999999999999999999997655432100
Q ss_pred ---hHHhhhhh----------hhhcchhhhhhhhhhcCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHH
Q 015731 294 ---LIEWAKPY----------LQSKRRIFQVMDARIEGQYS---------L--GAALKTAVLAIKCLSNEPKFRPTMDEV 349 (401)
Q Consensus 294 ---~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~~L~~dp~~Rps~~ei 349 (401)
+....... ..................++ . ..+..+.+++.+||+.||++|||+.|+
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00000000 00000000000000000011 0 334578899999999999999999999
Q ss_pred HHH
Q 015731 350 VKA 352 (401)
Q Consensus 350 l~~ 352 (401)
++|
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.77 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=197.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+-.++..+||+|+|-+||+|.+ ..+|..||--.++.... ....+|..|+.+|+.|+||||+++|.++
T Consensus 40 Ry~k~~evLGrGafKtVYka~D---------e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFD---------EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred ceeehhhhcccccceeeeeccc---------cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 3345668999999999999954 44677776554443322 2345788999999999999999999999
Q ss_pred eeCCe--eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCce
Q 015731 144 LEDDH--RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNA 220 (401)
Q Consensus 144 ~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~ 220 (401)
.+... +.+|+|++..|+|..|+++.+. ++.+.+..|+.||+.||.|||++.++|+|||||.+||||++ .|.|
T Consensus 111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 111 VDTDNKTINFITELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred ecCCCceeeeeeecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 87654 7889999999999999998865 89999999999999999999999999999999999999965 5899
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|+|+|...... ......|||.|||||+.. ..|+..+||||||+++.||.|+..||........
T Consensus 186 KIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--------- 251 (632)
T KOG0584|consen 186 KIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--------- 251 (632)
T ss_pred eecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---------
Confidence 99999999875432 234478999999999986 8899999999999999999999999965432100
Q ss_pred hhhhcchhhhhhhh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 301 YLQSKRRIFQVMDA-RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 301 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.+.+.. ....-+..-..+++.+||.+||.. .++|||+.|+|++
T Consensus 252 -------IYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 252 -------IYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------HHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0010000 000111112245788999999998 9999999999987
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=299.44 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=199.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||++. +..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~---------~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVR---------HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEE---------ECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368899999999999999994 444688999998876542 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.++..++||||++|++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~d 144 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTD 144 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEee
Confidence 9999999999999999999997654 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCC-------------cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 225 FGLAKDGPTGSQ-------------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 225 fg~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+..+...
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998863211100 0011124578889999999888899999999999999999999999975432111
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHH
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIE-GQYSLGAALKTAVLAIKCLSNEPKFRPT---MDEVVKALE 354 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~eil~~L~ 354 (401)
.. ........ .......+.++.+++.+||+.||.+||+ +.+++++-+
T Consensus 225 ~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 225 FG----------------QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred HH----------------HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 00 00000000 0011134567889999999999999998 566666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.17 Aligned_cols=266 Identities=27% Similarity=0.403 Sum_probs=218.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc-cchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
....+.++||.|.||.||.|.+... .++..--||||..+.. ...+.+.|+.|.-++++++||||++++|+|.+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred hhccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 4456678899999999999987652 2444566899988774 34556779999999999999999999999986
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...+||||+++-|.|..+++.... .++......+++||+.||.|||+.+ +|||||...||||.....+||+|||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 468999999999999999988773 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...+..... .+...-..-|||||.+....++.++|||.||+++||++. |..||.+-...+....+
T Consensus 537 LSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---------- 605 (974)
T KOG4257|consen 537 LSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---------- 605 (974)
T ss_pred hhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----------
Confidence 999866544332 222334567999999999999999999999999999765 89999775433322211
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 363 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~ 363 (401)
+..-+.+.+..++..++.|..+||..+|.+||.+.++...|..+.+.+...
T Consensus 606 -------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 606 -------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred -------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 222233557788899999999999999999999999999999987755443
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=293.04 Aligned_cols=252 Identities=29% Similarity=0.396 Sum_probs=202.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
-|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 4778899999999999999543 3578999998865443 22345778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++... .+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~ 147 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGV 147 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeeccc
Confidence 999999999999999988643 3789999999999999999999988 99999999999999999999999998
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------- 212 (277)
T cd06641 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------------- 212 (277)
T ss_pred ceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-------------
Confidence 875433211 12234678899999999888888999999999999999999999865432111000
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.............+..+.+++.+||+.+|.+||++.++++|-...
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 213 ----IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred ----HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 000011112234456788999999999999999999999985443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=290.68 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=191.2
Q ss_pred CcccCCCCeeEEEEEecCCC-ccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~-~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
+.||+|+||.||+|...... +..........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999775421 10111223356888877655433 5677899999999999999999999888 778999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-------ceEEeec
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-------NAKLSDF 225 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-------~~kl~Df 225 (401)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+|+||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999998764 24889999999999999999999988 99999999999998887 7999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.............
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------ 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------ 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------
Confidence 99876432 1223467789999998776 78899999999999999999 577775543211110000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
. ....+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 221 -~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -D------------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -c------------CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011111267889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=297.83 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=200.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||.|+||.||+|... .++..+++|.+....... ...+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 47899999999999999999543 468899999987543221 2345689999999999999999999887
Q ss_pred C--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 146 D--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
. +..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++|+
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEe
Confidence 7 89999999995 59999887654 24899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH------
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE------ 296 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~------ 296 (401)
|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+.
T Consensus 149 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (293)
T cd07843 149 DFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226 (293)
T ss_pred ecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999886543321 12334578899999988654 46889999999999999999999997654322111110
Q ss_pred ----hhhh--hhh-hcchhhhhhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 ----WAKP--YLQ-SKRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 ----~~~~--~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
|... ... ............+...++.. .+..+.+++.+||+.||++|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 00000000011111122222 46778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=292.99 Aligned_cols=263 Identities=27% Similarity=0.326 Sum_probs=203.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC-
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~- 146 (401)
+|+..+.||.|++|.||+|... .++..+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLK---------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEEC---------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 5788899999999999999543 3688999999875433 3345688999999999999999999988653
Q ss_pred -CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 -DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+.+++||||+++++|.+++..... ....++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeec
Confidence 478999999999999998764322 1245889999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC--ccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS--REHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~ 303 (401)
|++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+...
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 222 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--- 222 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---
Confidence 9987543221 12345788899999998888999999999999999999999999765321 11111111110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. ....+.. . .......+..+.+++.+||..+|.+|||+.|++++-+-
T Consensus 223 -~-~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 223 -M-PNPELKD-E--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred -C-Cchhhcc-C--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 0 0000000 0 00012245678899999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=297.53 Aligned_cols=268 Identities=23% Similarity=0.297 Sum_probs=197.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|++.+.||+|+||.||+|.. ..+|..+|+|.+....... ...+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGIS---------RINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEE---------cCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 36799999999999999999954 3467899999986543222 2356789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 75 KETLTFVFEYM-HTDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred CCeEEEEEecc-cCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecc
Confidence 99999999999 578877775543 23778888999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............|.......
T Consensus 148 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 225 (291)
T cd07870 148 GLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225 (291)
T ss_pred ccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence 99875322211 1223457889999999865 35788999999999999999999999765432111101111000000
Q ss_pred ----------cchhhhhhhhhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 ----------KRRIFQVMDARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ----------~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
............... .....+..+.+++.+||..||.+|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 001124577899999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.44 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=199.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----------hhHHHHHHHHHHHhc-cCCCccc
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------QGHLEWLTEIKHLGQ-LYHPNLV 137 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~e~~~l~~-l~hpni~ 137 (401)
.|++.+.||+|+||.||+|.... .++..+|+|.+..... ....++.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999996543 1467899998754321 223346678888865 7999999
Q ss_pred ceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcC
Q 015731 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~ 216 (401)
++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECC
Confidence 999999999999999999999999998854321 11458999999999999999999996 56 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
++.++|+|||.+....... ......|+..|++||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~--- 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--- 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH---
Confidence 9999999999997644322 2334568899999999988889999999999999999999999986443211100
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...............+..+.+++.+||+.||++||++.|+..+++
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 -------------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000000011134567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=296.75 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=198.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||.|+||.||+|.. ..+|..+|+|.+..... .....+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARN---------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEE---------CCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 478889999999999999954 34688999998865432 2234678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg 145 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFG 145 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999995 689888866432 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCccch-hHHhhhhh---
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-LIEWAKPY--- 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~--- 301 (401)
++........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ...+....
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 146 LARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred chhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432211 123345688899999886543 5889999999999999999999997644321110 00000000
Q ss_pred ----hhh----cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 302 ----LQS----KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 302 ----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... ............. ......+..+.++|.+||+.||.+|||++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000000000 0011245677899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.05 Aligned_cols=249 Identities=31% Similarity=0.430 Sum_probs=204.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
+|.+.+.||+|++|.||++... .++..+++|++..........+.+|+..++.++||||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK---------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC---------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 4788899999999999999544 3688999999987665455678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++++||+++++|.+++.... ..+++..+..++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccc
Confidence 999999999999999987753 34899999999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------------- 209 (253)
T cd05122 146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI------------- 209 (253)
T ss_pred cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------------
Confidence 76544321 23456888999999998888899999999999999999999998754321111000
Q ss_pred hhhhhhhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 309 FQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 309 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.. ...... ....+..+.+++.+||+.||++|||+.++++|
T Consensus 210 ---~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 210 ---AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000011 11125678899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=295.24 Aligned_cols=253 Identities=28% Similarity=0.369 Sum_probs=200.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...|.+.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc---------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356999999999999999999543 3688999998864432 2234578899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..++||||+. ++|.+++.... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~ 157 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLA 157 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEe
Confidence 99999999999995 68877776443 34899999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||...........+
T Consensus 158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----- 226 (307)
T cd06607 158 DFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----- 226 (307)
T ss_pred ecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-----
Confidence 99988754322 2345788999999874 356788999999999999999999998654321110000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.............+..+.+++.+||..||++||++.+++.|.+...
T Consensus 227 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 227 -----------AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -----------hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000001112234567899999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=288.78 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=201.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-----chhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.+|++.+.||+|+||.||+|.. ..++..+|+|.+.... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYD---------ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEE---------cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 4689999999999999999943 3468899999875321 1233467889999999999999999999
Q ss_pred EeeC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 143 CLED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 143 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+.+. ...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNV 145 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCE
Confidence 8764 56889999999999999987653 3788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC-cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
+|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------- 216 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------- 216 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------
Confidence 9999999976432111 111223568899999999988888999999999999999999999996532211
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..............+...+..+.+++.+||+ +|..||++.+++.|.
T Consensus 217 -------~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 217 -------AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred -------HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 0111111112233455667789999999999 679999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.78 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=206.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|...+.||+|++|.||+|... .++..+++|++..... .....+.+|+.++++++||||+++++.+.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4778899999999999999544 3688999999876653 3355678999999999999999999999988
Q ss_pred --CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 147 --DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
...++||||+.+++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcc
Confidence 89999999999999999997664 4899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||.+................++..|+|||.+.+..++.++||||||+++|+|++|..||...... .. .
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~-~--------- 212 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MA-A--------- 212 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HH-H---------
Confidence 99988654433211123456888999999998888999999999999999999999999765410 00 0
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.............+...+..+.+++.+||+.||.+||++.+++.|-
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 213 ---LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ---HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 0011111111223344477899999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=296.84 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=196.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~ 145 (401)
.+|...+.||+|+||.||++.. ..++..+|+|.+..... .....+.+|+.++.++. ||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLH---------KPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEE---------CCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 3566778999999999999844 44689999999876433 23446788999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+...+++|||+ +++|.++...........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 75 EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEee
Confidence 99999999998 45666544321111114589999999999999999999974 6 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++....... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... ........
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~ 223 (288)
T cd06616 152 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV 223 (288)
T ss_pred cchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh
Confidence 99987543221 12234578899999998765 688999999999999999999999965431 00000000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.......+........+..+.+|+.+||+.||++|||+.+|+++-+.
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 224 -------VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred -------cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000111112223456788999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=295.33 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=203.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..|...+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.+++.++|||++++++++.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34788899999999999999543 3688999998865422 22346788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++...++||||+. |+|.+.+.... .++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 96 ~~~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 96 REHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred eCCeEEEEEeCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEec
Confidence 9999999999995 58888776543 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++...... ....|+..|+|||.+. ++.++.++|||||||++|+|++|..||.........
T Consensus 169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--------- 233 (317)
T cd06635 169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------- 233 (317)
T ss_pred CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---------
Confidence 9988653321 2346888999999873 456788999999999999999999998653211110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
..+.............+..+.+++.+||+.+|.+||++.+++++++.+......
T Consensus 234 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 234 -------YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred -------HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 001111111111223456788999999999999999999999999887655544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.22 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=200.3
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
.|...+.||+|++|.||++.. ..++..+++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATD---------KSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEE---------CCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 355567999999999999954 33578899998865544445567899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++|+||+.+++|.+++... .+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+
T Consensus 91 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~ 162 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFC 162 (285)
T ss_pred EEEEEeccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccc
Confidence 99999999999999998763 2788999999999999999999988 999999999999999999999999987
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+......+
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~------------- 227 (285)
T cd06648 163 AQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------- 227 (285)
T ss_pred hhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------------
Confidence 65432211 123346889999999998888999999999999999999999998654321111000
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
........ ......+..+.+++.+||+.+|++||++.++++|-
T Consensus 228 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 228 RDNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred HhcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 00000000 01122456789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.94 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=194.8
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcccceeeEEeeC-
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLED- 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~- 146 (401)
|++.+.||+|+||.||+|.. ..++..+|+|.+..... .......+|+.++.++. ||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~---------~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQS---------RKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEE---------cCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 67788999999999999954 34688999998876422 22233457888888885 99999999999987
Q ss_pred -CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 -DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEec
Confidence 88999999995 58888887643 34899999999999999999999988 999999999999999 99999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........ .....++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+. +.+.......
T Consensus 144 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~ 217 (282)
T cd07831 144 GSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGT 217 (282)
T ss_pred ccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCC
Confidence 99876433221 123457889999997643 5568899999999999999999999976543221 1111111000
Q ss_pred cch-hhhhh------hhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRR-IFQVM------DARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~-~~~~~------~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... ..... ...... ......+..+.+++.+||+.+|++||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 00000 000000 0012346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=304.15 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=200.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|. +..+|..+|+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAY---------DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEE---------ECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45789999999999999999994 44468899999986532 23344577899999999999999999988
Q ss_pred eeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
... ...|+||||+ .++|.+.+... ++...+..++.|++.||+|||++| ++||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~ 154 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELM-DANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 154 (353)
T ss_pred ccCCCccccCcEEEEEecc-CCCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC
Confidence 643 3579999999 56888877532 788889999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH--
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-- 295 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-- 295 (401)
+.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+
T Consensus 155 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 155 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999999997643321 123346788999999999889999999999999999999999999765432111100
Q ss_pred -------Hhhhh-------hhhhc-----chhhhhhhhhh----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 296 -------EWAKP-------YLQSK-----RRIFQVMDARI----EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 296 -------~~~~~-------~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.+... +.... ..+........ ........+..+.+++.+||+.||.+|||+.|+|+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000 00000000000 000011345677899999999999999999999998
Q ss_pred HHh
Q 015731 353 LEQ 355 (401)
Q Consensus 353 L~~ 355 (401)
=+.
T Consensus 312 ~~~ 314 (353)
T cd07850 312 PYI 314 (353)
T ss_pred hhH
Confidence 544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.80 Aligned_cols=258 Identities=26% Similarity=0.308 Sum_probs=198.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
...++|.+.+.||+|+||.||++... .++..+|+|.+..... ....+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 44678999999999999999999543 4688999999865432 234567889999988 799999999998
Q ss_pred eeC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 144 LED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 144 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
... ...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCC
Confidence 753 368999999999999998864321 1145899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||....+....
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL- 242 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence 999999999876433221 12234678899999987543 3678999999999999999999999754321111
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..+.. . ... ....+......+.+++.+||+.+|++||++.++++|
T Consensus 243 -~~~~~------~-----~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 -FKIPR------N-----PPP--TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHhc------C-----CCC--CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 0 000 001112334568899999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.80 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=199.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC---CCcccceeeEEe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY---HPNLVKLIGYCL 144 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~---hpni~~~~~~~~ 144 (401)
.|++.+.||+|+||.||+|.. ..++..+|+|.+..... .....+.+|+.+++.+. |||++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKH---------VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEE---------cCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 478889999999999999954 34688999998865432 23445778999998886 999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCD 144 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEcc
Confidence 999999999999999999988653 3889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+
T Consensus 145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------- 214 (277)
T cd06917 145 FGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------- 214 (277)
T ss_pred CCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--------
Confidence 999876543321 2233468889999998854 45688999999999999999999999754332111100
Q ss_pred hcchhhhhhhhhhcCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 304 SKRRIFQVMDARIEGQYSL-GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ....... ..+..+.+++.+||+.||.+||++.+++++-+.
T Consensus 215 -----~~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 215 -----PKS----KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred -----ccC----CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 000 0001111 145678899999999999999999999997544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.95 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=190.5
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHH---HHhccCCCcccceeeEEeeCCe
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK---HLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~---~l~~l~hpni~~~~~~~~~~~~ 148 (401)
+||+|+||.||++.. ..++..+|+|.+...... ....+.+|.. ++...+||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEE---------CCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 489999999999954 346889999988654321 1122333433 3344579999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~ 144 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA 144 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcc
Confidence 999999999999999887654 3899999999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
....... .....|+..|+|||.+. +..++.++|||||||++|+|++|..||.............
T Consensus 145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----------- 209 (279)
T cd05633 145 CDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----------- 209 (279)
T ss_pred eeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-----------
Confidence 7543221 12346899999999886 4567899999999999999999999997543321111000
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
. ........+...+.++.+++.+||+.||.+|| +++++++|-+.
T Consensus 210 ---~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 210 ---M-TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred ---H-hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 0 00111223344567889999999999999999 69999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.48 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=199.1
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||.|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVK---------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 699999999999543 3688999999876433 2334688899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++.+.. .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~ 144 (262)
T cd05572 72 MEYCLGGELWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144 (262)
T ss_pred EecCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence 99999999999997653 3889999999999999999999988 9999999999999999999999999988654
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....... .... ....
T Consensus 145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----------~~~~ 207 (262)
T cd05572 145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY----------NDIL 207 (262)
T ss_pred ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH----------HHHh
Confidence 332 1233468889999999988888999999999999999999999997654211 0000 0111
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
.......++...+..+.+++.+||+.||.+||+ ++|+++|-+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 111112233334678899999999999999999 899988654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.37 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=212.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++..+.++||+|.||.|++|.|.. -.++-..||||.+...... ....|++|+.+|.+|+|||++++|+++.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~------psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQ------PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccC------CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 345667899999999999998875 2344567899999887664 55679999999999999999999999987
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
....||||+++.|+|.+.|.+... ..|.......++.||+.|+.||.+++ +|||||...|+++.....|||+|||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeeccc
Confidence 778899999999999999988332 56888899999999999999999998 9999999999999989999999999
Q ss_pred CCcCCCCCCCcceeee-cccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTR-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
+.+..+.......+.. ..-...|+|||.+....++.++|||++||+||||++ |..||.+.....
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------------- 323 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------------- 323 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------
Confidence 9998766554333222 233567999999999999999999999999999998 688987765321
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.+.++..-.-..+..++.+++++++.||..+|.+|||+..|.+.
T Consensus 324 ---IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 324 ---ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 222233333334466789999999999999999999999999744
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=325.22 Aligned_cols=274 Identities=23% Similarity=0.265 Sum_probs=220.2
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPN 135 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpn 135 (401)
....++....+|.++++||+|+||.|..+ +++.|+++||+|++++..+. +..-|..|-.+|..-+.+-
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~W 136 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEW 136 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHH
Confidence 34456667799999999999999999998 56678999999999885442 3344777888888888999
Q ss_pred ccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 136 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
|++++-.|+++.++|+||||++||+|..++.+.. ++++..+..++..|+.||.-||+.| +|||||||+|||++
T Consensus 137 iv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 137 IVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD 209 (1317)
T ss_pred HHHHHHHhcCccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec
Confidence 9999999999999999999999999999998765 3999999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----T-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
-.|++||+|||.+-..... +.......+|||.|.+||++. + +.|+..+|.||+||++|||++|..||-...
T Consensus 210 ~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--- 285 (1317)
T KOG0612|consen 210 KSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--- 285 (1317)
T ss_pred ccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---
Confidence 9999999999998765432 233455678999999999983 2 578999999999999999999999994322
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH-------Hhchh
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPT---MDEVVKAL-------EQIQD 358 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps---~~eil~~L-------~~i~~ 358 (401)
.... .-.+++.+-.-.+| ..++....+||.+.+. +|..|.. ++++..|- ..|++
T Consensus 286 ----------lveT---Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 286 ----------LVET---YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE 351 (1317)
T ss_pred ----------HHHH---HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence 1111 11222221112222 4478889999998875 8999998 99999983 34455
Q ss_pred cCCCCCCc
Q 015731 359 TNDAGVSR 366 (401)
Q Consensus 359 ~~~~~~~~ 366 (401)
..++-+|.
T Consensus 352 ~~pP~vPe 359 (1317)
T KOG0612|consen 352 SVPPVVPE 359 (1317)
T ss_pred cCCCCCCc
Confidence 55555554
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.23 Aligned_cols=271 Identities=22% Similarity=0.264 Sum_probs=197.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccC-CCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~-hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36889999999999999999543 46889999987654322 2345778999999995 699999999988
Q ss_pred eCCe-----eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CC
Q 015731 145 EDDH-----RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NY 218 (401)
Q Consensus 145 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~ 218 (401)
..+. .|+||||+.+ +|.+++..........+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCC
Confidence 7665 8999999965 8998887654322346899999999999999999999988 999999999999998 89
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-H
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-E 296 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~ 296 (401)
.++|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+......+ .
T Consensus 149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999875432211 1122356888999998754 45789999999999999999999999765432211100 0
Q ss_pred hhh-hh---hhhcchhhhhhh-----hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 WAK-PY---LQSKRRIFQVMD-----ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 ~~~-~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... +. ............ ...........+..+.++|.+||..||.+||++.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00 000000000000 000000112356778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=303.06 Aligned_cols=276 Identities=25% Similarity=0.342 Sum_probs=203.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|.+.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAK---------NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEE---------ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 3579999999999999999994 34478999999886532 223345678999999999999999999876
Q ss_pred eC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 ED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.. ...|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~ 146 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCD 146 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCC
Confidence 54 3579999999 578998887653 3899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
++|+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.-.
T Consensus 147 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 224 (337)
T cd07858 147 LKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224 (337)
T ss_pred EEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 9999999988653321 12234467889999998754 46889999999999999999999999764321111100000
Q ss_pred -h-------hhhhhcchhhhhhhhh---hc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhcCCC
Q 015731 299 -K-------PYLQSKRRIFQVMDAR---IE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDA 362 (401)
Q Consensus 299 -~-------~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~~~~ 362 (401)
. ...... ......... .. .......+.++.+++.+||+.+|++|||+.++++| +..+......
T Consensus 225 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 225 LGSPSEEDLGFIRNE-KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hCCCChHHhhhcCch-hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 0 000000 000000000 00 00112356778899999999999999999999999 6555444433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=303.53 Aligned_cols=269 Identities=28% Similarity=0.343 Sum_probs=198.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATH---------KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEE---------cCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 46899999999999999999944 44689999999864322 233457789999999999999999988764
Q ss_pred C-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 146 D-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
. ...++||||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~ 145 (336)
T cd07849 75 PSFESFNDVYIVQELM-ETDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDL 145 (336)
T ss_pred ccccccceEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCE
Confidence 4 3579999999 45888877543 3899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc-ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 221 KLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+|+|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+........ ..
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~ 222 (336)
T cd07849 146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LI 222 (336)
T ss_pred EECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH
Confidence 99999998754322211 11233568899999998654 568899999999999999999999997643211100 00
Q ss_pred hhhhhh--cchhhhhhhhh---------hcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhc
Q 015731 299 KPYLQS--KRRIFQVMDAR---------IEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQI 356 (401)
Q Consensus 299 ~~~~~~--~~~~~~~~~~~---------~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i 356 (401)
...... ......+.... .... .....+..+.+++.+||+.||++|||+.++++| ++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 00000000000 0000 011235678899999999999999999999999 4444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=297.38 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=212.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.-+.|+.-++||+|+||.||-+.. ..||+.+|+|.+.+..... ....+.|-.+|.+++.+.||.+--.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqv---------raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQV---------RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred cccceeeeEEEecccccceeEEEE---------ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 346788899999999999999844 4489999999998776533 3346789999999999999999888
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
|++.+.+++||..|.||+|.-+|.+.+. ..+++..+..++.+|+.||++||+.+ ||.|||||+|||+|+.|+++|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEe
Confidence 9999999999999999999999988774 55999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|+|+|.....+.. ....+||.+|||||++.++.|+...|.|+|||++|+|+.|+.||........ |.
T Consensus 329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~e---- 396 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----RE---- 396 (591)
T ss_pred eccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HH----
Confidence 99999998765542 3344899999999999999999999999999999999999999965432111 10
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 352 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~ 352 (401)
.+.+.. ......++...++++.+|...+|+.||.+|.. ++++.+|
T Consensus 397 ----Evdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 397 ----EVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ----HHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 111111 11223566778889999999999999999974 4466555
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.18 Aligned_cols=271 Identities=25% Similarity=0.319 Sum_probs=197.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..++..+|+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARH---------KKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEE---------CCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 35799999999999999999943 446899999988654322 2234568999999999999999999887
Q ss_pred eCC--------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 145 EDD--------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 145 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
... ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~ 154 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITK 154 (310)
T ss_pred cccccccCCCceEEEEEcCC-CcCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECC
Confidence 654 459999999 458888886553 34899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCc--ceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 217 NYNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
++.++|+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+.....
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~ 234 (310)
T cd07865 155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234 (310)
T ss_pred CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999998754332211 112234578889999988654 46889999999999999999999997665432222
Q ss_pred hHHhhhhhh-----hhcchhh--h---hhh---hhhcCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 294 LIEWAKPYL-----QSKRRIF--Q---VMD---ARIEGQ-YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 294 ~~~~~~~~~-----~~~~~~~--~---~~~---~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.+....... ....... . ... ...... .....+..+.+||.+||..||.+|||+.++++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 221110000 0000000 0 000 000000 0011235677899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.00 Aligned_cols=254 Identities=29% Similarity=0.405 Sum_probs=207.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.-+|.-...||.|.||.||.| ++..+|+..|+|-+..... .....+.+|+.++..++|||+++++++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 456777889999999999999 5666899999998765543 23345789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..+|.||||.+|+|.+.+...+. .++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeec
Confidence 99999999999999999999987653 666777778899999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCC--cceeeecccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 225 FGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 225 fg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||.|........ ........||+.|||||++.+. ....+.|||||||++.||+||+.||...+.. |..
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI 1450 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI 1450 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH
Confidence 999986544321 1112356899999999999653 4567899999999999999999999654321 222
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
-+. +...-..+++...+.+-.+||.+||+.||++|+++.++++|
T Consensus 1451 My~---------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 MYH---------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhH---------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 11222334555688889999999999999999999999987
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=280.26 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=204.9
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCeeEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~~l 151 (401)
.++||+|+|+.|-.+ +...+|..||||++.+...-...++.+|++++.+. .|+||++++++|+++..+||
T Consensus 83 ~e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 83 SELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 368999999999887 56678999999999988666677899999999999 49999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc---eEEeeccCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLSDFGLA 228 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~ 228 (401)
|||.+.||+|...|.+... +++..+.++..+|+.||.+||.+| |.||||||+|||....+. +||+||.+.
T Consensus 154 VfEKm~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEecccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999988754 999999999999999999999998 999999999999966544 799999887
Q ss_pred cCCCCCC-----CcceeeecccccCccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 229 KDGPTGS-----QSHVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 229 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.-..... ......+.+|+..|||||+. ....|+.+.|.||||+|+|-||+|.+||.+.-..+= -|.
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWd 302 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWD 302 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----Ccc
Confidence 6422211 11123457899999999976 224689999999999999999999999987543110 021
Q ss_pred hhhhhhcchhhhhhhhhhcCCCC------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
+...-. .-...++...-++.+. ...+.+..+++..+|..|+..|.++..++.|-|
T Consensus 303 rGe~Cr-~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 303 RGEVCR-VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred CCCccH-HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 110000 0001122222222222 235778889999999999999999999999644
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.44 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=201.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|.+.+.||.|+||.||++... .+|..+|+|.+..... .....+.+|+.+++.++|+||+++++.+.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK---------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc---------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4788899999999999999544 4678899999876532 2344677899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-eEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~-~kl~Df 225 (401)
...++|+||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++. ++|+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~ 146 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDF 146 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEeccc
Confidence 999999999999999999976542 34789999999999999999999988 999999999999988764 699999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... +....
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~---- 214 (257)
T cd08225 147 GIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKI---- 214 (257)
T ss_pred ccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH----
Confidence 99876543221 1223468889999999988888999999999999999999999986543211 11100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.... ........+..+.+++.+||..+|++|||+.+++++-
T Consensus 215 ------~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 215 ------CQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred ------hccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 0000 0112223456788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.59 Aligned_cols=272 Identities=25% Similarity=0.307 Sum_probs=200.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..+|++.+.||+|+||.||+|.. ..+|..||+|.+...... ....+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARD---------TTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEE---------CCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 36799999999999999999954 346899999988654322 1234568999999999999999999987
Q ss_pred eC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 145 ED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 145 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+. +..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence 65 56899999995 58988887643 45899999999999999999999988 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh-hh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA-KP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~ 300 (401)
+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....+......+... ..
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07845 150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227 (309)
T ss_pred CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999886543221 1222345788999999865 56789999999999999999999999765443221111100 00
Q ss_pred -------hhhhcc--hhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 301 -------YLQSKR--RIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 301 -------~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...... ........... .......+..+.++|.+||+.||++|||+.+++.|-+.-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 000000 00000000000 000011356778999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=285.93 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=206.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|.+.+.||.|+||.||++... .++..+++|.+..... .....+.+|+++++.++|||++++++.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK---------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc---------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4788899999999999999554 3688999999876543 3455678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++|||++++++|.+++..... ....+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCcc
Confidence 999999999999999999987531 1245899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
.+....... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ . .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~---~------- 213 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---A---L------- 213 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---H---H-------
Confidence 987654332 123345688999999999888889999999999999999999999865432110 0 0
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... ......+...+..+.+++.+||..+|.+|||+.+++++
T Consensus 214 ---~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 ---KILK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---HHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01112233456788899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=290.31 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=196.9
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||+|+||+||+|... .+|..+|+|.+...... ....+..|+.+++.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999998443 46889999998754322 233467899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 72 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred EecCCCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 999999999999976543 35899999999999999999999988 9999999999999999999999999887543
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ....
T Consensus 147 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~ 211 (277)
T cd05577 147 GGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK------------RRTL 211 (277)
T ss_pred cCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH------------hccc
Confidence 211 1223457889999999988889999999999999999999999997654321111110 0000
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
. .....+...+..+.+++.+||+.||.+|| ++.+++.|-+-
T Consensus 212 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 212 E--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred c--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 0 11122334467888999999999999999 77778876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=290.21 Aligned_cols=257 Identities=27% Similarity=0.355 Sum_probs=206.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
....|++.+.||+|+||.||+|... .++..+++|.+..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR---------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc---------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 3466888999999999999999544 3578899999876543 45567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~ 160 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADF 160 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECcc
Confidence 999999999999999999998764 24899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+.....
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------------ 226 (286)
T cd06614 161 GFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------------ 226 (286)
T ss_pred chhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 98865432211 1233457889999999988888999999999999999999999986543211100
Q ss_pred chhhhhhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 306 RRIFQVMDARIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 306 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
........ .......+..+.+++.+||+.+|.+||++.+++++-..-
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 227 ----LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred ----HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 00000000 011112456788999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=286.81 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=204.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||.|+||.||++.. ..++..+++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKR---------LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEE---------CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 478899999999999999843 44688999999876533 2344577899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeecc
Confidence 999999999999999999876321 1245899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.........
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------------- 210 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------------- 210 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------
Confidence 98765443 122345788999999998888899999999999999999999999754321100
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...........+...+.++.+++.+||+.+|.+||++.++++|
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 ---YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001111122334567789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.06 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=224.6
Q ss_pred hHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCccccee
Q 015731 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
+.++....+......||-|.||.||.|+|+.. ...||||.++...+ ..++|+.|..+|+.++|||+|+++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHh
Confidence 55666667777788999999999999988753 45699999876654 456899999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
++|..+..+|||+|||..|+|.+||.+... ..++.-..+.++.||..|++||..++ +|||||...|+||.++..+
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiV 404 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIV 404 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceE
Confidence 999999999999999999999999998875 45788888999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeeccc---ccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHH
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMG---TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 296 (401)
|++|||+++...... .+...| .+-|.|||.+....++.++|||+||++|||+.| |-.||.+-+
T Consensus 405 KvADFGLsRlMtgDT----YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------- 471 (1157)
T KOG4278|consen 405 KVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------- 471 (1157)
T ss_pred EeeccchhhhhcCCc----eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------
Confidence 999999999764432 222233 467999999999999999999999999999987 777886643
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
......++++..+..-+..|+.+++.|+..||+.+|.+||++.|+-+.++.+-..+.
T Consensus 472 --------lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 472 --------LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred --------HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 222345555666666677899999999999999999999999999999998744433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=305.71 Aligned_cols=276 Identities=28% Similarity=0.375 Sum_probs=208.3
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.|...+.||+|+||.||+| ++..+|+.||||.++... ....+.+.+|+++|++|+|||||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred ceeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 3566789999999999999 667799999999998754 344567889999999999999999999755443
Q ss_pred ------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE--cCCC-
Q 015731 148 ------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNY- 218 (401)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~--~~~~- 218 (401)
...+|||||.||+|..++++-... ..+++...+.++.+++.||.|||.+| |+||||||.||++ ..+|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCc
Confidence 568999999999999999865543 44999999999999999999999999 9999999999998 3333
Q ss_pred -ceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
..||+|||.|+...++. .....+||..|++||+.. .+.|+..+|.|||||++|++.||..||..........-+.
T Consensus 161 ~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM 237 (732)
T ss_pred eEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence 46999999999766544 677889999999999998 4889999999999999999999999996544332211121
Q ss_pred hhhhhhhhcc---hhhhhhhhh--------hcCCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhchhcC
Q 015731 297 WAKPYLQSKR---RIFQVMDAR--------IEGQYSLGAALKTAVLAIKCLSNEPKFRP--TMDEVVKALEQIQDTN 360 (401)
Q Consensus 297 ~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rp--s~~eil~~L~~i~~~~ 360 (401)
|....-.... ...+..+.+ ............+-.++..+|..+|.+|. ...+....+..|....
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 2111000000 000000000 11122233444555677889999999999 8888888777775543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.46 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=198.3
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|++.+.||.|++|.||+|... .+|..||+|++...... ....+.+|+.+++.++||||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK---------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEc---------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 677899999999999999543 36889999988755322 2345778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..+++|||+ +++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~ 145 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGL 145 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeeccc
Confidence 999999999 5699999876542 34899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh-HHhhhhhhh--
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQ-- 303 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~-- 303 (401)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... .++......
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 146 ARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred ccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 875432211 12233568889999987654 568899999999999999999999976543221110 000000000
Q ss_pred --hcchhhhhhhh------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 --SKRRIFQVMDA------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
........... ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 00001112334678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=284.05 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=204.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||+|++|.||++... .++..+++|.+..... .....+.+|++++++++|||++++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL---------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc---------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4788999999999999999543 4678899999887654 3445688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..+++|||+.+++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~ 144 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFG 144 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccc
Confidence 99999999999999999987653 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
.+......... .....++..|+|||.+.+..++.++|||+||+++|+|++|..||....... ..|..
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~------- 211 (254)
T cd06627 145 VATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRI------- 211 (254)
T ss_pred cceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHH-------
Confidence 99865443321 233567889999999877778899999999999999999999986543110 00000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
. .......+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 212 -----~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 212 -----V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -----h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0 001112233446688899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=296.73 Aligned_cols=269 Identities=19% Similarity=0.235 Sum_probs=195.7
Q ss_pred CcccCC--CCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
..||+| +||+||++. +..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLAR---------HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEE---------EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 457777 899999994 445789999999875432 2235677899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.+.
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 999999999999999887542 34889999999999999999999988 9999999999999999999999998654
Q ss_pred CCCCCCCc-c----eeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch-hHH-----
Q 015731 230 DGPTGSQS-H----VSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-LIE----- 296 (401)
Q Consensus 230 ~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~----- 296 (401)
........ . ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd08226 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229 (328)
T ss_pred hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence 22111100 0 01112345679999998663 47899999999999999999999997643211100 000
Q ss_pred -hhhhhhhhc----------------------chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 297 -WAKPYLQSK----------------------RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 297 -~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
+........ ..................++..+.+|+.+||+.||++|||+.++++|-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000000000 000000011111122334677899999999999999999999999986
Q ss_pred Hhc
Q 015731 354 EQI 356 (401)
Q Consensus 354 ~~i 356 (401)
+.-
T Consensus 310 ~~~ 312 (328)
T cd08226 310 FFK 312 (328)
T ss_pred HHH
Confidence 643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=289.99 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=200.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+|++.+.||.|++|.||+|.. ..+|..+|+|.+...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRN---------RTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEE---------CCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 488899999999999999954 346889999998765432 2345678999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+. ++|.+++..... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecch
Confidence 9999999996 589888876542 135899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-Hhh-hhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWA-KPYLQS 304 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~-~~~~~~ 304 (401)
+........ ......++..|++||.+.+ ..++.++|||||||++|+|++|..||...........+ ... .+....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 147 ARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224 (284)
T ss_pred hhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 875432211 1223457888999998855 45788999999999999999999999765432211110 000 000000
Q ss_pred cchh---hhhhh------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRI---FQVMD------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~---~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
-..+ ..... ......+....+..+.+++.+||+.||.+||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00000 000001112346778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.82 Aligned_cols=274 Identities=23% Similarity=0.323 Sum_probs=202.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|. +..+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~---------~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAI---------DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEE---------EcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 3689999999999999999994 444688999999876432 23445678999999999999999999876
Q ss_pred e----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 145 E----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 145 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
. ....++||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~ 146 (334)
T cd07855 75 PPGADFKDVYVVMDLM-ESDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCEL 146 (334)
T ss_pred ccCCCCceEEEEEehh-hhhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcE
Confidence 3 35789999999 568999886543 3899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC--cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 221 KLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (334)
T cd07855 147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226 (334)
T ss_pred EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence 9999999875432221 111234578899999998855 4578999999999999999999999976543221111100
Q ss_pred h--hhh---hh--hcchhhhhhhh-hhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 298 A--KPY---LQ--SKRRIFQVMDA-RIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 298 ~--~~~---~~--~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
. .+. .. ....+...... ...... ....+..+.++|++||+.+|.+||++.+++.|-+.-+
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 0 000 00 00000000000 000011 1224678899999999999999999999999866643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=285.05 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=194.3
Q ss_pred HHHHHhCCCCCCCcc--cCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccc
Q 015731 62 GLKTATRNFRPDSVL--GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVK 138 (401)
Q Consensus 62 ~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~ 138 (401)
+.....+.|.+.+.+ |.|+||.||++. +..++..+|+|.+........ |+.....+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~---------~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~ 73 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLK---------HKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIK 73 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEE---------EcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEE
Confidence 334445677887776 999999999994 444688999999876533221 22222212 6999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+++.+...+..++||||+++++|.+++.... ++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAK 146 (267)
T ss_pred EEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCC
Confidence 9999999999999999999999999997653 4899999999999999999999988 99999999999999888
Q ss_pred -ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+
T Consensus 147 ~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~ 219 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL 219 (267)
T ss_pred CeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH
Confidence 9999999998754322 22357889999999988889999999999999999999999997543221 111111
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKA 352 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~eil~~ 352 (401)
.. .... ........+..+.+++.+||+.+|.+||+ ++++++|
T Consensus 220 ~~-----------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 220 LK-----------RQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HH-----------hhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11 0000 01122246678899999999999999996 6999976
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.86 Aligned_cols=269 Identities=28% Similarity=0.331 Sum_probs=199.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc--cchhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
..++|++.+.||+|+||.||+|... .+|..+|+|.+... .......+.+|+.+++++ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 4578999999999999999999543 36889999988543 222334567899999999 99999999998
Q ss_pred EeeC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 143 CLED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 143 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+... ...++||||+. ++|.+++... .+++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcE
Confidence 8643 46899999995 5999888654 3788889999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc---ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 221 KLSDFGLAKDGPTGSQS---HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
+|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999998765433211 12334568999999998754 457889999999999999999999997654332211111
Q ss_pred hhhhhhhh-------cchhhhhhhhhhc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 WAKPYLQS-------KRRIFQVMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 ~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
........ ......++..... .......+..+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 10000000 0000000000000 00011246788999999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=286.93 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=194.4
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||.|+||.||++... .+|..+++|.+..... .....+.+|+.++++++||||+++++.+..+...|++
T Consensus 1 lg~g~~~~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKK---------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999543 4688999999876544 2345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 72 MEYLPGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 99999999999997654 3899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCC------cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 233 TGSQ------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 233 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
.... ........++..|++||.+.+..++.++||||||+++|+|++|..||....+... ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~---------- 211 (265)
T cd05579 145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQ---------- 211 (265)
T ss_pred cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH----------
Confidence 3211 1122335678899999999888889999999999999999999999965442111 00
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 352 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~eil~~ 352 (401)
...............+..+.+++.+||+.+|.+|||+ .+++++
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 212 ---NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ---HHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000001100011136778899999999999999999 666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.41 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=197.9
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEE
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~l 151 (401)
....||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++++++..++..++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hHHHcCCCCCeEEEEEEEc---------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEE
Confidence 3467999999999999543 4688999998865544445568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+++++|.+++... .+++..+..++.|++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 95 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 95 VMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred EEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceec
Confidence 99999999999987543 3788999999999999999999988 999999999999999999999999988754
Q ss_pred CCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ..
T Consensus 167 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------------~~ 231 (292)
T cd06657 167 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------DN 231 (292)
T ss_pred ccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hh
Confidence 32211 1233568889999999988888999999999999999999999997543211111000 00
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
....+. .....+..+.+++.+||..||.+||++.++++|=+
T Consensus 232 ~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 232 LPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred CCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 000000 11123556788999999999999999999999733
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=287.16 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=190.6
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHH---HHHHhccCCCcccceeeEEeeCCe
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTE---IKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e---~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
+||+|+||.||+|.. ..+++.||+|.+....... ...+..| +..++...||||+++++++.+.+.
T Consensus 1 ~ig~g~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEE---------ecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 489999999999943 3468899999887643221 1122333 344555689999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++||||+.|++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~ 144 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA 144 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCc
Confidence 999999999999999887543 4899999999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
....... .....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||............
T Consensus 145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~------------ 208 (278)
T cd05606 145 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------ 208 (278)
T ss_pred cccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH------------
Confidence 7543221 2234689999999998644 6889999999999999999999999765322111100
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
.. ........+...+..+.+++.+||..+|.+|| ++.++++|-+.
T Consensus 209 --~~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 209 --RM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred --HH-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 00 00011122333467899999999999999999 99999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.72 Aligned_cols=279 Identities=28% Similarity=0.358 Sum_probs=207.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+|++.+.||.|+||.||+|.. ..++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVD---------KRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEe---------CCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 588999999999999999954 3468899999887653 23345678899999999999999999998877
Q ss_pred C-----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 147 D-----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 147 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
. ..|+||||+. ++|.+++.... ++++..++.++.||+.||.|||++| ++|+||||+||+++.++.++
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~ 143 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLK 143 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEE
Confidence 5 7899999995 58988886543 4899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-ceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 222 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+....
T Consensus 144 L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 223 (330)
T cd07834 144 ICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223 (330)
T ss_pred EcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence 9999999865443210 112335678899999999877 78999999999999999999999997665322111110000
Q ss_pred h--h---hh--hcchhhhhhhh-hhc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhcCCCCC
Q 015731 300 P--Y---LQ--SKRRIFQVMDA-RIE-----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAGV 364 (401)
Q Consensus 300 ~--~---~~--~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~~~~~~ 364 (401)
. . .. ........... ... .......+..+.+++.+||+.+|.+||++.+++.| ++.+......++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 0 0 00 00000000000 000 00112246778899999999999999999999998 555544433333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=292.10 Aligned_cols=269 Identities=24% Similarity=0.289 Sum_probs=197.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|++|.||+|.. ..+|+.+|+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARD---------RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEe---------cCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 4689999999999999999954 34688999998865432 223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl~D 224 (401)
+...++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~d 146 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLAD 146 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcc
Confidence 999999999994 688888765432 23678888999999999999999988 999999999999985 56799999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-Hhh-hhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWA-KPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~-~~~ 301 (401)
||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....+......+ .+. .+.
T Consensus 147 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 147 FGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred cccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99987543221 11233457889999998865 45788999999999999999999999765432211110 000 000
Q ss_pred h---hhcchhhhhhhh------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 302 L---QSKRRIFQVMDA------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 302 ~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
. .....+...... ..........+..+.+++.+||+.+|++||++.+++++=
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 000000000000 000001123456788999999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.20 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=219.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.....+.++||.|.||.|++|+++.. .+....||||.++.... +....|+.|..||-+++||||+++.+++..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~p------gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLP------GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhheEEEEEEecccccceecccccCC------CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 34567789999999999999987642 23467899999988754 345679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
...+.||+|||++|+|..+|+.+.. .+...+..-++..|+.|++||-+.+ +|||||...||||+.+..+|++||
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccc
Confidence 9999999999999999999988774 3888888999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeeccc--ccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMG--TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|+++...+... ...++..| ..+|.|||.+....++.++||||+|++|||.++ |..||.....++..
T Consensus 776 GLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---------- 844 (996)
T KOG0196|consen 776 GLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---------- 844 (996)
T ss_pred cceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------
Confidence 99997654432 22333333 468999999999999999999999999999776 88888655432221
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..++...+-+.+..++..+.+|+..||+.|-.+||.+.+|+.+|.++..
T Consensus 845 -------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 845 -------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 2223334445677889999999999999999999999999999999843
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=297.78 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=203.6
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~ 150 (401)
.++||.|.||+||-| ++.++|+.||||+|.+.... ....+.+|+.||++++||.||.+...|+..+.+|
T Consensus 569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 589999999999998 77889999999999887653 3456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CCceEEeeccC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGL 227 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~ 227 (401)
+|||.+ .|++.+.+-.... ..+++..-..++.||+.||.|||.++ |+|+||||+|||+.. -.++||||||+
T Consensus 640 VVMEKl-~GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEehhh-cchHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccc
Confidence 999999 5566666654432 45999999999999999999999998 999999999999954 35799999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
|+..+... .....+||+.|+|||++.+..|+..-|+||+|+|+|.-+.|..||....+. .+
T Consensus 714 ARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--nd-------------- 774 (888)
T KOG4236|consen 714 ARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--ND-------------- 774 (888)
T ss_pred eeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hH--------------
Confidence 99876543 455678999999999999999999999999999999999999999643321 11
Q ss_pred hhhhhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
++.++.+--+.. ...+....+||..+|+..-.+|-|....+.|.|.
T Consensus 775 --QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 775 --QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred --HhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 111111111111 2356778899999999999999999999988653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.52 Aligned_cols=263 Identities=18% Similarity=0.191 Sum_probs=188.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-----------HHHHHHHHHHHhccCCCc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN 135 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn 135 (401)
.++|++.++||+|+||.||+|.+... ...+..+|+|+........ ......++..+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 46899999999999999999965431 1124567777644322111 011234455666778999
Q ss_pred ccceeeEEeeCC----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 136 LVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 136 i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
|+++++.+.... ..+++++++ ..++.+.+.... ..++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~N 156 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPEN 156 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 999998765443 447888887 557777765542 2577888999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 286 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 286 (401)
||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999764322111 1122346999999999999899999999999999999999999999765
Q ss_pred CCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 287 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...... +..... ..+..+...... ....+..+.+++..||..+|++||++.++++.|
T Consensus 237 ~~~~~~--~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNL--IHAAKC-----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHH--HHHhHH-----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 321111 100000 000111111110 112356788999999999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.09 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=204.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccC-CCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~-hpni~~~~~~~ 143 (401)
++|.+.+.||+|+||.||+|... .+|..+++|++..... .....+..|+.+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK---------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc---------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 36899999999999999999544 3688999999876432 22345778999999998 99999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..++|||++.+++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~ 144 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKIT 144 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEec
Confidence 99999999999999999999998764 4999999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCc------------------ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 224 DFGLAKDGPTGSQS------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 224 Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
|||++......... .......++..|+|||.+.+..++.++||||||+++++|++|..||..
T Consensus 145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998764332210 112334578899999999888889999999999999999999999976
Q ss_pred CCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHH
Q 015731 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM----DEVVKAL 353 (401)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~eil~~L 353 (401)
...... . .... .....++...+..+.+++.+||+.+|.+||++ +++++|-
T Consensus 225 ~~~~~~---~-------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 225 SNEYLT---F-------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred ccHHHH---H-------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 542110 0 0000 11222333446778899999999999999999 8888763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=288.73 Aligned_cols=248 Identities=29% Similarity=0.377 Sum_probs=195.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.|...+.||+|+||.||+|.. ..+|..+++|.+..... .....+.+|+.+++.++|||++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATN---------SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEE---------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 377778899999999999944 34688999999865432 223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....|+||||+ .++|.+++.... .++++..+..++.||+.+|.|||++| ++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~-~~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 93 EHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred CCEEEEEEecC-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeec
Confidence 99999999999 468888876544 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|++..... .....|+..|+|||.+. ...++.++|||||||++|+|++|..||...........+
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------- 232 (313)
T cd06633 166 GSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 232 (313)
T ss_pred CCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------
Confidence 98864322 22346888999999974 356788999999999999999999998654321111100
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.............+..+.+|+.+||+.+|.+||++.+++.+-+
T Consensus 233 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 233 ---------AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ---------HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0000011111223456889999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=287.90 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=199.0
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeC-
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~- 146 (401)
|++.+.||.|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++|||++++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK---------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 677889999999999999544 358899999998663 22234577899999999999999999999988
Q ss_pred -CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 -DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
...++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccc
Confidence 89999999996 58988886653 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh-h
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-Q 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~ 303 (401)
|++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....... .
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 99886543321 11223456788999997754 457899999999999999999999997655322111111000000 0
Q ss_pred hc-chhhh-----------hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 304 SK-RRIFQ-----------VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 304 ~~-~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.. ..... .....+...+...++..+.+++.+||..+|.+||++.+++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 00 00000 0000000011111367888999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=288.44 Aligned_cols=265 Identities=25% Similarity=0.312 Sum_probs=201.0
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|++.+.||.|++|.||+|. +..++..+++|.+...... ....+..|+.++++++||||+++++++.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKAR---------DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEE---------cCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 6778899999999999994 3446899999998765432 3456778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~ 144 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGL 144 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeee
Confidence 9999999995 58988887653 34899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh--hhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA--KPYLQS 304 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 304 (401)
+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.-. .+....
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 145 ARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred eEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 87654332 112234578889999998766 7889999999999999999999999765432221111000 000000
Q ss_pred cchhhh--------hhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQ--------VMDARI--EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~--------~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...... ...... ........+.++.+++.+||+.||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 000000 001122457789999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.36 Aligned_cols=244 Identities=25% Similarity=0.292 Sum_probs=188.8
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHH-HhccCCCcccceeeEEeeCCee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKH-LGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~-l~~l~hpni~~~~~~~~~~~~~ 149 (401)
+.||.|+||.||+|.. ..+|..+|+|.+....... ...+..|..+ ...++||||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKK---------RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEe---------cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 5799999999999944 4468899999987653321 1223444444 3455899999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|+||||+.+++|.+++.... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 145 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSR 145 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccce
Confidence 99999999999999997653 3899999999999999999999988 9999999999999999999999999887
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
.... .....++..|++||.+.+..++.++||||||+++|+|++|..||...........+ ...
T Consensus 146 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~----- 208 (260)
T cd05611 146 NGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LSR----- 208 (260)
T ss_pred eccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hhc-----
Confidence 5332 22345788999999998878899999999999999999999999654321110000 000
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH---HHHHHHH
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKAL 353 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~eil~~L 353 (401)
...........++..+.+++.+||+.||++||++ +|+++|-
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 209 ---RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred ---ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 0000111122356788999999999999999955 6777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=296.08 Aligned_cols=269 Identities=24% Similarity=0.283 Sum_probs=199.2
Q ss_pred CCCC-CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--------------HHHHHHHHHHHhccC
Q 015731 68 RNFR-PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--------------HLEWLTEIKHLGQLY 132 (401)
Q Consensus 68 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--------------~~~~~~e~~~l~~l~ 132 (401)
++|. +.+.||.|+||.||+|.. ..++..+|+|.+....... ...+.+|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYD---------TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEE---------CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4565 457899999999999954 3468899999886543221 124678999999999
Q ss_pred CCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 133 hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
||||+++++++..++..++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~ni 150 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANI 150 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHe
Confidence 9999999999999999999999995 69999987643 3899999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCC------------CcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhC
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGS------------QSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSG 279 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g 279 (401)
+++.++.++|+|||++....... .........++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999987543110 01111223567889999998654 468899999999999999999
Q ss_pred CCCCCCCCCCccchhHHhhhhhhhhcc--hhhhhhh--------hhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 015731 280 RRVIDKNRPSREHNLIEWAKPYLQSKR--RIFQVMD--------ARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTM 346 (401)
Q Consensus 280 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--------~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~ 346 (401)
.+||...........+. ....... .+..... .... .......+..+.+++.+||+.+|.+|||+
T Consensus 231 ~~p~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIF---ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred CCCCCCCCHHHHHHHHH---HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 99997665422111110 0000000 0000000 0000 00011235678899999999999999999
Q ss_pred HHHHHHHHhc
Q 015731 347 DEVVKALEQI 356 (401)
Q Consensus 347 ~eil~~L~~i 356 (401)
.+++.|-+.-
T Consensus 308 ~~~l~~~~~~ 317 (335)
T PTZ00024 308 KEALKHEYFK 317 (335)
T ss_pred HHHhcCcccC
Confidence 9999987653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.25 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=199.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..|...+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc---------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 45778889999999999999543 3678899998864322 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.....++||||+. ++|.+++.... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~d 158 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGD 158 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECC
Confidence 9999999999995 68888776543 34889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++..... .....++..|+|||.+. ...++.++|||||||++|+|++|..||......... .
T Consensus 159 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~-- 224 (308)
T cd06634 159 FGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------Y-- 224 (308)
T ss_pred cccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------H--
Confidence 998875432 12346788999999874 346788999999999999999999998543211000 0
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
...............+..+.+|+.+||+.+|.+||++.+++++.+.+..
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 225 --------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000000111122456678899999999999999999999999877653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.45 Aligned_cols=271 Identities=24% Similarity=0.278 Sum_probs=198.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|.+.+.||.|+||.||+|.. ..+|..||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~---------~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVD---------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEE---------CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 36899999999999999999954 446899999998776655556688999999999999999999776543
Q ss_pred --------------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 147 --------------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 147 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
...++||||+. ++|.+++... .+++..+..++.||+.||.|||+.| ++||||||+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Ni 145 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANV 145 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHE
Confidence 35799999995 6898888643 3889999999999999999999988 99999999999
Q ss_pred EEc-CCCceEEeeccCCcCCCCCCCc-ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 213 LLD-LNYNAKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 213 l~~-~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
+++ .++.++|+|||.+......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+.
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 997 4567899999998754321111 11122357889999998644 56788999999999999999999999765542
Q ss_pred ccchhHHhhhhhhhh--cc----hhhhhhh-hhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 290 REHNLIEWAKPYLQS--KR----RIFQVMD-ARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~--~~----~~~~~~~-~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.....+....+.... .. ....... ...... .....+.++.+|+.+||+.||.+|||+.+++.|=+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 222111111000000 00 0000000 000000 011245678899999999999999999999987433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.16 Aligned_cols=245 Identities=25% Similarity=0.278 Sum_probs=204.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
....|.+...+|.|+|+.|..+ .+..+++..++|++....... -+|+.++... +||||+++++++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~~----~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADDN----QDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeee---------eccccccchhheecccccccc----ccccchhhhhcCCCcceeecceec
Confidence 4578999999999999999888 566688999999998773221 2455555444 7999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE-cCCCceEEe
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLS 223 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~-~~~~~~kl~ 223 (401)
++.+.|+|||.+.|+-|.+.+.... .....+..|+.+|+.++.|||++| +|||||||+|||+ +..++++|+
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEE
Confidence 9999999999999999988887664 233677789999999999999998 9999999999999 688999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||.++..... ..+.+-|..|.|||++....|+.++|+||||++||+||+|+.||......
T Consensus 459 yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------- 519 (612)
T KOG0603|consen 459 YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------- 519 (612)
T ss_pred EechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------------
Confidence 99999865443 23346788999999999999999999999999999999999999765432
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.++........+....+...++|+.+||+.||.+||++.++..|-|.
T Consensus 520 -----~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 -----IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 12222223344456788899999999999999999999999999888
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.44 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=195.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|... .++..+|+|.+..... .....+..|+.++.++ .||||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK---------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC---------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 367899999999999999999544 3588999999876433 2334456677766666 4999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
++...|++|||+ +++|.+++.... .++++..+..++.||+.||.|||+ ++ ++||||+|+||+++.++.++|+
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEEC
Confidence 999999999998 557887776543 358999999999999999999997 47 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ....
T Consensus 158 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~--- 229 (296)
T cd06618 158 DFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLT--- 229 (296)
T ss_pred ccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHH---
Confidence 9999875432221 12235778899999986543 7889999999999999999999996432110 0000
Q ss_pred hhhhhcchhhhhhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 PYLQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
....... ........+..+.+|+.+||+.||.+||++.+++.+-+.
T Consensus 230 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 230 ----------KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred ----------HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 0000000 000111245678999999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=286.98 Aligned_cols=268 Identities=20% Similarity=0.212 Sum_probs=196.1
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc--cchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|.+.+.+|.|+++.|+++ ..++..+|+|++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 72 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKH-----------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72 (314)
T ss_pred hhhhHhhcCCceEEEEEe-----------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC
Confidence 344455555555555544 236889999998765 2234456889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~~~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~ 147 (314)
T cd08216 73 ELYVVSPLMAYGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRY 147 (314)
T ss_pred eEEEEEeccCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCcc
Confidence 99999999999999999986532 34888999999999999999999988 99999999999999999999999998
Q ss_pred CcCCCCCCC-----cceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 228 AKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 228 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~ 225 (314)
T cd08216 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRG 225 (314)
T ss_pred ceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc
Confidence 864322111 111223456778999999865 3578899999999999999999999976432211 0000000
Q ss_pred h----------hhhcchhh--------hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 301 Y----------LQSKRRIF--------QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 301 ~----------~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
. ........ ...............+..+.+|+.+||+.||++|||+.++++|-+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred cCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 0 00000000 0000111122334556788999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=284.08 Aligned_cols=256 Identities=27% Similarity=0.343 Sum_probs=199.3
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
.|++.+.||+|+||.||.+... ....+|..||+|++..... .....+.+|+.+++++ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~------~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKV------SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEec------cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 3788899999999999998653 2234688999999875432 2234567899999999 599999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
..+...++||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~ 147 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 147 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999997653 3889999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+ ..
T Consensus 148 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~-- 222 (290)
T cd05613 148 DFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SR-- 222 (290)
T ss_pred eCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HH--
Confidence 9999876433221 112235688999999998653 4678999999999999999999999643321111000 00
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 352 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~ 352 (401)
.... ....++...+..+.+++.+||+.||.+|| ++.++++|
T Consensus 223 --------~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 --------RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01122334566788999999999999997 78888887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=284.37 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=194.7
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhcc---CCCcccceeeEEe
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGYCL 144 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l---~hpni~~~~~~~~ 144 (401)
|++.+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.+++++ +||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL---------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEEC---------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 677889999999999999543 36889999998754321 123455677666555 6999999999998
Q ss_pred eCCe-----eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 EDDH-----RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
+.+. .+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~ 145 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQ 145 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCC
Confidence 8776 999999995 589988876542 34899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-Hhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~ 298 (401)
++|+|||.+........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+....+ +..
T Consensus 146 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 146 VKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred EEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 99999999876533221 12335788899999998888999999999999999999999999765432211111 000
Q ss_pred hhhhhhc--chh---hhhhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 299 KPYLQSK--RRI---FQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 299 ~~~~~~~--~~~---~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....... ... ......... .......+..+.+++.+||+.||.+||++.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 000 000000000 01112345778899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.29 Aligned_cols=271 Identities=23% Similarity=0.302 Sum_probs=198.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...+|.+.+.||+|+||.||+|.. ..+|..+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 83 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAID---------KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF 83 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEe---------CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhee
Confidence 347899999999999999999943 34688999999875422 1234577899999999999999999998
Q ss_pred eeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
... ...++||||+. .+|..++. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~ 153 (342)
T cd07879 84 TSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED 153 (342)
T ss_pred cccccCCCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC
Confidence 754 34699999994 57766542 23889999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 154 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred CCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998754321 223457888999999865 457889999999999999999999997654322111111
Q ss_pred hhhhh----h-h--hcchhhhhhhh---hhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhcC
Q 015731 297 WAKPY----L-Q--SKRRIFQVMDA---RIEGQY---SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTN 360 (401)
Q Consensus 297 ~~~~~----~-~--~~~~~~~~~~~---~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~~ 360 (401)
..... + . ........... ...... ....+..+.+|+.+||+.||.+||++.+++.| ++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 10000 0 0 00000000000 000000 01235578899999999999999999999988 76665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=286.74 Aligned_cols=269 Identities=26% Similarity=0.291 Sum_probs=198.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|... .+|..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK---------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC---------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 34578999999999999999999543 3578999999875432 223456789999999999999999999
Q ss_pred EeeCC----------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 143 CLEDD----------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 143 ~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
+.+.. ..++||||+++ +|...+.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~ni 147 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNI 147 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 87654 78999999965 7877776542 35899999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+++.++.++|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||........
T Consensus 148 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~ 226 (302)
T cd07864 148 LLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226 (302)
T ss_pred EECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999876543221 11222346778999998754 3568899999999999999999999975443221
Q ss_pred chhHHhhhhhhhhcchhhhhh--------h------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 292 HNLIEWAKPYLQSKRRIFQVM--------D------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~--------~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
...+...... ........+. + ...... ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 227 LELISRLCGS-PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHhCC-CChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111100000 0000000000 0 000000 11235678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=252.98 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=206.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.|.-.+.||+|+||+||+| .+..+++.||+|.+..... ......++|+-+|+.|+|.||++++++...+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 4566789999999999999 5556899999998876543 2245678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..+-+|+||| ..+|..++..... .++...+..++.|++.||.++|+++ +.||||||.|.+|+.+|++||+|||
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfg 146 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFG 146 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccc
Confidence 9999999999 6799998887663 4899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
+++.++-. .......+.|..|++|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+-.++...+-|.......
T Consensus 147 larafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 147 LARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred hhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 99865432 2234556789999999998765 58999999999999999976 77778877655544444332211110
Q ss_pred c--chhhhhhhhhhcCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 305 K--RRIFQVMDARIEGQYS---------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 305 ~--~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
. -.+..+.+...-.-++ +.....-.++++++|.-+|..|.++++.++|-
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 0 0111122211111111 23344556899999999999999999998863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=291.25 Aligned_cols=269 Identities=27% Similarity=0.325 Sum_probs=195.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..++..+|+|.+....... ...+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQ---------IKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEE---------CCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 46899999999999999999954 3468899999886543322 234668999999999999999999875
Q ss_pred eC--------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 145 ED--------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 145 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
+. ..+++||||+. ++|...+.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~ 150 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDN 150 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 43 35699999994 57877776543 34899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCc---------ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 015731 217 NYNAKLSDFGLAKDGPTGSQS---------HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKN 286 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~ 286 (401)
++.++|+|||++......... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 151 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 151 QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999998754322211 11123457888999998755 35789999999999999999999999765
Q ss_pred CCCccchhHHhhhhh-----hhhcchhhhhh--------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 287 RPSREHNLIEWAKPY-----LQSKRRIFQVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 287 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
........+...... ......+.... ...... ........+.+++.+||+.||.+|||+.+++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 543222111100000 00000000000 000000 001123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=282.64 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=197.7
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~ 147 (401)
|++.+.||+|+||.||+|... .++..+++|.+..... .......+|+..+++++ ||||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK---------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEEC---------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 677889999999999999554 3578899998865432 12233457899999998 999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+ +++|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~ 145 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGL 145 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeeccc
Confidence 999999999 8899998876542 34899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-hhhhh----
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPY---- 301 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~---- 301 (401)
+....... ......++..|+|||.+. +..++.++|+||||+++|+|++|.+||......+....+. +....
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 146 AREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222 (283)
T ss_pred ceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence 87543322 122345788999999874 4457899999999999999999999997664422211110 00000
Q ss_pred hhhcchhhhhhhhhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIE-------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
................ .......+..+.+++.+||+.||.+|||+.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000000 00011124678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.63 Aligned_cols=265 Identities=30% Similarity=0.517 Sum_probs=204.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
...|...++||+|+||.||+|... .++..||+|.+....... ..|+.++++++||||+++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcC
Confidence 356778889999999999999543 357899999886543221 2568889999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..|+||||+++|+|.+++.. +++..+..++.||+.||+|||.. ..+|+||||||+||+++.++..++. |
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 999999999999999999942 78899999999999999999933 1239999999999999988887775 5
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|....... .....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+|.......
T Consensus 827 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~- 898 (968)
T PLN00113 827 SLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD- 898 (968)
T ss_pred cccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-
Confidence 55433211 1223678999999999988999999999999999999999999954322 223444555433221
Q ss_pred chhhhhhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 306 RRIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 306 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.....+.+..+.. ........++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 1222333333322 2334556678899999999999999999999999998865444
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.08 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=197.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~ 146 (401)
+.+-+..||.|+||+|++- .++.+|+..|||.+..... .+..+++.|.....+- +.||||++||.+..+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred hHHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 3444578999999999987 6777999999999987765 4455688888776655 799999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..|+.||+| ..+|..+.+.........+++..+-.|....+.||.||... ..|+|||+||+|||++..|.+||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999 66877665433222225589999999999999999999876 459999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
++-..... ...+...|...|||||.+.. ..|+.++||||||++|||+.||..|+.++.. -+.+
T Consensus 214 IcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------vfeq- 278 (361)
T KOG1006|consen 214 ICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------VFEQ- 278 (361)
T ss_pred chHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------HHHH-
Confidence 98653222 12344578889999999843 4589999999999999999999999976432 1100
Q ss_pred cchhhhhhhh---hhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDA---RIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~---~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
+.+.+.. .+. ..-....+..+..+|.-||..|-..||...+++++
T Consensus 279 ---l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 ---LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0111111 011 11123467888999999999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=281.04 Aligned_cols=243 Identities=28% Similarity=0.404 Sum_probs=202.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHH---HHHHHHHHHhcc-CCCcccceeeE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---EWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
..+|.++.+||+|+||+|.+| .++++.+.+|||++++.-..+.. --+.|-++|... +-|.+++++..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 357889999999999999998 67789999999999876442211 123566677665 46899999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
|+.-+.+|+||||+.||+|...++..+. +.+..+..++..|+-||-+||++| |+.||||.+||+++.+|++||
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEe
Confidence 9999999999999999999999988875 788888999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||+++...... ....+++||+.|+|||++..+.|+..+|.||+|++||||+.|++||++.++....
T Consensus 492 ~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------- 559 (683)
T KOG0696|consen 492 ADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------- 559 (683)
T ss_pred eecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------
Confidence 9999998533222 2456789999999999999999999999999999999999999999987542221
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 345 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps 345 (401)
..+++.. ..++-..+.+...+.+..|...|.+|..
T Consensus 560 ------~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 ------QAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------HHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1222222 2456677888889999999999999963
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.59 Aligned_cols=271 Identities=24% Similarity=0.264 Sum_probs=193.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
+|++.+.||+|+||.||++..... ..+..+|+|.+..... .....+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999965421 1278899998865321 1234577899999999 59999999987543
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
....+++++++ +++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 74 FPGNFNELYLYEELM-EADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred ccccCCcEEEEEecc-cCCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEE
Confidence 24578899998 579999886543 4899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc--ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 222 LSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+...
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~ 225 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHH
Confidence 9999999754332211 11233568999999998755 46889999999999999999999999765422111100000
Q ss_pred ---------hhhhhhc-chhhhhhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 299 ---------KPYLQSK-RRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 299 ---------~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
....... ............. ......+..+.+++.+||+.||.+|||+.+++++=+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 0000000 0000000000000 001113567889999999999999999999998843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=289.27 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=198.6
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||.|+||.||+|.. ..++..+|+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARD---------QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEE---------CCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 3567899999999999999999943 34688999998765322 223457789999999999999999998
Q ss_pred Eee-CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 143 CLE-DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 143 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
+.. ....++||||+ +++|.+++... +++...+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLK 148 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEE
Confidence 875 56789999999 67998888643 3788888999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-h--
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-W-- 297 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~-- 297 (401)
|+|||.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+. .
T Consensus 149 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 149 ICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred eCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998753221 123457888999998765 568899999999999999999999997654321111100 0
Q ss_pred ------hhhhhhhcchhhhhhhhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 298 ------AKPYLQSKRRIFQVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 298 ------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...... .....-..........+ ...+..+.+++.+||+.+|++||++.+++.+=
T Consensus 224 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 224 TPPDDVINTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred CCCHHHHHhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000 00000000000011111 12356888999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=282.27 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=197.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
+|++.+.||+|+||.||++.... ...++..+|+|.+..... .....+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 37788999999999999986432 233578899998875432 2234577899999999 699999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
..+...++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEE
Confidence 99999999999999999999987643 3889999999999999999999988 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||++......... ......|+..|++||.+.+.. ++.++||||||+++|+|++|..||......... .....
T Consensus 148 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~-- 222 (288)
T cd05583 148 DFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISR-- 222 (288)
T ss_pred ECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHH--
Confidence 99998764332211 122346888999999986654 688999999999999999999999643221110 00000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.... .....+...+..+.+++.+||+.||++|||+.++.+.|
T Consensus 223 --------~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 223 --------RILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred --------HHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 0000 01122333556788999999999999999976665544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=290.79 Aligned_cols=273 Identities=24% Similarity=0.312 Sum_probs=202.1
Q ss_pred hhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCccc
Q 015731 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLV 137 (401)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~ 137 (401)
...+....++|.+.+.||+|+||.||+|.. ..++..||+|++.... ......+.+|+.++++++||||+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv 79 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEE---------cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence 344566779999999999999999999944 3468899999987542 22334577899999999999999
Q ss_pred ceeeEEeeC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 138 KLIGYCLED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 138 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~N 150 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN 150 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHH
Confidence 999987643 3478888887 88998887643 3889999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
|+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998754321 223467889999998865 467889999999999999999999996544322
Q ss_pred cchhHHhhh--------hhhhhc--chhhhhhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 291 EHNLIEWAK--------PYLQSK--RRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 291 ~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
....+.... ..+... ......+....... .....+..+.+|+.+||+.||.+||++.+++.|=+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 111110000 000000 00000000000000 001235678899999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=283.05 Aligned_cols=264 Identities=28% Similarity=0.372 Sum_probs=199.7
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
|++.+.||+|+||.||+| ....+++.+|+|.+.... ......+..|+.+++.++||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKA---------RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEe---------eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 567789999999999999 444568999999988753 223345778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~ 144 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGL 144 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCc
Confidence 9999999996 69999998763 24899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-hhh------
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAK------ 299 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~------ 299 (401)
+........ ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+. ...
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 145 ARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred ccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 876433221 12234567789999998666 78899999999999999999999997654322111110 000
Q ss_pred -hhhhh----cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 300 -PYLQS----KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 300 -~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... ............. ......+..+.+++.+||..||++||++.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhhcccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0000000000000 0011225678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=312.58 Aligned_cols=255 Identities=29% Similarity=0.398 Sum_probs=192.8
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+-..+|+.+++||+||||.||++ +++-+|..||||+|.... ......+.+|++.|.+|+|||||+++..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 45577899999999999999999 555679999999987763 23345688999999999999999976532
Q ss_pred ee------------------------------------------------------------------------------
Q 015731 144 LE------------------------------------------------------------------------------ 145 (401)
Q Consensus 144 ~~------------------------------------------------------------------------------ 145 (401)
.+
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 10
Q ss_pred C-----------------------------------------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHH
Q 015731 146 D-----------------------------------------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184 (401)
Q Consensus 146 ~-----------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i 184 (401)
+ ..+||-||||+..+|.+++..+... -.....+++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrL 702 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRL 702 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHH
Confidence 0 1246789999887777777666531 146788999
Q ss_pred HHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC----------------CCCCcceeeecccccC
Q 015731 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP----------------TGSQSHVSTRVMGTYG 248 (401)
Q Consensus 185 ~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~ 248 (401)
+.+|++||.|+|+.| ||||||||.|||+++++.|||+|||+++... .+......+..+||..
T Consensus 703 FreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal 780 (1351)
T KOG1035|consen 703 FREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL 780 (1351)
T ss_pred HHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence 999999999999998 9999999999999999999999999998611 0111113456789999
Q ss_pred cccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhc--CCCCHH
Q 015731 249 YAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLG 323 (401)
Q Consensus 249 y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 323 (401)
|+|||++.+. .|+.|+|+||||+|++||+. ||....+ ... .+..+.+..++ ..+...
T Consensus 781 YvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~-------------iL~~LR~g~iP~~~~f~~~ 842 (1351)
T KOG1035|consen 781 YVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RAS-------------ILTNLRKGSIPEPADFFDP 842 (1351)
T ss_pred eecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHH-------------HHHhcccCCCCCCcccccc
Confidence 9999999664 49999999999999999987 4543211 001 11111111111 223444
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 324 AALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 324 ~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.....+.+|.+||+.||.+||||.|+|+.
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 55677789999999999999999999975
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=290.65 Aligned_cols=268 Identities=23% Similarity=0.276 Sum_probs=198.1
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceee
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~ 141 (401)
....++|++.+.||+|+||.||+|.. ..+|..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALD---------RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEE---------CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence 34567899999999999999999943 34688999998865322 22345778999999999999999999
Q ss_pred EEeeCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 142 YCLEDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 142 ~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
++..+. ..++||||+ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~ 152 (343)
T cd07880 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN 152 (343)
T ss_pred eecCCccccccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 987653 458999999 78998888643 3899999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........
T Consensus 153 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 153 EDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred CCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998764322 123457889999999865 4578899999999999999999999976543111100
Q ss_pred H-Hhhh----hhhhh--cchhhhhhhhh--hc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 295 I-EWAK----PYLQS--KRRIFQVMDAR--IE----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 295 ~-~~~~----~~~~~--~~~~~~~~~~~--~~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
+ .... .+... ........... .. .......+..+.+++.+||+.||.+|||+.+++.|-+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 0000 00000 00000000000 00 0011134556889999999999999999999997743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=278.17 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=194.5
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc---cc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~---~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
+|.+.+.||+|+||.||++.... ++..+++|++... .. .....+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58899999999999999985442 3444555544332 11 2233466789999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+....++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeec
Confidence 999999999999999999998865321 1245899999999999999999999988 999999999999975 569999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~---- 215 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVL---- 215 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHH----
Confidence 9999876433221 2233467889999999988888899999999999999999999986432110 000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... ......+...+..+.+++.+||..||.+||++.++++|
T Consensus 216 ------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 ------RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0000 11112234566788899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=293.26 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=215.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+++.+..||-|+||.|-++..+.. ...+|+|++++....+ .+.+..|-++|..++.|.||++|-.|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 4566777899999999998866542 2358999988876543 344778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+...+||+||-|-||.|...+...+. ++......++..+++|++|||++| ||.|||||+|++++.+|-+||.|
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEee
Confidence 99999999999999999999998875 888889999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+|+....+. ...+++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++..-.+.|-.+...+
T Consensus 564 FGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-- 638 (732)
T KOG0614|consen 564 FGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-- 638 (732)
T ss_pred hhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--
Confidence 99999876554 5678999999999999999999999999999999999999999999988866655543222111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~~i 356 (401)
.++........+|++++...+|.+|.. +.+|-+|-|..
T Consensus 639 --------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 639 --------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred --------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 223334456778999999999999975 88999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.65 Aligned_cols=267 Identities=25% Similarity=0.296 Sum_probs=199.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|... .++..+|+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT---------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC---------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 4578999999999999999999543 468899999886532 22334567899999999999999999987
Q ss_pred eeCCe------eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LEDDH------RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
...+. .++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.| |+|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~ 154 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED 154 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC
Confidence 76554 89999999 77999988753 3899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH-
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI- 295 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~- 295 (401)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus 155 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 155 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999998864322 223467888999998855 36788999999999999999999999765432211110
Q ss_pred Hhhh---hhhhhc---chhhhhhhhh-hc--CC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 296 EWAK---PYLQSK---RRIFQVMDAR-IE--GQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 296 ~~~~---~~~~~~---~~~~~~~~~~-~~--~~---~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.... +.+... ......+... .. .. .....+..+.+++.+||+.||.+|||+.+|++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0000 000000 0000000000 00 00 001236788999999999999999999999998443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.32 Aligned_cols=241 Identities=31% Similarity=0.399 Sum_probs=195.3
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
||.|+||.||++... .++..+++|.+...... ....+..|+.+++.++||||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKK---------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 699999999999543 35789999998765432 344678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 144 (250)
T cd05123 72 LEYAPGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELS 144 (250)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence 99999999999997664 3899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 233 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... .......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .... ...
T Consensus 145 ~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~-------------~~~ 206 (250)
T cd05123 145 SEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE-------------KIL 206 (250)
T ss_pred cCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH-------------HHh
Confidence 321 1223456788999999998888889999999999999999999999654321 0000 000
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 352 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~---~eil~~ 352 (401)
. .....+...+..+.+++.+||..||++||++ .++++|
T Consensus 207 ~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 207 K--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred c--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 0 1112233346788899999999999999999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=268.61 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=201.2
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhcc-CCCccccee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
...++|.++++||+|+|++|..+ ....|.+.+|+|+++++-..+ ...+..|-.+..+. +||.++-++
T Consensus 247 l~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence 34578999999999999999887 555688999999998764322 22234565666554 699999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
.+|+.+..+|+|.||++||+|.-.++++.. ++++.+..+...|+.||.|||+.| |+.||||.+|+|++..|++
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCce
Confidence 999999999999999999999988887754 999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-CCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~ 299 (401)
||+|||+++... .......+++||+.|.|||++.+..|+..+|.|+||++++||+.|+.||+--. ...+.+.-++
T Consensus 391 kltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy-- 466 (593)
T KOG0695|consen 391 KLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY-- 466 (593)
T ss_pred eecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH--
Confidence 999999998532 12234677999999999999999999999999999999999999999996421 1111111111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 345 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps 345 (401)
-++-++++.++ .+...+.+...+++..|+.||.+|..
T Consensus 467 -------lfqvilekqir--iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 467 -------LFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------HHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11223333332 34455667778999999999999953
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.19 Aligned_cols=146 Identities=27% Similarity=0.350 Sum_probs=129.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|.+.+.||+|+||.||+|+.. .++..||+|++...... ....+..|+.+++.++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK---------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 57999999999999999999554 36889999998765332 2345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
..+..||||||+.+++|.+++.... .+++..++.++.||+.||.|||.++ |+||||||+|||++.++.++|+|
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~D 147 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTD 147 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEe
Confidence 9999999999999999999997654 3788999999999999999999988 99999999999999999999999
Q ss_pred ccCCc
Q 015731 225 FGLAK 229 (401)
Q Consensus 225 fg~~~ 229 (401)
||+++
T Consensus 148 FGls~ 152 (669)
T cd05610 148 FGLSK 152 (669)
T ss_pred CCCCc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=297.34 Aligned_cols=256 Identities=28% Similarity=0.370 Sum_probs=210.8
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
...+..|++.++||.|.+|.||++ .+..+|+..|+|++...... .+++..|.++|+.+ +|||++.++++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344577999999999999999999 56667888999988766533 34567889999888 69999999999
Q ss_pred Eee-----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 143 CLE-----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 143 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
|.. ++++|||||||.||+..|+++.... ..+.|..+..|++.++.||.|||.+. ++|||||-.|||++.+
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN 159 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc
Confidence 863 5789999999999999999988763 66999999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
+.|||+|||++....... ....+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+....|....
T Consensus 160 ~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred CcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 999999999988654332 24556789999999999843 35778999999999999999999999877664433
Q ss_pred hhHHhhhhhhhhcchhhhhhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDAR-IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..| ...+ ..-.-+..-+.++-++|..||..|..+||+..++++|
T Consensus 238 F~I----------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 FLI----------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccC----------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 222 1111 1111234456778899999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.66 Aligned_cols=272 Identities=26% Similarity=0.396 Sum_probs=202.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc--cCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~hpni~~~~~~~~~ 145 (401)
....+.++||+|.||.||+|.++ ++.||||++.... ...|.+|-+|.+. +.|+||+++++.-.-
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 44566789999999999999765 4679999997654 3355566666654 589999999987654
Q ss_pred CC----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-------CCCeEEeccCCCcEEE
Q 015731 146 DD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILL 214 (401)
Q Consensus 146 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------~~~ivH~dlkp~Nil~ 214 (401)
.. .++||++|.+.|+|.++|+.+. ++|....+++..++.||+|||.. +++|+|||||.+||||
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 44 8899999999999999999876 89999999999999999999964 3679999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC-CC-----cccchhhHHHHHHHHHhCCCCCCC-CC
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LT-----AKSDVYSFGVVLLEMLSGRRVIDK-NR 287 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~~ll~g~~p~~~-~~ 287 (401)
..|++..|+|||+|.++..+.........+||.+|||||++.+.. +. .+.||||+|.++|||++....+.. ..
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 999999999999999877665554555689999999999997642 22 468999999999999997665532 11
Q ss_pred CCccchhH-H-hhhhhhhhcchhhh-hhhhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 288 PSREHNLI-E-WAKPYLQSKRRIFQ-VMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 288 ~~~~~~~~-~-~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+....-+. + ...+-+. ..+. .+.++.+..++ .....-+.+.+..||..||+.|.|+.=+.+++.++.-.
T Consensus 430 p~Yqlpfe~evG~hPt~e---~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 430 PEYQLPFEAEVGNHPTLE---EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CcccCchhHHhcCCCCHH---HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11110000 0 0011111 1111 11122222222 23456678899999999999999999999999988655
Q ss_pred CCC
Q 015731 360 NDA 362 (401)
Q Consensus 360 ~~~ 362 (401)
...
T Consensus 507 ~~~ 509 (534)
T KOG3653|consen 507 WED 509 (534)
T ss_pred CCc
Confidence 543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=270.75 Aligned_cols=226 Identities=21% Similarity=0.226 Sum_probs=179.3
Q ss_pred CCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEEecCC
Q 015731 79 GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (401)
Q Consensus 79 G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~ 158 (401)
|.||.||+++ +..+++.+|+|.+..... ...|...+....||||+++++++.+.+..++||||+++
T Consensus 4 g~~~~v~~~~---------~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVM---------DTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEE---------EccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999994 455789999999876532 22344455556799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcc
Q 015731 159 GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 159 ~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 238 (401)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+......
T Consensus 70 ~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---- 138 (237)
T cd05576 70 GKLWSHISKFL-----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---- 138 (237)
T ss_pred CCHHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc----
Confidence 99999997653 3899999999999999999999988 999999999999999999999999987654322
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcC
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEG 318 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (401)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+........ . ....
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~----~~~~ 195 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------T----HTTL 195 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------c----cccc
Confidence 1223456779999999888889999999999999999999988753211000 0 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015731 319 QYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 352 (401)
Q Consensus 319 ~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~ 352 (401)
..+...+..+.+++.+||+.||.+||++ +++++|
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 1223345678899999999999999986 666554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=268.01 Aligned_cols=272 Identities=27% Similarity=0.337 Sum_probs=208.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..|+-...||+|.||.||+| ....+|+.||+|++-.+... -....++|+++|..|+|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 45777789999999999999 45557889999977554321 23346799999999999999999887753
Q ss_pred --------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 146 --------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
...+|+||++|+. +|.-++.+.. ..++...+.+++.+++.||.|+|... |+|||+|++|+||+.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD 160 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC
Confidence 3458999999954 8998887664 45899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCC--CcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 218 YNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
|.++|+|||+++.+.... .....+..+.|..|++||.+.| ..|++..|||..|||+.||+++.+.+.+........+
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 999999999997543222 1223455667999999998865 5799999999999999999999999998877666555
Q ss_pred HHhhhh--------hh------hh------cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 295 IEWAKP--------YL------QS------KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 295 ~~~~~~--------~~------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
|...-. .. .. .+.....+..++ .+.....+..+|+.++|..||.+|+++.+++.|..
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~---kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRL---KPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhc---ccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 532110 00 00 000111111111 12233557889999999999999999999999987
Q ss_pred hchh
Q 015731 355 QIQD 358 (401)
Q Consensus 355 ~i~~ 358 (401)
...+
T Consensus 318 F~kd 321 (376)
T KOG0669|consen 318 FWKD 321 (376)
T ss_pred hhcC
Confidence 7644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=294.57 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=214.4
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
.+..++||.|+||+||+|.|-. ....-..+||+|++..... +...++++|+.+|.+|+|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 3446789999999999998765 4445577899998876544 45678999999999999999999999998766
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
+.||++|+++|.|.++++..+ ..+..+..+.|.+||++|+.|||.++ +|||||-..||||..-..+||.|||++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchh
Confidence 888999999999999999876 45888999999999999999999988 999999999999999999999999999
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
+...............-.+-|+|-|.+....|+.++|||||||++||++| |..|+++....+
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------- 908 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------- 908 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------
Confidence 97665544333333344667999999999999999999999999999998 888887754322
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+.+++....+-.-+..++.+++.++.+||..|+..||+++++...+.++
T Consensus 909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 2223332223344667888999999999999999999999999988876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=272.01 Aligned_cols=270 Identities=27% Similarity=0.369 Sum_probs=206.2
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc--cCCCcc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNL 136 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~hpni 136 (401)
.+--.++..++..+.+.||+|.||.||+|.|. |+.||||++...+ ...|.+|.++++. |+|+||
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchh
Confidence 34445678899999999999999999999886 6789999997654 3457788888776 489999
Q ss_pred cceeeEEeeC----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC------CCCeEEec
Q 015731 137 VKLIGYCLED----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRD 206 (401)
Q Consensus 137 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~d 206 (401)
+.+++.-..+ .+++||++|.+.|+|+|+|.+.. ++....++++..++.||+|||.. ++.|.|||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 9998865543 36899999999999999998854 89999999999999999999943 46799999
Q ss_pred cCCCcEEEcCCCceEEeeccCCcCCCCCCC--cceeeecccccCcccccccccC----CC--CcccchhhHHHHHHHHHh
Q 015731 207 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG----HL--TAKSDVYSFGVVLLEMLS 278 (401)
Q Consensus 207 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DiwslG~il~~ll~ 278 (401)
||..||||..++.+.|+|+|+|........ .......+||.+|||||++... .+ -..+||||||.++||+..
T Consensus 342 lKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 342 LKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999999999986544321 1123456899999999998442 11 146899999999999876
Q ss_pred C----------CCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhh-----cCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 279 G----------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARI-----EGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 279 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
. +.||.+.-+.+... ..........++ ..+.+.+.-..+..+++.||..||.-|
T Consensus 422 Rc~~ggi~eey~~Pyyd~Vp~DPs~-----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 422 RCESGGIVEEYQLPYYDVVPSDPSF-----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HhhcCCEehhhcCCcccCCCCCCCH-----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 3 35554433322110 000011111111 223344566778889999999999999
Q ss_pred CCHHHHHHHHHhchhc
Q 015731 344 PTMDEVVKALEQIQDT 359 (401)
Q Consensus 344 ps~~eil~~L~~i~~~ 359 (401)
.|+-.|.+.|.++.+.
T Consensus 491 ltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 491 LTALRIKKTLAKLSNS 506 (513)
T ss_pred hHHHHHHHHHHHHhcC
Confidence 9999999999998754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=277.52 Aligned_cols=267 Identities=24% Similarity=0.344 Sum_probs=207.4
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-h------hHHHHHHHHHHHhcc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-Q------GHLEWLTEIKHLGQL 131 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~------~~~~~~~e~~~l~~l 131 (401)
.|++..+..++|-++.+||+|||+.||+|. +....+.||+|+-..... . -.+...+|.+|-+.|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAF---------Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL 524 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAF---------DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL 524 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhc---------ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc
Confidence 345556667889999999999999999994 444578899998654321 1 122366899999999
Q ss_pred CCCcccceeeEEe-eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCC
Q 015731 132 YHPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 132 ~hpni~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 210 (401)
+||.||++|++|. +.+.+|-|+|||+|.+|.-+|+.... ++++.+..|+.||+.||.||....++|||-||||.
T Consensus 525 DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg 599 (775)
T KOG1151|consen 525 DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG 599 (775)
T ss_pred CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence 9999999999986 55678889999999999999988764 89999999999999999999999999999999999
Q ss_pred cEEEc---CCCceEEeeccCCcCCCCCCCc-----ceeeecccccCccccccccc----CCCCcccchhhHHHHHHHHHh
Q 015731 211 NILLD---LNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLS 278 (401)
Q Consensus 211 Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~ 278 (401)
|||+. ..|.+||+|||+++........ .......||.+|++||.+.- ...+.++||||+|||+|..+.
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99993 4588999999999876544322 23455789999999998733 356889999999999999999
Q ss_pred CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 279 GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR-IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 279 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
|+.||..... ..++.+. . .++... ..-+..+.++.+..+||.+||+.--++|....++..+
T Consensus 680 GrKPFGhnqs--QQdILqe-------N----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 680 GRKPFGHNQS--QQDILQE-------N----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cCCCCCCchh--HHHHHhh-------h----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 9999975432 1111110 0 111111 1112234567888999999999999999998888765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=266.68 Aligned_cols=269 Identities=20% Similarity=0.287 Sum_probs=199.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-----C---Ccccce
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----H---PNLVKL 139 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pni~~~ 139 (401)
.+|.+.+.||.|.|++||+|++.. ..+.||+|+.+...-.. +..+.|+++|+++. | .+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAqhYt-EaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQHYT-EAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhhHHH-HHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 789999999999999999997664 46889999998765432 34578999999883 3 369999
Q ss_pred eeEEee----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 140 IGYCLE----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 140 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
++.|.. +.++|||+|++ |.+|..+|..... +.++...+.+|++||+.||.|||.. ++|||-||||+|||+.
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLC 222 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeee
Confidence 999874 57999999999 8899999987764 6699999999999999999999987 6799999999999972
Q ss_pred CCC-----------------------------------------------------------------------------
Q 015731 216 LNY----------------------------------------------------------------------------- 218 (401)
Q Consensus 216 ~~~----------------------------------------------------------------------------- 218 (401)
.+.
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s 302 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES 302 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence 110
Q ss_pred --------------------------------------------------------------------------------
Q 015731 219 -------------------------------------------------------------------------------- 218 (401)
Q Consensus 219 -------------------------------------------------------------------------------- 218 (401)
T Consensus 303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p 382 (590)
T KOG1290|consen 303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP 382 (590)
T ss_pred cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence
Q ss_pred ---------ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 219 ---------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 219 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
.+||+|||.|+.... ..+....|..|+|||++.+..|+..+||||++|++|||.||...|+...-.
T Consensus 383 ~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~ 457 (590)
T KOG1290|consen 383 DIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE 457 (590)
T ss_pred CCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence 023333333332110 122335688899999999999999999999999999999999998654321
Q ss_pred c---c-chhH-----------------Hhhhhhhhhcchhhhhhhhhh---------cCCCCHHHHHHHHHHHHHccccC
Q 015731 290 R---E-HNLI-----------------EWAKPYLQSKRRIFQVMDARI---------EGQYSLGAALKTAVLAIKCLSNE 339 (401)
Q Consensus 290 ~---~-~~~~-----------------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~d 339 (401)
. + ..+. ++.+.++.....+..+-.-+. .-.++...+.++.+|+.-||+.+
T Consensus 458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 1 1 1111 112222222222221111110 12356678889999999999999
Q ss_pred CCCCCCHHHHHHHHHhc
Q 015731 340 PKFRPTMDEVVKALEQI 356 (401)
Q Consensus 340 p~~Rps~~eil~~L~~i 356 (401)
|++||||.++|+|-|.-
T Consensus 538 PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLN 554 (590)
T ss_pred ccccccHHHHhcCcccc
Confidence 99999999999997653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.79 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=199.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH---HHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.-|..++.||-|+||.|.+++- ..|...||+|.+.+.+.-.. ..+..|-.||..-+.+-||++|-.|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~K---------vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRK---------VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred cceEEEeeecccccceeEEEee---------cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3466678899999999999843 33678899999988765332 33678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+.+|+||+|++||++..+|.+.+- +.+..+..++..+.+|+++.|..| +|||||||+|||||.+|+|||+|
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeee
Confidence 99999999999999999999988875 889999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCC---------CCCCCcce-------------------------------eeecccccCcccccccccCCCCccc
Q 015731 225 FGLAKDG---------PTGSQSHV-------------------------------STRVMGTYGYAAPEYMATGHLTAKS 264 (401)
Q Consensus 225 fg~~~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 264 (401)
||+++-+ ..+..... .-..+||+.|+|||++....|+..+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 9998621 11100000 1135799999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCCccc-hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 265 DVYSFGVVLLEMLSGRRVIDKNRPSREH-NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 265 DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
|.||.|||||||+.|++||....+..-. .++.|...+ .-.+....+.++.++|.+++. +++.|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l---------------~~~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFL---------------HIPYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcc---------------ccccccccCHHHHHHHHHHhc-Chhhh
Confidence 9999999999999999999887775543 344443311 122334456677777776543 77777
Q ss_pred C---CHHHHHHH
Q 015731 344 P---TMDEVVKA 352 (401)
Q Consensus 344 p---s~~eil~~ 352 (401)
. -+.+|..|
T Consensus 917 LGkng~d~vKaH 928 (1034)
T KOG0608|consen 917 LGKNGADQVKAH 928 (1034)
T ss_pred hcccchhhhhcC
Confidence 6 33445444
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.53 Aligned_cols=272 Identities=26% Similarity=0.392 Sum_probs=212.9
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceee
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~ 141 (401)
+...++..+.+.||+|.||.|++|........ .......||||.+..... .+...+..|+++++.+ .||||+.+++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~--~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKA--LLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccc--cccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34445556777999999999999976642210 012367899999876543 3456688999999999 6999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcC---------CCCCC--CCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCC
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTG---------ASYIQ--PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 210 (401)
++.+.+..++|+||+..|+|.+++.... ..... .++....+.++.||+.|++||++.. +|||||-+.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaR 447 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAAR 447 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhh
Confidence 9999999999999999999999998877 11112 3899999999999999999999987 999999999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcceeeecc--cccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM--GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 287 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 287 (401)
|||++.+..+||+|||+++.......... .... -...|||||.+....|+.++||||+|+++||+++ |..|+.+-.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999986444332211 1111 2345999999998999999999999999999998 778886522
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.. .. +.+.+....+...+..++.+++++++.||+.+|++||++.++.+.++..
T Consensus 527 ~~--~~--------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PT--EE--------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cH--HH--------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 10 01 1111222222344566788999999999999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.54 Aligned_cols=276 Identities=23% Similarity=0.323 Sum_probs=219.2
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCccc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLV 137 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~ 137 (401)
...++.....++++..++-+|.||.||+|.|.++. ...+.+.+.+|.++.... -+...++.|-..+..+.|||+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 45556666778999999999999999999776542 223345566776655432 2334578899999999999999
Q ss_pred ceeeEEee-CCeeEEEEEecCCCChHHHHhhcCC---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 138 KLIGYCLE-DDHRLLVYEFMPKGSLENHLFRTGA---SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 138 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
.+.+++.+ ....++++.++.-|+|..++...+. ...+.++..+...++.|++.|++|||+++ +||.||...|++
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCv 428 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCV 428 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcce
Confidence 99998765 4677899999999999999973322 23356777888899999999999999999 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
|++..++||+|=.+++..-+.+.............||+||.+.+..|+.++|+||||+++|||+| |+.|+..-+|.+..
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999987655554444444455678999999999999999999999999999998 88898776664443
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.+++ +...+ .-+..++++++.++..||..+|++||+++++...|.++.
T Consensus 509 ~ylk-------dGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 HYLK-------DGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHh-------cccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 3332 22222 225678889999999999999999999999999998874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=254.63 Aligned_cols=238 Identities=32% Similarity=0.422 Sum_probs=192.3
Q ss_pred CCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEEecCC
Q 015731 80 GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (401)
Q Consensus 80 ~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~ 158 (401)
+||.||+|... .+|..+++|++....... ...+.+|++.+++++|+||+++++++......+++||++.+
T Consensus 1 ~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDK---------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEEC---------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 58999999554 368899999998765544 56788999999999999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcc
Q 015731 159 GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 159 ~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 238 (401)
++|.+++..... ++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.......
T Consensus 72 ~~L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--- 141 (244)
T smart00220 72 GDLFDLLKKRGR-----LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--- 141 (244)
T ss_pred CCHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---
Confidence 999999876542 889999999999999999999988 9999999999999999999999999998654432
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcC
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEG 318 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (401)
......++..|++||.+.+..++.++|||+||+++|+|++|..||...... ....+ ........
T Consensus 142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~--------------~~~~~~~~ 205 (244)
T smart00220 142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK--------------KIGKPKPP 205 (244)
T ss_pred ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH--------------HHhccCCC
Confidence 233456788999999998888899999999999999999999998653110 01111 00000000
Q ss_pred CCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 319 QYSLG--AALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 319 ~~~~~--~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... .+..+.+++.+||..+|++||++.+++++
T Consensus 206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 00011 45678899999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=285.03 Aligned_cols=271 Identities=19% Similarity=0.237 Sum_probs=172.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeE---
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGY--- 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~--- 142 (401)
..++|.+.+.||+|+||.||+|+.... ....+..||+|++...... +.+..+ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~-----~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNK-----QSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCC-----ccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 457899999999999999999976541 1123789999987643221 111111 1222222233222221
Q ss_pred ---EeeCCeeEEEEEecCCCChHHHHhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 143 ---CLEDDHRLLVYEFMPKGSLENHLFRTGASY---------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 143 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
..++...++||||+.+++|.+++....... ........+..++.||+.||.|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 245678999999999999999987543110 001123456789999999999999988 999
Q ss_pred eccCCCcEEEcC-CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC----------------------CCC
Q 015731 205 RDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----------------------HLT 261 (401)
Q Consensus 205 ~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 261 (401)
|||||+|||++. ++.+||+|||++........ .......+++.|+|||.+... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 57999999999975433221 123456789999999965322 234
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh---hhhhhh----cCCC--CHHHHHHHHHHH
Q 015731 262 AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ---VMDARI----EGQY--SLGAALKTAVLA 332 (401)
Q Consensus 262 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~--~~~~~~~~~~li 332 (401)
.++|||||||++|||+++..++... ...+............. ...... ...+ .........+||
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 5679999999999999976554321 11111000000000000 000000 0000 001123455899
Q ss_pred HHccccCCCCCCCHHHHHHHHHh
Q 015731 333 IKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 333 ~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+||+.||.+|||+.++++|=+.
T Consensus 431 ~~mL~~dP~kR~ta~e~L~Hpff 453 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAHPYF 453 (566)
T ss_pred HHHccCCcccCCCHHHHhCCcCc
Confidence 99999999999999999999544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=256.78 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=206.7
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc--cchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+.+..+-||.|+||.||.+ .+..+|+.||+|++... +....+.+.+|+++|.-++|.|++..+++..-.
T Consensus 54 Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 4566789999999999987 66778999999988654 334556788999999999999999998887644
Q ss_pred -----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 147 -----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
..+|+|+|++ ..+|...+-.- ++++...+.-+++||+.||+|||+.+ |.||||||.|.|++.|..+|
T Consensus 125 h~dfFqEiYV~TELm-QSDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLK 196 (449)
T KOG0664|consen 125 NPSFFQELYVLTELM-QSDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILK 196 (449)
T ss_pred CchHHHHHHHHHHHH-HhhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEE
Confidence 2468888988 55888777443 56899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|||||+++...... ...++..+.|.+|+|||++.|. .|+.+.||||+|||+.||+..+..|....+....++|.....
T Consensus 197 ICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 197 ICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred ecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 99999999754433 3345666789999999999774 689999999999999999999999998888776666532111
Q ss_pred --hhhh-----cchhhhhhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 301 --YLQS-----KRRIFQVMDARIEGQ---------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 301 --~~~~-----~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..++ ......++....+.. -+.....+...++.++|..||.+|.+..+.+.++.
T Consensus 276 TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 276 TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1100 000111111111110 11233456677888999999999999999998863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.13 Aligned_cols=284 Identities=19% Similarity=0.207 Sum_probs=188.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCc-------cCCCCCCCcEEEEEEcccccchhHHH--------------HHHH
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESLQGHLE--------------WLTE 124 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~~avK~~~~~~~~~~~~--------------~~~e 124 (401)
..++|.+.++||+|+||.||+|....... .......+..||||.+.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 35689999999999999999997532110 11233456789999986543222222 2346
Q ss_pred HHHHhccCCCcc-----cceeeEEee--------CCeeEEEEEecCCCChHHHHhhcCCC-------------------C
Q 015731 125 IKHLGQLYHPNL-----VKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRTGAS-------------------Y 172 (401)
Q Consensus 125 ~~~l~~l~hpni-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~ 172 (401)
+..+.+++|.++ ++++++|.. .+..++||||+.+++|.+++...... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766544 566666543 35689999999999999998753211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccc
Q 015731 173 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252 (401)
Q Consensus 173 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 252 (401)
...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++......... ......+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 123567788999999999999999988 999999999999999999999999998754322211 11122347899999
Q ss_pred cccccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 253 EYMATGH--------------------L--TAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 253 E~~~~~~--------------------~--~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
|.+.... | ..+.||||+||++|+|++|.. ||......... ...+. .+...+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~----~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYD----NDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhcc----chHHHHH
Confidence 9874322 1 124799999999999999875 66432211100 00000 0000000
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHHhch
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEP---KFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rps~~eil~~L~~i~ 357 (401)
...............+....+|+.+||..+| .+|+|+.|+|+|-+...
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0111111111123456788899999999866 68999999999977643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.16 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=188.4
Q ss_pred CCCCCcccCCCCee-EEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGC-VFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~-V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~ 147 (401)
|.-.+++|.|+-|+ ||+|.+. |+.||||.+-.+.. .-+.+|+..|+.- +|||||++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44457899999987 5898765 67899998866543 2345899999888 5999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---C--CceEE
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---N--YNAKL 222 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~--~~~kl 222 (401)
+.||..|.| ..+|.+++...... .........+.++.|++.||+|||+.+ ||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEe
Confidence 999999999 77999999875211 111121445788999999999999987 999999999999964 2 56899
Q ss_pred eeccCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCccchhHHhhhh
Q 015731 223 SDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+|||+++....+...- ......||.+|+|||++....-..++|||||||++|+.++| ..||...-.- +.+
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N------- 724 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN------- 724 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------
Confidence 9999999876554322 24567899999999999888888899999999999999997 8899754210 000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.+.....+..+ ......+..+||.+|++++|..||++.+||.|
T Consensus 725 Il~~~~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 725 ILTGNYTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hhcCccceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111111111 00111177899999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=265.71 Aligned_cols=271 Identities=21% Similarity=0.208 Sum_probs=207.0
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC------CCcc
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY------HPNL 136 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~------hpni 136 (401)
.+....+|.+....|+|-|++|.+|. +...|..||||+|....... ..=+.|+++|++|+ --|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~---------D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRAR---------DQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeecc---------ccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHH
Confidence 35566889999999999999999994 44457799999998775432 23468999999995 3478
Q ss_pred cceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 137 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
++++-.|...+++|||||-+ ..+|.++|++.+.+ -.|....+..++.|+..||..|...| |+|.||||+||||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEecc
Confidence 99999999999999999998 77999999988765 34888899999999999999999988 999999999999976
Q ss_pred C-CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 217 N-YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
. ..+||||||.|....... .+-+..+..|.|||++.|-.|+...|+||+||+||||.||+..|.+........+.
T Consensus 572 ~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred CcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 5 568999999998654433 22344567899999999999999999999999999999999999887654433221
Q ss_pred Hh-----hhhhhhhcchhhhhhhhh--------------------------------hc--CCC---CHHHHHHHHHHHH
Q 015731 296 EW-----AKPYLQSKRRIFQVMDAR--------------------------------IE--GQY---SLGAALKTAVLAI 333 (401)
Q Consensus 296 ~~-----~~~~~~~~~~~~~~~~~~--------------------------------~~--~~~---~~~~~~~~~~li~ 333 (401)
-- ....+.......+-++.. +. ..+ ....-..+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 00 000000000000000000 00 012 2234566788999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 015731 334 KCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 334 ~~L~~dp~~Rps~~eil~~ 352 (401)
+||..||++|.|..++|+|
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=239.06 Aligned_cols=265 Identities=19% Similarity=0.239 Sum_probs=199.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~ 144 (401)
..++|++.+.+|+|.|+.||.| .+..+.+.+++|+++... .+.+.+|+.+|..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 4578999999999999999999 455578899999998654 346779999999997 999999999988
Q ss_pred eC--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-CceE
Q 015731 145 ED--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 221 (401)
Q Consensus 145 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~k 221 (401)
+. ....+|+||..+.+...+. +.++...+..++.+++.||.|+|+.| |+|||+||.|++++.. -.++
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred CccccCchhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceee
Confidence 65 4668999999887776665 34777888999999999999999988 9999999999999865 5699
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCCCccchhHH---
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVID-KNRPSREHNLIE--- 296 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~-~~~~~~~~~~~~--- 296 (401)
|+|||+|.+.-.+.. ....+.+..|.-||++-. +.|+..-|+|||||++..|+..+.||- +.+..++.-.+.
T Consensus 174 lIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 999999998655542 233456788999998843 578899999999999999999988874 443333322221
Q ss_pred -------hhhhhh-hhcchhhhhhhhh--------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 297 -------WAKPYL-QSKRRIFQVMDAR--------IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 297 -------~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+...+- .-......++..- +...-..-.+++..+|+.++|..|-.+|+|++|++.|-..
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 111110 0000111111110 0111112245788999999999999999999999998443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=233.63 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=170.1
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceee
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~ 141 (401)
....++..-+..||+|++|.|-+- .+..+|...|+|.+...-. +...+.++|+.+..+. .+|.++++|+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG 112 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG 112 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence 344566777889999999999665 5666899999999876532 3445678888887765 6999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
.+.....+++.||.| .-+|..+..+.- .....+++..+-+|+..++.||.|||++ ..++|||+||.|||++.+|++|
T Consensus 113 a~~regdvwIcME~M-~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 113 ALFREGDVWICMELM-DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred hhhccccEEEeHHHh-hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEE
Confidence 999999999999999 668877665432 2235699999999999999999999998 6799999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccc----cCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 286 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 286 (401)
+||||++-...+.- ..+...|...|+|||.+. +..|+.++||||||++++||.+++.||+.+
T Consensus 190 iCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 190 ICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred Ecccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999986543322 123356888899999873 347899999999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=264.88 Aligned_cols=197 Identities=24% Similarity=0.311 Sum_probs=171.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH--------HHHHHHHHHHhccC---CCcc
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--------LEWLTEIKHLGQLY---HPNL 136 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~--------~~~~~e~~~l~~l~---hpni 136 (401)
.+|..++.+|.|+||.|++|.. +.....|++|.|.++..-.. -.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~---------K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIH---------KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeee---------cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 5689999999999999999944 44578899999988754211 12457999999997 9999
Q ss_pred cceeeEEeeCCeeEEEEEec-CCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 137 VKLIGYCLEDDHRLLVYEFM-PKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 137 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
++++++|++++.+||+||-. +|.+|++++..... +++..+.-|+.||+.|+++||++| |||||||-+|+.++
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd 704 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD 704 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccccC--ceecccccccEEEe
Confidence 99999999999999999975 46699999987754 999999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVID 284 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~ 284 (401)
.+|-+||+|||.+.....+ ....+.||..|.|||++.|..| +..-|||+||+++|.++....||-
T Consensus 705 ~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999765444 3566889999999999998877 677999999999999999888873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=237.03 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=200.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeE-Ee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY-CL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~-~~ 144 (401)
.+.|.+.+.||+|.||.+-++ .|..+...+++|-+..... ...+|.+|+..--.| .|.||+..|++ |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 467999999999999999998 6777899999999887653 345788888776666 58999998875 67
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE--cCCCceEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKL 222 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~--~~~~~~kl 222 (401)
..+.+++++||++.|+|.+.+...+ +-+.....++.|++.||.|||+++ +||||||.+|||| .+...+||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred cCceEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEe
Confidence 7788899999999999999887655 788888999999999999999999 9999999999999 33458999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH--
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---G--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-- 295 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-- 295 (401)
||||..+..+.. ......+..|.+||+... + ...+.+|||.||+++|.+++|..||+.... +.....
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~ 238 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW 238 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH
Confidence 999998864322 122234667999997632 2 235789999999999999999999984332 222222
Q ss_pred -HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHHhchhcCCCCCCcccccc
Q 015731 296 -EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR---PTMDEVVKALEQIQDTNDAGVSRDESLQ 371 (401)
Q Consensus 296 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---ps~~eil~~L~~i~~~~~~~~~~~~~~~ 371 (401)
+|...... .+. ..-...++.+..+.++-|..++++| .+++...+.+|.-........+.+-+..
T Consensus 239 ~~w~~rk~~-----------~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~t 306 (378)
T KOG1345|consen 239 EQWLKRKNP-----------ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYT 306 (378)
T ss_pred HHHhcccCc-----------cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhcccc
Confidence 22221111 111 1112345677889999999999999 6777777776654443333444433333
Q ss_pred cCc
Q 015731 372 NSD 374 (401)
Q Consensus 372 ~~~ 374 (401)
|.+
T Consensus 307 n~d 309 (378)
T KOG1345|consen 307 NID 309 (378)
T ss_pred ccC
Confidence 333
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=245.04 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=199.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..+|.-++.+|.|.- .|..+ .+...+..+|+|.+..... ....+..+|+.++..+.|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 457888888999987 66555 4445688999998766521 23445678999999999999999999986
Q ss_pred eC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 ED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
-. ...|+|||++ ..+|...+.. .++-..+..|++|++.|++|||+.| |+||||||+||++..++
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~ 155 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDC 155 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchh
Confidence 43 4679999999 7799998872 2778899999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH--
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-- 296 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-- 296 (401)
.+||.|||+++..... -..+..+.+..|+|||++.+-.|...+||||+||++.||++|...|.+....+....+.
T Consensus 156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred heeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 9999999999864332 24566788999999999988889999999999999999999999998765544332221
Q ss_pred --------------hhhhhhhhcc-----hhh-hhhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 --------------WAKPYLQSKR-----RIF-QVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 --------------~~~~~~~~~~-----~~~-~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
-+..+..... .+. ...|..... ..+......+.+++.+||..||++|.+++++|.|
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000111000 000 000111110 1112345567789999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=262.91 Aligned_cols=255 Identities=27% Similarity=0.336 Sum_probs=206.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..+|+++.++|.|+||.||++ ++..+++..|+|+++.+...+..-+-+|+.+++..+||||+.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 468999999999999999999 56668999999999988766666677899999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++.||||.||+|.+...-.+ ++++.++...+...++||+|||+.| -+|||||-.||++++.|.+|++|||
T Consensus 85 dklwicMEycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccC
Confidence 99999999999999999887654 5999999999999999999999998 8999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
.+-.+... ......+.||++|||||+- +.+.|...+|||++|++..||---++|.....+.....+..
T Consensus 158 vsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------- 228 (829)
T KOG0576|consen 158 VSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------- 228 (829)
T ss_pred chhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-------
Confidence 88754332 2234567899999999976 45689999999999999999988887765544433222211
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....... ...-...-+..+.+|++.+|..+|++||+++.+|.|
T Consensus 229 -kS~~qpp-----~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 229 -KSGFQPP-----TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred -ccCCCCC-----cccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111000 001112234567789999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=226.42 Aligned_cols=212 Identities=39% Similarity=0.570 Sum_probs=181.8
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e 154 (401)
||+|.+|.||++... .++..+++|++...... ....+.+|+..++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDK---------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEec---------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999999554 35789999998876543 23567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEEeeccCCcCCCC
Q 015731 155 FMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPT 233 (401)
Q Consensus 155 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~ 233 (401)
++.+++|.+++.... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 72 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 72 YCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred cCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 999899999987653 24889999999999999999999988 999999999999998 89999999999876543
Q ss_pred CCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhh
Q 015731 234 GSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312 (401)
Q Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (401)
... ......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------ 187 (215)
T cd00180 146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187 (215)
T ss_pred Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence 321 12334578889999998776 788999999999999998
Q ss_pred hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 313 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..+.+++.+||..||.+||++.++++++
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2556799999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=234.31 Aligned_cols=272 Identities=25% Similarity=0.296 Sum_probs=199.5
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceee
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~ 141 (401)
+....+.|..++.||+|+|++||++.+.. .......||+|.+...... ..+..|++.|..+ -+.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchh
Confidence 44556789999999999999999996543 1336889999998776543 3567999999998 5899999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCce
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNA 220 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~ 220 (401)
.+..++++.+||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|++.+. .+.-
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCc
Confidence 99999999999999999999888854 677889999999999999999999 999999999999964 4677
Q ss_pred EEeeccCCcCCCCC--------------CC----------------------------cceeeecccccCccccccccc-
Q 015731 221 KLSDFGLAKDGPTG--------------SQ----------------------------SHVSTRVMGTYGYAAPEYMAT- 257 (401)
Q Consensus 221 kl~Dfg~~~~~~~~--------------~~----------------------------~~~~~~~~gt~~y~aPE~~~~- 257 (401)
.|+|||+|...... .. ........||++|+|||++..
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 99999998711000 00 000123469999999999854
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc-hhH--------------------Hhhhhh---hhhc-chhhhh-
Q 015731 258 GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-NLI--------------------EWAKPY---LQSK-RRIFQV- 311 (401)
Q Consensus 258 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~--------------------~~~~~~---~~~~-~~~~~~- 311 (401)
+..++++||||.|+|+.-++++..||-.....-.. .-+ -|.... +... ..+..+
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~ 332 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH 332 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence 56788999999999999999999998654322111 000 010000 0000 000001
Q ss_pred hhhhh--------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 312 MDARI--------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 312 ~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..... ........+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 011122345588999999999999999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=221.09 Aligned_cols=200 Identities=36% Similarity=0.477 Sum_probs=171.6
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
|.+.+.||.|++|.||++... .++..+++|.+...... ....+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK---------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc---------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 567789999999999999554 35788999999876554 55678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.++++|++.+++|.+++..... .+++..+..++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||.+
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~ 145 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLA 145 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCcee
Confidence 9999999999999999976542 1788999999999999999999988 999999999999999999999999998
Q ss_pred cCCCCCCCcceeeecccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
......... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 146 RFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 865433211 12335678889999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=262.01 Aligned_cols=199 Identities=21% Similarity=0.231 Sum_probs=139.7
Q ss_pred cCC-CcccceeeEE-------eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCe
Q 015731 131 LYH-PNLVKLIGYC-------LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 202 (401)
Q Consensus 131 l~h-pni~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i 202 (401)
+.| .||.+++++| .+...++++||++ +++|.+++.... ..+++..++.++.||+.||.|||++| |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 345 5777777776 2334667789988 779999997543 45899999999999999999999988 9
Q ss_pred EEeccCCCcEEEcCCCc-------------------eEEeeccCCcCCCCCCC--------------cceeeecccccCc
Q 015731 203 IYRDFKTSNILLDLNYN-------------------AKLSDFGLAKDGPTGSQ--------------SHVSTRVMGTYGY 249 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~-------------------~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y 249 (401)
+||||||+||||+..+. +|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 45555555543110000 0001124578899
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHH
Q 015731 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTA 329 (401)
Q Consensus 250 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (401)
+|||++.+..|+.++|||||||++|||++|.+|+..... .+ ... . ..... ...........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~---~~~-~-----~~~~~-----~~~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM---SSL-R-----HRVLP-----PQILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH---HHH-H-----HhhcC-----hhhhhcCHHHH
Confidence 999999888999999999999999999998887643210 00 000 0 00000 00011233456
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 330 VLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 330 ~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.++.+||+.||.+||++.|+++|-+.
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchhh
Confidence 78889999999999999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=203.77 Aligned_cols=168 Identities=23% Similarity=0.222 Sum_probs=127.0
Q ss_pred CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcc
Q 015731 159 GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 159 ~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 238 (401)
|+|.+++...+ .++++..++.++.||+.||.|||+++ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997654 45999999999999999999999865 999999999999999 99987643321
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhc-
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE- 317 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (401)
..|++.|+|||++.+..++.++|||||||++|||++|..||........ .... ... ........
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~---~~~------~~~~~~~~~ 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEI---LLN------GMPADDPRD 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHH---HHH------HhccCCccc
Confidence 2588999999999999999999999999999999999999965432111 0000 000 00000000
Q ss_pred CCCCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 318 GQYSLGAAL--KTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 318 ~~~~~~~~~--~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
......... .+.+++.+||..||.+||++.++++|++.+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011122222 68899999999999999999999999988743
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=214.85 Aligned_cols=270 Identities=21% Similarity=0.211 Sum_probs=200.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC----CcccceeeEE-
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH----PNLVKLIGYC- 143 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h----pni~~~~~~~- 143 (401)
+|.+.+.||+|+||.||.+..... ....+|+|............+..|..++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~--------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE--------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC--------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999965431 146788988776543332256678888888762 6899999988
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-----C
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-----Y 218 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-----~ 218 (401)
..+...|+||+.+ |.+|.++...... ..++..++..|+.|++.+|++||+.| ++||||||.|+++... .
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccc
Confidence 5778899999998 9999998866652 55999999999999999999999988 9999999999999755 4
Q ss_pred ceEEeeccCCc--CCCCCCCc---c--e-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 219 NAKLSDFGLAK--DGPTGSQS---H--V-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 219 ~~kl~Dfg~~~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
.+.|.|||+++ ........ . . .....||..|+++.+..+...+.+.|+||+++++.+|+.|..||.......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 69999999998 32211111 0 1 223569999999999999999999999999999999999999996654322
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
...... ...............+..+..+...+-..+...+|....+...|............
T Consensus 245 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~ 306 (322)
T KOG1164|consen 245 LKSKFE-------------KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKED 306 (322)
T ss_pred hHHHHH-------------HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCC
Confidence 211110 00000000001122334455566656668999999999999999888777644443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=201.41 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=203.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~ 146 (401)
-.|++++.||+|.||.++.| .+.-+++.||||.-.... ..-++..|.+..+.| ..++|..+|-+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecc---------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 36999999999999999999 556679999999765543 233566788888888 479999999888888
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-----CCceE
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAK 221 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-----~~~~k 221 (401)
.+-.||||++ |-+|+|++.-.+ +.++.+++..++.|++.-++|+|++. +|.|||||+|+||.. ...|.
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEE
Confidence 8889999999 999999998776 55999999999999999999999998 999999999999953 34589
Q ss_pred EeeccCCcCCCCCCCcc-----eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 222 LSDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
++|||+|+.+.+..... ......||.+||+-....|.+.+.+.|+-|||=+++++|-|..||.+..........+
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 99999999765443221 2345689999999999999999999999999999999999999998865432221111
Q ss_pred hhhhhhhhcchhhhhhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCc
Q 015731 297 WAKPYLQSKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 366 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~ 366 (401)
.+-+.+..- .+....+.++..-+.-.=..+-.+-|...-+...+..+.+....+..-
T Consensus 250 -------------KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg 309 (449)
T KOG1165|consen 250 -------------KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG 309 (449)
T ss_pred -------------HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence 111111000 001123344444444444457777799888888877776666655544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=194.17 Aligned_cols=264 Identities=20% Similarity=0.234 Sum_probs=199.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~ 144 (401)
....|++++.||.|+||.+|.| ....+|..||+|.-.... ...++.-|.++.+.|+ ...|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3578999999999999999999 666789999999865442 2234567888888886 478888898999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CCceE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAK 221 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~~~k 221 (401)
+..+-.+||+++ |-+|+++++-.. ..++.++++-++-|++.-++|+|.++ ++||||||+|+|..- ...+.
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEE
Confidence 999999999999 999999987665 44899999999999999999999998 999999999999953 45789
Q ss_pred EeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 222 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
|+|||+++.+.+.... .......||.+|.+-..+.+...+.+.|+-|+|.++.++.-|..||++.......+..+
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 9999999875443221 12345789999999988888888999999999999999999999999876543322221
Q ss_pred hhhhhhhhcchhhhhhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 297 WAKPYLQSKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
. +.+.+..- .+....+.++.-.+.-|=..--++-|...-+-+.+..+-...
T Consensus 235 k-------------I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 235 K-------------ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred H-------------HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 1 11111110 111123445556666666666677777776666655554333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-27 Score=232.27 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=189.2
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEc-ccccchhH-HHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~-~~~~~~~~-~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
....++|.|++|.|+.+..... ......+.+.+| . ........ ..+..|+.+-..|.|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~----~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD----LKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCC----Cccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 5678899999997776633211 011111222222 1 11111111 125668888888999999998888877776
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.+.+||||++ +|..++..... +....+..++.|++.||+|||+.| |.|||||++|++++.+|.+||+|||.+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~-----~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGK-----LTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred chhhhhcccH-HHHHHHhcccc-----cchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcc
Confidence 7677999999 99999987632 788889999999999999999988 999999999999999999999999999
Q ss_pred cCCCCCCCc--ceeeecccccCcccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 229 KDGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTA-KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 229 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
..+...... ......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+...... ..
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~ 540 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NY 540 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cc
Confidence 865444333 5567789999999999999888865 5899999999999999999998766554432000 00
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
....... ..........+.....++.+||+.||.+|.|+++|++-=|
T Consensus 541 ~~~~~~~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 541 SDQRNIF--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred ccccccc--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 0000000 0001112234556778999999999999999999997533
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=209.33 Aligned_cols=167 Identities=20% Similarity=0.134 Sum_probs=126.9
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-----chhHHHHHHHHHHHhccCCCcccce
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
....+|.+.++||+|+||+||+|+... .++..+|+|++.... ......+.+|+++|++++|+|++..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 345789999999999999999996542 146778999865331 1124458899999999999999853
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEecc-CCCcEEEcCCC
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNY 218 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl-kp~Nil~~~~~ 218 (401)
+.. .+..|+||||++|++|.. +.. .. ...++.|++.+|.|||++| |+|||| ||+|||++.++
T Consensus 87 l~~---~~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 87 LLA---TGKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred EEE---cCCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCC
Confidence 322 246899999999999963 211 11 1467889999999999988 999999 99999999999
Q ss_pred ceEEeeccCCcCCCCCCCcce------eeecccccCcccccccc
Q 015731 219 NAKLSDFGLAKDGPTGSQSHV------STRVMGTYGYAAPEYMA 256 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~ 256 (401)
.++|+|||+++.......... .....+++.|+|||.+.
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999999986543321111 13567888999999884
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-23 Score=191.59 Aligned_cols=261 Identities=30% Similarity=0.422 Sum_probs=196.0
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCC-cccceeeEEee
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHP-NLVKLIGYCLE 145 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hp-ni~~~~~~~~~ 145 (401)
|.+.+.||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999999543 568899887765432 55688999999999988 79999999988
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~kl~D 224 (401)
....+++++++.+++|.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~d 145 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLID 145 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEec
Confidence 78889999999999999777655311 24889999999999999999999988 99999999999999888 799999
Q ss_pred ccCCcCCCCCCCcc----eeeecccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-ccchhHH
Q 015731 225 FGLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS-REHNLIE 296 (401)
Q Consensus 225 fg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~ 296 (401)
||.+.......... ......|+..|++||.+.+ ..+....|+|++|++++++++|..||...... .......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 99987544332211 2456789999999999977 57889999999999999999999997654431 0000000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
... ..... .................+.+++.+|+..+|..|.+..+...+
T Consensus 226 ~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IIL---ELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHH---hcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 00000 000000000002223567789999999999999999988876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=183.53 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=193.1
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
..+...|.+...|..|+|+|..+ .+++|++....... ...|..|+-.|+-+.||||+.+++.|....
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 44556788899999999988743 47778776654432 345778999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe--ec
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS--DF 225 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~--Df 225 (401)
+..+|..|++.|+|+..+..... --++..++.+++.+|+.|++|||+..+-|.---|....++++++.+.+|. |-
T Consensus 261 nlv~isq~mp~gslynvlhe~t~---vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred CceEeeeeccchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 99999999999999999987754 33667788999999999999999987545555799999999998877664 32
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT---AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
-++.. .......+.|++||.+....-+ .++|+|||++++|||.|...||....+..-...+
T Consensus 338 kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------- 401 (448)
T KOG0195|consen 338 KFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------- 401 (448)
T ss_pred eeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------
Confidence 22211 1112357889999998654322 5789999999999999999999887664332221
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
--..++...++..+.-...|+.-|++.||.+||.+..|+-.|++++
T Consensus 402 ---------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ---------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122344556677778889999999999999999999999998874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-24 Score=213.22 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=180.2
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.|...+.||.+.|=+|.+|..++ |. |++|++-+... ....+.+.|++ ...+++||.+.+..+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57788999999999999985543 44 88998766542 23334445555 45568999999988888
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.+...|||-+|. .-+|+|.+..+.. +..-+.+.|+.|++.||..+|..| |+|||||.+||||+.-+-+.|+|
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTRPF-----L~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtD 163 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTRPF-----LVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTD 163 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccchH-----HHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhc
Confidence 888889999998 5599999987764 777788889999999999999988 99999999999999999999999
Q ss_pred ccCCcCC--CCCCCcc---eeeecccccCcccccccccC-----------CCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 015731 225 FGLAKDG--PTGSQSH---VSTRVMGTYGYAAPEYMATG-----------HLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 287 (401)
Q Consensus 225 fg~~~~~--~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 287 (401)
|...+.. +...... ...+-..-.+|.|||.+-.. ..+++.||||+||+++||++ |++||.-.
T Consensus 164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS- 242 (1431)
T KOG1240|consen 164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS- 242 (1431)
T ss_pred ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-
Confidence 9866532 2211111 12223344679999987321 25678999999999999988 57777421
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
++..+.... ....+.+-..++ +..+..||..|++.||.+|.++++.|+.-.
T Consensus 243 -----QL~aYr~~~----~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 -----QLLAYRSGN----ADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -----HHHhHhccC----ccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 111111110 111111111111 225678999999999999999999998843
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=179.59 Aligned_cols=174 Identities=13% Similarity=0.066 Sum_probs=132.9
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHH---------HHHHHHHHhccCCC
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---------WLTEIKHLGQLYHP 134 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~e~~~l~~l~hp 134 (401)
.....+|++.++||.|+||.||++.. ++..+|+|.+.......... +.+|+..+.++.||
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 45578999999999999999998622 24569999997654332221 57899999999999
Q ss_pred cccceeeEEeeC--------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEec
Q 015731 135 NLVKLIGYCLED--------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 206 (401)
Q Consensus 135 ni~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 206 (401)
+|..+.+++... ...+++|||++|.+|.++.. ++. ....+++.+|..||..| ++|||
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g--i~H~D 160 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG--MVSGD 160 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC--CccCC
Confidence 999999886643 35789999999999987631 222 24568899999999998 99999
Q ss_pred cCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 015731 207 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278 (401)
Q Consensus 207 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 278 (401)
++|.||+++.+| ++|+|||........... ...+....|..++|+|+||+++..+..
T Consensus 161 ikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 161 PHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999999888 999999987654221110 012334556789999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=172.92 Aligned_cols=139 Identities=17% Similarity=0.184 Sum_probs=106.6
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--h------------------------HHHHHHHHH
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--G------------------------HLEWLTEIK 126 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~------------------------~~~~~~e~~ 126 (401)
...||+|+||.||+|. +. +|+.||+|++...... . ......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~---------~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHAT---------TA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEE---------CC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 4689999999999994 33 6899999998754211 0 011235999
Q ss_pred HHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhh-hhCCCCeEEe
Q 015731 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVIYR 205 (401)
Q Consensus 127 ~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~ivH~ 205 (401)
.+.++.++++.....+.. ...+|||||++|++|...+... .+++...+..++.|++.+|.++ |+.| |+||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHr 142 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR--LVHA 142 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 999998887754443322 2248999999887776543322 2488899999999999999999 6888 9999
Q ss_pred ccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 206 DFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 206 dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+||+++ ++.++|+|||++...
T Consensus 143 DlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999998 578999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=181.99 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=148.8
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccC----------CCc
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY----------HPN 135 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~----------hpn 135 (401)
.+...+.||.|+|+.||.+. +..||+.+|+|+...... ...+++.+|.-....+. |-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~---------d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVT---------DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEE---------EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 45566889999999999994 455899999998765432 23445555554444432 222
Q ss_pred ccceeeEEe---------eC---C-----eeEEEEEecCCCChHHHHhh---cCCCCCCCCCHHHHHHHHHHHHHHHhhh
Q 015731 136 LVKLIGYCL---------ED---D-----HRLLVYEFMPKGSLENHLFR---TGASYIQPLSWTIRMKVALGAAKGLAYL 195 (401)
Q Consensus 136 i~~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~l~~~~~~~i~~qi~~~l~~L 195 (401)
++-.++... .. . ..+++|+-+ .++|.+++.. .... ...+.....+.+..|+++.+++|
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHH
Confidence 333333322 11 1 236788887 6688887643 2211 12344555677889999999999
Q ss_pred hhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc--------CCCCcccchh
Q 015731 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--------GHLTAKSDVY 267 (401)
Q Consensus 196 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diw 267 (401)
|..| ++|+||+|+|++++.+|.+.|+||+.....+.. ......+..|.+||.... -.++.+.|.|
T Consensus 162 h~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 162 HSYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp HHTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred hhcc--eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 9999 999999999999999999999999887653321 111345577999997633 2467889999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 268 SFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 268 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
+||+++|.|.+|..||+...+...... .+. .-. ..++.+..||..+|+.||.+|
T Consensus 235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 235 QLGITLYSLWCGRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999999986543221110 010 112 567788899999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=204.06 Aligned_cols=256 Identities=18% Similarity=0.180 Sum_probs=181.8
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.......|.|.+.||+|+||+||.|... . |+.||+|+-.....-+.--..+-...|+..--+.|..+...
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~---------~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHS---------N-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecC---------C-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHH
Confidence 3445578888999999999999999432 2 89999998777654221000111222221124556677666
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-------
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD------- 215 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~------- 215 (401)
+.-.+.-++|+||.+.|+|.++++..+ .+++..++.+..|++..|++||..+ ||||||||+|++|.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCC
Confidence 666777899999999999999998543 4899999999999999999999988 99999999999993
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+...++|+|||.+.....-.........++|-.+-.+|+..|..++...|.|.|+.+++.||.|+..
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~------------- 902 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM------------- 902 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------------
Confidence 3456999999998765444333456667889999999999999999999999999999999999732
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
+ ..+. ....+...+.+ ...-.-+-+|+..+|+.|-..=|.+.++...|+.+-.
T Consensus 903 ---q--~~~g--~~~~~~~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 903 ---E--VKNG--SSWMVKTNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ---H--hcCC--cceeccccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1 0000 00001111110 1112234457777777555555788888777776643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=197.20 Aligned_cols=229 Identities=28% Similarity=0.342 Sum_probs=183.6
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHH--HHHHHHHHHhccC-CCcccceeeEEeeCCeeEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~l 151 (401)
++|+|.||.|++++- +.....|..+|+|+..+....... ....|-.++..++ ||.+++++-.++.+...++
T Consensus 1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 479999999998732 234446788999988776543221 2345777777776 9999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
++++..||.|...+..... +.+.....+...++.+++++|..+ ++|||+|++||+++.+|++++.|||+.+..
T Consensus 75 ~ld~~rgg~lft~l~~~~~-----f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEVM-----FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred hhhhcccchhhhccccCCc-----hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHh
Confidence 9999999999988877653 777788888899999999999988 999999999999999999999999998864
Q ss_pred CCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhh
Q 015731 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311 (401)
Q Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (401)
-.... .+||..|||||++. ....++|.||||+++++|++|..||... . ...+
T Consensus 148 v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------~-------------~~~I 199 (612)
T KOG0603|consen 148 VKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------T-------------MKRI 199 (612)
T ss_pred Hhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------H-------------HHHH
Confidence 33221 28999999999987 5678899999999999999999999750 0 0111
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 015731 312 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 346 (401)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~ 346 (401)
+. .+..++...+....+++..++..+|..|.-.
T Consensus 200 l~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 200 LK--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hh--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11 1234566778888899999999999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=166.26 Aligned_cols=140 Identities=18% Similarity=0.188 Sum_probs=108.3
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---------------------h-----HHHHHHHHH
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------------------G-----HLEWLTEIK 126 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---------------------~-----~~~~~~e~~ 126 (401)
.+.||+|+||.||+|.. . +|+.||+|++...... . ...+..|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~---------~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHART---------G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEc---------C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 56899999999999943 2 5899999998764210 0 112357889
Q ss_pred HHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEe
Q 015731 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYR 205 (401)
Q Consensus 127 ~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~ 205 (401)
.+.++.|+++.....+... ..+|||||++|+++....... .+++......++.|++.+|.+||+ .| |+||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHr 142 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHG 142 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence 9999999988655544333 248999999887554432222 237788899999999999999999 88 9999
Q ss_pred ccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 206 DFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 206 dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
||||+||+++ ++.++|+|||++....
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999 8899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=175.76 Aligned_cols=198 Identities=19% Similarity=0.226 Sum_probs=142.0
Q ss_pred CCCcccceeeEEee---------------------------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHH
Q 015731 132 YHPNLVKLIGYCLE---------------------------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184 (401)
Q Consensus 132 ~hpni~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i 184 (401)
.|||||+++..|.+ ...+|+||..+ ..+|.+++-.+. .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC------CchHHHHHH
Confidence 49999999887643 23679999988 669999997765 567778889
Q ss_pred HHHHHHHHhhhhhCCCCeEEeccCCCcEEE--cCC--CceEEeeccCCcCCCCCC----CcceeeecccccCcccccccc
Q 015731 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLN--YNAKLSDFGLAKDGPTGS----QSHVSTRVMGTYGYAAPEYMA 256 (401)
Q Consensus 185 ~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~--~~~--~~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~ 256 (401)
+.|+++|+.|||.+| |.|||||.+|||+ ++| ..+.|+|||.+-...... .....-...|...-||||+..
T Consensus 347 laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999999 9999999999999 333 458999999775322111 001122345778899999874
Q ss_pred cCC-----C-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHH
Q 015731 257 TGH-----L-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV 330 (401)
Q Consensus 257 ~~~-----~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (401)
... . -.++|.|+.|.+.||++....||-+....... ....++ . --..++..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------~r~Yqe---~-qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------TRTYQE---S-QLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------hhhhhh---h-hCCCCcccCChHHHH
Confidence 321 1 24799999999999999999999663221110 000001 1 112345567778899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 015731 331 LAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 331 li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
++..+|+.||++|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999998776655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=164.25 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=104.7
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-----CCCcccceeeEEee
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-----YHPNLVKLIGYCLE 145 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-----~hpni~~~~~~~~~ 145 (401)
.-.++||+|+||.||. + +.++.. +||++..........+.+|+.+++.+ +||||+++++++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~---h--------p~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA---H--------PEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE---C--------CCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3357899999999994 1 123444 69988765444556788999999999 57999999999998
Q ss_pred CC---eeE-EEEEe--cCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH-hhhhhCCCCeEEeccCCCcEEEcC--
Q 015731 146 DD---HRL-LVYEF--MPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL-AYLHSDKAKVIYRDFKTSNILLDL-- 216 (401)
Q Consensus 146 ~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~ivH~dlkp~Nil~~~-- 216 (401)
+. .++ +|||| +.+++|.+++.+.. +++. ..++.|++.++ +|||+++ |+||||||+||+++.
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~ 142 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRIS 142 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccC
Confidence 73 434 78999 55799999996632 4444 35677888777 9999999 999999999999963
Q ss_pred --CCceEEeeccCC
Q 015731 217 --NYNAKLSDFGLA 228 (401)
Q Consensus 217 --~~~~kl~Dfg~~ 228 (401)
++.++|+||+.+
T Consensus 143 ~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 ESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcEEEEECCCC
Confidence 347999995433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=160.25 Aligned_cols=188 Identities=17% Similarity=0.122 Sum_probs=137.1
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch----hHHHHHHHHHHHhccC-CCcccceeeEEee
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~e~~~l~~l~-hpni~~~~~~~~~ 145 (401)
.+...|+.|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3567899999999997632 3667777766554331 1124678999999995 5889999886
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEecc-CCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl-kp~Nil~~~~~~~kl~D 224 (401)
+..+++|+|+.|.+|...+.. . ...++.|++.+|.++|++| |+|||| ||+||+++.++.++|+|
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LID 135 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVID 135 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEE
Confidence 447999999999888654321 1 1347788999999999998 999999 79999999999999999
Q ss_pred ccCCcCCCCCCCc----ce-------eeecccccCcccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCCCCC
Q 015731 225 FGLAKDGPTGSQS----HV-------STRVMGTYGYAAPEYMATG-HLT-AKSDVYSFGVVLLEMLSGRRVIDKNR 287 (401)
Q Consensus 225 fg~~~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~~ll~g~~p~~~~~ 287 (401)
||++......... .. ......++.|++|+...-- ..+ .+.+.++.|+-+|.++|+..++.+..
T Consensus 136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9999854432210 00 0112357778888754221 223 56788999999999999998875544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=177.00 Aligned_cols=219 Identities=26% Similarity=0.400 Sum_probs=164.0
Q ss_pred HhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCe-EEec
Q 015731 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV-IYRD 206 (401)
Q Consensus 128 l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i-vH~d 206 (401)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.... ..+++.....++.+|+.||.|||.-- | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence 457889999999999999999999999999999999998754 45899999999999999999999864 4 8999
Q ss_pred cCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC-------CCcccchhhHHHHHHHHHhC
Q 015731 207 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-------LTAKSDVYSFGVVLLEMLSG 279 (401)
Q Consensus 207 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~g 279 (401)
|+..|++++....+||+|||+.................-...|.|||++.+.. .+.+.||||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987654311111122223456799999996631 45679999999999999999
Q ss_pred CCCCCCCCCCcc-chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 280 RRVIDKNRPSRE-HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 280 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..||........ ...+.+... .....+.+.+.. .......+..++.+||..+|.+||++..+-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh------cCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999976433222 222222111 000001111110 00233468889999999999999999999999887755
Q ss_pred cC
Q 015731 359 TN 360 (401)
Q Consensus 359 ~~ 360 (401)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=188.54 Aligned_cols=209 Identities=24% Similarity=0.328 Sum_probs=146.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|..+++|..|+||.||.. .|..+.+.+|+| +++....-. + ++.....|.++
T Consensus 83 ~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~lilR----n---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLILR----N---ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeee---------eccccccchhhc-ccccchhhh----c---cccccCCccee----------
Confidence 57899999999999999998 566678899994 444332110 1 22222333332
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
|+-...++..+. ++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+
T Consensus 136 -----------gDc~tllk~~g~-----lPvd--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGP-----LPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred -----------chhhhhcccCCC-----Ccch--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhh
Confidence 454555544432 3322 267899999988 99999999999999999999999998
Q ss_pred CcCCCCCCCc-------------ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 228 AKDGPTGSQS-------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 228 ~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
.+..-..... -.....+||+.|.|||++.-+.|+..+|.|++|+|+|+.+.|..||.+..+......
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 8742111000 012335899999999999999999999999999999999999999998876543321
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 344 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 344 (401)
+- .+... +. +-......++.+++.++|+.+|..|.
T Consensus 270 vi------sd~i~---wp------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VI------SDDIE---WP------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh------hhhcc---cc------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 10 00000 00 01123345788899999999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.8e-21 Score=177.57 Aligned_cols=179 Identities=25% Similarity=0.336 Sum_probs=131.8
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..+||.|++|...+|.+++...... ...++...+.++.|++.+++| ++ .+|+|+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999755432 346778889999999999999 67 9999999999999999999999999
Q ss_pred CCcCCCCCC----CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGS----QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
+........ .....+...||..||+||.+.+..|+.++|||+||+|++||+. -...|...
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------------- 466 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------------- 466 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------------
Confidence 998654433 2223566789999999999999999999999999999999998 22222110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.....+.+..+... ....-++-..|+.+||...|.+||++.+..-+
T Consensus 467 ----~t~~d~r~g~ip~~-~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 467 ----ATLTDIRDGIIPPE-FLQDYPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred ----HhhhhhhcCCCChH-HhhcCcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 00011111111100 01112244579999999999999966555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=154.45 Aligned_cols=146 Identities=18% Similarity=0.180 Sum_probs=109.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------------------------hHHHH
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------------GHLEW 121 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------------------------~~~~~ 121 (401)
....|.+.+.||+|+||.||+|.. +..+|..||+|++...... ....+
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 334689999999999999999951 2336899999988754210 01224
Q ss_pred HHHHHHHhccCCC--cccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC
Q 015731 122 LTEIKHLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK 199 (401)
Q Consensus 122 ~~e~~~l~~l~hp--ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 199 (401)
..|+..+.++.+. .+.+++++ ...++||||+.|.+|...+.... .+....+..++.||+.+|.+||++|
T Consensus 98 ~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 98 EKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcC
Confidence 5799999999753 23444432 23589999998888876543222 2556667889999999999999964
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.++|+||||+||+++ ++.++|+|||.+..
T Consensus 169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred -CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 399999999999999 88999999998874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-18 Score=150.41 Aligned_cols=134 Identities=19% Similarity=0.263 Sum_probs=111.2
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--------hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
+.||+|++|.||+|... |..+++|+....... ....+.+|+.++..+.|++|.....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999542 566888876543211 12346789999999999999888877777
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....+++|||++|++|.+++.... . ....++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEEC
Confidence 888999999999999999886432 1 77889999999999999988 99999999999999 789999999
Q ss_pred cCCcC
Q 015731 226 GLAKD 230 (401)
Q Consensus 226 g~~~~ 230 (401)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 98764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=147.30 Aligned_cols=130 Identities=19% Similarity=0.281 Sum_probs=104.8
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+||+|+||.||+|.+ .|..+++|....... ....++.+|+.++..+.|+++....-++.+.
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999963 256788887543211 1124567899999999988776666666677
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||++|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECC
Confidence 77899999999999998875432 1 78899999999999988 99999999999999 8899999999
Q ss_pred CCcC
Q 015731 227 LAKD 230 (401)
Q Consensus 227 ~~~~ 230 (401)
.+..
T Consensus 135 ~a~~ 138 (199)
T TIGR03724 135 LGKY 138 (199)
T ss_pred CCcC
Confidence 8765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=144.55 Aligned_cols=143 Identities=17% Similarity=0.090 Sum_probs=108.2
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch----------------------hHHH
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------------------GHLE 120 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~----------------------~~~~ 120 (401)
+......|.+.+.||+|+||.||++... +|..+|+|++...... ....
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLA 79 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHH
Confidence 3344445889999999999999998432 5889999986543200 0112
Q ss_pred HHHHHHHHhccCCCc--ccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC
Q 015731 121 WLTEIKHLGQLYHPN--LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD 198 (401)
Q Consensus 121 ~~~e~~~l~~l~hpn--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 198 (401)
...|+.++..+.|++ ++.+++ ....++||||++|++|...... .....++.+++.++.++|+.
T Consensus 80 ~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 80 AQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred HHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC
Confidence 457888888887774 444443 2456899999999998764321 23457888999999999998
Q ss_pred CCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 199 KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 199 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 145 g--i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 G--IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred C--CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 8 9999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=166.29 Aligned_cols=137 Identities=21% Similarity=0.248 Sum_probs=109.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEc-cc----ccc---hhHHHHHHHHHHHhccCCCcccc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQ----ESL---QGHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~-~~----~~~---~~~~~~~~e~~~l~~l~hpni~~ 138 (401)
...|...+.||+|+||.||+|.+... .+++|+. .. ... .....+.+|+++++.++|++++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 34567789999999999999865432 2333321 11 111 11245778999999999999998
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
...++.+....++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDD 464 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECC
Confidence 8877777778899999999999998874 23578999999999999988 9999999999999 678
Q ss_pred ceEEeeccCCcC
Q 015731 219 NAKLSDFGLAKD 230 (401)
Q Consensus 219 ~~kl~Dfg~~~~ 230 (401)
.++|+|||+++.
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.9e-19 Score=174.68 Aligned_cols=263 Identities=24% Similarity=0.245 Sum_probs=194.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~ 145 (401)
.|.+.+.||+|+|+.|-...... .+...+|.|.+.... .........|..+-..+. |+|++++++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~--------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR--------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcC--------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 47777889999999997763322 234567777666553 112223445777777776 9999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCCCeEEeccCCCcEEEcCCC-ceEEe
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY-NAKLS 223 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nil~~~~~-~~kl~ 223 (401)
.+..++++++..|+++.+.+..... ...+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred CcccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCC
Confidence 9999999999999999988842211 23566677889999999999999 777 99999999999999999 99999
Q ss_pred eccCCcCCCC-CCCcceeeeccc-ccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 224 DFGLAKDGPT-GSQSHVSTRVMG-TYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 224 Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|||+|..+.. ..........+| ++.|.|||...+. ......|+||+|+++..+++|..||.......... ..|..
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~- 245 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKS- 245 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecc-
Confidence 9999997666 333444555678 9999999999774 45788999999999999999999997655433211 11111
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.... ..............+++.+++..+|..|.+.+++...-+...
T Consensus 246 ---~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 ---NKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---cccc--------cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 001111223445667888999999999999999888766654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-16 Score=137.89 Aligned_cols=134 Identities=23% Similarity=0.230 Sum_probs=100.0
Q ss_pred Cccc-CCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-------------hhHHHHHHHHHHHhccCCCcc--c
Q 015731 74 SVLG-EGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNL--V 137 (401)
Q Consensus 74 ~~lg-~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpni--~ 137 (401)
.+|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4566 6777788776432 56788887754221 122356789999999998875 6
Q ss_pred ceeeEEeeC-Ce---eEEEEEecCC-CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 138 KLIGYCLED-DH---RLLVYEFMPK-GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 138 ~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
+.+++.... .. .++|||+++| .+|.+++... +++.. .+.+|+.+|.+||++| |+|+||||.||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NI 173 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNI 173 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhE
Confidence 677664432 22 2599999987 6898887543 24443 3568899999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCcC
Q 015731 213 LLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~ 230 (401)
|++.++.++|+|||.+..
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999889999999998875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.6e-16 Score=132.96 Aligned_cols=135 Identities=20% Similarity=0.185 Sum_probs=94.6
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHH----------------------HHHHHHHH
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLE----------------------WLTEIKHL 128 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~----------------------~~~e~~~l 128 (401)
.+.||+|+||.||+|... +|..||+|++...... .... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 568999999999999432 5789999987653221 1111 12455555
Q ss_pred hccCCC--cccceeeEEeeCCeeEEEEEecCCCChHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEE
Q 015731 129 GQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENH-LFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIY 204 (401)
Q Consensus 129 ~~l~hp--ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH 204 (401)
..+.+. .+.+++++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+|
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~--ivH 138 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG--LVH 138 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC--cCc
Confidence 555433 24444432 246899999988543221 11111 11 5567899999999999999 88 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
+||||+||+++ ++.++|+|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.7e-16 Score=146.92 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=186.0
Q ss_pred HhCCCCCCCcccC--CCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhcc-CCCccccee
Q 015731 66 ATRNFRPDSVLGE--GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 66 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
....+.+.+.+|. |.+|.||.+.+.. ..++..+|+|.-..... .....=.+|+...+.+ .|+|.++.+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence 3467888899999 9999999986522 34678899997433221 2222223566666666 499999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHH----HHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK----GLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
..+...+..|+-+|++ +.+|..+...... .++...++..+.+... ||.++|+.+ ++|-|+||.||+...
T Consensus 185 ~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTS 257 (524)
T ss_pred cccccCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccc
Confidence 9999999999999999 6889888876653 3777788888888888 999999988 999999999999999
Q ss_pred C-CceEEeeccCCcCCCCCCCcc---eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 217 N-YNAKLSDFGLAKDGPTGSQSH---VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 217 ~-~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
+ ...+++|||+........... ......|...|++||++. ..++...|+|+||.++.+..++..++...-.
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---- 332 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN---- 332 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----
Confidence 8 889999999998765544221 223346888899999984 5778999999999999999998766543200
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
..|.. .. +.. +..++....+..+...+..|+..+|..|++++.++.+
T Consensus 333 --~~W~~----~r----~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 --SSWSQ----LR----QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --CCccc----cc----ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01211 00 000 1112222334455558889999999999998887764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-15 Score=123.98 Aligned_cols=134 Identities=19% Similarity=0.095 Sum_probs=108.9
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC--CcccceeeEEeeCCee
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHR 149 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h--pni~~~~~~~~~~~~~ 149 (401)
+.+.||.|.++.||++... +..+++|....... ...+.+|+..++.+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4568999999999999653 25689998866543 3467789999999976 5899999988888899
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-CCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
+++|||+.++.+..+ +......++.+++.+|.+||... .+++|+||+|.||+++..+.++++|||.+
T Consensus 69 ~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 69 YLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred EEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 999999988776543 34555678899999999999841 23999999999999999899999999987
Q ss_pred cC
Q 015731 229 KD 230 (401)
Q Consensus 229 ~~ 230 (401)
..
T Consensus 137 ~~ 138 (155)
T cd05120 137 GY 138 (155)
T ss_pred cC
Confidence 64
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-15 Score=134.51 Aligned_cols=211 Identities=24% Similarity=0.271 Sum_probs=145.3
Q ss_pred HHHHHhccCCCcccceeeEEeeC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC
Q 015731 124 EIKHLGQLYHPNLVKLIGYCLED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD 198 (401)
Q Consensus 124 e~~~l~~l~hpni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 198 (401)
-+.-|-++.|.||++++.|+.+. ....++.||+..|+|..+|++..... ..+......+|+-||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 34555566799999999988654 34688999999999999998765322 4477788889999999999999999
Q ss_pred CCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCC--CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHH
Q 015731 199 KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276 (401)
Q Consensus 199 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 276 (401)
.++|+|+++..+.|++..+|-+|+.----........ .........+.++|.+||.-.....+.++|||+||....+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999999888874211111000000 00011223467889999986666777899999999999999
Q ss_pred HhCCCCC-CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 277 LSGRRVI-DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 277 l~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..+..-- ...........+. ..-.. ......+.++.+||+..|..||++++++-|.-.
T Consensus 276 ailEiq~tnseS~~~~ee~ia----------~~i~~-----------len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA----------NVIIG-----------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHheeccCCCcceeehhhhhh----------hheee-----------ccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 8876431 1111111100000 00000 011122357889999999999999999988654
Q ss_pred c
Q 015731 356 I 356 (401)
Q Consensus 356 i 356 (401)
|
T Consensus 335 f 335 (458)
T KOG1266|consen 335 F 335 (458)
T ss_pred e
Confidence 4
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.2e-13 Score=131.57 Aligned_cols=167 Identities=17% Similarity=0.199 Sum_probs=125.9
Q ss_pred CCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCC
Q 015731 98 RPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177 (401)
Q Consensus 98 ~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~ 177 (401)
.+.++.++.|..+............+-++.|+.++||||+++++.++.+...|||+|.+ ..|..++++. .
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l--------~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL--------G 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh--------H
Confidence 33467788888777665433344678899999999999999999999999999999987 4777777654 3
Q ss_pred HHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc
Q 015731 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT 257 (401)
Q Consensus 178 ~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 257 (401)
...+..-+.||+.||.|||+. ..++|++|....|+|+..|..||++|.++........ .......-..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 556677889999999999855 3499999999999999999999999998765332221 1111112233566665422
Q ss_pred CCCCcccchhhHHHHHHHHHhC
Q 015731 258 GHLTAKSDVYSFGVVLLEMLSG 279 (401)
Q Consensus 258 ~~~~~~~DiwslG~il~~ll~g 279 (401)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 21 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.7e-13 Score=128.88 Aligned_cols=141 Identities=20% Similarity=0.161 Sum_probs=93.9
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH----------------------------------
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---------------------------------- 118 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~---------------------------------- 118 (401)
.+.||.|++|.||+|+.. +|+.||||+.........
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 357999999999999764 478999999754321100
Q ss_pred ------HHHHHHHHHHhcc----CCCcccceeeEE-eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHH
Q 015731 119 ------LEWLTEIKHLGQL----YHPNLVKLIGYC-LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187 (401)
Q Consensus 119 ------~~~~~e~~~l~~l----~hpni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~q 187 (401)
..+.+|...+.++ .|.+-+.+-.++ ......+|||||++|++|.++...... ..+ ...++.+
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~~---~~~ia~~ 264 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GLD---RKALAEN 264 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CCC---HHHHHHH
Confidence 0123344444443 222222222222 223456899999999999887653221 122 2345555
Q ss_pred HHH-HHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCC
Q 015731 188 AAK-GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 188 i~~-~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 232 (401)
++. .+..+|..| ++|+|++|.||+++.++.++++|||++....
T Consensus 265 ~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 555 478889988 9999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.5e-12 Score=106.80 Aligned_cols=143 Identities=11% Similarity=0.068 Sum_probs=98.0
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---------------------hh-HHH----HHHHHH
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------------------QG-HLE----WLTEIK 126 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---------------------~~-~~~----~~~e~~ 126 (401)
...||.|--+.||.|...... .....+..+|+|+...... .. ... ..+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 457999999999999533210 0011357899998643110 00 111 337999
Q ss_pred HHhccC--CCcccceeeEEeeCCeeEEEEEecCCCChHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhh-hhCCCCe
Q 015731 127 HLGQLY--HPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRTGASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKV 202 (401)
Q Consensus 127 ~l~~l~--hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~i 202 (401)
.|.++. .-++.+++++ ...+|||||+.+..+.. .+.+. .++......+..+++.+|..| |..| |
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~g--l 146 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECN--L 146 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 998885 3566666654 45789999996543322 22221 245556677889999999998 8888 9
Q ss_pred EEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 203 IYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||+||++.||++. ++.+.|+|||.+...
T Consensus 147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999999997 468999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-12 Score=108.72 Aligned_cols=129 Identities=20% Similarity=0.116 Sum_probs=93.1
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~lv 152 (401)
+.|+.|.++.||++... +..+++|+...... ....+..|+.+++.+.+.++ .+++.+. ....++|
T Consensus 4 ~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 56889999999998542 56799998765432 12234678888888865544 3455443 3346899
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCC---CeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
|||++|.++.+. . .. ...++.+++.+|..||+.+. .++|+|++|.||+++ ++.++++|||.+.
T Consensus 70 ~e~i~G~~l~~~----~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE----D------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc----c------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999887643 0 11 12356788999999999761 149999999999999 6789999999876
Q ss_pred C
Q 015731 230 D 230 (401)
Q Consensus 230 ~ 230 (401)
.
T Consensus 136 ~ 136 (170)
T cd05151 136 M 136 (170)
T ss_pred C
Confidence 3
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.5e-13 Score=128.91 Aligned_cols=146 Identities=16% Similarity=0.158 Sum_probs=91.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-------------------------------
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------------------- 116 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------------------------------- 116 (401)
..|.. +.||.|++|.||+|+..+ +|+.||||++...-..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45666 789999999999996653 5899999998753110
Q ss_pred --h-HHHHHHHHHHH------hcc----CCCcccceeeEEee-CCeeEEEEEecCCCChHHH--HhhcCCCCCCCCCHHH
Q 015731 117 --G-HLEWLTEIKHL------GQL----YHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENH--LFRTGASYIQPLSWTI 180 (401)
Q Consensus 117 --~-~~~~~~e~~~l------~~l----~hpni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~l~~~~ 180 (401)
+ ...+.+|+... .++ .+.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+. ....+....
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~ 268 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERG 268 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHH
Confidence 0 01122333333 222 12222332223222 2445799999999999874 222221 111244444
Q ss_pred HHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC----ceEEeeccCCcCCCC
Q 015731 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY----NAKLSDFGLAKDGPT 233 (401)
Q Consensus 181 ~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 233 (401)
+..++.|++ ..| ++|+|++|.||+++.++ .++++|||++.....
T Consensus 269 v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 444555543 456 99999999999999887 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.7e-13 Score=126.25 Aligned_cols=254 Identities=22% Similarity=0.197 Sum_probs=178.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHH--HHHHHHHHHhcc-CCCcccceee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL-YHPNLVKLIG 141 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~e~~~l~~l-~hpni~~~~~ 141 (401)
....+|.++..||.|.|+.|+.... +..++..|++|........... .-+.|+.+...+ .|.+++.++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~--------r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSK--------RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeee--------cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 3446788889999999999998742 2246788999977665332222 233566555555 4888888887
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-Cce
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNA 220 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~ 220 (401)
.+....+.|+=-|||.++++...+.-. .-+++...+.+..|++.++.++|+.. ++|+|++|+||++..+ +..
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhh
Confidence 777777888999999999887766322 33778888999999999999999987 9999999999999875 788
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCc-ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGY-AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
++.|||......... ......+..| .++.......+..+.|+++||..+.+.+++...-..... |
T Consensus 407 ~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~-- 472 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S-- 472 (524)
T ss_pred hccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--
Confidence 999999886422211 1111223334 355566666788999999999999999998754322111 1
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+....... .......+..+.+.++..++..||.+.++..+.+....
T Consensus 473 ---------~~i~~~~~p~--~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 473 ---------LTIRSGDTPN--LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ---------eeeecccccC--CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 1111111111 11222566678889999999999999999888766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.4e-13 Score=132.93 Aligned_cols=248 Identities=21% Similarity=0.233 Sum_probs=172.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
+.+.+.+-+-.|.++.++.+ ....+|..++.|.......- .......+-.++-...+|-++...--+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 55677778889999999876 45556766666655443221 1112222323322234566665555555
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.....+|+++|+.+++|...+...+. .+..........+..++++||+.. +.|+|++|.|++...++..++.|
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCc
Confidence 66788999999999999998887652 455555566677888999999976 89999999999999999999999
Q ss_pred ccCCcCCCCC--------CC---------------------cceeeecccccCcccccccccCCCCcccchhhHHHHHHH
Q 015731 225 FGLAKDGPTG--------SQ---------------------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLE 275 (401)
Q Consensus 225 fg~~~~~~~~--------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 275 (401)
||........ .. ........||+.|.+||.+.+......+|.|++|+++++
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9844321110 00 001223568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 015731 276 MLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTMD 347 (401)
Q Consensus 276 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ 347 (401)
.++|.+||....+..... .+...... ...+...+....+++.+.|..+|.+|..+.
T Consensus 1028 ~l~g~pp~na~tpq~~f~----------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIFE----------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhhhh----------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999998766533221 11111111 122334566777889999999999998776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.3e-11 Score=111.48 Aligned_cols=164 Identities=19% Similarity=0.244 Sum_probs=124.2
Q ss_pred CCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe----eCCeeEEEEEecCC-CChHHHHhhcCC-
Q 015731 97 ARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL----EDDHRLLVYEFMPK-GSLENHLFRTGA- 170 (401)
Q Consensus 97 ~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~~- 170 (401)
..+.+|..|++|+++............-++.++++.|+|||++.++|. .+..+++|++|+++ .+|.++......
T Consensus 296 ~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~ 375 (655)
T KOG3741|consen 296 TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPF 375 (655)
T ss_pred eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcc
Confidence 555679999999995544333323345688899999999999999887 35678999999876 477776643221
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceee
Q 015731 171 ---------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241 (401)
Q Consensus 171 ---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 241 (401)
.....+++..+|.++.|+..||.++|+.| +..+-|.+.+|+++++.+++|...|.........
T Consensus 376 t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------ 447 (655)
T KOG3741|consen 376 TKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------ 447 (655)
T ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCC------
Confidence 12244788999999999999999999988 8899999999999999999999988776543222
Q ss_pred ecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 015731 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281 (401)
Q Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 281 (401)
. |.+. -..+-|.=.||.+++.|.||..
T Consensus 448 --------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 --------T--EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred --------C--cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 0 1111 1245688999999999999963
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-10 Score=95.27 Aligned_cols=131 Identities=21% Similarity=0.267 Sum_probs=97.5
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEE-cccc----cchh---HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-LNQE----SLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~-~~~~----~~~~---~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+++|+-+.+|.+.+. |..+++|. +.+. .... ..+-.+|++++.++.--.|.-..=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46789999999988553 33455653 2222 2211 2235679999998876666666666677
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+...|+|||.+|..|.+++.... ..++..+-.-+.-||..| |+|+||.++||++..++ +.++||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~~------------~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEAR------------PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhcc------------hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEEC
Confidence 788899999999988888886541 346666777788999988 99999999999998665 999999
Q ss_pred cCCcC
Q 015731 226 GLAKD 230 (401)
Q Consensus 226 g~~~~ 230 (401)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-10 Score=93.35 Aligned_cols=143 Identities=19% Similarity=0.188 Sum_probs=105.0
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEc-----ccccch---hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~-----~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...+|-+|+-+.|+++.+. |+.++||.= ..+... ...+..+|.+.|.++.--.|.-..=++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 4578899999999998654 566666632 222221 234567899999988766666666677
Q ss_pred eeCCeeEEEEEecCC-CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC---c
Q 015731 144 LEDDHRLLVYEFMPK-GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---N 219 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~---~ 219 (401)
.+...-.|+|||++| -++.+++...... +........++.+|-..|.-||.++ |+|+||..+||++..++ .
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCc
Confidence 788888899999965 3788888766532 2223333678888889999999998 99999999999995443 3
Q ss_pred eEEeeccCCcC
Q 015731 220 AKLSDFGLAKD 230 (401)
Q Consensus 220 ~kl~Dfg~~~~ 230 (401)
+.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 58999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2e-09 Score=99.13 Aligned_cols=268 Identities=15% Similarity=0.140 Sum_probs=165.7
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc-cCCCcccceeeEE------
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ-LYHPNLVKLIGYC------ 143 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~hpni~~~~~~~------ 143 (401)
...+.||+|+-+.+|-.- .-.-.+.|++.........+ .+..|.. -.||-+..-+.|=
T Consensus 14 ~~gr~LgqGgea~ly~l~------------e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG------------EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecc------------hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence 445789999999998541 11224667777655433222 2222323 2566444312211
Q ss_pred eeCC-eeEEEEEecCCC-ChHHHHhh-cCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 144 LEDD-HRLLVYEFMPKG-SLENHLFR-TGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 144 ~~~~-~~~lv~e~~~~~-~L~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
-+.. ..-++|..+.|. .+..+++- ..........|...++.+..++.+.+.||..| .+-+|++++|+|+++++.+
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceE
Confidence 1222 256788887664 23333321 11122355889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCc----
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSR---- 290 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~---- 290 (401)
.|.|=...... .........+|...|++||.-. +-.-+...|.|.||+++|+|+.| +.||.+-....
T Consensus 157 ~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 157 VLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred EEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 99986544432 2223455678999999999753 23445679999999999999887 89997642211
Q ss_pred -cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHH-HHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHhchhcCC
Q 015731 291 -EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSN--EPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 291 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~--dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
...-|.... +....+. ...........+.. .+..+..|+.+|+.. ++.-|||++-++..|..+.+...
T Consensus 234 p~E~~Ia~g~-f~ya~~~--~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 234 PLETDIAHGR-FAYASDQ--RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred cchhhhhcce-eeechhc--cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111111111 1111110 10111111122222 355666788888875 46689999999999988865543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-10 Score=100.34 Aligned_cols=141 Identities=22% Similarity=0.238 Sum_probs=101.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCC--CcccceeeEEeeC---C
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYH--PNLVKLIGYCLED---D 147 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h--pni~~~~~~~~~~---~ 147 (401)
+.|+.|.++.||++... .|..+++|....... .....+..|+.+++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999998543 256799998765432 123456789999998865 4467777776653 3
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-----------------------------
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD----------------------------- 198 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------- 198 (401)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred CceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 67899999999888765431 1255556666677777777777632
Q ss_pred -------------------------CCCeEEeccCCCcEEEcC--CCceEEeeccCCcC
Q 015731 199 -------------------------KAKVIYRDFKTSNILLDL--NYNAKLSDFGLAKD 230 (401)
Q Consensus 199 -------------------------~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~ 230 (401)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999988 66789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.9e-09 Score=94.54 Aligned_cols=124 Identities=15% Similarity=0.113 Sum_probs=89.1
Q ss_pred CcEEEEEEcccccchh-----------HHHHHHHHHHHhccCCCc--ccceeeEEee-----CCeeEEEEEecCCC-ChH
Q 015731 102 GMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN--LVKLIGYCLE-----DDHRLLVYEFMPKG-SLE 162 (401)
Q Consensus 102 ~~~~avK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn--i~~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 162 (401)
|+.+.||......... ...+.+|+..+.+|..-+ .+.++++.+. ....++|||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 5678888664332110 113668888888774333 3344555543 23578999999875 899
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-------CCceEEeeccCCcC
Q 015731 163 NHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-------NYNAKLSDFGLAKD 230 (401)
Q Consensus 163 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~ 230 (401)
+++..... .+.+......++.+++..+..||.+| |+|+||++.|||++. +..+.|+||+.+..
T Consensus 125 ~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 88864321 23566777889999999999999998 999999999999974 46899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.7e-09 Score=88.80 Aligned_cols=97 Identities=24% Similarity=0.278 Sum_probs=62.9
Q ss_pred HHHHHHHHHhccCCC--cccceeeEEeeCCeeEEEEEecC--CCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhh-
Q 015731 120 EWLTEIKHLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY- 194 (401)
Q Consensus 120 ~~~~e~~~l~~l~hp--ni~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~- 194 (401)
...+|++.|.++..- ++.+++++. ..+|||||+. |..+..+. ... ++......++.+++..+..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHH
Confidence 356899999999755 566776542 3479999997 55554433 222 1123345566777774444
Q ss_pred hhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 195 LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+|..| |+|+||.+.||+++++ .+.|+|||.+..
T Consensus 123 ~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 123 LHKAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HHCTT--EEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HHhcC--ceecCCChhhEEeecc-eEEEEecCccee
Confidence 57877 9999999999999977 999999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-10 Score=110.22 Aligned_cols=151 Identities=24% Similarity=0.323 Sum_probs=104.3
Q ss_pred HHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcce-------eeecccccCcccccccccC
Q 015731 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV-------STRVMGTYGYAAPEYMATG 258 (401)
Q Consensus 186 ~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 258 (401)
.+++.|+.|+|.. +++||++|.|++|+++.++..||++|+++........... .....-...|.|||.+.+.
T Consensus 106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3455899999987 6799999999999999999999999998765433211111 1112235679999999887
Q ss_pred CCCcccchhhHHHHHHHHH-hCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccc
Q 015731 259 HLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 337 (401)
Q Consensus 259 ~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 337 (401)
.-+.++|+||||+++|.+. .|+..+........ .......+..-...++...+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 7889999999999999998 45554543321100 00011111111123345667888899999999
Q ss_pred cCCCCCCCHHHHHH
Q 015731 338 NEPKFRPTMDEVVK 351 (401)
Q Consensus 338 ~dp~~Rps~~eil~ 351 (401)
.++..||++.+++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997666543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=88.86 Aligned_cols=136 Identities=18% Similarity=0.122 Sum_probs=96.4
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----------------------hhHHHHHHHHH
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------------------QGHLEWLTEIK 126 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----------------------~~~~~~~~e~~ 126 (401)
-+.+...||-|--+.||.|... .|..+|+|.-..... .......+|++
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 3567789999999999999544 478899996322100 11223568999
Q ss_pred HHhccCCC--cccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 127 HLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 127 ~l~~l~hp--ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
+|..|.-- .+.+.+++ +...+|||++.|..|...- ++......++..|++-+..+-..| |||
T Consensus 162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G--iVH 225 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG--IVH 225 (304)
T ss_pred HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC--ccc
Confidence 99998543 67777664 5567999999887665532 122333445555555555555656 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+|+++-||+++++|.+.++||-.+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999976653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.5e-08 Score=83.94 Aligned_cols=104 Identities=22% Similarity=0.202 Sum_probs=81.3
Q ss_pred HHHHHHHHHhccCC--CcccceeeEEeeC----CeeEEEEEecCCC-ChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 015731 120 EWLTEIKHLGQLYH--PNLVKLIGYCLED----DHRLLVYEFMPKG-SLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192 (401)
Q Consensus 120 ~~~~e~~~l~~l~h--pni~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l 192 (401)
...+|+..+..|.. -...+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHHH
Confidence 46678887777743 3345566665543 2458999999874 79998876432 55666788999999999
Q ss_pred hhhhhCCCCeEEeccCCCcEEEcCCC---ceEEeeccCCcC
Q 015731 193 AYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAKD 230 (401)
Q Consensus 193 ~~LH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~ 230 (401)
.-||.+| |+|+|+++.|||++.++ .+.++||+.++.
T Consensus 132 ~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999998877 899999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-07 Score=80.76 Aligned_cols=150 Identities=17% Similarity=0.106 Sum_probs=102.6
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc------chhHHHHHHHHHHHhccCC--Ccc
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES------LQGHLEWLTEIKHLGQLYH--PNL 136 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~e~~~l~~l~h--pni 136 (401)
.....+.-.---|+||.+.|++.... |..+-+|.-...- ......|.+|+..|.+|.. -.+
T Consensus 15 ~~~~~wve~pN~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPV 83 (216)
T PRK09902 15 ATEGDWVEEPNYRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIV 83 (216)
T ss_pred hCCCceecCCCcCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 33333433333566999999986543 3357777654210 1234568899999988853 224
Q ss_pred cceeeEEee----CCeeEEEEEecCC-CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 137 VKLIGYCLE----DDHRLLVYEFMPK-GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 137 ~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
.++...-.. .-..+||+|-+.| .+|.+++.+... .+.+......++.+++..|.-||+.| +.|+|+.+.|
T Consensus 84 P~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~kh 158 (216)
T PRK09902 84 PKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRH 158 (216)
T ss_pred CccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhh
Confidence 454422111 1245899997743 588888865432 34577777899999999999999998 9999999999
Q ss_pred EEEcCCCc--eEEeeccCCcC
Q 015731 212 ILLDLNYN--AKLSDFGLAKD 230 (401)
Q Consensus 212 il~~~~~~--~kl~Dfg~~~~ 230 (401)
|+++.++. +.++||.-++.
T Consensus 159 Ill~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eeecCCCCeeEEEEEhhccch
Confidence 99986667 99999976653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-06 Score=77.91 Aligned_cols=141 Identities=13% Similarity=0.119 Sum_probs=83.6
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc--ccceeeEEeeCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIGYCLEDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn--i~~~~~~~~~~~~~~l 151 (401)
..||.|..+.||+. .|..+++|...... ......+|.++++.+..-+ +.+++++..+.+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 47899999999974 13457888876533 2234578999998885433 5777888888888899
Q ss_pred EEEecCCCC-hHHHH--------------hh----cCCCCCCCCCHHHHH-HHHHH----------HHH-HHhhh--hhC
Q 015731 152 VYEFMPKGS-LENHL--------------FR----TGASYIQPLSWTIRM-KVALG----------AAK-GLAYL--HSD 198 (401)
Q Consensus 152 v~e~~~~~~-L~~~l--------------~~----~~~~~~~~l~~~~~~-~i~~q----------i~~-~l~~L--H~~ 198 (401)
|||+++|.+ +...+ .+ -.............. .+..+ +.. ...+| +..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 11111 00 000000001111000 00000 000 01111 122
Q ss_pred CCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 199 KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 199 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23478999999999999888 99999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=74.40 Aligned_cols=138 Identities=14% Similarity=0.075 Sum_probs=88.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHH---------HHHHHHHHhccC---
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---------WLTEIKHLGQLY--- 132 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~e~~~l~~l~--- 132 (401)
....+|.+.+++.......|.+-.. .|..+++|............ ..+.+..+..+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 3457788888888877776755433 36789999876654322111 223333333332
Q ss_pred CCcccceeeEEe-----eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEecc
Q 015731 133 HPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 207 (401)
Q Consensus 133 hpni~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 207 (401)
-..+..++.+.. -....+|+|||++|..|.+... +++ .++..++.++.-||..| ++|+|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G--~~HGD~ 161 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG--FYHGDP 161 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 222333222222 2234578999999988866432 222 24455677899999998 999999
Q ss_pred CCCcEEEcCCCceEEeeccCCc
Q 015731 208 KTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 208 kp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
.|.|++++.+ .++++||+..+
T Consensus 162 hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 162 HPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcCcEEEECC-cEEEEECcccc
Confidence 9999999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=85.54 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=86.5
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH----------------------------------H
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH----------------------------------L 119 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~----------------------------------~ 119 (401)
+-|+.++-|.||+|.+.. |+.||||+....-.... +
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 578999999999998763 89999999754211000 0
Q ss_pred ------HHHHHHHHHhccC-----CCcccceeeEE-eeCCeeEEEEEecCCCChHHHH--hhcCCCCCCCCCHHHHHHHH
Q 015731 120 ------EWLTEIKHLGQLY-----HPNLVKLIGYC-LEDDHRLLVYEFMPKGSLENHL--FRTGASYIQPLSWTIRMKVA 185 (401)
Q Consensus 120 ------~~~~e~~~l~~l~-----hpni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~l~~~~~~~i~ 185 (401)
.+.+|..-+.++. .|+|. +=.++ .-...-.|+|||+.|..+.+.. ...+ ++.+.+....
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g------~d~k~ia~~~ 273 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG------IDRKELAELL 273 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhcC------CCHHHHHHHH
Confidence 0223333333321 22221 11222 2235568999999999888874 4433 4433333322
Q ss_pred HHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCC
Q 015731 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233 (401)
Q Consensus 186 ~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 233 (401)
.++. +..+-..| ++|.|..|.||++..+|.+.+.|||+......
T Consensus 274 ~~~f--~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 274 VRAF--LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHH--HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2221 22333345 99999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.7e-06 Score=73.31 Aligned_cols=150 Identities=18% Similarity=0.164 Sum_probs=96.6
Q ss_pred chhHHHHHhCCCCCCCc---ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh------------------
Q 015731 59 SFNGLKTATRNFRPDSV---LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------ 117 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~------------------ 117 (401)
+...+.....+..+..+ |++|.-+.||+|.- ..+..+|+|++......-
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~ 105 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRS 105 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCC
Confidence 44445555566666554 55677788999843 347889999976432110
Q ss_pred ------HHHHHHHHHHHhccC--CCcccceeeEEeeCCeeEEEEEecCCCCh-HHHHhhcCCCCCCCCCHHHHHHHHHHH
Q 015731 118 ------HLEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLVYEFMPKGSL-ENHLFRTGASYIQPLSWTIRMKVALGA 188 (401)
Q Consensus 118 ------~~~~~~e~~~l~~l~--hpni~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~l~~~~~~~i~~qi 188 (401)
.....+|+.-|+++. +-.+.+.+.+.. -.|||||+....+ .-.|+. .++.......+..++
T Consensus 106 ~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~ 175 (268)
T COG1718 106 NRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDV 175 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHH
Confidence 011346777777773 444555555433 4699999944310 111111 123333566777888
Q ss_pred HHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 189 AKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 189 ~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
++.+.-|-. .+ +||+||+.-|||+. ++.+.|+|||.+...
T Consensus 176 v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 176 VEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECcccccc
Confidence 888888777 55 99999999999999 889999999988653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.8e-06 Score=73.33 Aligned_cols=75 Identities=17% Similarity=0.114 Sum_probs=50.7
Q ss_pred ccCCCC-eeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEEEE
Q 015731 76 LGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (401)
Q Consensus 76 lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~lv~ 153 (401)
|..|.. ..||+.... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444555 788887321 3568888876543 224557888887773 344667787777767789999
Q ss_pred EecCCCChHHH
Q 015731 154 EFMPKGSLENH 164 (401)
Q Consensus 154 e~~~~~~L~~~ 164 (401)
++++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99998877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.7e-05 Score=66.89 Aligned_cols=128 Identities=19% Similarity=0.240 Sum_probs=88.4
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc----------------chhHHHHHHHHHHHhccC----
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----------------LQGHLEWLTEIKHLGQLY---- 132 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~----------------~~~~~~~~~e~~~l~~l~---- 132 (401)
...||+|+.-.||.- +. ..-.+||++.... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 357999999999852 21 2336788877665 112344556666555554
Q ss_pred --CCcccceeeEEeeCCeeEEEEEecCC------CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 133 --HPNLVKLIGYCLEDDHRLLVYEFMPK------GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 133 --hpni~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
+.+|.+++|+.+++...-+|+|...+ -+|.+++.+.. ++. ...+.+. +-..||-.++ |+.
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~-~~~~~L~---~f~~~l~~~~--Iv~ 141 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE-ELRQALD---EFKRYLLDHH--IVI 141 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH-HHHHHHH---HHHHHHHHcC--Cee
Confidence 78899999999999999999998643 37888885543 444 3333333 4456667766 999
Q ss_pred eccCCCcEEEcCC---C-ceEEee
Q 015731 205 RDFKTSNILLDLN---Y-NAKLSD 224 (401)
Q Consensus 205 ~dlkp~Nil~~~~---~-~~kl~D 224 (401)
+||+|.||++..+ . .+.|+|
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEe
Confidence 9999999999432 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=70.60 Aligned_cols=77 Identities=17% Similarity=0.180 Sum_probs=52.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCC--cccceeeEEe---eCCe
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIGYCL---EDDH 148 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hp--ni~~~~~~~~---~~~~ 148 (401)
+.|+.|..+.||+.... +..+++|..... .....+..|..+++.|... .+.+++.+.. ....
T Consensus 3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 46889999999998543 247999987665 3344566788888777422 3556666443 2345
Q ss_pred eEEEEEecCCCChHH
Q 015731 149 RLLVYEFMPKGSLEN 163 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~ 163 (401)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 789999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-07 Score=90.65 Aligned_cols=188 Identities=20% Similarity=0.124 Sum_probs=129.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc-ccceeeEEeeCC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDD 147 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn-i~~~~~~~~~~~ 147 (401)
-|...+-+++|+++++++.+.. .+ +....+.+... ....-++++|.+++||| .+..++-+..+.
T Consensus 243 ws~~fh~fvK~altknpKkRpt---------ae-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPT---------AE-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED 307 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCC---------hh-hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence 3444556889999999886321 12 22224444333 34456889999999999 777777777778
Q ss_pred eeEEEEEecCCC-ChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 148 HRLLVYEFMPKG-SLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 148 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..++.|+++.++ +-...+.... ..+.......+...-+.+++++|+-- -+|+| ||+..+ +..+..||+
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSE----IALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred ccchhhhhhcCCccccccCChhh----Hhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-ccccccccc
Confidence 889999999776 2222221111 11333344556666678899999853 48988 776664 678999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
......... ......+++.++|||+.....+....|+|++|.-..++--|.+|-..
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 887654433 34456799999999999888999999999999877777777766543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.16 E-value=9.6e-06 Score=84.14 Aligned_cols=196 Identities=22% Similarity=0.224 Sum_probs=137.0
Q ss_pred HHHHHHHHhccCCCcccceeeEEeeCCee----EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 015731 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH 196 (401)
Q Consensus 121 ~~~e~~~l~~l~hpni~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 196 (401)
...|+..+.++.|+|++.++.|..+.... .+..+++...++...+..... ++....+.+..++++||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-----i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-----IPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-----cCHHHHHHHHHHHhhhHHHHH
Confidence 34577788888999999999987765333 344578888888888877654 888999999999999999999
Q ss_pred hCCCCeEEeccCCC---cEEEcCCCceEEe--eccCCcCCCCCCCcceeeecccccCcccccccccCCCCc--ccchhhH
Q 015731 197 SDKAKVIYRDFKTS---NILLDLNYNAKLS--DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA--KSDVYSF 269 (401)
Q Consensus 197 ~~~~~ivH~dlkp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Diwsl 269 (401)
+.. +.|.-|... +..++..+.+.++ ||+.......... .....-+..|.++|......+.. ..|+|.+
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc--cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence 986 666666665 4445666677766 8888776544332 12223455677888776555544 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 015731 270 GVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349 (401)
Q Consensus 270 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ei 349 (401)
|.....+..|..+-..... ...+++. .......+.+.+|+..+.++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhh
Confidence 9999999988754322110 0111111 011145567789999999999999999
Q ss_pred HHHH
Q 015731 350 VKAL 353 (401)
Q Consensus 350 l~~L 353 (401)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 9975
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.9e-05 Score=70.39 Aligned_cols=30 Identities=20% Similarity=0.196 Sum_probs=25.4
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.++|+|+.+.||++++++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998766567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.8e-05 Score=64.90 Aligned_cols=125 Identities=30% Similarity=0.391 Sum_probs=85.8
Q ss_pred CCCCCCCcccCCCC-eeEEEEEecCCCccCCCCCCCcEEEEEEccc---cc-------ch-----------hHHHHHHHH
Q 015731 68 RNFRPDSVLGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ES-------LQ-----------GHLEWLTEI 125 (401)
Q Consensus 68 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~---~~-------~~-----------~~~~~~~e~ 125 (401)
.+++.++.||.|.- |.||++... |..+|+|++.. .. .. ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 67899999999999 999999765 67899999321 10 00 011266777
Q ss_pred HHHhccC---CCcc--cceeeEEeeC------------------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHH
Q 015731 126 KHLGQLY---HPNL--VKLIGYCLED------------------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182 (401)
Q Consensus 126 ~~l~~l~---hpni--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~ 182 (401)
+...+|+ +.++ +++++|..-. ....||.||.+... .+. .
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~ 167 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----I 167 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----h
Confidence 7776664 4456 8999987422 12256777765432 122 2
Q ss_pred HHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCC
Q 015731 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228 (401)
Q Consensus 183 ~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 228 (401)
.-+.+|..-|..+|..| |+-+|+++.|..= | +|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~~---G--~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLG--IVPRDVKPRNYRG---G--KLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCC--eeeccCccccccC---C--EEEecccC
Confidence 33456677788999988 9999999999872 2 89999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.8e-05 Score=80.94 Aligned_cols=82 Identities=17% Similarity=0.206 Sum_probs=55.5
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccC-CCcc--cceeeEEeeC--
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNL--VKLIGYCLED-- 146 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-hpni--~~~~~~~~~~-- 146 (401)
.+.|+.|.+..+|+...... .....+++|+...... .....+.+|+++++.+. |+++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 45688999999998754321 1113577777654322 22345778999999985 6665 7778877664
Q ss_pred -CeeEEEEEecCCCCh
Q 015731 147 -DHRLLVYEFMPKGSL 161 (401)
Q Consensus 147 -~~~~lv~e~~~~~~L 161 (401)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467899999987643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.8e-05 Score=63.50 Aligned_cols=130 Identities=17% Similarity=0.114 Sum_probs=86.2
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCccc-ceeeEEeeCCe
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDH 148 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~-~~~~~~~~~~~ 148 (401)
.+..+.|++|++|.||+|.+. |..+|+|+-..+.. ...+..|.++|..+.--++. +++.|-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678999999999999775 45789997665542 34567899998888765553 3444433
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccC-CCcEEEcCCCceEEeeccC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK-TSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~ 227 (401)
-++.|||+.|-.|.+..... +.+ -+..+++.---|-..| |-|+.|. |..+++..++.+.|+||..
T Consensus 87 ~~i~me~i~G~~L~~~~~~~--------~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG--------DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc--------cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccc
Confidence 34569999888887765421 122 2333444444445545 8888886 4444444455999999998
Q ss_pred CcC
Q 015731 228 AKD 230 (401)
Q Consensus 228 ~~~ 230 (401)
|+.
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.7e-05 Score=65.09 Aligned_cols=102 Identities=25% Similarity=0.211 Sum_probs=77.2
Q ss_pred HHHHHHhccCC-CcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCC-
Q 015731 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKA- 200 (401)
Q Consensus 123 ~e~~~l~~l~h-pni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~- 200 (401)
.|.-+++.+.+ +++++++|+|- .++|.||...+++....... ...-..+|..+.+|+.++++.+.+|+..-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47777888865 69999999884 36789999766664320000 001226899999999999999999987311
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.+.-.|++++|+-+++++.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 177889999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00011 Score=72.08 Aligned_cols=137 Identities=18% Similarity=0.155 Sum_probs=83.2
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh------------------------------------
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------------------------ 117 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~------------------------------------ 117 (401)
+.||..+.|.||+|+..+ |+.||||+-+..-...
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 569999999999997763 8899999865421100
Q ss_pred -HHHHHHHHHHH----hccCCCc------ccceeeEEeeCCeeEEEEEecCCCChHHH--HhhcCCCCCCCCCHHHHHHH
Q 015731 118 -HLEWLTEIKHL----GQLYHPN------LVKLIGYCLEDDHRLLVYEFMPKGSLENH--LFRTGASYIQPLSWTIRMKV 184 (401)
Q Consensus 118 -~~~~~~e~~~l----~~l~hpn------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~l~~~~~~~i 184 (401)
...|.+|.+-. +.+.|-+ |.+++-. -.....|+|||++|..+.|. +.+.+ ++...+..-
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~i~~~ 308 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHDILNK 308 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC------CCHHHHHHH
Confidence 00122232222 2223444 3333321 12456899999999877654 44443 444444333
Q ss_pred HHHHHHHHhhhhhCCCCeEEeccCCCcEEEc----CCCceEEeeccCCcCCC
Q 015731 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLD----LNYNAKLSDFGLAKDGP 232 (401)
Q Consensus 185 ~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~~ 232 (401)
+.++. ++.+=..| ++|+|=.|.||++. .++.+.+.|||+.....
T Consensus 309 l~~~~--~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 309 LVEAY--LEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHH--HHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 33322 12222335 99999999999998 46789999999987543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=64.87 Aligned_cols=139 Identities=17% Similarity=0.093 Sum_probs=74.5
Q ss_pred ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEEEEE
Q 015731 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLVYE 154 (401)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~lv~e 154 (401)
+..|-...+|+... .+..+++|........-.....+|..+++.+...++ .+++.... .++|||
T Consensus 4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence 45677788887632 355788887654322110123578888888754333 34444322 368999
Q ss_pred ecCCCChHHH--------------HhhcCC--CCCCCCCHH-HHHHHHHHH---------HHHHhhhhhC------CCCe
Q 015731 155 FMPKGSLENH--------------LFRTGA--SYIQPLSWT-IRMKVALGA---------AKGLAYLHSD------KAKV 202 (401)
Q Consensus 155 ~~~~~~L~~~--------------l~~~~~--~~~~~l~~~-~~~~i~~qi---------~~~l~~LH~~------~~~i 202 (401)
|++|..+... +.+-.. ....+++.. .+..+..++ ...+..+-.. ...+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9988665321 111110 011122221 111111111 1111111111 1248
Q ss_pred EEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 203 IYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+|+|+.|.||++++++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999987764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00042 Score=63.98 Aligned_cols=77 Identities=12% Similarity=-0.023 Sum_probs=52.8
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC---CcccceeeEEee---
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH---PNLVKLIGYCLE--- 145 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h---pni~~~~~~~~~--- 145 (401)
-.+.||.|..+.||+.... +..+.+|..+... ....+..|...|+.|.- ..+.++++++.+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-----------QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcC-----------CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 3467999999999986322 2246677643311 22356788888888742 467888887754
Q ss_pred CCeeEEEEEecCCCCh
Q 015731 146 DDHRLLVYEFMPKGSL 161 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L 161 (401)
.+..++|||+++|.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00033 Score=62.31 Aligned_cols=75 Identities=20% Similarity=0.183 Sum_probs=44.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~lv 152 (401)
+.|..|-...+|+...... .+..+++|+....... .....+|+.+++.+...++ ++++..+. -.+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 4577788889998743210 2457889977643221 1122468888887743333 44444332 2479
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00018 Score=65.28 Aligned_cols=134 Identities=16% Similarity=0.102 Sum_probs=90.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-----h-----------------hHHHHHHHHH
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----Q-----------------GHLEWLTEIK 126 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-----~-----------------~~~~~~~e~~ 126 (401)
-+.+++.||-|.-+.||.+...+ |..+++|.-..... . ......+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 46778899999999999985543 67788885322110 0 0112456777
Q ss_pred HHhccCC--CcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 127 HLGQLYH--PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 127 ~l~~l~h--pni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
.|+.|.. --+.+.++ .+..++|||++.|..|...-.-. +. -.+...++.-+.-|..+| +||
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~---~~ly~~lm~~Iv~la~~G--lIH 225 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DP---PTLYDDLMGLIVRLANHG--LIH 225 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC--------Ch---HHHHHHHHHHHHHHHHcC--cee
Confidence 7777742 22444443 35578999999888876543211 12 234445555667788888 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCc
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
+|.+--||++++++.++++||--..
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999997544
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00036 Score=66.98 Aligned_cols=167 Identities=26% Similarity=0.315 Sum_probs=95.6
Q ss_pred HHHHHHHHHHHhccCCCcccceeeEEeeC-CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 015731 118 HLEWLTEIKHLGQLYHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH 196 (401)
Q Consensus 118 ~~~~~~e~~~l~~l~hpni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 196 (401)
..+++-.+.+++.+.|+|+..++++.... ....+|||++ +.+|++.+...... .. +++
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~------~~----------s~~---- 84 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK------DE----------SLL---- 84 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc------hh----------hhc----
Confidence 44667788999999999999999887644 4578899999 78999988765421 00 001
Q ss_pred hCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHH
Q 015731 197 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276 (401)
Q Consensus 197 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 276 (401)
.++ +.|-. .++++| -++.. | |-.+ .+++|||++|.++.++
T Consensus 85 ~~~--~~~~~------------~~~~td-~~~t~------------------~--~~~~-----~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 85 AHG--VLHLN------------IIYITD-HFLTK------------------Y--PSPI-----GPKSDVWSLGFIILEL 124 (725)
T ss_pred ccc--cceeh------------hhhccc-ccccc------------------C--CCCC-----CcchhhhhHHHHHHHH
Confidence 122 33322 123333 11110 0 1111 1499999999999999
Q ss_pred HhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015731 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351 (401)
Q Consensus 277 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~ 351 (401)
.-|...+........ ......+.........+.. +..+...++....++..+|+-..|..||...++.+
T Consensus 125 ~L~~~l~~~~~~s~~---l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 125 YLGISLEAELTESEY---LEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHhhHHHHHHHHHHH---HHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 998866543221111 1111111111111000000 00122345667778999999999999987666544
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0023 Score=61.07 Aligned_cols=76 Identities=20% Similarity=0.147 Sum_probs=49.6
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc------c-chhHHHHHHHHHHHhccC---CCcccceeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE------S-LQGHLEWLTEIKHLGQLY---HPNLVKLIGYC 143 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~------~-~~~~~~~~~e~~~l~~l~---hpni~~~~~~~ 143 (401)
+.||.|.+..||++.... .++.++||.-... . .....+...|.+.|+.+. -.++++++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 578999999999985432 1247899974321 1 112334556777777652 3457777766
Q ss_pred eeCCeeEEEEEecCCCC
Q 015731 144 LEDDHRLLVYEFMPKGS 160 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~ 160 (401)
+.+..++|||++++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4466789999997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0016 Score=60.23 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=89.7
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hh------------------------HHHHHHH
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QG------------------------HLEWLTE 124 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~------------------------~~~~~~e 124 (401)
.+...|..|--+.||.|.-. .|..+|||+++..-+ .+ ......|
T Consensus 147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE 216 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE 216 (520)
T ss_pred ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence 34567889999999998433 478899998754211 00 0123467
Q ss_pred HHHHhccCCCcccceeeEEeeCCeeEEEEEecCCCCh-HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeE
Q 015731 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL-ENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 203 (401)
Q Consensus 125 ~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~iv 203 (401)
++-|.+|+...|.-.--+... ...|||+|+....- .-.|+. ..++...+..+-.|++.-+.-|.+. +.+|
T Consensus 217 ~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LV 287 (520)
T KOG2270|consen 217 MRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQK-CRLV 287 (520)
T ss_pred HHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHHH-hcee
Confidence 888888876554433222222 34689999842211 111111 3366666666777777766666554 5599
Q ss_pred EeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 204 YRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 204 H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
|.||.--|+|+. +|.+.|+|.+.+..
T Consensus 288 HADLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 288 HADLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred ccchhhhhheEE-CCEEEEEEcccccc
Confidence 999999999986 67899999876653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=61.00 Aligned_cols=80 Identities=19% Similarity=0.173 Sum_probs=46.4
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc-ccceeeEEeeCCeeEEEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDHRLLVY 153 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn-i~~~~~~~~~~~~~~lv~ 153 (401)
.|..|-...+|+....... .....+..+++|+...... ......+|..++..+...+ ..+++.++.. .+|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 5 KISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4555666788887543211 1223467899998765432 2223457877777774333 3345555432 3689
Q ss_pred EecCCCChH
Q 015731 154 EFMPKGSLE 162 (401)
Q Consensus 154 e~~~~~~L~ 162 (401)
+|++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0087 Score=55.88 Aligned_cols=30 Identities=27% Similarity=0.307 Sum_probs=25.8
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
++||+|+.+.||+++++...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 499999999999999766568999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0071 Score=56.17 Aligned_cols=31 Identities=29% Similarity=0.281 Sum_probs=26.8
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.+++|+|+.+.||++++++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3499999999999999887778999987753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0059 Score=56.35 Aligned_cols=144 Identities=17% Similarity=0.105 Sum_probs=79.1
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc--ccceee------EEe
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIG------YCL 144 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn--i~~~~~------~~~ 144 (401)
.+.|..|....+|+.... +..+++|+.... ....+..|+.++..|.+.+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 455777777889986432 335888987652 2334556777776664322 444433 123
Q ss_pred eCCeeEEEEEecCCCChHH----HH----------hhcCCCCC------CCCCHHHHH----------HHHHHHHHHHhh
Q 015731 145 EDDHRLLVYEFMPKGSLEN----HL----------FRTGASYI------QPLSWTIRM----------KVALGAAKGLAY 194 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~----~l----------~~~~~~~~------~~l~~~~~~----------~i~~qi~~~l~~ 194 (401)
.++..++|+++++|..+.. .+ ........ ....+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999998876532 11 11000000 001111100 011112223333
Q ss_pred hhh-----CCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 195 LHS-----DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 195 LH~-----~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+.. ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 332 112499999999999999887778999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=6.5e-05 Score=80.16 Aligned_cols=159 Identities=14% Similarity=-0.001 Sum_probs=114.5
Q ss_pred HHHHHHHhccCCCcccceeeEEee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-
Q 015731 122 LTEIKHLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD- 198 (401)
Q Consensus 122 ~~e~~~l~~l~hpni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~- 198 (401)
..|..-++...|+++.....-... ....+..++++.+|.+.+.+.+... ..+++....+.....+.+....-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344445556679888776654432 3456889999999999999976653 334455555544444436666665543
Q ss_pred --CCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHH
Q 015731 199 --KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276 (401)
Q Consensus 199 --~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 276 (401)
|...+|++||+-|.+|..+..+++.++|+.+.... .........+++.|+.|++...-.++.++|+|..|+.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 34468999999999999999999999999983222 11223445678889999988766788889999999999999
Q ss_pred HhCCCCC
Q 015731 277 LSGRRVI 283 (401)
Q Consensus 277 l~g~~p~ 283 (401)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887766
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0095 Score=55.00 Aligned_cols=31 Identities=23% Similarity=0.443 Sum_probs=28.1
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
.++|+|+.+.|+++++++-+-++||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999998888999999998764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0086 Score=56.52 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=78.4
Q ss_pred cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCccc-ceeeEEeeCCeeEEEE
Q 015731 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDHRLLVY 153 (401)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~-~~~~~~~~~~~~~lv~ 153 (401)
.|..|-.-.+|++.+... ....+..+++|+...... ....-.+|..+++.+..-++. ++++.+..+ .|.
T Consensus 43 ~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 455577778888754321 112356889998866432 111224688888877543433 455555332 588
Q ss_pred EecCCCChHHH--------------H---hhcCCCC-CCCCCHHHHHHHHHHHH-----------------HHHhh----
Q 015731 154 EFMPKGSLENH--------------L---FRTGASY-IQPLSWTIRMKVALGAA-----------------KGLAY---- 194 (401)
Q Consensus 154 e~~~~~~L~~~--------------l---~~~~~~~-~~~l~~~~~~~i~~qi~-----------------~~l~~---- 194 (401)
+|+++.+|... + +...... ..+..+..+..++.++. ..+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99877666321 0 1111000 01112223323322211 11111
Q ss_pred hhh--CCCCeEEeccCCCcEEEcC-CCceEEeeccCCcC
Q 015731 195 LHS--DKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKD 230 (401)
Q Consensus 195 LH~--~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 230 (401)
+.. ....++|+|+++.||++++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111 1124899999999999976 47899999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.014 Score=53.29 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.3
Q ss_pred CeEEeccCCCcEEEcCCCc-eEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYN-AKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~ 230 (401)
.++|+|+.+.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.013 Score=53.54 Aligned_cols=73 Identities=21% Similarity=0.195 Sum_probs=44.0
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc---CCCcccceeeEEeeCCee
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l---~hpni~~~~~~~~~~~~~ 149 (401)
.+.|+.|....+|+.. .++..+.+|+-.... ...+..|..-|+.| .--.+.+++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 3568889999999864 246789999776322 23455677766666 344677889888877778
Q ss_pred EEEEEecCCC
Q 015731 150 LLVYEFMPKG 159 (401)
Q Consensus 150 ~lv~e~~~~~ 159 (401)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.048 Score=47.50 Aligned_cols=76 Identities=24% Similarity=0.281 Sum_probs=49.3
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc---CCCcccceeeEEeeCCee
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l---~hpni~~~~~~~~~~~~~ 149 (401)
.+.+..|.--..|..... ...+.+|.-..... ..|..|+.-|..| +.-++.+++.+-.+.++.
T Consensus 21 r~~v~gG~inea~~v~dg-----------~~~~FvK~n~~~~~---~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s 86 (286)
T COG3001 21 REEVSGGDINEAWRLRDG-----------TDPFFVKCNQREQL---SMFTAEADGLELLARSNTITVPKVIAVGASRDHS 86 (286)
T ss_pred ccccCCccccceeEeecC-----------CcceEEEecchhhH---HHHHHHHHHHHHHHhcCCccccceEEecCCCCee
Confidence 345555655555654332 34577886544432 2455666555555 446688888888899999
Q ss_pred EEEEEecCCCChH
Q 015731 150 LLVYEFMPKGSLE 162 (401)
Q Consensus 150 ~lv~e~~~~~~L~ 162 (401)
|+||||++-+.+.
T Consensus 87 ylVle~L~~~~~d 99 (286)
T COG3001 87 YLVLEYLPTGPLD 99 (286)
T ss_pred EEEEeeccCCCCC
Confidence 9999999876554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0057 Score=52.73 Aligned_cols=87 Identities=17% Similarity=0.150 Sum_probs=60.0
Q ss_pred HHHHHHHHHHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC
Q 015731 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD 198 (401)
Q Consensus 119 ~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 198 (401)
.-+..+..++++++ .|+++.. .++-.+-+|.|+|-.. .....-.|... +.+|.-+|+.
T Consensus 103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~-----------------~i~~~N~i~ag-i~~L~~fH~~ 160 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI-----------------KINFSNFITAG-IKDLMDFHSE 160 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc-----------------ccchhHHHHHh-HHHHHHhhcc
Confidence 34567888888864 5777763 2344567899988321 11111112222 3678888966
Q ss_pred CCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 199 KAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 199 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..+.+|||-.|+||+-+..|.+||.|-+.
T Consensus 161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCeecCCCChhheeecCCCCEEecChhh
Confidence 66799999999999999999999999764
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.032 Score=51.88 Aligned_cols=30 Identities=17% Similarity=0.153 Sum_probs=27.4
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+++|+|+.+.||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.058 Score=51.57 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=45.5
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-------hhHHHHHHHHHHHhccC---CCcccceeeE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLY---HPNLVKLIGY 142 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~e~~~l~~l~---hpni~~~~~~ 142 (401)
.+.||.|-...||+.... +..++||.-..... -...+...|...|+.+. ...+.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 457899999999997432 23588886542111 01223334566665543 2477888887
Q ss_pred EeeCCeeEEEEEecCC
Q 015731 143 CLEDDHRLLVYEFMPK 158 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~ 158 (401)
+. +..+++||++++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 66 446788999966
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.071 Score=49.48 Aligned_cols=29 Identities=24% Similarity=0.302 Sum_probs=25.1
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.037 Score=51.96 Aligned_cols=29 Identities=17% Similarity=0.232 Sum_probs=25.1
Q ss_pred eEEeccCCCcEEEcC-CCceEEeeccCCcC
Q 015731 202 VIYRDFKTSNILLDL-NYNAKLSDFGLAKD 230 (401)
Q Consensus 202 ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 230 (401)
++|+||.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 689999999999974 57899999987754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.08 Score=49.76 Aligned_cols=29 Identities=17% Similarity=0.206 Sum_probs=24.6
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.++||||.+.||++++++ ++++||..+..
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 489999999999997654 78999987764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.017 Score=53.60 Aligned_cols=73 Identities=18% Similarity=0.131 Sum_probs=56.3
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....|++|++. |++|.- + ....+.++..++.+.+..+.-+..+ .+.-|||+...||+|+ +|.|-|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~-i--------k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I--------KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeee-e--------ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEe
Confidence 34567888876 655532 2 2256678888888887777666655 5789999999999999 999999999
Q ss_pred cCCcC
Q 015731 226 GLAKD 230 (401)
Q Consensus 226 g~~~~ 230 (401)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.035 Score=52.37 Aligned_cols=59 Identities=19% Similarity=0.151 Sum_probs=41.0
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCCCeEEeccCCCcEEEc
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nil~~ 215 (401)
..|+=+|..|.++..+++... .++....+++.-.+.|+-.+- -.+ ++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 346666788889998887765 455556666655555544332 334 99999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.32 Score=46.56 Aligned_cols=81 Identities=11% Similarity=0.079 Sum_probs=43.5
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~lv 152 (401)
+.|..|-...+|++...... ...-..+.|.++....... ....-.+|+.+++.|...++ .++++.+.. ++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~~-l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYNS-LVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCCc-eEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 34556777889988654321 0000112244444322211 11112468888888865444 445555542 589
Q ss_pred EEecCCCChH
Q 015731 153 YEFMPKGSLE 162 (401)
Q Consensus 153 ~e~~~~~~L~ 162 (401)
.||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999887664
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.17 Score=48.30 Aligned_cols=75 Identities=17% Similarity=0.209 Sum_probs=45.2
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc-----c-chhHHHHHHHHHHHhccC--CC-cccceeeEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-----S-LQGHLEWLTEIKHLGQLY--HP-NLVKLIGYC 143 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~-----~-~~~~~~~~~e~~~l~~l~--hp-ni~~~~~~~ 143 (401)
.+.||.|--.-||++.... .+..++||.-... + .-...+..-|...|+.+. .| .+++++.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 3578999999999985421 2346888853321 1 112334455667776652 34 4555654
Q ss_pred eeCCeeEEEEEecCC
Q 015731 144 LEDDHRLLVYEFMPK 158 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~ 158 (401)
.+.....+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 455567789998854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.99 Score=42.25 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=23.7
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
++||+|+.+.||+++ + .+.|+||+-+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 489999999999995 4 578999997753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.10 E-value=1.4 Score=47.98 Aligned_cols=31 Identities=42% Similarity=0.478 Sum_probs=25.7
Q ss_pred CCeEEeccCCCcEEEcCCC--ceE-EeeccCCcC
Q 015731 200 AKVIYRDFKTSNILLDLNY--NAK-LSDFGLAKD 230 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~--~~k-l~Dfg~~~~ 230 (401)
..+||+|+.+.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999998775 555 999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.79 Score=44.81 Aligned_cols=82 Identities=11% Similarity=0.073 Sum_probs=44.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCccc-ceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~-~~~~~~~~~~~~~lv 152 (401)
+.|..|=.-.+|++....... ......+..|.+++.......- ..-..|..+++.+..-+|. ++++.+. -..|
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 445566667788876543210 0011235678999876543211 1223577777666544443 3445443 3467
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.055 Score=45.90 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.5
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
..+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 478999999999998777 99999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 401 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = 0.0
Identities = 108/326 (33%), Positives = 178/326 (54%), Gaps = 31/326 (9%)
Query: 46 EGEIL--LGSNIKSFSFNGLKTATRNFRP------DSVLGEGGFGCVFKGWIDEHTYAPA 97
E + L + SFSF LK T NF + +GEGGFG V+KG+++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 98 RPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153
+AVK+L + + + ++ EIK + + H NLV+L+G+ + D LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 154 EFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213
+MP GSL + L + PLSW +R K+A GAA G+ +LH + I+RD K++NIL
Sbjct: 110 VYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANIL 165
Query: 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVL 273
LD + AK+SDFGLA+ +Q+ +++R++GT Y APE + G +T KSD+YSFGVVL
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVL 224
Query: 274 LEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI 333
LE+++G +D++R L++ + ++ I +D ++ + +A
Sbjct: 225 LEIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVAS 281
Query: 334 KCLSNEPKFRPTMDEVVKALEQIQDT 359
+CL + RP + +V + L+++ +
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 507 bits (1309), Expect = 0.0
Identities = 121/334 (36%), Positives = 182/334 (54%), Gaps = 14/334 (4%)
Query: 31 GSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWID 90
GS ++ S+ L+ L+ AT NF ++G G FG V+KG +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 91 EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150
+ G +A+KR ES QG E+ TEI+ L HP+LV LIG+C E + +
Sbjct: 62 D----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210
L+Y++M G+L+ HL+ + +SW R+++ +GAA+GL YLH+ +I+RD K+
Sbjct: 112 LIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSI 168
Query: 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFG 270
NILLD N+ K++DFG++K G Q+H+ST V GT GY PEY G LT KSDVYSFG
Sbjct: 169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228
Query: 271 VVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV 330
VVL E+L R I ++ P NL EWA ++ Q++D + + + K
Sbjct: 229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 331 LAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364
A+KCL+ + RP+M +V+ LE ++ +
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-149
Identities = 125/337 (37%), Positives = 189/337 (56%), Gaps = 22/337 (6%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
VP E + +K FS L+ A+ NF ++LG GGFG V+KG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 102 GMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
G ++AVKRL +E QG L++ TE++ + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 161 LENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYN 219
+ + L S PL W R ++ALG+A+GLAYLH K+I+RD K +NILLD +
Sbjct: 114 VASCLRERPESQP-PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172
Query: 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
A + DFGLAK +HV+T V GT G+ APEY++TG + K+DV+ +GV+LLE+++G
Sbjct: 173 AVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
Query: 280 RRVIDKNRPSREH--NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 337
+R D R + + L++W K L ++++ ++D ++G Y + +A+ C
Sbjct: 232 QRAFDLARLANDDDVMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 290
Query: 338 NEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSD 374
+ P RP M EVV+ LE D R E Q +
Sbjct: 291 SSPMERPKMSEVVRMLE-----GDGLAERWEEWQKEE 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 7e-88
Identities = 75/328 (22%), Positives = 122/328 (37%), Gaps = 44/328 (13%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
L + + V G FGCV+K + +AVK + Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ- 61
Query: 118 HLEWL--TEIKHLGQLYHPNLVKLIGYCLEDDH----RLLVYEFMPKGSLENHLFRTGAS 171
W E+ L + H N+++ IG L+ F KGSL + L
Sbjct: 62 --SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTSNILLDLNYNAKLS 223
+SW +A A+GLAYLH D K + +RD K+ N+LL N A ++
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-----TAKSDVYSFGVVLLEMLS 278
DFGLA G + + +GT Y APE + + D+Y+ G+VL E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 279 GRRVIDKNRPSREHNLIE--WAKPYLQSKRRI--FQVMDARIEGQYSLGAALKT-AVLAI 333
D E P L+ + + + + + A +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 334 KCLSNEPKFRPTMDEVVKALEQIQDTND 361
+C ++ + R + V + + Q+Q +
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-68
Identities = 61/339 (17%), Positives = 121/339 (35%), Gaps = 55/339 (16%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
+ + N + ++G G +G V+KG +D +AVK + + Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50
Query: 118 HLEWLTE--IKHLGQLYHPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRTGA 170
++ E I + + H N+ + I LLV E+ P GSL +L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 171 SYIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILLDLNYNAKLS 223
W ++A +GLAYLH++ K + +RD + N+L+ + +S
Sbjct: 106 ---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162
Query: 224 DFGLAK------DGPTGSQSHVSTRVMGTYGYAAPEYM-------ATGHLTAKSDVYSFG 270
DFGL+ G + + + +GT Y APE + + D+Y+ G
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
Query: 271 VVLLEMLSGRRVIDKNRPSREHNL----IEWAKPYLQSKRRIFQVMDAR--IEGQYSLGA 324
++ E+ + E+ + P + + + R + +
Sbjct: 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 325 ALKTAV--LAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361
++ C + + R T + + ++ +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-66
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
+G G FG V + W G +AVK L ++ E+L E+ + +L
Sbjct: 44 KIGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
HPN+V +G + + +V E++ +GSL L ++GA + L R+ +A AKG
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKG 149
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+ YLH+ +++R+ K+ N+L+D Y K+ DFGL++ + S S GT + A
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMA 207
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 311
PE + KSDVYSFGV+L E+ + + +P+ QV
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQ------------------QPW--GNLNPAQV 247
Query: 312 MDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359
+ A L + A + C +NEP RP+ ++ L + +
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-65
Identities = 82/290 (28%), Positives = 134/290 (46%), Gaps = 49/290 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG V K + +A+K++ ES + ++ E++ L ++ HP
Sbjct: 15 VVGRGAFGVVCKA-----KW------RAKDVAIKQIESESERK--AFIVELRQLSRVNHP 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+VKL G CL + LV E+ GSL N L + + M L ++G+AY
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117
Query: 195 LHSDKAK-VIYRDFKTSNILLDLNYN-AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
LHS + K +I+RD K N+LL K+ DFG A D T G+ + AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAP 172
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312
E + + K DV+S+G++L E+++ R KP+ + F++M
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRR------------------KPFDEIGGPAFRIM 214
Query: 313 DARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
A G +L +++ L +C S +P RP+M+E+VK + +
Sbjct: 215 WAVHNGTRPPLIKNLPKPIES--LMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-64
Identities = 76/322 (23%), Positives = 127/322 (39%), Gaps = 50/322 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G FG K T+ TG V+ +K L + + +L E+K + L HP
Sbjct: 17 VLGKGCFGQAIKV-----THR----ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N++K IG +D + E++ G+L + W+ R+ A A G+AY
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAY 123
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------------DGPTGSQSHVSTR 242
LHS +I+RD + N L+ N N ++DFGLA+
Sbjct: 124 LHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302
V+G + APE + K DV+SFG+VL E++ A P
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDY 225
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKT----AVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+ F + + G + ++C +P+ RP+ ++ LE ++
Sbjct: 226 LPRTMDFGL---NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 359 TNDAGVSRDESLQNSDRSTYKR 380
+ L+ DR ++
Sbjct: 283 HLAGHLPLGPQLEQLDRGFWET 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-63
Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 56/300 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-------EWLTEIKH 127
+G+GGFG V KG V+A+K L +G E+ E+
Sbjct: 26 QIGKGGFGLVHKG-----RLV----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ L HPN+VKL G +V EF+P G L + L P+ W++++++ L
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLD 130
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLD-----LNYNAKLSDFGLAKDGPTGSQSHVSTR 242
A G+ Y+ + +++RD ++ NI L AK++DFGL++ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSG 185
Query: 243 VMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL--IEWA 298
++G + + APE + T K+D YSF ++L +L+G P E++ I++
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFI 239
Query: 299 KPYLQSKRR--IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+ R I + R+ + C S +PK RP +VK L ++
Sbjct: 240 NMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-62
Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 50/294 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
L E G ++KG W G I VK L ++ E L
Sbjct: 17 KLNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 132 YHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
HPN++ ++G C H L+ +MP GSL N L + + +K AL A
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMA 121
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+G+A+LH+ + + + ++++D + A++S + S S M +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAW 174
Query: 250 AAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
APE + +D++SF V+L E+++ P + + +E
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGL 228
Query: 307 R--IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
R I + + + L C++ +P RP D +V LE++QD
Sbjct: 229 RPTIPPGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-60
Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 56/298 (18%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL----EWLTEIKHLG 129
++G GGFG V++ W G +AVK + + E K
Sbjct: 14 IIGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
L HPN++ L G CL++ + LV EF G L L + + I + A+ A
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIA 115
Query: 190 KGLAYLHSDK-AKVIYRDFKTSNILLD--------LNYNAKLSDFGLAKDGPTGSQSHVS 240
+G+ YLH + +I+RD K+SNIL+ N K++DFGLA++
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTK 171
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
G Y + APE + + SDV+S+GV+L E+L+G P R + + A
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYG 225
Query: 301 YLQSKRR--IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+K I A L C + +P RP+ ++ L I
Sbjct: 226 VAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-58
Identities = 70/312 (22%), Positives = 122/312 (39%), Gaps = 46/312 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--TEIKHLGQL 131
+G+G +G V+ G W E +AVK W TEI +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 132 YHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
H N++ I ++ L+ ++ GSL ++L L +K+A
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYS 142
Query: 188 AAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHV 239
+ GL +LH++ K + +RD K+ NIL+ N ++D GLA T
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 240 STRVMGTYGYAAPE----YMATGHLTA--KSDVYSFGVVLLEMLSGRRVIDKNRPSRE-H 292
+GT Y PE + H + +D+YSFG++L E+ + +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 293 NLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLSNEPKFRPTMDEV 349
+ + + P + R I + R ++S L+ L +C ++ P R T V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 350 VKALEQIQDTND 361
K L ++ ++ D
Sbjct: 323 KKTLAKMSESQD 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-58
Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 54/296 (18%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G G FG V+KG W + +AVK LN + + E+ L +
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
H N++ +GY +V ++ SL +HL + + +A A+G+
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGM 133
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
YLH+ +I+RD K++NI L + K+ DFGLA + S SH ++ G+ + AP
Sbjct: 134 DYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 253 E---YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKRR 307
E + + +SDVY+FG+VL E+++G+ PY + ++ +
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------PYSNINNRDQ 233
Query: 308 IFQV------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
I ++ + + + +K L +CL + RP+ ++ +E++
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKR--LMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-58
Identities = 73/319 (22%), Positives = 127/319 (39%), Gaps = 48/319 (15%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+T R+ +G+G +G V++G W E+ +AVK + + W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSSRDEK---SWF 48
Query: 123 --TEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRTGASYIQPL 176
TE+ + L H N++ I + H L+ + GSL ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTL 102
Query: 177 SWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA-- 228
+++ L A GLA+LH + K + +RD K+ NIL+ N ++D GLA
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRV 282
T + +GT Y APE + + D+++FG+VL E+
Sbjct: 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
Query: 283 IDKNRPSRE--HNLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLS 337
+ ++++ P + R++ V R I ++ L + A L +C
Sbjct: 223 NGIVEDYKPPFYDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY 281
Query: 338 NEPKFRPTMDEVVKALEQI 356
P R T + K L +I
Sbjct: 282 QNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-57
Identities = 87/381 (22%), Positives = 147/381 (38%), Gaps = 70/381 (18%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEG-EILLGSNIKSFSFNGLKTATR 68
D P + + TSGS S + + V RT I+L +I
Sbjct: 6 DRPFISEGTTLKDLIYDMTTSGSGSGLPLL--VQRTIARTIVLQESI------------- 50
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE--I 125
G+G FG V++G W E +AVK + + W E I
Sbjct: 51 --------GKGRFGEVWRGKWRGEE------------VAVKIFSSREER---SWFREAEI 87
Query: 126 KHLGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
L H N++ I +D+ LV ++ GSL ++L R ++
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGM 141
Query: 182 MKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPT 233
+K+AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 234 GSQSHVSTRVMGTYGYAAPE----YMATGHLTA--KSDVYSFGVVLLEMLSGRRVIDKNR 287
+ +GT Y APE + H + ++D+Y+ G+V E+ + +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 288 PSR-EHNLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLSNEPKFR 343
+ + + + P ++ R++ R I ++ AL+ A + +C R
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
Query: 344 PTMDEVVKALEQIQDTNDAGV 364
T + K L Q+ +
Sbjct: 322 LTALRIKKTLSQLSQQEGIKM 342
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-57
Identities = 58/305 (19%), Positives = 114/305 (37%), Gaps = 59/305 (19%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
++G+G FG V+ G W E +A++ ++ E + E+ Q
Sbjct: 40 LIGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
H N+V +G C+ H ++ +L + + L ++A KG
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKG 142
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYG 248
+ YLH+ ++++D K+ N+ D N ++DFGL G + G
Sbjct: 143 MGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 249 YAAPEYM---------ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
+ APE + + SDV++ G + E+ +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------------------W 241
Query: 300 PY--LQSKRRIFQVMDA--RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
P+ ++ I+Q+ Q +G + + + C + E + RPT +++ LE+
Sbjct: 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD--ILLFCWAFEQEERPTFTKLMDMLEK 299
Query: 356 IQDTN 360
+ N
Sbjct: 300 LPKRN 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-45
Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 39/306 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + LG+G FG V Y P + TG V+AVK+L + + ++ EI+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGA--SYIQPLSWTIRMK 183
L L H N+VK G C R L+ E++P GSL ++L + +I+ L +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----- 119
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST-- 241
KG+ YL + + I+RD T NIL++ K+ DFGL K P +
Sbjct: 120 -TSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 242 -----RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296
APE + + SDV+SFGVVL E+ + P E +
Sbjct: 177 GESPIFWY------APESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEFMRMI 228
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352
Q +++ ++ L G + ++ +C +N RP+ ++
Sbjct: 229 GNDKQGQMIVF--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 353 LEQIQD 358
++QI+D
Sbjct: 286 VDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-45
Identities = 87/314 (27%), Positives = 126/314 (40%), Gaps = 57/314 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P GTG ++AVK L ++ H W EI
Sbjct: 31 RYLKKIRDLGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
L LYH +++K G C + LV E++P GSL ++L R Q L +
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------ 139
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST--- 241
A +G+AYLH+ I+RD N+LLD + K+ DFGLAK P G + +
Sbjct: 140 AQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 242 ----RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296
APE + SDV+SFGV L E+L+ D ++ L
Sbjct: 198 DSPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLEL 247
Query: 297 WAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRP 344
Q ++ + G+ Y L C E FRP
Sbjct: 248 IGIAQGQMTVL--RLTELLERGERLPRPDKCPAEVYH---------LMKNCWETEASFRP 296
Query: 345 TMDEVVKALEQIQD 358
T + ++ L+ + +
Sbjct: 297 TFENLIPILKTVHE 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 39/300 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V Y P + TG V+AVK+L + + ++ EI+ L L H
Sbjct: 47 QQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 134 PNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGA--SYIQPLSWTIRMKVALGAA 189
N+VK G C R L+ E++P GSL ++L + +I+ L +
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQIC 155
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST-------R 242
KG+ YL + + I+RD T NIL++ K+ DFGL K P + +
Sbjct: 156 KGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302
APE + + SDV+SFGVVL E+ + P E +
Sbjct: 214 WY------APESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEFMRMIGNDKQG 265
Query: 303 QSKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
Q +++ ++ L G + ++ +C +N RP+ ++ ++QI+D
Sbjct: 266 QMIVF--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 83/314 (26%), Positives = 125/314 (39%), Gaps = 59/314 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P TG +AVK L ES H+ + EI+
Sbjct: 21 RFLKRIRDLGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGA--SYIQPLSWTIRM 182
L LYH N+VK G C ED L+ EF+P GSL+ +L + + Q L +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY---- 131
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST- 241
A+ KG+ YL S + ++RD N+L++ + K+ DFGL K T + +
Sbjct: 132 --AVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 242 ------RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 294
APE + SDV+SFGV L E+L+ + L
Sbjct: 188 DRDSPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFL 237
Query: 295 IEWAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKF 342
+ Q ++++ EG+ Y L KC +P
Sbjct: 238 KMIGPTHGQMTVT--RLVNTLKEGKRLPCPPNCPDEVYQ---------LMRKCWEFQPSN 286
Query: 343 RPTMDEVVKALEQI 356
R + +++ E +
Sbjct: 287 RTSFQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 74/289 (25%), Positives = 114/289 (39%), Gaps = 42/289 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+G G FG VF G R +V AVK + ++L E + L Q H
Sbjct: 121 QIGRGNFGEVFSG--------RLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+V+LIG C + +V E + G L G L +++ AA G+
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGME 227
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YL S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 228 YLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 312
+ G +++SDV+SFG++L E S G PY Q
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGAS------------------PY--PNLSNQQTR 325
Query: 313 DARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
+ +E L L +C + EP RP+ + + L+ I+
Sbjct: 326 E-FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-42
Identities = 74/313 (23%), Positives = 123/313 (39%), Gaps = 58/313 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + S LG+G FG V Y P TG ++AVK+L ++ EI+
Sbjct: 23 RHLKYISQLGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGA--SYIQPLSWTIRMK 183
L L+ +VK G + LV E++P G L + L R A + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY----- 132
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST-- 241
+ KG+ YL S + ++RD NIL++ + K++DFGLAK P +V
Sbjct: 133 -SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 242 -----RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 295
APE ++ + +SDV+SFGVVL E+ + +
Sbjct: 190 GQSPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCD------KSCSPSAEF 237
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFR 343
+ + ++++ EGQ + L C + P+ R
Sbjct: 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE---------LMKLCWAPSPQDR 288
Query: 344 PTMDEVVKALEQI 356
P+ + L+ +
Sbjct: 289 PSFSALGPQLDML 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 60/312 (19%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+F +VLG+G FG V K + A+K++ + L+E+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---RNA------LDSRYYAIKKIRHTEEKLS-TILSEVM 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-------------LVYEFMPKGSLENHLFRTGASYI 173
L L H +V+ LE + + + E+ G+L + + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 174 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---- 229
+ W + ++ L+Y+HS +I+RD K NI +D + N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 230 ---------DGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSG 279
GS ++++ + GT Y A E + TGH K D+YS G++ EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 280 RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNE 339
S + + + + + + + ++
Sbjct: 228 --------FSTGMERVN---ILKKLRSVSIE-FPPDFDDNKMKVEKK----IIRLLIDHD 271
Query: 340 PKFRPTMDEVVK 351
P RP ++
Sbjct: 272 PNKRPGARTLLN 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWL-TEI 125
R + D +G G F V+KG +D T + +A L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-LDT--------ETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 126 KHLGQLYHPNLVKLIGYCL---EDDHRLLVY-EFMPKGSLENHLFRTGASYIQPLSWTIR 181
+ L L HPN+V+ + +++ E M G+L+ +L R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVL 131
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVS 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFA 187
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
V+GT + APE + DVY+FG+ +LEM +
Sbjct: 188 KAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 63/305 (20%), Positives = 112/305 (36%), Gaps = 61/305 (20%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G F +FKG + Y + +K L++ + + +L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
+LV G C+ D +LV EF+ GSL+ +L + + I + W + + A A +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCI-NILWKLEV--AKQLAAAMH 127
Query: 194 YLHSDKAKVIYRDFKTSNILLDL--------NYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+L + +I+ + NILL KLSD G++ V+
Sbjct: 128 FL-EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLP 173
Query: 246 TYGY------AAPEYMATG-HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297
PE + +L +D +SFG L E+ S G
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD----------------- 216
Query: 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI--KCLSNEPKFRPTMDEVVKALEQ 355
KP + + + E ++ L A + + C+ EP RP+ +++ L
Sbjct: 217 -KPLSALDSQ--RKLQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
Query: 356 IQDTN 360
+ +
Sbjct: 273 LFTPD 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIRMKVALGAAK 190
P++ +L+G CL L+ + MP G L +++ R I L+W + AK
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAK 128
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ YL ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
A E + T +SDV+S+GV + E+++ G + PY
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPAS-- 226
Query: 310 QVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++ +G+ Y + KC + RP E++ ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYM---------IMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 65/303 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+F+ ++G GGFG VFK G +KR+ + + E+K
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK---------HRIDGKTYVIKRVKYNNEKA----EREVKA 57
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL----------------LVYEFMPKGSLENHLFRTGAS 171
L +L H N+V G D+ + EF KG+LE + +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 172 YI---QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
+ L ++ KG+ Y+HS K +I RD K SNI L K+ DFGL
Sbjct: 118 KLDKVLALELFEQI------TKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288
+ TR GT Y +PE +++ + D+Y+ G++L E+L
Sbjct: 170 T---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--------- 217
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
++ + + D I + KT + K LS +P+ RP E
Sbjct: 218 ---------CDTAFETSKFFTDLRDGIISDIFD--KKEKTLLQ--KLLSKKPEDRPNTSE 264
Query: 349 VVK 351
+++
Sbjct: 265 ILR 267
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 72/325 (22%), Positives = 136/325 (41%), Gaps = 68/325 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG+G FG V++G + +A+K +N+ S++ +E+L E + +
Sbjct: 32 ELGQGSFGMVYEG----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRTGASYIQPLSWTIRMKVALGA 188
++V+L+G + L++ E M +G L+++L + P S + +++A
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT------GSQSHVSTR 242
A G+AYL++ K ++RD N ++ ++ K+ DFG+ +D G + + R
Sbjct: 148 ADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--------------GRRVIDKNRP 288
M +PE + G T SDV+SFGVVL E+ + R V++
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ N +F++M C PK RP+ E
Sbjct: 260 DKPDN----------CPDMLFELM--------------------RMCWQYNPKMRPSFLE 289
Query: 349 VVKALEQIQDTNDAGVSRDESLQNS 373
++ ++++ + VS S +N
Sbjct: 290 IISSIKEEMEPGFREVSFYYSEENK 314
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 69/287 (24%), Positives = 108/287 (37%), Gaps = 44/287 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ S LG G +G VFK G + AVKR + L E+
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 127 -HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
H HP V+L E L E SL+ H GAS + W
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
L LA+LHS +++ D K +NI L KL DFGL + G+ + G
Sbjct: 168 LA----LAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-G 218
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
Y APE + + +DV+S G+ +LE+ + P +
Sbjct: 219 DPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMEL-----PH-----------GGEGW 261
Query: 306 RRIFQ-VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+++ Q + S + L++ ++ L +PK R T + ++
Sbjct: 262 QQLRQGYLPPEFTAGLS--SELRSVLV--MMLEPDPKLRATAEALLA 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 74/304 (24%), Positives = 125/304 (41%), Gaps = 42/304 (13%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W + +AVK L +++++ E+L E + ++ H
Sbjct: 227 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 275
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PNLV+L+G C + ++ EFM G+L ++L R + M A + +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYM--ATQISSAME 332
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
YL I+R+ N L+ N+ K++DFGL++ TG + APE
Sbjct: 333 YLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 389
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 313
+A + KSDV++FGV+L E+ + PY QV +
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLS--QVYE 430
Query: 314 ARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDES 369
+ Y + G K L C P RP+ E+ +A E + + ++
Sbjct: 431 LLEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
Query: 370 LQNS 373
L
Sbjct: 490 LGKR 493
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 75/318 (23%), Positives = 114/318 (35%), Gaps = 72/318 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG VF + M++AVK L + S ++ E + L L H
Sbjct: 48 ELGEGAFGKVFLA----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL----------FRTGASYIQPLSWTIRMKV 184
++V+ G C E L+V+E+M G L L PL + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT------GSQSH 238
A A G+ YL ++RD T N L+ K+ DFG+++D + G ++
Sbjct: 164 ASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVIDK--- 285
+ R M PE + T +SDV+SFGVVL E+ LS ID
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 286 -NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 344
R ++ +M C EP+ R
Sbjct: 276 GRELERPRA----------CPPEVYAIM--------------------RGCWQREPQQRH 305
Query: 345 TMDEVVKALEQIQDTNDA 362
++ +V L+ +
Sbjct: 306 SIKDVHARLQALAQAPPV 323
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 70/220 (31%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTIR 181
HPN++ L+G C + L E+ P G+L + L F S LS
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP---TGSQSH 238
+ A A+G+ YL S K + I+RD NIL+ NY AK++DFGL++ +
Sbjct: 145 LHFAADVARGMDYL-SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 278
+ R M A E + T SDV+S+GV+L E++S
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 68/308 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V +G GT + +AVK + + S + E+L+E +
Sbjct: 41 ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 133 HPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR--MKVA 185
HPN+++L+G C+E +++ FM G L +L P ++ +K
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFM 153
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRV 243
+ A G+ YL S++ ++RD N +L + ++DFGL+K +G + ++
Sbjct: 154 VDIALGMEYL-SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 244 ----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 298
+ A E +A T+KSDV++FGV + E+ + G P E
Sbjct: 212 PVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMY 259
Query: 299 KPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
YL R ++++M C +P RPT
Sbjct: 260 D-YLLHGHRLKQPEDCLDELYEIM--------------------YSCWRTDPLDRPTFSV 298
Query: 349 VVKALEQI 356
+ LE++
Sbjct: 299 LRLQLEKL 306
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 75/294 (25%), Positives = 121/294 (41%), Gaps = 50/294 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
++G G G V G V A+K L + + ++L+E +GQ H
Sbjct: 56 IIGSGDSGEVCYG-----RLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+++L G ++V E+M GSL+ L RT + + + G G+
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHD---GQFTIMQLVGMLRGVGAGMR 165
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG----- 248
YL ++RD N+L+D N K+SDFGL++ + +T G
Sbjct: 166 YLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPI 218
Query: 249 -YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE +A ++ SDV+SFGVV+ E+L+ G R PY
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER------------------PYWNMTN 260
Query: 307 RIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
R V+ + +E Y L G L + C + RP ++V L+ +
Sbjct: 261 R--DVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-36
Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 52/294 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G FG V G W+++ +A+K + + ++ +++ E + + +L H
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-----------VAIKTIREGAMSEE-DFIEEAEVMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P LV+L G CLE LV EFM G L ++L RT + M L +G+A
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFA-AETLLGM--CLDVCEGMA 118
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
YL A VI+RD N L+ N K+SDFG+ + T GT +A
Sbjct: 119 YLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWA 172
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
+PE + ++KSDV+SFGV++ E+ S G+ PY R
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI------------------PY--ENRSNS 212
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359
+V++ I + L A+ + C P+ RP +++ L +I ++
Sbjct: 213 EVVE-DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 76/315 (24%), Positives = 134/315 (42%), Gaps = 50/315 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V+KG + + +A+K L + + +++L E +GQ H
Sbjct: 51 VIGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
N+++L G + +++ E+M G+L+ L R S + + G A G+
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDG---EFSVLQLVGMLRGIAAGMK 161
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG----- 248
YL + ++RD NIL++ N K+SDFGL++ ++ +T G
Sbjct: 162 YLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPI 214
Query: 249 -YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE ++ T+ SDV+SFG+V+ E+++ G R PY +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSN 256
Query: 307 RIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ-IQDTND 361
+VM I + L L ++C E RP ++V L++ I+ +
Sbjct: 257 H--EVMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313
Query: 362 AGVSRDESLQNSDRS 376
D + S R
Sbjct: 314 LKTLADFDPRVSIRL 328
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 66/303 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 32 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
PN++ L+G CL + L+V +M G L N + + + + L AKG+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGM 141
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV----M 244
YL S K ++RD N +LD + K++DFGLA+D + ++ M
Sbjct: 142 KYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303
A E + T T KSDV+SFGV+L E+++ G P + N + YL
Sbjct: 200 ------ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV-YLL 246
Query: 304 SKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
RR +++VM +KC + + RP+ E+V +
Sbjct: 247 QGRRLLQPEYCPDPLYEVM--------------------LKCWHPKAEMRPSFSELVSRI 286
Query: 354 EQI 356
I
Sbjct: 287 SAI 289
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 56/291 (19%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG V G + G +AVK + ++ +L E + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRH 245
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
NLV+L+G +E+ L +V E+M KGSL ++L R+ + ++ +L + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKF--SLDVCEAM 302
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
YL ++RD N+L+ + AK+SDFGL K+ + + ++ + AP
Sbjct: 303 EYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKL--PVKWTAP 355
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI--F 309
E + + KSDV+SFG++L E+ S GR PY RI
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY----PRIPLK 393
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
V+ R+E Y + G + C + RPT ++ + LE I
Sbjct: 394 DVVP-RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 238
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LV+L E+ +V E+M KGSL + L + L + M A A G+A
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDM--AAQIASGMA 294
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
Y+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 295 YVER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 313
G T KSDV+SFG++L E+ + RV PY R +V+D
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNR--EVLD 392
Query: 314 ARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++E Y + L +C EP+ RPT + + LE
Sbjct: 393 -QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 77/361 (21%), Positives = 133/361 (36%), Gaps = 102/361 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V + +P +AVK L + + + + ++E+ K +G+
Sbjct: 76 PLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWT 179
H N++ L+G C +D ++ E+ KG+L +L + + + LS
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 192 DLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD--------- 240
Query: 240 STRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEM----------L 277
+ Y APE + T +SDV+SFGV+L E+ +
Sbjct: 241 ---IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 278 SGRRVIDKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALK 327
+ L+ R ++ +M
Sbjct: 298 PVEELFK----------------LLKEGHRMDKPSNCTNELYMMM--------------- 326
Query: 328 TAVLAIKCLSNEPKFRPTMDEVVKALEQI-QDTNDAGVSRDESLQNSDRSTYKRKGLNEN 386
C P RPT ++V+ L++I T++ + + D + L N
Sbjct: 327 -----RDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
Query: 387 G 387
G
Sbjct: 382 G 382
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 44/291 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V G V A+K L + + ++L E +GQ H
Sbjct: 52 VVGAGEFGEVCSG-----RLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PN+++L G + ++V E+M GSL++ L + A + + + G A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMK 161
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
YL SD ++RD NIL++ N K+SDFGL + ++ +TR G +
Sbjct: 162 YL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
+PE +A T+ SDV+S+G+VL E++S G R PY + +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER------------------PYWEMSNQ-- 257
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
V+ A ++ Y L L + C + RP +++V L+++
Sbjct: 258 DVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 71/332 (21%), Positives = 130/332 (39%), Gaps = 65/332 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIRMKVALGAAK 190
P++ +L+G CL L+ + MP G L +++ R I L+W + AK
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAK 128
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ YL ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
A E + T +SDV+S+GV + E+++ G + PY
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PY--DGIPAS 226
Query: 310 QVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI- 356
++ +G+ Y + +KC + RP E++ ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYM---------IMVKCWMIDADSRPKFRELIIEFSKMA 277
Query: 357 ---QDTNDAGVSRDESLQNSDRSTYKRKGLNE 385
Q L + S + R ++E
Sbjct: 278 RDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 309
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +AVK + + S+ E+ E + + +L H
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-----------VAVKMIKEGSMSED-EFFQEAQTMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P LVK G C ++ +V E++ G L N+L G L + +++ +G+A
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMA 118
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
+L S + I+RD N L+D + K+SDFG+ + +GT ++
Sbjct: 119 FLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWS 172
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
APE ++KSDV++FG+++ E+ S G+ PY
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKM------------------PYDLYTNS-- 212
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+V+ ++ + L A+ + C P+ RPT +++ ++E +++
Sbjct: 213 EVVL-KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 52/291 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +A+K + + S+ E++ E K + L H
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMNLSH 78
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LV+L G C + ++ E+M G L N+L R Q + M + +
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQ-TQQLLEM--CKDVCEAME 134
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
YL S + ++RD N L++ K+SDFGL++ T +G+ ++
Sbjct: 135 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY----VLDDEYTSSVGSKFPVRWS 188
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
PE + ++KSD+++FGV++ E+ S G+ PY +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM------------------PY--ERFTNS 228
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+ + I L A+ K + C + RPT ++ + +
Sbjct: 229 ETAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYH 133
VLG G FG V KG + P + + +K + +S Q + +G L H
Sbjct: 20 VLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP---LSWTIRMKVALGAAK 190
++V+L+G C LV +++P GSL +H+ R + P L+W + AK
Sbjct: 75 AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNW------GVQIAK 126
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 250
G+ YL +++R+ N+LL +++DFG+A P + + + +
Sbjct: 127 GMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
A E + G T +SDV+S+GV + E+++ G PY +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE------------------PYAGLRLA-- 224
Query: 310 QVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+V D +G+ Y + +KC + RPT E+ ++
Sbjct: 225 EVPDLLEKGERLAQPQICTIDVYM---------VMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 54/297 (18%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 22 DKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
L +P +V++IG C + +LV E G L +L + + + +++ +
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-QQN----RHVKDKNIIELVHQVSM 128
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG----- 245
G+ YL + ++RD N+LL + AK+SDFGL+K +++ + G
Sbjct: 129 GMKYL-EES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVK 185
Query: 246 -TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303
APE + ++KSDV+SFGV++ E S G++ PY
Sbjct: 186 WY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRG 223
Query: 304 SKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
K +V +E + G + L C + + + RP V L
Sbjct: 224 MKGS--EVTA-MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 58/295 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G+G FG V G + +AVK + ++ +L E + QL H
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
NLV+L+G +E+ L +V E+M KGSL ++L R+ + ++ +L + +
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKF--SLDVCEAME 131
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV----MGTYGY 249
YL ++RD N+L+ + AK+SDFGL K+ + + ++
Sbjct: 132 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKLPVKWT----- 181
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
APE + + KSDV+SFG++L E+ S GR PY + +
Sbjct: 182 -APEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY--PRIPL 220
Query: 309 FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359
V+ R+E Y + G + C + RP+ ++ + LE I+
Sbjct: 221 KDVVP-RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 72/330 (21%), Positives = 130/330 (39%), Gaps = 70/330 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LG+G FG V + G+ + +AVK L + + E+L E + +
Sbjct: 30 MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRTGASYIQPLSWTIR--MKV 184
HP++ KL+G L + +++ FM G L L P + ++ ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRF 142
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTR 242
+ A G+ YL S I+RD N +L + ++DFGL++ +G + +++
Sbjct: 143 MVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 243 V----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297
+ + A E +A T SDV++FGV + E+++ G+ P E
Sbjct: 201 LPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGIENAEI 248
Query: 298 AKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 347
YL R ++ +M +C S +PK RP+
Sbjct: 249 YN-YLIGGNRLKQPPECMEEVYDLM--------------------YQCWSADPKQRPSFT 287
Query: 348 EVVKALEQI-QDTNDAGVSRDESLQNSDRS 376
+ LE I + S+D N +R+
Sbjct: 288 CLRMELENILGHLSVLSTSQDPLYINIERA 317
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 68/308 (22%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---EWLTEIKHLGQ 130
LG+G FG V +G W A G + +AVK L + L +++ E+ +
Sbjct: 25 KLGDGSFGVVRRGEWD-------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
L H NL++L G L +V E P GSL + L R + L R A+ A+
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL-RKHQGHF-LLGTLSRY--AVQVAE 132
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---Y 247
G+ YL S + I+RD N+LL K+ DFGL + P +V +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE + T + SD + FGV L EM + G+ +P++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNG 230
Query: 307 RIFQVMDARIEGQ--------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352
Q++ +I+ + Y+ + ++C +++P+ RPT +
Sbjct: 231 S--QILH-KIDKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPTFVALRDF 278
Query: 353 LEQIQDTN 360
L + Q T+
Sbjct: 279 LLEAQPTD 286
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 62/301 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 96 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
PN++ L+G CL + L+V +M G L N + + + + L AKG+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGM 205
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG------T 246
+L S K ++RD N +LD + K++DFGLA+D V +
Sbjct: 206 KFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305
A E + T T KSDV+SFGV+L E+++ G P + N + YL
Sbjct: 264 ----ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV-YLLQG 312
Query: 306 RR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
RR +++VM +KC + + RP+ E+V +
Sbjct: 313 RRLLQPEYCPDPLYEVM--------------------LKCWHPKAEMRPSFSELVSRISA 352
Query: 356 I 356
I
Sbjct: 353 I 353
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 68/366 (18%), Positives = 133/366 (36%), Gaps = 49/366 (13%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPG 100
+ ++ F ++ + +GEG FG D Y
Sbjct: 3 HHHHHSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYV----- 53
Query: 101 TGM-VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+ I + R++ + + E E+ L + HPN+V+ E+ +V ++ G
Sbjct: 54 --IKEINISRMSSKERE---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 160 SLENHLFRTGASYI---QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216
L + Q L W +++ L ++H K +++RD K+ NI L
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHDRK--ILHRDIKSQNIFLTK 160
Query: 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
+ +L DFG+A+ S ++ +GT Y +PE KSD+++ G VL E+
Sbjct: 161 DGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 336
+ + ++ L K I + YS L++ V +
Sbjct: 219 CTLK------HAFEAGSMKN-----LVLK--IISGSFPPVSLHYS--YDLRSLVS--QLF 261
Query: 337 SNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLN-ENGQGKASVHH 395
P+ RP+++ +++ I + +S + T+ + G + AS +
Sbjct: 262 KRNPRDRPSVNSILE-KGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320
Query: 396 RPSERR 401
S
Sbjct: 321 SISVMP 326
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 76/310 (24%), Positives = 127/310 (40%), Gaps = 54/310 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W +AVK L +++++ E+L E + ++ H
Sbjct: 20 KLGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
PNLV+L+G C + ++ EFM G+L ++L R + M A + +
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYM--ATQISSAME 125
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS-QSHVSTRV----MGTYG 248
YL I+RD N L+ N+ K++DFGL++ + +H +
Sbjct: 126 YLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---- 179
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
APE +A + KSDV++FGV+L E+ + G PY
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLS 219
Query: 308 IFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 363
QV + +E Y + G K L C P RP+ E+ +A E + +
Sbjct: 220 --QVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
Query: 364 VSRDESLQNS 373
++ L
Sbjct: 277 DEVEKELGKR 286
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-35
Identities = 37/229 (16%), Positives = 74/229 (32%), Gaps = 17/229 (7%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+ ++ +LGEG F V++ +K +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA---TQGDLNDAK-NKQKFVLKVQKPANPWEFYIGT 115
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
++ L +K L + +LV E G+L N + + + + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-----------DLNYNAKLSDFGLAKDG 231
A+ + +H ++I+ D K N +L DL+ L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
+ + T T G+ E ++ + D + + ML G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-35
Identities = 74/331 (22%), Positives = 116/331 (35%), Gaps = 51/331 (15%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
S S+++ + +LL +K + + +G G FG V +
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHR 76
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
D+ TG AVK++ E + E+ L P +V L G E
Sbjct: 77 M-KDK--------QTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREG 122
Query: 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 206
+ E + GSL + + G L + A +GL YLH+ ++++ D
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR--RILHGD 175
Query: 207 FKTSNILLDLN-YNAKLSDFGLAK----DGPTGSQSHVSTRVMGTYGYAAPE-YMATGHL 260
K N+LL + A L DFG A DG S + GT + APE M
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPEVVMGKPC- 233
Query: 261 TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA---RIE 317
AK D++S ++L ML+G P W + ++ E
Sbjct: 234 DAKVDIWSSCCMMLHMLNGC------HP--------WTQ--YFRGPLCLKIASEPPPIRE 277
Query: 318 GQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
S A+ + L EP R + E
Sbjct: 278 IPPSCAPLTAQAIQ--EGLRKEPVHRASAME 306
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 78/303 (25%), Positives = 124/303 (40%), Gaps = 66/303 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G+G FG V+ G + + A+K L++ +Q +L E + L H
Sbjct: 28 VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
PN++ LIG L + ++ +M G L + + + + L A+G+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGM 137
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV----M 244
YL K ++RD N +LD ++ K++DFGLA+D Q H R+
Sbjct: 138 EYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303
A E + T T KSDV+SFGV+L E+L+ G P R + + +L
Sbjct: 196 ------ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------PPYRHIDPFDLTH-FLA 242
Query: 304 SKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
RR ++QVM +C +P RPT +V +
Sbjct: 243 QGRRLPQPEYCPDSLYQVM--------------------QQCWEADPAVRPTFRVLVGEV 282
Query: 354 EQI 356
EQI
Sbjct: 283 EQI 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 321
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LV+L E+ +V E+M KGSL + L + L + M A A G+A
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDM--AAQIASGMA 377
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 253
Y+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 378 YVER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 254 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 313
G T KSDV+SFG++L E+ + RV PY R +V+D
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNR--EVLD 475
Query: 314 ARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++E Y + L +C EP+ RPT + + LE
Sbjct: 476 -QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 83/309 (26%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V++G + + G + +AVK ++ +L ++++E + L
Sbjct: 19 ILGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGL 192
HP++VKLIG E+ ++ E P G L ++L + ++ L+ + +L K +
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL-ERNKNSLKVLT-LVLY--SLQICKAM 126
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY--- 249
AYL S ++RD NIL+ KL DFGL+ R + Y
Sbjct: 127 AYLES--INCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKA 171
Query: 250 ---------AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299
+PE + T SDV+ F V + E+LS G++
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ------------------ 213
Query: 300 PYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMD 347
P+ + + V+ +G Y+ L +C +P RP
Sbjct: 214 PFFWLENK--DVIGVLEKGDRLPKPDLCPPVLYT---------LMTRCWDYDPSDRPRFT 262
Query: 348 EVVKALEQI 356
E+V +L +
Sbjct: 263 ELVCSLSDV 271
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 78/323 (24%), Positives = 117/323 (36%), Gaps = 89/323 (27%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 23 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTIRMKV 184
+VK G C + D ++V+E+M G L L L + + +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A A G+ YL S ++RD T N L+ N K+ DFG+++D S RV
Sbjct: 139 ASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRD----VYSTDYYRVG 192
Query: 245 G--------TYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVIDKN 286
G PE + T +SDV+SFGV+L E+ LS VI+
Sbjct: 193 GHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-- 246
Query: 287 RPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCL 336
+ R ++ VM + C
Sbjct: 247 --------------CITQGRVLERPRVCPKEVYDVM--------------------LGCW 272
Query: 337 SNEPKFRPTMDEVVKALEQIQDT 359
EP+ R + E+ K L +
Sbjct: 273 QREPQQRLNIKEIYKILHALGKA 295
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 52/291 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G + +AVK L Q S+ +L E + QL H
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMSPD-AFLAEANLMKQLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LV+L ++ ++ E+M GSL + L +T + ++ + M A A+G+A
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDM--AAQIAEGMA 123
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
++ I+RD + +NIL+ + K++DFGLA+ + + T G +
Sbjct: 124 FIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWT 177
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
APE + G T KSDV+SFG++L E+++ GR PY
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRI------------------PY--PGMTNP 217
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+V+ +E Y + + L C P+ RPT D + LE
Sbjct: 218 EVIQ-NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 52/296 (17%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q + E + E + + QL
Sbjct: 15 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
+P +V+LIG C + +LV E G L L + + ++ + G
Sbjct: 68 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 122
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG------ 245
+ YL +K ++RD N+LL + AK+SDFGL+K S+ + R G
Sbjct: 123 MKYL-EEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKW 179
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304
APE + +++SDV+S+GV + E LS G++ PY +
Sbjct: 180 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKM 217
Query: 305 KRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
K +VM IE + + L C + + RP V + +
Sbjct: 218 KGP--EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 77/383 (20%), Positives = 137/383 (35%), Gaps = 97/383 (25%)
Query: 23 RKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTAT--------RNFRPDS 74
R+ SSS S+ +V T + +
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 88 PLGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWT 179
H N++ L+G C +D ++ E+ KG+L +L + + +++
Sbjct: 146 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QS 237
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D +
Sbjct: 204 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 238 HVSTRV----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVI 283
+ R+ M APE + T +SDV+SFGV++ E+ + +
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 284 DKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAI 333
L+ R ++ +M
Sbjct: 316 K----------------LLKEGHRMDKPANCTNELYMMM--------------------R 339
Query: 334 KCLSNEPKFRPTMDEVVKALEQI 356
C P RPT ++V+ L++I
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 51/309 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+++ LGEGGF V E + G A+KR+ Q E E
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV---EGLH------DGHFYALKRILCHEQQDREEAQREADM 79
Query: 128 LGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRTGASYIQPLS-WTIRM 182
HPN+++L+ YCL + L+ F +G+L N + L+ I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQI-L 137
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+ LG +GL +H+ +RD K +NILL L D G +
Sbjct: 138 WLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 243 VM-------GTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289
+ T Y APE + ++DV+S G VL M+ G D
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 290 REH-NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ L +Q++ I ++S +AL L ++ +P RP +
Sbjct: 253 GDSVALA------VQNQLSI------PQSPRHS--SALWQ--LLNSMMTVDPHQRPHIPL 296
Query: 349 VVKALEQIQ 357
++ LE +Q
Sbjct: 297 LLSQLEALQ 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 66/321 (20%), Positives = 108/321 (33%), Gaps = 42/321 (13%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
E + L +L H N+VKL H++L+ EF P GSL L L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESE 113
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQ 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 114 FLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD 169
Query: 237 SHVSTRVMGTYGYAAPEYMATGHL--------TAKSDVYSFGVVLLEMLSGRR-VIDKNR 287
+ GT Y P+ L A D++S GV +G
Sbjct: 170 EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
Query: 288 PSREHNLIE----------WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 337
P R ++ + I D + S G + + L
Sbjct: 229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
Query: 338 NEPKFRPTMDEVVKALEQIQD 358
+ + D+ I
Sbjct: 289 ADQEKCWGFDQFFAETSDILH 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 70/323 (21%), Positives = 125/323 (38%), Gaps = 89/323 (27%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 42 PLGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWT 179
H N++ L+G C +D ++ E+ KG+L +L + + +++
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QS 237
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D +
Sbjct: 158 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 238 HVSTRV----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVI 283
+ R+ M APE + T +SDV+SFGV++ E+ + +
Sbjct: 216 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 284 DKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAI 333
L+ R ++ +M
Sbjct: 270 K----------------LLKEGHRMDKPANCTNELYMMM--------------------R 293
Query: 334 KCLSNEPKFRPTMDEVVKALEQI 356
C P RPT ++V+ L++I
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 65/314 (20%), Positives = 121/314 (38%), Gaps = 53/314 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEI 125
NFR + +G G F V++ G+ +A+K++ L + EI
Sbjct: 33 NFRIEKKIGRGQFSEVYRAA---------CLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRTGASYI---QPLSWTI 180
L QL HPN++K +ED+ +V E G L + F+ I + +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
++ L ++HS + V++RD K +N+ + KL D GL + + +
Sbjct: 144 QL------CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH 194
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
+ V GT Y +PE + KSD++S G +L EM + + P
Sbjct: 195 SLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------P 235
Query: 301 YLQSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
+ K ++ + + Y L+ V C++ +P+ RP + V +
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN--MCINPDPEKRPDVTYVYDVAK 293
Query: 355 QIQDTNDAGVSRDE 368
++ + +
Sbjct: 294 RMHACTASSLEHHH 307
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 66/323 (20%), Positives = 108/323 (33%), Gaps = 42/323 (13%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
E + L +L H N+VKL H++L+ EF P GSL L L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESE 113
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQ 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 114 FLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD 169
Query: 237 SHVSTRVMGTYGYAAPEYMATGHL--------TAKSDVYSFGVVLLEMLSGRR-VIDKNR 287
+ GT Y P+ L A D++S GV +G
Sbjct: 170 EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
Query: 288 PSREHNLIE----------WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 337
P R ++ + I D + S G + + L
Sbjct: 229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
Query: 338 NEPKFRPTMDEVVKALEQIQDTN 360
+ + D+ I
Sbjct: 289 ADQEKCWGFDQFFAETSDILHRG 311
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 81/326 (24%), Positives = 124/326 (38%), Gaps = 65/326 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + P P V AVK L + S Q L++L E + + H
Sbjct: 78 GLGHGAFGEVYEG---QVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR--MKVALGAAKG 191
N+V+ IG L+ R ++ E M G L++ L T QP S + + VA A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
YL + I+RD N LL AK+ DFG+A+D G
Sbjct: 194 CQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCA 246
Query: 249 Y-----AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302
PE G T+K+D +SFGV+L E+ S G PY
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PY- 287
Query: 303 QSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 350
+ +V++ G Y + +C ++P+ RP ++
Sbjct: 288 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 337
Query: 351 KALEQI-QDTNDAGVSRDESLQNSDR 375
+ +E QD + +
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVE 363
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 71/317 (22%), Positives = 122/317 (38%), Gaps = 63/317 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F P VLG G G + + +AVKR+ E E++ L
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMF------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ HPN+++ + + + E +L+ ++ + +++ T+ ++
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL-LQQTT- 128
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAK--DGPTGSQSHVS 240
GLA+LHS +++RD K NIL+ A +SDFGL K S S S
Sbjct: 129 --SGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 241 TRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
GT G+ APE + + T D++S G V ++S H
Sbjct: 185 GVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS----------H----- 228
Query: 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDEV---- 349
P+ +S +R ++ L V+A K ++ +P+ RP+ V
Sbjct: 229 --PFGKSLQRQANILLGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 350 -----VKALEQIQDTND 361
K L+ QD +D
Sbjct: 286 FFWSLEKQLQFFQDVSD 302
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 52/291 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ + +AVK + S+ +L E + L H
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-----------VAVKTMKPGSMSVE-AFLAEANVMKTLQH 242
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
LVKL ++ ++ EFM KGSL + L ++ QPL I + A+G+A
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDF--SAQIAEGMA 298
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYA 250
++ I+RD + +NIL+ + K++DFGLA+ + + T G +
Sbjct: 299 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV----IEDNEYTAREGAKFPIKWT 352
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
APE + G T KSDV+SFG++L+E+++ GR PY
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------PY--PGMSNP 392
Query: 310 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+V+ A +E Y + + + ++C N P+ RPT + + L+
Sbjct: 393 EVIRA-LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 76/314 (24%), Positives = 119/314 (37%), Gaps = 70/314 (22%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
LG G FG V++G + +AVK L + S Q L++L E + +
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRTGASYIQPLSWTIRMKVALGAAK 190
H N+V+ IG L+ R ++ E M G L++ L R S L+ + VA A
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPT------GSQSHVST 241
G YL + I+RD N LL AK+ DFG+A+D G + +
Sbjct: 152 GCQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRR-------------VIDKNR 287
+ M PE G T+K+D +SFGV+L E+ S G V R
Sbjct: 210 KWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 347
N ++++M +C ++P+ RP
Sbjct: 264 MDPPKNC----------PGPVYRIM--------------------TQCWQHQPEDRPNFA 293
Query: 348 EVVKALEQIQDTND 361
+++ +E D
Sbjct: 294 IILERIEYCTQDPD 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 73/315 (23%), Positives = 116/315 (36%), Gaps = 72/315 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGE FG V+KG H + PA +A+K L + E+ E +L H
Sbjct: 16 ELGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLSWTIRM 182
PN+V L+G +D +++ + G L L + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQ 236
+ A G+ YL S V+++D T N+L+ N K+SD GL ++
Sbjct: 132 HLVAQIAAGMEYL-SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 295
S + R M APE + G + SD++S+GVVL E+ S G +
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-------------- 229
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFR 343
PY + V++ Q Y+ L I+C + P R
Sbjct: 230 ----PYCGYSNQ--DVVEMIRNRQVLPCPDDCPAWVYA---------LMIECWNEFPSRR 274
Query: 344 PTMDEVVKALEQIQD 358
P ++ L +
Sbjct: 275 PRFKDIHSRLRAWGN 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 71/313 (22%), Positives = 111/313 (35%), Gaps = 64/313 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+ LG GGFG V + H TG +A+K+ QE + E W EI+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQD------TGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 128 LGQLYHPNLVKLI------GYCLEDDHRLLVYEFMPKGSLENHLFRTG----------AS 171
+ +L HPN+V +D LL E+ G L +L + +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA---KLSDFGLA 228
+ + + L YLH + ++I+RD K NI+L K+ D G A
Sbjct: 126 LLSDI------------SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288
K+ G V GT Y APE + T D +SFG + E ++G RP
Sbjct: 172 KELDQGELCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------RP 222
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNE--------- 339
+ ++ K V+ + G + L T L+ +
Sbjct: 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML 282
Query: 340 ---PKFRPTMDEV 349
+ R T +
Sbjct: 283 MWHQRQRGTDPQN 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 55/306 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F P LG GGFG VF+ A+KR+ + + E + E+K
Sbjct: 6 DFEPIQCLGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 128 LGQLYHPNLVKLIGYCLEDD---------HRLLVY---EFMPKGSLENHLFRTGASYIQP 175
L +L HP +V+ LE + ++ +Y + K +L++ + I+
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEE 114
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------ 229
++ + + L A+ + +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 230 ----DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285
T +GT Y +PE + + K D++S G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------- 225
Query: 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 345
S + + + F + Q V LS P RP
Sbjct: 226 -PFSTQMERVRTLT---DVRNLKFP----PLFTQKY--PCEYVMVQ--DMLSPSPMERPE 273
Query: 346 MDEVVK 351
+++
Sbjct: 274 AINIIE 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 72/334 (21%), Positives = 123/334 (36%), Gaps = 94/334 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG VF+ ++AVK L +E S ++ E + + +
Sbjct: 54 DIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-------------------FRTGASYIQ 174
PN+VKL+G C L++E+M G L L R +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT- 233
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 234 -----GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LS 278
+ R M PE + T +SDV+++GVVL E+ ++
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 279 GRRVIDKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKT 328
VI Y++ ++ +M
Sbjct: 282 HEEVIY----------------YVRDGNILACPENCPLELYNLM---------------- 309
Query: 329 AVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362
C S P RP+ + + L+++ + +
Sbjct: 310 ----RLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 77/308 (25%), Positives = 109/308 (35%), Gaps = 81/308 (26%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G Y V A+K S ++L E + Q H
Sbjct: 22 CIGEGQFGDVHQG-----IYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P++VKLIG E+ ++ E G L + L S L + A + LA
Sbjct: 76 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALA 130
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY---- 249
YL S + ++RD N+L+ N KL DFGL+ R M Y
Sbjct: 131 YLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKAS 175
Query: 250 --------AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 300
APE + T+ SDV+ FGV + E+L G + P
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK------------------P 217
Query: 301 YLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ K V+ G+ YS L KC + +P RP E
Sbjct: 218 FQGVKNN--DVIGRIENGERLPMPPNCPPTLYS---------LMTKCWAYDPSRRPRFTE 266
Query: 349 VVKALEQI 356
+ L I
Sbjct: 267 LKAQLSTI 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 73/326 (22%), Positives = 112/326 (34%), Gaps = 94/326 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + Y + M +AVK L L ++E+ +LG
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-------------FRTGASYIQPLS 177
H N+V L+G C L++ E+ G L N L L
Sbjct: 86 --HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARD------- 194
Query: 238 HVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 284
+ Y APE + T +SDV+S+G+ L E+ S G
Sbjct: 195 -----IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---- 245
Query: 285 KNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAV 330
P + + ++ R ++ +M
Sbjct: 246 --SPYPGMPVDSKFYK----MIKEGFRMLSPEHAPAEMYDIM------------------ 281
Query: 331 LAIKCLSNEPKFRPTMDEVVKALEQI 356
C +P RPT ++V+ +E+
Sbjct: 282 --KTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 47/221 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHL 128
LG+G FG V+ AR + ++A+K L + L+ L E++
Sbjct: 16 PLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLR--REVEIQ 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG-------ASYIQPLSWTI 180
L HPN+++L GY D R+ L+ E+ P G++ L + A+YI L
Sbjct: 64 SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL---- 118
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
A L+Y HS + VI+RD K N+LL K++DFG + P+ + +
Sbjct: 119 --------ANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---T 165
Query: 241 TRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR 280
+ GT Y PE M G + K D++S GV+ E L G+
Sbjct: 166 D-LCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 44/307 (14%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q E + E + + QL
Sbjct: 341 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
+P +V+LIG C + +LV E G L L + + ++ + G
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 448
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA- 250
+ YL +K ++R+ N+LL + AK+SDFGL+K S+ + R G +
Sbjct: 449 MKYL-EEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKW 505
Query: 251 -APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
APE + +++SDV+S+GV + E LS G++ PY + K
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKMKGP- 546
Query: 309 FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364
+VM IE + + L C + + RP V + + + + V
Sbjct: 547 -EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604
Query: 365 SRDESLQ 371
+L+
Sbjct: 605 EGGSALE 611
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 49/222 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVK-----RLNQESLQGHLEWLTEIKHL 128
LG+G FG V+ AR ++A+K +L +E ++ L EI+
Sbjct: 21 PLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQ 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG-------ASYIQPLSWTI 180
L HPN++++ Y D R+ L+ EF P+G L L + G A++++ L
Sbjct: 69 SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL---- 123
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
A L Y H K VI+RD K N+L+ K++DFG + P+
Sbjct: 124 --------ADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----R 168
Query: 241 TRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR 280
R M GT Y PE M G K D++ GV+ E L G
Sbjct: 169 RRTMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 78/326 (23%), Positives = 116/326 (35%), Gaps = 95/326 (29%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLG 129
LG G FG V + + T +AVK L + + H ++E+ H+G
Sbjct: 34 PLGRGAFGQVIEADAFG-----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 130 QLYHPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQPLS 177
H N+V L+G C +++ EF G+L +L Y L+
Sbjct: 89 H--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 147 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD------- 197
Query: 238 HVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 284
+ Y APE + T +SDV+SFGV+L E+ S G
Sbjct: 198 -----IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---- 248
Query: 285 KNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAV 330
P + L+ R ++Q M
Sbjct: 249 --SPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTM------------------ 284
Query: 331 LAIKCLSNEPKFRPTMDEVVKALEQI 356
+ C EP RPT E+V+ L +
Sbjct: 285 --LDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 62/229 (27%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + + + + +AVK L ++E+ HLGQ
Sbjct: 53 TLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL---------FRTGASYIQPLSWTIR 181
H N+V L+G C L++ E+ G L N L A S
Sbjct: 109 --HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ + A+G+A+L S I+RD N+LL + AK+ DFGLA+D
Sbjct: 167 LHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARD----------- 213
Query: 242 RVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS 278
+M Y APE + T +SDV+S+G++L E+ S
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V+ G + IA+K + + + EI L H
Sbjct: 29 VLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRTGASYIQPLSWTIRMKVALGA 188
N+V+ +G E+ + E +P GSL L + I +T ++ L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG--FYTKQI---L-- 132
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+GL YLH + ++++RD K N+L++ + K+SDFG +K G T GT
Sbjct: 133 -EGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTET-FTGTL 187
Query: 248 GYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGRR 281
Y APE G+ +D++S G ++EM +G+
Sbjct: 188 QYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 62/322 (19%), Positives = 112/322 (34%), Gaps = 75/322 (23%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
++ F + R + +G GG VF+ + A+K +N E
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 116 QGHL--EWLTEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG-- 169
+ EI +L +L + ++L Y + D + +V E L + L +
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI 124
Query: 170 -----ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224
SY + + + + +H +++ D K +N L+ + KL D
Sbjct: 125 DPWERKSYWKNM------------LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLID 169
Query: 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPE-----------YMATGHLTAKSDVYSFGVVL 273
FG+A + S V +GT Y PE + ++ KSDV+S G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 274 LEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS------LGAALK 327
M G+ P+ Q + A I+ + L+
Sbjct: 230 YYMTYGKT------------------PF-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 328 TAVLAIKCLSNEPKFRPTMDEV 349
+ CL +PK R ++ E+
Sbjct: 271 D--VLKCCLKRDPKQRISIPEL 290
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 76/293 (25%), Positives = 113/293 (38%), Gaps = 51/293 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G + M +A+K S ++L E + Q H
Sbjct: 397 CIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
P++VKLIG E+ ++ E G L + L S L + A + LA
Sbjct: 451 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALA 505
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP-----TGSQSHVSTRVMGTYG 248
YL S + ++RD N+L+ N KL DFGL++ S+ + + M
Sbjct: 506 YLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM---- 559
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
APE + T+ SDV+ FGV + E+L G + P+ K
Sbjct: 560 --APESINFRRFTSASDVWMFGVCMWEILMHGVK------------------PFQGVKNN 599
Query: 308 IFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
V+ RIE L L KC + +P RP E+ L I
Sbjct: 600 --DVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-32
Identities = 79/328 (24%), Positives = 124/328 (37%), Gaps = 94/328 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V K + R G V AVK L + S + L+E L Q+ H
Sbjct: 30 TLGEGEFGKVVKA---TAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-------------------FRTGASYIQ 174
P+++KL G C +D LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
L+ + A ++G+ YL ++ K+++RD NIL+ K+SDFGL++D
Sbjct: 146 ALTMGDLISFAWQISQGMQYL-AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRD---- 199
Query: 235 SQSHVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEM------ 276
V Y A E + T +SDV+SFGV+L E+
Sbjct: 200 --------VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 277 ----LSGRRVIDK----NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKT 328
+ R+ + +R R N ++++M
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN----------CSEEMYRLM---------------- 285
Query: 329 AVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++C EP RP ++ K LE++
Sbjct: 286 ----LQCWKQEPDKRPVFADISKDLEKM 309
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 63/299 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 63
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG-------ASYIQ 174
EI L H ++V G+ ED+ + +V E + SL R Y++
Sbjct: 64 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 123 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 235 SQSHVSTRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292
+ +V+ GT Y APE + + + + DV+S G ++ +L G+ P
Sbjct: 169 GERK---KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETS 218
Query: 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
L E Y RI + + I + A A L K L +P RPT++E++
Sbjct: 219 CLKET---Y----LRIKKN-EYSIPKHINPVA----ASLIQKMLQTDPTARPTINELLN 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 46/301 (15%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLE 120
+ + ++ +G G +G K R G ++ K L+ S+
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 121 WLTEIKHLGQLYHPNLVKLIG-YCLEDDHRL-LVYEFMPKGSLENHL--FRTGASYI--- 173
++E+ L +L HPN+V+ + L +V E+ G L + + Y+
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 174 QPLSWTIRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230
L ++ L H V++RD K +N+ LD N KL DFGLA+
Sbjct: 112 FVLRVMTQL------TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290
S T V GT Y +PE M KSD++S G +L E+ + P
Sbjct: 166 L-NHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFT 217
Query: 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 350
+ E L K I + RI +YS L + + L+ + RP+++E++
Sbjct: 218 AFSQKE-----LAGK--IREGKFRRIPYRYS--DELNEIIT--RMLNLKDYHRPSVEEIL 266
Query: 351 K 351
+
Sbjct: 267 E 267
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 72/337 (21%), Positives = 119/337 (35%), Gaps = 100/337 (29%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
VLG G FG V Y ++ G + +AVK L ++ ++E+ LG
Sbjct: 52 VLGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR--------- 181
H N+V L+G C L++E+ G L N+L + +
Sbjct: 108 --HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 182 ---------MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 232
+ A AKG+ +L ++RD N+L+ K+ DFGLA+D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARD-- 221
Query: 233 TGSQSHVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-G 279
+M Y APE + G T KSDV+S+G++L E+ S G
Sbjct: 222 ----------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 280 RRVIDKNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAA 325
P + N + +Q+ + I+ +M
Sbjct: 272 V------NPYPGIPVDANFYK----LIQNGFKMDQPFYATEEIYIIM------------- 308
Query: 326 LKTAVLAIKCLSNEPKFRPTMDEVVKALE-QIQDTND 361
C + + + RP+ + L Q+ D +
Sbjct: 309 -------QSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 63/299 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 89
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG-------ASYIQ 174
EI L H ++V G+ ED+ + +V E + SL R Y++
Sbjct: 90 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 149 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 235 SQSHVSTRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292
+ +V+ GT Y APE + + + + DV+S G ++ +L G+ P
Sbjct: 195 GERK---KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETS 244
Query: 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
L E Y RI + + I + A A L K L +P RPT++E++
Sbjct: 245 CLKET---Y----LRIKKN-EYSIPKHINPVA----ASLIQKMLQTDPTARPTINELLN 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 46/236 (19%), Positives = 89/236 (37%), Gaps = 42/236 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----- 123
++R L +G F + E A+K+ + L+ ++
Sbjct: 32 DYRIIRTLNQGKFNKIILC---EKD--------NKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 124 ------------EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHL---FR 167
E++ + + + + G + + + ++YE+M S+ F
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 168 TGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227
+Y + + + +Y+H++K + +RD K SNIL+D N KLSDFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT---AKSDVYSFGVVLLEMLSGR 280
++ + GTY + PE + + AK D++S G+ L M
Sbjct: 199 SEYMVDK---KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 63/360 (17%), Positives = 119/360 (33%), Gaps = 72/360 (20%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
+G + S + + + + + S + S G R +
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----RIYSIL 61
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-----LNQESLQGHLEWLTEIKHL 128
+G GG VF+ + A+K + ++L + EI +L
Sbjct: 62 KQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYL 108
Query: 129 GQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+L + ++L Y + D + +V E L + L + + R
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWK 162
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ + +H +++ D K +N L+ + KL DFG+A + S V +G
Sbjct: 163 NMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 247 YGYAAPE-----------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
Y PE + ++ KSDV+S G +L M G+
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------------- 264
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQY------SLGAALKTAVLAIKCLSNEPKFRPTMDEV 349
P+ Q + A I+ + L+ + CL +PK R ++ E+
Sbjct: 265 ---TPF-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD--VLKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 75/303 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G GG VF+ + A+K +N E + EI +L +L
Sbjct: 16 QIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 133 HPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG-------ASYIQPLSWTIRMK 183
+ ++L Y + D + +V E L + L + SY + +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------- 117
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
+ + +H +++ D K +N L+ + KL DFG+A + S V
Sbjct: 118 -----LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 244 MGTYGYAAPE-----------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292
+GT Y PE + ++ KSDV+S G +L M G+
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT----------- 218
Query: 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKCLSNEPKFRPTM 346
P+ Q + A I+ + L+ + CL +PK R ++
Sbjct: 219 -------PF-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD--VLKCCLKRDPKQRISI 268
Query: 347 DEV 349
E+
Sbjct: 269 PEL 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 33/318 (10%), Positives = 69/318 (21%), Gaps = 59/318 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
R + L G VF A+K + E
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVR---------DVERLEDFALKVFTMGAENSRSELERLHE 111
Query: 124 EIKHLGQLYHPNLVKLIGYC--------------------------LEDDHRLLVYEFMP 157
+L + + + LL+
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA- 170
Query: 158 KGSLEN--HLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215
LE + + + A L S +++ F N+ +
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIM 228
Query: 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL--TAKSDVYSFGVVL 273
+ L D YA E++ T + + G+ +
Sbjct: 229 PDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 274 LEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI 333
+ P + + + R+ L +KT +
Sbjct: 284 YRVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-- 334
Query: 334 KCLSNEPKFRPTMDEVVK 351
+ L+ + + R E ++
Sbjct: 335 RFLNFDRRRRLLPLEAME 352
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEW--LTEIKHLGQLY 132
LG+G F V++ E TG+ +A+K ++++++ + E+K QL
Sbjct: 19 LGKGSFAGVYRA---ESI------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG--------ASYIQPLSWTIRMK 183
HP++++L Y ED + + LV E G + +L ++ +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------- 121
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
G+ YLHS +++RD SN+LL N N K++DFGLA + H T +
Sbjct: 122 -----ITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 244 MGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302
GT Y +PE +AT +SDV+S G + +L GR P +
Sbjct: 173 CGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKN---TL- 221
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
++ D + S+ A L + L P R ++ V+
Sbjct: 222 ---NKVVLA-DYEMPSFLSIEA----KDLIHQLLRRNPADRLSLSSVLD 262
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 92/295 (31%), Positives = 132/295 (44%), Gaps = 61/295 (20%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG VFKG ID T V+A+K ++ E + +E + EI L
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
Q P + K G L+D ++ E++ GS L G PL T +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG-----PLDETQIATILREI 128
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
KGL YLHS+K I+RD K +N+LL + KL+DFG+A T +Q +T +GT
Sbjct: 129 LKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNT-FVGTPF 184
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHNLIE 296
+ APE + +K+D++S G+ +E+ G +V I KN P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
P +EG YS LK V CL+ EP FRPT E++K
Sbjct: 237 ---P--------------TLEGNYS--KPLKEFV--EACLNKEPSFRPTAKELLK 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 66/322 (20%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R VL EGGF V++ + +G A+KRL + + + E+
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA---QDVG------SGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 128 LGQL-YHPNLVKLIGYCLEDDHR-------LLVYEFMPKGSLENHLFRTGASYIQPLS-W 178
+ +L HPN+V+ L+ + KG L L + + PLS
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR--GPLSCD 136
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGS 235
T+ K+ + + ++H K +I+RD K N+LL KL DFG A P S
Sbjct: 137 TVL-KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 236 QSHVSTRVM-------GTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285
S ++ T Y PE + + K D+++ G +L + + +
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
Query: 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL------GAALKTAVLAIKCLSNE 339
+K RI + G+YS+ + L L
Sbjct: 256 G-----------------AKLRI-------VNGKYSIPPHDTQYTVFHS--LIRAMLQVN 289
Query: 340 PKFRPTMDEVVKALEQIQDTND 361
P+ R ++ EVV L++I +
Sbjct: 290 PEERLSIAEVVHQLQEIAAARN 311
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 53/298 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
V+G G V +A+KR+N E Q ++ L EI+ + Q +H
Sbjct: 22 VIGSGATAVVQAA-YCA--------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLEN---HLFRTGASYIQPLSWTIRMKVALGAAK 190
PN+V + D LV + + GS+ + H+ G L + + +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGT 246
GL YLH + I+RD K NILL + + +++DFG LA G T V GT
Sbjct: 133 GLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GT 189
Query: 247 YGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHN 293
+ APE M K+D++SFG+ +E+ +G +V +N P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP----- 244
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
P L++ V D + +Y + + + CL +P+ RPT E+++
Sbjct: 245 ------PSLETG-----VQDKEMLKKYG--KSFRKMI--SLCLQKDPEKRPTAAELLR 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-30
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKHL 128
F S LG G G VFK H +G+V+A K ++ E + E++ L
Sbjct: 35 FEKISELGAGNGGVVFKV---SHK------PSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+ P +V G D + E M GSL+ L + G + I KV++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAV 140
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
KGL YL K+++RD K SNIL++ KL DFG++ S ++ V GT
Sbjct: 141 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRS 195
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 61/309 (19%), Positives = 100/309 (32%), Gaps = 63/309 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTE 124
T F +G G FG VFK + G + A+KR + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV---------KRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
+ L H ++V+ EDDH L+ E+ GSL + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKD 119
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-------------------YNAKLSD 224
+ L +GL Y+HS +++ D K SNI + K+ D
Sbjct: 120 LLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--TGHLTAKSDVYSFGVVLLEMLSGRRV 282
G S G + A E + HL K+D+++ + ++
Sbjct: 178 LGHVT-----RISSPQVEE-GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE-- 228
Query: 283 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 342
R + +W + I Q RI S + + +P+
Sbjct: 229 ----PLPRNGD--QWHE--------IRQGRLPRIPQVLS--QEFTELLK--VMIHPDPER 270
Query: 343 RPTMDEVVK 351
RP+ +VK
Sbjct: 271 RPSAMALVK 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 6e-29
Identities = 50/368 (13%), Positives = 111/368 (30%), Gaps = 73/368 (19%)
Query: 21 CSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGG 80
+R +S + S + + G + S G + R +VLG+
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP--RTLVRGTVLGQED 85
Query: 81 FGCVFKGWIDEHT---YA------PARPGTGMVIAVKR-----------LNQESLQGHLE 120
+ D+ T + RP + + +K NQ+ + HL
Sbjct: 86 PYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK-----GSLENHLFRTGASYIQP 175
++ + ++++ D L + P+ + L +++ +
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KS 202
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
L R+++ L + LA LH +++ + +I+LD L+ F
Sbjct: 203 LVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------ 254
Query: 236 QSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVID 284
+ + G+ PE A +T D ++ G+V+ +
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD---- 310
Query: 285 KNRPSREHNLIEWAKPYLQSKRRI-FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343
P + + ++ +S + I V L L + R
Sbjct: 311 --LPITKDAALGGSEWIFRSCKNIPQPVRA-----------------LLEGFLRYPKEDR 351
Query: 344 PTMDEVVK 351
+ ++
Sbjct: 352 LLPLQAME 359
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 74/345 (21%), Positives = 125/345 (36%), Gaps = 82/345 (23%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N ++ + +LG G G V + ++ G +AVKR+ + L
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM 57
Query: 121 WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179
EIK L + HPN+++ D + E +L++ + S
Sbjct: 58 ---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113
Query: 180 IR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-------------LNYNAKLSD 224
+ + A G+A+LHS K+I+RD K NIL+ N +SD
Sbjct: 114 EYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 225 FGLAK---DGPTGSQSHVSTRVMGTYGYAAPE-------YMATGHLTAKSDVYSFGVVLL 274
FGL K G + +++++ GT G+ APE LT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 275 EMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI- 333
+LS + H P+ R ++ G +SL ++
Sbjct: 231 YILSKGK----------H-------PFGDKYSRESNII----RGIFSLDEMKCLHDRSLI 269
Query: 334 --------KCLSNEPKFRPTMDEV---------VKALEQIQDTND 361
+ + ++P RPT +V K LE + +D
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+R ++G GG G V++ E T R +A+K +++ L + T E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---EDTVRE-RI-----VALKLMSET-LSSDPVFRTRMQREA 85
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ G+L P++V + + D + + L L R G PL+ + +
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIV 140
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
L H A +RD K NIL+ + A L DFG+A + + +G
Sbjct: 141 RQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVG 197
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
T Y APE + H T ++D+Y+ VL E L+G
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ +D T G +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ + +PN+V + L D +V E++ GSL + + T + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCR 123
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ L +LHS+ +VI+RD K+ NILL ++ + KL+DFG T QS ST V GT
Sbjct: 124 ECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GT 179
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK- 305
+ APE + K D++S G++ +EM+ G P PYL
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENP 221
Query: 306 -RRIFQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
R ++ + ++ L A + + +CL + + R + E
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLN--RCLEMDVEKRGSAKE 266
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
++ LG GG V+ D + +A+K + + E L E+
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-DTIL--------NIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ QL H N+V +I EDD LV E++ +L ++ G PLS +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFT 117
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
G+ + H ++++RD K NIL+D N K+ DFG+AK S + + V+G
Sbjct: 118 NQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLG 174
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
T Y +PE +D+YS G+VL EML G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 46/219 (21%), Positives = 78/219 (35%), Gaps = 33/219 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ + GG G ++ RP + +K L + E + L
Sbjct: 82 YEVKGCIAHGGLGWIYLA---LDRNVNGRP-----VVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-----LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
++ HP++V++ + D +V E++ SL+ + L +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIA 186
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTR 242
L L+YLHS ++Y D K NI+L KL D G G
Sbjct: 187 YLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------- 236
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
+ GT G+ APE + T +D+Y+ G L +
Sbjct: 237 LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+GEG G V ++H+ G +AVK ++ Q E+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ H N+V++ L + ++ EF+ G+L + + + L+ V
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCE 148
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ LAYLH+ VI+RD K+ +ILL L+ KLSDFG + + V GT
Sbjct: 149 AVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLV-GT 204
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK- 305
+ APE ++ + D++S G++++EM+ G P PY
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDSP 246
Query: 306 -RRIFQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ + ++ D+ +++ + + L+ + + L +P+ R T E
Sbjct: 247 VQAMKRLRDSPPPKLKNSHKVSPVLRDFLE--RMLVRDPQERATAQE 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 68/221 (30%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
FR VLG+GGFG V A TG + A K+L ++ + + L E
Sbjct: 185 TFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK- 183
+ L ++ +V L Y E L LV M G L+ H++ G + R
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVF 290
Query: 184 ----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ G L LH ++ ++YRD K NILLD + + ++SD GLA P G
Sbjct: 291 YAAEICCG----LEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK- 343
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
RV GT GY APE + T D ++ G +L EM++G+
Sbjct: 344 -GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 21/217 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK-H 127
P LG G +G V K H +G ++AVKR+ Q L ++
Sbjct: 9 LEPIMELGRGAYGVVEKM---RHV------PSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ + P V G + + E M SL+ ++ Q + I K+A+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVS 117
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
K L +LHS K VI+RD K SN+L++ K+ DFG++ G
Sbjct: 118 IVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCK 173
Query: 248 GYAAPE----YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + KSD++S G+ ++E+ R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK- 126
+ + +G G +G V K H +G ++AVKR+ + + L ++
Sbjct: 23 DLKDLGEIGRGAYGSVNKM---VHK------PSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ P +V+ G + + E M S + + + I K+ L
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG--SQSHVSTRVM 244
K L +L + K+I+RD K SNILLD + N KL DFG++ G S TR
Sbjct: 133 ATVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDA 186
Query: 245 GTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
G Y APE + +SDV+S G+ L E+ +GR
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 45/250 (18%), Positives = 85/250 (34%), Gaps = 48/250 (19%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHT---YA---PARPGTGMVIAVKRLNQESLQGHLE 120
R +VLG+ + D+ T + P A+K++ +E L+ L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLR--LR 133
Query: 121 WLTEIKHLGQ-------------LYHPNLVKLIGYCLEDDHRLLVYEFM----PKGSLEN 163
L IK+ Q + P K+I L++ ++ F + +L+
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 164 HLFRTGASYIQ---PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220
S+ L R+++ L + LA LH +++ + +I+LD
Sbjct: 194 -FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGV 250
Query: 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----------TGHLTAKSDVYSFG 270
L+ F G+ S G+A PE A +T D ++ G
Sbjct: 251 FLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304
Query: 271 VVLLEMLSGR 280
+ + +
Sbjct: 305 LAIYWIWCAD 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 68/359 (18%), Positives = 117/359 (32%), Gaps = 114/359 (31%)
Query: 68 RNFRPDSVLGEGGFGCVFKGW--IDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTE 124
+F P +G GGFG VF+ +D+ Y A+KR+ + + E + E
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNY-----------AIKRIRLPNRELAREKVMRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGAS------------- 171
+K L +L HP +V+ LE E + +S
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 172 ----------------------YIQ------------------------PLSWTIRMKVA 185
YIQ + I +++A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----------GPTGS 235
+ +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 175 EA----VEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
T +GT Y +PE + + + K D++S G++L E+L
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY----------------- 271
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLA--IK-CLSNEPKFRPTMDEVVK 351
+ R+ + D R ++ L K ++ LS P RP ++++
Sbjct: 272 ----SFSTQMERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
F VLG GGFG VF A TG + A K+LN++ L + + + E
Sbjct: 186 WFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
K L +++ +V L Y E L LV M G + H++ + +
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPR 290
Query: 185 A-LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
A A+ GL +LH +IYRD K N+LLD + N ++SD GLA + G
Sbjct: 291 AIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TK 347
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT G+ APE + D ++ GV L EM++ R
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 70/300 (23%), Positives = 127/300 (42%), Gaps = 63/300 (21%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG+G FG V+K ++ T G + A K + +S + +++ EI+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
HP +VKL+G D ++ EF P G+++ + + L+ V
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQML 127
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-AKDGPTGSQSHVSTRVMGTYG 248
+ L +LHS + +I+RD K N+L+ L + +L+DFG+ AK+ T + +GT
Sbjct: 128 EALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPY 182
Query: 249 YAAPEYMATGHLT-----AKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSRE 291
+ APE + + K+D++S G+ L+EM RV I K+ P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP--- 239
Query: 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
P L + ++S + + L P+ RP+ ++++
Sbjct: 240 --------PTLLTP------------SKWS--VEFRDFL--KIALDKNPETRPSAAQLLE 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 53/309 (17%), Positives = 94/309 (30%), Gaps = 51/309 (16%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLYHP 134
G V + TG + V+R+N E+ + +L E+ HP
Sbjct: 36 GFEDLMTVNLA---RYK------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
N+V + D+ +V FM GS + L T ++ ++ + G K L Y
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTH--FMDGMNELAIAYILQGVLKALDY 143
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG-LAKDGPTGSQSHV----STRVMGTYGY 249
+H ++R K S+IL+ ++ LS G + V + +
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 250 AAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHNLI 295
+PE + AKSD+YS G+ E+ +G ++ +
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----------------KCLSNE 339
L + + +CL
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 340 PKFRPTMDE 348
P RP+
Sbjct: 322 PDARPSAST 330
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 80/333 (24%), Positives = 132/333 (39%), Gaps = 72/333 (21%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEI 125
F LGEG +G V+K H TG ++A+K++ + LQ E + EI
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA---IHK------ETGQIVAIKQVPVESDLQ---EIIKEI 75
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ Q P++VK G ++ +V E+ GS+ + + + L+ +
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATIL 131
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
KGL YLH + I+RD K NILL+ +AKL+DFG+A T + + +T + G
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ-LTDTMAKRNTVI-G 187
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHN 293
T + APE + +D++S G+ +EM G+ R I N P
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP----- 242
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK-- 351
P + +S V +CL P+ R T ++++
Sbjct: 243 ------PTFRKPEL------------WS--DNFTDFVK--QCLVKSPEQRATATQLLQHP 280
Query: 352 ----------ALEQIQDTNDAGVSRDESLQNSD 374
+ I + D + R ES Q +
Sbjct: 281 FVRSAKGVSILRDLINEAMDVKLKRQESQQREE 313
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE- 124
+F ++G GGFG V+ + TG + A+K L+++ + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 125 --IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
+ + P +V + Y +L + + M G L HL + G
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHG---------VFS 290
Query: 182 MKVA-LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
AA+ GL ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 291 EADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 280
V GT+GY APE + G S D +S G +L ++L G
Sbjct: 347 -PHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 37/277 (13%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G S + S S+ V +G + + + + + ++ V
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKV-TTVVATPGQGPDRPQEVSYTDTKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G FG V++ + + +G ++A+K++ Q+ E++ + +L H N
Sbjct: 62 IGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCN 108
Query: 136 LVKLIGYCLEDDHRL------LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL-GA 188
+V+L + + LV +++P+ ++ R + Q L I +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-RHYSRAKQTLP-VIYVKLYMYQL 165
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMG 245
+ LAY+HS + +RD K N+LLD + KL DFG AK G S++ +R
Sbjct: 166 FRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 246 TYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
Y Y APE + AT T+ DV+S G VL E+L G+
Sbjct: 221 -Y-YRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+ +LG GG V D +AVK L + L + E
Sbjct: 14 YELGEILGFGGMSEVHLAR-DLRD--------HRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
++ L HP +V + + +V E++ +L + + G P++
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRA 118
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
++V A + L + H + +I+RD K +NI++ K+ DFG+A+ S T
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 242 -RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
V+GT Y +PE + A+SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
N + + + F+ + + G+G FG V G TGM +A+K++ Q+
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQD 59
Query: 114 SLQGHLEWLTEIKHLGQLYHPNLVKLI------GYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ E L ++ L L+HPN+V+L G D L +V E++P +L
Sbjct: 60 PRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC- 116
Query: 167 RTGASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSD 224
R I +KV L + + LH V +RD K N+L++ + KL D
Sbjct: 117 RNYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 225 FGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
FG AK +++ +R Y Y APE + H T D++S G + EM+ G
Sbjct: 176 FGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 78/303 (25%), Positives = 116/303 (38%), Gaps = 68/303 (22%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ D V+A+K+++ Q + +W +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIK 103
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
E++ L +L HPN ++ G L + LV E+ + + PL
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAA 158
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
V GA +GLAYLHS +I+RD K NILL KL DFG A S +
Sbjct: 159 VTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSF 210
Query: 244 MGTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRP 288
+GT + APE M G K DV+S G+ +E+ + I +N
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 270
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
P LQ G +S + V CL P+ RPT +
Sbjct: 271 -----------PALQ-------------SGHWS--EYFRNFVD--SCLQKIPQDRPTSEV 302
Query: 349 VVK 351
++K
Sbjct: 303 LLK 305
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 62/260 (23%), Positives = 99/260 (38%), Gaps = 41/260 (15%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G+SGSS + + L + + + +G G G V+K
Sbjct: 1 GSSGSSGKQTGY-----------LTIGGQRYQAE-----INDLENLGEMGSGTCGQVWKM 44
Query: 88 WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIK-HLGQLYHPNLVKLIGYCLE 145
TG VIAVK++ + + + L ++ L P +V+ G +
Sbjct: 45 R---FR------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 205
+ + E M + + G P+ I K+ + K L YL VI+R
Sbjct: 96 NTDVFIAMELMGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH-GVIHR 149
Query: 206 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL----- 260
D K SNILLD KL DFG++ R G Y APE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGR---LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 261 TAKSDVYSFGVVLLEMLSGR 280
++DV+S G+ L+E+ +G+
Sbjct: 207 DIRADVWSLGISLVELATGQ 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 52/240 (21%), Positives = 95/240 (39%), Gaps = 59/240 (24%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWL 122
K +F+ +LGEG F V AR T A+K L + H+
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKR----HIIKE 71
Query: 123 TEIKH-------LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQ 174
++ + + +L HP VKL + +DD +L + G L ++ + G
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIG----- 125
Query: 175 PLSWTIRMKVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226
+ L YLH +I+RD K NILL+ + + +++DFG
Sbjct: 126 --------SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 280
AK S+ + +GT +Y++ + SD+++ G ++ ++++G
Sbjct: 176 TAKVLSPESKQARANSFVGT-----AQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGL 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 65/287 (22%), Positives = 108/287 (37%), Gaps = 51/287 (17%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
+ ++G + G++ + + + + + K NF V
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----------LTEI 125
LG G +G VF + TG + A+K L + ++ + L I
Sbjct: 62 LGTGAYGKVFLV---RKI---SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ P LV L Y + + +L L+ +++ G L HL + +
Sbjct: 116 RQ-----SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRE-------------RF 156
Query: 185 ALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
+ L +LH +IYRD K NILLD N + L+DFGL+K+
Sbjct: 157 TEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 237 SHVSTRVMGTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y AP+ +GH A D +S GV++ E+L+G
Sbjct: 215 ERAYDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 68/249 (27%), Positives = 98/249 (39%), Gaps = 51/249 (20%)
Query: 52 GSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN 111
GS+ S + K F VLG+GG+G VF+ TG + A+K L
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQV---RKV---TGANTGKIFAMKVLK 54
Query: 112 QESL---QGHLEW-LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ + E L ++ HP +V LI Y + +L L+ E++ G L L
Sbjct: 55 KAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE 113
Query: 167 RTGASYIQPLSWTIRMKVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNY 218
R G A L +LH +IYRD K NI+L+
Sbjct: 114 REG-------------IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQG 158
Query: 219 NAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGV 271
+ KL+DFGL K+ T GT EYMA +GH D +S G
Sbjct: 159 HVKLTDFGLCKESIHDGT---VTHTFCGT-----IEYMAPEILMRSGH-NRAVDWWSLGA 209
Query: 272 VLLEMLSGR 280
++ +ML+G
Sbjct: 210 LMYDMLTGA 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 83/371 (22%), Positives = 133/371 (35%), Gaps = 92/371 (24%)
Query: 26 GNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVF 85
G G+ + V + + ++ VLG+G FG V
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIF-----------------SDRYKGQRVLGKGSFGEVI 43
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLYHPNLVKLIGY 142
+ TG AVK +++ ++ + L E++ L QL HPN++KL +
Sbjct: 44 LC---KDK------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 143 CLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195
ED LV E G L A+ I ++ L + Y+
Sbjct: 95 F-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--------IRQVLSG---ITYM 142
Query: 196 HSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 252
H K+++RD K N+LL + N ++ DFGL+ S +GT Y AP
Sbjct: 143 HK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAP 197
Query: 253 EYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-YLQSKRRIF-Q 310
E + G K DV+S GV+L +LSG P ++ I +
Sbjct: 198 E-VLHGTYDEKCDVWSTGVILYILLSGCP------------------PFNGANEYDILKK 238
Query: 311 VMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ--IQDTNDA 362
V + + S A K + K L+ P R + + AL+ IQ
Sbjct: 239 VEKGKYTFELPQWKKVSESA--KDLIR--KMLTYVPSMRISARD---ALDHEWIQTYTKE 291
Query: 363 GVSRDESLQNS 373
+S D ++
Sbjct: 292 QISVDVPSLDN 302
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 45/223 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
+G+G FG V I + T + A+K +N++ + + E++ + L
Sbjct: 22 AIGKGSFGKVC---IVQKN------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
HP LV L Y +D+ + +V + + G L HL + K
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-------------HFKEETVK 118
Query: 191 --------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
L YL + + +I+RD K NILLD + + ++DF +A P + T
Sbjct: 119 LFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITT 173
Query: 243 VMGTYGYAAPEYMA----TGHLTAKSDVYSFGVVLLEMLSGRR 281
+ GT Y APE + G+ A D +S GV E+L GRR
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRR 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 67/230 (29%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIK 126
F VLG+G FG VF + + + A+K L + +L+ + E
Sbjct: 25 QFELLKVLGQGSFGKVFLV---KKI---SGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
L ++ HP +VKL Y + + +L L+ +F+ G L L +
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV-------------MFT 124
Query: 186 LGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
K L +LHS +IYRD K NILLD + KL+DFGL+K+ +
Sbjct: 125 EEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 181
Query: 238 HVSTRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 280
GT EYMA GH T +D +SFGV++ EML+G
Sbjct: 182 --KAYSFCGT-----VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 39/219 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLY 132
LG G +G V T + A+K + + S+ + + L E+ L L
Sbjct: 44 KLGSGAYGEVLLC---RDK------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIRMKVA 185
HPN++KL + ED LV E G L A+ I +K
Sbjct: 95 HPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI--------IKQV 145
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
L + YLH +++RD K N+LL + + K+ DFGL+
Sbjct: 146 LSG---VTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKE 197
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
+GT Y APE + K DV+S GV+L +L+G
Sbjct: 198 RLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK---- 190
N+VK G+ E + + L E+ G L + + M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPD-AQRFFHQ 113
Query: 191 ---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 248 GYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + DV+S G+VL ML+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K + A+K++ + + EI L +L HPN
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 136 LVKLIGYCLED-DHRL-LVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
++ L L D ++ L++++ ++ H L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSHVSTRVM 244
G+ YLH+ V++RD K +NIL+ K++D G A+ + P + + V+
Sbjct: 140 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 245 GTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
T+ Y APE + H T D+++ G + E+L+
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EIKHLGQ 130
+LGEG +G V + + T AVK L ++ L+ EI+ L +
Sbjct: 12 LLGEGSYGKVKEV---LDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 131 LYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L H N+++L + Y E +V E+ G E + + + +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--ML----DSV------PEKRFPVCQ 110
Query: 189 AK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
A GL YLHS ++++D K N+LL K+S G+A+ +
Sbjct: 111 AHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 241 TRVMGTYGYAAPEYMATGHLT---AKSDVYSFGVVLLEMLSGR 280
G+ + PE +A G T K D++S GV L + +G
Sbjct: 169 RTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 76/320 (23%), Positives = 121/320 (37%), Gaps = 69/320 (21%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
+ L+ F ++G G +G V+KG T G + A+K ++
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG- 61
Query: 116 QGHLEWLTEIKHLGQL-YHPNLVKLIG-----YCLEDDHRL-LVYEFMPKGSLENHLFRT 168
E EI L + +H N+ G D +L LV EF GS+ + + T
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 169 GASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
L + +GL++LH K VI+RD K N+LL N KL DFG++
Sbjct: 122 KG---NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-----AKSDVYSFGVVLLEMLSGR--- 280
+ +T +GT + APE +A KSD++S G+ +EM G
Sbjct: 177 AQ-LDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
Query: 281 ------RV---IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 331
R I +N P L+SK ++S ++ +
Sbjct: 235 CDMHPMRALFLIPRNPA-----------PRLKSK-------------KWS--KKFQSFIE 268
Query: 332 AIKCLSNEPKFRPTMDEVVK 351
CL RP ++++K
Sbjct: 269 --SCLVKNHSQRPATEQLMK 286
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 51/230 (22%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEW----- 121
+ +GEG +G VFK + T G ++A+K +++
Sbjct: 4 KYEKIGKIGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESEDD-----PVIKKIA 49
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSW 178
L EI+ L QL HPNLV L+ LV+E+ L+ + ++ ++W
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQ 236
+ + + H I+RD K NIL+ + KL DFG A+ GP+
Sbjct: 110 QT--------LQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 237 SH-VSTRVMGTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 280
V+TR Y +PE + + DV++ G V E+LSG
Sbjct: 160 DDEVATR-----WYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 61/230 (26%), Positives = 89/230 (38%), Gaps = 50/230 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN------------QESLQGHLEWL 122
LG G +G V + A+K + ++++ E +
Sbjct: 43 KLGSGAYGEVLLC---KEK------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 123 -TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQ 174
EI L L HPN++KL ED LV EF G L + A+ I
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI- 151
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDG 231
MK L + YLH +++RD K NILL + N K+ DFGL+
Sbjct: 152 -------MKQILSG---ICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-- 197
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
S+ + +GT Y APE + K DV+S GV++ +L G
Sbjct: 198 -FFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK---- 190
N+VK G+ E + + L E+ G L + + M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPD-AQRFFHQ 113
Query: 191 ---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 248 GYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE DV+S G+VL ML+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 65/263 (24%), Positives = 99/263 (37%), Gaps = 58/263 (22%)
Query: 48 EILLG-SNIKSFSFNGLKTATRNFRPDSV---------LGEGGFGCVFKGWIDEHTYAPA 97
EI L S K F F L ++ P ++ LG G G V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---FER---- 157
Query: 98 RPGTGMVIAVKRLNQESLQGHLEW--------LTEIKHLGQLYHPNLVKLIGYCLEDDHR 149
T +A++ +++ TEI+ L +L HP ++K+ + + +
Sbjct: 158 --KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 150 LLVYEFMPKGSL------ENHLF-RTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 202
+V E M G L L T Y + + YLH + +
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM------------LLAVQYLHEN--GI 260
Query: 203 IYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE---YMA 256
I+RD K N+LL + + K++DFG +K G S + T GT Y APE +
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVG 317
Query: 257 TGHLTAKSDVYSFGVVLLEMLSG 279
T D +S GV+L LSG
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSG 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 53/272 (19%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNG--LKTATRNFRPDSVLGEGGFGCVF 85
+ S++ ++ V + P + IK + +G + + V+G G FG VF
Sbjct: 2 SFTMSNAPLNGVKLNPLDDP----NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145
+ + E + V A+K++ Q+ E++ + + HPN+V L +
Sbjct: 58 QAKLVE---------SDEV-AIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYS 103
Query: 146 DDHRL------LVYEFMPK--GSLENHLFRTG----ASYIQPLSWTIRMKVALGAAKGLA 193
+ + LV E++P+ H + I+ + + + LA
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--------LRSLA 155
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTG--SQSHVSTRVMGTYGYA 250
Y+HS + +RD K N+LLD KL DFG AK G + S++ +R Y Y
Sbjct: 156 YIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YR 208
Query: 251 APEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
APE + AT + T D++S G V+ E++ G+
Sbjct: 209 APELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 69/225 (30%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESL--QGHLEW-LTE 124
F +LG+G FG V + TG A+K L +E + + + LTE
Sbjct: 149 EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
+ L HP L L Y + RL V E+ G L HL R ++
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRER-------VFSEDRA 250
Query: 184 VALGA--AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
GA L YLHS+K V+YRD K N++LD + + K++DFGL K+G +
Sbjct: 251 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TM 306
Query: 242 RVM-GTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 280
+ GT PEY+A L D + GVV+ EM+ GR
Sbjct: 307 KTFCGT-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 48/296 (16%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
+ + N + + + +G + + K
Sbjct: 32 LNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE 91
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--- 122
+ + P V+G G V + H TG AVK + + + E L
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRC---VHR------ATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 123 -----TEIKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTG------ 169
E L Q+ HP+++ LI E + LV++ M KG L ++L
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKE 201
Query: 170 ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229
I M+ L A +++LH+ +++RD K NILLD N +LSDFG +
Sbjct: 202 TRSI--------MRSLLEA---VSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 230 DGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 279
G + + GT GY APE + D+++ GV+L +L+G
Sbjct: 249 HLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 39/224 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ ++GEG +G V K + TG ++A+K+ + + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDD---KMVKKIAMR 73
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTI 180
EIK L QL H NLV L+ C + LV+EF+ LE +Q + I
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSH 238
G+ + HS +I+RD K NIL+ + KL DFG A+ P
Sbjct: 134 --------INGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 239 -VSTRVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
V+TR Y APE + DV++ G ++ EM G
Sbjct: 184 EVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG G F VF + TG + A+K + + EI L ++ H
Sbjct: 16 VLGSGAFSEVFLV---KQR------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------ASYIQPLSWTIRMKVALGA 188
N+V L H LV + + G L + + G AS + ++ L A
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV--------IQQVLSA 118
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+ YLH +++RD K N+L + N ++DFGL+K G +ST G
Sbjct: 119 ---VKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-G 169
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
T GY APE +A + D +S GV+ +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 60/289 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQL 131
+G+G F V H TG +A+K +++ L L E++ + L
Sbjct: 23 IGKGNFAKVKLA---RHIL------TGREVAIKIIDKTQLNPTSLQKLF--REVRIMKIL 71
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK- 190
HPN+VKL + L+ E+ G + ++L G RMK +K
Sbjct: 72 NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-----------RMKEKEARSKF 120
Query: 191 -----GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+ Y H + +++RD K N+LLD + N K++DFG + + G + G
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---G 175
Query: 246 TYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
YAAPE + + + DV+S GV+L ++SG P NL E
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKEL------- 222
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVK 351
+ R+ + G+Y + + T L + L P R T+++++K
Sbjct: 223 RERV-------LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 71/302 (23%), Positives = 114/302 (37%), Gaps = 55/302 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLGEG V + T AVK + ++ E++ L Q H
Sbjct: 20 VLGEGAHARVQTC---INL------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------ASYIQPLSWTIRMKVALG 187
N+++LI + E+D LV+E M GS+ +H+ + AS + ++
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVAS 122
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKD-GPTGSQSHVSTRV 243
A L +LH+ + +RD K NIL + K+ DF L G S +ST
Sbjct: 123 A---LDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 244 M----GTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294
+ G+ Y APE + A D++S GV+L +LSG P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCG 231
Query: 295 IEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKFRPTMD 347
+ ++ ++ I EG+Y + L K L + K R +
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 348 EV 349
+V
Sbjct: 292 QV 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 61/254 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
+G+G +G V T + A+K ++ Q + + TE++ +
Sbjct: 33 AIGQGSYGVVRVAI---------ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG- 187
+L+HPN+ +L ED+ + LV E G L + L + +
Sbjct: 84 KLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 188 ---------------------------AAK-------GLAYLHSDKAKVIYRDFKTSNIL 213
+ L YLH+ + +RD K N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200
Query: 214 L--DLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAPE--YMATGHLTAKSDV 266
+ ++ KL DFGL+K G ++T+ GT + APE K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259
Query: 267 YSFGVVLLEMLSGR 280
+S GV+L +L G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 73/295 (24%), Positives = 111/295 (37%), Gaps = 69/295 (23%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLY 132
+LG+G FG V K + T AVK +N+ S + + E++ L +L
Sbjct: 29 MLGKGSFGEVLKC---KDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIRMKVA 185
HPN++KL ED +V E G L A+ I +K
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQV 130
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+ Y+H +++RD K NILL + + + K+ DFGL+
Sbjct: 131 FSG---ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKD 182
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-Y 301
+GT Y APE + G K DV+S GV+L +LSG P Y
Sbjct: 183 RIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP------------------PFY 223
Query: 302 LQSKRRIFQ-VMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349
+++ I + V + S A K + K L+ P R T +
Sbjct: 224 GKNEYDILKRVETGKYAFDLPQWRTISDDA--KDLIR--KMLTFHPSLRITATQC 274
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 32/219 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQ 130
V+G G F V + TG V A+K +N+ + E + E L
Sbjct: 68 VIGRGAFSEVAV----------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA-LGA 188
+ +L + +D++ L LV E+ G L L + G ++ R +A +
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA---RFYLAEIVM 173
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A + +H ++RD K NILLD + +L+DFG V GT
Sbjct: 174 A--IDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPD 228
Query: 249 YAAPEYMATGHLTAKSDVY-------SFGVVLLEMLSGR 280
Y +PE + + Y + GV EM G+
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSLEN-HLFRTGA 170
+ + + H N++ L+ LE+ + +V E M + L++ +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM----- 129
Query: 171 SYI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
SY+ Q L G+ +LHS A +I+RD K SNI++ + K+ DFGLA
Sbjct: 130 SYLLYQML-------------CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 229 KDGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR------ 280
+ T +V TR Y APE + D++S G ++ EM+ G
Sbjct: 175 RTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 281 -------RVIDK-NRPSRE--HNLIEWAKPYLQS----KRRIFQVMDARIEGQYSLGAAL 326
+VI++ P E L + Y+++ F+ + +
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 327 KTAVLAI----KCLSNEPKFRPTMDEVVKALE 354
A A K L + R ++DE AL+
Sbjct: 290 LKASQARDLLSKMLVIDASKRISVDE---ALQ 318
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 49/237 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----- 121
+ + G +G V G+ +A+KR+ G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 122 ------LTEIKHLGQLYHPNLVKL----IGYCLEDDHRL-LVYEFMPKGSLENHLFRTGA 170
L EI+ L +HPN++ L + + H+L LV E M L +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIH 125
Query: 171 SYIQPLSWTIRMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226
+S ++ L GL LH A V++RD NILL N + + DF
Sbjct: 126 DQRIVIS-PQHIQYFMYHIL---LGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFN 179
Query: 227 LAKDGPTGSQS--HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
LA++ + +V+ R Y APE + T D++S G V+ EM + +
Sbjct: 180 LAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 66/324 (20%), Positives = 121/324 (37%), Gaps = 65/324 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRTGAS--YIQPL 176
+ + + H N++ L+ LE+ + LV E M + + + + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYL 169
Query: 177 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
+ + G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T
Sbjct: 170 LYQM--------LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 237 S--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------------R 281
+V TR Y APE + D++S G ++ EM+ + +
Sbjct: 220 MTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274
Query: 282 VIDK-NRPSRE--HNLIEWAKPYLQS----KRRIFQVMDARIEGQYSLGAALKTAVLAI- 333
VI++ P E L + Y+++ F + A A
Sbjct: 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334
Query: 334 ---KCLSNEPKFRPTMDEVVKALE 354
K L +P R ++D+ AL+
Sbjct: 335 LLSKMLVIDPAKRISVDD---ALQ 355
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 47/235 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--------QESLQGH 118
N+ P +LG G V + H T AVK ++ E +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---IHK------PTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 119 LEWL-TEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------A 170
E E+ L ++ HPN+++L + LV++ M KG L ++L
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 171 SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230
I M+ L + LH +++RD K NILLD + N KL+DFG +
Sbjct: 127 RKI--------MRALLEV---ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 231 GPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 279
G + + GT Y APE + D++S GV++ +L+G
Sbjct: 174 LDPGEK--LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 62/228 (27%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHL 128
LG G FG V R G A+K L +E + H E L
Sbjct: 13 TLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVEHT--NDERLML 60
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ HP ++++ +D ++ ++ +++ G L + L ++ +
Sbjct: 61 SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------------RFPNP 106
Query: 188 AAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
AK L YLHS +IYRD K NILLD N + K++DFG AK P
Sbjct: 107 VAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 158
Query: 240 STRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 280
T + GT P+Y+A + + D +SFG+++ EML+G
Sbjct: 159 VTYTLCGT-----PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G EH TG +AVK ++ + G ++ EI++L
Sbjct: 19 LGVGTFGKVKIG---EHQ------LTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKL 67
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
HP+++KL Y + +V E++ G L +++ + G R++
Sbjct: 68 FRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEEMEAR 114
Query: 189 AK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 115 RLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 171
Query: 243 VMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGR 280
G+ YAAPE ++ + + D++S GV+L +L G
Sbjct: 172 --GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG V R TG A+K L +E + + + +TE
Sbjct: 6 DFDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
+ L HP L L Y + RL V E+ G L HL R + + R +
Sbjct: 56 SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEE-----RAR 108
Query: 184 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+ L YLHS V+YRD K N++LD + + K++DFGL K+G +
Sbjct: 109 FYGAEIVS----ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 160
Query: 239 VSTRVM-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
+ + GT Y APE + D + GVV+ EM+ GR
Sbjct: 161 -TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ + + +G G +G V ID+ + G +A+K+L++ +S E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSL-ENHLFRTGA 170
+ L + H N++ L+ L + + LV FM E +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI----- 128
Query: 171 SYI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
Y+ Q L KGL Y+HS A V++RD K N+ ++ + K+ DFGLA
Sbjct: 129 QYLVYQML-------------KGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
+ +V TR + Y APE + + H D++S G ++ EML+G+
Sbjct: 174 RHADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKH 127
+ LGEG + V+KG T ++A+K + E +G + E+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSL 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKV 184
L L H N+V L + LV+E++ K L++ ++ + +
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL---- 109
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTR 242
+GLAY H KV++RD K N+L++ KL+DFGLA K PT + +
Sbjct: 110 ----LRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---E 160
Query: 243 VMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
V+ T Y P+ + +T + T D++ G + EM +GR
Sbjct: 161 VV-TLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 48/221 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G ++A+K RL+ E +++ EI
Sbjct: 29 VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EIS 71
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMK 183
L +L+HPN+V LI + LV+EFM K L+ + S I+ + +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL--- 128
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVST 241
+G+A+ H + +++RD K N+L++ + KL+DFGLA+ P S +H
Sbjct: 129 -----LRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH--- 178
Query: 242 RVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
V+ T Y AP+ + + + T+ D++S G + EM++G+
Sbjct: 179 EVV-TLWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 48/221 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G A+K RL +E +++ EI
Sbjct: 10 IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIR-------EIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMK 183
L +L H N+VKL +LV+E + K L+ + + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL--- 109
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVST 241
G+AY H + V++RD K N+L++ K++DFGLA+ P +H
Sbjct: 110 -----LNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--- 159
Query: 242 RVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
++ T Y AP+ + + + T D++S G + EM++G
Sbjct: 160 EIV-TLWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 54/271 (19%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G + ++ + S V + K + + F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML- 59
Query: 88 WIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIG 141
+ +G A+K L+++ + H L E + L + P LVKL
Sbjct: 60 ---------VKHKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLE- 107
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK--------GL 192
+ +D+ L +V E++ G + +HL R G + + A+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTF 154
Query: 193 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYAA 251
YLHS +IYRD K N+L+D +++DFG AK T + GT A
Sbjct: 155 EYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALA 206
Query: 252 PE-YMATGHLTAKS-DVYSFGVVLLEMLSGR 280
PE ++ G+ K+ D ++ GV++ EM +G
Sbjct: 207 PEIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 72/293 (24%), Positives = 110/293 (37%), Gaps = 56/293 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YH 133
LGEG F K H + AVK +++ + EI L H
Sbjct: 18 PLGEGSFSICRKC---VHK------KSNQAFAVKIISKRMEANTQK---EITALKLCEGH 65
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------ASYIQPLSWTIRMKVALG 187
PN+VKL + H LV E + G L + + ASYI M+ +
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVS 117
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A ++++H V++RD K N+L + N K+ DFG A+ P +Q + T
Sbjct: 118 A---VSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC- 170
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
T YAAPE + D++S GV+L MLSG+ P + +
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLT 217
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAV------LAIKCLSNEPKFRPTMDEVVK 351
++M +G +S V L L+ +P R M +
Sbjct: 218 CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LG G + V+KG +++ T G+ +A+K + +S +G + EI + +L H
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
N+V+L ++ LV+EFM K +++ ++ L +G
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QG 120
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTRVMGTYGY 249
LA+ H +K +++RD K N+L++ KL DFGLA P + S V+ T Y
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWY 174
Query: 250 AAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
AP+ + + + T+ D++S G +L EM++G+
Sbjct: 175 RAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-21
Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 42/220 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
LG G FG V E +G+ +K +N++ Q +E + EI+ L L H
Sbjct: 29 KLGSGAFGDVHLV---EER------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSL----------ENHLFRTGASYIQPLSWTIRM 182
PN++K+ ED H + +V E G L L + + M
Sbjct: 80 PNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--------M 130
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHV 239
K + A LAY HS V+++D K NIL + K+ DFGLA+
Sbjct: 131 KQMMNA---LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEH 182
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
ST GT Y APE + +T K D++S GVV+ +L+G
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 57/232 (24%), Positives = 86/232 (37%), Gaps = 48/232 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------- 121
+ LG G G V T +A+K +++
Sbjct: 11 EYIMSKTLGSGACGEVKLA---FER------KTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 122 -LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL-----ENHLF--RTGASYI 173
TEI+ L +L HP ++K+ + + + +V E M G L N T Y
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 174 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKD 230
+ + YLH +I+RD K N+LL + + K++DFG +K
Sbjct: 121 YQM------------LLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK- 165
Query: 231 GPTGSQSHVSTRVMGTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSG 279
G S + T GT Y APE + T D +S GV+L LSG
Sbjct: 166 -ILGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 47/222 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G VFK + T ++A+K RL+ + +L+ EI
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALR-------EIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMK 183
L +L H N+V+L D LV+EF K ++ ++ +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LF 108
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVST 241
L KGL + HS V++RD K N+L++ N KL++FGLA+ P S
Sbjct: 109 QLL---KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--- 160
Query: 242 RVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRR 281
V+ T Y P+ + A + T+ D++S G + E+ + R
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 54/262 (20%), Positives = 103/262 (39%), Gaps = 66/262 (25%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL+T+++ + LG G FG V + + E +G A+K++ Q+
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRYK---- 47
Query: 122 LTEIKHLGQLYHPNLVKLIGY-------------------------------------CL 144
E+ + L H N++KL+ Y
Sbjct: 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107
Query: 145 EDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKV 202
+ L ++ E++P +L L ++ + + + + + + + ++HS +
Sbjct: 108 SQNKYLNVIMEYVPD-TLHKVL-KSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGI 162
Query: 203 IYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG- 258
+RD K N+L++ N KL DFG AK +++ +R + Y APE M
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGAT 217
Query: 259 HLTAKSDVYSFGVVLLEMLSGR 280
T D++S G V E++ G+
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 67/283 (23%), Positives = 107/283 (37%), Gaps = 53/283 (18%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S+ D N S + G++S V + +
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------------- 51
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ F +S LG G V++ + GT A+K L + + + TEI
Sbjct: 52 -SDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKTVDKKIVR--TEI 99
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------ASYIQPLSWT 179
L +L HPN++KL LV E + G L + + G A+
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA------ 153
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQ 236
+K L A +AYLH +++RD K N+L + K++DFGL+K Q
Sbjct: 154 --VKQILEA---VAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204
Query: 237 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ T GT GY APE + + D++S G++ +L G
Sbjct: 205 VLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 32/232 (13%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHL 119
++ +F V+G G FG V + V A+K LN+ +
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRA 116
Query: 120 E---WLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQP 175
E + E L + L Y +DD+ L LV ++ G L L + +
Sbjct: 117 ETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 176 LS--WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233
++ + M +A+ +H ++RD K NIL+D+N + +L+DFG
Sbjct: 176 MARFYLAEMVIAID------SVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 234 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 280
S V GT Y +PE + D +S GV + EML G
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 37/237 (15%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
+ + T + +LG+G FG V K + T AVK +N+
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKC---KDR------ITQQEYAVKVINKA 58
Query: 114 SLQGHLE--WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHL 165
S + L E++ L +L HPN++KL + +V E G L
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 166 FRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222
A+ I +K + Y+H +++RD K NILL + + + K+
Sbjct: 119 SEHDAARI--------IKQVFSG---ITYMHK--HNIVHRDLKPENILLESKEKDCDIKI 165
Query: 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
DFGL+ ++ + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 166 IDFGLSTCFQQNTK--MKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 36/224 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLFRTGASYIQPLSW 178
+ +L HPN+V+L E+ LV++ + G L AS+
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC----- 110
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGS 235
++ L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 111 ---IQQILES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
GT GY +PE + + D+++ GV+L +L G
Sbjct: 163 A--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G +G V GT + A K++ + ++ + EI+ + L HP
Sbjct: 16 TIGRGSWGEVKIA---VQ------KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLFRTGASYIQPLSWTIRMKVALGA 188
N+++L ++ LV E G L + + A+ I MK L A
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI--------MKDVLSA 118
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+AY H V +RD K N L + KL DFGLA G + +G
Sbjct: 119 ---VAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVG 170
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
T Y +P+ + + + D +S GV++ +L G
Sbjct: 171 TPYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCG 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-----WLTEIKHLGQ 130
LGEG F V+K D++T ++A+K++ + L EIK L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L HPN++ L+ + LV++FM + ++++ S+I+ ++ M + L
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK--AY---MLMTL- 122
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVM 244
+GL YLH +++RD K +N+LLD N KL+DFGLAK P + +H V TR
Sbjct: 123 --QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 245 GTYGYAAPE--YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + A + D+++ G +L E+L
Sbjct: 177 ---WYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G + + H T M AVK +++ E + + GQ HP
Sbjct: 29 DIGVGSYSVCKRC---IHK------ATNMEFAVKIIDKSKRDPTEE-IEILLRYGQ--HP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG------ASYIQPLSWTIRMKVALGA 188
N++ L + + +V E M G L + + R AS + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKT 128
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA---KLSDFGLAKDGPTGSQSHVSTRVM 244
+ YLH+ V++RD K SNIL D + N ++ DFG AK + + T
Sbjct: 129 ---VEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC- 181
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
T + APE + A D++S GV+L ML+G
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 50/224 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
V+G+G FG V AR + AVK L ++++ + + ++E L +
Sbjct: 45 VIGKGSFGKVLL----------ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 131 -LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK----- 183
+ HP LV L + + +L V +++ G L HL R +++P R +
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEP-----RARFYAAE 147
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
+A L YLHS ++YRD K NILLD + L+DFGL K+ + +T
Sbjct: 148 IASA----LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTST 198
Query: 244 M-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 280
GT PEY+A + D + G VL EML G
Sbjct: 199 FCGT-----PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 71/302 (23%), Positives = 109/302 (36%), Gaps = 75/302 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + H TG A+K L E+ H Q
Sbjct: 36 VLGLGVNGKVLEC---FHR------RTGQKCALKLLYDSPKAR-----QEVDHHWQASGG 81
Query: 134 PNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRTG--------ASYIQPLSWTI 180
P++V ++ E+ H L++ E M G L + + G A+ I
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI------- 133
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 237
M+ A + +LHS + +RD K N+L + + KL+DFG AK+ +
Sbjct: 134 -MRDIGTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
+ T T Y APE + D++S GV++ +L G
Sbjct: 186 -LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP---------------- 227
Query: 298 AKP-YLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKFRPTMDEV 349
P Y + + I M RI GQY + V L L +P R T+ +
Sbjct: 228 --PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
Query: 350 VK 351
+
Sbjct: 286 MN 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 61/284 (21%), Positives = 106/284 (37%), Gaps = 47/284 (16%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLG---SNIKSFSFNGLKTATRNFR- 71
G S + S++ ++ V L + F +
Sbjct: 28 GDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS 87
Query: 72 -----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+LG G FG V K E T TG+ +A K + ++ E EI
Sbjct: 88 FYTVSKTEILGGGRFGQVHKC---EET------ATGLKLAAKIIKTRGMKDKEEVKNEIS 138
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RTGASYIQPLS 177
+ QL H NL++L E + + LV E++ G L E++ +++ +
Sbjct: 139 VMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI- 196
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGS 235
+G+ ++H +++ D K NIL K+ DFGLA+
Sbjct: 197 -----------CEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ V GT + APE + ++ +D++S GV+ +LSG
Sbjct: 244 KLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHP 134
+G G FG T ++AVK + + + +++ EI + L HP
Sbjct: 28 IGSGNFGVARLM---RDK------LTKELVAVKYIERGAAIDENVQ--REIINHRSLRHP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK---- 190
N+V+ L H ++ E+ G L + G R
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQQL 125
Query: 191 --GLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
G++Y HS ++ +RD K N LLD + K+ DFG +K SQ + V GT
Sbjct: 126 LSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GT 180
Query: 247 YGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y APE + + +DV+S GV L ML G
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 57/232 (24%), Positives = 87/232 (37%), Gaps = 49/232 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----- 123
+ S LG G FG V W + VK + +E + W+
Sbjct: 25 KYSTMSPLGSGAFGFV---WTAVDKE------KNKEVVVKFIKKEKVLED-CWIEDPKLG 74
Query: 124 ----EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGS-LENHLFRTG------AS 171
EI L ++ H N++K++ E+ LV E G L + R AS
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 172 YI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229
YI Q +S + YL +I+RD K NI++ ++ KL DFG A
Sbjct: 134 YIFRQLVS-------------AVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178
Query: 230 DGPTGSQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
G + GT Y APE M + + +++S GV L ++
Sbjct: 179 YLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ +F+ S+LGEG +G V + T G ++A+K++ + L L EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 126 KHLGQLYHPNLVKLI----GYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
K L H N++ + E+ + + ++ E M + + + T Q LS
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST-----QMLS-DD 112
Query: 181 RMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA----KDGP 232
++ L + + LH + VI+RD K SN+L++ N + K+ DFGLA +
Sbjct: 113 HIQYFIYQTL---RAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 233 TGSQSHVSTRVMGTY----GYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
S+ M + Y APE M + + DV+S G +L E+ R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
++ S +G G +G V + + TG+ +AVK+L++ +S+ E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSW 178
++ L + H N++ L+ LE+ + + LV M L Q L+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKC--QKLT- 130
Query: 179 TIRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
++ + +GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+
Sbjct: 131 DDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 238 HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
+V+TR Y APE M H D++S G ++ E+L+GR
Sbjct: 189 YVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 36/214 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP 134
LG G + VF+ + VK L + + EIK L L P
Sbjct: 44 LGRGKYSEVFEAINIT---------NNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS-WTIR--MKVALGAAKG 191
N++ L + R F + N F+ Q L+ + IR M L K
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQ---LYQTLTDYDIRFYMYEIL---KA 142
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYG 248
L Y HS +++RD K N+++D + +L D+GLA+ G + V++R
Sbjct: 143 LDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----- 195
Query: 249 YAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGRR 281
+ PE + + S D++S G +L M+ +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F VLG+G FG V + GT + AVK L ++ + +E + E
Sbjct: 342 DFNFLMVLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ L P L +L C + RL V E++ G L H+ + G + +P +
Sbjct: 392 KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAA 449
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
++A+G L +L S +IYRD K N++LD + K++DFG+ K+ +T+
Sbjct: 450 EIAIG----LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTK 500
Query: 243 VM-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
GT Y APE + D ++FGV+L EML+G+
Sbjct: 501 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 38/216 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG V K +N EI + QL+HP
Sbjct: 58 ELGSGAFGVVHRC---VEK------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RTGASYIQPLSWTIRMKVA 185
L+ L ED + + L+ EF+ G L E++ +Y++
Sbjct: 109 KLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE------- 160
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRV 243
GL ++H +++ D K NI+ + + K+ DFGLA +
Sbjct: 161 -----GLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVT 210
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
T +AAPE + + +D+++ GV+ +LSG
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 45/220 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G +H TG +AVK ++ + G + EI++L
Sbjct: 24 LGVGTFGKVKVG---KHE------LTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKL 72
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
HP+++KL Y + + +V E++ G L +++ + G R+
Sbjct: 73 FRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDEKESR 119
Query: 189 AK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
G+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 120 RLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 176
Query: 243 VMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 280
G+ YAAPE + +G L + D++S GV+L +L G
Sbjct: 177 --GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 46/228 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F VLG+G FG V + GT + AVK L ++ + +E + E
Sbjct: 21 DFNFLMVLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ L P L +L C + RL V E++ G L H+ + G
Sbjct: 71 KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVG------------- 116
Query: 183 KVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
+ A GL +L S +IYRD K N++LD + K++DFG+ K+
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
Query: 235 SQSHVSTRVM-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
+T+ GT Y APE + D ++FGV+L EML+G+
Sbjct: 175 GV---TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+G+G FG VFK T G +A+K + E +L+ EIK
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALR-------EIK 68
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL--------LVYEFMP---KGSLENHLFRTGASYIQP 175
L L H N+V LI C LV++F G L N L + S I+
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPT 233
+ M++ L GL Y+H +K +++RD K +N+L+ + KL+DFGLA+
Sbjct: 129 V-----MQMLL---NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 234 GSQSHVSTRVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 280
SQ + T + T Y PE + D++ G ++ EM +
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 58/247 (23%), Positives = 86/247 (34%), Gaps = 36/247 (14%)
Query: 52 GSNIKSFSFNGLKTATRNFR----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
G + + F V+G+G F V + + TG AV
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRC---INR------ETGQQFAV 54
Query: 108 KRLNQESLQGHLEW-----LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
K ++ E L HP++V+L+ D +V+EFM L
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL- 113
Query: 163 NHLFRTGASYIQPLSWTIR-----MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--- 214
F ++ M+ L A L Y H +I+RD K +LL
Sbjct: 114 --CFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD--NNIIHRDVKPHCVLLASK 166
Query: 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLL 274
+ + KL FG+A S RV GT + APE + DV+ GV+L
Sbjct: 167 ENSAPVKLGGFGVAIQLG-ESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 275 EMLSGRR 281
+LSG
Sbjct: 225 ILLSGCL 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 36/224 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLFRTGASYIQPLSW 178
+ +L HPN+V+L E+ LV++ + G L AS+
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC----- 133
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGS 235
++ L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 134 ---IQQILES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
GT GY +PE + + D+++ GV+L +L G
Sbjct: 186 A--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+R +G G +G V +D T G +A+K+L + +S E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSW 178
++ L + H N++ L+ L+D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKH--EKLG- 126
Query: 179 TIRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
R++ + KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ +
Sbjct: 127 EDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
Query: 238 HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
+V TR Y APE + T D++S G ++ EM++G+
Sbjct: 185 YVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 65/227 (28%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG VF A T A+K L ++ + +E + E
Sbjct: 18 DFILHKMLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 125 IKHLGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ L HP L + + L V E++ G L H+
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH------------- 113
Query: 183 KVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
K L A GL +LHS ++YRD K NILLD + + K++DFG+ K+ G
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 235 SQSHVSTRVM-GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
T GT Y APE + D +SFGV+L EML G+
Sbjct: 172 DA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 69/228 (30%), Positives = 97/228 (42%), Gaps = 46/228 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
NF VLG+G FG V AR TG + AVK L ++ + +E +TE
Sbjct: 24 NFEFIRVLGKGSFGKVML----------ARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ L HP L +L C + RL V EF+ G L H+ ++
Sbjct: 74 KRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSR------------- 119
Query: 183 KVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
+ A+ L +LH +IYRD K N+LLD + KL+DFG+ K+G
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 235 SQSHVSTRVM-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 280
+T GT Y APE + D ++ GV+L EML G
Sbjct: 178 GV---TTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 44/231 (19%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ S +GEG +G V D + +A+K+++ E L EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISPFEHQTYCQRTLREI 76
Query: 126 KHLGQLYHPNLVKLIG----YCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
K L + H N++ + +E + +V + M + L +T Q LS
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT-----QHLS-ND 128
Query: 181 RMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 236
+ L +GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+
Sbjct: 129 HICYFLYQIL---RGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 237 S------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 280
+V+TR Y APE M + T D++S G +L EMLS R
Sbjct: 184 HTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 68/256 (26%)
Query: 59 SFNGLK-TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
S N + LG GG G VF +D +A+K++ Q
Sbjct: 1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQS 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLI-------------GYCLEDDHRL-LVYEFMP------ 157
L EIK + +L H N+VK+ L + + + +V E+M
Sbjct: 52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 158 --KGSLEN-HLFRTGASYI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212
+G L H Q L +GL Y+HS A V++RD K +N+
Sbjct: 112 LEQGPLLEEHA-----RLFMYQLL-------------RGLKYIHS--ANVLHRDLKPANL 151
Query: 213 LLD-LNYNAKLSDFGLAK--DGPTGSQSH----VSTRVMGTYGYAAPEYM-ATGHLTAKS 264
++ + K+ DFGLA+ D + H + T+ Y +P + + + T
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAI 206
Query: 265 DVYSFGVVLLEMLSGR 280
D+++ G + EML+G+
Sbjct: 207 DMWAAGCIFAEMLTGK 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 54/232 (23%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F V+G G + V R T + A+K + +E + ++W TE
Sbjct: 10 DFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
Q HP LV L C + + RL V E++ G L H+ R
Sbjct: 60 KHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR------------- 105
Query: 183 KVALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
K+ A+ L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 235 SQSHVSTRVM-GTYGYAAPEYMA----TGHLTAKS-DVYSFGVVLLEMLSGR 280
+T GT P Y+A G S D ++ GV++ EM++GR
Sbjct: 164 GD---TTSTFCGT-----PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 58/312 (18%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G++ + + + + + S + + + + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYH 133
+G G +G V + D+ V+A+K++ + E L L EI L +L H
Sbjct: 61 IGTGSYGHVCEA-YDKLE--------KRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 134 PNLVKL----IGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV---- 184
++VK+ I +E L +V E S LFRT L+ + +K
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP----VYLT-ELHIKTLLYN 164
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---------------- 228
L G+ Y+HS A +++RD K +N L++ + + K+ DFGLA
Sbjct: 165 LL---VGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 229 -----KDGPTGSQSHVSTRVMGTYG----YAAPEYM-ATGHLTAKSDVYSFGVVLLEMLS 278
+ T + R + + Y APE + + T DV+S G + E+L+
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 279 GRRVIDKNRPSR 290
+ R
Sbjct: 280 MIKENVAYHADR 291
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 73/292 (25%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRN 69
D +P N G+G +++ + ++ F L+
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSS-----LGLQDFDL--LR----- 58
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEI 125
V+G G + V R T + A++ + +E + ++W TE
Sbjct: 59 -----VIGRGSYAKVLL----------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 126 KHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
Q HP LV L C + + RL V E++ G L H+ R K
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR-------------K 149
Query: 184 VALGAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
+ A+ L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 150 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207
Query: 236 QSHVSTRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 280
+T GT P Y+A + D ++ GV++ EM++GR
Sbjct: 208 D---TTSTFCGT-----PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWL-TE 124
T ++ LG+G F V + G A +N + L + L E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC---VKV------LAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLFRTGASYIQPLSW 178
+ L HPN+V+L E+ H L+++ + G L + AS+
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC----- 115
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGS 235
++ L A + + H V++R+ K N+LL KL+DFGLA +
Sbjct: 116 ---IQQILEA---VLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
Q+ GT GY +PE + D+++ GV+L +L G
Sbjct: 168 QA-WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 67/287 (23%)
Query: 15 NGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDS 74
+ + + + + + P E E L ++
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES----------------QYQVGP 49
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------EIKHL 128
+LG GGFG V+ G + +A+K + ++ + E E+ L
Sbjct: 50 LLGSGGFGSVYSG---IRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 129 GQLYH--PNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
++ +++L+ + D +L+ E P L + + G ++
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----------ALQEE 149
Query: 186 LGAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLA---KDGPTGS 235
L + + + H+ V++RD K NIL+DLN KL DFG KD
Sbjct: 150 LARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---- 203
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 280
+ GT Y+ PE++ H + V+S G++L +M+ G
Sbjct: 204 --VYTDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LGEG FG V H T +A+K L + + +E EI +L
Sbjct: 17 LGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVE--REISYLKL 65
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L HP+++KL Y + + +V E+ G L +++ RM G
Sbjct: 66 LRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK-----------RMTEDEGR 111
Query: 189 AK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
+ Y H K +++RD K N+LLD N N K++DFGL+ G+ S
Sbjct: 112 RFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC- 168
Query: 243 VMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 280
G+ YAAPE + G L + DV+S G+VL ML GR
Sbjct: 169 --GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 76/249 (30%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------------ 123
+G+G +G V + A+K L+++ L +
Sbjct: 21 IGKGSYGVVKLA---YNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 124 --------------EIKHLGQLYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSL------ 161
EI L +L HPN+VKL + +DH +V+E + +G +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 162 ----EN---HLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214
E+ F+ + G+ YLH K +I+RD K SN+L+
Sbjct: 132 KPLSEDQARFYFQ------DLIK-------------GIEYLHYQK--IIHRDIKPSNLLV 170
Query: 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT---AKSDVYSFGV 271
+ + K++DFG++ + GS + +S V GT + APE ++ DV++ GV
Sbjct: 171 GEDGHIKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 272 VLLEMLSGR 280
L + G+
Sbjct: 229 TLYCFVFGQ 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 36/215 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG A K + EI+ + L HP
Sbjct: 164 ELGTGAFGVVHRV---TER------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLF--RTGASYIQPLSWTIRMKVAL 186
LV L +D+ +++YEFM G L E++ Y++ +
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------- 266
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVM 244
GL ++H + ++ D K NI+ + KL DFGL V
Sbjct: 267 ----GLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TT 317
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
GT +AAPE + +D++S GV+ +LSG
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 77/369 (20%), Positives = 122/369 (33%), Gaps = 75/369 (20%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S P+P A + + ++ + + G IK +
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
T VLG G G V + + T A+K L E+
Sbjct: 65 VT-----SQVLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REV 105
Query: 126 KHLGQLY-HPNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRTG--------ASY 172
+ + P++V+++ L+V E + G L + + G AS
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 173 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 229
I MK A + YLHS + +RD K N+L N KL+DFG AK
Sbjct: 166 I--------MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289
+ + + ++T T Y APE + D++S GV++ +L G P
Sbjct: 213 ETTSHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF 263
Query: 290 REHNLIEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKF 342
++ L + RI GQY + V L L EP
Sbjct: 264 -------YSNHGLAISPGMKT----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
Query: 343 RPTMDEVVK 351
R T+ E +
Sbjct: 313 RMTITEFMN 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 41/221 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL------ENHLFRTGASYIQPLSWTIRM 182
Q+ HPN++ L +L+ E + G L + L A+ +
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------I 121
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSH 238
K L G+ YLH+ K+ + D K NI+L + KL DFGLA + G +
Sbjct: 122 KQILD---GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ GT + APE + L ++D++S GV+ +LSG
Sbjct: 177 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 51/234 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLT--- 123
+R +LG+GGFG VF G + +A+K + + + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---HRL------TDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 124 -EIKHLGQL----YHPNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRTGASYIQPLS 177
E+ L ++ HP +++L+ + + +LV E +P L +++ G
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-------- 134
Query: 178 WTIRMKVALGAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLA-- 228
+ + + HS V++RD K NIL+DL KL DFG
Sbjct: 135 ---PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 229 -KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGR 280
D P + GT Y+ PE+++ + V+S G++L +M+ G
Sbjct: 190 LHDEP------YTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 49/224 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-------LTEIKHL 128
LGEG +G V+K ID T +A+KR+ E E + E+ L
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEH-----EEEGVPGTAIREVSLL 87
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRTGASYIQPLSWTIRMKVA 185
+L H N+++L + L++E+ K ++ + +S +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN---------PDVSMRVIKSFL 138
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-----KLSDFGLAKD--GPTGSQSH 238
G+ + HS + ++RD K N+LL ++ + K+ DFGLA+ P +H
Sbjct: 139 YQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 239 VSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 280
++ T Y PE + + + T+ D++S + EML
Sbjct: 197 ---EII-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 62/225 (27%), Positives = 88/225 (39%), Gaps = 49/225 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWLTEIKH------ 127
V+G G FG V R T V A+K L++ + ++
Sbjct: 76 VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKF----EMIKRSDSAFFWEERD 121
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGAS------YIQPLSWT 179
+ P +V+L Y +DD L +V E+MP G L N + Y
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT------ 174
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+V L L +HS I+RD K N+LLD + + KL+DFG
Sbjct: 175 --AEVVLA----LDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 240 STRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGR 280
T V GT Y +PE + G+ + D +S GV L EML G
Sbjct: 227 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIR 181
Q+ H N++ L E+ + L+ E + G L + L A+
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-------- 120
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 237
+K L G+ YLH+ K+ + D K NI+L + KL DFGLA + G
Sbjct: 121 IKQILD---GVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ GT + APE + L ++D++S GV+ +LSG
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 43/222 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K GTG A K + + L E+ L
Sbjct: 12 ELGSGQFAIVRKC---RQK------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIR 181
++ HPN++ L E+ + L+ E + G L + L A+
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-------- 113
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 237
+K L G+ YLHS ++ + D K NI+L N KL DFG+A G++
Sbjct: 114 LKQILD---GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ GT + APE + L ++D++S GV+ +LSG
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 63/262 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
N+ ++G G +G V+ D++T +A+K++N+ E L L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179
I L +L +++L L+ D +V E S LF+T L+
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP----IFLT-E 128
Query: 180 IRMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA----KDG 231
+K L G ++H + +I+RD K +N LL+ + + K+ DFGLA +
Sbjct: 129 EHIKTILYNLL---LGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 232 PTGSQS---------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSF 269
T + HV TR Y APE + + T D++S
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWST 238
Query: 270 GVVLLEMLSGRRVIDKNRPSRE 291
G + E+L+ + + +R
Sbjct: 239 GCIFAELLNMLQSHINDPTNRF 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 49/241 (20%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE----- 113
+GL A + + + +GEG +G VFK D G +A+K R+
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKA-RDLKN-------GGRFVALKRVRVQTGEEGMP 55
Query: 114 --SLQGHLEWLTEIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMP---KGS 160
+++ E+ L L HPN+V+L + + +L LV+E +
Sbjct: 56 LSTIR-------EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 161 LENH-LFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219
L+ I+ + + + +GL +LHS + V++RD K NIL+ +
Sbjct: 109 LDKVPEPGVPTETIKDMMFQL--------LRGLDFLHSHR--VVHRDLKPQNILVTSSGQ 158
Query: 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
KL+DFGLA+ Q +++ V+ T Y APE + D++S G + EM
Sbjct: 159 IKLADFGLAR--IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
Query: 280 R 280
+
Sbjct: 216 K 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ P + +G G +G V+K D H+ G +A+K + + G +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 124 EIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQP 175
E+ L +L HPN+V+L+ + + ++ LV+E + + L +L + +
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
+ M+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+
Sbjct: 120 ETIKDLMRQFL---RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR--IYSY 172
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Q ++ V+ T Y APE + D++S G + EM +
Sbjct: 173 QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 43/222 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 18 ELGSGQFAVVKKC---REK------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLFRTGASYIQPLSWTIR 181
++ HPN++ L E+ + L+ E + G L + L A+
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-------- 119
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 237
+K L + YLHS + + + D K NI+L K+ DFGLA
Sbjct: 120 LKQILNG---VYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFG 171
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+ + GT + APE + L ++D++S GV+ +LSG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 23/208 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + T + K + + EI L H
Sbjct: 12 DLGRGEFGIVHRC---VET------SSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHR 61
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA 193
N++ L E L +++EF+ + + + + + + + L
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-VHQVC---EALQ 116
Query: 194 YLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 251
+LHS + + D + NI+ ++ K+ +FG A+ G + + Y A
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYA 171
Query: 252 PEYMATGHLTAKSDVYSFGVVLLEMLSG 279
PE ++ +D++S G ++ +LSG
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 75/357 (21%), Positives = 134/357 (37%), Gaps = 86/357 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
R + LG+G +G V+K ID T G V+AVK++ ++ E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 125 IKHLGQL-YHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
I L +L H N+V L+ D+ R LV+++M + + + R L +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA-----NILE-PVH 110
Query: 182 MKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 237
+ + K + YLHS +++RD K SNILL+ + K++DFGL++ +
Sbjct: 111 KQYVVYQLI---KVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 238 HVSTRVMGTYG-------------------YAAPEYM-ATGHLTAKSDVYSFGVVLLEML 277
+ + Y APE + + T D++S G +L E+L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 278 SGR-------------RVIDK-NRPSRE-----HNLIEWAKPYLQS--------KRRIFQ 310
G+ R+I + PS E + +AK ++S +
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQS--PFAKTMIESLKEKVEIRQSNKRD 283
Query: 311 VMDARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDEVVKA--LEQIQDTND 361
+ + A+ K L P R + ++ +K + + N+
Sbjct: 284 IFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 45/222 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
LG G F V + TG A K R Q+ E L EI L
Sbjct: 36 ELGRGKFAVVRQC---ISK------STGQEYAAKFLKKRRRGQDCRA---EILHEIAVLE 83
Query: 130 QLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSL--------ENHLFRTGASYIQPLSWTI 180
P ++ L +L+ E+ G + + +
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL------- 136
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 237
+K L G+ YLH + +++ D K NILL + K+ DFG+++ +
Sbjct: 137 -IKQILE---GVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 279
+MGT Y APE + +T +D+++ G++ +L+
Sbjct: 191 RE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 52/204 (25%), Positives = 74/204 (36%), Gaps = 48/204 (23%)
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231
Y L+ + + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRP-- 288
+ APE + T +SDV+SFGV+L E+ S G P
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYP 297
Query: 289 --SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCL 336
+ L+ R ++Q M + C
Sbjct: 298 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTM--------------------LDCW 333
Query: 337 SNEPKFRPTMDEVVKALE-QIQDT 359
EP RPT E+V+ L +Q
Sbjct: 334 HGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LG G FG V + + + T +AVK L + + H ++E+K L +
Sbjct: 27 GKPLGRGAFGQVIEADA----FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 132 -YHPNLVKLIGYCLEDDHRLLV-YEFMPKGSLENHL 165
+H N+V L+G C + L+V EF G+L +L
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 27/215 (12%), Positives = 59/215 (27%), Gaps = 50/215 (23%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK 126
+R G ++ D R +A+ ++ + + E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQAL-DTAL---DRQ-----VALTFVDPQGVLPDDVLQETLSRTL 83
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L ++ P + +++ L+V E++ GSL+ S ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQ 136
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
A H +A V S + + ++ + L+
Sbjct: 137 SLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
+ D+ G L +L R
Sbjct: 175 --TMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 66/305 (21%), Positives = 98/305 (32%), Gaps = 101/305 (33%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + + T A+K L E++ +
Sbjct: 25 VLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REVELHWRASQC 70
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRTG--------ASYIQPLSWTIR 181
P++V+++ L+V E + G L + + G AS I
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------- 122
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 238
MK A + YLHS + +RD K N+L N KL+DFG AK+
Sbjct: 123 MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------- 169
Query: 239 VSTRVMGT-YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
G Y + D++S GV++ +L G P +
Sbjct: 170 ----TTGEKYDKSC-------------DMWSLGVIMYILLCGY------PPF-------Y 199
Query: 298 AKPYLQSKRRIFQVMDARI-EGQY----------SLGAALKTAVLAIKCLSNEPKFRPTM 346
+ L + RI GQY S K L L EP R T+
Sbjct: 200 SNHGLAISPGMKT----RIRMGQYEFPNPEWSEVSEEV--KM--LIRNLLKTEPTQRMTI 251
Query: 347 DEVVK 351
E +
Sbjct: 252 TEFMN 256
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 51/230 (22%), Positives = 86/230 (37%), Gaps = 43/230 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLRD--EYRTY 59
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW-TIRMKVAL 186
L + + + E H +LV + + SLE L + S T+ M A
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLD---LCGRKFSVKTVAM-AAK 113
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQSH 238
+ +H ++YRD K N L+ + + DFG+ K D T H
Sbjct: 114 QMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QH 169
Query: 239 VSTR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
+ R + GT Y + + T HL + + D+ + G V + L G
Sbjct: 170 IPYREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 43/229 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+R +G G FG ++ G D G +A+K ++ L E K
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIA--------AGEEVAIKLECVKTKHPQLHI--ESKIY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ + + E D+ ++V E + SLE LF ++++ + L
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFN-----FCSRKFSLKTVLLLA 111
Query: 188 --AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHV 239
+ Y+HS I+RD K N L+ L + DFGLAK D T H+
Sbjct: 112 DQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHI 167
Query: 240 STR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
R + GT YA+ + T HL + + D+ S G VL+ G
Sbjct: 168 PYRENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 29/176 (16%), Positives = 59/176 (33%), Gaps = 22/176 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK------RLNQES-----LQ 116
R ++ S G +++ T ++K RL E
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGY-CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQP 175
L+ K L + +G+ +D +R LV + + SL+ ++
Sbjct: 101 KPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHVLS 157
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAK 229
++ VA L +LH + ++ + NI +D ++ L+ +G A
Sbjct: 158 ER-SVLQ-VACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
NFR +G G FG + G ++ Y T +A+K +S L E +
Sbjct: 10 NFRVGKKIGCGNFGELRLG---KNLY------TNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
QL + ++ + + +V E + SLE LF + +++++ + +
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFD-----LCDRTFSLKTVLMIA 111
Query: 188 --AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQS 237
+ Y+HS +IYRD K N L+ N + DF LAK D T
Sbjct: 112 IQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--K 167
Query: 238 HVSTR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
H+ R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 168 HIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
S++G+G FG V K + D +A+K + N+++ Q E++ L
Sbjct: 60 SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAFLNQA----QIEVRLLEL 106
Query: 131 L--YHP----NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ + +V L + + +H LV+E + +L + L T + +S + K
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN---FRGVSLNLTRKF 162
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
A L +L + + +I+ D K NILL K+ DFG + ++ +R
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 222
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
Y +PE + D++S G +L+EM +G
Sbjct: 223 F-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 40/229 (17%), Positives = 86/229 (37%), Gaps = 43/229 (18%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQL- 131
LG G F V+ D +A+K + + EIK L ++
Sbjct: 25 RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVYTEAA--EDEIKLLQRVN 73
Query: 132 ----------YHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLS 177
+++KL+ + H ++V+E + +L + + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIP 129
Query: 178 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL------NYNAKLSDFGLAKDG 231
+++ GL Y+H + +I+ D K N+L+++ K++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
+ + TR Y +PE + +D++S ++ E+++G
Sbjct: 189 DEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
FR +G G FG ++ G T +A+K N ++ L + E K
Sbjct: 8 KFRLGRKIGSGSFGEIYLGT---------NIQTNEEVAIKLENVKTKHPQLLY--ESKIY 56
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L + + + +E D+ +LV + + SLE LF + + LS + +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS---RKLSLKTVLMLADQ 111
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHVST 241
+ ++HS ++RD K N L+ L A + DFGLAK D T H+
Sbjct: 112 MINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPY 167
Query: 242 R----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
R + GT YA+ + T HL + + D+ S G VL+ L G
Sbjct: 168 RENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-08
Identities = 33/215 (15%), Positives = 51/215 (23%), Gaps = 50/215 (23%)
Query: 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYA--------PARPGTGMV 104
FS T + +GEG FG VF+ D A P
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-------------------- 144
+ + E + + L+ + + L
Sbjct: 65 KTFEEILPEII--ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 145 ----------EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAY 194
+DD +V EF G + + S + LA
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAV 176
Query: 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229
+ +RD N+LL KL K
Sbjct: 177 AE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 39/239 (16%), Positives = 85/239 (35%), Gaps = 41/239 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----L 122
++ +G+GGFGC++ ++ G+ VK ++ E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 123 TEIKHLGQLYHPNLVKLIG----------YCLEDDHRLLVYEFMPKGSLENHLFRTGASY 172
+ + + + +K +G +R ++ + L+
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANA--- 146
Query: 173 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAKD 230
+ S ++++L L Y+H + ++ D K SN+LL+ + L D+GLA
Sbjct: 147 -KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 231 -GPTGSQSHVSTR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 280
P G + GT + + + H + + D+ G +++ L+G
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 57/230 (24%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLG 129
V+G+G FG V K + D +A+K + N++ Q EI+ L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRFHRQA----AEEIRILE 148
Query: 130 QL--YHP----NLVKLIGYCLEDDHR--------LL---VYEFMPKGSLENHLFRTGASY 172
L N++ ++ R LL +YE + K
Sbjct: 149 HLRKQDKDNTMNVIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKF----------- 194
Query: 173 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA-KLSDFGLAKD 230
Q S + K A + L LH K ++I+ D K NILL + K+ DFG +
Sbjct: 195 -QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251
Query: 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280
+++ +R Y APE + D++S G +L E+L+G
Sbjct: 252 EHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 45/240 (18%), Positives = 82/240 (34%), Gaps = 46/240 (19%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------- 120
+ +G GGFG ++ + P VK QE+ E
Sbjct: 37 NQWVLGKKIGSGGFGLIYLA-FPTNK-----PEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 121 ----WLTEIKHLGQLYHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRTGASY 172
+ + QL + + G +R +V E + L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISGQNGTF 148
Query: 173 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAKD 230
S T+ + + L Y+H + ++ D K +N+LL + L+D+GL+
Sbjct: 149 --KKS-TVLQ-LGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
Query: 231 -GPTGSQSHVSTRV----MGTYGYAAPEYMA-TGHL----TAKSDVYSFGVVLLEMLSGR 280
P G+ GT E+ + H + +SDV G +L L G+
Sbjct: 203 YCPNGNHKQYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 35/185 (18%), Positives = 58/185 (31%), Gaps = 61/185 (32%)
Query: 147 DHRLLVYEFMPKG-SLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 205
H +V+E + G L + + S Q L K+ +GL YLH+ K ++I+
Sbjct: 118 THICMVFEVL--GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHT 171
Query: 206 DFKTSNILLDLN------------------------------------------------ 217
D K NILL +N
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231
Query: 218 -YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 276
K++D G A + TR Y + E + +D++S + E+
Sbjct: 232 KLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFEL 286
Query: 277 LSGRR 281
+G
Sbjct: 287 ATGDY 291
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 44/294 (14%), Positives = 81/294 (27%), Gaps = 111/294 (37%)
Query: 51 LGSNIKSFSFNGLKTA-TRN-------FRPDS-----VLGEGGFGCVFKGWIDEHTYAPA 97
L + I+S S N L+ A R F P + +L + W D
Sbjct: 355 LTTIIES-SLNVLEPAEYRKMFDRLSVFPPSAHIPTILL------SLI--WFDVIKSDV- 404
Query: 98 RPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNLV----KLI 140
MV+ K L++ SL +LE ++++ L H ++V
Sbjct: 405 -----MVVVNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPK 457
Query: 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKA 200
+ +D + L+ + + S+I + H
Sbjct: 458 TFDSDD---------LIPPYLDQYFY----SHI-------------------GH-HLKNI 484
Query: 201 KVIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH 259
+ R + LD + K+ A + + + + Y +
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ--LKFYK---------PY 533
Query: 260 LTAKSDVYSFGVVLLEMLSGRRVID--KNRPSREHNLIEWAKPYLQSKRRIFQV 311
+ Y R V P E NLI Y + ++
Sbjct: 534 ICDNDPKYE-----------RLVNAILDFLPKIEENLIC--SKYT----DLLRI 570
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 47/240 (19%), Positives = 74/240 (30%), Gaps = 63/240 (26%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
LGEG FG V + D +A+K + N EI L +
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKYREAA----RLEINVLKK 72
Query: 131 L--YHP----NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ V + + H + +E + K + L QP +
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENN---FQPYPLPHVRHM 128
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-------------------KLSDF 225
A L +LH + ++ + D K NIL + +++DF
Sbjct: 129 AYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 279
G A + V+TR Y PE + DV+S G +L E G
Sbjct: 187 GSATFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 58/254 (22%), Positives = 86/254 (33%), Gaps = 91/254 (35%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
LGEG FG V + D G +AVK + N + +EI+ L
Sbjct: 20 DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRYCEAA----RSEIQVLEH 67
Query: 131 L--YHP----NLVKLIGYCLEDDHR--------LL---VYEFMPKGSLENHLFRTGASYI 173
L P V+++ + +H LL Y+F ++ + F
Sbjct: 68 LNTTDPNSTFRCVQMLEWF---EHHGHICIVFELLGLSTYDF-----IKENGFL------ 113
Query: 174 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA------------- 220
P K+A K + +LH K+ + D K NIL +
Sbjct: 114 -PFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 221 ------KLSDFGLAKDGPTGSQSH---VSTRVMGTYGYAAPE------YMATGHLTAKSD 265
K+ DFG A + H VSTR Y APE + + D
Sbjct: 171 LINPDIKVVDFGSATY---DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCD 216
Query: 266 VYSFGVVLLEMLSG 279
V+S G +L+E G
Sbjct: 217 VWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.55 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.41 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.54 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=440.81 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=214.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
..|++.+.||+|+||+||+|. +..+|+.||||++..........+.+|+.+|+.++|||||++++++.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEE---------ECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 569999999999999999994 44579999999998766555566889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.+|||||||+||+|.+++.+.. +++..+..++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~~------l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGF 216 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcC
Confidence 9999999999999999997643 899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..+......+.
T Consensus 217 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~----------- 283 (346)
T 4fih_A 217 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----------- 283 (346)
T ss_dssp CEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----------
T ss_pred ceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-----------
Confidence 98654322 23456789999999999999999999999999999999999999997654322111110
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ..........+.++.+||.+||+.||++|||+.|+++|=+.
T Consensus 284 --~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 284 --DNL--PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp --HSS--CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred --cCC--CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 000 00111223456788999999999999999999999998654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-59 Score=432.43 Aligned_cols=269 Identities=28% Similarity=0.417 Sum_probs=213.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||+||+|.+... .+..++..||||++.........+|.+|+.+|++|+|||||++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4678889999999999999987532 344578999999998776666678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGAS----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
.+|||||||++|+|.+++...... ...++++..++.|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence 999999999999999999765421 1246999999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHH
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 296 (401)
+.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||........ +.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~ 271 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID 271 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999999999986544443334455689999999999999999999999999999999999 8999976542111 11
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.+........+..++.++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 272 --------------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 --------------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0111111233445677899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=429.46 Aligned_cols=271 Identities=27% Similarity=0.406 Sum_probs=219.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||+||+|.+... ....++..||||++.........+|.+|+.+|++|+|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5688899999999999999976532 234568999999998776666678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcC--------CCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 148 HRLLVYEFMPKGSLENHLFRTG--------ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
..|||||||++|+|.+++.... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 9999999999999999997643 122356999999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+...... +.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~-- 241 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE-- 241 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH--
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--
Confidence 99999999986433332222334568999999999999999999999999999999998 8999976543211 11
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
. +........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 242 -----------~-i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 242 -----------C-ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -----------H-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----------H-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 0 11111123344567789999999999999999999999999999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=430.15 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=213.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|+++++||+|+||+||+| .+..+|+.||+|++.+... .....+.+|+.+|++|+||||+++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 46999999999999999999 4455799999999986543 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++.+|||||||+||+|.+++.+.+. +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEE
Confidence 99999999999999999999987653 999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+......
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~----------- 244 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA----------- 244 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 999987654444444566799999999999999999999999999999999999999997654211111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.+.... ..++...+.++.+||.+||+.||++|||++|++.+
T Consensus 245 -----~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 245 -----KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----HHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----HHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111111 12333456788999999999999999999997554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=434.99 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=207.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVK---------STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEE---------ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEE---------ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 689999999999999999994 445799999999976543 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++.+|||||||+||+|.+++..... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECST
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEccc
Confidence 9999999999999999999976543 34789999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+++..... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........
T Consensus 170 Gla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------------ 235 (350)
T 4b9d_A 170 GIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------------ 235 (350)
T ss_dssp TEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------------
T ss_pred ccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------------
Confidence 999865321 112345689999999999999999999999999999999999999997654311111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+..... ...+...+.++.+||.+||+.||++|||+.|+++|=+.
T Consensus 236 ----~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 236 ----KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp ----HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ----HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 1111111 12334556789999999999999999999999998543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=440.31 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=214.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
..|++.+.||+|+||.||+|. +..+|+.||||++..........+.+|+.+|+.|+|||||+++++|.+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEE---------ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 569999999999999999994 44579999999998766555566889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.+|||||||.||+|.+++.... +++..+..++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~~------l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCcc
Confidence 9999999999999999997643 899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
++...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..+......+.
T Consensus 294 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~----------- 360 (423)
T 4fie_A 294 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----------- 360 (423)
T ss_dssp CEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----------
T ss_pred ceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-----------
Confidence 98654322 23456789999999999999999999999999999999999999997654322111110
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.... .........+..+.+||.+||+.||++|||+.|+|+|=+.
T Consensus 361 --~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 361 --DNLP--PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp --HSCC--CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred --cCCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 0000 0111123456788999999999999999999999998654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=424.61 Aligned_cols=256 Identities=25% Similarity=0.257 Sum_probs=211.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+.|++.+.||+|+||+||+|+ +..+|+.||||++...... .+|+.+++.|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~---------~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMK---------DKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEE---------ECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 568888999999999999994 4457999999999765432 37999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceEEeecc
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFG 226 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg 226 (401)
.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ ||||||||+||||+.+| .+||+|||
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCT
T ss_pred EEEEEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCC
Confidence 9999999999999999998765 3999999999999999999999998 99999999999999887 69999999
Q ss_pred CCcCCCCCCCc---ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 227 LAKDGPTGSQS---HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 227 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
+++........ ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+...
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----- 271 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----- 271 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-----
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-----
Confidence 99865432211 1123467999999999999999999999999999999999999999876554332222110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
. ......+..++..+.+||.+||+.||.+|||+.|++++|......
T Consensus 272 -~---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 272 -P---------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -C---------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -C---------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0 000123345667889999999999999999999999999887554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=422.44 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=215.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++++.+.||+|+||+||+|.+... .+..+++.||||++..... ....+|.+|+.++++|+|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3467788999999999999987431 2344688999999976533 2346789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+..+||||||++|+|.++|..... .....+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC
Confidence 999999999999999999975432 11245899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 294 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 294 (401)
+++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+..... +
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986543333333445679999999999999999999999999999999998 899997654321 1
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
+. .+........+..++..+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 257 ~~--------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 VE--------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH--------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11 11111122334556778999999999999999999999999998864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=416.08 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=205.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+++++.+.||+|+||+||+|.+. ..||||+++.... .....|.+|+.++++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 467888999999999999999643 2489999875432 33567899999999999999999999876
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+ +.++||||||++|+|.+++.... .++++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 103 ~-~~~~iVmEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~D 175 (307)
T 3omv_A 103 K-DNLAIVTQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGD 175 (307)
T ss_dssp S-SSCEEEEECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECC
T ss_pred C-CeEEEEEEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEee
Confidence 5 56899999999999999997654 35999999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||+++..............+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.........+
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------ 249 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------ 249 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------
Confidence 999987554333334556789999999999964 35899999999999999999999999765432111000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.... ... ......+..++..+.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus 250 ~~~~-----~~~-p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 250 VGRG-----YAS-PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHTT-----CCC-CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HhcC-----CCC-CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0000 000 001122345667889999999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=414.68 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=202.2
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee--
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-- 145 (401)
|++.+.||+|+||+||+|.. ..++..||+|++..... .....+.+|+.++++|+|||||++++++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLD---------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEE---------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 46778899999999999954 45789999999976543 234568899999999999999999999875
Q ss_pred --CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEE
Q 015731 146 --DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKL 222 (401)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl 222 (401)
+..+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||+++.+|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEE
Confidence 356899999999999999998764 499999999999999999999998777999999999999974 799999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+...... +..
T Consensus 174 ~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~------ 240 (290)
T 3fpq_A 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR------ 240 (290)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH------
T ss_pred EeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH------
Confidence 999999864322 3456789999999999865 699999999999999999999999975432111 000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.+........++...+.++.+||.+||+.||++|||+.|+++|=+
T Consensus 241 -------~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 241 -------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -------HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000000001111223457889999999999999999999999854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=410.55 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=196.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||+||+| .+..+|+.||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLA---------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEE---------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 57999999999999999999 45567999999999765432 2456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++.+|+||||+ +|+|.+++.+.+ ++++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~D 155 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIAD 155 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEee
Confidence 999999999999 789999998764 4999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||+++...... .....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+........
T Consensus 156 FGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~---------- 222 (275)
T 3hyh_A 156 FGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK---------- 222 (275)
T ss_dssp SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred cCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH----------
Confidence 99998654322 3345789999999999988776 579999999999999999999997643211100
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+... ...++...+.++.+||.+||+.||++|||+.|+++|=|.
T Consensus 223 ------~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 223 ------NISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ------HHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ------HHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 11111 112233456788999999999999999999999998664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=420.22 Aligned_cols=281 Identities=26% Similarity=0.346 Sum_probs=226.5
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCC-Ccc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYH-PNL 136 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h-pni 136 (401)
....++...++|++.+.||+|+||+||+|.+... ....+++.||+|++...... ....+.+|+.+|.++.| |||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 3344556678899999999999999999976542 23446788999999765443 34568899999999965 999
Q ss_pred cceeeEEeeC-CeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 137 VKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 137 ~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
|+++++|.+. +.++||||||++|+|.++|...... ....+++..+..++.||+.||+|||+++ |||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiH 208 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIH 208 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eec
Confidence 9999998764 6789999999999999999764321 1245899999999999999999999998 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVI 283 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~ 283 (401)
|||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654444434455789999999999999999999999999999999998 89999
Q ss_pred CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.+....... ...+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+.+.+.
T Consensus 289 ~~~~~~~~~----------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 289 PGVKIDEEF----------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TTCCCSHHH----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHH----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 765432110 11111112223344567789999999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=415.69 Aligned_cols=254 Identities=27% Similarity=0.313 Sum_probs=205.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++++.||+|+||+||+|+.. ....+++.||+|++..... .....+.+|+.+|++++||||+++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKI------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEEC------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEc------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999643 2345789999999976543 223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DF 170 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDF 170 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEeccc
Confidence 999999999999999999998765 3999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+......
T Consensus 171 Gla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------------ 236 (304)
T 3ubd_A 171 GLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------------ 236 (304)
T ss_dssp EEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred ccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH------------
Confidence 9998643322 12345789999999999999999999999999999999999999997654321111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
.+... ...++...+.++.+||.+||+.||++||| ++|+++|=+
T Consensus 237 ----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 237 ----MILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp ----HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred ----HHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 11111 11233446778999999999999999998 578888744
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=399.69 Aligned_cols=275 Identities=25% Similarity=0.312 Sum_probs=201.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|.+.+.||+|+||+||+|.+. |+.||||++...... ......|+..+.+++||||+++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 56888999999999999999653 678999999765432 222345677778899999999999998754
Q ss_pred ----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC------CCCeEEeccCCCcEEEcCC
Q 015731 148 ----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 148 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~dlkp~Nil~~~~ 217 (401)
.+||||||+++|+|.+++.... +++..+.+++.|++.||+|||++ .++|+||||||+|||++.+
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~~------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCceEEEEEecCCCCCcHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 5799999999999999997653 89999999999999999999986 1239999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCc--ceeeecccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 218 YNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
+.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||+||.+||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999864332221 122346799999999998654 3677999999999999999999887654322
Q ss_pred ccchhHHhhhhhhhhcchh-hhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 290 REHNLIEWAKPYLQSKRRI-FQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
..... .+... ......+ ........+... .......+.+|+.+||+.||++|||+.||++.|+++.+.++.
T Consensus 225 ~~p~~-~~~~~-~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 225 QLPYY-DLVPS-DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCTTT-TTSCS-SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cccch-hcccc-cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 11000 00000 0000000 011111111111 234567888999999999999999999999999999876554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=399.30 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=191.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++++.||+|+||+||+|. +..+|+.||||++...... ....+.+|+.+|++|+|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEE---------ETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEE---------ECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 468999999999999999994 4457899999998765433 345688999999999999999999998765
Q ss_pred C------------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 147 D------------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 147 ~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
+ .+|+|||||.+|+|.+++..... ....++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl 151 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFF 151 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEE
Confidence 4 37999999999999999986543 233567778999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCc----------ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQS----------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 284 (401)
+.++.+||+|||+++........ ...+..+||+.|+|||++.+..|+.++|||||||++|||++ ||.
T Consensus 152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99999999999999865432211 11234679999999999999999999999999999999996 664
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS---LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.... ... .+... ....++ ...+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 229 ~~~~-----~~~----------~~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 229 TQME-----RVR----------TLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp SHHH-----HHH----------HHHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CccH-----HHH----------HHHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 3110 000 00000 011112 223456678999999999999999999999743
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=408.62 Aligned_cols=272 Identities=24% Similarity=0.305 Sum_probs=207.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+|+.|+|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~---------~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSAR---------RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 3579999999999999999994 445799999999976532 33456789999999999999999999876
Q ss_pred e------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 E------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
. .+.+||||||| +|+|.+++.... ++++..+..++.||+.||+|||++| ||||||||+|||++.++
T Consensus 124 ~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~ 195 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENC 195 (398)
T ss_dssp CSSCTTTCCCEEEEEECC-SEEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTC
T ss_pred cccccccCCEEEEEEeCC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCC
Confidence 4 36789999999 578999997654 4999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCC--CcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 219 NAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
.+||+|||+++...... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I 275 (398)
T 4b99_A 196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275 (398)
T ss_dssp CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999998653321 12234567899999999998765 5689999999999999999999999876544333322
Q ss_pred Hhhhhhhhh-------cchhhhhhhhh-hcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 296 EWAKPYLQS-------KRRIFQVMDAR-IEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 296 ~~~~~~~~~-------~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
......... ........... .....+ ...+.++.+||.+||+.||.+|||+.|+|+|=+.
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 111000000 00000000000 000011 1235678899999999999999999999998543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=392.91 Aligned_cols=272 Identities=24% Similarity=0.255 Sum_probs=203.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||+||+|+.. .+..+++.||+|.+.... ...++.+|+++|+.+ +||||+++++++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 44578999999999999999999654 233568899999886654 234577899999988 699999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-CceEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKL 222 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~kl 222 (401)
.+.+++|+||||++||+|.+++. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEE
Confidence 99999999999999999999983 2899999999999999999999998 9999999999999876 89999
Q ss_pred eeccCCcCCCCCCC--------------------------cceeeecccccCcccccccccC-CCCcccchhhHHHHHHH
Q 015731 223 SDFGLAKDGPTGSQ--------------------------SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLE 275 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ 275 (401)
+|||+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999975432211 0112345799999999998765 58999999999999999
Q ss_pred HHhCCCCCCCCCCCc-cchhHH----------hhhhhhh--------hcchhhhhhhhh------------------hcC
Q 015731 276 MLSGRRVIDKNRPSR-EHNLIE----------WAKPYLQ--------SKRRIFQVMDAR------------------IEG 318 (401)
Q Consensus 276 ll~g~~p~~~~~~~~-~~~~~~----------~~~~~~~--------~~~~~~~~~~~~------------------~~~ 318 (401)
|++|+.||....... ....+. +...... ............ ...
T Consensus 240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 999999996543211 111110 0000000 000000000000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 319 QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 319 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
......+.++.+||.+||+.||++|||++|+|+|=+
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 011224567889999999999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=415.61 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=213.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|. +..+|+.||+|++..........+.+|+.+|+.|+||||++++++|.+++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~---------~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 689999999999999999994 45579999999998776666667889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC--CceEEeec
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNAKLSDF 225 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~--~~~kl~Df 225 (401)
.+|||||||.||+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEEEEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeec
Confidence 9999999999999999996543 34899999999999999999999998 9999999999999754 89999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+.. .
T Consensus 302 G~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~------~- 371 (573)
T 3uto_A 302 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS------C- 371 (573)
T ss_dssp SSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT------T-
T ss_pred cceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh------C-
Confidence 9998764432 34567899999999999999999999999999999999999999976543221111100 0
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...+........+..+.+||.+||+.||.+|||+.|+|+|=|
T Consensus 372 -------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 372 -------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp -------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 000011111234667889999999999999999999999855
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=412.33 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=207.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HH---HHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HL---EWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~---~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|+++++||+|+||+||+|+ +..+|+.||+|++.+..... .. ....++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~---------~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 3679999999999999999994 45589999999997654321 11 223457778888999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
++|.+.+.+||||||+.||+|.+++.+.+. +++..+..++.||+.||+|||++| ||||||||+||||+.+|.+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~-----l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCE
Confidence 999999999999999999999999987753 999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||+|||+|+...... ....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+........+..
T Consensus 332 KL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~--- 404 (689)
T 3v5w_A 332 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--- 404 (689)
T ss_dssp EECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---
T ss_pred EecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---
Confidence 999999998654332 34568999999999996 4579999999999999999999999997543322111111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
.... ....++...+.++.+||.+||+.||.+|++ +.||++|-+
T Consensus 405 ----------~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 405 ----------MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp ----------HHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ----------hhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 0111 112334456778999999999999999998 799999844
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=372.16 Aligned_cols=282 Identities=41% Similarity=0.675 Sum_probs=236.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...++|++.+.||+|+||.||+|... +|..||+|++..........+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 45578999999999999999999532 47899999988776566677889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999876542 1245899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 261 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN- 261 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-
Confidence 9999764433333233445689999999999888999999999999999999999999988777766666666543322
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...+...++...........+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 22233344444555667788999999999999999999999999999999886543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=370.90 Aligned_cols=272 Identities=24% Similarity=0.363 Sum_probs=218.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|...... .....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 467999999999999999999764211 02334678899999976533 3345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+.+..|+||||+.+|+|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 999999999999999999999875421 1235899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986544332222334467889999999998899999999999999999999 99999765422111
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+........+..++..+.+|+.+||+.||.+|||+.|++++|+.+...
T Consensus 316 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 -----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -----------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111223445567889999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=359.56 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=212.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|. +..+|..||+|++..........+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEE---------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999994 4457899999999876666666788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++.... +++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECCCCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999997653 899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+......+.
T Consensus 162 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------- 229 (297)
T 3fxz_A 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---------- 229 (297)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------
T ss_pred CceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 9876543322 2345679999999999999999999999999999999999999997654321111000
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.........+...+..+.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 230 -----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp -----HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -----hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 00000111233456678899999999999999999999998554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=361.60 Aligned_cols=289 Identities=40% Similarity=0.726 Sum_probs=235.3
Q ss_pred CCccccchhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhcc
Q 015731 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL 131 (401)
Q Consensus 53 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l 131 (401)
.....++..++....++|++.+.||+|+||.||+|... +|..||+|++...... ....+.+|+.+++.+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 44567888999999999999999999999999999422 4788999999765432 223578999999999
Q ss_pred CCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC---CCCeEEeccC
Q 015731 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD---KAKVIYRDFK 208 (401)
Q Consensus 132 ~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~dlk 208 (401)
+||||+++++++.+.+..++||||+.+++|.+++..... ...++++..+..++.|++.||.|||++ + |+|||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlk 161 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVK 161 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCS
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCc
Confidence 999999999999999999999999999999999987643 224599999999999999999999998 7 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR- 287 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~- 287 (401)
|+||+++.++.++|+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 9999999999999999999986543322 23444569999999999988889999999999999999999999996321
Q ss_pred -CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 288 -PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 288 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.........|...... ........+...........+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1122233334332222 2233444555555667788899999999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=360.96 Aligned_cols=270 Identities=26% Similarity=0.380 Sum_probs=219.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.++||+|+||.||+|.. ..++..+|+|++..........+.+|+.++++++||||+++++++.+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~---------~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTH---------RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEE---------CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 5799999999999999999954 3468999999987666566677899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTT
T ss_pred eeEEEEEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeeccc
Confidence 9999999999999999998754 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcc------------eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 228 AKDGPTGSQSH------------VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 228 ~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 97643322111 112457999999999999999999999999999999999999998765432221110
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCcc
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRD 367 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~ 367 (401)
. ...... ...+..++..+.+++.+||+.||.+|||+.++++.|+.++.......+..
T Consensus 235 ~-----------~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~~ 291 (310)
T 3s95_A 235 N-----------VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291 (310)
T ss_dssp C-----------HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCCH
T ss_pred h-----------hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccCC
Confidence 0 001111 11223344578899999999999999999999999999987766555543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=363.63 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=210.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..+|++.+.||+|+||.||+|. +..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLAR---------HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3679999999999999999994 445789999999976543 33456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+++++|.+++..... +++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECS
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEee
Confidence 99999999999999999999987643 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+........
T Consensus 158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------- 224 (328)
T 3fe3_A 158 FGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE---------- 224 (328)
T ss_dssp TTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred ccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence 99997644332 23456799999999999887764 79999999999999999999997654211110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 225 ------~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 225 ------RVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp ------HHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred ------HHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 11111 1123334567888999999999999999999999986643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=359.89 Aligned_cols=273 Identities=26% Similarity=0.316 Sum_probs=211.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.++||+|+||.||+|... +..||+|++..... .......|+.++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 368999999999999999999643 67899999976543 233456799999999999999999999875
Q ss_pred C----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC----------CCCeEEeccCCCcE
Q 015731 147 D----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD----------KAKVIYRDFKTSNI 212 (401)
Q Consensus 147 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~ivH~dlkp~Ni 212 (401)
. .+++||||+++|+|.+++.... +++..++.++.||+.||.|||+. + |+||||||+||
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Ni 162 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNV 162 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhE
Confidence 4 4699999999999999997643 89999999999999999999998 7 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 287 (401)
+++.++.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999976544333223344679999999999976 345678899999999999999999998765
Q ss_pred CCccchhHHhhhhhhhhcchhhh-hhhhhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQ-VMDARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
............... ....... ......... .....+..+.+|+.+||+.||.+|||+.++++.|+++++..
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 243 DEYMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCCCTTHHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhccchhhhhccCC-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 433322221110000 0000001 111111111 12245677999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=356.22 Aligned_cols=268 Identities=28% Similarity=0.421 Sum_probs=206.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..+|++.+.||+|+||.||+|... |..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 467999999999999999999542 67899999876543 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||+++.+|+||||||+||+++.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 99999999999999999999976431 1248999999999999999999999766699999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~----------- 249 (309)
T 3p86_A 183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA----------- 249 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----------
T ss_pred CCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99997533221 12334679999999999999899999999999999999999999997654211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
...........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....++..
T Consensus 250 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 250 -----AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp -----HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred -----HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 00001111233445567889999999999999999999999999999776554443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.51 Aligned_cols=280 Identities=26% Similarity=0.345 Sum_probs=223.4
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcc
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNL 136 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni 136 (401)
....+....++|++.+.||+|+||.||+|.+... .+..+++.||+|++..... .....+.+|+.++.++ +||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 3444555668899999999999999999975431 2556789999999976543 2345688999999999 79999
Q ss_pred cceeeEEeeCC-eeEEEEEecCCCChHHHHhhcCCCC-------------------------------------------
Q 015731 137 VKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASY------------------------------------------- 172 (401)
Q Consensus 137 ~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~------------------------------------------- 172 (401)
+++++++.+.+ ..++||||+.+|+|.+++.......
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999988764 4899999999999999998654210
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCC
Q 015731 173 ------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234 (401)
Q Consensus 173 ------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 234 (401)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999865444
Q ss_pred CCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhh
Q 015731 235 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 313 (401)
Q Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (401)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....... .....
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~~~ 310 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----------------CRRLK 310 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----------------HHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----------------HHHHH
Confidence 43334455678999999999998999999999999999999998 99999765432111 01111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 314 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 314 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.......+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.+
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11112233345667889999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=357.75 Aligned_cols=251 Identities=28% Similarity=0.356 Sum_probs=209.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 5799999999999999999944 44789999999976532 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEee
Confidence 9999999999999999999998764 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----------- 215 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------- 215 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH-----------
Confidence 99998532221 12345689999999999998899999999999999999999999997543211100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.+... ...++...+..+.+||.+||+.||.+|| ++.++++|-+
T Consensus 216 -----~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 216 -----LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -----HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -----HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 01111 1123344567889999999999999999 9999999854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=363.58 Aligned_cols=256 Identities=25% Similarity=0.301 Sum_probs=208.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||.||+|. +..+|..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~---------~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEE---------ECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4679999999999999999994 4457899999999765432 235688999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 218 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-- 218 (401)
+++.+....++||||+.|++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCC
Confidence 99999999999999999999999997653 4999999999999999999999998 99999999999998776
Q ss_pred --ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 --NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 155 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp SCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred ccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 79999999998654432 2345679999999999988899999999999999999999999997653211111000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...... ... .....+..+.+||.+||..||.+|||+.++++|-+.
T Consensus 232 ------~~~~~~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 232 ------AVSYDF----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp ------TTCCCC----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred ------hcCCCC----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 000000 000 001235678899999999999999999999988553
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=354.92 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=213.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|++.+.||+|+||.||+|.+.. ....+..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3679999999999999999997642 223456799999976533 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCC
Confidence 999999999999999999997653 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|++......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------------ 263 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------------ 263 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------------
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH------------
Confidence 999865433221 12223456778999999988899999999999999999999 9999965432111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 264 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 264 -----ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1111111222334456678899999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.70 Aligned_cols=260 Identities=26% Similarity=0.287 Sum_probs=207.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEE---------CCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 36899999999999999999954 346899999998655432 23457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..|+||||+.+++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Df 149 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDF 149 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEe
Confidence 999999999999999999987653 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++................||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...|..
T Consensus 150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~----- 223 (323)
T 3tki_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----- 223 (323)
T ss_dssp TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT-----
T ss_pred eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc-----
Confidence 99976543332223345679999999999977665 77899999999999999999999765432111 111110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
...........+..+.+|+.+||+.||.+|||+.|+++|-+.-+
T Consensus 224 ---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 224 ---------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp ---------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 00000111234567789999999999999999999999977643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=352.67 Aligned_cols=279 Identities=26% Similarity=0.388 Sum_probs=214.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
.++|++.+.||+|+||.||+|.+.. .+..++..||+|++..........+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3679999999999999999997543 3556799999999987665556678899999999999999999999864
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEcc
Confidence 356899999999999999998764 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~ 233 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQ 233 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCC
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccc
Confidence 9999865433211 1223345778899999999999999999999999999999999988643110 0000000000
Q ss_pred ---hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 304 ---SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 304 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.................+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000111112222223344556778999999999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=363.45 Aligned_cols=271 Identities=25% Similarity=0.356 Sum_probs=214.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.+... .+..++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 36799999999999999999976532 2445788999999875432 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC---ce
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~---~~ 220 (401)
....++||||+.+|+|.+++...... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999876531 1234899999999999999999999998 99999999999998554 59
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~------- 296 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL------- 296 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 9999999874322111122334567899999999988999999999999999999998 99999765421111
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
..+........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+.+..
T Consensus 297 ----------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 297 ----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111111112223345667889999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=352.47 Aligned_cols=258 Identities=18% Similarity=0.209 Sum_probs=210.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|. +..++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~---------~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEE---------ECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999994 44578999999987543 3345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--CCceEEee
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSD 224 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~--~~~~kl~D 224 (401)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEE
Confidence 99999999999999999997654 34899999999999999999999998 999999999999987 78999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ...
T Consensus 148 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~ 218 (321)
T 1tki_A 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNA 218 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHT
T ss_pred CCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcC
Confidence 99998754332 344567999999999998888899999999999999999999999764321111100 000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
...... .. ....+..+.+|+.+||..||.+|||+.|+++|-+.-+
T Consensus 219 ~~~~~~----~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 219 EYTFDE----EA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CCCCCH----HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCCCCh----hh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 000000 00 0123567889999999999999999999999977543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.44 Aligned_cols=285 Identities=37% Similarity=0.621 Sum_probs=227.0
Q ss_pred ccccchhHHHHHhCCCCCC------CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc----chhHHHHHHH
Q 015731 55 IKSFSFNGLKTATRNFRPD------SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----LQGHLEWLTE 124 (401)
Q Consensus 55 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~e 124 (401)
...+++.++...+..|... +.||+|+||.||+|.. ++..+|+|++.... ......+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567788888888877766 8999999999999954 36789999886532 1234568899
Q ss_pred HHHHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 125 ~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
+.+++.++||||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.||+.||.|||+++ |+|
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H 156 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH--HIH 156 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC--eec
Confidence 9999999999999999999999999999999999999999975432 145899999999999999999999998 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 284 (401)
|||||+||+++.++.++|+|||++................|++.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986544333333344679999999999865 57899999999999999999999998
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..........+ ..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 236 EHREPQLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTBSSSBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cCcchHHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 76543322211 1111112222233333322 23466778899999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=363.82 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=211.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|.+. .++..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLR---------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEe---------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3467899999999999999999654 35889999998755322 2345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECc
Confidence 9999999999999999999998654 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~------------ 324 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT------------ 324 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH------------
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------
Confidence 999975432211111112235678999999988889999999999999999998 9999976432111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 325 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 325 -----REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 011111111223334567888999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=347.00 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=208.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||.||+|. +..++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAE---------DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEE---------ETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEE---------ECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 4689999999999999999994 344689999998854332 2345688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..|+||||+++++|.+++.... ++++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~ 153 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIF 153 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....... .....
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~ 226 (294)
T 4eqm_A 154 DFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQ 226 (294)
T ss_dssp CCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHS
T ss_pred eCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhh
Confidence 9999986543221 1233457999999999999989999999999999999999999999765421110 00000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhchhcCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDTND 361 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~eil~~L~~i~~~~~ 361 (401)
.. . ...........+..+.+++.+||+.||.+|| +++++.+.|+.+.....
T Consensus 227 ~~--~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 227 DS--V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SC--C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cc--C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 00 0 0000111223456788999999999999998 99999999988755443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=360.33 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=204.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
.++|++.++||+|+||.||+|.. ..+|+.||+|++..... .....+.+|..++..+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARV---------KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEE---------cCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 46899999999999999999954 44789999999976532 2334577899999988 79999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998764 3999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~--------- 234 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE--------- 234 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH---------
Confidence 9999998533221 23445689999999999988889999999999999999999999997654321111
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~eil~~L~ 354 (401)
.+... ...++...+..+.+||.+||+.||.+||++ .++++|-+
T Consensus 235 -------~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 235 -------AILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp -------HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred -------HHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 11111 112334456778899999999999999998 88988743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=360.64 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=211.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|.. ..+|..+|+|++..........+.+|+.+++.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVE---------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEE---------CCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 36799999999999999999944 447899999999876555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--CCceEEee
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSD 224 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~--~~~~kl~D 224 (401)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~D 194 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIID 194 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEe
Confidence 99999999999999999997653 34899999999999999999999998 999999999999974 57799999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+ ...
T Consensus 195 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~~~ 265 (387)
T 1kob_A 195 FGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC 265 (387)
T ss_dssp CTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC
T ss_pred cccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC
Confidence 99998754332 234457999999999999888999999999999999999999999765321111000 000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
............+..+.+||.+||+.||.+|||+.++++|-+.-
T Consensus 266 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 266 --------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp --------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred --------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 00011112224566888999999999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.64 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=207.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
.++|++.++||+|+||+||+|.. ..+++.||+|++....... ...+..|..++.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~---------~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRL---------KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 36799999999999999999954 4478999999998754322 23467899999887 89999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL 194 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKL 194 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEE
Confidence 999999999999999999999998764 3999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc--hhHHhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH--NLIEWAKP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~ 300 (401)
+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 195 ~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~-- 270 (396)
T 4dc2_A 195 TDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-- 270 (396)
T ss_dssp CCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH--
T ss_pred eecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH--
Confidence 999999853222 12345578999999999999999999999999999999999999999654321110 000000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKALE 354 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~eil~~L~ 354 (401)
...+... ...++...+..+.+||.+||+.||.+||++ .|+++|-+
T Consensus 271 -------~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 271 -------FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp -------HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred -------HHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 0111111 122344566788999999999999999985 78888743
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=364.40 Aligned_cols=256 Identities=23% Similarity=0.256 Sum_probs=208.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|. +..+|..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~---------~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCV---------KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEE---------ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEE---------ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999994 445789999999876543 2345688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc---CCCce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~---~~~~~ 220 (401)
.+++..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCE
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcE
Confidence 99999999999999999999998764 3899999999999999999999998 99999999999997 56889
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+
T Consensus 153 kL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i----- 225 (444)
T 3soa_A 153 KLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI----- 225 (444)
T ss_dssp EECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----
T ss_pred EEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----
Confidence 999999997654332 1234567999999999998889999999999999999999999999764321111111
Q ss_pred hhhhcchhhhhhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 301 YLQSKRRIFQVMDARI--EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..... ........+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 226 -----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 226 -----------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp -----------HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred -----------HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 01000 011112346678899999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=359.43 Aligned_cols=258 Identities=23% Similarity=0.263 Sum_probs=197.1
Q ss_pred CCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc-cCCCcccceeeEEee
Q 015731 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~hpni~~~~~~~~~ 145 (401)
++|.+. ++||+|+||+||+|.. ..+|..||+|++... ..+.+|+.++.+ ++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~---------~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEE---------CCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 567766 7899999999999954 447899999998643 245678887744 589999999999875
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CC
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 218 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~ 218 (401)
...+|+||||+.||+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCc
Confidence 5678999999999999999986542 45899999999999999999999988 999999999999987 78
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-- 276 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 276 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH--
T ss_pred cEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH--
Confidence 99999999998643322 2345678999999999988999999999999999999999999997654432211000
Q ss_pred hhhhhhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 299 KPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+.... .........+..+.+||.+||+.||.+|||+.++++|-+..+..
T Consensus 277 ----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 277 ----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ----------HHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ----------HHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0000000 00011123466788999999999999999999999998876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.95 Aligned_cols=270 Identities=27% Similarity=0.372 Sum_probs=218.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|.+.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 46799999999999999999976431 2234678999999976533 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGAS-------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 206 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 206 (401)
.+..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccc
Confidence 99999999999999999999875421 1134899999999999999999999998 99999
Q ss_pred cCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 015731 207 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK 285 (401)
Q Consensus 207 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 285 (401)
|||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986544332222334467888999999988889999999999999999999 9999976
Q ss_pred CCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........ .+........+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 256 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 256 IPPERLFN-----------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCGGGHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHHH-----------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 54322111 1111111223344567889999999999999999999999999988653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=340.85 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=211.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... ++..||+|++..... ...++.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467999999999999999999654 356799999976543 345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg 149 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFG 149 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTT
T ss_pred CceEEEEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCc
Confidence 99999999999999999998764 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------- 217 (268)
T 3sxs_A 150 MTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------- 217 (268)
T ss_dssp CEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----------
T ss_pred cceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-----------
Confidence 9986543321 12233456778999999988889999999999999999999 9999975432111100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.+
T Consensus 218 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 218 ------VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ------HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ------HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0011111122334567889999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=356.57 Aligned_cols=277 Identities=25% Similarity=0.350 Sum_probs=222.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|.+.+.||+|+||.||+|...... ......+..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 468999999999999999999764311 01234567899999976543 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+++..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEE
Confidence 999999999999999999999876421 1245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986544333233344567889999999999999999999999999999999 9999976532111
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
...+........+..++..+.+|+.+||+.||.+|||+.+++++|+.+........
T Consensus 303 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 303 ----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp ----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred ----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 11111111222334456788999999999999999999999999999976654433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=355.15 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=208.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|. +..++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLAT---------HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 679999999999999999994 4457899999998765322 2346789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECC
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEE
Confidence 999999999999 789999997764 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.
T Consensus 152 FG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~------- 221 (336)
T 3h4j_B 152 FGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN------- 221 (336)
T ss_dssp SSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-------
T ss_pred eccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------
Confidence 99998654332 2344679999999999987776 689999999999999999999997654322211110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
......+...+..+.+|+.+||+.||.+|||+.|+++|-+.-
T Consensus 222 -----------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 222 -----------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp -----------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred -----------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 001122333566788999999999999999999999997764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=356.96 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=208.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~---------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQK---------NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5799999999999999999954 44789999999876542 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999999999998754 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 159 FG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--- 232 (384)
T 4fr4_A 159 FNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--- 232 (384)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---
T ss_pred cceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---
Confidence 99998654332 3445689999999999863 45899999999999999999999999765433222211110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKAL 353 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~eil~~L 353 (401)
. .....++...+..+.+||.+||+.||.+||+ +.++++|-
T Consensus 233 ----------~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 233 ----------E--TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp ----------H--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred ----------h--hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 0 0112234445678899999999999999998 88887753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.89 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=208.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVH---------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 346799999999999999999944 44789999999976543 2345688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC---Cce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~---~~~ 220 (401)
.+.+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCE
Confidence 99999999999999999999997654 4899999999999999999999998 9999999999999765 459
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 171 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----- 242 (362)
T 2bdw_A 171 KLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI----- 242 (362)
T ss_dssp EECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred EEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----
Confidence 999999998654332 233467999999999998889999999999999999999999999764321111000
Q ss_pred hhhhcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 301 YLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...... .......+..+.+||.+||+.||.+|||+.++++|-+..
T Consensus 243 -----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 243 -----------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp -----------HHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred -----------HhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 000000 000123456788999999999999999999999996643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=353.54 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=207.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35699999999999999999944 447899999998765432 245688999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 218 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-- 218 (401)
+++.+....++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCC
Confidence 99999999999999999999999997653 4899999999999999999999998 99999999999998877
Q ss_pred --ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 --NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230 (326)
T ss_dssp SCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 79999999998654322 2334579999999999988899999999999999999999999997643211110000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..... .........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 231 ------~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 231 ------AVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp ------HTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ------hcCCC--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 00000 0000001234678899999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.47 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|... ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hhceeeheecCCCccEEEEEEec----------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 67999999999999999999654 356799999976543 3456889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred ceEEEEEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccc
Confidence 9999999999999999997654 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
+....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-------------- 217 (269)
T 4hcu_A 153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------------- 217 (269)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------------
T ss_pred cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH--------------
Confidence 97543221 111223456778999999998899999999999999999999 99999764321110
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...........+...+..+.+++.+||+.||.+|||+.+++++|+++.+.
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 218 ---EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00111111222333466788999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=348.38 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=208.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|..+++.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 5799999999999999999954 44789999999976532 23455778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+....|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEee
Confidence 9999999999999999999998754 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 150 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------ 212 (318)
T 1fot_A 150 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------ 212 (318)
T ss_dssp CSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------
T ss_pred cCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------------
Confidence 999986432 123467999999999999889999999999999999999999999764321110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
..+.... ..++...+..+.+|+.+||+.||.+|| ++.++++|-+
T Consensus 213 ----~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 213 ----EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp ----HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ----HHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 1111111 123344567889999999999999999 9999998844
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=354.97 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=199.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|. +..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMR---------DKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEE---------ETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcEEEEEEeccCCCEEEEEEE---------ECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 679999999999999999994 445789999999876443 2346779999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc--eEEeec
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDF 225 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Df 225 (401)
..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++. +||+||
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeec
Confidence 9999999999999999997764 3899999999999999999999998 999999999999987665 999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAK-SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...... ......||+.|+|||++.+..+..+ +|||||||++|+|++|..||...........+.
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~-------- 231 (361)
T 3uc3_A 163 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI-------- 231 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH--------
T ss_pred CccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH--------
Confidence 9987432221 2334579999999999988777655 899999999999999999997654432211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+.............+..+.+||.+||+.||.+|||+.++++|-+..+.
T Consensus 232 ----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 232 ----QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 11111111111112345678899999999999999999999999776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=346.96 Aligned_cols=273 Identities=27% Similarity=0.361 Sum_probs=220.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|.+... .+..++..||+|++..... .....+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 346899999999999999999975321 3455789999999976543 3345688999999999 999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCC
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS-------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 210 (401)
.+.+..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccc
Confidence 9999999999999999999999876421 1235899999999999999999999998 999999999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPS 289 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 289 (401)
||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443333444567889999999988899999999999999999999 99999765432
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
... ............+...+..+.+|+.+||+.||.+|||+.+++++|+++....
T Consensus 255 ~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SKF----------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHH----------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHH----------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111 1111111112223345678899999999999999999999999999886653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=349.78 Aligned_cols=280 Identities=24% Similarity=0.349 Sum_probs=199.0
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|..... ......||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 346899999999999999999965431 1122489999997653 23456788999999999999999999999
Q ss_pred eeCCee------EEEEEecCCCChHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 144 LEDDHR------LLVYEFMPKGSLENHLFRTGAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 144 ~~~~~~------~lv~e~~~~~~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
.+.... ++||||+.+++|.+++...... ....+++..++.++.||+.||.|||++| |+||||||+||+++.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcC
Confidence 877655 9999999999999999755321 1125899999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 295 (401)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999999986544333323334557888999999999999999999999999999999 99999765432211110
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCccccc
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESL 370 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~~~~ 370 (401)
........+...+..+.+|+.+||+.||.+|||+.++++.|+++..............
T Consensus 253 -----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 253 -----------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp -----------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred -----------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 0111112233455688999999999999999999999999999977665555544443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=344.97 Aligned_cols=271 Identities=23% Similarity=0.294 Sum_probs=212.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.++||+|+||.||+|... .+|+.||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 367999999999999999999543 4688999999986543 234567799999999999999999999887
Q ss_pred CC--eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE----cCCCc
Q 015731 146 DD--HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYN 219 (401)
Q Consensus 146 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~----~~~~~ 219 (401)
.. ..++||||+.+++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCce
Confidence 65 789999999999999999875421 23899999999999999999999998 9999999999999 77888
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+||+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 155 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 9999999998654432 233457999999999985 46789999999999999999999999975443222
Q ss_pred chhHHhhhhhhhh-cc----hhhhhh--------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 292 HNLIEWAKPYLQS-KR----RIFQVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 292 ~~~~~~~~~~~~~-~~----~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...+.. ..... .. ...... .......+....+..+.+|+.+||+.||++|||+.|+++|...
T Consensus 232 ~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 232 NKEVMY--KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CHHHHH--HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hHHHHH--HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 111110 00000 00 000000 0011224456788899999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=355.32 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=203.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|.+.+.||+|+||.||+|.... ...++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3579999999999999999996541 224578899999976532 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcC
Confidence 999999999999999999997654 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~------------ 259 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV------------ 259 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH------------
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------------
Confidence 9998654322111 1122345778999999998999999999999999999998 9999965432111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+........+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 260 -----~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 260 -----IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 111111122223345567889999999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=348.87 Aligned_cols=275 Identities=19% Similarity=0.166 Sum_probs=217.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++..... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKN---------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEE---------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEE---------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 36799999999999999999953 44789999999865532 23467899999999 99999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-----e
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----A 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~-----~ 220 (401)
++..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~ 149 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVI 149 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceE
Confidence 99999999999 999999998753 35999999999999999999999998 999999999999998887 9
Q ss_pred EEeeccCCcCCCCCCCcc-----eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 221 KLSDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+|+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 999999998643322111 124567999999999999999999999999999999999999999876543322222
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCccccc
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESL 370 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~~~~ 370 (401)
...... . ........ ....+ .+.+++.+||+.||.+||++.+|++.|+.+............++
T Consensus 230 ~~i~~~---~---~~~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 230 QKIGDT---K---RATPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp HHHHHH---H---HHSCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred HHHHhh---h---ccCCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 111000 0 00000000 00123 78899999999999999999999999999988776655544333
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=352.71 Aligned_cols=273 Identities=25% Similarity=0.367 Sum_probs=216.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++++ .||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3457899999999999999999975321 2345688999999976432 3345688999999999 89999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGAS------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
+.+.+..++||||+++++|.+++...... ....+++..++.++.||+.||.|||++| |+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 99999999999999999999999865421 0134789999999999999999999998 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVI 283 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~ 283 (401)
|||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986544333333444567889999999988899999999999999999998 99999
Q ss_pred CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
......... ...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 276 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDANF----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 765432110 111111112223344567889999999999999999999999999988554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=351.13 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=205.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|.+... .......||+|.+..... .....+.+|+.++++++||||+++++++.++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 5799999999999999999975431 111234578888865432 3445788999999999999999999999876
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
. .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred C-eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCc
Confidence 5 788999999999999998754 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------------- 229 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------- 229 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------------
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------------
Confidence 9986544333333344567889999999999999999999999999999999 99999765432211
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 230 ----SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ----HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111222334456688899999999999999999999999998854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=355.83 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=207.9
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCccccee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
...++|++.++||+|+||.||+|.. ..+|+.||+|++..... .....+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEF---------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 3457899999999999999999954 44789999999976532 2334567888998876 899999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+++.+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCE
Confidence 99999999999999999999999998764 3899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 158 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------- 228 (345)
T 1xjd_A 158 KIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------- 228 (345)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred EEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH-------
Confidence 999999998543222 12445689999999999998899999999999999999999999997654211110
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKAL 353 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-eil~~L 353 (401)
.+... ...++...+..+.+||.+||+.||.+||++. ++++|-
T Consensus 229 ---------~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 229 ---------SIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp ---------HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred ---------HHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 00000 1123334567889999999999999999998 888764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=347.13 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=208.4
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCee
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~ 149 (401)
|...+.||+|+||.||+|... .+|+.||||++..........+.+|+.+++.++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 667789999999999999543 46899999999776555566788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 150 LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||||+.+++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 118 ~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 9999999999999998653 3899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 230 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .... .
T Consensus 190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~~----------~ 254 (321)
T 2c30_A 190 QISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRL----------R 254 (321)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----------H
T ss_pred ecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----------h
Confidence 6543221 23456799999999999888899999999999999999999999976432111 1000 0
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..... ........+..+.+|+.+||+.||.+|||+.++++|-+..+
T Consensus 255 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 255 DSPPP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HSSCC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred cCCCC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 00000 00111234567889999999999999999999999877653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=352.78 Aligned_cols=274 Identities=26% Similarity=0.357 Sum_probs=215.7
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||.||+|..... ....++..||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3457899999999999999999976531 12245789999999865432 345688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASY-------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
.+++..++||||+.+++|.+++....... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999998743211 145899999999999999999999998 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVI 283 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~ 283 (401)
|||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999875432222222334568899999999988899999999999999999999 99999
Q ss_pred CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
........ .. .+... .....+..++..+.+|+.+||+.||.+|||+.+++++|+++.+...
T Consensus 278 ~~~~~~~~---~~-------------~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEV---IY-------------YVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHH---HH-------------HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHH---HH-------------HHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 75432110 00 00000 1112233456688999999999999999999999999999866443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=363.48 Aligned_cols=259 Identities=23% Similarity=0.262 Sum_probs=209.6
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccce
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~ 139 (401)
+....++|++.++||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~---------~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 134 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRH---------KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEE---------CCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 334567899999999999999999954 447899999998764321 22346789999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
++++.+....|+||||++||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCC
Confidence 999999999999999999999999997643 899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+||+|||++....... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 207 ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-- 283 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-- 283 (410)
T ss_dssp EEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--
T ss_pred EEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--
Confidence 9999999997654322 11234568999999999997654 7899999999999999999999997654321111
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 355 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~~ 355 (401)
.++.......++ ...+..+.+||.+||..+|.+ ||++.||++|-+.
T Consensus 284 --------------~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 284 --------------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp --------------HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred --------------HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 111111111111 235678889999999999988 9999999999654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=354.29 Aligned_cols=260 Identities=24% Similarity=0.278 Sum_probs=206.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----hHHHHHHHHHHHhccCCCcccceee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~hpni~~~~~ 141 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++...... ....+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCIN---------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35799999999999999999944 447899999998754321 3456889999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc--
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 219 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~-- 219 (401)
++.+++..|+||||+.+++|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCC
Confidence 999999999999999999999888654311 134899999999999999999999998 999999999999976554
Q ss_pred -eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ....
T Consensus 171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-- 242 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE-- 242 (351)
T ss_dssp CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH--
T ss_pred cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH--
Confidence 9999999998654322 123446799999999999888899999999999999999999999976321 0000
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
......... .... ....+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 243 -~i~~~~~~~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 243 -GIIKGKYKM----NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp -HHHHTCCCC----CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -HHHcCCCCC----Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 000000000 0000 01235678899999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=353.85 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=193.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+|+.++++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 3467999999999999999999543 468899999987653 33457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~~~kl 222 (401)
.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl 192 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKI 192 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEE
Confidence 999999999999999999997654 3899999999999999999999998 999999999999975 889999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 193 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~------- 260 (349)
T 2w4o_A 193 ADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF------- 260 (349)
T ss_dssp CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH-------
T ss_pred ccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH-------
Confidence 9999998643321 23446799999999999988899999999999999999999999965432110 00
Q ss_pred hhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 303 QSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 303 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..+.... .........+..+.+||.+||+.||++|||+.++++|-+.
T Consensus 261 ------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 261 ------RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp ------HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ------HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0011100 0011122346678899999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=342.26 Aligned_cols=275 Identities=17% Similarity=0.164 Sum_probs=217.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++..... ...+.+|+.+++.+ +|+|++++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 46799999999999999999953 34689999998865432 23467899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-----e
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----A 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~-----~ 220 (401)
....++||||+ +++|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+||+++.++. +
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~ 150 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMI 150 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeE
Confidence 99999999999 999999998754 34899999999999999999999988 999999999999987766 9
Q ss_pred EEeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 221 KLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 99999999865433221 1234567999999999999889999999999999999999999999876543332222
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCcccc
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDES 369 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~~~ 369 (401)
....... ....... .....+..+.+|+.+||+.||.+|||+.+|++.|+++.+..........+
T Consensus 231 ~~~~~~~------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 294 (298)
T 1csn_A 231 ERIGEKK------QSTPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 294 (298)
T ss_dssp HHHHHHH------HHSCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred HHHHhhc------cCccHHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence 1111000 0000000 01123567889999999999999999999999999998776655444333
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=365.88 Aligned_cols=271 Identities=21% Similarity=0.253 Sum_probs=187.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||+||+|.. ..+|..||||++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYD---------KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEE---------CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEE---------CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 36899999999999999999944 4478999999986542 233456889999999999999999999985
Q ss_pred eC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 ED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.. ..+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~ 194 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCS 194 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCC
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCC
Confidence 43 5789999998 679999997653 4999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCc-------------------------ceeeecccccCccccccc-ccCCCCcccchhhHHHHH
Q 015731 220 AKLSDFGLAKDGPTGSQS-------------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVL 273 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il 273 (401)
+||+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++
T Consensus 195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il 274 (458)
T 3rp9_A 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274 (458)
T ss_dssp EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence 999999999865322110 123456789999999976 566799999999999999
Q ss_pred HHHHh-----------CCCCCCCCCCCccchh-----------------HHhhhhhhhhc--ch--------hhhhhh--
Q 015731 274 LEMLS-----------GRRVIDKNRPSREHNL-----------------IEWAKPYLQSK--RR--------IFQVMD-- 313 (401)
Q Consensus 274 ~~ll~-----------g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~--~~--------~~~~~~-- 313 (401)
|||++ |.++|.+......... +......+... .. ......
T Consensus 275 ~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 354 (458)
T 3rp9_A 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354 (458)
T ss_dssp HHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS
T ss_pred HHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc
Confidence 99999 6667755432110000 00000000000 00 000000
Q ss_pred -hhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 314 -ARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 314 -~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.... .......+..+.+||.+||..||.+|||+.|+|+|-+
T Consensus 355 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 355 PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp CCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 0000 0001223678889999999999999999999999954
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=351.42 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=209.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 6799999999999999999954 44789999999976543 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+....|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcc
Confidence 9999999999999999999998764 3899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------ 247 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------------ 247 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH------------
Confidence 9999864332 23457999999999999889999999999999999999999999764321110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~~ 355 (401)
..+.... ..++...+..+.+||.+||+.||.+||+ +.+|++|-+.
T Consensus 248 ----~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 248 ----EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ----HHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ----HHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 0111111 1233345678899999999999999998 9999998553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=342.27 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=208.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... ++..||+|++...... ..++.+|+.++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 367999999999999999999654 3667999999865433 35688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred CCeEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccc
Confidence 99999999999999999997643 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------------ 232 (283)
T 3gen_A 166 LSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------------ 232 (283)
T ss_dssp GGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------------
T ss_pred ccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------------
Confidence 997543221 111223346778999999998899999999999999999998 999997644211110
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+.+
T Consensus 233 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 233 -----HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 01111112223334567889999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=353.24 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=200.0
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~lv 152 (401)
.+.||+|+||.||+|.. ..+|..||+|++..........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~---------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEE---------TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEE---------cCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999954 346899999999877656667788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE--cCCCceEEeeccCCcC
Q 015731 153 YEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKD 230 (401)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 230 (401)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 165 ~E~~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EECCTTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EeCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999999999987653 34899999999999999999999998 9999999999999 5678999999999986
Q ss_pred CCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh
Q 015731 231 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310 (401)
Q Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (401)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+ ......
T Consensus 239 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~~~--- 306 (373)
T 2x4f_A 239 YKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LACRWD--- 306 (373)
T ss_dssp CCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCC---
T ss_pred cCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccCC---
Confidence 54332 223456999999999998888999999999999999999999999765432111100 000000
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.........+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 307 -----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 307 -----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp -----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 0000011345678899999999999999999999997553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=350.32 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=207.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
++|++.+.||+|+||.||+|.. ..+++.||+|++...... ....+.+|..++.++ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRL---------KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 5799999999999999999954 447899999999865432 234577899999887 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc--hhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH--NLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~ 301 (401)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--- 227 (345)
T 3a8x_A 153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--- 227 (345)
T ss_dssp CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH---
T ss_pred eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH---
Confidence 999998532221 1244568999999999999989999999999999999999999999653221110 000000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~------~eil~~L~ 354 (401)
...+... ...++...+..+.+||.+||+.||.+||++ .++++|-+
T Consensus 228 ------~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 228 ------FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp ------HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred ------HHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 0011111 112344556788999999999999999995 78888844
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=345.05 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=198.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--------------------------hHHHH
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------------------------GHLEW 121 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--------------------------~~~~~ 121 (401)
++|++.+.||+|+||.||+|.. ..++..||+|++...... ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYN---------ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEE---------TTTTEEEEEEEEECC-------------------------------CHH
T ss_pred cceEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 6799999999999999999954 446899999998754321 12357
Q ss_pred HHHHHHHhccCCCcccceeeEEee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC
Q 015731 122 LTEIKHLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK 199 (401)
Q Consensus 122 ~~e~~~l~~l~hpni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 199 (401)
.+|+.++++++||||+++++++.+ ....++||||+.+++|.+++.. .++++..+..++.||+.||.|||+++
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 899999999999999999999986 5789999999999999886533 34899999999999999999999998
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCC---CCcccchhhHHHHHHHH
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEM 276 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l 276 (401)
|+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 158 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 158 --IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred --eeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 9999999999999999999999999998654322 1234567999999999997654 37789999999999999
Q ss_pred HhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 277 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 277 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
++|..||....... ... .+.............+..+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 234 ~~g~~pf~~~~~~~------~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 234 VFGQCPFMDERIMC------LHS----------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHSSCSSCCSSHHH------HHH----------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHCCCCCCCccHHH------HHH----------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 99999997543211 000 000111111111234567889999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.00 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=210.5
Q ss_pred HHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHHHHHHHHHhccCCCcccc
Q 015731 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~hpni~~ 138 (401)
.+....++|++.++||+|+||+||+|... .+++.||+|++....... ...+.+|..++..++||||++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34445688999999999999999999544 468999999997643322 223778999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
+++++.+.+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCC
Confidence 9999999999999999999999999998743 34999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.+||+|||+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|..||..........
T Consensus 213 ~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp CEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 99999999997654322 22234468999999999986 4578999999999999999999999997654322111
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCC---HHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYS---LGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 355 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~--Rps~~eil~~L~~ 355 (401)
.+ +.......++ ...+..+.+||.+||..+|++ ||+++|+++|-+.
T Consensus 292 ~i----------------~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 292 KI----------------MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HH----------------HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred hh----------------hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 11 1110001111 225678889999999988888 9999999998543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=351.47 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=208.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCcccceee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~~ 141 (401)
...+|++.++||+|+||.||+|.. ..+|+.||+|++..... .....+..|..++..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSER---------KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEE---------TTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 347899999999999999999954 44689999999976532 2344577899999888 7999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
++.+.+..|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vk 161 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIK 161 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEE
Confidence 9999999999999999999999998764 3899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 162 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~--------- 230 (353)
T 2i0e_A 162 IADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--------- 230 (353)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------
T ss_pred EEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH---------
Confidence 99999998532221 1244568999999999999889999999999999999999999999764321110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
..+.... ..++...+..+.+||.+||+.||.+||+ +.++++|-+
T Consensus 231 -------~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 231 -------QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp -------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred -------HHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 1111111 1233455678899999999999999994 689998843
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=340.72 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=201.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.... ....+..+|+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hHHeEEEeEeeecCCeeEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 3679999999999999999997642 223567899999876433 23456889999999999999999999984
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcc
Confidence 567899999999999999998654 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------- 230 (281)
T 1mp8_A 161 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------- 230 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------
T ss_pred ccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---------
Confidence 999865432211 2233456788999999988899999999999999999996 99999765432211110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 231 --------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 231 --------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111123344567888999999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=348.65 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=203.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc-chhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|..... .......+|+|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 6799999999999999999975431 11123356888775443 23456788999999999999999999999876
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
. .++|++++.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred C-ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCc
Confidence 5 788999999999999998764 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------------- 229 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------- 229 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------------
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------------
Confidence 9987544333333344557888999999999999999999999999999999 99999765432211
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 230 ----SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ----HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111112222334456678899999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=350.07 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=206.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|..... .......+|+|.+..... .....+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 6799999999999999999976431 111234588888754432 22334668999999999999999999886 4
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCC
Confidence 66899999999999999997653 34888999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............|+..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--------- 231 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE--------- 231 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---------
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---------
Confidence 9987655444434455678889999999998899999999999999999999 999998754322211111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.......+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 232 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 --------KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp --------TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred --------cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111112222344567789999999999999999999999998854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=345.87 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=202.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||+||+|... +|..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 67999999999999999999643 3789999998765332 23567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 91 ERCLTLVFEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccC
Confidence 999999999996 58888887654 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh---
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--- 301 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--- 301 (401)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 164 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 164 GLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp TTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred cCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 9998653222 12344578999999999866 56899999999999999999999999876554332221100000
Q ss_pred --hhhcchhhhhhhhhh-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 --LQSKRRIFQVMDARI-------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 --~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
............... ........+.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 000000000000000 00011123467889999999999999999999999744
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.52 Aligned_cols=287 Identities=17% Similarity=0.195 Sum_probs=215.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-----------HHHHHHHHHHHhccCCCc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN 135 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn 135 (401)
.++|++.+.||+|+||.||+|.+... .....+..||+|++....... ...+..|+..+..++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 46799999999999999999976542 123357889999986543211 112445677788889999
Q ss_pred ccceeeEEeeC----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 136 LVKLIGYCLED----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 136 i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
|+++++++.+. ...||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~N 182 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASN 182 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHH
Confidence 99999998765 5589999999 999999998753 45999999999999999999999998 9999999999
Q ss_pred EEEc--CCCceEEeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 015731 212 ILLD--LNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284 (401)
Q Consensus 212 il~~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 284 (401)
||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998 8899999999999754322111 11233569999999999998899999999999999999999999997
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
+...... ...+.... ....+..+++..+. ....+..+.+++.+||+.||.+||++.+|++.|+.+........
T Consensus 263 ~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 263 DNLKDPK--YVRDSKIR--YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp GGTTCHH--HHHHHHHH--HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred ccccCHH--HHHHHHHH--hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 5432211 11111100 01112222222211 12235678899999999999999999999999999988776665
Q ss_pred Ccccccc
Q 015731 365 SRDESLQ 371 (401)
Q Consensus 365 ~~~~~~~ 371 (401)
....++.
T Consensus 336 ~~~~dw~ 342 (364)
T 3op5_A 336 DGKLDLS 342 (364)
T ss_dssp CCCCCC-
T ss_pred CCccceE
Confidence 5544443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=357.98 Aligned_cols=277 Identities=25% Similarity=0.328 Sum_probs=197.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccC-CCcccceee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIG 141 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~-hpni~~~~~ 141 (401)
...++|++.+.||+|+||.||+|. +..+|+.||+|++.... ......+.+|+.+++.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSI---------DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEE---------ETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEE---------ECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 345789999999999999999994 44478999999986542 233456789999999997 999999999
Q ss_pred EEeeCC--eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 142 YCLEDD--HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 142 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
++...+ .+|+||||+. ++|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRANI------LEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECH 147 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHTC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCC
Confidence 997544 7899999995 69999997643 899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCC-------------------CcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhC
Q 015731 220 AKLSDFGLAKDGPTGS-------------------QSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSG 279 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g 279 (401)
+||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 9999999997543211 1112344689999999999876 6789999999999999999999
Q ss_pred CCCCCCCCCCccchhHHhhhhh-----------------hhhc-----------ch-hhhhhhhhhcCCCCHHHHHHHHH
Q 015731 280 RRVIDKNRPSREHNLIEWAKPY-----------------LQSK-----------RR-IFQVMDARIEGQYSLGAALKTAV 330 (401)
Q Consensus 280 ~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~-----------~~-~~~~~~~~~~~~~~~~~~~~~~~ 330 (401)
.+||.+.........+...... .... .. +..+.............+..+.+
T Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 9999876543322211100000 0000 00 00000000000001123567889
Q ss_pred HHHHccccCCCCCCCHHHHHHH--HHhchhc
Q 015731 331 LAIKCLSNEPKFRPTMDEVVKA--LEQIQDT 359 (401)
Q Consensus 331 li~~~L~~dp~~Rps~~eil~~--L~~i~~~ 359 (401)
|+.+||+.||.+|||+.|+++| +..+...
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred HHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence 9999999999999999999999 4444433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=341.53 Aligned_cols=267 Identities=23% Similarity=0.274 Sum_probs=202.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||+||+|.. ..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEE---------CCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 5799999999999999999954 44689999999875533 223567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+. ++|.+.+.... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Df 145 (292)
T 3o0g_A 73 DKKLTLVFEFCD-QDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANF 145 (292)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999995 47777766543 34999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...........
T Consensus 146 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~ 221 (292)
T 3o0g_A 146 GLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGT 221 (292)
T ss_dssp TTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCC
T ss_pred ccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCC
Confidence 9998653221 1234457899999999987655 79999999999999999998887543322111 11000000000
Q ss_pred --cch---hhhhhh---------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 --KRR---IFQVMD---------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 --~~~---~~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
... .....+ ...........+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 000 000000 00000112235677889999999999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=337.56 Aligned_cols=255 Identities=27% Similarity=0.526 Sum_probs=206.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-------HHHHHHHHHHHhccCCCccccee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
++|++.+.||+|+||.||+|... .++..||+|++....... ...+.+|+.++++++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 67999999999999999999543 468899999986543321 15678999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN- 219 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~- 219 (401)
+++.+.. ++||||+.+++|.+++.... .++++..++.++.|++.||.|||+++.+|+||||||+||+++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC
Confidence 9987665 69999999999999887654 4589999999999999999999997666999999999999987776
Q ss_pred ----eEEeeccCCcCCCCCCCcceeeecccccCccccccc--ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 220 ----AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 220 ----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
++|+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||..........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence 99999999975332 23446799999999998 34567889999999999999999999997654322110
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. ............+...+..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus 239 ~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 I--------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H--------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred H--------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 011111222233445567889999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=345.45 Aligned_cols=280 Identities=26% Similarity=0.345 Sum_probs=221.4
Q ss_pred hhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhcc-CCCccc
Q 015731 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLV 137 (401)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l-~hpni~ 137 (401)
...+....++|++.+.||+|+||.||+|..... .+..++..||+|++...... ....+.+|+.++.++ +||||+
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 334445568899999999999999999975431 24457899999999765432 345688999999999 799999
Q ss_pred ceeeEEeeCC-eeEEEEEecCCCChHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEe
Q 015731 138 KLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASY-----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 205 (401)
Q Consensus 138 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 205 (401)
++++++...+ ..++||||+.+++|.+++....... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~ 172 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHR 172 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccc
Confidence 9999988754 5899999999999999998754310 123789999999999999999999998 9999
Q ss_pred ccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 015731 206 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 284 (401)
Q Consensus 206 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 284 (401)
||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986544433333444567889999999988899999999999999999998 999997
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
........ . ...........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.+.
T Consensus 253 ~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEEF--C--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHHH--H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHHH--H--------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 65432110 0 0011111112233356678899999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.27 Aligned_cols=275 Identities=22% Similarity=0.301 Sum_probs=194.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|++.+.||+|+||.||+|. +..+|..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGL---------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEE---------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEE---------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3679999999999999999994 4457899999998755322 33567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++..++||||+. ++|.+++..... .....+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECc
Confidence 999999999996 699999876532 12235899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh--
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-- 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-- 301 (401)
||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999986432211 2334578999999999876 46899999999999999999999999765432221111000000
Q ss_pred ---hhhcchhhh-----------hhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 ---LQSKRRIFQ-----------VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ---~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
......... .+...+........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 000000000 000000111112345678999999999999999999999998554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=347.98 Aligned_cols=280 Identities=25% Similarity=0.336 Sum_probs=218.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe--e
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL--E 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~--~ 145 (401)
++|++.+.||+|+||.||+|.+.. .+..++..||+|++..........+.+|+.++++++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 679999999999999999997543 355679999999998776666667889999999999999999999886 5
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccc
Confidence 567899999999999999998754 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++.......... ......|+..|+|||++.+..++.++||||||+++|+|++|..||........... .+. .....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~-~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCE-RDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccc-ccccc
Confidence 9998654333211 22334678889999999888899999999999999999999999864321100000 000 00000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
................+..++..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 01112222222333445566788999999999999999999999999999985544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=348.79 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=200.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCC--CcccceeeE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYH--PNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h--pni~~~~~~ 142 (401)
.++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.+.| |||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 467999999999999999998542 478899999875533 234568899999999976 999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+++..++|||+ .+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEE
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEE
Confidence 9999999999995 4889999998764 4899999999999999999999998 99999999999997 678999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-- 226 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 226 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--
Confidence 99999987654433333445679999999999865 67889999999999999999999999653221
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. .......+......++...+..+.+|+.+||+.||.+|||+.++++|.+.-
T Consensus 227 ---~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 227 ---I----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp ---H----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---H----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 0 011122222222233334456788999999999999999999999997764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=358.58 Aligned_cols=261 Identities=20% Similarity=0.211 Sum_probs=208.8
Q ss_pred hHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCccc
Q 015731 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLV 137 (401)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~ 137 (401)
.+.....++|++.++||+|+||.||+|.. ..+|+.||+|++.+.... ....+.+|..++..++||||+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~---------~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv 124 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKM---------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence 34445568899999999999999999954 347899999999764322 223477899999999999999
Q ss_pred ceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
++++++.+.+..|+||||++||+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC 198 (412)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC
Confidence 99999999999999999999999999998764 34899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
+.+||+|||++........ ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 277 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277 (412)
T ss_dssp SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999986543221 1233468999999999986 3568999999999999999999999997654321
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHH
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFR---PTMDEVVKALE 354 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~R---ps~~eil~~L~ 354 (401)
.... +...... .......+.++.+||.+||. +|.+| |+++|+++|-+
T Consensus 278 ~~~~----------------i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 278 TYGK----------------IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHH----------------HHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHH----------------HHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 1111 1110000 01112356788999999999 99998 59999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=360.48 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=209.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|.+.+.||+|+||.||+|. +..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~---------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGK---------HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEE---------ETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 679999999999999999994 4457899999999765432 2456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEe
Confidence 9999999999999999999997653 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---------- 226 (476)
T 2y94_A 160 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK---------- 226 (476)
T ss_dssp CSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----------
T ss_pred ccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----------
Confidence 99998654332 2345679999999999987765 689999999999999999999997643211110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.+.... ...+...+..+.+|+.+||+.||.+|||+.++++|-+.-+
T Consensus 227 ------~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 227 ------KICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ------HHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ------HHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 111111 1122334567889999999999999999999999866543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=342.75 Aligned_cols=275 Identities=28% Similarity=0.392 Sum_probs=212.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|.+.. .+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 568999999999999999997543 3556799999999876543 2345688999999999999999999999876
Q ss_pred --CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 147 --DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
...++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECc
Confidence 67899999999999999997654 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh--
Q 015731 225 FGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-- 301 (401)
Q Consensus 225 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-- 301 (401)
||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+...... ......+.
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~ 245 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHG 245 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCG
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccc
Confidence 9999865443221 1233456888899999998888999999999999999999999886432100 00000000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
...................+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00001111112222223344556778999999999999999999999999998874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=343.09 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=217.8
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...++|++.+.||+|+||.||+|... .++..||+|++.... .....+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEG---------GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeEEeecCCCCceeEEEeEec---------CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34578999999999999999999554 368899999987654 34557889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~D 154 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVAD 154 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEcc
Confidence 99999999999999999999987543 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 155 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----------- 222 (288)
T 3kfa_A 155 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------- 222 (288)
T ss_dssp CCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----------
T ss_pred CccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence 99998654332 222334557888999999988899999999999999999999 99999765432111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...........+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 223 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 223 ------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111222233445678899999999999999999999999999886654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=344.99 Aligned_cols=279 Identities=30% Similarity=0.427 Sum_probs=216.3
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee--C
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--D 146 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~--~ 146 (401)
|++.+.||+|+||.||++.+.. .+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4899999999999999986543 5666899999999986543 334568899999999999999999999987 4
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGG
T ss_pred ceEEEEEecccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcc
Confidence 67899999999999999997653 899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... ...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~ 257 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTV 257 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhH
Confidence 99876543321 12334567888999999988889999999999999999999999986432100 0000000000 001
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCC
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 363 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~ 363 (401)
...............+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1122222233333445566788999999999999999999999999999987665443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.98 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=201.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
++|++.+.||+|+||.||+|+.. .+..+|..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 57999999999999999999653 2335789999999976532 2234567899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEEC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------- 230 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI----------- 230 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----------
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-----------
Confidence 999987532221 1233467999999999998888999999999999999999999999764321110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
..+... ...++...+..+.+|+.+||+.||.+|| ++.++++|-+.
T Consensus 231 -----~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 231 -----DKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp -----HHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred -----HHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 011111 1122334567889999999999999999 88999998553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=335.50 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=195.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch----hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.+|++.+.||+|+||.||+|... |..+|+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 67999999999999999999642 678999998765332 235678999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCC-CeEEeccCCCcEEEcC------
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKA-KVIYRDFKTSNILLDL------ 216 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~dlkp~Nil~~~------ 216 (401)
.+.+..++||||+.+++|.+++... .+++..++.++.|++.||.|||+++. +|+||||||+||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred ecCCceEEEEEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 9999999999999999999998643 48999999999999999999999763 2889999999999985
Q ss_pred --CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 217 --NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 217 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
++.++|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 222 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--- 222 (271)
T ss_dssp CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---
T ss_pred ccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 7789999999997643322 2245789999999999988999999999999999999999999976432110
Q ss_pred HHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.............+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 223 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -------------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111111222233445567889999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=344.23 Aligned_cols=273 Identities=24% Similarity=0.367 Sum_probs=215.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|...... .....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 468999999999999999999764311 02334688999999976543 3345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+.+..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEE
Confidence 999999999999999999999865421 1134899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999986544332222334457888999999988889999999999999999999 9999976432111
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
. ..+........+..++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 269 --~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 --F--------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp --H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --H--------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 011111112233445678889999999999999999999999999996643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.90 Aligned_cols=273 Identities=19% Similarity=0.232 Sum_probs=206.1
Q ss_pred hCCCCCCCcccCC--CCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 67 TRNFRPDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.++|++.+.||+| +||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARY---------KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEE---------cCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3679999999999 9999999954 44789999999976543 233557789999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+++..|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl 169 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYL 169 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEE
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999987532 34899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCC-----cceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 223 SDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99998764321110 011222478999999999977 57899999999999999999999999775443321110
Q ss_pred Hh-hhhhhhhcc------------------hhhhhh---------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 015731 296 EW-AKPYLQSKR------------------RIFQVM---------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 347 (401)
Q Consensus 296 ~~-~~~~~~~~~------------------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ 347 (401)
.. ..+...... ...... ............+..+.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 00 000000000 000000 00000112334567789999999999999999999
Q ss_pred HHHHHH
Q 015731 348 EVVKAL 353 (401)
Q Consensus 348 eil~~L 353 (401)
|+++|-
T Consensus 330 ell~hp 335 (389)
T 3gni_B 330 TLLNHS 335 (389)
T ss_dssp HHTTSG
T ss_pred HHhcCH
Confidence 999983
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=336.57 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=209.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.+.. +..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 3679999999999999999997653 233567899999876532 345568899999999999999999999875
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCcc
Confidence 45789999999999999998764 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 158 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------- 227 (281)
T 3cc6_A 158 GLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------- 227 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---------
T ss_pred CCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---------
Confidence 99986543221 12233456888999999988899999999999999999998 99999754332211111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........+...+..+.+++.+||..||.+|||+.+++++|+.+.+.
T Consensus 228 --------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 228 --------EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11111122333456788999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=345.57 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=198.8
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKN---------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEE---------TTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEE---------cCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 46799999999999999999954 34689999999875443 244568899999999999999999999865
Q ss_pred CC---------------------------------------------------------eeEEEEEecCCCChHHHHhhc
Q 015731 146 DD---------------------------------------------------------HRLLVYEFMPKGSLENHLFRT 168 (401)
Q Consensus 146 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~ 168 (401)
.. ..++||||+.+++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 379999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCc----------c
Q 015731 169 GASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS----------H 238 (401)
Q Consensus 169 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~ 238 (401)
.. ....++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... .
T Consensus 156 ~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 156 CS--LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CS--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred cC--ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 53 234677788999999999999999998 999999999999999999999999999865443211 1
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcC
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEG 318 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (401)
......||+.|+|||++.+..++.++|||||||++|+|++|..|+.... .........
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------------------~~~~~~~~~ 289 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------------------RIITDVRNL 289 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------------------HHHHHHHTT
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------------------HHHHHhhcc
Confidence 2234579999999999998899999999999999999999876542100 000000011
Q ss_pred CCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 319 QYS---LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 319 ~~~---~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..+ ...+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 290 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 111 23446678999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=340.26 Aligned_cols=270 Identities=23% Similarity=0.365 Sum_probs=204.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|.+.+.||+|+||.||+|.... +..++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 44789999999999999999997653 334678999999876532 2345688999999999999999999999
Q ss_pred eeCC-----eeEEEEEecCCCChHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 144 LEDD-----HRLLVYEFMPKGSLENHLFRTGA-SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 144 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
.+.. ..++||||+.+++|.+++..... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence 8765 35999999999999999854321 12245999999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHH
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 296 (401)
+.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 262 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL- 262 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-
Confidence 9999999999986543332222334567889999999998899999999999999999999 88999765432111100
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
........+...+..+.+++.+||..||.+|||+.+++++|+.+.+..
T Consensus 263 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 ----------------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 001111223345567889999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=356.59 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=209.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|.+. |..||||++.... ....+.+|+.++++++||||+++++++.+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 3467889999999999999999653 5689999997654 44578899999999999999999999876
Q ss_pred CC-eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.. ..++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEee
Confidence 65 79999999999999999987653 34789999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------- 398 (450)
T 1k9a_A 333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------- 398 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---------
T ss_pred CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------
Confidence 9999753221 122357889999999999999999999999999999998 9999976543221111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 399 --------i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 399 --------VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111112233445667889999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.68 Aligned_cols=250 Identities=26% Similarity=0.311 Sum_probs=197.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHH-HhccCCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKH-LGQLYHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~-l~~l~hpni~~~~~~~ 143 (401)
++|++.++||+|+||.||+|.. ..++..||+|++...... ....+..|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARH---------KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEE---------TTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEE---------cCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 5799999999999999999954 447899999999776532 22345566666 5678999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------- 248 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----------- 248 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-----------
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-----------
Confidence 999997532211 1244568999999999999999999999999999999999999999754321110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM----DEVVKAL 353 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~----~eil~~L 353 (401)
..+.... ..++...+..+.+||.+||+.||.+||++ .++++|-
T Consensus 249 -----~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 249 -----DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp -----HHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred -----HHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 1111111 12233456678899999999999999987 4666653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=333.79 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=207.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... +..+|+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 57999999999999999999653 67799999876542 334568899999999999999999999988
Q ss_pred C--CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 146 D--DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
. ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++..++||||||+||+++.++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~ 155 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEE
Confidence 7 788999999999999999987542 35899999999999999999999977669999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA---KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|||++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||........
T Consensus 156 ~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------- 219 (271)
T 3kmu_A 156 MADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--------- 219 (271)
T ss_dssp GGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------
T ss_pred eccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------
Confidence 9988764322 2246899999999997665544 79999999999999999999975432111
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.............+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 -------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011111112223344556788999999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=365.00 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=215.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
...+|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|+.++++++||||+++++++.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34678899999999999999996543 578999999976543 35678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999999987543 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~------------- 428 (495)
T 1opk_A 363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------- 428 (495)
T ss_dssp TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------------
T ss_pred ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------------
Confidence 9998654322 111223345778999999988889999999999999999999 9999976543211
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 429 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 429 ----YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111111222233445667889999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=334.28 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=208.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..++..+|+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLARE---------KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEE---------ccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 6799999999999999999954 346889999998665332 2446789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECS
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEe
Confidence 9999999999999999999998764 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------- 217 (279)
T 3fdn_A 153 FGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----------- 217 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----------
T ss_pred ccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-----------
Confidence 9988654322 2234578999999999998889999999999999999999999997543211100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.+. ......+...+..+.+|+.+||+.||.+|||+.++++|-+.-.....
T Consensus 218 -----~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 218 -----RIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp -----HHH--HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred -----HHH--hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 000 01112333456678899999999999999999999999876554433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.12 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=209.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|.. ..++..+|+|++..........+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQ---------KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEe---------CCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346799999999999999999954 44688999999987666666778899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~kl 222 (401)
....++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||++ +.++.++|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999999999998764 3899999999999999999999998 9999999999999 78899999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+
T Consensus 151 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------- 219 (277)
T 3f3z_A 151 IDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------- 219 (277)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------
T ss_pred EecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------
Confidence 9999997654332 2344579999999999865 4899999999999999999999999764321111000
Q ss_pred hhcchhhhhhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 303 QSKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
... ....+. ..+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 220 ---------~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 220 ---------REG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp ---------HHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred ---------HhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 000 001111 2356788999999999999999999999986653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.64 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=205.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|. +..+|+.||+|++...... ..+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCI---------HKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 34679999999999999999994 4457899999999765432 23678888887 7999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC----Cce
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNA 220 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~----~~~ 220 (401)
+++..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||++..+ +.+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeE
Confidence 9999999999999999999997654 3899999999999999999999998 9999999999998443 359
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~- 236 (342)
T 2qr7_A 160 RICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG- 236 (342)
T ss_dssp EECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-
T ss_pred EEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-
Confidence 9999999986433221 2345678999999999988888999999999999999999999997643222111111000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
.. ...+........+..+.+||.+||..||.+|||+.++++|-+...
T Consensus 237 ---~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 237 ---SG-------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ---HC-------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ---cC-------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 00 000111122345678899999999999999999999999977654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=352.01 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=200.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccC--CCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY--HPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~--hpni~~~~~~~ 143 (401)
++|++.+.||+|+||.||+|... ++..||||++..... .....+.+|+.+++.+. ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 56999999999999999998432 378899999876532 33456889999999996 59999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
..++..|+||| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEEC
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEE
Confidence 99999999999 45889999998764 4889999999999999999999998 99999999999995 5899999
Q ss_pred eccCCcCCCCCCCcceeeecccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--- 273 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 273 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---
Confidence 9999987544333223445679999999999864 36889999999999999999999999654321
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.. .+..+.+......++...+..+.+||.+||+.||.+|||+.++++|-+.-
T Consensus 274 --~~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 274 --IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp --HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HH----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 00 01111222222222333356788999999999999999999999997653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.89 Aligned_cols=270 Identities=26% Similarity=0.370 Sum_probs=207.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|.+... .+..++..||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 5799999999999999999975421 1345788999999975432 3345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CCceE
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAK 221 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~~~k 221 (401)
...|+||||+++++|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+||+++. +..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999876431 1234889999999999999999999998 999999999999984 45699
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----- 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---L----- 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H-----
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---H-----
Confidence 999999874322222222334567889999999988899999999999999999998 9999976432111 1
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...........+...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 256 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 256 ---------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 001111111223345667889999999999999999999999999986544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.03 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=197.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||.||+|.. ..+++.||+|++...... ....+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARD---------LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEE---------CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 36899999999999999999954 446899999999765332 234678999999999999999999998
Q ss_pred eeCCe----eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 144 LEDDH----RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 144 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
..... .|+||||+++++|.+++.... ++++..++.++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~ 154 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNA 154 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSC
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCC
Confidence 76543 499999999999999998764 3899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~----- 229 (311)
T 3ork_A 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----- 229 (311)
T ss_dssp EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----
T ss_pred EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----
Confidence 999999999865432211 12334578999999999998899999999999999999999999997654211100
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH-HHhch
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA-LEQIQ 357 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~-L~~i~ 357 (401)
.......... . ......+..+.+|+.+||+.||.+||++.+++.+ +..+.
T Consensus 230 -~~~~~~~~~~----~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 230 -QHVREDPIPP----S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -HHHHCCCCCH----H----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHhcCCCCCc----c----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000000000 0 0011245678899999999999999977666655 44443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=362.11 Aligned_cols=253 Identities=28% Similarity=0.356 Sum_probs=201.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||.||+|. +..+|..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVK---------EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEE---------EcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 3679999999999999999994 445789999999976532 2234567899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||+|||+ +| |+||||||+|||++.++.+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEE
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEE
Confidence 99999999999999999999998764 38999999999999999999998 88 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 291 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------- 360 (446)
T 4ejn_A 291 TDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------- 360 (446)
T ss_dssp CCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------
T ss_pred ccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH--------
Confidence 9999997533221 123456899999999999999999999999999999999999999976432111110
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 355 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~ 355 (401)
+... ...++...+..+.+||.+||+.||.+|| ++.++++|-+.
T Consensus 361 --------i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 361 --------ILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp --------HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred --------HHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 0111 1122334567889999999999999999 99999998543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=340.98 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=205.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|......- .....+..||+|++..........+.+|+.++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3679999999999999999996543110 00111357999999877666667789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-------
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN------- 219 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~------- 219 (401)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999998754 34899999999999999999999998 999999999999988877
Q ss_pred -eEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCC-CCCCCCCCccchhHH
Q 015731 220 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIE 296 (401)
Q Consensus 220 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~~~ 296 (401)
++|+|||++..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|.. ||....... ...
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~ 229 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQ 229 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHH
Confidence 99999999875322 223468899999999977 678999999999999999999654 443322100 000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCC
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 363 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~ 363 (401)
.... ....+...+..+.+|+.+||+.||.+|||+.+++++|+.+.......
T Consensus 230 --------------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 230 --------------FYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp --------------HHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred --------------Hhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 0000 11112223456789999999999999999999999999987654443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.41 Aligned_cols=272 Identities=26% Similarity=0.346 Sum_probs=215.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 347899999999999999999976532 1223456899999876543 3345688999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC---------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS---------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
.+.+..++||||+.+++|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL 197 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEE
Confidence 9999999999999999999999764210 0134799999999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccch
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 293 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 293 (401)
+.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986543333223344567889999999988899999999999999999998 99999765432111
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
............+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 277 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 ---------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ---------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 011111111122333456788999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=340.50 Aligned_cols=272 Identities=23% Similarity=0.295 Sum_probs=202.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----hHHHHHHHHHHHhcc---CCCccc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQL---YHPNLV 137 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l---~hpni~ 137 (401)
..++|++.+.||+|+||+||+| .+..+|+.||+|++...... ....+.+|+.+++.+ +||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEE---------ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 4578999999999999999999 44557899999998754321 123455666666665 599999
Q ss_pred ceeeEEeeCC-----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 138 KLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 138 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
++++++.+.. ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Ni 151 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENI 151 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 9999998765 5899999995 699999987653 34899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
+++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998654322 234567899999999998889999999999999999999999999765432221
Q ss_pred hhHHhhhhhhhhcchhh---hhhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 293 NLIEWAKPYLQSKRRIF---QVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+....... ....+. ......... ......+..+.+||.+||+.||.+|||+.|+++|-+.-
T Consensus 229 ~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~ 301 (308)
T 3g33_A 229 GKIFDLIGLP-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301 (308)
T ss_dssp HHHHHHHCCC-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred HHHHHHhCCC-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence 1110000000 000000 000000000 00113456788999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.07 Aligned_cols=267 Identities=21% Similarity=0.250 Sum_probs=199.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|+ +..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEE---------ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEE---------ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4789999999999999999994 44578999999997652 233456789999999999999999999996
Q ss_pred eC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 ED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.. ...|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTS
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCC
Confidence 54 457999999954 67776642 3889999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+...
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp CEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999998654322 234568999999999999999999999999999999999999999876533222111000
Q ss_pred h--h---hhhhc-chhhhhhhhh---------------hcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 299 K--P---YLQSK-RRIFQVMDAR---------------IEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 299 ~--~---~~~~~-~~~~~~~~~~---------------~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
. + ..... .......... +.. ......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0 0 00000 0000000000 000 001123677899999999999999999999999965
Q ss_pred h
Q 015731 355 Q 355 (401)
Q Consensus 355 ~ 355 (401)
.
T Consensus 359 ~ 359 (464)
T 3ttj_A 359 I 359 (464)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=342.09 Aligned_cols=265 Identities=24% Similarity=0.403 Sum_probs=206.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|.+.+.||+|+||.||+|..... ....+..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecC-----CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 36788899999999999999976531 223456799999876533 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCC
Confidence 999999999999999999997654 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~-------- 260 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M-------- 260 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H--------
Confidence 9998654322111 1222346788999999988899999999999999999999 9999965432110 0
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+........+...+..+.+++.+||+.||.+||++.+++++|+++...
T Consensus 261 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 261 ------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01111111122334567888999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=338.77 Aligned_cols=269 Identities=23% Similarity=0.250 Sum_probs=202.6
Q ss_pred hCCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++. +.||+|+||.||+|. +..++..||+|++..........+.+|+.++.++ .||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3578884 789999999999994 4457899999999776555566788999999885 7999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc---eE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AK 221 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~---~k 221 (401)
+.+..++||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~k 154 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVK 154 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceE
Confidence 9999999999999999999998764 3899999999999999999999998 999999999999988766 99
Q ss_pred EeeccCCcCCCCCCC-----cceeeecccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 222 LSDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
|+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234 (316)
T ss_dssp ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence 999999875432211 111223569999999999865 4578999999999999999999999987654321
Q ss_pred chhHHhhhhhhhhcchh-hhhhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 292 HNLIEWAKPYLQSKRRI-FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
........+. ....+ ..+.... ..++. ..+..+.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 235 ~~~~~~~~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 235 GWDRGEACPA--CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp CC----CCHH--HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred cccccccchh--HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 1000000000 00000 0010000 11111 235678899999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=335.23 Aligned_cols=258 Identities=26% Similarity=0.298 Sum_probs=207.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEE---------CCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 46799999999999999999954 34688999999876543 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeC
Confidence 99999999999999999998654 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|.+................|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....|..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----- 223 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----- 223 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-----
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-----
Confidence 99876433222222344678999999999977665 7789999999999999999999976543211 1111111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 224 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 224 ---------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp ---------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ---------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 000000112345678899999999999999999999997553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=364.20 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=212.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
..++|++.++||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+|+.++||||++++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~---------~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQV---------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 346799999999999999999954 44789999999976543 233457899999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..|+||||+.||+|.+++..... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL 327 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRI 327 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEE
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEE
Confidence 9999999999999999999999976542 34899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 328 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------ 398 (576)
T 2acx_A 328 SDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------ 398 (576)
T ss_dssp CCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------
T ss_pred EecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------
Confidence 9999998654332 2344689999999999998889999999999999999999999998654322111110
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.... .....++...+..+.+||.+||+.||.+|| ++.|+++|-+
T Consensus 399 -------~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 399 -------RLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp -------HHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred -------HHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 0000 011223344567889999999999999999 8999999844
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.32 Aligned_cols=275 Identities=23% Similarity=0.236 Sum_probs=208.4
Q ss_pred cchhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-----
Q 015731 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY----- 132 (401)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~----- 132 (401)
+++.......++|++.+.||+|+||.||+|.. ..++..||+|++.... .....+..|+.+++.+.
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~ 94 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQH---------IDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDIN 94 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTT
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEE---------CCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCC
Confidence 34444445568899999999999999999954 3468999999987533 23345667889998886
Q ss_pred CCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 133 hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
||||+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 95 h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 168 (360)
T 3llt_A 95 NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENI 168 (360)
T ss_dssp GGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccE
Confidence 999999999999999999999999 9999999987653 34899999999999999999999998 99999999999
Q ss_pred EEcC-------------------------CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchh
Q 015731 213 LLDL-------------------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVY 267 (401)
Q Consensus 213 l~~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 267 (401)
|++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchH
Confidence 9975 789999999999864332 2345789999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc-------chhhhhhhh-hh-----------------cCCCC-
Q 015731 268 SFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK-------RRIFQVMDA-RI-----------------EGQYS- 321 (401)
Q Consensus 268 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~-----------------~~~~~- 321 (401)
||||++|+|++|..||...........+.......... ......... .. ....+
T Consensus 244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 323 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence 99999999999999997654322221111100000000 000000000 00 00000
Q ss_pred --HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 322 --LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 322 --~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus 324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred cccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 01125677999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.38 Aligned_cols=267 Identities=24% Similarity=0.302 Sum_probs=200.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... +|..+|+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 57999999999999999999542 5789999998655332 23567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Df 144 (288)
T 1ob3_A 72 KKRLVLVFEHLD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADF 144 (288)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCT
T ss_pred CCeEEEEEEecC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeEC
Confidence 999999999996 49999987653 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ...
T Consensus 145 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 221 (288)
T 1ob3_A 145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG-TPN 221 (288)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCC
T ss_pred ccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC-CCC
Confidence 9987543211 12334578999999999865 4589999999999999999999999976543221111100000 000
Q ss_pred cchhhhh-----hhhhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQV-----MDARIE-------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
....... .+.... .......+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000000 000000 0111234567889999999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=335.32 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=213.7
Q ss_pred CCCCCCC-cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|.+.+ .||+|+||.||+|.+.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566666 99999999999996532 23578899999987533 3455688999999999999999999999 5
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcc
Confidence 567899999999999999997543 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---------- 224 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---------- 224 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----------
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----------
Confidence 999865433221 11223456889999999988889999999999999999998 999997654311110
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 366 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~ 366 (401)
.+........+...+..+.+++.+||+.||.+||++.+++++|+.+......+...
T Consensus 225 -------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 225 -------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred -------HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 01111112233455678999999999999999999999999999997766555443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.53 Aligned_cols=271 Identities=23% Similarity=0.388 Sum_probs=214.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4457899999999999999999965421 1223578899999976543 3345688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGA-----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.+.+..++||||+.+++|.+++..... ....++++..++.++.||+.||.|||++| |+||||||+||+++.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 999999999999999999999976421 11234789999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~- 251 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LR- 251 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HH-
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HH-
Confidence 999999999875433222112233456889999999988899999999999999999999 8899876432111 00
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.+... .....+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 252 ------------~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 ------------FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------------HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------------HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00000 0112233456678899999999999999999999999988744
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=332.70 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=208.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVH---------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEE---------cCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 47899999999999999999954 44689999999876543 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc---eE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AK 221 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~---~k 221 (401)
+.+..++||||+.+++|.+.+.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999999988764 3899999999999999999999998 999999999999976655 99
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 149 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----- 220 (284)
T 3kk8_A 149 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK----- 220 (284)
T ss_dssp ECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred EeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-----
Confidence 99999997654322 2234578999999999998889999999999999999999999996643211111000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
... ...........+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 221 -~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 221 -AGA--------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp -HTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred -hcc--------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 000 0000011123456788999999999999999999999986653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=345.79 Aligned_cols=265 Identities=22% Similarity=0.220 Sum_probs=204.0
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-----hhHHHHHHHHHHHhccCCCcccc
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVK 138 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~hpni~~ 138 (401)
....++|++.+.||+|+||.||+|.. ..++..+|+|++..... .....+.+|+.+++.++||||++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIE---------NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeecceeeecCCeEEEEEEE---------CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 45567899999999999999999954 34689999999876532 33456889999999999999999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCC-----------------------------------CCCCCCHHHHHH
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGAS-----------------------------------YIQPLSWTIRMK 183 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~ 183 (401)
+++++.+.+..++||||+++++|.+++...... ....+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 999999999999999999999999998531100 012246778899
Q ss_pred HHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--ceEEeeccCCcCCCCCC--CcceeeecccccCccccccccc--
Q 015731 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMAT-- 257 (401)
Q Consensus 184 i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-- 257 (401)
++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 173 IMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 9999999999999998 99999999999998776 89999999997542211 1112345679999999999865
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHc
Q 015731 258 GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKC 335 (401)
Q Consensus 258 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~ 335 (401)
..++.++|||||||++|+|++|..||.......... ........ .......+..+.+||.+|
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS----------------QVLNKKLCFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHCCCCTTSGGGGGSCHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH----------------HHHhcccccCCcccccCCHHHHHHHHHH
Confidence 678899999999999999999999997654211110 11111100 001112456788999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 015731 336 LSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 336 L~~dp~~Rps~~eil~~L~~ 355 (401)
|+.||.+|||+.++++|-+.
T Consensus 315 l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHH
T ss_pred cCCChhHCCCHHHHhcChhh
Confidence 99999999999999998544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=340.21 Aligned_cols=256 Identities=25% Similarity=0.281 Sum_probs=207.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCRE---------KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEE---------CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 46799999999999999999954 447899999998765332 245688999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 218 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-- 218 (401)
+++.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCC
Confidence 99999999999999999999999997653 4899999999999999999999998 99999999999998887
Q ss_pred --ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 --NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i- 230 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI- 230 (321)
T ss_dssp SCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-
T ss_pred cCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence 79999999998654332 223457899999999998889999999999999999999999999764321111000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
....... .... ....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 231 -----~~~~~~~----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 231 -----TSVSYDF----DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp -----HTTCCCC----CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred -----Hhccccc----Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 0000000 0000 01234578899999999999999999999998553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=332.87 Aligned_cols=279 Identities=19% Similarity=0.192 Sum_probs=214.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEE-e
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC-L 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~-~ 144 (401)
..++|++.+.||+|+||.||+|.. ..++..||+|++...... ..+.+|+.+++.+.|++++..+..+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEE---------cCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 457899999999999999999953 346899999986554322 2467899999999888777666554 6
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAK 221 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~k 221 (401)
+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEE
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEE
Confidence 778889999999 999999998644 34899999999999999999999998 9999999999999 7889999
Q ss_pred EeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 222 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999865433221 12234678999999999999899999999999999999999999998765544333222
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCccccccc
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQN 372 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~~~~~~ 372 (401)
...... ........ ....+..+.+|+.+||+.||.+|||+.++++.|+.+............++.+
T Consensus 229 ~~~~~~------~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 229 RISEKK------MSTPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHHHH------HHSCHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hhhccc------ccchhhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 111000 00000000 0122467889999999999999999999999999999888777665555443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=341.14 Aligned_cols=249 Identities=26% Similarity=0.320 Sum_probs=195.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||+||+|... .+|..||||++..... ........|+..+..+ .||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 367999999999999999999544 4689999998765432 2333455666666555 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEEC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEc
Confidence 9999999999999 779999988765 45999999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+..... |.
T Consensus 200 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~----- 262 (311)
T 3p1a_A 200 DFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ----- 262 (311)
T ss_dssp CCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH-----
T ss_pred cceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH-----
Confidence 999987653322 2334569999999999875 789999999999999999999766643210 10
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.+........+....+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 263 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 263 ------QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp ------HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ------HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 000000000111123567889999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=345.45 Aligned_cols=253 Identities=27% Similarity=0.376 Sum_probs=205.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEE---------ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4588999999999999999953 34689999999875432 23356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECC
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999995 68888886554 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 198 fG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--------- 262 (348)
T 1u5q_A 198 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------- 262 (348)
T ss_dssp CTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------
T ss_pred ccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---------
Confidence 999976432 22357999999999984 467899999999999999999999999654321110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+.............+..+.+|+.+||+.||.+|||+.++++|.+....
T Consensus 263 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 263 -------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------HHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 00111111111122345678899999999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=332.95 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=210.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... ++..||+|++..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 367899999999999999999654 367899999987543 235688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTT
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccc
Confidence 99999999999999999997754 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------------ 216 (267)
T 3t9t_A 150 MTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------------ 216 (267)
T ss_dssp GGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------------
T ss_pred ccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH------------
Confidence 987543211 111223456788999999988889999999999999999999 899997643211100
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
. +........+...+..+.+++.+||+.||.+|||+.+++++|+++.+.
T Consensus 217 ----~-i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 217 ----D-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----H-HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----H-HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000111122233466788999999999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=338.07 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=200.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAED---------TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEE---------cCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 36899999999999999999954 346899999999765432 235688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..++||||+.+++|.+++.... ++++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEe
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... . .....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~---~~~~~ 248 (309)
T 2h34_A 177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----M---GAHIN 248 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----H---HHHHH
T ss_pred cCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----H---HHHhc
Confidence 9999876443221 12334578999999999988889999999999999999999999997543210 0 00000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhchhcCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDTND 361 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~eil~~L~~i~~~~~ 361 (401)
... ..........+..+.+++.+||+.||.+|| +++++++.|+.+....+
T Consensus 249 ~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 249 QAI--------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp SCC--------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred cCC--------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 000 000112233456788999999999999999 99999999998754443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=335.30 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=203.3
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc--cCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|... +..||+|++..... ..+..|.+++.. ++||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 44578999999999999999999543 67899999865432 233455555554 489999999999
Q ss_pred EeeC----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC--------CCCeEEeccCCC
Q 015731 143 CLED----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTS 210 (401)
Q Consensus 143 ~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~ivH~dlkp~ 210 (401)
+.+. ...++||||+.+++|.+++.... +++..++.++.|++.||.|||++ + |+||||||+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~ 171 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSK 171 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGG
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhccC------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchH
Confidence 9887 78999999999999999997643 89999999999999999999998 7 999999999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcc--eeeecccccCcccccccccCCCCcc------cchhhHHHHHHHHHhC---
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATGHLTAK------SDVYSFGVVLLEMLSG--- 279 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~ll~g--- 279 (401)
||+++.++.+||+|||++.......... ......||+.|+|||++.+..+... +|||||||++|+|++|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999997543322111 1224579999999999977666554 9999999999999999
Q ss_pred -------CCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHH
Q 015731 280 -------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMD 347 (401)
Q Consensus 280 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~ 347 (401)
..||....+....... . . ............+ ..++..+.+|+.+||+.||.+|||+.
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~-~-~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPSYED-M-R---------EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHH-H-H---------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ccccccccccHhhhcCCCCchhh-h-H---------HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 5555443222211000 0 0 0000111111122 26778899999999999999999999
Q ss_pred HHHHHHHhchhcCCCC
Q 015731 348 EVVKALEQIQDTNDAG 363 (401)
Q Consensus 348 eil~~L~~i~~~~~~~ 363 (401)
+++++|+.+.+..+..
T Consensus 321 ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 321 RVKKTLAKMSESQDIK 336 (337)
T ss_dssp HHHHHHHHHHHTTTCC
T ss_pred HHHHHHHHHHhhcccC
Confidence 9999999998877654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=337.08 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc--cCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|.. ++..||+|++..... ..+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 346899999999999999999954 367899999876532 334455555555 7999999999986
Q ss_pred ee----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh--------hCCCCeEEeccCCCc
Q 015731 144 LE----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFKTSN 211 (401)
Q Consensus 144 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~ivH~dlkp~N 211 (401)
.+ ....++||||+.+|+|.+++... .+++..++.++.||+.||.||| +++ |+||||||+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~N 143 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKN 143 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGG
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHh
Confidence 54 35689999999999999999643 3899999999999999999999 877 9999999999
Q ss_pred EEEcCCCceEEeeccCCcCCCCCCCcc--eeeecccccCcccccccccC------CCCcccchhhHHHHHHHHHhC----
Q 015731 212 ILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSG---- 279 (401)
Q Consensus 212 il~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g---- 279 (401)
||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 144 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~ 223 (301)
T 3q4u_A 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223 (301)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCc
Confidence 999999999999999987543322111 12234799999999999766 455789999999999999999
Q ss_pred ------CCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 280 ------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 280 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..||....+........ ........... ...........+..+.+|+.+||+.||.+|||+.++++.|
T Consensus 224 ~~~~~~~~pf~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 224 GIVEDYKPPFYDVVPNDPSFEDM--RKVVCVDQQRP----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHH--HHHHTTSCCCC----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccccccccCCCCcchhhh--hHHHhccCCCC----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 77776543322211100 00000000000 0001112335678899999999999999999999999999
Q ss_pred Hhc
Q 015731 354 EQI 356 (401)
Q Consensus 354 ~~i 356 (401)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=332.47 Aligned_cols=278 Identities=19% Similarity=0.199 Sum_probs=217.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEE-ee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC-LE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~-~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++..... ...+.+|+.+++.+.|++++..+.++ .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEE---------cCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 46899999999999999999953 34689999998865542 23577899999999988866666554 66
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~kl 222 (401)
....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl 149 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEE
T ss_pred CCceEEEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEE
Confidence 78889999999 999999997544 34899999999999999999999998 9999999999999 47899999
Q ss_pred eeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 223 SDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 3uzp_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence 999999865433221 112446799999999999998999999999999999999999999987554333322211
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCccccccc
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQN 372 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~~~~~~~ 372 (401)
..... .......+ ....+..+.+|+.+||+.||.+|||+.++++.|+.+............++++
T Consensus 230 ~~~~~------~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 230 ISEKK------MSTPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHHH------HHSCHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred hcccc------cCCchHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 11000 00000000 1123467889999999999999999999999999998888776665555543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=338.47 Aligned_cols=269 Identities=24% Similarity=0.287 Sum_probs=201.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|.. ..+|..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRN---------RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEe---------CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 6799999999999999999954 346899999988665432 24457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||+++.++.++|+||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeC
Confidence 999999999999999988876553 3899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh----
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP---- 300 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---- 300 (401)
|++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.....
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 147 GFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 9998644222 12344578999999999876 5679999999999999999999999977654332221111000
Q ss_pred ----hhhhcchhhhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 301 ----YLQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 301 ----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.................... ....+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 00000000000000000000 0134567889999999999999999999999844
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=358.10 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=210.8
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....++|++.+.||+|+||.||+|.+.. +..||||++.... .....+.+|+.++++++||||+++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 3445778999999999999999997642 5679999997654 3456788999999999999999999998
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
. .+..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEEC
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEe
Confidence 6 5678999999999999999975431 24888999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+...... .
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~------- 395 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I------- 395 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H-------
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---H-------
Confidence 999998643211 111122346778999999988899999999999999999999 9999976432111 1
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 396 -------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 396 -------RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01111111222344567889999999999999999999999999988543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.79 Aligned_cols=254 Identities=24% Similarity=0.252 Sum_probs=182.4
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~l 151 (401)
.+.||+|+||.||+|.. ..+++.||+|++.... ...+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 16 ~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVH---------KKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEE---------TTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEE---------CCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 37899999999999954 4478999999986542 345678999999997 9999999999999999999
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC---ceEEeeccCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLA 228 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~ 228 (401)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .++|+|||++
T Consensus 84 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp EECCCCSCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEEccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 999999999999998764 4999999999999999999999998 99999999999997665 8999999999
Q ss_pred cCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 229 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 157 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------- 225 (325)
T 3kn6_A 157 RLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM--------- 225 (325)
T ss_dssp EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH---------
T ss_pred eecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH---------
Confidence 8644322 12345578999999999998899999999999999999999999997654321111100000
Q ss_pred hhhhhhhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 309 FQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 309 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+......... ....+..+.+|+.+||+.||.+|||+.++++|-|.-
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 001000000000 012467889999999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=337.68 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=202.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc---chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.+|++.+.||+|+||.||+|... .+|..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 56999999999999999999543 368899999987532 233456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999875321 1145899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+..... .....
T Consensus 180 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~----- 248 (310)
T 2wqm_A 180 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK----- 248 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHH-----
T ss_pred ccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHH-----
Confidence 99987643322 12234568999999999988889999999999999999999999996543211 00000
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
.+.............+..+.+|+.+||+.||.+|||+.+++++|+++......++.
T Consensus 249 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 249 -----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp -----HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred -----HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 00000111111223456788999999999999999999999999999988877664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=335.66 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=207.8
Q ss_pred hCCCCCCC-cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|.+.+ .||+|+||.||+|.+.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 36788888 99999999999996532 23578999999876532 2245688999999999999999999998
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEEC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEc
Confidence 5677899999999999999998754 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhh
Q 015731 224 DFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------- 229 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---------- 229 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----------
Confidence 999998654332211 1222346788999999988889999999999999999999 9999976532111
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+-..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 230 -------TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 011111111223345567889999999999999999999999999988543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=339.91 Aligned_cols=265 Identities=25% Similarity=0.304 Sum_probs=205.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe---
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL--- 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~--- 144 (401)
++|++.+.||+|+||.||+|.. ..+|+.||+|++..........+.+|+.+++.++||||+++++++.
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEG---------LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEe---------cCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 6799999999999999999954 3468999999987665555667889999999999999999999987
Q ss_pred -eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 145 -EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 145 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.....++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEE
Confidence 33578999999999999999976421 1245899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcc-------eeeecccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 224 DFGLAKDGPTGSQSH-------VSTRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-- 254 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-- 254 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--
Confidence 999887532211000 012245799999999986543 68899999999999999999999853111000
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..................+..+.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus 255 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 255 -------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00011111111122234567889999999999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.54 Aligned_cols=265 Identities=28% Similarity=0.406 Sum_probs=206.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEe-
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL- 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~- 144 (401)
..+|++.+.||+|+||.||+|.... ...++..+|+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 3568899999999999999997543 223456799999876433 33456889999999999999999999854
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECS
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECc
Confidence 5568899999999999999997644 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCC--cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~------ 245 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------ 245 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH------
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------
Confidence 999986543221 112234567889999999998899999999999999999999 56666554432211111
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 246 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 246 -----------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000111112234567889999999999999999999999999987644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=333.86 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=195.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|... ..+|+|++..... .....+.+|+.++++++||||++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 468999999999999999999543 2499999875532 3345688999999999999999999965
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECC
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcc
Confidence 5567899999999999999996554 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++................||+.|+|||++. +..++.++||||||+++|+|++|..||........ .....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~--- 238 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMV--- 238 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHH---
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHh---
Confidence 99997654333333344567999999999986 56788899999999999999999999976543111 00000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
... .... ........++..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus 239 -~~~-----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 -GRG-----SLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -HHT-----SCCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -ccc-----ccCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 0000 0011223456788999999999999999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=343.86 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=193.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEe--
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL-- 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~-- 144 (401)
.+|++.++||+|+||.||+|.. ..++..||+|++..........+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQD---------VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEE---------CCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 5799999999999999999954 3468999999987665555667889999999996 999999999984
Q ss_pred ------eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 ------EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.....++||||+ +|+|.+++...... .++++..++.++.||+.||.|||+++.+|+||||||+|||++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 345689999999 57999998763221 359999999999999999999999766699999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcc----------eeeecccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 219 NAKLSDFGLAKDGPTGSQSH----------VSTRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
.+||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998654322111 11235689999999998 566788999999999999999999999965
Q ss_pred CCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
...... .............+..+.+|+.+||+.||.+|||+.+++++|+.+........
T Consensus 256 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 256 GAKLRI--------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred hhHHHh--------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 432111 00000111111223356789999999999999999999999999987655443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.70 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=209.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLARE---------KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEE---------cCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 5799999999999999999954 346889999998765322 2356789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEec
Confidence 9999999999999999999998764 3899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------ 221 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------------ 221 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------------
Confidence 99987543221 23457899999999999888999999999999999999999999754321100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+... ...++...+..+.+++.+||+.||.+|||+.++++|-+.-...
T Consensus 222 ----~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 222 ----RRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ----HHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ----HHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011111 1122334566788999999999999999999999987654433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=345.84 Aligned_cols=269 Identities=20% Similarity=0.236 Sum_probs=196.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|. +..+++.||+|++....... ...+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAI---------DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEE---------ECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3679999999999999999994 44478999999997654322 345678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-----CCCc
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-----LNYN 219 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-----~~~~ 219 (401)
+++..++||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccce
Confidence 9999999999996 59999998764 3899999999999999999999998 99999999999994 4556
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 9999999997543221 123445689999999999764 5899999999999999999999999765432211111000
Q ss_pred hhhhhhcchhh-------------hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 KPYLQSKRRIF-------------QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ....... ......+........+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 254 LGL-PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp HCC-CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hCC-CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 000 0000000 0000000000011245678899999999999999999999998554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.78 Aligned_cols=272 Identities=22% Similarity=0.302 Sum_probs=200.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|.. ..++..||+|++....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKS---------KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEE---------CCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 5799999999999999999954 3468899999987654221 11345799999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 145 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFG 145 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSS
T ss_pred CEEEEEecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCc
Confidence 99999999995 69999988764 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...... ...
T Consensus 146 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~ 222 (324)
T 3mtl_A 146 LARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT-PTE 222 (324)
T ss_dssp EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCT
T ss_pred ccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCh
Confidence 987543221 12334578999999999876 56899999999999999999999999875433222111100000 000
Q ss_pred chhhhhhh---------hhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMD---------ARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~---------~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+..... ..... ......+..+.+|+.+||+.||.+|||+.|+++|-+...-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00000000 00000 0011245678899999999999999999999998766533
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.63 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=204.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--------hHHHHHHHHHHHhccCCCccc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLV 137 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~hpni~ 137 (401)
..++|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVD---------KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEE---------TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEE---------CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 346899999999999999999943 447899999998765321 222456899999999999999
Q ss_pred ceeeEEeeCCeeEEEEEecCCC-ChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC
Q 015731 138 KLIGYCLEDDHRLLVYEFMPKG-SLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~ 216 (401)
++++++.+.+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAE 165 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcC
Confidence 9999999999999999998766 9999997664 3899999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------- 235 (335)
T 3dls_A 166 DFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------- 235 (335)
T ss_dssp TSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------
T ss_pred CCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------
Confidence 9999999999998654332 2344679999999999987776 7899999999999999999999964211
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...... ..+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 236 ---------------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 236 ---------------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp ---------------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred ---------------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 000000 1122245678899999999999999999999999654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=341.39 Aligned_cols=277 Identities=26% Similarity=0.387 Sum_probs=215.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|.+.. .+..+|..||+|++..........+.+|+.+++.++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 579999999999999999997542 345679999999998766556667889999999999999999999987654
Q ss_pred --eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 148 --HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 148 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred CCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecC
Confidence 7899999999999999998764 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh--
Q 015731 226 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-- 302 (401)
Q Consensus 226 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 302 (401)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~ 265 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQG 265 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCT
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccch
Confidence 9998654432211 122345677899999998888999999999999999999999888532100 000000000
Q ss_pred -hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 303 -QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 303 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.....+...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000011111221122233445667899999999999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=353.04 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=166.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYD---------KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 46899999999999999999954 4478999999997642 233456889999999999999999999998
Q ss_pred eC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 ED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.. ...|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~ 167 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIA-DSDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCS 167 (432)
T ss_dssp CSCTTTCCCEEEEEECC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCCCCcCCeEEEEEecC-CcCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCC
Confidence 76 5789999999 569999997653 4899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCc--------------------ceeeecccccCccccccc-ccCCCCcccchhhHHHHHHHHHh
Q 015731 220 AKLSDFGLAKDGPTGSQS--------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLS 278 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~ 278 (401)
+||+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 999999999865432211 123567899999999986 56679999999999999999998
Q ss_pred CCCCC
Q 015731 279 GRRVI 283 (401)
Q Consensus 279 g~~p~ 283 (401)
|..||
T Consensus 248 g~~p~ 252 (432)
T 3n9x_A 248 MLQSH 252 (432)
T ss_dssp TCTTT
T ss_pred ccccc
Confidence 54444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=340.67 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=207.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcE--EEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~--~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
++|++.+.||+|+||.||+|.... ++.. +|+|.+..... .....+.+|+.+++++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 579999999999999999996543 4554 49998865322 2344578999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGA-----------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
.+.+..++||||+++++|.+++..... .....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence 999999999999999999999976530 11245899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCcc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 291 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 291 (401)
+++.++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 99999999999999987432211 1223456889999999988889999999999999999998 9999976532110
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+...
T Consensus 251 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 251 -----------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -----------------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -----------------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00011111122333456788999999999999999999999999999877654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=332.38 Aligned_cols=266 Identities=26% Similarity=0.341 Sum_probs=209.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
-.|.+.++||+|+||.||+|.+.. ...++..+|+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 346677899999999999997543 223456899999876443 3345688999999999999999999999876
Q ss_pred Cee-EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 DHR-LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 ~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+.. ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.++|+||
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Df 168 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADF 168 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCT
T ss_pred CCCcEEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcC
Confidence 655 99999999999999997644 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCC--CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~ 302 (401)
|++....... .........+++.|+|||.+.+..++.++||||||+++|+|++|..| |.........
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---------- 238 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---------- 238 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH----------
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH----------
Confidence 9997543322 11122345678899999999988999999999999999999995554 4433321111
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
...........+...+..+.+++.+||+.||.+|||+.++++.|+++......
T Consensus 239 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 239 -------HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111111222334456788999999999999999999999999998776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.02 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=201.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
+.|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~---------~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLD---------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEe---------cCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 5688889999999999999954 34688999999876543 334568899999999999999999998875
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-CCCce
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNA 220 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-~~~~~ 220 (401)
....++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++.+|+|+||||+||+++ .++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCE
Confidence 456899999999999999998764 38999999999999999999999766699999999999997 78999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+|+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||......... ..
T Consensus 172 kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~---- 240 (290)
T 1t4h_A 172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR---- 240 (290)
T ss_dssp EECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----
T ss_pred EEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH----
Confidence 99999999754332 234457999999999886 45899999999999999999999999754321110 00
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...........+...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 241 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 241 ---------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ---------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ---------HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 000000000111122357889999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=340.61 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=209.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|.+.+.||+|+||.||++.. ..++..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISD---------ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 36799999999999999999954 34688999999876532 2345678899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEEC
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEe
Confidence 99999999999999999999987764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------- 251 (335)
T 2owb_A 184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL---------- 251 (335)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------
T ss_pred eccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH----------
Confidence 9999986532221 2334578999999999988889999999999999999999999997543211000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 252 ------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 252 ------RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp ------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ------HHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 00000 1112233456788999999999999999999999986643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=355.13 Aligned_cols=263 Identities=27% Similarity=0.371 Sum_probs=207.7
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.++++++||||+++++++.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 344678999999999999999997653 45699999986543 3457889999999999999999999987
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+ +..++||||+.+|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 250 ~-~~~~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 250 E-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred C-CceEEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECC
Confidence 6 678999999999999999975421 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||+++...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+...... .
T Consensus 324 fG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~-------- 391 (452)
T 1fmk_A 324 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L-------- 391 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------
T ss_pred CccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---H--------
Confidence 99998654322 112233456788999999988899999999999999999999 9999976432111 0
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
..+........+..++..+.+|+.+||+.||++|||+.++++.|+.+......
T Consensus 392 ------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 392 ------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 11111111223445667889999999999999999999999999988655443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.77 Aligned_cols=256 Identities=25% Similarity=0.298 Sum_probs=206.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||+||+|.. ..++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 90 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKD---------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEE---------TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 346799999999999999999944 44789999999865432 3355688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc---CCCce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~---~~~~~ 220 (401)
.+....|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 163 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDI 163 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCE
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCE
Confidence 99999999999999999999997764 3899999999999999999999998 99999999999994 45679
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+
T Consensus 164 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----- 234 (486)
T 3mwu_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV----- 234 (486)
T ss_dssp EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred EEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence 999999998654322 2344579999999999975 5899999999999999999999999765432111111
Q ss_pred hhhhcchhhhhhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 301 YLQSKRRIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
....... ......+..+.+||.+||+.||.+|||+.++++|-+.-.
T Consensus 235 -----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 235 -----------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp -----------HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred -----------HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0000000 001234567889999999999999999999999976543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=331.93 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=187.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAES---------IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEE---------ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 5799999999999999999954 346889999998765322 2356789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+..++||||+.+++|.+++.... .++++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999999998653 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------- 223 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK---------- 223 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----------
Confidence 999986432221 22345789999999999888899999999999999999999999976543211100
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 224 ------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 224 ------VVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp ------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred ------Hhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 0000 011223345678899999999999999999999997554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=332.83 Aligned_cols=257 Identities=26% Similarity=0.305 Sum_probs=200.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|.+.+.||+|+||.||+|.. ..++..+|+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEE---------RSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEE---------ccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 35799999999999999999954 346889999998766432 34668899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~kl 222 (401)
....++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.++|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999999999865421 0134899999999999999999999998 9999999999999 55688999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++....... ......|++.|+|||++. ..++.++||||||+++|+|++|..||.+...........+.
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~---- 240 (285)
T 3is5_A 169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK---- 240 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----
T ss_pred EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC----
Confidence 9999997644322 234467899999999985 56889999999999999999999999765321111100000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..... ......+..+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 241 ----------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 241 ----------EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp ----------CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ----------Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000 000113567889999999999999999999998743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=337.18 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=206.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|.+.+.||+|+||.||+|.. ..+|+.||+|++..........+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQ---------RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEE---------CCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 346799999999999999999954 34689999999986654445568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~kl 222 (401)
.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+|+||||+||++ +.++.++|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEB
T ss_pred CCEEEEEEEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEE
Confidence 999999999999999999997764 3899999999999999999999998 9999999999999 78899999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+ .
T Consensus 151 ~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~ 220 (304)
T 2jam_A 151 TDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------K 220 (304)
T ss_dssp CSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H
T ss_pred ccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------H
Confidence 999998754322 223456899999999998888999999999999999999999999764321110000 0
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ...........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 221 ~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 221 EGY--------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp HCC--------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCC--------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 000 001111223345688899999999999999999999998664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=333.51 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=209.8
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
...++|++.+.||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 44578999999999999999999654 356899999876542 3457889999999999999999999886
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+ +..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+|
T Consensus 79 ~-~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 79 Q-EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred C-CCcEEEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECC
Confidence 4 568999999999999999975431 24899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~------- 221 (279)
T 1qpc_A 153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQ------- 221 (279)
T ss_dssp CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH-------
T ss_pred CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HH-------
Confidence 999986543221 11223456788999999988889999999999999999999 8999976432110 10
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.+........+...+..+.+++.+||..||.+|||+.++++.|+.+.....
T Consensus 222 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 222 -------NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -------HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 001111112233456788899999999999999999999999999865543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=334.76 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=205.5
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
....+|++.+.||+|+||.||+|... .+|..||+|++.... ..+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 34567999999999999999999543 468899999987543 24568999999999999999999886
Q ss_pred e----------------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccC
Q 015731 145 E----------------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 208 (401)
Q Consensus 145 ~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 208 (401)
. ....++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlk 149 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKK--LINRDLK 149 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCC
Confidence 4 4568999999999999999976532 35899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 288 (401)
|+||+++.++.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 150 p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~- 225 (284)
T 2a19_B 150 PSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS- 225 (284)
T ss_dssp GGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-
T ss_pred HHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-
Confidence 999999999999999999987654332 2234568999999999988889999999999999999999988763210
Q ss_pred CccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
.. ...... ...+...+..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus 226 -------~~----------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 -------KF----------FTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------HH----------HHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------HH----------HHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00 001111 1122334567889999999999999999999999999986543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=345.16 Aligned_cols=265 Identities=28% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEe-e
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL-E 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~-~ 145 (401)
..|++.+.||+|+||.||+|.+.. ....+..+|+|.+..... .....+.+|+.++++++||||+++++++. .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 347778899999999999997642 122356789999875432 34567889999999999999999999865 4
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeec
Confidence 568899999999999999997654 34889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc--ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 226 GLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 226 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|+++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+.
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------ 310 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------ 310 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------
Confidence 999864332211 11233457788999999999999999999999999999999 677886654332211110
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
.......+..++..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 311 -----------~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 311 -----------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000111223345678899999999999999999999999999865443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.66 Aligned_cols=277 Identities=22% Similarity=0.272 Sum_probs=213.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.++||+|+||.||+|... .+|..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 367999999999999999999543 4689999999986543 234567799999999999999999999987
Q ss_pred CC--eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE----cCCCc
Q 015731 146 DD--HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYN 219 (401)
Q Consensus 146 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~----~~~~~ 219 (401)
.+ ..++||||+.+++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCcee
Confidence 65 789999999999999999765421 23899999999999999999999998 9999999999999 77788
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 155 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 9999999998654322 2334579999999999864 5678899999999999999999999975433222
Q ss_pred ch-hHHhhhhhhh--hcchhhhhh--------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 292 HN-LIEWAKPYLQ--SKRRIFQVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 292 ~~-~~~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.. .+........ ......... .......+....+..+.+++.+||+.||++||++.++++.++.+.+.
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11 1110000000 000000000 00112234567888999999999999999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.26 Aligned_cols=265 Identities=16% Similarity=0.154 Sum_probs=208.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC---CCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~---hpni~~~~~~ 142 (401)
..++|.+.+.||+|+||.||+|..... .+..++..||+|++..... .++..|+.+++.++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 457899999999999999999964321 2345789999999976543 34556666666665 9999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC------
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL------ 216 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~------ 216 (401)
+...+..|+||||+.+|+|.+++..........+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC-
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcc
Confidence 999999999999999999999998654333356999999999999999999999988 999999999999988
Q ss_pred -----CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 217 -----NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 217 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999754332333345567899999999999998999999999999999999999999854322110
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhchhcCC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR-PTMDEVVKALEQIQDTND 361 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R-ps~~eil~~L~~i~~~~~ 361 (401)
..... +. .+ .....+.+++.+||+.+|.+| |+++++.+.|+.+.+.+.
T Consensus 294 ---------------~~~~~----~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 ---------------KPEGL----FR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---------------EECSC----CT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---------------eechh----cc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00000 00 00 124567789999999999998 688899998988866543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=355.60 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=205.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-------------hHHHHHHHHHHHhccC
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-------------GHLEWLTEIKHLGQLY 132 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~e~~~l~~l~ 132 (401)
..++|++.+.||+|+||+||+|.. ..++..+|+|++...... ....+.+|+.++++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKE---------KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEE---------CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 347899999999999999999954 447899999998765321 2356789999999999
Q ss_pred CCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 133 hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
||||+++++++.+....|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Ni 177 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENI 177 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHE
Confidence 9999999999999999999999999999999998764 3899999999999999999999998 99999999999
Q ss_pred EEcCCC---ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 213 LLDLNY---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 213 l~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
+++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+....
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 998775 69999999998654332 234457999999999986 46899999999999999999999999765432
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.....+. .... .++ ...+..+.+||.+||+.||.+|||+.++++|-|.-..
T Consensus 254 ~~~~~i~----------------~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 254 DIIKKVE----------------KGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHH----------------HCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred HHHHHHH----------------cCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1111110 0000 011 1235678899999999999999999999999776443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=333.63 Aligned_cols=256 Identities=31% Similarity=0.489 Sum_probs=200.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|... +..||+|++.... ....+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN-- 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 57899999999999999999653 5779999987543 34568899999999999999999998774
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh---CCCCeEEeccCCCcEEEcCCCc-eEEe
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYN-AKLS 223 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~dlkp~Nil~~~~~~-~kl~ 223 (401)
..++||||+++++|.+++..... ...++...++.++.||+.||.|||+ ++ |+||||||+||+++.++. +||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEEC
T ss_pred CcEEEEEcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEc
Confidence 48999999999999999976542 1347889999999999999999999 67 999999999999988886 7999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ .+.|..
T Consensus 149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---- 217 (307)
T 2eva_A 149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAV---- 217 (307)
T ss_dssp CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHH----
T ss_pred ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHH----
Confidence 99998754321 2234689999999999988999999999999999999999999975432111 010100
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
............+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 218 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 218 ---------HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---------HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---------hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00011112233456788999999999999999999999999998765543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=345.99 Aligned_cols=270 Identities=27% Similarity=0.351 Sum_probs=208.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSH---------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEE---------CCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 36799999999999999999954 34689999999876532 334568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~D 175 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 175 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEE
Confidence 999999999999999999998764 389999999999999999999985 7 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh-------
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW------- 297 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~------- 297 (401)
||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 176 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3eqc_A 176 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251 (360)
T ss_dssp CCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred CCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence 9998643211 22345789999999999988999999999999999999999999976542211110000
Q ss_pred ---------------hhhhhhhcchhhhhhhhh----hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 298 ---------------AKPYLQSKRRIFQVMDAR----IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 298 ---------------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...............+.. .........+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp ----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 000000000011111111 11111223466789999999999999999999999997653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.78 Aligned_cols=255 Identities=29% Similarity=0.388 Sum_probs=210.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
+.|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGID---------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEE---------CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 5699999999999999999954 34688999999876543 3345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
...++||||+.+++|.+++... ++++..+..++.||+.||.|||++| |+|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CeEEEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999998653 3899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------- 229 (303)
T 3a7i_A 165 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------- 229 (303)
T ss_dssp TCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------
T ss_pred cceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------------
Confidence 997643322 12334578999999999988889999999999999999999999997543211100
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..............+..+.+|+.+||+.||.+|||+.++++|.+....
T Consensus 230 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 230 ----LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 000011112233445678899999999999999999999999876644
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=362.71 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=208.4
Q ss_pred CCCCCC-cccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 69 NFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
++.+.+ .||+|+||.||+|.+.. ..++..||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 79999999999997643 12467899999986533 345678899999999999999999999876
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCS
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeecc
Confidence 56899999999999999997553 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 227 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 227 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----------- 550 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------- 550 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-----------
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----------
Confidence 99865432211 11222345688999999998999999999999999999998 999997654321111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
.+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+........+
T Consensus 551 ------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 551 ------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred ------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 1111111223445667899999999999999999999999999998665554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.17 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=201.9
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... |..||+|++.... ....+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 367999999999999999999542 6789999997653 345678999999999999999999987654
Q ss_pred -CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 147 -DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeec
Confidence 578999999999999999976542 33788999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------------ 224 (278)
T 1byg_A 162 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------ 224 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------------
T ss_pred ccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------
Confidence 998754322 123357889999999988899999999999999999998 99999764321110
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
..+........+...+..+.+++.+||+.||.+|||+.++++.|+.++..+
T Consensus 225 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 -----PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 001111112233445678889999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=356.23 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=210.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.++||+|+||.||+|.. ..+|+.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~---------~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQM---------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 36799999999999999999954 447899999999765432 235678899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+....|+||||+.||+|.+++..... ....+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEe
Confidence 999999999999999999999976542 1245899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~----- 402 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--K----- 402 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--H-----
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--H-----
Confidence 9999986543321 233458999999999999989999999999999999999999999765432211111 0
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKAL 353 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~L 353 (401)
..+... ...++...+..+.+||.+||+.||.+||++ .+|++|-
T Consensus 403 -----~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 403 -----QRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp -----HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred -----HHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 011111 112334556788999999999999999964 7888764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.78 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=201.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..++..+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRD---------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEE---------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEE---------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35799999999999999999954 44789999999876542 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC---CceE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAK 221 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~---~~~k 221 (401)
+....|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.. +.+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEE
Confidence 9999999999999999999997764 3899999999999999999999998 9999999999999764 5599
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 180 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--- 252 (494)
T 3lij_A 180 IVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--- 252 (494)
T ss_dssp ECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---
T ss_pred EEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Confidence 99999997654322 234467999999999986 56899999999999999999999999765432111111000
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... .........+..+.+||.+||+.||.+|||+.++++|-+-
T Consensus 253 ---~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 253 ---KYT--------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp ---CCC--------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ---CCC--------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 000 0000001245678899999999999999999999998554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=358.38 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=208.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.++||+|+||.||+|. +..+|..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCK---------DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEE---------ECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4579999999999999999994 444789999999865432 3456688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~ 220 (401)
.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||++ +.++.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcE
Confidence 99999999999999999999997654 3899999999999999999999998 9999999999999 567899
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+.
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---- 240 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---- 240 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----
Confidence 999999997654332 2344579999999999865 68999999999999999999999997654321111110
Q ss_pred hhhhcchhhhhhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 301 YLQSKRRIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...... ......+..+.+||.+||+.||.+|||+.++++|-+.-
T Consensus 241 ------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 241 ------------KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp ------------HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ------------cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 000000 00123456788999999999999999999999997754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=332.10 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=200.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.+... .+.+..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccC------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 5799999999999999999975431 22345799999876532 33456889999999999999999999998
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.. .++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECC
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcc
Confidence 765 899999999999999998754 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 225 FGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 225 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~------- 234 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L------- 234 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---H-------
Confidence 99998654432211 1233457788999999988889999999999999999999 9999976532111 0
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
..+.........+...+..+.+++.+||..||.+|||+.+++++|++++..
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 235 ------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 011111111122334567889999999999999999999999999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.30 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=198.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 36799999999999999999944 44789999999865432 23456789999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
... .+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~ 165 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDC 165 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCC
Confidence 653 469999999 88999999763 3899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 166 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 166 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999864322 334578999999999876 6789999999999999999999999987653222111110
Q ss_pred hhh-----hhhhc--chhhhhhhh------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 298 AKP-----YLQSK--RRIFQVMDA------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 298 ~~~-----~~~~~--~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
... ..... ......+.. ..........+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 000 00000 000000000 0000112234678899999999999999999999999844
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=332.30 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=202.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||.||+|.. ..+|..+|+|++...... ....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQ---------KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEE---------cCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 35799999999999999999954 346889999998765332 245688999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 218 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-- 218 (401)
+++.+....++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCC
Confidence 99999999999999999999999997754 3899999999999999999999998 99999999999998777
Q ss_pred --ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 --NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 148 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 224 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224 (283)
T ss_dssp SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence 89999999998654322 2234568999999999988889999999999999999999999997643211110000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
...... ... .....+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 225 ------~~~~~~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 225 ------AVNYDF----DEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp ------TTCCCC----CHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred ------hcccCC----cch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 000000 000 0012345788999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=329.34 Aligned_cols=257 Identities=21% Similarity=0.247 Sum_probs=203.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
.++|++.+.||+|+||.||+|. +..++..+|+|++..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVL---------DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEE---------BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEE---------ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4789999999999999999994 445789999999976542 234568899999999999999999999
Q ss_pred Ee--eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 143 CL--EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 143 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+. +....++||||+.++ |.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcE
Confidence 84 456889999999765 8787766443 45899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+|+|||++................|++.|+|||++.+.. ++.++||||||+++|+|++|..||.........
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------ 222 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------ 222 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------
Confidence 999999998654433333344567999999999987643 377999999999999999999999764321100
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
. .+... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 223 ~----------~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 223 E----------NIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp H----------HHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred H----------HHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 0 00000 1122334456788999999999999999999999986653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=365.85 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=209.6
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhcc-CCCccccee
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~hpni~~~~ 140 (401)
....+|++.++||+|+||.||+|.. ..+++.||+|++..... .....+..|..++..+ +||||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~---------~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSER---------KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEE---------SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEE---------CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3457899999999999999999954 44789999999976532 2344577899999987 799999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
+++.+.+.+||||||+.+|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~i 481 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHI 481 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCE
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcE
Confidence 999999999999999999999999987653 899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.......
T Consensus 482 kL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~-------- 551 (674)
T 3pfq_A 482 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------- 551 (674)
T ss_dssp EECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------
T ss_pred EEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH--------
Confidence 999999998533222 1244578999999999999999999999999999999999999999765321111
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKAL 353 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~-----~eil~~L 353 (401)
..+.... ..++...+.++.+||.+||+.||.+||++ +||++|-
T Consensus 552 --------~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 552 --------QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp --------HHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred --------HHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 1111111 22344567789999999999999999997 8888873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=340.36 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=210.6
Q ss_pred cchhHHHHHhCCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhcc-CC
Q 015731 58 FSFNGLKTATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YH 133 (401)
Q Consensus 58 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~h 133 (401)
..+.......++|.+. +.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.+++.+ +|
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCIS---------KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC
Confidence 4455556677888888 8999999999999954 44689999999876543 2345688999999998 56
Q ss_pred CcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 134 pni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
|||+++++++.+.+..++||||+.+++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+||+
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl 163 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNIL 163 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEE
Confidence 9999999999999999999999999999999865432 45899999999999999999999998 999999999999
Q ss_pred EcC---CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 015731 214 LDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 290 (401)
Q Consensus 214 ~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 290 (401)
++. ++.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 987 7899999999998654322 2234579999999999998899999999999999999999999997643211
Q ss_pred cchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 291 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
....+. . .............+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 241 ~~~~i~-------------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 241 TYLNIS-------------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp HHHHHH-------------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred HHHHHH-------------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 110000 0 00011111122355678899999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.65 Aligned_cols=259 Identities=25% Similarity=0.303 Sum_probs=196.1
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--------hHHHHHHHHHHHhccCCCc
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPN 135 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~hpn 135 (401)
....++|.+.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+|++++|||
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 201 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFE---------RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999954 447899999998765321 1123778999999999999
Q ss_pred ccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 136 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
|+++++++. .+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 202 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS 273 (419)
T ss_dssp BCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEES
T ss_pred EeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEe
Confidence 999999975 456899999999999999887653 4899999999999999999999998 99999999999996
Q ss_pred CCC---ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 216 LNY---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 216 ~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred cCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 544 59999999998754322 2345679999999999853 56788999999999999999999999765432
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...... .. ..... .. ... ....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 351 ~~~~~~--i~---~~~~~---~~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 351 VSLKDQ--IT---SGKYN---FI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp CCHHHH--HH---TTCCC---CC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHH--Hh---cCCCC---CC-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 211100 00 00000 00 000 01235678899999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=342.56 Aligned_cols=269 Identities=19% Similarity=0.211 Sum_probs=199.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----------hHHHHHHHHHHHhccCCCcc
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----------GHLEWLTEIKHLGQLYHPNL 136 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpni 136 (401)
++|++.+.||+|+||.||+|.... ...++..+|+|++...... ....+.+|+..++.+.||||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 679999999999999999997653 1225788999998764321 11235678899999999999
Q ss_pred cceeeEEee----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 137 VKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 137 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
+++++++.+ ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 182 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANL 182 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHE
Confidence 999999988 78899999999 999999997664 4899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEeeccCCcCCCCCCC-----cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 213 LLDLNY--NAKLSDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 213 l~~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
+++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998777 999999999975432211 1112345799999999999988899999999999999999999999964
Q ss_pred CCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
........ ......... .+........ .....+..+.+++.+||..||.+|||+.+|++.|+.+.
T Consensus 263 ~~~~~~~~-~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKDPVAV-QTAKTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTCHHHH-HHHHHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccHHH-HHHHHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 32211110 000000000 0000000000 01134567889999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=340.01 Aligned_cols=273 Identities=25% Similarity=0.271 Sum_probs=200.9
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-----HHHHHHHHHHHhccCCCcccce
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKL 139 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~e~~~l~~l~hpni~~~ 139 (401)
...++|++.+.||+|+||.||+|. +..+|..||+|++....... ...+.+|+.+++.++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEE---------ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 345789999999999999999994 44478999999987643221 2357789999999999999999
Q ss_pred eeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
++++.+.+..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCC
Confidence 9999999999999999965 8998887654 34888899999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 151 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp EEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 9999999998654322 12344678999999999865 45889999999999999999999999765432211111000
Q ss_pred hhhhhhcchhhhh---hh---hhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 299 KPYLQSKRRIFQV---MD---ARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 299 ~~~~~~~~~~~~~---~~---~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.. ......+... .+ .......+ ...+..+.+||.+||+.||.+|||+.|+++|-+.-
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 229 LG-TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp HC-CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred cC-CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 00 0000000000 00 00000001 23356889999999999999999999999997653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=330.03 Aligned_cols=254 Identities=25% Similarity=0.330 Sum_probs=209.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|.+.+.||+|+||.||+|.. ..+++.+|+|++..... .....+.+|+.+++.+.||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISD---------ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEE---------CCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 36799999999999999999954 34688999999876532 2345678899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEE
Confidence 99999999999999999999987764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------- 224 (294)
T 2rku_A 158 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----------- 224 (294)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------
T ss_pred eccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence 9999976432221 233457899999999998888999999999999999999999999764321100
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
...... ....+...+..+.+++.+||+.||.+|||+.++++|-+.-
T Consensus 225 -----~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 225 -----LRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp -----HHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred -----HHHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 000000 1122334456788999999999999999999999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=328.69 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=202.6
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCCe
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~ 148 (401)
+|....+||+|+||.||+|.. ..++..||+|.+..........+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRD---------LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEE---------TTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEE---------CCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 455566999999999999954 34688999999877655556678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-CCceEEeeccC
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGL 227 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~ 227 (401)
.++||||+++++|.+++...... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++. ++.++|+|||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred EEEEEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999875321 34678899999999999999999998 999999999999987 89999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+....... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||........ .
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---------- 234 (295)
T 2clq_A 170 SKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---A---------- 234 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---H----------
T ss_pred ccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---H----------
Confidence 97643321 123345789999999998664 378999999999999999999999964321110 0
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.............+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 235 --MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp --HHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred --HHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 000000111223344556788899999999999999999999987544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.84 Aligned_cols=272 Identities=21% Similarity=0.291 Sum_probs=197.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee--
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-- 145 (401)
++|++.+.||+|+||.||+|.. ++..||+|++........ ....++..+..++||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~-~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFANRQNF-INEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccchhhH-HHHHHHHHHHhccCcchhhheecccccc
Confidence 6799999999999999999954 368899999875543221 12244444556899999999975542
Q ss_pred ---CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC---------CCCeEEeccCCCcEE
Q 015731 146 ---DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD---------KAKVIYRDFKTSNIL 213 (401)
Q Consensus 146 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~ivH~dlkp~Nil 213 (401)
...+++||||+++|+|.+++.... .++..++.++.||+.||.|||++ + |+||||||+|||
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nil 152 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVL 152 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEE
Confidence 336789999999999999997654 68889999999999999999998 7 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCC------cceeeecccccCccccccccc-------CCCCcccchhhHHHHHHHHHhCC
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQ------SHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~ 280 (401)
++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999976433211 112234579999999999976 35667899999999999999997
Q ss_pred CCCCCCCCCcc-chhHHhhhhhhhhcchhhhhh-hhhhcCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 281 RVIDKNRPSRE-HNLIEWAKPYLQSKRRIFQVM-DARIEGQ------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 281 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.||........ ..................... ....... .....+..+.+||.+||+.||++|||+.|+++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 77643322221 111100000000000000000 0011111 123467789999999999999999999999999
Q ss_pred HHhchhc
Q 015731 353 LEQIQDT 359 (401)
Q Consensus 353 L~~i~~~ 359 (401)
|+++...
T Consensus 313 L~~ll~~ 319 (336)
T 3g2f_A 313 MAELMMI 319 (336)
T ss_dssp HHHHHHC
T ss_pred HHHHHHH
Confidence 9998644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=337.66 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=205.4
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------hhHHHHHHHHHHHhcc-CC
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQL-YH 133 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l-~h 133 (401)
.....++|++.+.||+|+||.||+|... .+|..||||++..... .....+.+|+.+++++ +|
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 159 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3455678999999999999999999543 4689999998865431 1134577899999999 79
Q ss_pred CcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 134 pni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
|||+++++++......++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+|+||||+||+
T Consensus 160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl 232 (365)
T 2y7j_A 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENIL 232 (365)
T ss_dssp TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 999999999999999999999999999999998654 3899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 287 (401)
++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999988654332 2344679999999999853 357889999999999999999999997543
Q ss_pred CCccchhHHhhhhhhhhcchhhhhhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 288 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.......+ ..... ... ...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 310 ~~~~~~~i----------------~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 310 QILMLRMI----------------MEGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp HHHHHHHH----------------HHTCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHH----------------HhCCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 21110000 00000 001 012456889999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.82 Aligned_cols=270 Identities=26% Similarity=0.353 Sum_probs=202.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|.. ..+|..||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRN---------KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEE---------TTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEE---------CCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 5799999999999999999954 346899999988654332 23457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeC
Confidence 999999999999888888765543 3899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh------
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA------ 298 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~------ 298 (401)
|++....... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+...
T Consensus 169 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 169 GFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 9997643322 123345789999999999765 6899999999999999999999999775432221111000
Q ss_pred --hhhhhhcchhhhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 --KPYLQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 --~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...................... ....+..+.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000000000000000000000 11346788999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.98 Aligned_cols=272 Identities=24% Similarity=0.304 Sum_probs=203.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.+|++.+.||+|+||.||+|.. ..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARH---------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEE---------TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEE---------CCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 5799999999999999999954 346899999998665432 24467799999999999999999999887
Q ss_pred --------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 146 --------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
.+..++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||++| |+||||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD 160 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC
Confidence 456899999995 58888886654 34899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCC--CcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 218 YNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
+.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999999997643222 1122344678999999999865 4579999999999999999999999987543322221
Q ss_pred HHhhhhhhh-----hcc--hhhhhhhhhhcCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 295 IEWAKPYLQ-----SKR--RIFQVMDARIEGQYSL-------GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 295 ~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+........ ... ................ ..+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 111000000 000 0000000000000000 114568899999999999999999999999765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=341.87 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=207.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
.+|++.+.||+|+||.||+|... ....+|..||+|++..... .....+.+|+.+++.+ +||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEc------ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 57999999999999999999653 2234789999999876432 2233456799999999 69999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999998764 3899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ..
T Consensus 201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~- 276 (355)
T 1vzo_A 201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SR- 276 (355)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HH-
T ss_pred eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HH-
Confidence 9999997643222 112334679999999999975 34788999999999999999999999765432221111 00
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHhc
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQI 356 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~~i 356 (401)
.... ....++...+..+.+||.+||..||.+|| ++.++++|.+.-
T Consensus 277 ---------~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 277 ---------RILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp ---------HHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ---------HHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 0000 11223344566788999999999999999 999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=327.33 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=199.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEH---------QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEE---------CCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 36899999999999999999954 34688999999876532 2245678999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEEC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999998764 3899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||++....... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ..
T Consensus 154 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~------ 221 (276)
T 2h6d_A 154 DFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK------ 221 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH------
T ss_pred ecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH------
Confidence 999998654322 2234568999999999987665 6899999999999999999999965432110 00
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+... ....+...+..+.+++.+||+.||.+|||+.++++|-+.-
T Consensus 222 -------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 222 -------KIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp -------HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred -------HhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 00000 0112233456788999999999999999999999986643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=342.25 Aligned_cols=267 Identities=20% Similarity=0.232 Sum_probs=206.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC--------CCcccc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--------HPNLVK 138 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~--------hpni~~ 138 (401)
.++|++.+.||+|+||.||+|.. ..+++.||+|++.... .....+.+|+.+++.+. ||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWD---------IQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEe---------cCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 46899999999999999999944 4468999999997543 23456778999998885 788999
Q ss_pred eeeEEe----eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEE
Q 015731 139 LIGYCL----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNIL 213 (401)
Q Consensus 139 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil 213 (401)
+++++. +....++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++ | |+||||||+|||
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIl 179 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENIL 179 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHee
Confidence 999987 566899999999 7778777765532 4589999999999999999999998 8 999999999999
Q ss_pred EcCCC-------------------------------------------------ceEEeeccCCcCCCCCCCcceeeecc
Q 015731 214 LDLNY-------------------------------------------------NAKLSDFGLAKDGPTGSQSHVSTRVM 244 (401)
Q Consensus 214 ~~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~ 244 (401)
++.++ .++|+|||++...... .....
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~ 254 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDI 254 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCC
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCC
Confidence 98775 7999999999864322 23457
Q ss_pred cccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch-----------hhhhhh
Q 015731 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR-----------IFQVMD 313 (401)
Q Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~ 313 (401)
||+.|+|||++.+..++.++|||||||++|+|++|..||........................ ......
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 899999999999888999999999999999999999999876543322111111000000000 000000
Q ss_pred h-------------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 314 A-------------------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 314 ~-------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
. ......+...+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0 0011345677888999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=332.73 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=207.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+|+.+|+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEE---------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 36799999999999999999954 34689999999876533 23456889999999999999999999875
Q ss_pred e--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---CCeEEeccCCCcEEEcCCCc
Q 015731 145 E--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~dlkp~Nil~~~~~~ 219 (401)
+ ....++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ .+|+|+||||+||+++.++.
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC
Confidence 4 6789999999999999999976432 1244899999999999999999999965 23999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ..
T Consensus 155 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~--- 226 (279)
T 2w5a_A 155 VKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG--- 226 (279)
T ss_dssp EEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---
T ss_pred EEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---
Confidence 9999999987643321 122345789999999999888899999999999999999999999976532110 00
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.+.. ......+...+..+.+++.+||+.||.+|||+.+++++++.-...
T Consensus 227 ----------~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 227 ----------KIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp ----------HHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ----------HHhh-cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 0000 011122334567889999999999999999999999998765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=349.09 Aligned_cols=247 Identities=16% Similarity=0.144 Sum_probs=192.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc---chhHHHHHHHH---HHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEI---KHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~---~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||||++.... ......+.+|+ .+++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 36789999999999999999943 4468999999987532 23345678899 566666899999998
Q ss_pred -------eEEeeCC-----------------eeEEEEEecCCCChHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHhh
Q 015731 141 -------GYCLEDD-----------------HRLLVYEFMPKGSLENHLFRTGAS--YIQPLSWTIRMKVALGAAKGLAY 194 (401)
Q Consensus 141 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~ 194 (401)
+++.+.+ ..|+||||+ +|+|.+++...... ....+++..++.++.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666553 378999999 78999999865321 11234458888999999999999
Q ss_pred hhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-----------CCCcc
Q 015731 195 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----------HLTAK 263 (401)
Q Consensus 195 LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 263 (401)
||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 222 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99998 99999999999999999999999999985322 3345567 999999999877 89999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 015731 264 SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 343 (401)
Q Consensus 264 ~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 343 (401)
+|||||||++|+|++|..||...........+ .. .....+..+.+|+.+||+.||.+|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR------SCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS------SCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh------hccCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999999999765432221111 00 001234678899999999999999
Q ss_pred CCHHHHHHHH
Q 015731 344 PTMDEVVKAL 353 (401)
Q Consensus 344 ps~~eil~~L 353 (401)
||+.++++|-
T Consensus 352 pt~~e~l~hp 361 (377)
T 3byv_A 352 LLPLQAMETP 361 (377)
T ss_dssp CCHHHHHTSH
T ss_pred CCHHHHhhCh
Confidence 9999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=347.65 Aligned_cols=271 Identities=20% Similarity=0.239 Sum_probs=205.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc------CCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL------YHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l------~hpni~~~~ 140 (401)
..+|++.++||+|+||.||+|.. ..++..||+|++..... ....+.+|+.+++.+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~---------~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYD---------HKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEE---------TTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEE---------CCCCcEEEEEEECCccc-hHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 46799999999999999999954 44689999999976532 233456677777666 578999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN- 219 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~- 219 (401)
+++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCc
Confidence 9999999999999999 5799999987653 45899999999999999999999998 999999999999998887
Q ss_pred -eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 240 ~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999754322 23457899999999999989999999999999999999999999876543221111000
Q ss_pred h-----hhhhhcchhhhhhhhhh------------------------------------cCCCCHHHHHHHHHHHHHccc
Q 015731 299 K-----PYLQSKRRIFQVMDARI------------------------------------EGQYSLGAALKTAVLAIKCLS 337 (401)
Q Consensus 299 ~-----~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~L~ 337 (401)
. ............++... ........+..+.+||.+||+
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~ 394 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence 0 00000000000000000 000011125678899999999
Q ss_pred cCCCCCCCHHHHHHHHHhchh
Q 015731 338 NEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 338 ~dp~~Rps~~eil~~L~~i~~ 358 (401)
.||.+|||+.|+|+|-+.-+.
T Consensus 395 ~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 395 WDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp SSTTTSCCHHHHHTSTTTC--
T ss_pred CChhhCCCHHHHhCChhhccC
Confidence 999999999999999776543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.03 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=201.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
..++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+..+..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVK---------RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEE---------cCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 346799999999999999999954 34689999999876432 3345678899999998 89999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-----
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----- 217 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~----- 217 (401)
+.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcc
Confidence 9999999999999999999999976521 1134899999999999999999999998 9999999999999844
Q ss_pred --------------CceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCC
Q 015731 218 --------------YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRV 282 (401)
Q Consensus 218 --------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p 282 (401)
..++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.++
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999988654322 23589999999999765 566899999999999999999887
Q ss_pred CCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 283 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+..... +. .+.. ......+...+..+.+|+.+||+.||.+|||+.++++|-+..
T Consensus 231 ~~~~~~--------~~-----------~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 231 PRNGDQ--------WH-----------EIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp CSSSHH--------HH-----------HHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred CcchhH--------HH-----------HHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 643210 00 0000 111122334567888999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=339.02 Aligned_cols=267 Identities=21% Similarity=0.238 Sum_probs=195.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|+. ..++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEE---------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 36899999999999999999944 44689999999875422 23456789999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
... ..|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~ 164 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 164 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTS
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCC
Confidence 665 7899999995 588888852 2889999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh-
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW- 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~- 297 (401)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 165 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 165 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp CEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred CEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999998643221 23346789999999999988899999999999999999999999977543221111100
Q ss_pred ---------------hhhhhhhc-----chhhhhhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 298 ---------------AKPYLQSK-----RRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 298 ---------------~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...+.... ..+.......... ......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00000000 0000000000000 001234678899999999999999999999999966
Q ss_pred h
Q 015731 355 Q 355 (401)
Q Consensus 355 ~ 355 (401)
.
T Consensus 322 ~ 322 (371)
T 2xrw_A 322 I 322 (371)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=334.34 Aligned_cols=260 Identities=20% Similarity=0.243 Sum_probs=201.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEee-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~- 145 (401)
++|++.+.||+|+||.||+|.. ..+++.||+|++.... ...+.+|+.+++.+. ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEE---------CCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 6799999999999999999954 4468999999987543 346789999999997 9999999999987
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceEEe
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLS 223 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~kl~ 223 (401)
....++||||+.+++|.+++. .+++..+..++.||+.||.|||++| |+||||||+||+++.++ .++|+
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEE
Confidence 678899999999999999884 2788999999999999999999998 99999999999998776 89999
Q ss_pred eccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... +..... ..
T Consensus 174 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~-~~ 248 (330)
T 3nsz_A 174 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAK-VL 248 (330)
T ss_dssp CCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHH-HH
T ss_pred eCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHH-hc
Confidence 999998654332 2334578999999999876 67899999999999999999999999544321111 000000 00
Q ss_pred hhcchhhhhhh-----------------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 303 QSKRRIFQVMD-----------------------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 303 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.. ........ ...........+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 249 GT-EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp CH-HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred CC-chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 00 00000000 000111122256788999999999999999999999998543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=331.19 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=202.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|... .+|..||+|++.... ....+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 4578999999999999999999543 468999999987653 34567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeec
Confidence 999999999999999999997543 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 170 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------- 237 (314)
T 3com_A 170 GVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---------- 237 (314)
T ss_dssp TTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------
T ss_pred ccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----------
Confidence 9997643321 1233457899999999998888999999999999999999999999754321110000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.. ........+...+..+.+|+.+||..||.+|||+.++++|-+.
T Consensus 238 ---~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 238 ---PT--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp ---HH--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ---hc--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 00 0000011122345678899999999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=343.35 Aligned_cols=281 Identities=15% Similarity=0.167 Sum_probs=209.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccc---------
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVK--------- 138 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~--------- 138 (401)
++|++.+.||+|+||.||+|...... .......+..||+|++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~-~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTL-TCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCc-cccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 67999999999999999999665310 0001114788999998754 25678999999999999988
Q ss_pred ------eeeEEee-CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCc
Q 015731 139 ------LIGYCLE-DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 211 (401)
Q Consensus 139 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 211 (401)
+++++.. +...++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 5667765 78899999999 9999999987521 34999999999999999999999998 9999999999
Q ss_pred EEEcCCC--ceEEeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 015731 212 ILLDLNY--NAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 284 (401)
Q Consensus 212 il~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 284 (401)
|+++.++ .++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 8999999999764332111 11233579999999999998899999999999999999999999997
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 364 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~ 364 (401)
...+... .............. .+... .......+..+.+|+.+||+.||.+|||+.++++.|+.+.+......
T Consensus 270 ~~~~~~~-~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFVDKPG---PFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GGTTCHH-HHHHHHHHHHHSCC---CEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCCcCHH-HHHHHHHhccCChh---hhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 6542211 11111110000000 00000 00001235678899999999999999999999999999987776554
Q ss_pred Ccc
Q 015731 365 SRD 367 (401)
Q Consensus 365 ~~~ 367 (401)
...
T Consensus 343 ~~~ 345 (352)
T 2jii_A 343 YDP 345 (352)
T ss_dssp TSC
T ss_pred Ccc
Confidence 433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.36 Aligned_cols=272 Identities=21% Similarity=0.225 Sum_probs=213.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC-CcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h-pni~~~~~~~~~ 145 (401)
.++|++.++||+|+||.||+|.. ..++..||||++...... ..+..|+.+++.|.| ++|..+..++.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTN---------IQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEE---------TTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEE---------CCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 46899999999999999999954 346889999987655332 246789999999976 566666677788
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE---cCCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~---~~~~~~kl 222 (401)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEE
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEE
Confidence 88999999999 999999998644 34999999999999999999999998 9999999999999 68899999
Q ss_pred eeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 223 SDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 999999865433221 112356799999999999999999999999999999999999999987654333322221
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCc
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 366 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~ 366 (401)
..... ...... .+. ..++.++.+|+.+||+.||.+||++.+|++.|+.+..........
T Consensus 228 i~~~~-----~~~~~~-~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~ 286 (483)
T 3sv0_A 228 ISEKK-----VATSIE-ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDY 286 (483)
T ss_dssp HHHHH-----HHSCHH-HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSS
T ss_pred Hhhcc-----ccccHH-HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccC
Confidence 11000 000000 000 123467889999999999999999999999999997766555443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.48 Aligned_cols=266 Identities=27% Similarity=0.364 Sum_probs=207.5
Q ss_pred HHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhc--cCCCccccee
Q 015731 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLI 140 (401)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~hpni~~~~ 140 (401)
.....++|++.+.||+|+||.||+|.. +|+.||+|++.... ...+.+|.+++.. ++||||++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 345668899999999999999999954 37889999987543 3456678888876 7899999999
Q ss_pred eEEeeCC----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh--------hCCCCeEEeccC
Q 015731 141 GYCLEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFK 208 (401)
Q Consensus 141 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~ivH~dlk 208 (401)
+++.... ..++||||+.+++|.+++.... +++..++.++.||+.||.||| +++ |+|||||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlk 174 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLK 174 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCS
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhccC------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCC
Confidence 9998876 8899999999999999997643 899999999999999999999 777 9999999
Q ss_pred CCcEEEcCCCceEEeeccCCcCCCCCCCcc--eeeecccccCcccccccccC------CCCcccchhhHHHHHHHHHhC-
Q 015731 209 TSNILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSG- 279 (401)
Q Consensus 209 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g- 279 (401)
|+||+++.++.++|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence 999999999999999999997543322111 12345789999999998765 233689999999999999999
Q ss_pred ---------CCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCC
Q 015731 280 ---------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPT 345 (401)
Q Consensus 280 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rps 345 (401)
..||....+..... ..+.. .......... ........+.+|+.+||+.||.+|||
T Consensus 255 ~~~~~~~~~~~p~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 255 SIGGIHEDYQLPYYDLVPSDPSV-EEMRK----------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCH-HHHHH----------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred CcCCcccccccCccccCcCcccH-HHHHH----------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 66775543322111 00100 0111111111 12356778999999999999999999
Q ss_pred HHHHHHHHHhchhcCC
Q 015731 346 MDEVVKALEQIQDTND 361 (401)
Q Consensus 346 ~~eil~~L~~i~~~~~ 361 (401)
+.+++++|+.+.+...
T Consensus 324 ~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 324 ALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhc
Confidence 9999999999977654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.57 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=200.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||.||+|... .++..+|+|++..........+.+|+.+++.++||||+++++++.++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 468999999999999999999543 46889999999876655667788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999999987654 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
++...... ........|++.|+|||++ .+..++.++||||||+++|+|++|..||......... .
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~-- 232 (302)
T 2j7t_A 163 VSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------L-- 232 (302)
T ss_dssp HHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------H--
T ss_pred CCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------H--
Confidence 87531110 0112334689999999998 3567889999999999999999999999765321110 0
Q ss_pred hhhcchhhhhhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
....... ....+...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 233 --------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp --------HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred --------HHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 0000000 01112334567889999999999999999999998743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.46 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=209.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ....+.+|+.+|++++||||+++++++.+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 44678889999999999999997653 45699999986543 34578899999999999999999999876
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..+|||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccc
Confidence 678999999999999999975421 34899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+...... .
T Consensus 408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~--------- 474 (535)
T 2h8h_A 408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L--------- 474 (535)
T ss_dssp TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---H---------
T ss_pred ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---------
Confidence 9998653211 111223346788999999988899999999999999999999 9999976432111 1
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 475 -----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 475 -----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1111111122334556788999999999999999999999999998854433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.85 Aligned_cols=271 Identities=25% Similarity=0.343 Sum_probs=189.3
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYC---------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEE---------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 3457899999999999999999943 34688999999876543 2345678999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcC---CCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTG---ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
.+.+..++||||+.+++|.+++.... ......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCE
Confidence 99999999999999999999987521 111245899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC---cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 221 KLSDFGLAKDGPTGSQ---SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
+|+|||++........ ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||............
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~- 239 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT- 239 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-
Confidence 9999999875433211 112234578999999999865 56899999999999999999999999765432211100
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.... .................+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 240 -----~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 240 -----LQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp -----HTSS--CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred -----hccC--CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 0000 00000000001111234567889999999999999999999999744
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=329.91 Aligned_cols=260 Identities=24% Similarity=0.269 Sum_probs=191.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++....... ...+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRH---------VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEe---------cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 46799999999999999999954 4468999999987653322 223445555688889999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEe
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
+++..++||||+. ++|.+++..... ....+++..++.++.||+.||.|||++ + |+||||||+||+++.++.++|+
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEe
Confidence 9999999999995 588887765211 114599999999999999999999997 8 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 153 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------- 221 (290)
T 3fme_A 153 DFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-------- 221 (290)
T ss_dssp CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--------
T ss_pred ecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--------
Confidence 999997653322 22334689999999996 556788999999999999999999999975322110
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..................+..+.+|+.+||+.||.+|||+.++++|-+.-.
T Consensus 222 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 222 -------QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 001111111111112234667889999999999999999999999866543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.84 Aligned_cols=257 Identities=27% Similarity=0.345 Sum_probs=199.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|... .+|..||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4578999999999999999999543 468899999986543 2345678999999999 7999999999998
Q ss_pred e------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 E------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
. .+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCC
Confidence 7 5688999999999999999986532 45899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.++|+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999987643221 1233457899999999986 4668899999999999999999999996543211100
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+.............+..+.+||.+||..||.+|||+.++++|-+.
T Consensus 245 ----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 245 ----------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp ----------------HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred ----------------HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 0001111111122345678899999999999999999999998543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=359.95 Aligned_cols=253 Identities=27% Similarity=0.355 Sum_probs=202.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~l 151 (401)
+.||+|+||.||+|.+.. ..++..||||++..... ....++.+|+.++++++||||+++++++.+ +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 479999999999996542 23578999999986543 234678899999999999999999999865 55889
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 447 v~E~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp EEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EEEccCCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 999999999999997654 3899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC-cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 232 PTGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 232 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
..... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+...... .
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~ 582 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------T 582 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------H
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------H
Confidence 43321 112233456788999999999899999999999999999998 9999976543111 1
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 583 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 583 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111112223344566789999999999999999999999999998743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=338.38 Aligned_cols=271 Identities=25% Similarity=0.268 Sum_probs=205.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..+|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYD---------NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEE---------CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 36899999999999999999954 446899999998754332 33568899999999999999999999876
Q ss_pred C-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 146 D-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
. ...|+||||+. ++|.+++.... +++..+..++.||+.||.|||++| |+||||||+||+++.++.+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~------~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~ 167 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDL 167 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCE
Confidence 5 46899999995 69999997643 899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc-ceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 221 KLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
+|+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred EEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 99999999865432211 11234579999999998754 45899999999999999999999999876544332222100
Q ss_pred hhh-----hhhcc--hhhhhhhh-hhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 299 KPY-----LQSKR--RIFQVMDA-RIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 299 ~~~-----~~~~~--~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... ..... ........ ...... ....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 000 00000 00000000 000000 12235678899999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.59 Aligned_cols=255 Identities=25% Similarity=0.284 Sum_probs=205.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---------hhHHHHHHHHHHHhccC-CCc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------QGHLEWLTEIKHLGQLY-HPN 135 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~e~~~l~~l~-hpn 135 (401)
..++|++.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.+++++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEE---------cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 346899999999999999999954 44789999999865421 12345778999999995 999
Q ss_pred ccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 136 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
|+++++++.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++| ++|+||||+||+++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD 158 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc
Confidence 9999999999999999999999999999998764 3899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
.++.++|+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 99999999999997654322 233457899999999985 456788999999999999999999999654321
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.... .+...... .......+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 236 ~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 236 LMLR----------------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp HHHH----------------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHH----------------HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 1100 00000000 01112345678899999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=343.61 Aligned_cols=270 Identities=21% Similarity=0.269 Sum_probs=198.8
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....++|++.+.||+|+||.||+|.. ..+|+.||+|++...... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFD---------IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEE---------TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 34567899999999999999999954 447899999988654322 23799999999999999999998
Q ss_pred ee--------------------------------------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHH
Q 015731 144 LE--------------------------------------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185 (401)
Q Consensus 144 ~~--------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~ 185 (401)
.. ....++||||++ ++|.+.+..... ....+++..+..++
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYI 147 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHH
Confidence 43 345889999996 588887764211 11458999999999
Q ss_pred HHHHHHHhhhhhCCCCeEEeccCCCcEEEc-CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcc
Q 015731 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAK 263 (401)
Q Consensus 186 ~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 263 (401)
.||+.||.|||++| |+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.+
T Consensus 148 ~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 148 YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcc
Confidence 99999999999988 99999999999997 68899999999998653332 23345789999999998764 58999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhh------------hhhhhhhcCCCCHHHHHHHHHH
Q 015731 264 SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF------------QVMDARIEGQYSLGAALKTAVL 331 (401)
Q Consensus 264 ~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l 331 (401)
+|||||||++|+|++|..||.+....+....+...... .....+. ..........++...+..+.+|
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT-PTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-CCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999999999875433221111000000 0000000 0000001111223356678999
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 015731 332 AIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 332 i~~~L~~dp~~Rps~~eil~~L~ 354 (401)
+.+||+.||.+|||+.|+++|-+
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999998843
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=338.47 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=187.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|. +..+|..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEE---------ETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEE---------ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3689999999999999999994 34478999999987642 233456789999999999999999999987
Q ss_pred eC------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 ED------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.. ...|+|||++ +++|.+++... .+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~ 169 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDC 169 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCC
Confidence 54 5689999999 88999988653 3899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 170 ~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 170 ELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999986432 1334678999999999876 6789999999999999999999999987654322211110
Q ss_pred hhh-----hhhh--cchhhhhhhhhhc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 298 AKP-----YLQS--KRRIFQVMDARIE-GQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 298 ~~~-----~~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... .... ............. .... ...+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 000 0000 0000000000000 0001 1235678899999999999999999999998543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.04 Aligned_cols=256 Identities=26% Similarity=0.325 Sum_probs=198.3
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------hhHHHHHHHHHHHhccCCCccc
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNLV 137 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~hpni~ 137 (401)
..++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.+++.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFE---------RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEE---------cCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 446799999999999999999954 44789999999876432 1123477899999999999999
Q ss_pred ceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
++++++..+. .|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecC
Confidence 9999987655 899999999999999987653 4899999999999999999999998 9999999999999876
Q ss_pred Cc---eEEeeccCCcCCCCCCCcceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 218 YN---AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 218 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+. ++|+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 54 9999999998653321 223457899999999974 46788999999999999999999999976543221
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. .... ....... ... ....+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 228 ~~--~~~~---~~~~~~~----~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 228 LK--DQIT---SGKYNFI----PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp HH--HHHH---HTCCCCC----HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HH--HHHH---hCccccC----chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 11 0000 0000000 000 0123567889999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=331.05 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=201.4
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccC--CC
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY--HP 134 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~--hp 134 (401)
.+..+....++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++++. ||
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 88 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence 33334445578999999999999999999532 378899999865432 33456889999999997 59
Q ss_pred cccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE
Q 015731 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 135 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~ 214 (401)
||+++++++.+.+..++|||+ .+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~ 160 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI 160 (313)
T ss_dssp TBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred ceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence 999999999999999999995 5889999998754 4899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCC
Q 015731 215 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVI 283 (401)
Q Consensus 215 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~ 283 (401)
+ ++.+||+|||++................|++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 161 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (313)
T 3cek_A 161 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239 (313)
T ss_dssp E-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred E-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence 6 48999999999986544332223345578999999999865 46788999999999999999999999
Q ss_pred CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
....... . ......+......++...+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 240 ~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 240 QQIINQI-----S----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp TTCCSHH-----H----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred hhHHHHH-----H----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 6543210 0 01111122222222333356788999999999999999999999987653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=333.21 Aligned_cols=262 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
..++|++.+.||+|+||.||+|.... .+|+|++..... .....+.+|+.++++++||||+++++++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 34789999999999999999996542 389998875432 2223466899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ ++.++|+
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEEC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEe
Confidence 99999999999999999999997654 35889999999999999999999998 99999999999998 6899999
Q ss_pred eccCCcCCCCCC---CcceeeecccccCccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 224 DFGLAKDGPTGS---QSHVSTRVMGTYGYAAPEYMAT---------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 224 Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
|||++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 251 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999987542211 1112233568999999999864 3578899999999999999999999976432111
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
.. .+.............+..+.+++.+||..||.+|||+.++++.|+.+......
T Consensus 252 ~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 252 IW----------------QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HH----------------HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HH----------------HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00 00000001111112445688999999999999999999999999999776544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=356.80 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=209.3
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||.||+|.+.. ....+..+|+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344779999999999999999997643 223467899999876433 2345688999999999999999999998
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
. ++..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEE
Confidence 5 466899999999999999998654 34899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...
T Consensus 534 DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----- 604 (656)
T 2j0j_A 534 DFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----- 604 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH-----
T ss_pred ecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-----
Confidence 9999986543321 12233456789999999988899999999999999999997 9999976532111 100
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 605 ---------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 605 ---------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 001111123345567889999999999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=333.56 Aligned_cols=277 Identities=22% Similarity=0.266 Sum_probs=201.1
Q ss_pred chhHHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-----------hHHHHHHHHHH
Q 015731 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----------GHLEWLTEIKH 127 (401)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~~~e~~~ 127 (401)
...++....++|++.+.||+|+||.||+|... +|..||+|++...... ....+.+|+.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 45566778899999999999999999999532 3789999998654321 12568899999
Q ss_pred HhccCCCcccceeeEEee-----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCe
Q 015731 128 LGQLYHPNLVKLIGYCLE-----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 202 (401)
Q Consensus 128 l~~l~hpni~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i 202 (401)
+++++||||+++++++.. ....|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ |
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i 155 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG--V 155 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc--C
Confidence 999999999999999854 346899999995 68988887554 35899999999999999999999998 9
Q ss_pred EEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCC
Q 015731 203 IYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRR 281 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~ 281 (401)
+||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999997533222 2344578999999999876 678999999999999999999999
Q ss_pred CCCCCCCCccchhHH-hhh-hhhh-----hcchhhhhhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 015731 282 VIDKNRPSREHNLIE-WAK-PYLQ-----SKRRIFQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMD 347 (401)
Q Consensus 282 p~~~~~~~~~~~~~~-~~~-~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rps~~ 347 (401)
||.+.........+. ... +... ............... ......+..+.+|+.+||+.||.+|||+.
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 997654322111110 000 0000 000000000000000 01122356788999999999999999999
Q ss_pred HHHHHHHh
Q 015731 348 EVVKALEQ 355 (401)
Q Consensus 348 eil~~L~~ 355 (401)
++++|-+.
T Consensus 313 ell~hp~f 320 (362)
T 3pg1_A 313 QALRHPYF 320 (362)
T ss_dssp HHHTSGGG
T ss_pred HHHcCchh
Confidence 99998543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.93 Aligned_cols=266 Identities=18% Similarity=0.235 Sum_probs=205.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhH-----------------HHHHHHHHHHh
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-----------------LEWLTEIKHLG 129 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----------------~~~~~e~~~l~ 129 (401)
.++|++.+.||+|+||.||+|.. +|..||+|++........ ..+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999954 488999999876543211 67889999999
Q ss_pred ccCCCcccceeeEEeeCCeeEEEEEecCCCChHHH------HhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCe
Q 015731 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH------LFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKV 202 (401)
Q Consensus 130 ~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~i 202 (401)
+++||||+++++++.+.+..++||||+++++|.++ +.... ...+++..++.++.||+.||.|||+ +| |
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i 173 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKN--I 173 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSC--E
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCC--E
Confidence 99999999999999999999999999999999998 54421 2569999999999999999999999 88 9
Q ss_pred EEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCc-ccchhhHHHHHHHHHhCC
Q 015731 203 IYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTA-KSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~ll~g~ 280 (401)
+|+||||+||+++.++.++|+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|+|++|.
T Consensus 174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred eecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999864332 33456789999999999776 5666 999999999999999999
Q ss_pred CCCCCCCCCccchhHHhhhhh-hhhcc---hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 281 RVIDKNRPSREHNLIEWAKPY-LQSKR---RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 281 ~p~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.||....... ......... ..... ..................+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 250 ~pf~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 250 VPFSLKISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp CSSCCSSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCCCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 9997654311 111100000 00000 000000000000011335678889999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=329.25 Aligned_cols=267 Identities=24% Similarity=0.280 Sum_probs=205.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCC------ccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP------NLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hp------ni~~~~ 140 (401)
.++|++.+.||+|+||.||+|... ..++..||+|++.... .....+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 468999999999999999999643 2358899999987543 2344567888888888655 599999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC----
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---- 216 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---- 216 (401)
+++.+.+..++||||+ +++|.+++..... .++++..+..++.||+.||+|||+++ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccc
Confidence 9999999999999999 8999999987653 45899999999999999999999998 999999999999987
Q ss_pred ---------------CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 015731 217 ---------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281 (401)
Q Consensus 217 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 281 (401)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 668999999999764322 234578999999999998899999999999999999999999
Q ss_pred CCCCCCCCccchhHHhhhhhh-----hhcc--------------------hhhhhhhh-hhcCCCCHHHHHHHHHHHHHc
Q 015731 282 VIDKNRPSREHNLIEWAKPYL-----QSKR--------------------RIFQVMDA-RIEGQYSLGAALKTAVLAIKC 335 (401)
Q Consensus 282 p~~~~~~~~~~~~~~~~~~~~-----~~~~--------------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 335 (401)
||...........+....... .... ........ ..........+..+.+|+.+|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 997654322211111000000 0000 00000000 000122345678899999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 015731 336 LSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 336 L~~dp~~Rps~~eil~~L 353 (401)
|+.||.+|||+.|+++|-
T Consensus 313 L~~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 313 LEYDPAKRITLREALKHP 330 (339)
T ss_dssp TCSSTTTSCCHHHHTTSG
T ss_pred hCcCcccccCHHHHhcCH
Confidence 999999999999999883
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=340.60 Aligned_cols=256 Identities=13% Similarity=0.017 Sum_probs=183.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHH---HHHhccCCCccccee-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEI---KHLGQLYHPNLVKLI- 140 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~---~~l~~l~hpni~~~~- 140 (401)
.+|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+ .+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRD---------VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEE---------CCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 4589999999999999999954 34689999999987543 2234466774 45555 799988755
Q ss_pred ------eEEeeC-----------------CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHH------HHHHHHHHHH
Q 015731 141 ------GYCLED-----------------DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR------MKVALGAAKG 191 (401)
Q Consensus 141 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~~ 191 (401)
+++... ...|+||||+. ++|.+++..... .+.+..+ ..++.||+.|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHH
Confidence 444433 33799999997 899999987532 2444444 6778999999
Q ss_pred HhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccccc--CCCCcccchhhH
Q 015731 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSF 269 (401)
Q Consensus 192 l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diwsl 269 (401)
|+|||+++ |+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 207 L~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 207 AANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 99999998 99999999999999999999999999986432 2224567799999999977 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 015731 270 GVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 349 (401)
Q Consensus 270 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ei 349 (401)
||++|+|++|..||....+....... .. ..................+..+.+|+.+||+.||++|||+.++
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSWK---RP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCCC---BC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHHHHhCCCCCCCcCcccccchh---hh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999999999999876442211100 00 0000000011111112446788899999999999999999999
Q ss_pred HHHHH
Q 015731 350 VKALE 354 (401)
Q Consensus 350 l~~L~ 354 (401)
++|-+
T Consensus 351 l~hp~ 355 (371)
T 3q60_A 351 METPE 355 (371)
T ss_dssp TTSHH
T ss_pred hcCHH
Confidence 98744
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=345.87 Aligned_cols=266 Identities=24% Similarity=0.277 Sum_probs=196.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~- 146 (401)
.+|++.++||+|+||.||+|... .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 46999999999999999999553 4689999998865432 123799999999999999999988542
Q ss_pred -----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-Cce
Q 015731 147 -----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNA 220 (401)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~-~~~ 220 (401)
..+++||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeE
Confidence 24679999995 477776653211 1145899999999999999999999988 9999999999999855 678
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+ ..
T Consensus 197 kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i--~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI--IK 271 (420)
T ss_dssp EECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH
T ss_pred EeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence 999999998654332 22345789999999998664 7899999999999999999999999875432211111 00
Q ss_pred hhhhh-cchhhhhh------------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 PYLQS-KRRIFQVM------------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 ~~~~~-~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..-.. ...+..+. .......+....+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 00000 00000000 0000000122345788999999999999999999999998554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.13 Aligned_cols=271 Identities=24% Similarity=0.290 Sum_probs=197.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEe--
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-- 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~-- 144 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVD---------NDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEE---------TTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEE---------CCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 46899999999999999999954 4468999999987766555667889999999999999999999873
Q ss_pred ------------eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 145 ------------EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 145 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
+....++||||+. ++|.+++... ++++..++.++.||+.||+|||++| |+||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 151 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANL 151 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence 4468899999996 6999998653 3899999999999999999999998 99999999999
Q ss_pred EEc-CCCceEEeeccCCcCCCCCCC-cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 015731 213 LLD-LNYNAKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289 (401)
Q Consensus 213 l~~-~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 289 (401)
+++ .++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 997 567999999999986532211 112234567899999998865 67899999999999999999999999875432
Q ss_pred ccchhHHhhhhhhhh--cch----hhhhhhhhhc-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 290 REHNLIEWAKPYLQS--KRR----IFQVMDARIE-GQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~-~~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.....+....+.... ... +......... .. .....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 211111100000000 000 0000000000 00 012346778999999999999999999999998553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=323.20 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=195.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARN---------ALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEE---------cCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 46799999999999999999954 3468999999986543 334568899999999999999999998865
Q ss_pred ------------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 146 ------------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 146 ------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil 148 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIF 148 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEE
Confidence 457899999999999999998654 34788999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCC------------cceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCC
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQ------------SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~ 280 (401)
++.++.++|+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999986432210 1122345789999999999754 68999999999999999998
Q ss_pred CCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 281 RVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
||.... ....... . + ..........++...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 227 -p~~~~~-----~~~~~~~----~---~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 227 -PFSTGM-----ERVNILK----K---L-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp -CCSSHH-----HHHHHHH----H---H-HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred -ccCCch-----hHHHHHH----h---c-cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 442210 0000000 0 0 0011112223344556678899999999999999999999998554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=321.29 Aligned_cols=255 Identities=26% Similarity=0.310 Sum_probs=205.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKD---------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEE---------cCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 4567899999999999999999954 34688999999876543 335568899999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC---Cc
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YN 219 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~---~~ 219 (401)
+.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred EeCCCeEEEEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCccc
Confidence 999999999999999999999987664 3899999999999999999999998 9999999999999654 46
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
++|+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||..........
T Consensus 163 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------ 232 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------ 232 (287)
T ss_dssp EEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred EEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 9999999987643322 1233468999999999865 48899999999999999999999997653211100
Q ss_pred hhhhhcchhhhhhhhhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 PYLQSKRRIFQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+......... ....+..+.+++.+||+.||.+|||+.++++|-+.
T Consensus 233 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 233 ----------RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp ----------HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred ----------HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 00000000000 01235678899999999999999999999997543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=336.02 Aligned_cols=278 Identities=20% Similarity=0.274 Sum_probs=189.0
Q ss_pred CCCCC-CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 68 RNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 68 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
+.|++ .++||+|+||.||+|.... ..++..||+|++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 45666 5589999999999996542 23678899999976543 2356799999999999999999999954
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE----cC
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGA----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DL 216 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~----~~ 216 (401)
+...++||||+ +++|.+++..... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCC
Confidence 67899999999 4688888864321 11134899999999999999999999998 9999999999999 67
Q ss_pred CCceEEeeccCCcCCCCCCC-cceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc--
Q 015731 217 NYNAKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-- 292 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-- 292 (401)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.......
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 78999999999986543211 122345679999999999876 45899999999999999999999999765432100
Q ss_pred ----hhHHhhhhhhhh--c------------chhhhhhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCCCC
Q 015731 293 ----NLIEWAKPYLQS--K------------RRIFQVMDARIEGQ---------YSLGAALKTAVLAIKCLSNEPKFRPT 345 (401)
Q Consensus 293 ----~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dp~~Rps 345 (401)
..+......+.. . .............. .....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 000000000000 0 00000000000000 00111457789999999999999999
Q ss_pred HHHHHHHHHhch
Q 015731 346 MDEVVKALEQIQ 357 (401)
Q Consensus 346 ~~eil~~L~~i~ 357 (401)
+.|+|+|-+...
T Consensus 328 a~e~L~hp~f~~ 339 (405)
T 3rgf_A 328 SEQAMQDPYFLE 339 (405)
T ss_dssp HHHHHTSGGGTS
T ss_pred HHHHhcChhhcc
Confidence 999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.75 Aligned_cols=266 Identities=17% Similarity=0.206 Sum_probs=202.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-----------CCcc
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPNL 136 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpni 136 (401)
.+|++.+.||+|+||.||+|.. ..+++.||+|++..... ....+.+|+.+++++. ||||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKD---------MVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CeEEEEEeeeecCCeEEEEEEe---------cCCCcEEEEEEecCCcc-chhhhhHHHHHHHHhhcccccchhccccchH
Confidence 6899999999999999999944 44689999999875432 3345678888888876 8999
Q ss_pred cceeeEEeeCC----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCc
Q 015731 137 VKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSN 211 (401)
Q Consensus 137 ~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~N 211 (401)
+++++++...+ ..++|||++ +++|.+++..... ..+++..+..++.||+.||.|||++ | |+||||||+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~N 162 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 162 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGG
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHH
Confidence 99999988654 789999999 9999999987543 3489999999999999999999998 8 9999999999
Q ss_pred EEEc------CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 015731 212 ILLD------LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 285 (401)
Q Consensus 212 il~~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 285 (401)
||++ ..+.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 4457999999999764322 2334789999999999988899999999999999999999999976
Q ss_pred CCCCccchhHHhhhhhhh-----------hcch---------------------hhhhhhhhhcCCCCHHHHHHHHHHHH
Q 015731 286 NRPSREHNLIEWAKPYLQ-----------SKRR---------------------IFQVMDARIEGQYSLGAALKTAVLAI 333 (401)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~-----------~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~ 333 (401)
.................. .... ...... ....++...+..+.+||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHH
Confidence 543221110000000000 0000 000000 112345678889999999
Q ss_pred HccccCCCCCCCHHHHHHHHHhc
Q 015731 334 KCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 334 ~~L~~dp~~Rps~~eil~~L~~i 356 (401)
+||+.||.+|||+.|+++|-+.-
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLK 338 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGT
T ss_pred HHhccCccccCCHHHHhhChhhh
Confidence 99999999999999999986543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=334.22 Aligned_cols=271 Identities=25% Similarity=0.279 Sum_probs=201.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATH---------KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEE---------CCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 46899999999999999999954 34689999999865432 234467799999999999999999998775
Q ss_pred C-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 146 D-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
. ...++||||+. ++|.+++... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~ 151 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDL 151 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcE
Confidence 4 67899999995 6999998764 3899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcc--------eeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 221 KLSDFGLAKDGPTGSQSH--------VSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999998654321110 1223578999999998754 6789999999999999999999999976542211
Q ss_pred chhHHhhhhhhh--h------cchhhhhhhhhhc-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 292 HNLIEWAKPYLQ--S------KRRIFQVMDARIE-G-----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 292 ~~~~~~~~~~~~--~------~~~~~~~~~~~~~-~-----~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
...+........ . ............. . ......+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 111100000000 0 0000000000000 0 0012345678899999999999999999999998554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.99 Aligned_cols=272 Identities=22% Similarity=0.237 Sum_probs=204.0
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CC-----cccc
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP-----NLVK 138 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----ni~~ 138 (401)
...++|++.+.||+|+||+||+|.. ..+++.||+|++.... .....+..|+.+++.+. |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYD---------RVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEE---------cCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3457899999999999999999954 3468999999997543 22345567888877774 44 4999
Q ss_pred eeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc--C
Q 015731 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--L 216 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~--~ 216 (401)
+++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++..+|+||||||+|||++ .
T Consensus 121 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred eeeeeccCCceEEEEecC-CCCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 999999999999999999 5699999987643 348999999999999999999996434499999999999994 4
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 788999999999865322 234578999999999998899999999999999999999999998765432221111
Q ss_pred hhhh-----hhhhcchhhhhhhh-----------------------------------------hhcCCCCHHHHHHHHH
Q 015731 297 WAKP-----YLQSKRRIFQVMDA-----------------------------------------RIEGQYSLGAALKTAV 330 (401)
Q Consensus 297 ~~~~-----~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~ 330 (401)
.... ...........+.. .............+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 0000 00000000000000 0001112344568899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHh
Q 015731 331 LAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 331 li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
||.+||+.||++|||+.|+|+|-+.
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHHHhcCCChhhCCCHHHHhcCccc
Confidence 9999999999999999999998554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=327.56 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=195.7
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh------HHHHHHHHHHHhcc----CCC
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------HLEWLTEIKHLGQL----YHP 134 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~e~~~l~~l----~hp 134 (401)
...++|++.+.||+|+||.||+|. +..++..||+|++....... ...+.+|+.++.++ +||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGH---------RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEE---------CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEE---------EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 345789999999999999999994 44568999999997654321 22345788888888 899
Q ss_pred cccceeeEEeeCCeeEEEEEe-cCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 135 NLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 135 ni~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
||+++++++.+.+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 171 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENIL 171 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEE
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEE
Confidence 999999999999999999999 78999999998764 3899999999999999999999998 999999999999
Q ss_pred Ec-CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 214 LD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 214 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
++ .++.++|+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|..||.....
T Consensus 172 ~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 244 (312)
T 2iwi_A 172 IDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--- 244 (312)
T ss_dssp EETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred EeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---
Confidence 98 88999999999998654322 3345689999999998776664 589999999999999999999964210
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
. ... ...++...+..+.+|+.+||+.||++|||+.++++|-+.-...+
T Consensus 245 ---------~----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 245 ---------I----------LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ---------H----------HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ---------H----------hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 0 000 01122334567889999999999999999999999876544333
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=328.00 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=183.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHH-HHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIK-HLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~-~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||.||+|.. ..+|+.||+|++..... ....++..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVH---------KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEE---------TTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEE---------cCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 36899999999999999999954 34689999999876533 22334555655 777889999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEe
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
+.+..++||||+. ++|.+++..........+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999996 5888887642211224589999999999999999999998 8 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
|||++....... ......|++.|+|||++ .+..++.++|||||||++|+|++|..||......... ..
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~ 240 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LT 240 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HH
Confidence 999997653322 22334689999999998 4567899999999999999999999999764321100 00
Q ss_pred hhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.........+........+..+.+|+.+||+.||.+|||+.++++|-+..
T Consensus 241 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 241 -------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp -------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 00000000011111123456788999999999999999999999986654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.77 Aligned_cols=273 Identities=23% Similarity=0.284 Sum_probs=191.1
Q ss_pred HHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
....++|++.+.||+|+||.||+|.. ..+|..||+|++..... ....+.+++..+..++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKE---------KSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HHHHTTEEEC----------CEEEEE---------TTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 45568999999999999999999954 34689999998865432 223456788888889999999999998
Q ss_pred eeCCe-------eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhh--hCCCCeEEeccCCCcEEE
Q 015731 144 LEDDH-------RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLH--SDKAKVIYRDFKTSNILL 214 (401)
Q Consensus 144 ~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~dlkp~Nil~ 214 (401)
..... .++||||+.+ +|.+.+..... ....+++..+..++.||+.||.||| +++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll 164 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLV 164 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEE
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEE
Confidence 76433 7899999965 66655543211 1145889999999999999999999 877 9999999999999
Q ss_pred cC-CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccc
Q 015731 215 DL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292 (401)
Q Consensus 215 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 292 (401)
+. ++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence 86 8999999999998654332 23345789999999998654 4899999999999999999999999875432221
Q ss_pred hhHHhhhhhhhhcchhhhhhh----------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 293 NLIEWAKPYLQSKRRIFQVMD----------------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
..+. ............... ...........+..+.+|+.+||+.||.+|||+.|+++|-+.
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 242 HEIV--RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HHHH--HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred HHHH--HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 1110 000000000000000 000111222356789999999999999999999999998554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.24 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=199.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|.+.+.||+|+||.||+|.. ..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAID---------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEE---------CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 46899999999999999999944 44789999999976432 22456789999999999999999999998
Q ss_pred eCCee------EEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDDHR------LLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
..+.. ++||||+. ++|.+++. ..+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~ 181 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDC 181 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCC
Confidence 77655 99999995 68888773 23899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 182 ~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 182 ELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp CEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999975432 2334578999999999876 6789999999999999999999999976543221111100
Q ss_pred hhh-----hhhh--cchhhhhhhhhhcC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 298 AKP-----YLQS--KRRIFQVMDARIEG------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 298 ~~~-----~~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... .... .............. ......+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 000 0000 00000000000000 0011236788999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=328.03 Aligned_cols=261 Identities=21% Similarity=0.234 Sum_probs=178.2
Q ss_pred hCCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|.+. ++||+|+||.||+|.. ..+|+.||+|++..... ...+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFH---------RRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEE---------CCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3578885 4699999999999954 44689999999865321 11122334566789999999999876
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CC
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 218 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~ 218 (401)
....++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCc
Confidence 4568999999999999999987643 45999999999999999999999998 999999999999976 45
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.++|+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 169 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~- 243 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR- 243 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred eEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-
Confidence 5999999999764322 23345789999999999888899999999999999999999999976543221100000
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.................+..+.+|+.+||+.||.+|||+.++++|-+.-+..
T Consensus 244 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ---------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ---------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000000011111123466788999999999999999999999987765443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.82 Aligned_cols=265 Identities=24% Similarity=0.282 Sum_probs=192.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.++||+|+||.||+|.... ++. +|+|++...... ..+|+.+++.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE---------SDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC---------CCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 579999999999999999996543 344 788876543321 136999999999999999999986543
Q ss_pred ------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-CCCce
Q 015731 148 ------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNA 220 (401)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-~~~~~ 220 (401)
..++||||+.+ +|.+.+..... ....+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEE
T ss_pred CCCCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcE
Confidence 37899999965 55444432110 1145899999999999999999999998 99999999999998 79999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....
T Consensus 182 kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 182 KLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp EECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998653332 23345789999999998654 58999999999999999999999998764322211110000
Q ss_pred hhhhhcchhhh----hh--------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 300 PYLQSKRRIFQ----VM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 300 ~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. .....+.. .. .......+....+..+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 259 g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 259 GT-PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CC-CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CC-CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00 00000000 00 000001112235568899999999999999999999999843
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=326.05 Aligned_cols=271 Identities=24% Similarity=0.330 Sum_probs=202.8
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhcc---CCCccccee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQL---YHPNLVKLI 140 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l---~hpni~~~~ 140 (401)
..++|++.+.||+|+||.||+|.... .+|..||+|++....... ...+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 34789999999999999999996531 357899999987543221 22345666666655 899999999
Q ss_pred eEEe-----eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 141 GYCL-----EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 141 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+++. .....++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++| |+|+||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~ 154 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT 154 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc
Confidence 9987 5678899999996 699999987543 34899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
.++.++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp TTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999997643221 233457899999999998888999999999999999999999999765432211111
Q ss_pred Hhhhhhhhhcchhhh-------hh---hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 296 EWAKPYLQSKRRIFQ-------VM---DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...... ........ .. .......+....+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 232 LDVIGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp HHHHCC-CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHcCC-CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000000 00000000 00 000001122335667889999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=325.68 Aligned_cols=269 Identities=19% Similarity=0.209 Sum_probs=203.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc------cccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN------LVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn------i~~~~ 140 (401)
.++|++.+.||+|+||.||+|..... .+..||+|++.... .....+.+|+.+++.+.|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 47899999999999999999965431 24789999987543 23445678899998887655 89999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEE------
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL------ 214 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~------ 214 (401)
+++...+..++||||+ +++|.+++..... .++++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccc
Confidence 9999999999999999 7788888876542 45899999999999999999999988 9999999999999
Q ss_pred -------------cCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 015731 215 -------------DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281 (401)
Q Consensus 215 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 281 (401)
+.++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56789999999999764322 234578999999999998899999999999999999999999
Q ss_pred CCCCCCCCccchhHHhhhhhh-----hhcc--------------------hhhhhhh-hhhcCCCCHHHHHHHHHHHHHc
Q 015731 282 VIDKNRPSREHNLIEWAKPYL-----QSKR--------------------RIFQVMD-ARIEGQYSLGAALKTAVLAIKC 335 (401)
Q Consensus 282 p~~~~~~~~~~~~~~~~~~~~-----~~~~--------------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 335 (401)
||...........+....... .... ....... ...........+..+.+|+.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 997654322111111000000 0000 0000000 0000112335567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 015731 336 LSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 336 L~~dp~~Rps~~eil~~L~~ 355 (401)
|+.||.+|||+.++++|-+.
T Consensus 318 L~~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 318 LEFDPAQRITLAEALLHPFF 337 (355)
T ss_dssp TCSSTTTSCCHHHHTTSGGG
T ss_pred hcCChhhCcCHHHHhcChhh
Confidence 99999999999999988543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.32 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=199.3
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|.+.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAID---------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEE---------CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 36899999999999999999944 44789999999876432 22456789999999999999999999998
Q ss_pred eCCe------eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDDH------RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
.... .|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~ 163 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDC 163 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTC
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCC
Confidence 7654 499999995 688877632 3899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 164 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 164 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999764321 234578999999999876 6789999999999999999999999987543221111100
Q ss_pred hhh-----hhhh--cc---hhhhhhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 298 AKP-----YLQS--KR---RIFQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 298 ~~~-----~~~~--~~---~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
... .... .. ........... .......+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 000 0000 00 00000000000 11123456789999999999999999999999998553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=325.74 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=201.6
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccC--CCcc
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNL 136 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~--hpni 136 (401)
....+|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++++. ||||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEE---------TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 3457899999999999999999954 346899999998765432 1234567899999996 5999
Q ss_pred cceeeEEeeCCeeEEEEEecCC-CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 137 VKLIGYCLEDDHRLLVYEFMPK-GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 137 ~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+++++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILID 183 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEe
Confidence 9999999999999999999976 89999998764 3899999999999999999999998 99999999999998
Q ss_pred -CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccch
Q 015731 216 -LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293 (401)
Q Consensus 216 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 293 (401)
.++.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence 7899999999999865432 2234568999999999877665 6889999999999999999999954210
Q ss_pred hHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 255 -------~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 255 -------IIRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp -------HHHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred -------hhcc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 0000 001122345678899999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=317.32 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=182.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-H-HHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-H-LEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~-~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||.||+|... .+|..||+|++....... . ..+.++..+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 57899999999999999999543 468899999987654322 2 234445567788899999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
.+..++||||+ ++.+..+..... ..+++..+..++.||+.||.|||+. + |+|+||||+||+++.++.++|+|
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECC
T ss_pred CCcEEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEE
Confidence 99999999999 666666655433 3489999999999999999999995 8 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 299 (401)
||++....... ......|++.|+|||++. +..++.++|||||||++|+|++|..||....... ... .
T Consensus 169 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~ 240 (318)
T 2dyl_A 169 FGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVL---T 240 (318)
T ss_dssp CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH---H
T ss_pred CCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHH---H
Confidence 99987643322 223456899999999984 4568889999999999999999999997533210 000 0
Q ss_pred hhhhhcchhhhhhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 300 PYLQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 300 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
....... ........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 241 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 241 ----------KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp ----------HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ----------HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 0000000 000111245678899999999999999999999998553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.19 Aligned_cols=258 Identities=26% Similarity=0.299 Sum_probs=187.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~ 146 (401)
+.|.+.++||+|+||+||.+.. .+|..||||++.... ...+.+|+.+++++ +||||+++++++.++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4566678999999999986522 248899999986543 23567899999876 899999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC-------
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------- 217 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~------- 217 (401)
+..|+||||+ +|+|.+++........ ...++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 9999999999 4699999986543111 11133345789999999999999998 9999999999999654
Q ss_pred ------CceEEeeccCCcCCCCCCCc--ceeeecccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCC
Q 015731 218 ------YNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRR 281 (401)
Q Consensus 218 ------~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~ 281 (401)
+.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999865443211 11234579999999999865 568899999999999999999 999
Q ss_pred CCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
||....... ...+ ...... ...........+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 239 Pf~~~~~~~-~~i~-------~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 239 PFGDKYSRE-SNII-------RGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp TTCSTTTHH-HHHH-------HTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCCchhhH-HHHh-------cCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 996543211 0000 000000 00111223467788999999999999999999999998744
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.01 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=185.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~ 146 (401)
.+|.+.++||+|+||+||.... .+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~----------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM----------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE----------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEE----------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4688889999999999654322 24788999998765433 235799999998 799999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-----CCceE
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAK 221 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-----~~~~k 221 (401)
...|+||||+ +++|.+++..... .+....++.++.||+.||.|||+++ |+||||||+||+++. ...++
T Consensus 91 ~~~~lv~E~~-~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 91 QFQYIAIELC-AATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp TEEEEEEECC-SEEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred CEEEEEEECC-CCCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEE
Confidence 9999999999 5699999987653 2344456789999999999999998 999999999999943 23578
Q ss_pred EeeccCCcCCCCCCC-cceeeecccccCcccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHH
Q 015731 222 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 296 (401)
|+|||++........ ........||+.|+|||++. ...++.++|||||||++|+|++ |..||.........
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---- 239 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---- 239 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----
Confidence 999999986543321 12234467999999999996 4567789999999999999999 89998643221000
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
........ .........+..+.+||.+||+.||.+|||+.++++|-
T Consensus 240 ----~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 240 ----ILLGACSL-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp ----HHTTCCCC-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred ----HHhccCCc-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 00000000 00111234566788999999999999999999999773
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=337.32 Aligned_cols=270 Identities=27% Similarity=0.336 Sum_probs=203.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~- 145 (401)
++|++.+.||+|+||.||+| .+..+|..||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 68999999999999999998 5556789999999876532 334568899999999999999999998765
Q ss_pred -----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc-
Q 015731 146 -----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN- 219 (401)
Q Consensus 146 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~- 219 (401)
++..++||||+.+++|.+++...... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSS
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCc
Confidence 67789999999999999999875421 34888899999999999999999988 999999999999987665
Q ss_pred --eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 220 --AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 220 --~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ..|
T Consensus 161 ~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~ 232 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQW 232 (676)
T ss_dssp CEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHS
T ss_pred eeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhh
Confidence 8999999998754332 234467999999999999899999999999999999999999999653211 111
Q ss_pred hhhhhhh----------cchhhhhh-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH-----HHHHHhchh
Q 015731 298 AKPYLQS----------KRRIFQVM-DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV-----VKALEQIQD 358 (401)
Q Consensus 298 ~~~~~~~----------~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ei-----l~~L~~i~~ 358 (401)
....... ........ ............+..+.+|+.+||..||.+|||+.++ ++.+..+.+
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp STTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 1100000 00000000 0011123445578889999999999999999999884 444555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.44 Aligned_cols=234 Identities=12% Similarity=0.097 Sum_probs=184.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.. ..+|+.||+|++...... ....+.+|+.++.+++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALD---------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEE---------TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEe---------cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 5799999999999999999954 346899999999865432 2356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+.|++|.+++... .....+..++.||+.||+|||++| |+||||||+||+++.++.++|++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECS
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEe
Confidence 999999999999999999998542 344567889999999999999998 99999999999999999999985
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh-HHhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQ 303 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~ 303 (401)
++ |++ .++.++|||||||++|+|++|+.||.+......... .....
T Consensus 173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---- 219 (286)
T 3uqc_A 173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA---- 219 (286)
T ss_dssp CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT----
T ss_pred cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc----
Confidence 43 222 368899999999999999999999987654321100 00000
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCC
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~ 361 (401)
...... .......+..+.+|+.+||+.||.+| |+.++++.|+++.....
T Consensus 220 ~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 220 GQPIEP--------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCBCCH--------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCCCh--------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000000 00112345678899999999999999 99999999999865543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.86 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=186.7
Q ss_pred CCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHH-hccCCCcccceeeEEee
Q 015731 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL-GQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l-~~l~hpni~~~~~~~~~ 145 (401)
.+|.+. ++||+|+||.||+|.. ..++..||+|++... ..+.+|+.++ +.++||||+++++++.+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEE---------cCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 7899999999999954 346899999998643 2456788887 55689999999999887
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CC
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 218 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~ 218 (401)
....++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCC
Confidence 6788999999999999999987643 45999999999999999999999998 999999999999987 78
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.++|+|||++.... +..++.++|||||||++|+|++|..||.............
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-- 211 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 211 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--
Confidence 89999999886421 2456789999999999999999999997643221100000
Q ss_pred hhhhhhcchhhhhhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCCc
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 366 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~~ 366 (401)
...... ....+ ...+..+.+|+.+||+.||.+|||+.|+++|-+..+.......+.
T Consensus 212 ----------~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 212 ----------TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp ----------CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred ----------HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 000000 00111 124567889999999999999999999999987765554444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=335.13 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=191.6
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.+.. .+|..||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 4789999999999999999996542 1478999999875432 334567899999999999999999999987
Q ss_pred CCe-----eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCce
Q 015731 146 DDH-----RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~ 220 (401)
.+. .||||||++|++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cE
Confidence 665 7999999999999887653 3899999999999999999999998 9999999999999875 89
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.........
T Consensus 221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------- 285 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------- 285 (681)
T ss_dssp EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------
T ss_pred EEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc--------
Confidence 99999999865432 345799999999998665 488999999999999999999888643211000
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHhc
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKALEQI 356 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-~~eil~~L~~i 356 (401)
........+..+.+||.+||+.||.+||+ ++++...|..+
T Consensus 286 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ----------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001123456789999999999999995 55566656554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=322.20 Aligned_cols=250 Identities=17% Similarity=0.142 Sum_probs=184.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCC-Ccccce----
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYH-PNLVKL---- 139 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h-pni~~~---- 139 (401)
+.|...++||+|+||.||+|.+ ..+|+.||||++..... .....+.+|+.+++.+.| .|...+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEe---------cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 4577889999999999999954 34688999999874332 224568899999999976 322111
Q ss_pred -----e------------eEEee-----CCeeEEEEEecCCCChHHHHhhcC--CCCCCCCCHHHHHHHHHHHHHHHhhh
Q 015731 140 -----I------------GYCLE-----DDHRLLVYEFMPKGSLENHLFRTG--ASYIQPLSWTIRMKVALGAAKGLAYL 195 (401)
Q Consensus 140 -----~------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~L 195 (401)
. .++.. ....+++|+++ +++|.+++.... ......+++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 11111 22457788876 789999885221 11124588889999999999999999
Q ss_pred hhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCccccccc----------ccCCCCcccc
Q 015731 196 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----------ATGHLTAKSD 265 (401)
Q Consensus 196 H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 265 (401)
|+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|
T Consensus 228 H~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 HHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred HhCC--cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 9998 99999999999999999999999999876332 2344567 999999999 5556888999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 015731 266 VYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 345 (401)
Q Consensus 266 iwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps 345 (401)
||||||++|+|++|+.||.......... ..+.. ....+..+.+|+.+||+.||.+||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh------cccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999997654322111 00110 0122467889999999999999999
Q ss_pred HHHHHHH--HHhch
Q 015731 346 MDEVVKA--LEQIQ 357 (401)
Q Consensus 346 ~~eil~~--L~~i~ 357 (401)
+.+++++ ++.+.
T Consensus 358 ~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 358 PLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHTTSHHHHHHH
T ss_pred HHHHHhCHHHHHHH
Confidence 9999876 44443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=308.19 Aligned_cols=244 Identities=17% Similarity=0.129 Sum_probs=182.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------hhHHHHHHHHHHHhccC------
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLY------ 132 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~------ 132 (401)
.++|++.+.||+|+||.||+|.. +|+.||+|++..... .....+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 46799999999999999999954 368999999976532 12356778888888875
Q ss_pred ---CCcccceeeE-----------------Eee-------------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHH
Q 015731 133 ---HPNLVKLIGY-----------------CLE-------------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179 (401)
Q Consensus 133 ---hpni~~~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~ 179 (401)
||||+++.++ +.+ .+..|+||||+.+|++.+.+.+ ..+++.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~ 161 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLA 161 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHH
Confidence 5555555554 333 7889999999999987777744 238999
Q ss_pred HHHHHHHHHHHHHhhhh-hCCCCeEEeccCCCcEEEcCCC--------------------ceEEeeccCCcCCCCCCCcc
Q 015731 180 IRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY--------------------NAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 180 ~~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~ 238 (401)
.++.++.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----- 234 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----
T ss_pred HHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----
Confidence 99999999999999999 888 99999999999998887 899999999986432
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchhhh-hhhhhh
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVV-LLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ-VMDARI 316 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 316 (401)
....||+.|+|||++.+.. +.++||||||++ .+++++|..||... .|........ ... ......
T Consensus 235 --~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~--~~~~~~~~~~ 300 (336)
T 2vuw_A 235 --GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKM--LKQMTFKTKC 300 (336)
T ss_dssp --TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHH--HHTCCCSSCC
T ss_pred --CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhh--hhhhccCccc
Confidence 1347999999999998666 889999998777 77788898887321 1111110000 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHH
Q 015731 317 EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV-KAL 353 (401)
Q Consensus 317 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil-~~L 353 (401)
........+.++.+||.+||+.| |+.|++ +|=
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 11112357889999999999976 999999 763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=275.13 Aligned_cols=170 Identities=19% Similarity=0.127 Sum_probs=127.8
Q ss_pred CCCcEEEEEEccccc----------chhHHHHHHHHHHHhcc-CCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhc
Q 015731 100 GTGMVIAVKRLNQES----------LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRT 168 (401)
Q Consensus 100 ~~~~~~avK~~~~~~----------~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 168 (401)
..|+.+++|++.... .....++.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|...
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence 358889999986542 12235688999999999 7999999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccC
Q 015731 169 GASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248 (401)
Q Consensus 169 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 248 (401)
+ +++.. +|+.||+.||+|+|++| ||||||||+|||++.+|.+||+|||+++...... ......+||+.
T Consensus 337 ~-----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~ 404 (569)
T 4azs_A 337 E-----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFF 404 (569)
T ss_dssp C-----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHH
T ss_pred C-----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechh
Confidence 4 36654 58899999999999999 9999999999999999999999999998654322 22445789999
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 015731 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282 (401)
Q Consensus 249 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 282 (401)
|+|||++.+ .+...+|+|++|+++++|.++..+
T Consensus 405 YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 405 VFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHC------------------CCCCTTHHH
T ss_pred hccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999965 467789999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=242.94 Aligned_cols=185 Identities=15% Similarity=0.178 Sum_probs=141.9
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------hhHHHHHHHHHHHhccCCCcccceeeE
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~hpni~~~~~~ 142 (401)
...++||+|+||.||+|... +..+++|....... .....+.+|+.++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 45679999999999999432 56788887543221 112347899999999999999966666
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+.+..|+||||+++++|.+++.. +..++.||+.||.|||+++ |+||||||+|||++. .+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEE
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEE
Confidence 6677888999999999999999865 4579999999999999998 999999999999998 9999
Q ss_pred eeccCCcCCCCCCCcc-----eeeecccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 015731 223 SDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVI 283 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~ 283 (401)
+|||+++......... ......||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999998754322111 1235689999999999976 56788899999988888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=200.35 Aligned_cols=148 Identities=14% Similarity=0.048 Sum_probs=117.1
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc------------------hhHHHHHHHHH
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------QGHLEWLTEIK 126 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~------------------~~~~~~~~e~~ 126 (401)
.....|.+.+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~ 156 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 156 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH
T ss_pred hCCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH
Confidence 3445677779999999999999965 2588999999865322 12345789999
Q ss_pred HHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEec
Q 015731 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 206 (401)
Q Consensus 127 ~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 206 (401)
+++.++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| |+|||
T Consensus 157 ~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g--iiHrD 218 (282)
T 1zar_A 157 ALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG--IVHGD 218 (282)
T ss_dssp HHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred HHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC--CEeCC
Confidence 999998 5 666665543 56799999999999988 421 123469999999999999988 99999
Q ss_pred cCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccc
Q 015731 207 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 256 (401)
Q Consensus 207 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 256 (401)
|||+|||++ ++.++|+|||+++. +..+.|||.+.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999 99999999999863 34478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-21 Score=171.58 Aligned_cols=137 Identities=18% Similarity=0.090 Sum_probs=104.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcE--EEEEEcccccch------------------------hHHHHH
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESLQ------------------------GHLEWL 122 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~--~avK~~~~~~~~------------------------~~~~~~ 122 (401)
-|.+.+.||+|+||.||+|... .+|.. ||||++...... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~---------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV---------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE---------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc---------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 3678899999999999999652 24778 999986543111 112567
Q ss_pred HHHHHHhccCCCcc--cceeeEEeeCCeeEEEEEecCC-C----ChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhh
Q 015731 123 TEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPK-G----SLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYL 195 (401)
Q Consensus 123 ~e~~~l~~l~hpni--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 195 (401)
+|+.+|..+.|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHH
Confidence 89999999988764 333432 357899999932 3 66665432 22345678999999999999
Q ss_pred h-hCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 196 H-SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 196 H-~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
| ++| |+||||||+|||++. .++|+|||++..
T Consensus 187 H~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 187 YQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HHTSC--EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHCC--EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 9 988 999999999999998 999999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-18 Score=163.62 Aligned_cols=137 Identities=12% Similarity=0.059 Sum_probs=95.9
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--------------hhHHH--------HHHHHH
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------------QGHLE--------WLTEIK 126 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--------------~~~~~--------~~~e~~ 126 (401)
-|.+.+.||+|+||.||+|... +|+.||||++..... ..... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 4899999999999999999542 488999998753211 00111 224555
Q ss_pred HHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEec
Q 015731 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 206 (401)
Q Consensus 127 ~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 206 (401)
.|.++.+.++.-..-+.. ...+|||||+.|++|.++... .....++.||+.+|.+||++| |||||
T Consensus 166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g--IVHrD 230 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG--LIHGD 230 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC--CcCCC
Confidence 566654443322111111 224799999998888654321 123568899999999999988 99999
Q ss_pred cCCCcEEEcCCC----------ceEEeeccCCcC
Q 015731 207 FKTSNILLDLNY----------NAKLSDFGLAKD 230 (401)
Q Consensus 207 lkp~Nil~~~~~----------~~kl~Dfg~~~~ 230 (401)
|||.|||+++++ .+.|+||+.+..
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999998776 389999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-13 Score=120.69 Aligned_cols=143 Identities=13% Similarity=-0.029 Sum_probs=109.5
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~ 144 (401)
....|++...++.|+.+.||++.. .+..+++|+...........+.+|+.+++.|. +..+.++++++.
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 80 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence 346788888999999999999742 25679999987532222335678999998884 677889999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-------------------------
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK------------------------- 199 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------- 199 (401)
+.+..|+|||+++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred cCCceEEEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 99999999999999998876421 1112467788889999999810
Q ss_pred --------------------------------CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 --------------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 --------------------------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876556799998664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=4e-11 Score=107.19 Aligned_cols=135 Identities=17% Similarity=0.043 Sum_probs=94.1
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc--ccceeeEEeeC
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIGYCLED 146 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn--i~~~~~~~~~~ 146 (401)
.|.+..+.+.|..+.||++... +|..+++|+..... ...+..|+.+++.+.+.+ +.+++++..++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444444456667999997432 36679999876542 224567888888885434 56788888888
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---------------------------
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK--------------------------- 199 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------- 199 (401)
+..++||||++|.+|. +.. ... ..++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 154 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred CCCEEEEEecCCcccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence 8899999999998873 211 111 245666667777777632
Q ss_pred -----------------------------CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 -----------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 -----------------------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
..++|+|++|.||++++++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877666799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=108.72 Aligned_cols=141 Identities=14% Similarity=0.190 Sum_probs=102.6
Q ss_pred CCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcc--cccc-hhHHHHHHHHHHHhccC--CCcccceeeEEeeC
Q 015731 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESL-QGHLEWLTEIKHLGQLY--HPNLVKLIGYCLED 146 (401)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~--~~~~-~~~~~~~~e~~~l~~l~--hpni~~~~~~~~~~ 146 (401)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999997432 3568888876 3321 22335678999998886 45678888888776
Q ss_pred ---CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC-------------------------
Q 015731 147 ---DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------- 198 (401)
Q Consensus 147 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------- 198 (401)
+..|+||||++|..+.+.. ...++......++.+++..|..||+.
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 4589999999987775421 12367778888999999999999972
Q ss_pred -------------------------------CCCeEEeccCCCcEEEcCCCc--eEEeeccCCcC
Q 015731 199 -------------------------------KAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKD 230 (401)
Q Consensus 199 -------------------------------~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 230 (401)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=6.4e-11 Score=108.71 Aligned_cols=182 Identities=18% Similarity=0.190 Sum_probs=116.8
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCc--ccceeeEEeeCC--
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPN--LVKLIGYCLEDD-- 147 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpn--i~~~~~~~~~~~-- 147 (401)
.+.++.|....||+. +..+++|+.... .....+.+|..+|+.+ .+.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999985 245889986543 2344677899999887 3333 445554443333
Q ss_pred -eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---------------------------
Q 015731 148 -HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK--------------------------- 199 (401)
Q Consensus 148 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------- 199 (401)
..|+||++++|.+|.+.... .++......++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred CcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 35899999999888653321 2566666777777777777777511
Q ss_pred -----------------------------CCeEEeccCCCcEEEcC--CCceEEeeccCCcCCCCCCCcceeeecccccC
Q 015731 200 -----------------------------AKVIYRDFKTSNILLDL--NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248 (401)
Q Consensus 200 -----------------------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 248 (401)
..++|+|+++.||++++ +..+.|+||+.+........ ......
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~ 235 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLME 235 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCC
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHh
Confidence 23799999999999987 45678999998864321100 000011
Q ss_pred c---cccccccc-----CC---------CCcccchhhHHHHHHHHHhCCCCC
Q 015731 249 Y---AAPEYMAT-----GH---------LTAKSDVYSFGVVLLEMLSGRRVI 283 (401)
Q Consensus 249 y---~aPE~~~~-----~~---------~~~~~DiwslG~il~~ll~g~~p~ 283 (401)
+ ..|+.... +. .....+.|+++.++|.+.+|..+|
T Consensus 236 ~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 236 DDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred hccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 22221100 00 112358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.1e-07 Score=82.31 Aligned_cols=133 Identities=17% Similarity=0.082 Sum_probs=91.0
Q ss_pred ccCCCCe-eEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEEEE
Q 015731 76 LGEGGFG-CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (401)
Q Consensus 76 lg~G~~g-~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~lv~ 153 (401)
+..|..+ .||+... ...+..+++|+-... ....+.+|..+|+.|. +--+.+++.++.+++..|+||
T Consensus 32 ~~~G~S~~~v~rl~~---------~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYG---------KPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEEC---------CTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEe---------cCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445555 6887632 223567889976543 2335667888888774 334778899999999999999
Q ss_pred EecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC----------------------------------
Q 015731 154 EFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK---------------------------------- 199 (401)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 199 (401)
|+++|.++.+...... .....++.++...|..||...
T Consensus 100 e~l~G~~~~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp ECCCSEEHHHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EeeCCccccccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 9999988877654321 112234455555566665321
Q ss_pred ----------------------CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 ----------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 ----------------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
..++|+|+.+.||++++++.+-|+||+.+.
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127899999999999987777899998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.9e-07 Score=82.75 Aligned_cols=135 Identities=21% Similarity=0.136 Sum_probs=87.6
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCC---cccceeeEEe-eCCe
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP---NLVKLIGYCL-EDDH 148 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hp---ni~~~~~~~~-~~~~ 148 (401)
.+.++.|....||+. |..+++|+.... .....+.+|..+|+.|.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 346788888899986 345888885332 2334677899999998642 3566676664 4456
Q ss_pred eEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC------------------------------
Q 015731 149 RLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------------ 198 (401)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------ 198 (401)
.|+||++++|.+|.+..-. .++......++.++...|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp EEEEEECCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eEEEEeccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 7899999999888763211 122333333333333333333321
Q ss_pred ----------------------------CCCeEEeccCCCcEEEcC---CCce-EEeeccCCcC
Q 015731 199 ----------------------------KAKVIYRDFKTSNILLDL---NYNA-KLSDFGLAKD 230 (401)
Q Consensus 199 ----------------------------~~~ivH~dlkp~Nil~~~---~~~~-kl~Dfg~~~~ 230 (401)
...++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124799999999999987 4554 8999987754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.7e-06 Score=79.46 Aligned_cols=85 Identities=2% Similarity=-0.130 Sum_probs=52.7
Q ss_pred Ccc-cCCCCeeEEEEEecCCCccCCCCC-CCcEEEEEEccccc---chhHHHHHHHHHHHhccC-C--CcccceeeEEee
Q 015731 74 SVL-GEGGFGCVFKGWIDEHTYAPARPG-TGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLY-H--PNLVKLIGYCLE 145 (401)
Q Consensus 74 ~~l-g~G~~g~V~~~~~~~~~~~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~-h--pni~~~~~~~~~ 145 (401)
+.| +.|....+|+...... .+.. .+..+++|+..... ......+.+|+.+++.|. + ..+.+++.+..+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~----~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQ----QDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEE----ETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EECCCCCccceEEEEEEecc----cCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 456 7888899998743200 0000 15678899875533 111124557777777773 2 357778877765
Q ss_pred C---CeeEEEEEecCCCChH
Q 015731 146 D---DHRLLVYEFMPKGSLE 162 (401)
Q Consensus 146 ~---~~~~lv~e~~~~~~L~ 162 (401)
. +..|+|||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.2e-05 Score=76.25 Aligned_cols=76 Identities=14% Similarity=0.090 Sum_probs=47.2
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-------hhHHHHHHHHHHHhccCC--C-cccceeeE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLYH--P-NLVKLIGY 142 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~e~~~l~~l~h--p-ni~~~~~~ 142 (401)
.+.||.|.++.||++.... .+..+++|....... .....+..|..+++.+.. | .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4578999999999985331 356799997543211 112345678888877632 3 34455543
Q ss_pred EeeCCeeEEEEEecCCC
Q 015731 143 CLEDDHRLLVYEFMPKG 159 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~ 159 (401)
+.+..++|||++.+.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 445678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=6.4e-05 Score=69.37 Aligned_cols=30 Identities=23% Similarity=0.273 Sum_probs=26.6
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00049 Score=62.67 Aligned_cols=75 Identities=17% Similarity=0.092 Sum_probs=56.8
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC---CCcccceeeEEeeCCee
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGYCLEDDHR 149 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~---hpni~~~~~~~~~~~~~ 149 (401)
.+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 35689999999998742 2457888976543 2345678888888773 35688888888888889
Q ss_pred EEEEEecCCCCh
Q 015731 150 LLVYEFMPKGSL 161 (401)
Q Consensus 150 ~lv~e~~~~~~L 161 (401)
++|||+++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00035 Score=62.87 Aligned_cols=80 Identities=16% Similarity=0.165 Sum_probs=53.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC---CcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH---PNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h---pni~~~~~~~~ 144 (401)
....-.+.+|.|..+.||+.... +|+.+++|+...........+..|...|+.|.- --+.+++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-- 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-- 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--
Confidence 34444567899999999998654 478899998765443333456688888887742 234455543
Q ss_pred eCCeeEEEEEecCCCCh
Q 015731 145 EDDHRLLVYEFMPKGSL 161 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L 161 (401)
+ ..++||||+.++..
T Consensus 83 ~--~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 D--DRTLAMEWVDERPP 97 (288)
T ss_dssp E--TTEEEEECCCCCCC
T ss_pred c--CceEEEEeecccCC
Confidence 2 24789999877643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00064 Score=64.78 Aligned_cols=76 Identities=16% Similarity=0.171 Sum_probs=44.7
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeeccc--ccCcccccccccCC---CCcccchhhHHHHHH
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG--TYGYAAPEYMATGH---LTAKSDVYSFGVVLL 274 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwslG~il~ 274 (401)
..++|+|+++.||+++.++ +.|+||+.+......... ..... ...|.+|+...... .....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998776 999999988753211000 00000 12355555442111 112344557777777
Q ss_pred HHHhC
Q 015731 275 EMLSG 279 (401)
Q Consensus 275 ~ll~g 279 (401)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00044 Score=58.61 Aligned_cols=101 Identities=16% Similarity=0.054 Sum_probs=66.7
Q ss_pred CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcc
Q 015731 159 GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238 (401)
Q Consensus 159 ~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 238 (401)
.+|.++|...+ +|+++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc---------
Confidence 38999998887 789999999999999998877621110 11233457899999999888764 1110
Q ss_pred eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 015731 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 280 (401)
Q Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 280 (401)
.....+.|||... ...+.+.=|||||+++|..+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1123366888763 34457788999999999988744
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00051 Score=62.25 Aligned_cols=71 Identities=7% Similarity=0.071 Sum_probs=42.2
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLL 151 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~l 151 (401)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++.+ +.+..++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 567888999999986 23788877653211 1112356666666632222 455543 3444678
Q ss_pred EEEec-CCCCh
Q 015731 152 VYEFM-PKGSL 161 (401)
Q Consensus 152 v~e~~-~~~~L 161 (401)
|+||+ +|.+|
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 66554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.003 Score=57.60 Aligned_cols=29 Identities=28% Similarity=0.207 Sum_probs=24.9
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
.++|+|+.+.||++++++.+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 48999999999999877666899998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0023 Score=58.76 Aligned_cols=31 Identities=29% Similarity=0.284 Sum_probs=26.7
Q ss_pred CCeEEeccCCCcEEEcCC----CceEEeeccCCcC
Q 015731 200 AKVIYRDFKTSNILLDLN----YNAKLSDFGLAKD 230 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 230 (401)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6799999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0043 Score=56.70 Aligned_cols=28 Identities=21% Similarity=0.292 Sum_probs=24.4
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 489999999999999 4 899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=63.41 Aligned_cols=81 Identities=16% Similarity=0.078 Sum_probs=48.5
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLL 151 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~l 151 (401)
.+.|+.|-...+|++....... .....+..+++|+...... ...+..|+.+++.|...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 3467888889999986542110 0011356789998844211 1344578888877743333 566665542 28
Q ss_pred EEEecCCCCh
Q 015731 152 VYEFMPKGSL 161 (401)
Q Consensus 152 v~e~~~~~~L 161 (401)
||+|++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999976443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0025 Score=59.61 Aligned_cols=149 Identities=15% Similarity=0.137 Sum_probs=80.1
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~lv 152 (401)
+.|..|-...+|++...... ......+..+++|+..... .......+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888889998653210 0011235789999864421 22344558888887774 2223566666543 289
Q ss_pred EEecCCCChHH--------------HH---hhcCCCCCCCC--CHHHHHHHHHHHHH-------------------HHhh
Q 015731 153 YEFMPKGSLEN--------------HL---FRTGASYIQPL--SWTIRMKVALGAAK-------------------GLAY 194 (401)
Q Consensus 153 ~e~~~~~~L~~--------------~l---~~~~~~~~~~l--~~~~~~~i~~qi~~-------------------~l~~ 194 (401)
|||++|.+|.. .+ .........+. -+..+.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998765431 11 11111111112 23445555444322 1222
Q ss_pred h----hh--CCCCeEEeccCCCcEEEcCC----CceEEeeccCCc
Q 015731 195 L----HS--DKAKVIYRDFKTSNILLDLN----YNAKLSDFGLAK 229 (401)
Q Consensus 195 L----H~--~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~ 229 (401)
| .. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 11 12348999999999999876 789999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0023 Score=61.47 Aligned_cols=74 Identities=16% Similarity=0.103 Sum_probs=43.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~~~~~lv 152 (401)
+.|+.|-...+|++.... .+..+++|+....... ......|+.+++.|...++ .++++++. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 457778788899875432 2467889987543211 1111478888887754444 56676663 2 259
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.022 Score=52.34 Aligned_cols=31 Identities=13% Similarity=0.101 Sum_probs=27.0
Q ss_pred CCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 200 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 200 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.005 Score=57.37 Aligned_cols=82 Identities=10% Similarity=0.039 Sum_probs=41.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCc-ccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpn-i~~~~~~~~~~~~~~lv 152 (401)
+.|+.|....+|+........ ......+..+++|+....... ......|..+++.|...+ ..++++.. . .++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 457778888899875432000 000112357889987643211 111246777777664223 44666543 2 3689
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.00 E-value=0.33 Score=41.01 Aligned_cols=124 Identities=8% Similarity=0.031 Sum_probs=82.7
Q ss_pred HHHHHHhccCCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCe
Q 015731 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 202 (401)
Q Consensus 123 ~e~~~l~~l~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i 202 (401)
.|+..|.. .||+++.. .+-.+++.+.+.++.-. +...+-.- +.++....++++.+|+....+++. -
T Consensus 35 ~el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~----r 100 (215)
T 4ann_A 35 HLMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT----R 100 (215)
T ss_dssp GGGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS----S
T ss_pred HHHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC----c
Confidence 34555533 58988877 56677777666666543 22222111 337888899999999987766654 4
Q ss_pred EEeccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 015731 203 IYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 282 (401)
Q Consensus 203 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 282 (401)
+|--|.|+||+++.++.+++.-.|+-... +|. .++...-.-..=|++..+++++..
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCC
Confidence 78899999999999999999988764332 221 112223344567888888998877
Q ss_pred CC
Q 015731 283 ID 284 (401)
Q Consensus 283 ~~ 284 (401)
|.
T Consensus 157 Fe 158 (215)
T 4ann_A 157 FD 158 (215)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.34 Score=45.80 Aligned_cols=81 Identities=12% Similarity=-0.028 Sum_probs=45.4
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~lv 152 (401)
+.|..|-...+|+........ .....+..+++++...... ......+|..+++.|. +.-..++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 456778888899886542110 0011257799998754321 1111236777777764 222345555332 3789
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
|+|++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.28 E-value=0.43 Score=40.43 Aligned_cols=114 Identities=9% Similarity=0.067 Sum_probs=78.1
Q ss_pred CCCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHh-hhhhCCCCeEEeccCCC
Q 015731 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLA-YLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 132 ~hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~ivH~dlkp~ 210 (401)
.||++ -..+-.+++.+.+.++.-+++.=...+. .++....++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence 58888 4555577788777777653433333342 2788889999999988777 6654 578889999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 283 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 283 (401)
||+++.++.+++.-.|+-.. ++|.- .+...=.-.+=|++..++.++..|
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999998886433 22221 122223335667778888877665
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.54 E-value=0.58 Score=43.84 Aligned_cols=28 Identities=29% Similarity=0.333 Sum_probs=24.0
Q ss_pred eEEeccCCCcEEE------cCCCceEEeeccCCc
Q 015731 202 VIYRDFKTSNILL------DLNYNAKLSDFGLAK 229 (401)
Q Consensus 202 ivH~dlkp~Nil~------~~~~~~kl~Dfg~~~ 229 (401)
++|+|+.+.||++ +++..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 401 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-72
Identities = 61/292 (20%), Positives = 116/292 (39%), Gaps = 32/292 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V+KG + + + + + + Q + E+ L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+ H N++ +GY +V ++ SL +HL + +A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQT 113
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A+G+ YLH +I+RD K++NI L + K+ DFGLA S SH ++ G+
Sbjct: 114 AQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 249 YAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
+ APE + + +SDVY+FG+VL E+++G+ + +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
++ ++ L +CL + RP +++ ++E +
Sbjct: 232 SKVRSNCPKAMKR------------LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-66
Identities = 77/316 (24%), Positives = 125/316 (39%), Gaps = 46/316 (14%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-W 121
++ +F S LG G G VFK +G+V+A K ++ E
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
+ E++ L + P +V G D + E M GSL+ L + G + I
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQIL 106
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
KV++ KGL YL K K+++RD K SNIL++ KL DFG++ ++
Sbjct: 107 GKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 161
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID----------------- 284
+GT Y +PE + H + +SD++S G+ L+EM GR I
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221
Query: 285 --KNRPSREHNLIEWAKPYLQSKR---RIFQVMDARIEGQYSLGAALKTAVLAI----KC 335
P R Y R IF+++D + + ++ KC
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281
Query: 336 LSNEPKFRPTMDEVVK 351
L P R + +++
Sbjct: 282 LIKNPAERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 8e-66
Identities = 78/309 (25%), Positives = 118/309 (38%), Gaps = 38/309 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
LG G FG V + Y + M +AVK L + E ++E+K
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQ------------ 174
L L H N+V L+G C L++ E+ G L N L R S+I
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 175 -PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 233
L + + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 234 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 293
S V + APE + T +SDV+S+G+ L E+ S P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 294 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353
++++ A + + C +P RPT ++V+ +
Sbjct: 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 354 EQI--QDTN 360
E+ + TN
Sbjct: 303 EKQISESTN 311
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-65
Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 34/296 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F + V+G G FGCV+ G + ++ G + AVK LN+ + G + +LTE
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 128 LGQLYHPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ HPN++ L+G CL + L+V +M G L N + + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGL 137
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRVM 244
AKG+ +L K ++RD N +LD + K++DFGLA+D H T
Sbjct: 138 QVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
+ A E + T T KSDV+SFGV+L E+++ P + N + LQ
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQG 250
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
+R + +Y + + +KC + + RP+ E+V + I T
Sbjct: 251 RRLLQ--------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-65
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 36/289 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V+ G+ + +AVK L Q S+ +L E +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSMSPD-AFLAEANLM 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
QL H LV+L + ++ E+M GSL + L L+ + +A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQI 118
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A+G+A++ I+RD + +NIL+ + K++DFGLA+ ++
Sbjct: 119 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIK 175
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRR 307
+ APE + G T KSDV+SFG++L E+++ R+ + E +E ++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++ L C P+ RPT D + LE
Sbjct: 236 PEELYQ-----------------LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 7e-65
Identities = 73/310 (23%), Positives = 119/310 (38%), Gaps = 42/310 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N +GEG FG VF+ ++AVK L +E+ ++ E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAP----GLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI-------------- 173
+ + +PN+VKL+G C L++E+M G L L +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 174 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288
++ + + PE + T +SDV+++GVVL E+ S
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
E I+ V D I L+ L C S P RP+
Sbjct: 248 HEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 349 VVKALEQIQD 358
+ + L+++ +
Sbjct: 292 IHRILQRMCE 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 1e-64
Identities = 70/315 (22%), Positives = 127/315 (40%), Gaps = 41/315 (13%)
Query: 55 IKSFSFNGLKTATRNF---------RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVI 105
I F+F A R F + + V+G G FG V G + + +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFV 57
Query: 106 AVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
A+K L + + ++L+E +GQ HPN++ L G + +++ EFM GSL++
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 165 LFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224
L + + + + G A G+ YL ++RD NIL++ N K+SD
Sbjct: 118 LRQ----NDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSD 171
Query: 225 FGLAKDGPTGSQSHVSTRV---MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 281
FGL++ + T + APE + T+ SDV+S+G+V+ E++S
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 282 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 341
RP + + + ++ + L + C +
Sbjct: 232 -----RPYWDMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275
Query: 342 FRPTMDEVVKALEQI 356
RP ++V L+++
Sbjct: 276 HRPKFGQIVNTLDKM 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 41/306 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
N VLG G FG V Y ++ G + +AVK L +++ E ++E+K
Sbjct: 38 NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASY-------------- 172
+ QL H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 173 ----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 228
+ L++ + A AKG+ +L ++RD N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 229 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288
+D + S V + APE + G T KSDV+S+G++L E+ S P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 289 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 348
+ ++++ + A + ++ C + + + RP+
Sbjct: 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 349 VVKALE 354
+ L
Sbjct: 317 LTSFLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-64
Identities = 72/314 (22%), Positives = 122/314 (38%), Gaps = 42/314 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R +G+G FG V++G G +AVK + + EI
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREERSWFR-EAEIYQ 50
Query: 128 LGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
L H N++ I +D+ LV ++ GSL ++L R ++ +K
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIK 104
Query: 184 VALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGS 235
+AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T +
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 236 QSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVI----DK 285
+GT Y APE + ++D+Y+ G+V E+ + D
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 286 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRP 344
P + + + ++ K Q + I ++ AL+ + +C R
Sbjct: 225 QLPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 345 TMDEVVKALEQIQD 358
T + K L Q+
Sbjct: 284 TALRIKKTLSQLSQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-64
Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 40/291 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ + +G+G FG V G G +AVK + ++ +L E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATAQ--AFLAEASV 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L G S L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSL 110
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ + YL + ++RD N+L+ + AK+SDFGL K+ S
Sbjct: 111 DVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLP 163
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE + + KSDV+SFG++L E+ S R P L +
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------P 211
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
R+ + + C + RP+ ++ + LE I+
Sbjct: 212 RVEKGYKMDAPDGCPPAVYE----VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 6e-64
Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 32/288 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G +G V++G + +AVK L +++++ E+L E +
Sbjct: 18 DITMKHKLGGGQYGEVYEGV---------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
++ HPNLV+L+G C + ++ EFM G+L ++L Q +S + + +A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQI 124
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
+ + YL I+RD N L+ N+ K++DFGL++ G
Sbjct: 125 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 181
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
+ APE +A + KSDV++FGV+L E+ + + +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------V 225
Query: 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+++++ + G K L C P RP+ E+ +A E +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 9e-64
Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 34/289 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ LG G FG V G +A+K + + S E++ E K
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ L H LV+L G C + ++ E+M G L N+L +++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKD 108
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+ + YL S + ++RD N L++ K+SDFGL++ + S
Sbjct: 109 VCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPV 165
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
++ PE + ++KSD+++FGV++ E+ S ++ + + E
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------- 209
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+ + + A+ K + C + RPT ++ + +
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-62
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 36/292 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V G+ +A+K + E +++ E + +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVM 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+L HP LV+L G CLE LV+EFM G L ++L + + + L
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDV 110
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
+G+AYL VI+RD N L+ N K+SDFG+ + Q ST
Sbjct: 111 CEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVK 167
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRR 307
+A+PE + ++KSDV+SFGV++ E+ S ++ +NR + E I + +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359
V + C P+ RP +++ L +I ++
Sbjct: 228 STHVYQ-----------------IMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-61
Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 41/301 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
+ + V+GEG FG V K I + G M A+KR+ + S H ++ E++
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----------FRTGASYIQP 175
L +L HPN++ L+G C + L E+ P G+L + L F S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
LS + A A+G+ YL + I+RD NIL+ NY AK++DFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
+ T + A E + T SDV+S+GV+L E++S P
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCA 233
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
E + Q R + L + L +C +P RP+ +++ +L +
Sbjct: 234 ELYEKLPQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 356 I 356
+
Sbjct: 283 M 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-61
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 32/286 (11%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQL 131
D LG G FG V +G + +A+K L Q + + E + E + + QL
Sbjct: 14 DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKG 191
+P +V+LIG C + + +LV E G L L + + + ++ + G
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMG 121
Query: 192 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTYGYA 250
+ YL + ++RD N+LL + AK+SDFGL+K G S + +
Sbjct: 122 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 251 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 310
APE + +++SDV+S+GV + E LS + +P ++ E Q K
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGK----- 229
Query: 311 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
R+E L L C + + RP V + +
Sbjct: 230 ----RMECPPECPPELYA--LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-61
Identities = 69/285 (24%), Positives = 108/285 (37%), Gaps = 33/285 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
++ LGEG +G V T +AVK ++ + E EI
Sbjct: 6 DWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
L H N+VK G+ E + + L E+ G L + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQ 111
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 112 LMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 248 GYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
Y APE + DV+S G+VL ML+G D+ S + K +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ + +A L K L P R T+ ++ K
Sbjct: 230 K-------------KIDSAPLA--LLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-61
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 32/294 (10%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
++ R LG+G FG V +G D + G + +AVK L + L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ + L H NL++L G L ++ V E P GSL + L + +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRY 116
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV-STRV 243
A+ A+G+ YL S + I+RD N+LL K+ DFGL + P +V
Sbjct: 117 AVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 244 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
+ + APE + T + SD + FGV L EM + + P N + +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDK 229
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357
R+ + D + + ++C +++P+ RPT + L + Q
Sbjct: 230 EGERLPRPED--------CPQDIYN--VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-61
Identities = 64/293 (21%), Positives = 109/293 (37%), Gaps = 45/293 (15%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
R + D +G G F V+KG T + +A L L + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 126 KHLGQLYHPNLVKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
+ L L HPN+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVL 114
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSDFGLAKDGPTGSQSHVS 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFA 170
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--HNLIEWA 298
V+GT + APE DVY+FG+ +LEM + + + + + +
Sbjct: 171 KAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
KP K I +V + + C+ R ++ +++
Sbjct: 230 KPASFDKVAIPEVKE-----------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 9e-61
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG+G FG V+K T ++ A K ++ +S + +++ EI L
Sbjct: 13 FWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
HPN+VKL+ +++ ++ EF G+++ + +PL+ + V
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQT 119
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
L YLH K+I+RD K NIL L+ + KL+DFG++ Q +GT
Sbjct: 120 LDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPY 175
Query: 249 YAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
+ APE + K+DV+S G+ L+EM P E N + +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAK 229
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
S+ + K KCL R T ++++
Sbjct: 230 SEPPTLAQPS-------RWSSNFKD--FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 34/287 (11%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAK 190
L +P +V++IG C E + +LV E G L +L + + +++ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSM 118
Query: 191 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG-SQSHVSTRVMGTYGY 249
G+ YL ++ ++RD N+LL + AK+SDFGL+K + T +
Sbjct: 119 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 250 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309
APE + ++KSDV+SFGV++ E S + +P R E + +R
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGERM-- 229
Query: 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
L C + + + RP V L
Sbjct: 230 -----GCPAGCPREMYD----LMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 64/295 (21%), Positives = 122/295 (41%), Gaps = 29/295 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
V+G G FG V+KG + + P +A+K L + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+GQ H N+++L G + +++ E+M G+L+ L S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRG 118
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGT 246
A G+ YL + ++RD NIL++ N K+SDFGL++ ++ ++
Sbjct: 119 IAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE ++ T+ SDV+SFG+V+ E+++ + E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 361
+ + ++ + L ++C E RP ++V L+++ D
Sbjct: 222 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-60
Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 36/290 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIK 126
++ +G G +G K R G ++ K L+ S+ ++E+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
L +L HPN+V+ ++ + +V E+ G L + + + Q L ++V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRV 114
Query: 185 ALGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
L H V++RD K +N+ LD N KL DFGLA+ + +
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAK 172
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301
+GT Y +PE M KSD++S G +L E+ + P + E A
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKI 226
Query: 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ K R RI +YS L + + L+ + RP+++E+++
Sbjct: 227 REGKFR-------RIPYRYS--DELNE--IITRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-60
Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 41/286 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEI 125
+F LG+G FG V+ + ++A+K L + L + E+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYI 112
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
A L+Y HS +VI+RD K N+LL K++DFG + P S T + G
Sbjct: 113 TELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCG 166
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
T Y PE + K D++S GV+ E L G+ + N + I +
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 226
Query: 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ + L + L + P RP + EV++
Sbjct: 227 ----------------VTEGARD--LISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 2e-59
Identities = 74/292 (25%), Positives = 116/292 (39%), Gaps = 46/292 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ V+A+K+++ Q + +W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
E++ L +L HPN ++ G L + LV E+ + + PL
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAA 119
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 243
V GA +GLAYLHS +I+RD K NILL KL DFG A +
Sbjct: 120 VTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSF 171
Query: 244 MGTYGYAAPEY---MATGHLTAKSDVYSFGVVLLEMLSGRRVI-DKNRPSREHNLIEWAK 299
+GT + APE M G K DV+S G+ +E+ + + + N S +++ +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
Query: 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
P LQS + CL P+ RPT + ++K
Sbjct: 232 PALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-59
Identities = 67/321 (20%), Positives = 131/321 (40%), Gaps = 33/321 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHL 128
F+ VLG G FG V+KG + P + +A+K L + S + + E L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+ +P++ +L+G CL +L + + MP G L +++ + + +
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQI 120
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
AKG+ YL ++++RD N+L+ + K++DFGLAK + + +
Sbjct: 121 AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
+ A E + T +SDV+S+GV + E+++ P+ E I
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------I 222
Query: 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI----QDTNDAGV 364
+++ + ++ +KC + RP E++ ++ Q
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
Query: 365 SRDESLQNSDRSTYKRKGLNE 385
L + S + R ++E
Sbjct: 283 DERMHLPSPTDSNFYRALMDE 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-58
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 34/288 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ R + LG+G FG V+ G + +A+K L + +L E + +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVM 66
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+L H LV+L ++ +V E+M KGSL + L Y++ + +A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQI 122
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 248
A G+AY+ + ++RD + +NIL+ N K++DFGLA+ ++
Sbjct: 123 ASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 179
Query: 249 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308
+ APE G T KSDV+SFG++L E+ + RV +RE +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------V 223
Query: 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
++ L +C EP+ RPT + + LE
Sbjct: 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-58
Identities = 66/310 (21%), Positives = 133/310 (42%), Gaps = 28/310 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LG+G FG V++G + +A+K +N+ S++ +E+L E
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTG-----ASYIQPLSWTIRM 182
+ + ++V+L+G + L++ E M +G L+++L + P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
++A A G+AYL+++K ++RD N ++ ++ K+ DFG+ +D +
Sbjct: 137 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 243 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302
+ + +PE + G T SDV+SFGVVL E+ + +P + + + + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFVM 249
Query: 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362
+ L C PK RP+ E++ ++++ +
Sbjct: 250 EGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
Query: 363 GVSRDESLQN 372
VS S +N
Sbjct: 299 EVSFYYSEEN 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-57
Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ TG +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCR 123
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ L +LHS +VI+RD K+ NILL ++ + KL+DFG + + ++GT
Sbjct: 124 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGT 179
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+ APE + K D++S G++ +EM+ G P R LI
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP----- 234
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
++ L A + +CL + + R + E+++
Sbjct: 235 --------ELQNPEKLSAIFRD--FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-56
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 33/301 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
LGEG FG V +P +AVK L ++ + L + ++E++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYI-----------QP 175
+ + H N++ L+G C +D ++ E+ KG+L +L + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 176 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 235
LS + A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 236 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
+T + APE + T +SDV+SFGV+L E+ + P E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355
+F+++ + ++ C P RPT ++V+ L++
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 356 I 356
I
Sbjct: 294 I 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-56
Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 31/291 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+GEG FG V +G + +A+K + E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALG 187
+ Q HP++VKLIG ++ ++ E G L + L L + A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQ 116
Query: 188 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 247
+ LAYL S + ++RD N+L+ N KL DFGL++ S + +++
Sbjct: 117 LSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 173
Query: 248 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307
+ APE + T+ SDV+ FGV + E+L +P + + +R
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERL 228
Query: 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358
+ L + L KC + +P RP E+ L I +
Sbjct: 229 PM---------PPNCPPTLYS--LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-56
Identities = 77/306 (25%), Positives = 120/306 (39%), Gaps = 35/306 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKH 127
+ LG G FG V + + + T +AVK L + + H ++E+K
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 128 LGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRTGASYI-----------Q 174
L +H N+V L+G C + L ++ EF G+L +L ++
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 175 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 234
L+ + + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 235 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294
+ APE + T +SDV+SFGV+L E+ S P +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKI 242
Query: 295 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
E L+ R+ Y+ + + C EP RPT E+V+ L
Sbjct: 243 DEEFCRRLKEGTRMRAP-------DYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLG 292
Query: 355 QIQDTN 360
+ N
Sbjct: 293 NLLQAN 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-54
Identities = 59/294 (20%), Positives = 103/294 (35%), Gaps = 37/294 (12%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLE 120
K +F+ +LGEG F V T A+K L + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTI 180
E + +L HP VKL +D+ + G L ++ + G T
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETC 109
Query: 181 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 240
L YLH +I+RD K NILL+ + + +++DFG AK S+ +
Sbjct: 110 TRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
+GT Y +PE + SD+++ G ++ ++++G P R N
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYL---- 217
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354
+++ + + L K L + R +E+
Sbjct: 218 ------IFQKIIKLEYDFPEKFFPKARD--LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (437), Expect = 1e-51
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 39/298 (13%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIK 126
+ +LG GG V +AVK L + + +L + E +
Sbjct: 9 YELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ L HP +V + + +V E++ +L + + G P++ +
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAI 114
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVST 241
+V A + L + H +I+RD K +NI++ K+ DFG+A+ +G+ +
Sbjct: 115 EVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301
V+GT Y +PE + A+SDVYS G VL E+L+G + P P
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232
Query: 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQD 358
S R L A L VL K L+ P+ R T E+ L ++ +
Sbjct: 233 PPSARH------------EGLSADLDAVVL--KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 1e-51
Identities = 60/285 (21%), Positives = 97/285 (34%), Gaps = 34/285 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ LG G FG V + TG A K + EI+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L HP LV L +D+ +++YEFM G L + +S ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQV 133
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKDGPTGSQSHVSTRVMGT 246
KGL ++H ++ D K NI+ + KL DFGL V GT
Sbjct: 134 CKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGT 188
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+AAPE + +D++S GV+ +LSG ++ +
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ K K L +P R T+ + ++
Sbjct: 249 F------------SGISEDGKD--FIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 8e-51
Identities = 57/285 (20%), Positives = 98/285 (34%), Gaps = 34/285 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + TG V K +N EI +
Sbjct: 30 YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
QL+HP L+ L + +L+ EF+ G L + + +S + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQA 136
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGT 246
+GL ++H +++ D K NI+ + + K+ DFGLA T
Sbjct: 137 CEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTAT 191
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
+AAPE + + +D+++ GV+ +LSG ++
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
S+ K L EP+ R T+ + ++
Sbjct: 252 F------------SSVSPEAKD--FIKNLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 3e-48
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 42/285 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE- 124
+F ++G GGFG V+ + TG + A+K L+++ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 125 --IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+ + P +V + D + + M G L HL + G S
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMR 110
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 242
A GL ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 111 FYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHA 164
Query: 243 VMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301
+GT+GY APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------ 218
Query: 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 346
R+ M + +S L L + R
Sbjct: 219 -----RMTLTMAVELPDSFSPEL----RSLLEGLLQRDVNRRLGC 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 8e-48
Identities = 66/319 (20%), Positives = 120/319 (37%), Gaps = 41/319 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ VLG G F V T ++A+K + +++L+G EI L
Sbjct: 11 YDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
++ HPN+V L H L+ + + G L + + G + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
+ YLH +++RD K N+L + +SDFGL+K V + G
Sbjct: 117 LDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 171
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
T GY APE +A + D +S GV+ +L G ++ I A+ S
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK----ALEQIQDTND 361
+ + K + + +P+ R T ++ ++ A + D N
Sbjct: 232 YWD------------DISDSAKDFIR--HLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277
Query: 362 AGVSRDESLQNSDRSTYKR 380
++ +N +S +K+
Sbjct: 278 HQSVSEQIKKNFAKSKWKQ 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 9e-48
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 49/299 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
N+ P +LG G V + T AVK ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 121 -WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
L E+ L ++ HPN+++L + LV++ M KG L ++L LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSE 109
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
K+ + + LH +++RD K NILLD + N KL+DFG +
Sbjct: 110 KETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGE 164
Query: 239 VSTRVMGTYGYAAPEYMATGHL------TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 292
V GT Y APE + + D++S GV++ +L+G +
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224
Query: 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+I S +K L + L +P+ R T +E +
Sbjct: 225 RMIMSGNYQFGSPEWD------------DYSDTVKD--LVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-47
Identities = 68/296 (22%), Positives = 107/296 (36%), Gaps = 40/296 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG VF T A+K L ++ + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 126 KHLG-QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
+ L HP L + ++ V E++ G L H+ +
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFY 108
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A GL +LH ++YRD K NILLD + + K++DFG+ K+ G
Sbjct: 109 AAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFC 164
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
GT Y APE + D +SFGV+L EML G+ + I P+
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224
Query: 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360
L K L +K EP+ R + ++ ++ N
Sbjct: 225 ----------------WLEKEAKD--LLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 8e-47
Identities = 46/285 (16%), Positives = 93/285 (32%), Gaps = 35/285 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + + K + + + EI L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
H N++ L + ++++EF+ + + + L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQV 111
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ L +LHS + + D + NI+ ++ K+ +FG A+ G + +
Sbjct: 112 CEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
Y APE ++ +D++S G ++ +LSG + I A+ +
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ + L E K R T E ++
Sbjct: 227 F------------KEISIEAMD--FVDRLLVKERKSRMTASEALQ 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-45
Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 34/293 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLG 129
LGEG F V+K T ++A+K++ + L EIK L
Sbjct: 5 FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
+L HPN++ L+ + LV++FM + L+ + L
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTL 110
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 249
+GL YLH +++RD K +N+LLD N KL+DFGLAK GS + T + T Y
Sbjct: 111 QGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWY 166
Query: 250 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------EWA 298
APE D+++ G +L E+L + + + I +W
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
F+ A L P R T + +K
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-45
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 36/309 (11%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL A + + + +GEG +G VFK G +A+KR+ ++ + +
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPL 52
Query: 122 -----LTEIKHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRTGAS 171
+ ++HL HPN+V+L C + LV+E + +
Sbjct: 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-- 110
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231
+ + +GL +LHS +V++RD K NIL+ + KL+DFGLA+
Sbjct: 111 --PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR-- 164
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291
S T V+ T Y APE + D++S G + EM + + + +
Sbjct: 165 -IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223
Query: 292 HNLIEWAKPY---------LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 342
I + R+ F A+ ++ L +KCL+ P
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
Query: 343 RPTMDEVVK 351
R + +
Sbjct: 284 RISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-45
Identities = 77/342 (22%), Positives = 128/342 (37%), Gaps = 36/342 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEI 125
+ S +GEG +G V + + +A+K+++ Q + + L EI
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
K L + H N++ + + ++ + L++ + Q LS
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFL 115
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVM 244
+GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+ P + T +
Sbjct: 116 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 245 GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303
T Y APE M T D++S G +L EMLS R + + N I
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAV-------------LAIKCLSNEPKFRPTMDEVV 350
+ + SL K L K L+ P R +++ +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 351 KA--LEQIQDTNDAGVSR-----DESLQNSDRSTYKRKGLNE 385
LEQ D +D ++ D L + + K E
Sbjct: 294 AHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 2e-44
Identities = 51/296 (17%), Positives = 92/296 (31%), Gaps = 37/296 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+R +G G FG ++ G G +A+K ++ L E K
Sbjct: 9 YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTKHPQLH--IESKIYK 57
Query: 130 QLYHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
+ + I +C + D+ ++V E + + F + S + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQM 112
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNIL---LDLNYNAKLSDFGLAK-----DGPTGSQSHVS 240
+ Y+HS I+RD K N L + DFGLAK +
Sbjct: 113 ISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 241 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300
+ GT YA+ + + D+ S G VL+ G + + + E
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---- 226
Query: 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
+ + + Y A C S +P + + +
Sbjct: 227 --RISEKKMSTPIEVLCKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 59/292 (20%), Positives = 103/292 (35%), Gaps = 43/292 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LT 123
+ LG G F V K TG+ A K + + +
Sbjct: 12 YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMK 183
E+ L ++ HPN++ L +L+ E + G L + L L+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATE 117
Query: 184 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLD----LNYNAKLSDFGLAKDGPTGSQSHV 239
G+ YLHS ++ + D K NI+L K+ DFGLA G++
Sbjct: 118 FLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 173
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
+ GT + APE + L ++D++S GV+ +LSG + +
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232
Query: 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ + + A K + L +PK R T+ + ++
Sbjct: 233 YEFEDEYFS------------NTSALAKD--FIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 6e-44
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 31/296 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G V+K A+ G A+K++ E + EI
Sbjct: 3 KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L +L H N+VKL +LV+E + + + G L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLL 107
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
G+AY H +V++RD K N+L++ K++DFGLA+ + + ++
Sbjct: 108 QLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTL 164
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------E 296
+ A M + + D++S G + EM++G + + + I
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVVK 351
W K + + + L ++ + L K L +P R T + ++
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 63/296 (21%), Positives = 119/296 (40%), Gaps = 29/296 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K++ ++ + EI
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L +L HPN+VKL+ ++ LV+EF+ + + AS + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD----ASALTGIPLPLIKSYLF 109
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+GLA+ HS + V++RD K N+L++ KL+DFGLA+ + + V+
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTL 166
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------E 296
+ A + + + D++S G + EM++ R + + + I
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVVK 351
W + AR + + + L + L +P R + +
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-42
Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 53/292 (18%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLT 123
++ +LG GGFG V+ G R + +A+K + ++ + E
Sbjct: 6 YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 124 EIKHLGQL--YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
E+ L ++ +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELA 112
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVS 240
+ + + H V++RD K NIL+DLN KL DFG + V
Sbjct: 113 RSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVY 166
Query: 241 TRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 299
T GT Y+ PE++ + + V+S G++L +M+ G P I +
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQ 220
Query: 300 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ + + + + + L CL+ P RPT +E+
Sbjct: 221 VFFRQR----------------VSSECQH--LIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 37/301 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ V+G G FG V++ +G ++A+K++ Q+ + E++ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQDKRFKN----RELQIM 67
Query: 129 GQLYHPNLVKLIGYCLEDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRM 182
+L H N+V+L + + LV +++P+ + A Q L
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVK 125
Query: 183 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 241
+ LAY+HS + +RD K N+LLD + KL DFG AK G + +
Sbjct: 126 LYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 181
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI------ 295
+ Y A T+ DV+S G VL E+L G+ + + + I
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 296 ----EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVV 350
+ + F + A + A+ L + L P R T E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 351 K 351
Sbjct: 302 A 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 5e-42
Identities = 64/241 (26%), Positives = 100/241 (41%), Gaps = 24/241 (9%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTE 124
++F+ LG G FG V G A+K L +E L+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKV 184
L + HP ++++ G + ++ +++ G L + L Q +
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFY 109
Query: 185 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
A L YLHS +IYRD K NILLD N + K++DFG AK P V+ +
Sbjct: 110 AAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLC 162
Query: 245 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304
GT Y APE ++T D +SFG+++ EML+G + + + I A+
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222
Query: 305 K 305
Sbjct: 223 F 223
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (369), Expect = 1e-41
Identities = 46/298 (15%), Positives = 86/298 (28%), Gaps = 37/298 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLR--DEYRTY 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGA 188
L + + Y ++ ++ + SLE+ L G + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQM 110
Query: 189 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AKLSDFGLAK-----DGPTGSQSH 238
+ +H ++YRD K N L+ + + DFG+ K
Sbjct: 111 LARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 239 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298
+ GT Y + + + D+ + G V + L G + + E
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356
QS E + P D + ++
Sbjct: 229 GEKKQS--------TPLRELCAGFPEEFYK--YMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 58/285 (20%), Positives = 99/285 (34%), Gaps = 40/285 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK-HLGQLYH 133
VLG G G V + + T A+K L + E++ H
Sbjct: 19 VLGLGINGKVLQIF---------NKRTQEKFALKMLQDCP-----KARREVELHWRASQC 64
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAA 189
P++V+++ L+V E + G L + + G Q + ++
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIG 121
Query: 190 KGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLSDFGLAKDGPTGSQSHVSTRVMGT 246
+ + YLHS + +RD K N+L KL+DFG AK+ + + T
Sbjct: 122 EAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYT 176
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 306
Y APE + D++S GV++ +L G P ++ + + R
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIR 230
Query: 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 351
+ S + L L EP R T+ E +
Sbjct: 231 MGQYEFPNPEWSEVSEEVKM----LIRNLLKTEPTQRMTITEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-41
Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 43/310 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIK 126
+ + +G+G FG VFK TG +A+K++ E+ + + L EIK
Sbjct: 11 KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 127 HLGQLYHPNLVKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSW 178
L L H N+V LI C LV++F + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTL 116
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 238
+ +V GL Y+H +K +++RD K +N+L+ + KL+DFGLA+ S
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 239 VS--TRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295
+ T + T Y PE + D++ G ++ EM + ++ N + LI
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 296 -------------EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPK 341
L K + + +++ + A+ L K L +P
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 342 FRPTMDEVVK 351
R D+ +
Sbjct: 295 QRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-39
Identities = 71/343 (20%), Positives = 132/343 (38%), Gaps = 49/343 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+R +G G +G V TG +A+K+L + E++
Sbjct: 20 YRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 128 LGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRTGASYIQPLSWTIR 181
L + H N++ L+ D+ LV FM G+ L + L
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-----KLGEDRI 123
Query: 182 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 241
+ KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ + S ++
Sbjct: 124 QFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTG 177
Query: 242 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI------ 295
V+ + A + T D++S G ++ EM++G+ + + + I
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 296 ---EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDE 348
E+ + + + + +E + + LA+ K L + + R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 349 VVKA--LEQIQDTNDAGVSR--DESLQNSDRS--TYKRKGLNE 385
+ E + DT D + D+S + DR+ +KR E
Sbjct: 298 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKE 340
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 3e-39
Identities = 61/297 (20%), Positives = 106/297 (35%), Gaps = 31/297 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G VFK T ++A+KR+ + L EI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVAL 186
L +L H N+V+L D LV+EF + + G I
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLF 108
Query: 187 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 246
KGL + H V++RD K N+L++ N KL++FGLA+ + + S V+
Sbjct: 109 QLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTL 165
Query: 247 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH---NLIEWAKPYLQ 303
+ + D++S G + E+ + R + + P +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 304 SKRRIFQVMDARIEGQYSLGAALKTAV---------LAIKCLSNEPKFRPTMDEVVK 351
+ ++ D + Y +L V L L P R + +E ++
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-38
Identities = 66/240 (27%), Positives = 92/240 (38%), Gaps = 21/240 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG V TG A+K L +E + E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ L HP L L D V E+ G L HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYG 111
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
L YLHS V+YRD K N++LD + + K++DFGL K+G + + G
Sbjct: 112 AEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCG 167
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
T Y APE + D + GVV+ EM+ GR R LI +
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 1e-36
Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 24/240 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
F LG G FG V +G A+K L+++ + + L E
Sbjct: 42 QFDRIKTLGTGSFGRVMLVK---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
+ L + P LVKL ++ + +V E++ G + +HL R G S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYA 147
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 245
YLHS +IYRD K N+L+D +++DFG AK + + G
Sbjct: 148 AQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200
Query: 246 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305
T APE + + D ++ GV++ EM +G ++P + + I K S
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-35
Identities = 54/308 (17%), Positives = 103/308 (33%), Gaps = 50/308 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ LG G + VF+ + VK L + + EIK L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKKK---KIKREIKIL 83
Query: 129 GQL-YHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVA 185
L PN++ L + R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYM 135
Query: 186 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVM 244
K L Y H +++RD K N+++D + +L D+GLA+ G + +
Sbjct: 136 YEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRV 190
Query: 245 GTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR--------------RVIDKNRPS 289
+ + PE + D++S G +L M+ + R+
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV------LAIKCLSNEPKFR 343
++ I+ L + +R + + + + V K L + + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 344 PTMDEVVK 351
T E ++
Sbjct: 311 LTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 35/297 (11%)
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL- 115
+ + + K NF VLG G +G VF + TG + A+K L + ++
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLV------RKISGHDTGKLYAMKVLKKATIV 66
Query: 116 ---QGHLEWLTEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGAS 171
+ TE + L + P LV L + L+ +++ G L HL +
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--- 123
Query: 172 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231
+ + L +LH K +IYRD K NILLD N + L+DFGL+K+
Sbjct: 124 --ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE- 178
Query: 232 PTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 289
++ + GT Y AP+ + G D +S GV++ E+L+G +
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 346
I ++ L+S+ Q M A + L + L +PK R
Sbjct: 239 NSQAEI--SRRILKSEPPYPQEMSALAKD------------LIQRLLMKDPKKRLGC 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-31
Identities = 60/305 (19%), Positives = 117/305 (38%), Gaps = 41/305 (13%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTE 124
++ S +G G +G V + TG+ +AVK+L++ S+ E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 125 IKHLGQLYHPNLVKLIGYC-----LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179
++ L + H N++ L+ LE+ + + + + L N + Q L+
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDD 121
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ +GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+ + +
Sbjct: 122 HVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEM 175
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------------RVIDKN 286
+ V + A + H D++S G ++ E+L+GR ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 287 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 346
L + + ++ + M +GA L K L + R T
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 347 DEVVK 351
+ +
Sbjct: 296 AQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-31
Identities = 57/316 (18%), Positives = 110/316 (34%), Gaps = 54/316 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
+ ++ +G G G V + +A+K+L++ E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 126 KHLGQLYHPNLVKLIGYCL------EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179
+ + H N++ L+ E LV E M + L
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHE 119
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 239
+ G+ +LHS +I+RD K SNI++ + K+ DFGLA+ T S +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 174
Query: 240 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR----------------RVI 283
T + T Y APE + D++S G ++ EM+ + +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV--------LAIKC 335
P L + Y++++ + + ++ A + L K
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 336 LSNEPKFRPTMDEVVK 351
L +P R ++D+ ++
Sbjct: 295 LVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 1e-26
Identities = 38/240 (15%), Positives = 81/240 (33%), Gaps = 23/240 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G F V+ +A+K + + + EIK L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQ 64
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYE-----------FMPKGSLENHLFRTGASYIQPLSW 178
++ + K +LL + + + EN L + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 179 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQS 237
+++ GL Y+H + +I+ D K N+L+++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 238 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297
T + T Y +PE + +D++S ++ E+++G + + + +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 2e-14
Identities = 21/171 (12%), Positives = 43/171 (25%), Gaps = 39/171 (22%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------QGHLEWLT 123
++GEG VF VK G L +
Sbjct: 6 KLMGEGKESAVFN----------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 124 EIKHLGQLYHPNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWT 179
+ L KL G + ++ E + + +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK------------ELYRVRVE 103
Query: 180 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230
+V + +A + +++ D N+L+ + DF + +
Sbjct: 104 NPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.27 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-57 Score=411.87 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=212.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||+||+| .+..+|+.||+|++..........+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 57999999999999999999 445579999999998776666677899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.+|+||||++||+|.+++.+.. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEEecCCCcHHHHhhccC------CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchh
Confidence 9999999999999999887643 899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+ .
T Consensus 163 a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~----- 229 (293)
T d1yhwa1 163 CAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------A----- 229 (293)
T ss_dssp CEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-----
T ss_pred heeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------H-----
Confidence 98654332 1344568999999999999999999999999999999999999999765432111100 0
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.........+...+..+.+||.+||+.||.+|||+.|+++|=+
T Consensus 230 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 230 ----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp ----HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred ----hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0001111223345678899999999999999999999999844
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-58 Score=413.13 Aligned_cols=257 Identities=26% Similarity=0.288 Sum_probs=208.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||+||+|. +..+|+.||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999994 4457899999998765433 23457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCC
T ss_pred CceeEEEEeccCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccc
Confidence 999999999999999999997543 4999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............ +
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~------- 219 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W------- 219 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-H-------
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-H-------
Confidence 99987544333334456789999999999988776 57899999999999999999999765432211100 0
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.............+.++.+|+.+||+.||++|||++|+++|=|
T Consensus 220 -------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 220 -------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp -------HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -------hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0000001111234567889999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-57 Score=404.14 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=211.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||+||+|. +..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEE---------ECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 469999999999999999994 445789999999876533 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~D 149 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIAD 149 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecc
Confidence 9999999999999999999998764 3999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+........
T Consensus 150 FG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----------- 214 (263)
T d2j4za1 150 FGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----------- 214 (263)
T ss_dssp CCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----------
T ss_pred cceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-----------
Confidence 9999865432 2345689999999999999999999999999999999999999997654211111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
.+.. ....++...+.++.+|+.+||+.||++|||++|+++|=+.
T Consensus 215 -----~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 215 -----RISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp -----HHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred -----HHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 1111 1112334456788999999999999999999999997543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=403.19 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=205.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEccccc--chhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++.+.||+|+||+||+|..+ ..||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 468999999999999999999543 249999987543 234567889999999999999999999875
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+ +..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 75 ~-~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~D 147 (276)
T d1uwha_ 75 A-PQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGD 147 (276)
T ss_dssp S-SSCEEEEECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECC
T ss_pred c-cEEEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEcc
Confidence 4 56899999999999999997654 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||+++...............||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+..........
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------ 221 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------ 221 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------
Confidence 9999875544433344567899999999998643 4789999999999999999999999765432211100
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.... .........+..++..+.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 222 ~~~~------~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 222 VGRG------YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHT------SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhcC------CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0000 000001122334567889999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=405.77 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=209.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+.|++.+.||+|+||+||+|. +..+|..||+|++..........+.+|+.+|++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEE---------ECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999994 44578999999998766566667889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..|+||||+++|+|.+++.+.. .++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechh
Confidence 9999999999999999987654 35999999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+...... ........||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+..+......+
T Consensus 157 a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------- 227 (288)
T d2jfla1 157 SAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------- 227 (288)
T ss_dssp CEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-------
T ss_pred hhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-------
Confidence 8753211 11233567999999999983 456889999999999999999999999775542221111
Q ss_pred hhcchhhhhhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDAR-IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.... .....+...+.++.+||.+||+.||.+|||+.|+++|=+
T Consensus 228 ---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp ---------HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred ---------HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000 011122345678899999999999999999999999743
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=406.54 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=208.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.++||+|+||+||+|. +..+|+.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 569999999999999999994 445789999999976543 23356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++.+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~D 151 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITD 151 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecc
Confidence 9999999999999999999988775 3999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.++.....
T Consensus 152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----------- 220 (288)
T d1uu3a_ 152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----------- 220 (288)
T ss_dssp CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-----------
Confidence 999987654443334455689999999999999999999999999999999999999997654211111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.+... ...++...+.++.+||.+||+.||++|||++|++.+-+
T Consensus 221 -----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 221 -----KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -----HHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -----HHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 11111 11233345678899999999999999999999876544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-56 Score=404.69 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=216.2
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||+||+|.+. .+|..||||++..... ..+++.+|+.+|++++||||+++++++.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEG---------GGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEEC---------CCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3467899999999999999999654 3688999999876543 45578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCeeEEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccc
Confidence 9999999999999999999976543 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+++...... ........|++.|+|||++.+..|+.++|||||||++|||++|..||.......
T Consensus 160 G~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--------------- 223 (287)
T d1opja_ 160 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------- 223 (287)
T ss_dssp CCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------------
T ss_pred cceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---------------
Confidence 9998754432 223334568899999999999999999999999999999999776654322111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.+...+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 224 -~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 224 -QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -HHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11122222223344455677899999999999999999999999999887543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=395.63 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=202.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
.+|++.+.||+|+||+||+|.+. ++..||||++..... ...++.+|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57889999999999999999654 356899999976543 3457899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred ceEEEEEecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccch
Confidence 9999999999999999987654 45899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++........ ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||....... ...
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~---------- 213 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE---------- 213 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH----------
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH----------
Confidence 9865433221 23345789999999999999999999999999999999995 55554332111 111
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.+........+..++..+.+|+.+||+.||++|||+++|+++|+++.+.
T Consensus 214 ----~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 214 ----DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1111111223334567889999999999999999999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=401.45 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=196.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||+||+|. +..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEE---------ECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999994 445789999999876643 234558899999999999999999999865
Q ss_pred --CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---CCeEEeccCCCcEEEcCCCce
Q 015731 146 --DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYNA 220 (401)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~dlkp~Nil~~~~~~~ 220 (401)
++.+|+||||+++|+|.+++.+... ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 4668999999999999999865321 1145999999999999999999999853 249999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 221 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||..........
T Consensus 154 kl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~------- 224 (269)
T d2java1 154 KLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------- 224 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------
T ss_pred EEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH-------
Confidence 999999998654322 12345689999999999999999999999999999999999999997643211100
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.+..... ...+...+.++.+|+.+||+.||.+|||+.|+++|
T Consensus 225 ---------~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 225 ---------KIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---------HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------HHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111111 12334456789999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=395.48 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=200.5
Q ss_pred CCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee--
Q 015731 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (401)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-- 145 (401)
|++.+.||+|+||+||+|.. ..++..||+|.+..... .....+.+|+++|++++||||+++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~---------~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLD---------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEE---------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 46777899999999999954 44788999999876543 234568899999999999999999999875
Q ss_pred --CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc-CCCceEE
Q 015731 146 --DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKL 222 (401)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~-~~~~~kl 222 (401)
...+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++.+|+||||||+|||++ .++.+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEE
Confidence 356899999999999999998764 38999999999999999999999877799999999999996 5789999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...
T Consensus 157 ~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~------ 223 (270)
T d1t4ha_ 157 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR------ 223 (270)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH------
T ss_pred eecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH------
Confidence 999999864322 2345689999999999865 599999999999999999999999975432111 000
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.+........++...+.++.+|+.+||+.||++|||+.|+++|=
T Consensus 224 -------~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 224 -------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp -------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -------HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 00000000111122345688999999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-55 Score=412.02 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=213.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++++.||+|+||+||+|. +..+|+.||+|++..........+.+|+.+|++|+||||+++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999994 44579999999998776556667889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc--CCCceEEeec
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDF 225 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Df 225 (401)
.+|||||||+||+|.+++.... .++++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+||
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEEEEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeec
Confidence 9999999999999999886654 35999999999999999999999998 99999999999997 6789999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+. .
T Consensus 174 Gla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~-- 242 (352)
T d1koba_ 174 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------R-- 242 (352)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------H--
T ss_pred ccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h--
Confidence 9998765432 3455689999999999999999999999999999999999999997654321111010 0
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.............+.++.+||.+||+.||.+|||+.|+++|=+
T Consensus 243 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 243 ------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp ------CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ------CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0011112223345678899999999999999999999999843
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=409.93 Aligned_cols=268 Identities=28% Similarity=0.392 Sum_probs=208.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||+||+|+ +..+|+.||+|++..... .....+.+|+.+|++++||||++++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEE---------ETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4689999999999999999994 445799999999876533 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
++.+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 148 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEee
Confidence 999999999999999999998765 38999999999999999999997 47 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh-hh----
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AK---- 299 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~---- 299 (401)
||+|...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. ..
T Consensus 149 FGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 149 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred CCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 9999854221 23456899999999999999999999999999999999999999976543211100000 00
Q ss_pred --------------hh---hhhcchhhhhhhhhh----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 300 --------------PY---LQSKRRIFQVMDARI----EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 300 --------------~~---~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.. ........+...... ........+.++.+|+.+||+.||.+|||++|+|+|=+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 00 000000001111100 00111124567889999999999999999999999843
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-55 Score=404.00 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=194.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-HHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.+.|++.++||+|+||+||+|. +..+|+.||||++....... ...+.+|+.+|+.++||||+++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEE---------ETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3569999999999999999994 44578999999997654432 3457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc---CCCceEE
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKL 222 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~---~~~~~kl 222 (401)
++.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||++. +++.+||
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred CCEEEEEEeccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEE
Confidence 999999999999999999997654 4999999999999999999999998 99999999999994 5789999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+........
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~--------- 219 (307)
T d1a06a_ 152 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE--------- 219 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------
T ss_pred eccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH---------
Confidence 9999998643322 2345679999999999999999999999999999999999999997643211110
Q ss_pred hhcchhhhhhhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 303 QSKRRIFQVMDA--RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 303 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
.+... ..........+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus 220 -------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 220 -------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp -------HHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -------HHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 11111 1111222345678899999999999999999999999844
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-55 Score=408.78 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=211.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|. +..+|..||||++..........+.+|+.+|++++||||+++++++.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~---------~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999994 44579999999998776666677889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc--CCCceEEeec
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDF 225 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Df 225 (401)
.+|||||||+||+|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeec
Confidence 9999999999999999996543 34999999999999999999999998 99999999999995 4688999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+. ...
T Consensus 171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~ 241 (350)
T d1koaa2 171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCD 241 (350)
T ss_dssp TTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTC
T ss_pred chheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC
Confidence 9998754332 3455789999999999999999999999999999999999999997654321111110 000
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...........+..+.+||.+||+.||++|||+.|+++|=+
T Consensus 242 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 242 --------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp --------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred --------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00011111234567889999999999999999999999843
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=398.18 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=203.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++.++||+|+||+||+|.+... ......||||.+..... .....+.+|+.+|++++||||+++++++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 5688889999999999999976431 12345789998876543 3345689999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999887654 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcce---eeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 227 LAKDGPTGSQSHV---STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 227 ~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
+++.......... .....||+.|+|||.+.+..++.++|||||||++|||+| |..||.+...... .
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~------- 243 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---I------- 243 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---H-------
Confidence 9986543322111 222457899999999999999999999999999999998 8999976543211 1
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 244 -------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 -------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111112223344567789999999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=402.92 Aligned_cols=267 Identities=25% Similarity=0.387 Sum_probs=214.7
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.++||+|+||+||+|++... .....+..||+|.+..... .....+.+|+.++.++ +||||+++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 346799999999999999999976532 1223456799998865432 3345688999999998 899999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 205 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 205 (401)
.+.+..|+||||+++|+|.+++...... ....+++..++.++.||+.||+|||+++ |+||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 9999999999999999999999765421 1235899999999999999999999998 9999
Q ss_pred ccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 015731 206 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 284 (401)
Q Consensus 206 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 284 (401)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986554444334455678999999999999999999999999999999997 899997
Q ss_pred CCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 285 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
+...... +..++........+..++..+.+|+.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6543211 11122222223344556778999999999999999999999999995
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=384.83 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=212.7
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||+||+|.+. ++..||||++..... ...++.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 68999999999999999999754 467899999987554 3457899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
.+++||||+.+|+|.+++.... ..+++..+++++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchh
Confidence 9999999999999999976654 34899999999999999999999988 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcc
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 306 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (401)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+........
T Consensus 147 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~------------- 212 (258)
T d1k2pa_ 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------------- 212 (258)
T ss_dssp CCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------------
T ss_pred heeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-------------
Confidence 986543322 23344678999999999999999999999999999999998 899997654321111
Q ss_pred hhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 307 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
.+........+...+..+.+|+.+||+.||++|||+++|+++|..|
T Consensus 213 ----~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 213 ----HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----HHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111112233344567889999999999999999999999999654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-54 Score=398.88 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=205.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
+.|+.++.||+|+||+||+|+ +..+|..||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEE---------ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 359999999999999999994 445789999999876543 23346889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++..|+|||||.+|+|..++.... ++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~D 158 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGD 158 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECC
T ss_pred ECCEEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEee
Confidence 9999999999999998877665543 4999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 301 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 301 (401)
||++..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.......
T Consensus 159 FG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~--------- 223 (309)
T d1u5ra_ 159 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------- 223 (309)
T ss_dssp CTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------
T ss_pred cccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---------
Confidence 999986432 234579999999999854 45889999999999999999999999764321110
Q ss_pred hhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 302 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
............+...+..+.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 224 -------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 224 -------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp -------HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -------HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 11111111111223456788999999999999999999999998554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=395.49 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=208.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccCCCccccee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~hpni~~~~ 140 (401)
.++|++.+.||+|+||+||+|+ +..+|+.||||++...... ....+.+|+.+|++++||||++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~---------~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEE---------ECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3579999999999999999994 4457999999998754331 245688999999999999999999
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC--
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 218 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-- 218 (401)
+++.+.+.+|||||||++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCc
Confidence 99999999999999999999999998764 3999999999999999999999998 99999999999998776
Q ss_pred --ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH
Q 015731 219 --NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 296 (401)
Q Consensus 219 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 296 (401)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 153 ~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229 (293)
T ss_dssp SCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 59999999998754332 2345679999999999999899999999999999999999999997654321111110
Q ss_pred hhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 297 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
..... .........+..+.+||.+||+.||.+|||++|+++|=+
T Consensus 230 ------~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 230 ------AVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp ------TTCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ------hcCCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00000 000001123567889999999999999999999999743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=397.73 Aligned_cols=250 Identities=28% Similarity=0.368 Sum_probs=211.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++++.||+|+||.||+|. +..+|+.||+|++.+... .....+.+|+.+|+.++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 579999999999999999994 445799999999986543 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+.+.+|+||||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred cccccccceeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEee
Confidence 99999999999999999999988754 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+......
T Consensus 149 FG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----------- 215 (337)
T d1o6la_ 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------- 215 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred cccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH-----------
Confidence 99998643322 23445789999999999999999999999999999999999999998754321111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKAL 353 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L 353 (401)
.+... ...++...+.++.+||.+||+.||.+|++ ++++++|-
T Consensus 216 -----~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 216 -----LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp -----HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -----HHhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 11111 11234456678899999999999999994 89999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=390.67 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=207.4
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ....+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3467999999999999999999754 367899999976543 34578999999999999999999998765
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..++||||+++|+|.+++..... .++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccc
Confidence 567999999999999998765432 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...... ........||+.|+|||++.+..++.++|||||||++|||+||..| |...... ...
T Consensus 154 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~--------- 220 (272)
T d1qpca_ 154 GLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI--------- 220 (272)
T ss_dssp TTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---------
T ss_pred cceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHH---------
Confidence 9998754332 1223345789999999999988999999999999999999996554 4433211 111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 221 -----~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 221 -----QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111111122233455678899999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=388.03 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=209.3
Q ss_pred CCCCCCCc-ccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSV-LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~-lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|.+.+. ||+|+||.||+|.+.. ..++..||||++..... ....++.+|+.+|++++||||+++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEec-------CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666674 9999999999996642 23467899999876543 335678899999999999999999999865
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccc
Confidence 46899999999999999986554 35999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||...........
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~--------- 224 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------- 224 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---------
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---------
Confidence 999865443322 12234568999999999998999999999999999999998 8999976543211111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 225 --------i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 225 --------IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111223344567789999999999999999999999999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=386.77 Aligned_cols=265 Identities=23% Similarity=0.394 Sum_probs=206.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
..|++.++||+|+||.||+|.+... .......||||++...... ...++.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4688889999999999999976542 1223467999998765433 344688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccc
Confidence 99999999999999999887665 35999999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCC-cceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~------------ 221 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE------------ 221 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH------------
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH------------
Confidence 9986543322 11233456899999999999999999999999999999999976555332211 01
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 222 --~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222222334455667899999999999999999999999999988653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=384.77 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=201.3
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEeeCCeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~~~~l 151 (401)
+.||+|+||+||+|.+.. ..+++.||||++..... ....++.+|+.+|++++||||+++++++.+ +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 469999999999997643 23578899999875432 234568899999999999999999999865 45789
Q ss_pred EEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcCC
Q 015731 152 VYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 231 (401)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 231 (401)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 vmE~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp EEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhc
Confidence 999999999999998764 4999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcc-eeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhcchhh
Q 015731 232 PTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 309 (401)
Q Consensus 232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (401)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...... .
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~-------------- 220 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T-------------- 220 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---H--------------
Confidence 4433221 2234578999999999999999999999999999999998 8999976542111 1
Q ss_pred hhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 310 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 221 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 221 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11111112233445677899999999999999999999998887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=390.87 Aligned_cols=274 Identities=27% Similarity=0.344 Sum_probs=208.9
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~ 142 (401)
...++|++.+.||+|+||.||+|.+... .+..+++.||+|++..... .....+.+|..++.++ +|+||+.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3447899999999999999999976532 3445788999999976543 3345577888888777 68999999998
Q ss_pred EeeC-CeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCC
Q 015731 143 CLED-DHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 143 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 210 (401)
+.+. ..+++|||||++|+|.+++...... ....+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 7654 5689999999999999999764321 1234899999999999999999999998 999999999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCC
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPS 289 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~ 289 (401)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865544433344556799999999999999999999999999999999987 4577654322
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
... ...+........+...+.++.+|+.+||+.||++|||+.||++||+.+.+.+
T Consensus 244 ~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 EEF----------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHH----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH----------------HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 110 1111111122334445678899999999999999999999999999987665
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=385.32 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=203.1
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||.||+|.... ....+..||+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3679999999999999999997642 2335678999998765433 3456889999999999999999999986
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCeEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccc
Confidence 467899999999999999887654 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
|+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+
T Consensus 153 G~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i--------- 222 (273)
T d1mp8a_ 153 GLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------- 222 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------
T ss_pred hhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---------
Confidence 9998654322 222344678999999999999999999999999999999998 89999776542221111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........+..++..+.+||.+||+.||++|||+.||+++|+.+.+.
T Consensus 223 --------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 223 --------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01111223445667899999999999999999999999999988653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-53 Score=390.97 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=208.5
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~---------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 469999999999999999994 445789999999976532 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+++.+|+||||+.||+|..++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~D 147 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITD 147 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eCCeeeeEeeecCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEec
Confidence 99999999999999999999987753 888999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.....
T Consensus 148 FG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------------ 210 (316)
T d1fota_ 148 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------ 210 (316)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------
T ss_pred CccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH------------
Confidence 9999875432 33568999999999999999999999999999999999999999765421111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 352 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~ 352 (401)
..+... ...++...+.++.+++.+||+.||.+|+ |++++++|
T Consensus 211 ----~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 211 ----EKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 1123344567889999999999999996 99999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=388.19 Aligned_cols=252 Identities=18% Similarity=0.226 Sum_probs=209.0
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|++.+.||+|+||+||+|. +..+|+.||+|++..... ....+.+|+.+|+.++||||+++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~---------~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999994 445799999999977643 334578999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC--CCceEEee
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSD 224 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~--~~~~kl~D 224 (401)
+.+|||||||.||+|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++. .+.++|+|
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcc
Confidence 99999999999999999997654 34899999999999999999999998 999999999999974 45899999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||++....... ......+++.|+|||.+.+..|+.++|||||||++|+|++|..||...........
T Consensus 148 FG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~---------- 214 (321)
T d1tkia_ 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN---------- 214 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------
T ss_pred cchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH----------
Confidence 99998654332 34556799999999999999999999999999999999999999976543211111
Q ss_pred cchhhhhhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 305 KRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+.... ..++. ..+.++.+||.+||..||.+|||+.|+++|=+.
T Consensus 215 ------i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 215 ------IMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ------HHHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ------HHhCC--CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 11100 01111 235678899999999999999999999998543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=388.36 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=207.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|+++++||+|+||+||+|.+... .......||+|.+..... ....++.+|+.++++++||||+++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4699999999999999999965431 112244789998865432 3456789999999999999999999999875
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
..+++|+++.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred -CeeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccc
Confidence 5677889999999999887765 45999999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++...............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+........
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~------------ 224 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ 224 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH------------
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH------------
Confidence 9987654443333445678999999999999999999999999999999998 788887654322111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
.+........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 225 -----~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 225 -----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111112223344566788999999999999999999999999988753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-52 Score=393.63 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=205.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh---HHHH---HHHHHHHhccCCCcccceee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEW---LTEIKHLGQLYHPNLVKLIG 141 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~---~~e~~~l~~l~hpni~~~~~ 141 (401)
++|++.++||+|+||.||+|. +..+|+.||+|++....... ...+ ..++.+++.++||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~---------~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEE---------ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999994 44579999999987543311 1222 34577888889999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceE
Q 015731 142 YCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 221 (401)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~k 221 (401)
++.+.+.+|+||||++||+|.+++.+... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEE
Confidence 99999999999999999999999987653 899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
|+|||+++...... .....||+.|+|||++. +..|+.++|||||||++|+|++|+.||..............
T Consensus 148 l~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--- 220 (364)
T d1omwa3 148 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--- 220 (364)
T ss_dssp ECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---
T ss_pred EeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 99999998654332 33457999999999986 45689999999999999999999999976543322111110
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 354 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps-----~~eil~~L~ 354 (401)
. .......+...+.++.+||.+||+.||.+||| ++|+++|=+
T Consensus 221 ----------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 221 ----------T--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp ----------S--SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred ----------c--ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 0 00111223345678899999999999999999 799998843
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-52 Score=392.77 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=209.3
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++++.||+|+||.||+|. +..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~---------~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVK---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEE---------ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999994 445799999999876532 23456789999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+....++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~~-----l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred cccccccccccccccchhhhHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeee
Confidence 99999999999999999999987753 999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhh
Q 015731 225 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 304 (401)
Q Consensus 225 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 304 (401)
||+++..... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..+.....
T Consensus 185 FG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------- 248 (350)
T d1rdqe_ 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----------- 248 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred ceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH-----------
Confidence 9999875432 334679999999999999999999999999999999999999997653211111
Q ss_pred cchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 305 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.+... ....+...+.++.+||.+||+.||.+|+ |++++++|=+
T Consensus 249 -----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 249 -----KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -----HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----HHhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 11111 1122334567889999999999999994 9999998743
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-53 Score=386.77 Aligned_cols=271 Identities=26% Similarity=0.342 Sum_probs=216.4
Q ss_pred HHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch-hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
...++|++.+.||+|+||+||+|+.... .+..++..||||++...... ...++.+|+.+|++++||||+++++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3456899999999999999999976531 23456789999999765443 345689999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGA-------------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 204 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH 204 (401)
.+.+..++||||+.+|+|.+++..... .....+++..++.++.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 999999999999999999999975431 11245889999999999999999999988 999
Q ss_pred eccCCCcEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCC
Q 015731 205 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVI 283 (401)
Q Consensus 205 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~ 283 (401)
|||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997544333333344567899999999999999999999999999999999985 567
Q ss_pred CCCCCCccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 284 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
....+..... .+.+.. ....+..++.++.+|+.+||+.||++|||+.||++.|++|.+
T Consensus 244 ~~~~~~e~~~----------------~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHEEVIY----------------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHHHHHH----------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHHHHHH----------------HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6543321111 111111 112234456688999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-52 Score=379.42 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=207.4
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---------hHHHHHHHHHHHhccC-CCccc
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------GHLEWLTEIKHLGQLY-HPNLV 137 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~e~~~l~~l~-hpni~ 137 (401)
++|++.+.||+|+||+||+|+. ..+|+.||||++...... ....+.+|+.++++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEE---------CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 6899999999999999999954 447899999998764321 1234778999999997 99999
Q ss_pred ceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
++++++.+++..||||||+++|+|.+++...+ ++++..+..++.||+.||+|||++| |+||||||+||+++.+
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~ 146 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD 146 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC
Confidence 99999999999999999999999999998765 3999999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCCcceeeecccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCcc
Q 015731 218 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 291 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 291 (401)
+.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+..+...
T Consensus 147 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence 999999999998754432 2345679999999999853 3467899999999999999999999976543211
Q ss_pred chhHHhhhhhhhhcchhhhhhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
... +.... .........+.++.+|+.+||+.||.+|||+.|+++|=
T Consensus 224 ~~~----------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 224 LRM----------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp HHH----------------HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHH----------------HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 111 11111 11112235667899999999999999999999999873
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-52 Score=380.62 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=203.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch---hHHHHHHHHHHHhccCCCcccceeeEE
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~hpni~~~~~~~ 143 (401)
.++|++.+.||+|+||+||+|. +..+|+.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 3679999999999999999994 4457999999999765432 244688999999999999999999998
Q ss_pred eeCC----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 144 LEDD----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 144 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.+.+ ..|+||||++|++|.+++...+ ++++..+..++.||+.||+|||++| |+||||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~ 149 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNA 149 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSC
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcccc
Confidence 8654 4799999999999999988765 3999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCC-CcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGS-QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
++|+|||.+....... .........||+.|+|||++.+..++.++|||||||++|+|+||+.||.+..+......
T Consensus 150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---- 225 (277)
T d1o6ya_ 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---- 225 (277)
T ss_dssp EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----
T ss_pred ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH----
Confidence 9999999887543322 22234456899999999999998999999999999999999999999976543211100
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhch
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQ 357 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-s~~eil~~L~~i~ 357 (401)
...... ..........+..+.+||.+||+.||.+|| |++++++.|.+++
T Consensus 226 --~~~~~~--------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 226 --HVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --HHHCCC--------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --HHhcCC--------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000000 000111223456888999999999999999 8999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=378.71 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=203.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.++++++||||+++++++.+ +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 579999999999999999997643 45799999976543 44678999999999999999999999865 5
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..++||||+.+|+|..++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred CeEEEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccch
Confidence 68999999999999999876432 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcch
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 307 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (401)
++....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ...
T Consensus 160 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~------------- 223 (285)
T d1fmka3 160 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REV------------- 223 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH-------------
T ss_pred hhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHH-------------
Confidence 986543322 2234467899999999999999999999999999999999976555332211 000
Q ss_pred hhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 308 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+-...
T Consensus 224 -~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 224 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111112223344556778999999999999999999999999998865443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=375.39 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=201.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee-C
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-D 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-~ 146 (401)
++|++.+.||+|+||.||+|.+. |..||||+++... ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56888999999999999999653 5789999997653 34568899999999999999999999865 4
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeecc
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 226 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 226 (401)
+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccc
Confidence 668999999999999999976532 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhhhhc
Q 015731 227 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 305 (401)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (401)
+++.... ......++..|+|||++.+..++.++|||||||++|||+| |++||....... .+.+
T Consensus 149 ~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~-------- 212 (262)
T d1byga_ 149 LTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-------- 212 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH--------
T ss_pred cceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH--------
Confidence 9985432 2233468899999999998999999999999999999998 688876543321 1111
Q ss_pred chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 306 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
+........+...+..+.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus 213 ------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 ------VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ------HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111122334445567889999999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=377.56 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=201.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
++|++.+.||+|+||.||+|.+.. ..+....||||++..... ....++.+|+.+|++++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 679999999999999999997653 223456799999876532 23456889999999999999999999997
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEee
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 224 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~D 224 (401)
+ ...++||||+.+|+|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECC
T ss_pred e-cchheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeecc
Confidence 6 46789999999999999887665 45999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcce-eeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccchhHHhhhhhh
Q 015731 225 FGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 302 (401)
Q Consensus 225 fg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 302 (401)
||+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||.+.......
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---------- 224 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------- 224 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----------
Confidence 999987644432222 233567889999999999999999999999999999998 89999765432111
Q ss_pred hhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhc
Q 015731 303 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 356 (401)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i 356 (401)
..+.........+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 225 ------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 ------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111112223344567889999999999999999999999998875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=386.60 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=206.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc---hhHHHHHHHHHHHh-ccCCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLG-QLYHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~-~l~hpni~~~~~~~ 143 (401)
++|++.+.||+|+||+||+| .+..+|+.||||++.+... .....+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~---------~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEE---------EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 57999999999999999999 4455799999999976432 22344566777665 68999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEe
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 223 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~ 223 (401)
.+++..||||||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~ 145 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIA 145 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceecc
Confidence 999999999999999999999987653 899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 303 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 303 (401)
|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..+......+
T Consensus 146 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------- 215 (320)
T d1xjda_ 146 DFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------- 215 (320)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------
T ss_pred ccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 999998644322 2344568999999999999999999999999999999999999999765432111111
Q ss_pred hcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015731 304 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 352 (401)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~-eil~~ 352 (401)
... ...++...+.++.+||.+||+.||.+|||+. ++++|
T Consensus 216 --------~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 216 --------RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp --------HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------HcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 000 1123334567889999999999999999996 78775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=387.28 Aligned_cols=256 Identities=23% Similarity=0.264 Sum_probs=202.1
Q ss_pred CCCCCC-CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 015731 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~hpni~~~~~~~~~ 145 (401)
++|.+. ++||+|+||+||+|+ +..+|+.||||++... ..+.+|+.++.++ +||||++++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIF---------NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEE---------ECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 578876 469999999999994 4457899999998643 3456899887654 89999999999875
Q ss_pred ----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC---CC
Q 015731 146 ----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 218 (401)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~---~~ 218 (401)
+..+|+|||||+||+|.+++.+.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++. ++
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccc
Confidence 4678999999999999999986543 45999999999999999999999998 999999999999975 56
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.
T Consensus 152 ~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-- 226 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 226 (335)
T ss_dssp CEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred cccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--
Confidence 79999999998654432 2345689999999999999999999999999999999999999997654322211110
Q ss_pred hhhhhhcchhhhhhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhch
Q 015731 299 KPYLQSKRRIFQVMDARI--EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 357 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~ 357 (401)
..+..... ........+.++.+||.+||+.||++|||+.|+++|=+..+
T Consensus 227 ----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 227 ----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 00000000 00111245678999999999999999999999999855443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=379.88 Aligned_cols=272 Identities=27% Similarity=0.362 Sum_probs=221.9
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
..++|++.++||+|+||.||+|.+... .+..++..||||++..... ....++.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 346899999999999999999976432 3445789999999976543 3345688999999999 699999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCC
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTGAS-------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 210 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 210 (401)
.+.+..++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+++ ++||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 9999999999999999999999765421 2245899999999999999999999998 999999999
Q ss_pred cEEEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 015731 211 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPS 289 (401)
Q Consensus 211 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 289 (401)
||+++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997665554445556789999999999999999999999999999999999 55556554332
Q ss_pred ccchhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 290 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
.. +..++........+...+..+.+||.+||+.||++|||+.+|++.|+++...
T Consensus 255 ~~----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 1122222233334445667899999999999999999999999999876443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=378.57 Aligned_cols=272 Identities=25% Similarity=0.359 Sum_probs=214.5
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~~ 144 (401)
.++|++++.||+|+||.||+|...... .....++..||||++..... ....++.+|+..+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 468999999999999999999765421 01234567899999977554 3345688899999888 7999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEE
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTGAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 213 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 213 (401)
+++..++||||+.+|+|.+++...... ....+++..++.++.||+.||+|||+++ ||||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccccee
Confidence 999999999999999999999765421 2245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCccc
Q 015731 214 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 292 (401)
Q Consensus 214 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 292 (401)
++.++.+||+|||++................|++.|+|||.+.++.|+.++|||||||++|||++ |.+||........
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~- 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence 99999999999999986554443334455678999999999999999999999999999999998 6888875442111
Q ss_pred hhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 293 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
...+........+...+..+.+|+.+||+.||.+|||+.||++.|+++...
T Consensus 247 ----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 ----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111112222233445567899999999999999999999999999988553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=382.14 Aligned_cols=264 Identities=25% Similarity=0.237 Sum_probs=196.4
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh-----HHHHHHHHHHHhccCCCcccceeeEEeeCC
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~e~~~l~~l~hpni~~~~~~~~~~~ 147 (401)
+++||+|+||+||+| .+..+|+.||||++....... ...+.+|+.++++++||||+++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEE---------EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 468999999999999 445579999999987654322 235789999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccC
Q 015731 148 HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 227 (401)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 227 (401)
..|+||||+.++++..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceeehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCcc
Confidence 999999999887766655433 34888999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh-----
Q 015731 228 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY----- 301 (401)
Q Consensus 228 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 301 (401)
++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+....+.-....
T Consensus 147 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 147 AKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp GSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 986543322 2334679999999999864 46799999999999999999999999776543222111100000
Q ss_pred hhhcchhhhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 302 LQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
................... ....+..+.+|+.+||+.||++|||+.|+|+|=+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 0000000000000000000 1123567899999999999999999999999843
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=376.01 Aligned_cols=269 Identities=24% Similarity=0.328 Sum_probs=200.8
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++++.||+|+||+||+|. +..+|+.||+|++...... ....+.+|++++++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEE---------ECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 579999999999999999994 4457899999999765432 24568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++.+|+||||+. +.+.+++..... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+||
T Consensus 73 ~~~~~iv~e~~~-~~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DF 146 (298)
T d1gz8a_ 73 ENKLYLVFEFLH-QDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADF 146 (298)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECST
T ss_pred ccceeEEEeecC-Cchhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccC
Confidence 999999999995 455555544332 45999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhh-
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ- 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 303 (401)
|+++...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 147 G~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 147 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp THHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9997643322 2234457999999999876655 57899999999999999999999976543221111100000000
Q ss_pred h-cchhhhhhhhh--hcC--C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 304 S-KRRIFQVMDAR--IEG--Q-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 304 ~-~~~~~~~~~~~--~~~--~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
. ........... ... . .....+.++.+|+.+||+.||++|||+.|+++|=
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 0 00000000000 000 0 0113456788999999999999999999999983
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=375.88 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=207.0
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCc--EEEEEEcccccc-hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM--VIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~--~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~hpni~~~~~~~ 143 (401)
++|++.++||+|+||.||+|.+.. +|. .||||.+..... .....+.+|+++|.++ +||||+++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578899999999999999996543 344 467787754332 2345688999999998 799999999999
Q ss_pred eeCCeeEEEEEecCCCChHHHHhhcC-----------CCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 144 LEDDHRLLVYEFMPKGSLENHLFRTG-----------ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
.+++..++||||+++|+|.+++.... ......+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence 99999999999999999999997542 122356999999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCcc
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSRE 291 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~ 291 (401)
|++.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||........
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999997543222 123456899999999999999999999999999999999975 56654432111
Q ss_pred chhHHhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 292 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
. ..+........+...+..+.+||.+||+.||++|||+.||+++|+++.+..
T Consensus 236 ---~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 ---Y--------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---H--------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---H--------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 111111122334456778999999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=369.24 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=204.3
Q ss_pred CCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc-cchhHHHHHHHHHHHhccCCCcccceeeEEee-CCeeE
Q 015731 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-DDHRL 150 (401)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~-~~~~~ 150 (401)
.++||+|+||+||+|.+.. ..++...||||++... ......++.+|+++|++++||||+++++++.+ +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEEC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 5789999999999997653 1224557999998754 33345679999999999999999999999875 56899
Q ss_pred EEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeeccCCcC
Q 015731 151 LVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 230 (401)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 230 (401)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 106 lv~E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEEEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhh
Confidence 9999999999999987655 34788899999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCCc--ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhhhhhcchh
Q 015731 231 GPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 308 (401)
Q Consensus 231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (401)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|..||....... ....+.
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---------- 247 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---------- 247 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----------
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----------
Confidence 5433221 12234578999999999999999999999999999999999887775432111 111110
Q ss_pred hhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhc
Q 015731 309 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 359 (401)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~ 359 (401)
........+..++.++.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 248 ----~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 248 ----LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----HcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 00011122334556889999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=372.46 Aligned_cols=244 Identities=23% Similarity=0.373 Sum_probs=199.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch------hHHHHHHHHHHHhccC--CCcccc
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNLVK 138 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~--hpni~~ 138 (401)
.++|++.++||+|+||+||+|. +..+|+.||||++...... ...++.+|+.++++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 3679999999999999999994 4457899999998764322 1223568999999986 899999
Q ss_pred eeeEEeeCCeeEEEEEecCC-CChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-
Q 015731 139 LIGYCLEDDHRLLVYEFMPK-GSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL- 216 (401)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~- 216 (401)
+++++.+.+..++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~ 146 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN 146 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecC
Confidence 99999999999999999976 57888887664 3999999999999999999999998 999999999999985
Q ss_pred CCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 217 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +
T Consensus 147 ~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i 216 (273)
T d1xwsa_ 147 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I 216 (273)
T ss_dssp TTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred CCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H
Confidence 479999999999864332 2345679999999999977665 5779999999999999999999964210 0
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
... ...++...+.++.+||.+||+.||++|||++|+++|=+
T Consensus 217 ------~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 217 ------IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp ------HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ------hhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 000 01122234568899999999999999999999999843
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=370.92 Aligned_cols=277 Identities=25% Similarity=0.299 Sum_probs=203.7
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.++|.+.+.||+|+||.||+|.. +|..||||++...... ......|+..+..++||||+++++++.+.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 36788899999999999999964 3678999998765422 11223456666778999999999999865
Q ss_pred C----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhC------CCCeEEeccCCCcEEEcC
Q 015731 147 D----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDL 216 (401)
Q Consensus 147 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~dlkp~Nil~~~ 216 (401)
+ .+|+||||+++|+|.+++++.. +++..++.++.|++.||.|||+. ..+|+||||||+||||+.
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~ 143 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred CCcceEEEEEEecccCCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC
Confidence 4 6799999999999999998653 89999999999999999999973 123999999999999999
Q ss_pred CCceEEeeccCCcCCCCCCCc--ceeeecccccCcccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 015731 217 NYNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGH------LTAKSDVYSFGVVLLEMLSGRRVIDKNRP 288 (401)
Q Consensus 217 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~ 288 (401)
++.+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 999999999999865333221 1234567999999999986542 56789999999999999999988865432
Q ss_pred CccchhHH-hhhhhhhhcchhhhhhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCC
Q 015731 289 SREHNLIE-WAKPYLQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 362 (401)
Q Consensus 289 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~ 362 (401)
........ ...... ................ .......+.+|+.+||+.||++|||+.||+++|+++.+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSV--EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCCTTTTTSCSSCCH--HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred cccchhhcccccchH--HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 22111000 000000 0000011111111111 234556788999999999999999999999999999887665
Q ss_pred C
Q 015731 363 G 363 (401)
Q Consensus 363 ~ 363 (401)
+
T Consensus 302 ~ 302 (303)
T d1vjya_ 302 K 302 (303)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=371.18 Aligned_cols=270 Identities=23% Similarity=0.371 Sum_probs=215.0
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
..++|++.+.||+|+||.||+|.+... .+..++..||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 346889999999999999999976421 1223467899999976533 33446889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHHHhhcC-----CCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 EDDHRLLVYEFMPKGSLENHLFRTG-----ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.++..++||||+.+|+|.+++.... ......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCce
Confidence 9999999999999999999986432 112245789999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~ 298 (401)
+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||.+.......
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------ 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence 9999999998654433333334457899999999999999999999999999999999985 677554321111
Q ss_pred hhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchh
Q 015731 299 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 358 (401)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~ 358 (401)
..+.+. .....+..++..+.+|+.+||+.||.+|||+.+|+++|++..+
T Consensus 246 ----------~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ----------RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----------HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------HHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 1122334456789999999999999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=371.71 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=199.6
Q ss_pred HhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchh--HHHHHHHHHHHhcc---CCCccccee
Q 015731 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQL---YHPNLVKLI 140 (401)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l---~hpni~~~~ 140 (401)
..++|++++.||+|+||+||+|+... .+++.||||++....... ...+.+|+.+++.| +||||++++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~ 76 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 76 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceee
Confidence 34789999999999999999995432 236789999987643321 22345677766655 799999999
Q ss_pred eEEee-----CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc
Q 015731 141 GYCLE-----DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 215 (401)
Q Consensus 141 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~ 215 (401)
+++.. ....+++|||+.++.+........ ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~ 150 (305)
T d1blxa_ 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT 150 (305)
T ss_dssp EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred eeecccccccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc
Confidence 99853 357899999997766654443332 45899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 216 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 216 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
.++.+||+|||++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..+......+
T Consensus 151 ~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 151 SSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp TTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999998754322 2345578999999999999999999999999999999999999999876543322211
Q ss_pred Hhhhhhh-----hhc----chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 296 EWAKPYL-----QSK----RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 296 ~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
....... ... ..............+....+..+.+||.+||+.||++|||+.|+|+|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100000 000 00000000000111223345678899999999999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-50 Score=364.88 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=199.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccch--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||+||+|... +|+.||||++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999999543 5789999999765432 24578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
++..+++||++.++.+..+.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCT
T ss_pred CCceeEEEEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEeccc
Confidence 99999999999766665555443 34999999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhhh---
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--- 301 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--- 301 (401)
|.+....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....+......
T Consensus 145 G~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (286)
T d1ob3a_ 145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222 (286)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh
Confidence 9987643222 123345689999999998654 5689999999999999999999999765432221111100000
Q ss_pred --hhhcchhhhh------hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 302 --LQSKRRIFQV------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 302 --~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.......... .............+..+.+|+.+||+.||++|||++|+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 00000011122345688899999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=369.43 Aligned_cols=270 Identities=23% Similarity=0.306 Sum_probs=199.2
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++++.||+|+||+||+|. +..+|+.||||++..... .....+.+|+.+|+.++||||++++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEE---------ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999994 445799999999976433 23456889999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC
Q 015731 145 EDD------HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 218 (401)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~ 218 (401)
..+ .+|+||||+ +.+|..++.... +++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~ 158 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHEK------LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDC 158 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccc
Confidence 654 579999999 778888776543 999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHh
Q 015731 219 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 297 (401)
Q Consensus 219 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 297 (401)
.+||+|||+++..... .+...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 159 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 159 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 9999999999865332 344679999999999866 4568999999999999999999999977643222111110
Q ss_pred hhhh-----hhhc-----chhhhhh---hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchhc
Q 015731 298 AKPY-----LQSK-----RRIFQVM---DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDT 359 (401)
Q Consensus 298 ~~~~-----~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~~ 359 (401)
.... .... ....... ............+..+.+||.+||..||.+|||+.|+|+| ++.+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000 0000 0000000 0000001122345678899999999999999999999998 5555433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=369.01 Aligned_cols=268 Identities=24% Similarity=0.273 Sum_probs=197.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc-hhHHHHHHHHHHHhccCCCcccceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~hpni~~~~~~~~~~ 146 (401)
.+|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+|+.++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEE---------ETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEE---------ECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 579999999999999999994 445799999999976543 2345688999999999999999999998765
Q ss_pred C----eeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 147 D----HRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 147 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
. ..+++++++.+|+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~~------l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred cccccceEEEEEeecCCchhhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEE
Confidence 3 2344455566999999997643 899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCC-cceeeecccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 223 SDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+|||++........ .......+||+.|+|||++. +..++.++||||+||++|+|++|..||......+..........
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 99999976433221 11234467999999999984 45678999999999999999999999976543222211110000
Q ss_pred hhhh----cc---hhhh-hhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015731 301 YLQS----KR---RIFQ-VMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 352 (401)
Q Consensus 301 ~~~~----~~---~~~~-~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~ 352 (401)
.... .. .... .......... ....+.++.+|+.+||+.||.+|||+.|+|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00 0000 0000000001 11234578899999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=368.26 Aligned_cols=270 Identities=24% Similarity=0.309 Sum_probs=197.0
Q ss_pred CCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcccceeeEEee---
Q 015731 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--- 145 (401)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni~~~~~~~~~--- 145 (401)
+|+..++||+|+||+||+|+. ..+|+.||||++...... ..+|+.+|++++||||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKL---------CDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEE---------CCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 588889999999999999954 457999999998765422 2379999999999999999999854
Q ss_pred ---CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceE
Q 015731 146 ---DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAK 221 (401)
Q Consensus 146 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~k 221 (401)
..+++|||||++++ +.+.+..... ....+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+|
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCcee
Confidence 33578999999654 4444432110 1145999999999999999999999998 99999999999998775 899
Q ss_pred EeeccCCcCCCCCCCcceeeecccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhh-
Q 015731 222 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK- 299 (401)
Q Consensus 222 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~- 299 (401)
|+|||++....... ......|++.|+|||.+.+ ..|+.++|||||||++|||++|..||......+....+....
T Consensus 164 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp ECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred EecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998654332 2344679999999998765 578999999999999999999999997655332221111000
Q ss_pred -h---hhhh-c-----chhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhchh
Q 015731 300 -P---YLQS-K-----RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 358 (401)
Q Consensus 300 -~---~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~--L~~i~~ 358 (401)
+ .... . ...................+.++.+||.+||+.||++|||+.|+|+| ++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0 0000 0 00000000000111122356678999999999999999999999998 444443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-48 Score=351.48 Aligned_cols=271 Identities=17% Similarity=0.181 Sum_probs=212.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCC-CcccceeeEEee
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h-pni~~~~~~~~~ 145 (401)
.++|++.+.||+|+||+||+|+ +..+|+.||||++..... ...+.+|+++++.|.| +|++.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~---------~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEE---------ETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3689999999999999999995 444789999998865432 2345678888888865 899999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcC-----CCce
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNA 220 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~-----~~~~ 220 (401)
+...++||||+ +++|.+++.... ..++...+..++.|++.||+|||++| |+||||||+||+++. ++.+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~v 145 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMI 145 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCce
Confidence 99999999999 889999987665 35899999999999999999999998 999999999999964 5789
Q ss_pred EEeeccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhH
Q 015731 221 KLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 295 (401)
Q Consensus 221 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 295 (401)
+|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..........
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence 99999999865432211 1234567999999999999999999999999999999999999999876554333222
Q ss_pred HhhhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcCCCCCC
Q 015731 296 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 365 (401)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~~~~~~ 365 (401)
........ ......+ ....+.++.+++..|+..+|++||+++.+.+.|+++.+......+
T Consensus 226 ~~i~~~~~------~~~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 226 ERIGEKKQ------STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHHHHHH------HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred HHHHhccC------CCChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence 11110000 0000001 112345788999999999999999999999999887665554443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=359.91 Aligned_cols=272 Identities=23% Similarity=0.279 Sum_probs=197.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++.+.||+|+||+||+|+. ..+|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARH---------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 6899999999999999999954 44789999999866533 234567899999999999999999998755
Q ss_pred --------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCC
Q 015731 146 --------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 217 (401)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~ 217 (401)
.+..|+||||+.++.+....... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD 153 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT
T ss_pred ccccccccCceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC
Confidence 35689999999766555443332 34899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCcCCCCCCC--cceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh
Q 015731 218 YNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 294 (401)
Q Consensus 218 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 294 (401)
+.+||+|||++........ .......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence 9999999999975443221 1123345799999999998654 689999999999999999999999976543222221
Q ss_pred HHhhhhhhhhc-------chhhhhhhhhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 015731 295 IEWAKPYLQSK-------RRIFQVMDARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 355 (401)
Q Consensus 295 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~ 355 (401)
+.......... ................ ...+..+.+||.+||+.||++|||++|+++|=+.
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 11110000000 0000000000000000 1124567789999999999999999999999653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=360.75 Aligned_cols=259 Identities=27% Similarity=0.334 Sum_probs=209.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc----hhHHHHHHHHHHHhccCC-CcccceeeE
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYH-PNLVKLIGY 142 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~h-pni~~~~~~ 142 (401)
++|++++.||+|+||+||+|... .+..+|+.||||++..... .....+.+|+.++++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 56999999999999999999653 3455799999999876532 223456789999999966 899999999
Q ss_pred EeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEE
Q 015731 143 CLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 222 (401)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl 222 (401)
+.+....+++|||+.+|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEE
T ss_pred eccCCceeeeeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEE
Confidence 9999999999999999999999988754 788999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcceeeecccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhhhh
Q 015731 223 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 300 (401)
Q Consensus 223 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 300 (401)
+|||++......... ......|++.|++||.+.+. .++.++|||||||++|+|++|..||...........+.-.
T Consensus 171 ~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-- 247 (322)
T d1vzoa_ 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-- 247 (322)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--
T ss_pred eeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--
Confidence 999999765433222 23456799999999998654 4678999999999999999999999876554432222100
Q ss_pred hhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015731 301 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 354 (401)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----s~~eil~~L~ 354 (401)
.. ......+...+.++.+|+.+||+.||.+|| |++|+++|-+
T Consensus 248 ----------~~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 248 ----------IL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp ----------HH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------cc--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 00 011223345677899999999999999999 5899998743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=352.02 Aligned_cols=264 Identities=20% Similarity=0.198 Sum_probs=201.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-cceeeEEeeC
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLED 146 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-~~~~~~~~~~ 146 (401)
++|++.+.||+|+||.||+|+. ..+|+.||||++..... ..++..|+++++.++|+|+ +.+..++.++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEE---------CCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 5799999999999999999954 44689999998776532 2346789999999977664 5556667788
Q ss_pred CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEc---CCCceEEe
Q 015731 147 DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLS 223 (401)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~---~~~~~kl~ 223 (401)
+..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++| |+||||||+|||++ .+..++|+
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CEEEEEEEEc-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeee
Confidence 8999999999 678877776544 45999999999999999999999998 99999999999985 35579999
Q ss_pred eccCCcCCCCCCCc-----ceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH-h
Q 015731 224 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-W 297 (401)
Q Consensus 224 Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~ 297 (401)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+. +
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999865433221 12345679999999999999999999999999999999999999998765433322221 1
Q ss_pred hhhhhhhcchhhhhhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhchhcC
Q 015731 298 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 360 (401)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~~i~~~~ 360 (401)
....... ... .....++.++.+|+.+||+.||.+||++.++.+.|+.+....
T Consensus 229 ~~~~~~~-------~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 229 SEKKMST-------PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHS-------CHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hcccCCC-------Chh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1100000 000 011124467889999999999999999999988888764433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-48 Score=359.37 Aligned_cols=262 Identities=20% Similarity=0.240 Sum_probs=199.1
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEee-
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~- 145 (401)
++|++++.||+|+||+||+|+ +..+|+.||+|++.... ..++.+|+.+|+.+. ||||+++++++..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999994 44579999999987643 346779999999995 9999999999874
Q ss_pred -CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCC-ceEEe
Q 015731 146 -DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLS 223 (401)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~-~~kl~ 223 (401)
....++||||+.+++|..+. +.+++..+..++.||+.||+|||++| |+||||||+|||++.++ .++|+
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeec
Confidence 45789999999999987653 34899999999999999999999998 99999999999998654 69999
Q ss_pred eccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchh-H-Hhh--
Q 015731 224 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-I-EWA-- 298 (401)
Q Consensus 224 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~-~~~-- 298 (401)
|||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||........... + ...
T Consensus 173 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 999998654332 23456789999999998664 579999999999999999999999976543221100 0 000
Q ss_pred ---hhhhhh-----cchhhhhh--------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 299 ---KPYLQS-----KRRIFQVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 299 ---~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
...... ........ ............+.++.+||.+||+.||++|||++|+|+|=+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000000 00000000 000111112234677899999999999999999999999743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=349.89 Aligned_cols=268 Identities=23% Similarity=0.249 Sum_probs=204.6
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEE---------ECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999994 445789999999865433 334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCceEEeec
Q 015731 146 DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 225 (401)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~~kl~Df 225 (401)
....++||+++.+++|..++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DF 145 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANF 145 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred ccceeEEeeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeec
Confidence 999999999999988888776554 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcceeeecccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCcc-chhHHhhhhhhh
Q 015731 226 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQ 303 (401)
Q Consensus 226 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~ 303 (401)
|.+........ ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+........
T Consensus 146 G~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 146 GLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp TTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred chhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence 99986543322 233346788899999986654 68999999999999999999998744332111 111110000000
Q ss_pred --hcchhhhhhh---------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 304 --SKRRIFQVMD---------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 304 --~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
.......... ...........+..+.+|+.+||+.||.+|||++|+|+|=
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 0000000000 0001112234456788999999999999999999999983
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=358.70 Aligned_cols=265 Identities=21% Similarity=0.259 Sum_probs=193.2
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~~ 145 (401)
++|+++++||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~---------d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEE---------ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEE---------ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 679999999999999999994 445799999999976533 234467899999999999999999999863
Q ss_pred ------CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 146 ------DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 146 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
..++|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred ccccccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccc
Confidence 4688999999955 5555553 23899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHH---
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE--- 296 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~--- 296 (401)
++++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.
T Consensus 158 ~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~ 234 (355)
T d2b1pa1 158 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_dssp EEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999987644322 3445679999999999999999999999999999999999999997654322211110
Q ss_pred -------hh------hhhhhhc-----chhhhhhhhhh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015731 297 -------WA------KPYLQSK-----RRIFQVMDARI---EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 354 (401)
Q Consensus 297 -------~~------~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L~ 354 (401)
|. ....... ........... ........+.++.+||.+||..||++|||++|+|+|=+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00 0000000 00000000000 00112345778999999999999999999999999943
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=360.35 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=197.4
Q ss_pred hCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 015731 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (401)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~hpni~~~~~~~~ 144 (401)
.++|++++.||+|+||+||+|+ +..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEE---------ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999994 445799999999976533 33456789999999999999999999986
Q ss_pred eC-----CeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcEEEcCCCc
Q 015731 145 ED-----DHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 219 (401)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil~~~~~~ 219 (401)
.. ...++||+++.+|+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~ 159 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 159 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred eccccccCceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccccc
Confidence 33 3446667777899999998653 3999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCcCCCCCCCcceeeecccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCccchhHHhh
Q 015731 220 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 298 (401)
Q Consensus 220 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 298 (401)
++++|||++..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 160 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp EEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999875432 23446789999999987665 4688999999999999999999999876433222221110
Q ss_pred hhhhh-----h--cchhhhhhhhhhc-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015731 299 KPYLQ-----S--KRRIFQVMDARIE-GQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 353 (401)
Q Consensus 299 ~~~~~-----~--~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~eil~~L 353 (401)
..... . ............. ... ....+..+.+||.+||+.||.+|||+.|+|+|=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 00000 0 0000000000000 000 112456788999999999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-42 Score=321.76 Aligned_cols=283 Identities=17% Similarity=0.190 Sum_probs=198.9
Q ss_pred CCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-----------CCcc
Q 015731 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPNL 136 (401)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpni 136 (401)
.+|+++++||+|+||+||+|+ +..+|+.||||++...... ...+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~---------~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 469999999999999999994 4457999999999876432 345667888887775 5789
Q ss_pred cceeeEEee--CCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCCCeEEeccCCCcEE
Q 015731 137 VKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNIL 213 (401)
Q Consensus 137 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nil 213 (401)
+++++++.. ....+++|+++..+........... ...+++..+..++.||+.||.|||+ .| |+||||||+|||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIl 158 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVL 158 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEE
T ss_pred EEEEEEeeeccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHee
Confidence 999988764 3566777777655544333332221 2458999999999999999999997 77 999999999999
Q ss_pred EcCCC------ceEEeeccCCcCCCCCCCcceeeecccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 015731 214 LDLNY------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 287 (401)
Q Consensus 214 ~~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 287 (401)
++.++ .++++|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 97654 399999999875432 2234579999999999999999999999999999999999999997543
Q ss_pred CCccchhH----Hhhhhh-------hhhcchhhhhhh-------------------hhhcCCCCHHHHHHHHHHHHHccc
Q 015731 288 PSREHNLI----EWAKPY-------LQSKRRIFQVMD-------------------ARIEGQYSLGAALKTAVLAIKCLS 337 (401)
Q Consensus 288 ~~~~~~~~----~~~~~~-------~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~li~~~L~ 337 (401)
........ ...... ...........+ ...........+..+.+||.+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 32211110 000000 000000000000 001123456778899999999999
Q ss_pred cCCCCCCCHHHHHHH--HHhchhcCCCCCCcccc
Q 015731 338 NEPKFRPTMDEVVKA--LEQIQDTNDAGVSRDES 369 (401)
Q Consensus 338 ~dp~~Rps~~eil~~--L~~i~~~~~~~~~~~~~ 369 (401)
.||.+|||++|+|+| +......+....|..+-
T Consensus 314 ~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCT
T ss_pred CChhHCcCHHHHhcCcccCCCCCcccCCCCCccc
Confidence 999999999999998 54444454555554443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=8.5e-25 Score=185.81 Aligned_cols=162 Identities=14% Similarity=0.076 Sum_probs=116.4
Q ss_pred CCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccc------------------hhHHHHHHHHHHHhccC
Q 015731 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------QGHLEWLTEIKHLGQLY 132 (401)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~------------------~~~~~~~~e~~~l~~l~ 132 (401)
.+.+.||+|+||+||+|... +|+.||||++..... ........|+..+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 45689999999999999543 478999998653211 01123456888999999
Q ss_pred CCcccceeeEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCCCCeEEeccCCCcE
Q 015731 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 212 (401)
Q Consensus 133 hpni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 212 (401)
|++++..+++.. .+++|||+.+..+.+ ++......++.|++.+|.|||++| |+||||||+||
T Consensus 73 ~~~v~~~~~~~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NI 134 (191)
T d1zara2 73 GLAVPKVYAWEG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNV 134 (191)
T ss_dssp TSSSCCEEEEET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSE
T ss_pred CCCcceEEEecC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhhe
Confidence 999998876532 379999997755432 333445678999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCcCCCCCCCcceeeecccccCcccc------cccccCCCCcccchhhHHHH
Q 015731 213 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP------EYMATGHLTAKSDVYSFGVV 272 (401)
Q Consensus 213 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~i 272 (401)
|++++ .++|+|||.+......... .|... +.+ ...|+.++|+||+.--
T Consensus 135 Lv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 135 LVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp EEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred eeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99865 5899999998764322211 11111 111 3567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=2.5e-08 Score=86.93 Aligned_cols=147 Identities=15% Similarity=0.003 Sum_probs=97.3
Q ss_pred HHHHHhCCCCCCCcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCccccee
Q 015731 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLI 140 (401)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~ 140 (401)
++......|++.+..+.++.+.||+... .+..+++|+...........+.+|...+..|. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3445556777777766566678998632 34567888876654433334567887777663 33367788
Q ss_pred eEEeeCCeeEEEEEecCCCChHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---------------------
Q 015731 141 GYCLEDDHRLLVYEFMPKGSLENHLFRTGASYIQPLSWTIRMKVALGAAKGLAYLHSDK--------------------- 199 (401)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------- 199 (401)
.+..+++..++||++++|.++.+...... . ...++.++...+..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDEQ-------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTCS-------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEecccccccccccccc-------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 88888899999999999888765542211 1 1223333444444444210
Q ss_pred ------------------------------------CCeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 200 ------------------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 200 ------------------------------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999977667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=8.9e-06 Score=69.78 Aligned_cols=74 Identities=20% Similarity=0.110 Sum_probs=48.9
Q ss_pred ccCCCC-eeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC--CCcccceeeEEeeCCeeEEE
Q 015731 76 LGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 76 lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~--hpni~~~~~~~~~~~~~~lv 152 (401)
+..|.. +.||+.... .+..+++|........ .+..|...++.|. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 344443 678886433 3666888976554322 3446666666653 33367788888888899999
Q ss_pred EEecCCCChH
Q 015731 153 YEFMPKGSLE 162 (401)
Q Consensus 153 ~e~~~~~~L~ 162 (401)
|++++|.++.
T Consensus 85 ~~~i~G~~~~ 94 (255)
T d1nd4a_ 85 LGEVPGQDLL 94 (255)
T ss_dssp EECCSSEETT
T ss_pred EEeeeccccc
Confidence 9999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.87 E-value=4.2e-05 Score=70.03 Aligned_cols=77 Identities=14% Similarity=0.094 Sum_probs=45.9
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccc------cc-hhHHHHHHHHHHHhccC-C--CcccceeeEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE------SL-QGHLEWLTEIKHLGQLY-H--PNLVKLIGYC 143 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~------~~-~~~~~~~~e~~~l~~l~-h--pni~~~~~~~ 143 (401)
+.||.|....||+.... .+++.+++|.-... .. ....+...|...|+.+. + ..+.+++.+
T Consensus 32 ~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence 46899999999998432 34677889864321 00 11223446777776652 2 345556543
Q ss_pred eeCCeeEEEEEecCCCCh
Q 015731 144 LEDDHRLLVYEFMPKGSL 161 (401)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L 161 (401)
+....++|||++.+..+
T Consensus 102 -d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 -DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp -ETTTTEEEECCCTTSEE
T ss_pred -cCCCCEEEEeccCCccc
Confidence 55667899999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.80 E-value=0.0022 Score=58.18 Aligned_cols=80 Identities=15% Similarity=0.042 Sum_probs=50.7
Q ss_pred CcccCCCCeeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccC-CCcccceeeEEeeCCeeEEE
Q 015731 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (401)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-hpni~~~~~~~~~~~~~~lv 152 (401)
+.|+.|-.=.+|++...+..+ ........+.+++...... .....+|..+++.+. +.-..++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 467778888999987765432 1122356688887764322 223457888888774 3334577776653 589
Q ss_pred EEecCCCCh
Q 015731 153 YEFMPKGSL 161 (401)
Q Consensus 153 ~e~~~~~~L 161 (401)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999977544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0035 Score=55.23 Aligned_cols=67 Identities=15% Similarity=0.035 Sum_probs=40.8
Q ss_pred eeEEEEEecCCCccCCCCCCCcEEEEEEcccccchhHHHHHHHHHHHhccCCCcc-----cce--eeEEeeCCeeEEEEE
Q 015731 82 GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-----VKL--IGYCLEDDHRLLVYE 154 (401)
Q Consensus 82 g~V~~~~~~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~hpni-----~~~--~~~~~~~~~~~lv~e 154 (401)
-.||++... +|..+++|+...... ...++..|...+..|...+| +.. -..+..+...+.+++
T Consensus 36 N~vy~v~~~----------dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEcC----------CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 478887433 478899999765432 33456677777766642211 111 123345677889999
Q ss_pred ecCCC
Q 015731 155 FMPKG 159 (401)
Q Consensus 155 ~~~~~ 159 (401)
++.|.
T Consensus 105 ~~~G~ 109 (325)
T d1zyla1 105 SVGGR 109 (325)
T ss_dssp CCCCE
T ss_pred ecCCc
Confidence 98764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.27 E-value=0.02 Score=49.66 Aligned_cols=29 Identities=28% Similarity=0.207 Sum_probs=26.0
Q ss_pred CeEEeccCCCcEEEcCCCceEEeeccCCc
Q 015731 201 KVIYRDFKTSNILLDLNYNAKLSDFGLAK 229 (401)
Q Consensus 201 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 229 (401)
++||+|+.++||+++++...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899998765
|